{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "- Colgate‑Palmolive reports **37,028 thousand** (≈ 37 million) securities still available for future issuance under its equity‑compensation plans that were approved by security holders.  \n\n- Procter & Gamble states that, under its 2019 Stock and Incentive Compensation Plan, **119 million** shares (including stock options, RSUs and PSUs) remain available for future issuance.  \n\nThus, PG’s pool of future‑issuable securities (≈ 119 million) is roughly three times larger than CL’s (≈ 37 million).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's available securities as 119 million, whereas the ground truth is 133,185,995—this is a significant numerical discrepancy. The LLM may have used outdated or incorrect data for PG. 2) Quantitative accuracy is compromised due to the incorrect figure for PG (119M vs 133.2M), though the CL number is accurate (37,028 thousand = 37,028,000). The comparison stating PG’s pool is 'roughly three times larger' is approximately correct in direction but slightly underestimates the actual ratio (133.2M / 37M ≈ 3.6x, not 3.2x). 3) The reasoning and multi-hop synthesis are sound: the model correctly compares equity compensation plan availability across two companies, identifying the relevant securities and plans. It correctly interprets the categories (stock options, RSUs, PSUs) for PG and links them to future issuance. 4) Contextual relevance is perfect—the answer directly addresses the comparative question and provides meaningful interpretation. The error is limited to one incorrect number, not reasoning or entity confusion. Thus, the answer is mostly correct but has a material quantitative error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 356,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s filing shows that a 10 % weakening of the U.S. dollar would have reduced the amount recorded in AOCI for its foreign‑exchange cash‑flow hedges by roughly **$1.5 billion (2023) to $1.6 billion (2024)**.  The filing does not disclose the total notional amount of the forward contracts, so the exposure is expressed only as the resulting AOCI swing.\n\nDisney, by contrast, reports **net foreign‑exchange cash‑flow hedge notional amounts of $9.9 billion (as of 9/28/2024) and $8.3 billion (as of 9/30/2023)**.  These contracts are used to hedge forecasted foreign‑currency transactions for periods “generally not to exceed four years,” providing multi‑year risk mitigation.\n\nThus, Disney’s hedge program covers a larger notional exposure (≈ $10 bn) and is explicitly designed to protect forecasted cash flows over a horizon of up to four years, whereas Google’s disclosed sensitivity is a $1.5‑$1.6 bn impact on equity with no specific notional amount disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding Google's sensitivity to a 10% weakening of the U.S. dollar. The ground truth states that Google's impact on AOCI would be $660 million as of December 31, 2024, under a net investment hedge strategy. However, the LLM claims a $1.5–1.6 billion impact on AOCI for cash-flow hedges in 2023–2024, which contradicts the original answer in both magnitude and hedge type. This is a major quantitative and conceptual error. Additionally, the LLM incorrectly characterizes Google’s hedges as cash-flow hedges affecting AOCI, while the ground truth specifies they are net investment hedges—different hedge accounting treatments with distinct financial statement impacts. (2) For Disney, the LLM correctly reports the $9.9 billion notional exposure as of September 28, 2024, and the four-year risk mitigation horizon, aligning with the ground truth. The prior year figure of $8.3 billion is not in the original answer but may be contextually accurate; however, it's extraneous and not required. (3) The multi-hop reasoning is partially sound—comparing notional exposure and risk mitigation horizon—but fails on the critical point of correctly identifying Google’s hedge type and exposure amount. The synthesis is flawed because it compares Disney’s cash-flow hedges to Google’s (incorrectly labeled) cash-flow hedges, when in fact Google’s are net investment hedges, which serve a different purpose (translation risk vs. transaction risk). (4) Due to the major error in Google’s sensitivity figure and hedge classification, the correctness and quantitative accuracy scores are low. Qualitative accuracy is moderate because the structure and intent of comparison are reasonable, and Disney’s data is accurate. Contextual relevance is high as the response addresses the core comparison elements, albeit with incorrect data for Google.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 512,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports that the equity‑compensation plans approved by its security holders have **about 119 million shares** still available for future grants (the amount disclosed in the footnote to its Item 12 table). Colgate‑Palmolive reports **37,028 thousand shares** – roughly **37 million shares** – available under the same category. Thus, P&G’s pool of issuable securities is roughly three times larger than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's figure as 'about 119 million shares', whereas the ground truth is 133,185,995—this is a significant numerical discrepancy (~14 million shares off). While the LLM cites a footnote from Item 12 as its source, the number still does not align with the verified data. (2) The calculation comparing P&G’s pool to Colgate’s is conceptually sound—P&G’s pool is indeed roughly 3–3.6 times larger—but due to the incorrect base number, the magnitude of the comparison is slightly overstated. The actual ratio is ~3.6x (133.2M / 37.0M), while the LLM implies ~3.2x (119M / 37M). (3) The multi-hop reasoning is solid: the model correctly identifies both companies, the relevant metric (securities available under shareholder-approved equity plans), and synthesizes the data for comparison. It also correctly interprets disclosure categories as comparable. (4) Despite the wording being clear and the structure effective, the quantitative inaccuracy in P&G’s figure reduces confidence in the factual correctness. The answer is directionally correct and contextually appropriate, but the core number for P&G is wrong, warranting a moderate correctness score. Semantic equivalence is mostly preserved, but not fully, due to the material numeric error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 396,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s filing in November 2023 (see page 95) is a straight‑forward infringement suit in the District of Delaware that accuses Sandoz and several other companies of violating AbbVie’s upadacitinib (Rinvoq) patents and seeks declaratory and injunctive relief. Amgen’s approach is similar in that it also sued Sandoz over a biosimilar—this time a denosumab product (Prolia/XGEVA) – and, after Sandoz replied with counterclaims asserting the patents are invalid or unenforceable, Amgen has moved to have those counterclaims dismissed and to obtain a preliminary injunction to block Sandoz’s launch (see pages 156‑157). Thus, both companies are using patent‑enforcement lawsuits against Sandoz to protect their branded drugs, but Amgen’s strategy explicitly includes a defensive push to defeat Sandoz’s invalidity counterclaims and secure an injunction, mirroring AbbVie’s broader effort to block generic competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AbbVie filed an infringement suit against Sandoz over upadacitinib, seeking injunctive relief; Amgen is defending its denosumab patents after Sandoz filed counterclaims of invalidity, and Amgen is moving to dismiss those and seek a preliminary injunction. The dates (November 2023) and document references (pages 95, 156–157) are consistent with source data. (2) There are no numeric inaccuracies—no financial figures or calculations were required, and the timeline references are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both AbbVie and Amgen are engaged in patent litigation with Sandoz, but in different strategic positions—AbbVie as plaintiff in a straightforward enforcement action, Amgen in a more complex defensive-offensive posture due to Sandoz’s counterclaims. The LLM accurately captures this contrast, though it slightly downplays the distinction by saying Amgen’s strategy 'mirrors' AbbVie’s, which could imply more similarity than warranted—the original answer emphasizes 'contrasting legal dynamics,' which is more precise. (4) Despite this minor nuance, the LLM answer is contextually rich, directly addresses the relationship between the two legal situations, and correctly identifies the strategic differences and similarities. The inclusion of specific filing details enhances credibility and relevance. Minor deduction in qualitative accuracy due to the slight overstatement of similarity in legal strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 430,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s charter lets each Class B share carry ten votes while a Class A share carries one vote, and the Class B shares are “non‑dilutable” – their aggregate voting power cannot be reduced by issuing other classes. When a holder converts a Class B share into Class A (or when a conversion is triggered by a sale or transfer), the ten‑vote share is replaced by a one‑vote share, directly diluting the voter’s power (the 33 % voting block of Class B would shrink if conversions occur). Alphabet’s (GOOGL) structure is similar in that Class B shares also have ten votes and Class A one vote, but in 2023 the company repurchased $62.2 billion of Class A and non‑voting Class C shares, which removes low‑ or non‑voting stock from the pool and therefore **concentrates** the remaining voting power in the high‑vote Class B shares rather than diluting it.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several correct elements: it correctly identifies GOOGL's $62.2 billion share repurchase in 2023, the 10-vote and 1-vote structure for Class B and Class A shares respectively, and the concept that repurchasing Class A and C shares concentrates voting power among remaining Class B shareholders. However, it makes a critical error regarding CMCSA's voting structure: it states that CMCSA Class B shares carry 'ten votes', while the ground truth specifies '15 votes'. This is a factual inaccuracy. Additionally, the LLM incorrectly implies that CMCSA Class B voting power dilutes upon conversion by stating 'the 33% voting block of Class B would shrink if conversions occur' — but the ground truth clarifies that CMCSA's Class B shares are protected from dilution under its articles of incorporation, meaning their aggregate voting power is structurally capped and protected, not diluted in the same way as GOOGL. 2) Quantitatively, the $62.2 billion figure and the 33 1/3% voting cap are correctly referenced (though the latter is misinterpreted in context), and the years/entities are accurate. The vote ratios for GOOGL are correct (10:1), but CMCSA's 15:1 ratio is wrong. 3) The multi-hop reasoning is partially sound — the model correctly infers that repurchasing low-vote shares increases relative control of high-vote shares. However, it fails to correctly contrast CMCSA’s stronger anti-dilution protection (constitutional cap and non-dilutability) with GOOGL’s lack thereof upon conversion. It mischaracterizes CMCSA’s mechanism as dilutive when it is explicitly designed to prevent dilution. 4) Contextual relevance is high — the answer addresses both companies, the conversion mechanisms, and the impact of repurchases. But due to key factual errors in vote count and misinterpretation of dilution protection, the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 516,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "The excerpts you provided do not include the specific figures needed for a comparison. Nike’s 2023 Form 10‑K pages 94‑98 do not show the number of shares reserved for future issuance under its Equity Compensation Plan, and Tesla’s 2023 Form 10‑K pages 99‑103 do not disclose the total shares represented by outstanding warrants. Therefore, based on the supplied pages, a direct comparison cannot be made.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to match the ground truth. (1) The original answer states that Nike reported 97,567,370 shares available for future issuance under its Equity Compensation Plan and Tesla had 11 million shares represented by outstanding warrants in 2023—both specific, factual figures. The LLM incorrectly claims these data points are not present in the filings, asserting that a comparison cannot be made based on the provided pages. (2) There are no numeric values in the LLM response, so quantitative accuracy is zero; it fails to report or calculate any correct figures. (3) The multi-hop reasoning required—comparing shares reserved under Nike’s plan to Tesla’s outstanding warrant shares—is not attempted; instead, the model abdicates the task by claiming insufficient information, despite the ground truth being available. (4) Contextual relevance is low but not zero because the model at least recognizes the relevant documents and sections (e.g., Form 10-K pages), though it misrepresents their content. Overall, this reflects a failure in information extraction and synthesis, resulting in a largely irrelevant and factually incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 332,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla reported that its outstanding warrants could be exercised for about **11 million shares** in 2023. Nike’s equity‑compensation disclosure shows **approximately 97.6 million shares** still available for future issuance under its plans. Thus, the shares issuable from Tesla’s warrants are roughly one‑tenth of the shares Nike has left to issue under its compensation arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correct: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 is accurately reported. Nike's 97,567,370 shares remaining available for future issuance is correctly rounded to 'approximately 97.6 million'—a reasonable and common practice that preserves accuracy. (2) The comparison stating Tesla's warrant shares are 'roughly one-tenth' of Nike's available pool is logically sound: 11 million is approximately 11.3% of 97.567 million, so 'one-tenth' is a valid approximation for high-level comparison. (3) The multi-hop reasoning—synthesizing data from Tesla's 2023 warrant disclosures and Nike's equity compensation plan disclosures—is correctly executed, with proper entity and metric alignment. (4) Minor deduction in qualitative accuracy due to the use of 'about' and 'approximately' where exact figures were available, though this does not undermine correctness. No factual or calculation errors; answer fully addresses the comparative question. Semantic equivalence is strong, and contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 330,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s charter creates three share classes, and each Class B share carries ten votes versus one vote for Class A and no vote for Class C (see GOOGL 10‑K p. 82). Because Class B stock can be converted to Class A but retains ten‑fold voting power, a relatively small group of insiders that holds Class B shares can control board elections and major corporate actions even though they own a minority of the total equity. In contrast, Netflix’s 10‑K (p. 60) states that every share of its common stock is entitled to one vote, so voting power is directly proportional to economic ownership, resulting in a more uniformly distributed governance structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that GOOGL's Class B shares carry 10 votes per share, Class A has 1 vote, and Class C has none—matching the original answer. It accurately contrasts this with NFLX's uniform one-vote-per-share structure. (2) All quantitative details are correct: the 10:1 voting ratio for Class B vs Class A is explicitly stated and aligns with the knowledge graph. No calculations are required, but the comparative voting weights are precisely conveyed. (3) The multi-hop reasoning is sound: the model synthesizes governance structures from two different companies (GOOGL and NFLX) using their respective 10-K filings, correctly inferring the implications for control and governance distribution. It highlights concentrated control in GOOGL due to disproportionate voting power and contrasts it with Netflix’s proportional, egalitarian model. (4) The answer is fully relevant, directly addressing the impact of differential voting rights on corporate governance as requested. Minor enhancements (e.g., naming 'key stakeholders' as insiders) add clarity without deviating from the truth. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 343,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s QG3 project contributed about **13 thousand barrels of crude oil per day** in 2021. When this is compared with Chevron’s total average daily net crude oil production for the year (≈ 161 thousand barrels per day across all segments), the QG3 share is roughly **8 percent** of the company’s 2021 average daily crude output. 【page_11】",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the QG3 project's daily production as 13 thousand barrels per day (MBD), which matches the ground truth. However, the original answer does not provide Chevron's total crude oil production, so the LLM introduces new information (≈161 MBD) not present in the ground truth to calculate a percentage (8%). This total production figure and the resulting 8% are not supported by the original answer, making the percentage claim unsupported and factually unverifiable based on the provided ground truth. (2) The number 13 MBD is accurate and correctly formatted (13 thousand barrels = 13 MBD). However, the calculation of 8% relies on an external figure (161 MBD total production) that is not confirmed in the ground truth, introducing a significant quantitative assumption. (3) The reasoning attempts a correct multi-hop synthesis—linking Chevron’s stake in Qatargas to QG3 production and then comparing it to total production—but fails because the total production volume is not part of the original answer, breaking the chain of verifiable logic. (4) The contextual relevance is high because the LLM addresses the core entities (Chevron, QG3, Qatargas, 2021, daily crude production) and attempts the right type of analysis. However, the unsupported calculation reduces correctness significantly. The original answer only states Chevron’s net production from QG3 via its 30% stake but does not compute or imply a percentage of total production, so the LLM overreaches in its conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 420,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both 3M and Honeywell now must disclose, in a dedicated note, the key terms of their supplier‑finance programs and show a roll‑forward of the confirmed obligations. The roll‑forward—effective 1 January 2024—lists the balance at the start of the year, invoices confirmed during the year, invoices paid, and the ending balance (e.g., 3M’s $0.3 billion and Honeywell’s $1.15 billion), making the size and movement of these liabilities visible in the accounts‑payable footnote and greatly increasing transparency.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 mandates enhanced disclosures including a roll-forward of confirmed obligations for both 3M and Honeywell, and notes the effective date of January 1, 2024, which aligns with the ground truth. However, the key quantitative data is incorrect: the LLM states 3M’s ending balance is $0.3 billion and Honeywell’s is $1.15 billion, whereas the ground truth reports $1.5 billion for both invoices confirmed and paid/adjusted by 3M in 2024, and does not specify Honeywell’s ending balance at all. These numbers are not only unsupported but contradict the original answer. (2) There is no calculation provided in the LLM answer, but the cited figures do not match the ground truth—$0.3B and $1.15B appear to be fabricated or misremembered. The ground truth emphasizes 3M’s $1.5B roll-forward activity (confirmed and paid), not an ending balance. (3) The multi-hop reasoning is partially sound: the model correctly links ASU 2022-04 to increased transparency via roll-forward disclosures and applies it to both companies. It also correctly identifies the timing (2024) and the components of the roll-forward (starting balance, invoices confirmed, paid, ending balance). However, it fails to accurately extract or report the actual disclosed figures from the knowledge base, undermining factual reliability. (4) Contextual relevance is high because the structure and intent of the response match the question’s focus on transparency and disclosure changes. Qualitative accuracy is moderate due to correct conceptual understanding but missing specifics about Honeywell’s adoption being aligned with phased implementation and lack of mention of comparability and risk assessment benefits. Quantitative accuracy is low due to significant factual errors in dollar amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 495,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin applies the Federal Acquisition Regulation (FAR) to its U.S.‑government work and treats those contracts as either firm‑fixed‑price or cost‑reimbursable.  Because the FAR‑based price is “estimated or actual costs + a reasonable profit margin,” the company records revenue on a percentage‑of‑completion, cost‑to‑cost basis as work is performed, recognizing contract assets or liabilities for billings versus costs incurred【page_77】.  \n\nRaytheon Technologies notes that a large share of its earnings comes from U.S.‑government contracts that are predominantly fixed‑price.  Consequently, the company is financially exposed to any cost overruns or contract‑price adjustments – a risk that can turn a fixed‑price award into a loss if the actual costs exceed the fixed price (or the ceiling on incentive‑fee contracts)【page_16】.  \n\nThus, while Lockheed Martin’s revenue‑recognition methodology is driven by FAR cost‑plus pricing and the percentage‑of‑completion method, Raytheon’s risk discussion emphasizes that its profitability can be adversely affected by the same fixed‑price structures when costs exceed the agreed price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that LMT uses cost-reimbursable (i.e., cost-plus-fixed-fee) contracts under FAR, with revenue recognized on a percentage-of-completion, cost-to-cost basis, aligning with the ground truth's description of predictable revenue due to cost reimbursement plus profit. It also accurately states that RTX has significant exposure from fixed-price contracts, particularly firm fixed-price (FFP), where cost overruns lead to financial risk. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes LMT’s revenue recognition approach and contrasts it with RTX’s financial exposure, drawing a valid comparison between the two companies’ contract structures and associated risks. (4) The only minor shortcoming is that the LLM does not explicitly name the 'cost-plus-fixed-fee' model as in the original answer, instead describing it as 'cost-reimbursable' and referencing FAR-based pricing. While semantically equivalent, the absence of the precise term slightly reduces qualitative precision. However, the explanation fully captures the economic and accounting implications. Overall, the answer is factually correct, contextually relevant, and effectively addresses the comparative, multi-entity nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 405,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s composition‑of‑matter patent (and related SPCs) on Eliquis is still being enforced across dozens of European countries and has not yet reached its expiry date, so BMS is counting on continued patent litigation to preserve European market exclusivity. In contrast, Merck’s key U.S. patent on the sitagliptin compound expired in January 2023, but later‑expiring patents keep the Januvia/Janumet family protected in the United States only until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR). Consequently, BMS’s strategy focuses on defending its European patents to delay generic entry, whereas Merck is preparing for the scheduled loss of U.S. exclusivity in 2026 and will need to rely on pricing, new formulations or other competitive tactics after that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Merck's sitagliptin compound patent expired in January 2023, with exclusivity extended to May 2026 for Januvia/Janumet and July 2026 for Janumet XR due to secondary patents—this matches the original answer exactly. The LLM correctly identifies BMS's (BMY's) ongoing litigation strategy in Europe to maintain Eliquis exclusivity, noting that the composition-of-matter patent and SPCs are still being enforced. (2) Quantitative accuracy is perfect: all dates (January 2023, May 2026, July 2026) are correct and match the ground truth. (3) Multi-hop reasoning is sound: the model correctly contrasts BMS’s fragmented, litigation-dependent European strategy with Merck’s U.S. strategy of leveraging secondary patents to extend exclusivity. (4) The only minor shortcoming is that the LLM omits specific country-level outcomes mentioned in the ground truth (e.g., positive decisions in Norway, Sweden, Switzerland; negative in UK; generic entry in Finland and Portugal). While not critical to the overall comparison, these details enrich the original answer. However, the LLM captures the strategic essence and timeline impact accurately. Wording differences (e.g., 'BMS' vs 'BMY') are acceptable as they refer to the same company. Semantic equivalence is maintained, and the conclusion about differing strategies and their implications on market exclusivity is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 408,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of about **$35 million** to secure stays of adverse verdicts that are on appeal.  Since October 2004, PM USA has paid roughly **$1 billion** in judgments and settlements (plus about $241 million in related interest), so the appeal‑bond amount is only a few percent of the total payments made on tobacco‑related litigation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported with acceptable formatting (e.g., 'about $35 million' = 'approximately $35 million'). (2) The comparison correctly characterizes the appeal bonds as a small fraction—specifically 'a few percent'—of total payments, which is logically sound given that $35M is about 3.5% of $1B (excluding interest) and even smaller when interest is included. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across time periods (since October 2004) and distinguishes between different types of financial outflows (bonds vs. actual payments). (4) All entities—PM USA, tobacco-related litigation, appeal bonds, judgments, settlements, interest—are accurately identified and contextually relevant. The answer is semantically equivalent to the original, with slightly more concise phrasing but no loss of meaning or accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 301,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment (which aggregates mainland China, Hong Kong and Taiwan) generated **$74.2 billion** in net sales, but the filing does not break out how much of that amount came from Taiwan alone【page_52】.  \n\nNVIDIA’s 2022 Form 10‑K does not provide a separate line for revenue earned in Taiwan in the excerpts supplied (pages 78‑82), so a direct Taiwan‑specific revenue figure is not disclosed.  \n\nTherefore, Apple’s Taiwan contribution is embedded within the $74.2 billion Greater China total, while NVIDIA’s Taiwan revenue is not separately reported in the available material.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims that NVIDIA’s 2022 10-K does not report a separate line for Taiwan revenue, which contradicts the ground truth stating that NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. This is a major quantitative and factual inaccuracy. While the Apple portion is correctly represented—$74.2 billion (i.e., $74,200 million) in net sales for Greater China, with no breakdown for Taiwan—the NVIDIA portion is entirely incorrect. The LLM appears to have missed or misread the NVIDIA filing data, leading to a false conclusion that Taiwan revenue was not disclosed. This undermines the multi-hop comparison the question hinges on. The reasoning would have been sound if based on correct data, and the contextual framing (embedded vs. direct reporting) is appropriate, but the failure to report NVIDIA’s actual $8,544 million figure severely limits correctness. Number formats are acceptable ($74.2 billion = $74,200 million), so formatting is not an issue. However, the absence of the key NVIDIA number and the incorrect claim of non-disclosure result in a low correctness score despite partial accuracy on Apple.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 331,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVIDIA does not report any stand‑alone revenue attributable to Taiwan in its 2022 Form 10‑K – the geographic revenue table shows $0 for Taiwan in 2020, 2021 and 2022, meaning its Taiwan‑related revenue grew 0 % over the 2020‑2022 period.  \n\nApple’s “Greater China” segment (which includes Taiwan) recorded net sales of $40.3 billion in FY 2020 and $74.2 billion in FY 2022, a rise of roughly **84 %**.  \n\nThus, Apple’s revenue growth in the region that includes Taiwan was far higher than NVIDIA’s (84 % versus 0 %).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its core claim that NVIDIA reported $0 revenue from Taiwan in its 10-K filings for 2020–2022. The ground truth states that NVDA's revenue from Taiwan was $3,025 million in 2020 and grew to $8,544 million in 2022 — a 182.5% increase. The LLM incorrectly asserts that NVIDIA reports $0 for Taiwan across all years, which contradicts the verified data in the knowledge graph. This error invalidates the entire comparison. (2) While the Apple revenue figures are correct — $40.3 billion in 2020 and $74.2 billion in 2022, representing an 84.1% increase — the LLM rounds this to 'roughly 84%' which is acceptable. However, the NVIDIA numbers are completely wrong: stating $0 in revenue for all years is a severe factual error. The calculation of 0% growth for NVIDIA is therefore also incorrect. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the revenue data for NVIDIA from Taiwan. It appears to have misread or misinterpreted the geographic revenue breakdown in the 10-K, leading to a false premise. The comparison between NVDA and AAPL is logically structured (growth vs. growth), but based on false data. (4) The contextual relevance is moderate because the answer addresses the right companies, regions, and time frame, and attempts the correct type of comparison. However, due to the critical error in NVIDIA’s revenue data, the conclusion is the opposite of the truth: it claims AAPL had higher growth when in fact NVDA had significantly higher growth (182.5% vs 84.1%). Thus, the correctness score is very low at 1 due to major factual and quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 457,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says that, although the OECD’s Pillar Two rules (a 15 % global minimum tax) will begin to apply to it in fiscal 2025, it does **does not expect a material increase** to its worldwide tax cost because it has little exposure to jurisdictions with rates below the 15 % floor. Broadcom makes the same conclusion – it notes that it **has no material operations in low‑tax jurisdictions**, so the Pillar Two minimum tax is **not expected to materially increase its global tax expense**. In short, both companies project only a negligible impact from the new global minimum tax, reflecting their differing but similarly limited exposure to low‑tax jurisdictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its characterization of Broadcom's exposure. While Microsoft's projected lack of material impact is correctly stated (aligned with ground truth), the LLM falsely claims Broadcom expects no material increase in tax expense, which contradicts the original answer stating Broadcom *may materially increase* its effective tax rate and cash tax costs. This misrepresents a key part of the comparison. (2) Quantitatively, the 15% global minimum tax rate, fiscal year 2025 for Microsoft, and fiscal year 2026 for Singapore’s adoption (relevant to Broadcom) are all correctly referenced or implied, so numeric accuracy is high. However, the LLM omits Singapore's role and the forward-looking nature of Broadcom’s exposure. (3) The multi-hop reasoning fails because the model incorrectly equates the two companies’ tax exposures, when the ground truth emphasizes a *divergence*: Microsoft has no material operations in low-tax jurisdictions (hence no impact), whereas Broadcom *does* rely on tax incentives that are at risk under Pillar Two. The LLM incorrectly synthesizes this as a similarity rather than a contrast. (4) Correctness is low (3/10) due to the major factual error in Broadcom’s assessment. Qualitative accuracy is also low due to flawed reasoning and entity synthesis. Quantitative accuracy is higher because numbers and percentages are correct. Contextual relevance is moderate as the answer addresses the right topic and framework but draws the wrong conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 420,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX’s charter gives every share of its common stock one vote, so each shareholder’s influence is directly proportional to the number of shares it owns【page_61】. In contrast, Alphabet’s Class B shares carry ten votes per share, giving holders of Class B stock ten‑times the voting power of a single share of NFLX (or a Class A share of Alphabet) and allowing a relatively small number of Class B shareholders to dominate corporate‑governance decisions【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: NFLX has 1 vote per share, GOOGL Class B has 10 votes per share—this matches the original answer exactly. There are no calculation errors. (2) The answer addresses all parts of the question: it compares the voting rights structures of NFLX and GOOGL, explains the impact on shareholder influence, and correctly identifies the disproportionate power of GOOGL's Class B shareholders. (3) Entity accuracy is strong: NFLX and GOOGL (Alphabet) are correctly identified, and the distinction between Class B and Class A shares at Alphabet is accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the per-share vote count to relative influence and governance control. The only minor shortcoming is that the LLM does not explicitly state that NFLX has a uniform voting structure across all shares (i.e., no multi-class system), which slightly weakens the contrast, but this is implied. Wording differs slightly (e.g., 'ten-times the voting power of a single share of NFLX') but is semantically equivalent. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 340,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported roughly **$1 billion** of net revenue from Taiwan in fiscal 2021. Apple’s “Greater China” segment – which includes mainland China, Hong Kong and Taiwan – generated about **$74.2 billion** of net sales in fiscal 2022. Thus, AMD’s Taiwan revenue in 2021 was only about **1‑2 %** of Apple’s 2022 Greater China revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: AMD's revenue from Taiwan in 2021 is correctly stated as approximately $1 billion (ground truth: $1,187 million), and Apple's Greater China revenue in 2022 is accurately reported as $74.2 billion (matches ground truth exactly). The percentage comparison (1–2%) is a reasonable approximation: $1,187M / $74,200M ≈ 1.6%, so the 1–2% range is correct. Minor rounding of AMD’s figure to $1 billion is acceptable per scoring guidelines. (2) Completeness: The answer addresses both companies, correct years (2021 for AMD, 2022 for Apple), correct regions (Taiwan vs. Greater China), and includes a meaningful comparison. (3) Entity accuracy: Companies (AMD, Apple), regions (Taiwan, Greater China), and fiscal years are all correctly identified. (4) Reasoning: The multi-hop synthesis across two different companies, regions, and years is sound. The conclusion that AMD’s Taiwan revenue is a small fraction of Apple’s Greater China revenue is logically derived. (5) Semantic equivalence: The LLM uses slightly different phrasing (e.g., 'net revenue' vs. 'revenue', 'net sales') but these are contextually equivalent in financial reporting. The only minor deduction is for rounding $1,187M to $1B without qualification, though this is common practice and not misleading. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 399,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan left only **about 5 million shares** of common stock available for future awards (including incentive‑stock‑option grants) as of the end of 2022. By contrast, Starbucks reported **49 million shares** reserved and available under its 2019 Equity Incentive Plan at year‑end 2021. Thus, Starbucks’ remaining equity‑grant capacity is roughly ten‑fold larger than Tesla’s, even though both companies rely on incentive‑stock options as a key element of their employee‑compensation programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both quantitative and entity-specific details. It states Tesla had about 5 million shares available as of the end of 2022, but the ground truth reports 49.0 million shares available as of December 31, 2021. Similarly, it claims Starbucks had 49 million shares available under its 2019 Plan at year-end 2021, but the correct figure is 99.7 million shares available as of October 2, 2022 — a different company, time period, and number. (2) The numbers are not only incorrect but reversed in magnitude: the LLM incorrectly suggests Starbucks has 49 million (vs. actual 99.7 million) and Tesla has 5 million (vs. actual 49.0 million), leading to a false conclusion that Starbucks’ capacity is tenfold larger, when in fact it is roughly double. Additionally, the LLM misattributes Starbucks’ share reserve to a '2019 Equity Incentive Plan' — while Starbucks does have equity plans, the original answer does not specify a '2019 Plan' by name, making this a speculative and potentially incorrect linkage. (3) The multi-hop reasoning is flawed: the comparison between Tesla and Starbucks relies on mismatched time periods (end-2022 vs. end-2021), incorrect share figures, and misaligned plan names. The qualitative point about both companies using incentive stock options is correct and aligns with the ground truth, showing partial understanding of compensation strategy. (4) The contextual relevance is moderate because the answer attempts the right comparison and mentions incentive stock options appropriately, but the severe quantitative and entity errors undermine the conclusion. Correctness and quantitative accuracy are very low due to core data errors; qualitative accuracy is slightly higher due to correct conceptual framing of equity use in compensation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 497,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD’s Level‑2 fair‑value measurement for its fixed‑income securities is based on a market‑approach that uses observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable assets, but the filing does not cite broker‑dealer quotes as a specific input. In contrast, Boeing (BA) states that its Level‑2 valuation of available‑for‑sale debt securities relies on third‑party pricing services that employ valuation models using observable data **including reported trades and broker/dealer quotes** on the same or similar securities. Thus, BA explicitly incorporates broker‑dealer quotes into its Level‑2 models, whereas GD’s methodology relies on other observable market inputs without mentioning broker‑dealer quotes.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding GD's use of broker/dealer quotes. The original answer (ground truth) states that GD *does* use broker/dealer quotes as part of its valuation models for Level 2 assets, but the LLM claims that 'the filing does not cite broker/dealer quotes as a specific input' and that GD's approach 'does not mention' them. This contradicts the ground truth and misrepresents GD's methodology. In contrast, the LLM correctly states that BA explicitly uses broker/dealer quotes, which aligns with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the model attempts to compare GD and BA's fair value methodologies, which is appropriate. However, the core synthesis fails because it incorrectly differentiates the two companies' approaches. The ground truth emphasizes that both companies use similar methods involving broker/dealer quotes and third-party pricing services, indicating a parallel approach. The LLM instead creates a false distinction, undermining the correct comparative conclusion. (4) The contextual relevance is high because the answer addresses the right concepts (Level 2 assets, fair value, broker/dealer quotes, third-party models) and compares GD and BA appropriately. However, due to the key factual error about GD’s methodology, the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 437,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Because the Federal Reserve has set the Counter‑cyclical Capital Buffer (CCyB) at **0 %**, it does not add anything to either firm’s Basel III buffer calculation.  \n\n* **Morgan Stanley** – Under the **Standardized Approach** the total buffer is the sum of the Stress Capital Buffer (SCB) and the G‑SIB surcharge (5.4 % + 3.0 % = 8.4 %). Under the **Advanced Approach** the SCB is not used; the buffer consists of the 2.5 % capital‑conservation buffer plus the 3.0 % G‑SIB surcharge (2.5 % + 3.0 % = 5.5 %). The 0 % CCyB therefore has no effect on either figure.  \n\n* **American Express** – The company is explicitly subject to the SCB, so its total buffer equals the SCB percentage plus the 3.0 % G‑SIB surcharge (e.g., 5.8 % + 3.0 % = 8.8 %). With the CCyB also at 0 %, no additional capital is required beyond the SCB‑plus‑G‑SIB amount.  \n\nIn short, the zero‑percent CCyB leaves the total capital‑buffer requirements unchanged: Morgan Stanley’s buffers remain 8.4 % (standardized) and 5.5 % (advanced), and American Express’s buffer remains the SCB + 3 % G‑SIB amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors that undermine its correctness. (1) Quantitative Accuracy: The percentages cited (e.g., 5.4%, 5.8%, 3.0% G-SIB surcharge) are not present in the original answer and lack grounding in the provided knowledge. The original answer does not specify numerical values for the SCB or G-SIB surcharge for either firm, so assigning specific percentages like 5.4% or 3.0% is unsupported. (2) The LLM incorrectly states that under the Advanced Approach, Morgan Stanley does *not* use the SCB—this directly contradicts the original answer, which explicitly states that Morgan Stanley *includes* the SCB in its Advanced Approach calculation. Instead, the LLM claims the Advanced Approach uses only the 2.5% Capital Conservation Buffer (CCB) plus G-SIB surcharge, which misrepresents the regulatory framework described. (3) Entity Accuracy: While both firms are correctly identified, the regulatory treatment is misrepresented—especially the claim that the SCB is excluded from the Advanced Approach, which is false per the original answer. (4) Reasoning: The multi-hop synthesis fails—the original answer emphasizes that both firms are affected by the SCB despite different approaches, and that the 0% CCyB means no additional requirement from that buffer. The LLM invents a dichotomy between Standardized and Advanced approaches with different SCB applicability that is not in the source. (5) Contextual Relevance: The answer addresses the zero CCyB impact correctly in principle but distorts the underlying capital structure. It attempts to provide detail but does so with fabricated numbers and incorrect regulatory logic. Overall, the core conclusion about CCyB having no effect is correct, but the characterization of how capital buffers work for each firm is fundamentally flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 504,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "American Tower raised the borrowing limit on its 2021 Credit Facility to $4 billion (up from the prior limit) and explicitly used the additional capacity to fund its two marquee purchases – the Telxius and CoreSite acquisitions – as well as other general corporate needs (see AMT 10‑K p.51 & p.111).  By contrast, Simon Property Group does not rely on a large revolving credit line; instead it finances acquisitions and development through equity‑based joint‑venture arrangements, providing partners with construction loans and other advances that total about $88 million (see SPG 10‑K p.116).  Thus AMT’s strategy is to secure substantial bank credit to directly fund deals, whereas SPG’s strategy is to leverage joint‑venture partnerships to supply the capital for its property investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $4.0 billion commitment increase for AMT and the $88 million (rounded from $88.4 million) provided by SPG to joint ventures are accurately reported. Minor rounding of $88.4 million to $88 million is acceptable and common in financial summaries. (2) The LLM correctly identifies that AMT used the increased credit facility to fund acquisitions like CoreSite and Telxius, which matches the ground truth's emphasis on leveraging credit for major transactions. (3) Entity accuracy is strong: AMT and SPG are correctly identified, with accurate references to their respective financing mechanisms and fiscal year (as of December 31, 2021, implied by 10-K references). (4) The reasoning is sound and captures the multi-hop contrast: AMT uses large-scale debt via credit facilities, while SPG relies on joint ventures with internal financing (construction loans). The LLM adds value by naming Telxius as an additional acquisition, which is consistent with the 10-K but not in the original answer—this is a minor enhancement, not an error. (5) Semantic equivalence is maintained: the core contrast in financing strategies is clearly and correctly articulated. The only reason for not scoring a 10 is that the original answer specifies 'interest-bearing construction loans' and 'diversify risk,' which the LLM mentions implicitly but could have included for full completeness. However, this does not detract from factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 423,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during fiscal 2022 (the count rose from 523 stores at Oct 3 2021 to 544 stores at Oct 2 2022)【page_12】. In Nike’s reporting, the Greater China segment – which includes Taiwan – generated ≈ $7.5 billion of revenue in FY 2022 (down from $8.3 billion in FY 2021)【page_88】. Thus, while Starbucks’ Taiwan footprint grew by a few dozen stores, Nike’s Greater China contribution is measured in billions of dollars, dwarfing the modest store‑count increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports that Starbucks added 21 licensed stores in Taiwan between fiscal 2021 and 2022 (from 523 to 544 stores), matching the ground truth's '21 net new stores'. The Nike revenue figure is correctly stated as approximately $7.5 billion (precisely $7,547 million in the original), with a note that it decreased from $8.3 billion in FY2021, which aligns with the knowledge graph data. (2) All numbers are quantitatively accurate: the store count change (544 - 523 = 21) is correct, and $7.5 billion is an acceptable rounding of $7,547 million. Fiscal years (FY2022) and geographic scope (Greater China includes Taiwan) are correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Starbucks and Nike), two different metrics (store count growth vs. regional revenue), and acknowledges the geographic inclusion of Taiwan within Greater China. The comparison highlights different modes of market engagement, as in the original answer. (4) Minor deduction in qualitative accuracy because the LLM emphasizes the decline in Nike’s revenue without linking it to broader context (e.g., market challenges), while the original focuses on the scale of revenue as a performance indicator. However, this does not make the answer incorrect—just slightly less balanced in interpretation. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 419,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s post‑retirement benefit (OPB) plan invests the bulk of its assets in a balanced index fund that is roughly 60 % equities (the remaining 40 % being debt securities)【page_96】.  \n\n3M’s pension plans held equity securities with a fair‑value total of about **$1.99 billion** as of December 31 2023 (U.S. pension equities $1,246 million plus international pension equities $740 million)【page_72】.  \n\nThus, Boeing’s OPB exposure is expressed as a 60 % equity allocation, whereas 3M’s pension plans directly own roughly $2 billion of equity assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Boeing's OPB plan is approximately 60% invested in equities through a balanced index fund, which matches the ground truth. However, it significantly misstates 3M's total fair value of equities. The ground truth reports $785 million, but the LLM claims $1.99 billion (summing $1,246 million and $740 million), which is more than double the correct amount. This major quantitative error undermines the comparison. (2) The calculation of 3M's equity value is incorrect: $1,246 million + $740 million = $1,986 million (~$1.99 billion), but according to the ground truth, the correct total is $785 million. There is no indication in the original answer that such a sum should be performed, suggesting the LLM misread or misinterpreted the source data. (3) The multi-hop reasoning is partially sound—linking Boeing’s indirect equity exposure to 3M’s direct equity holdings is appropriate—but the faulty data for 3M breaks the validity of the comparison. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts proper synthesis. Qualitative accuracy is moderate due to correct identification of entities, metrics, and structure, but quantitative accuracy is low due to the severe dollar amount error. Correctness score is reduced to 4 due to the critical factual inaccuracy in the 3M equity value, despite correct percentage for Boeing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 395,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower financed the CoreSite acquisition by drawing the full $3 billion 364‑day loan and the $1.5 billion two‑year loan under its 2021 USD Delayed‑Draw Term‑Loan program – a total of roughly **$4.5 billion** of unsecured term debt that carries a LIBOR‑plus‑margin rate, has no amortization requirement and can be prepaid at any time.  \n\nSimon Property Group’s joint‑venture financing is far smaller, consisting of **about $88 million** of interest‑bearing construction loans and other advances to its real‑estate JV partners, recorded as deferred costs and other assets rather than a large revolving or term‑loan facility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that AMT utilized $4.5 billion in delayed-draw term loans ($3 billion 364-day + $1.5 billion two-year), but the ground truth specifies a $10.5 billion financing structure for the CoreSite acquisition. The $4.5 billion figure is incorrect and represents only a portion of the total financing, missing additional funding sources or tranches that make up the full $10.5 billion. The SPG financing amount is approximately correct at $88 million (vs. $88.4 million in the original), which is acceptable within rounding. (2) Calculations: The sum of $3B + $1.5B = $4.5B is mathematically correct, but this total does not reflect the full scope of AMT’s financing as described in the ground truth. The LLM fails to mention that the $10.5B structure avoided bridge loans, a key qualitative and structural point. (3) Multi-hop reasoning is partially sound—LLM correctly identifies AMT’s use of delayed-draw term loans and SPG’s use of construction loans to JVs—but fails to fully synthesize the comparative scale and purpose. The contrast in magnitude and intent (acquisition vs. real estate development) is noted, but the underreporting of AMT’s total financing undermines the comparison. (4) Entity accuracy is strong: AMT, SPG, CoreSite acquisition, delayed-draw term loans, and JV financing mechanisms are correctly identified. Contextual relevance is high as the answer directly addresses the question’s focus on dollar amounts and financing structure. However, due to the major error in the AMT financing amount, the correctness and quantitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 457,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "Exxon Mobil’s downstream business treats crude oil as its core feedstock, running roughly 1.8 million barrels per day of refining capacity that depends on a steady supply of crude.  Chevron’s Kazakh‑produced crude—about 1.2 million barrels per day in 2024—is shipped out through the Caspian Pipeline Consortium, in which Chevron (via CVX) holds a 15 % equity stake.  Consequently, the crude that fuels XOM’s refineries could be sourced from the same Kazakhstan output that CVX helps move, linking XOM’s raw‑material reliance to CVX’s ownership of the CPC pipeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core relationship between XOM's reliance on crude oil and CVX's 15% stake in the CPC, correctly identifying that Chevron's operations in Kazakhstan produce about 1.2 million barrels per day, which is shipped via the CPC. However, it introduces a new figure—XOM's 1.8 million barrels per day of refining capacity—which is not present in the ground truth and cannot be verified from the provided context. The ground truth states that CPC transports 1.4 million barrels per day total, with 1.2 million from Kazakhstan; the LLM incorrectly implies that Chevron alone produces 1.2 million barrels per day, without clarifying that this is the volume from fields like Tengiz and Karachaganak where CVX has stakes, not necessarily all Chevron-operated. (2) Quantitative accuracy is partially compromised: while the 15% ownership and 1.2 million bpd from Kazakhstan align with the original, the 1.8 million bpd refining capacity for XOM is unsupported in the source and appears to be an external addition. The year '2024' is also introduced without basis in the original answer. (3) The multi-hop reasoning is generally sound—linking XOM’s crude dependency to CVX’s logistical role via CPC—but slightly oversimplifies by suggesting XOM’s crude could be directly sourced from this stream without acknowledging the global nature of crude markets and lack of direct supply chain linkage. (4) Despite these issues, the answer remains contextually relevant and semantically close to the original, with accurate entity identification (XOM, CVX, CPC, Kazakhstan operations) and correct emphasis on the strategic intersection of upstream production, midstream infrastructure, and downstream dependence on crude. The reasoning is logical but overreaches slightly in implying a direct supply connection. Hence, correctness is reduced due to unsupported numbers and minor misrepresentation of sourcing, but core facts and synthesis remain largely intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 533,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "Both NextEra Energy (NEE) and Duke Energy acknowledge that a decline in the market value of the assets held in their nuclear‑decommissioning trusts could create a funding shortfall. NEE warns that poor investment performance “could materially adversely affect NEE’s… liquidity, financial condition and results of operations,” while Duke notes that “a decline in the market value of the assets… may increase the funding requirements… and could negatively affect the Registrants’ results of operations, financial position and cash flows.” Thus, the two companies face essentially the same risk – the possibility that decommissioning trusts underperform and force additional capital outlays – but each frames it as a potential material impact on liquidity (NEE) or on earnings and cash flow (Duke).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual information is correct: both NEE and Duke Energy face decommissioning funding risks tied to market performance of their trust funds. The LLM correctly identifies that NEE emphasizes liquidity, financial condition, and results of operations, while Duke highlights impacts on funding requirements, results of operations, financial position, and cash flows. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes risk exposure across two companies, correctly identifying the shared nature of trust fund volatility and framing differences in disclosure emphasis. (4) The LLM captures the core comparison—both companies are exposed to nuclear decommissioning trust fund volatility, with similar underlying risks but slightly different framing in disclosures. The only minor shortcoming is that the LLM does not explicitly name Duke Energy’s subsidiaries (Duke Energy Carolinas, Duke Energy Progress, Duke Energy Florida) as in the original, but this detail is not central to the comparative risk assessment. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 364,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s (LOW) notes state that its Level 3 fair‑value amounts are derived with pricing models – the same models that are used for Level 2 but, for Level 3, they rely on “significant unobservable inputs” such as pre‑payment, discount‑rate and other assumptions (the company’s fair‑value policy requires the lowest‑level input that is material to dictate the hierarchy).  General Motors (GM) explicitly describes its Level 3 valuations as being based on “unobservable inputs” and classifies any instrument whose fair value depends on such inputs as Level 3.  Thus, both companies apply the hierarchy rule that Level 3 measurements are driven by unobservable assumptions; LOW emphasizes the use of pricing‑model calculations, whereas GM emphasizes the presence of unobservable inputs in those models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that LOW uses pricing models with significant unobservable inputs (e.g., pre-payment, discount rate) for Level 3 fair value measurements, particularly noting that the same models are used for Level 2 but become Level 3 when unobservable inputs are material—this aligns with the stated accounting policy that the lowest-level material input determines the hierarchy. GM is correctly described as classifying valuations based on the presence of unobservable inputs, placing them in Level 3. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes the application of fair value hierarchies at two different companies (LOW and GM), compares their approaches, and correctly links both to the FASB fair value framework based on input observability. The only minor shortcoming is that the LLM omits specific examples mentioned in the ground truth—LOW’s contingent consideration related to the Canadian retail business sale and GM’s use of static pool modeling and macroeconomic forecasts (e.g., unemployment, GDP) in GM Financial receivables. These details add context but do not alter the fundamental correctness of the comparison. (4) Despite these omissions, the LLM captures the essential equivalence in how both firms apply the Level 3 classification based on unobservable inputs, with LOW emphasizing model mechanics and GM emphasizing input classification. The answer is semantically equivalent and contextually precise, warranting high scores in all categories, with a 9 in correctness and qualitative accuracy due to the missing illustrative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 487,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s $10.5 billion of committed financing (the amount available under its 2021 Multicurrency Credit Facility that allowed it to terminate a $10.5 billion bridge‑loan commitment) is a large, centralized revolving‑credit capacity that the company taps to fund big acquisitions such as CoreSite and to refinance existing debt, concentrating its financing risk in a single, highly flexible facility.  \n\nIn contrast, Simon Property Group’s joint‑venture activity relies on modest construction‑loan and other advances of about $88 million to its 84 JV properties, a strategy that spreads capital across many partners and projects, thereby diversifying risk rather than concentrating it in a single corporate borrowing source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $10.5 billion for AMT’s committed financing and approximately $88 million (vs. $88.4 million in the original) for SPG’s joint venture financing. The minor rounding of $88.4 million to $88 million is acceptable and common in financial reporting. Dates (2021) and entities (AMT, SPG, CoreSite) are correctly identified. (2) The reasoning correctly contrasts AMT’s centralized, large-scale acquisition-focused financing strategy with SPG’s decentralized, risk-diversifying approach via smaller joint venture loans. (3) Multi-hop synthesis is sound: the model connects AMT’s credit facility to acquisition activity and contrasts it with SPG’s joint venture capital deployments, accurately reflecting strategic differences. (4) The only minor shortcoming is a slight omission of the explicit mention of 'interest-bearing construction loans' and the exact number of JVs (84 is mentioned, which matches the knowledge graph), but the core strategic contrast in capital deployment and risk diversification is clearly and correctly articulated. Wording differs slightly but maintains semantic equivalence. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 350,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 sales to customers in Taiwan were $1.84 billion out of total net revenue of $22.68 billion – roughly 8 percent of the company’s revenue. Qualcomm, by contrast, does not cite a revenue‑share figure but repeatedly notes that a “significant portion” of its chipset supply comes from its foundry partners in Taiwan, making the company’s manufacturing operations highly dependent on those Taiwanese fabs. Thus AMD’s exposure is quantified at about 8 percent of revenue, while Qualcomm’s exposure is a qualitative, critical reliance on Taiwanese foundries for its product supply.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.84 billion in sales to Taiwan is correctly reported (matches $1,841 million in original answer), and the total revenue of $22.68 billion is accurate, leading to the correct ~8% revenue exposure calculation. The format variation ($1.84 billion vs $1,841 million) is acceptable. (2) The LLM correctly identifies that Qualcomm does not disclose a specific revenue figure but relies on qualitative disclosures about supply chain dependency, accurately reflecting the original answer’s point about QCOM’s reliance on Taiwanese foundries. (3) Multi-hop reasoning is sound: the model correctly distinguishes AMD’s revenue exposure (downstream, customer-facing) from QCOM’s operational/supply chain dependency (upstream, manufacturing), synthesizing information across both companies and domains. (4) The only minor shortcoming is that the LLM omits the forward-looking risk statement about a 'significant or prolonged military conflict' having a 'material adverse impact' on QCOM, which slightly reduces qualitative completeness. However, the core idea of critical reliance and risk to manufacturing continuity is conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only a slight omission in risk elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 381,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks notes that the OECD‑Pillar 2 15 % global minimum tax will not become effective for the Company until fiscal 2025 and, because it will be phased in across the various countries where it operates, the firm does **not** expect the rule to have a material impact on its consolidated financial statements. McDonald’s 10‑K does not contain a comparable quantitative or qualitative comment on Pillar 2, indicating that the company likewise does not anticipate a material near‑term effect (or has chosen not to disclose any) and that any impact would be spread over the staggered implementation dates in the jurisdictions where it does business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative accuracy: the 15% global minimum tax under OECD's Pillar 2, SBUX's fiscal 2025 effective date, and the phased implementation across jurisdictions are all accurately represented. There are no numerical or date inaccuracies, so quantitative accuracy is perfect. However, the qualitative accuracy is slightly lower because the LLM incorrectly states that McDonald’s 10-K 'does not contain a comparable quantitative or qualitative comment on Pillar 2.' This contradicts the ground truth, which confirms that MCD *does* state it does not expect a material impact—meaning there *is* a qualitative disclosure. The LLM misinterprets the absence of detailed analysis as absence of any comment, which undermines the multi-hop synthesis. Despite this, the overall conclusion that both companies do not expect a material impact is correct, and the contextual relevance is high as it directly addresses the comparison and implementation timelines. The reasoning is mostly sound but flawed in one key inference, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 308,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s governance model puts the responsibility for identifying, measuring and controlling risk squarely on the line‑of‑business units (first line) and on the firm‑wide risk executives who oversee those assessments (second line). Because risk ownership is embedded throughout the firm, its stress‑testing is treated as a routine, firm‑wide analytical tool that supports day‑to‑day risk monitoring and limit‑setting rather than being a separate, capital‑regulatory exercise. In contrast, Goldman Sachs explicitly links its stress‑testing program to capital‑adequacy assessments in its capital‑planning process, using firm‑wide stress scenarios primarily to demonstrate that capital buffers are sufficient under adverse conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorgan Chase's firmwide risk ownership model involving first- and second-line functions is accurately described, and the characterization of stress testing as embedded in routine risk monitoring (rather than a standalone capital exercise) is consistent with the governance-driven approach. Goldman Sachs’s explicit linkage of stress testing to capital adequacy and capital planning is correctly identified. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect data earns a perfect score by default. (3) The multi-hop reasoning—comparing two firms’ risk governance models and their implications for stress testing methodology and purpose—is sound and well-synthesized. The LLM correctly infers that JPMorgan’s decentralized ownership leads to integrated, operational use of stress testing, while Goldman Sachs uses it more formally for capital validation. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is minor: the original answer includes additional context about Goldman Sachs evaluating 'financial and nonfinancial risks' and 'tail risks', which the LLM omits. This is a small but relevant detail that slightly reduces completeness. Otherwise, the semantic meaning, structure, and insight are equivalent. Contextual relevance is perfect—the response directly addresses the comparative framework and purpose of stress testing as influenced by governance models.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 454,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "Exxon Mobil’s long‑lived assets located in Kazakhstan total about **$8.5 billion** (2021 figure).  By contrast, Chevron’s stake in the same field’s joint venture, Tengizchevroil, consists of a **50 % equity ownership** and a **$4.5 billion loan** to the venture, giving Chevron a combined financial interest of roughly **$9 billion**.  Thus, XOM’s Kazakhstan asset exposure is roughly the same size as Chevron’s combined equity‑plus‑loan position in Tengizchevroil.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: The $8.5 billion figure for XOM's long-lived assets in Kazakhstan is a rounded version of the exact $8,463 million (i.e., ~$8.463 billion), which is acceptable under format variation rules. CVX's 50% equity stake in Tengizchevroil and the $4.5 billion loan (matching $4,500 million) are correctly reported. The LLM calculates a 'combined financial interest of roughly $9 billion'—this is a reasonable approximation assuming the equity value equals the loan amount, though the ground truth does not explicitly state the equity's value. While the exact equity value isn't provided in the original, it's logical to infer that 50% ownership in a major project with a $4.5B loan implies substantial equity, making the $9B estimate plausible but slightly inferential. (2) Completeness: The answer addresses all parts—XOM's asset exposure, CVX's equity and loan stakes, and a comparative synthesis. (3) Entity accuracy: XOM, CVX, Tengizchevroil (TCO), and the 2021 timeframe are correctly identified. (4) Reasoning: The multi-hop synthesis across companies and financial instruments (assets vs. equity + loan) is sound and leads to a valid conclusion about comparable exposure. (5) Semantic equivalence is maintained—wording differs but meaning aligns closely. The only minor issue is the implied equivalence of equity value to loan amount without explicit confirmation, which slightly affects quantitative precision. However, given the context and reasonable inference, this does not constitute a factual error. Thus, the answer is excellent with near-perfect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 455,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Qualcomm warns that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from our foundry partners, particularly those located in Taiwan” (QCOM 10‑K p. 35‑36). NVIDIA makes a parallel disclosure, stating that “geopolitical tensions…such as those involving Taiwan and China…could have a material adverse impact on us because a large portion of our wafer capacity and other critical components are produced by foundries and contract manufacturers in Taiwan, potentially disrupting supply continuity” (NVDA 10‑K p. 17‑18).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies both QCOM and NVDA as relying on foundry partners in Taiwan and highlights the risk of geopolitical tensions involving China and Taiwan disrupting their supply chains. The citations to specific pages in the 10-K filings (QCOM p. 35-36, NVDA p. 17-18) add precision and authenticity. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth that require verification—only qualitative disclosures—so quantitative accuracy is not applicable but no errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk disclosures from both companies’ SEC filings, connects their shared dependency on Taiwanese foundries, and explains how geopolitical instability could impact supply continuity for both. (4) The answer is contextually highly relevant, directly addressing the question about how geopolitical tensions might impact QCOM's chipset supply and NVDA's supply continuity through their reliance on foundry partners in Taiwan. Wording differs from the original but conveys the same meaning with strong fidelity to source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 347,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company warns that the capital and operating outlays required to meet new environmental rules – and the portion of those costs that must be recovered through retail rates – could push electricity (and natural‑gas) rates higher and, in turn, cause some commercial and industrial customers to cut back their consumption.  Duke Energy’s risk factors, by contrast, focus on the volatility of industrial demand that stems from broader economic downturns or recession‑related production cuts, rather than from rate‑driven demand‑side effects of environmental compliance.  Thus, Southern’s potential demand shift is a regulatory‑cost‑induced, rate‑sensitive reduction, while Duke’s exposure is to general economic‑driven swings in industrial usage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: Southern Company's environmental compliance costs may lead to higher rates and reduced industrial demand due to both pass-through costs and customers' own compliance burdens; Duke Energy emphasizes industrial demand volatility from economic conditions, not regulatory cost effects. The LLM correctly captures this distinction in exposure—regulatory-cost-induced demand reduction for Southern versus economic-driven swings for Duke. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond the absence of errors—scored as 10. (3) The multi-hop reasoning is sound: the model synthesizes risk factor disclosures from both companies, correctly contrasting the nature of industrial demand risk (rate-sensitive regulatory effects vs. macroeconomic sensitivity). The only minor omission is that the original answer notes industrial customers may face their own compliance costs, which the LLM implies but does not explicitly state—this slight reduction in completeness prevents a perfect 10. (4) The response is fully contextually relevant, directly addressing both parts of the comparative question with precise, focused reasoning. Overall, the answer demonstrates strong qualitative and factual alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 391,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange cash‑flow hedge program had a net notional amount of **$9.9 billion** at September 28 2024 (NKE 10‑K, p. 121).  \n\nMcDonald’s disclosed its largest foreign‑currency net‑asset exposures for 2024 as $1.48 billion (AUD), $1.15 billion (GBP), $0.64 billion (PLN), $0.33 billion (CNY) and $0.23 billion (HKD) – a total of roughly **$3.8 billion** (MCD 10‑K, p. 24).  \n\nThus, Nike’s hedge notional is about **$6 billion larger (≈2½‑times)** than the aggregate foreign‑currency net‑asset exposures that McDonald’s manages, indicating Nike employs a substantially larger hedging scale to mitigate its cross‑border currency risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, the ground truth does not provide specific net asset exposure values for MCD (such as $1.48B AUD, $1.15B GBP, etc.), nor does it state a total of $3.8 billion in foreign currency net asset exposures for McDonald’s. These figures appear to be fabricated or misattributed, as the original answer only states that MCD manages risk through diversified net asset exposures without quantifying them. Therefore, the calculation comparing $9.9B (NKE) to $3.8B (MCD) and concluding a $6B difference or 2.5x ratio is entirely unsupported by the ground truth. This invalidates the quantitative accuracy. While the $9.9 billion notional amount for NKE is correctly stated and cited, the MCD numbers are not present in the original answer, making the comparison invalid. The qualitative reasoning attempts multi-hop synthesis by contrasting NKE’s active hedging with MCD’s balance sheet approach, which aligns with the original answer’s theme, but the introduction of false quantitative data undermines the logic. The contextual relevance is high because the response addresses cross-border risk management and attempts a comparative analysis, but the core factual error in MCD’s exposure values severely limits correctness. The model incorrectly shifts from a qualitative strategy comparison to a precise quantitative one not supported by the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 394,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure to Ukraine comes only through its bottling partner Coca‑Cola HBC, which operates two manufacturing sites in the country that together represent **less than 1 % of The Coca‑Cola Company’s consolidated net sales and net earnings** (KO 10‑K, p. 23). Procter & Gamble’s Ukraine footprint is also very small – its Ukraine‑related assets amount to **under 1 % of total net assets**, indicating that the company’s manufacturing and supply‑chain operations are not materially dependent on Ukraine (PG 10‑K, p. 24). Thus, both firms have only marginal, non‑material exposure, with Coca‑Cola’s being indirect through a bottler and P&G’s being a direct but tiny asset base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: both Coca-Cola's exposure (less than 1% of net sales and net earnings) and P&G's asset exposure (under 1% of net assets) are accurately reported, with proper sourcing from respective 10-Ks. These figures match the semantic meaning of the original answer, which states P&G’s assets are less than 1% and implies Coca-Cola’s exposure is minimal through HBC. (2) The LLM adds more precise data (specific reference to net sales and net earnings for KO) not explicitly in the ground truth, but consistent with it. However, the original answer includes additional context about Coca-Cola HBC being part of the top five bottlers contributing 41% of global unit case volume—a multi-hop detail the LLM omits. This is a minor gap in completeness but does not distort the comparison. (3) Entity accuracy is strong: correct company names (Coca-Cola Company, Coca-Cola HBC, Procter & Gamble), correct metrics (net sales, net earnings, net assets), and proper distinction between indirect (bottler) vs. direct exposure. (4) Reasoning is sound: the LLM correctly synthesizes that both companies have minimal exposure, one indirectly via a bottler, the other through direct but small assets. The conclusion that exposure is non-material is logically supported. (5) Semantic equivalence is high—though wording differs, the core message about scale, structure, and risk is consistent. The only reason for not scoring 10 is the omission of the 41% bottler network context, which adds strategic depth to Coca-Cola’s exposure. Overall, the answer is factually excellent, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 461,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "- **Combined exposure** – MetLife’s fixed‑maturity securities held at fair value (which include its CMBS holdings) total **$281.4 billion**, and Bank of America’s CMBS portfolio is reported at an amortized‑cost of **$10.9 billion**.  Together the two companies have about **$292 billion** of exposure to CMBS‑type securities as of 31 Dec 2023.  \n\n- **Valuation comparison** – MetLife records its CMBS (as part of the fixed‑maturity securities) at **estimated fair value** (the $281.4 billion figure), whereas Bank of America records its CMBS at **amortized cost** of **$10.9 billion**.  Thus MetLife’s CMBS exposure is measured at fair value, while BAC’s is measured at amortized cost.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key numbers. According to the ground truth, MET's CMBS exposure at fair value is $4,551 million ($4.551 billion), not $281.4 billion as stated by the LLM. The $281.4 billion figure appears to be MET's total fixed-maturity securities, not just CMBS, indicating a critical misinterpretation of the data. BAC's amortized cost of $10,922 million ($10.922 billion) is approximately correct (rounded to $10.9 billion is acceptable). However, the combined exposure is therefore grossly overstated: correct total is $15,473 million ($15.473 billion), not $292 billion. (2) Calculations are incorrect due to wrong inputs. The sum of $281.4B + $10.9B = $292.3B is mathematically correct but based on invalid data, so quantitative accuracy is very low. (3) Multi-hop reasoning is partially sound in structure—LLM correctly identifies that MET uses fair value and BAC uses amortized cost—but fails in entity-metric linkage: it conflates total fixed maturities with CMBS for MET, failing to isolate the specific asset class. This breaks the multi-hop synthesis required. (4) Contextual relevance is moderate because the answer addresses the right companies, time frame (Dec 31, 2023), and accounting treatments, but uses incorrect financial figures, undermining the core of the question. Semantic equivalence fails on numbers, which are central to the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 392,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Both companies say that a cyber‑intrusion at a nuclear site could trigger new NRC security and licensing requirements that raise capital and operating costs. For Duke Energy, higher security spending would add to the funding needed for its nuclear de‑commissioning trusts (the NDTF), potentially forcing extra cash contributions if market‑valued trust assets fall short. For Southern Company, similar cyber‑driven compliance costs could exceed the balances in its de‑commissioning trusts, requiring additional capital outlays and prompting the firm to shift resources toward enhanced cyber‑security and possibly adjust its nuclear‑generation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: both Duke Energy and Southern Company face increased financial and operational risks due to cyber intrusion threats affecting nuclear operations. Duke Energy's decommissioning trusts (NDTF) are exposed to market fluctuations, and underperformance could necessitate additional cash contributions—this is accurately reflected. Southern Company faces higher compliance and security costs due to cyber risks, which could impact its capital allocation and operational strategy. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised; all references to financial mechanisms (trusts, capital outlays) are consistent. (3) Multi-hop reasoning is sound: the LLM correctly links cyber intrusion risks → regulatory (NRC) response → increased costs → impact on decommissioning trusts and operational strategies for both firms. It synthesizes across entities (Duke Energy subsidiaries, Southern Nuclear) and financial mechanisms appropriately. (4) The only reason for not scoring a perfect 10 is that the LLM slightly overemphasizes decommissioning trust shortfalls for Southern Company, while the original answer focuses more on compliance and licensing costs as direct outcomes—though the implication of potential capital outlays is reasonable. Overall, the answer is highly relevant, factually correct, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 423,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s unvested restricted‑stock units earn dividend equivalents that are settled as **additional shares of common stock when the units vest**, thereby expanding the number of shares outstanding at the vesting date. In contrast, Lowe’s did not issue new shares for dividend equivalents; instead, under its 2021 accelerated‑share‑repurchase (ASR) agreements the company **received additional shares from the financial‑institution counterparties** at settlement – approximately 7.5 million extra shares (0.2 m in Q1, 4 m in Q2, 1.7 m in Q3 and 1.6 m in Q4).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core mechanisms at both HD and LOW — HD issues additional shares for dividend equivalents on unvested RSUs upon vesting, and LOW receives additional shares through ASR agreements. This reflects accurate qualitative understanding and contextual relevance. (2) However, there are quantitative inaccuracies: the LLM states LOW received approximately 7.5 million additional shares with a breakdown of 0.2M (Q1), 4M (Q2), 1.7M (Q3), and 1.6M (Q4). But the ground truth specifies ASR settlements in Q1, Q4, and Q2 — not Q3 — with 0.2M, 1.6M, and 4M shares respectively. The mention of Q3 and 1.7M shares is incorrect and unsupported by the original answer. Additionally, the total (7.5M) is close but not exact (actual total is 5.8M), and the order of quarters is confused. (3) The multi-hop reasoning is mostly sound: the model correctly distinguishes between HD’s employee-compensation-driven share issuance and LOW’s capital-return-driven share receipt via ASRs. It synthesizes across two companies and two distinct financial mechanisms appropriately. (4) The correctness score is 7 because the core conceptual comparison is accurate and complete, but the incorrect attribution of a Q3 ASR and fabricated 1.7M share number constitutes a significant quantitative error. The qualitative and contextual scores are higher due to strong reasoning and relevance, despite numerical flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 395,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Both companies’ auditors – Ernst & Young LLP – relied on sensitivity analyses to probe the most judgment‑heavy estimates in each firm’s financials. For AT&T, EY “performed independent sensitivity analyses” as part of the goodwill‑impairment test on the $67,854 million goodwill balance, stressing assumptions such as terminal growth rates, long‑term EBITDA margins and the weighted‑average cost of capital. For Netflix, EY “performed sensitivity analyses” to gauge how changes in the historical and forecasted viewing‑hour assumptions would affect the amount of content amortization recorded.  In short, EY used similar analytical techniques, but AT&T’s were applied to goodwill valuation models, whereas Netflix’s were applied to content‑amortization forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on terminal growth rates, WACC, and EBITDA margins for goodwill impairment is consistent with the original. For Netflix, the focus on viewing-hour assumptions affecting content amortization is correctly identified. The auditor, Ernst & Young LLP, is correctly named, and the comparison of analytical techniques across both firms is sound. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) is exact and properly formatted. No calculations were required, but the numbers are used appropriately. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies, two distinct accounting estimates (goodwill vs. content amortization), and the common auditor’s role in applying sensitivity analyses. The only minor shortcoming is that the original emphasizes the auditor evaluating 'the reasonableness and robustness of management’s assumptions,' a nuance slightly underemphasized in the LLM answer, though implied. (4) The answer is fully contextually relevant, directly addressing all parts of the question: comparison of sensitivity analyses, application areas, and the shared auditor. Wording differs but meaning is semantically equivalent. Thus, a 9/10 correctness score reflects near-perfect accuracy with only a slight omission in framing the auditor's objective.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 420,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that regulations such as PSD2 and the rise of fintech‑built payment platforms could “disintermediate” issuers and route transactions away from its network, giving fintechs a competitive edge if they develop their own end‑to‑end solutions【page_31】. In contrast, Visa’s response is to embed fintechs within its ecosystem—offering a “Fintech Fast Track,” startup‑engagement programs and the global Fintech Partner Connect platform—to expand acceptance points and new flows, positioning partnerships as a way to compete in a regulator‑driven market【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies Mastercard's concern about disintermediation due to fintechs building end-to-end platforms, particularly under regulatory pressures like PSD2, which aligns with the original answer's emphasis on data-sharing risks and transaction rerouting. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—no numbers were misstated. (3) The multi-hop reasoning is sound: the model synthesizes Mastercard’s risk perception with Visa’s strategic response, correctly contrasting Mastercard’s defensive stance with Visa’s proactive integration of fintechs via programs like 'Fintech Fast Track' and 'Partner Connect,' which reflects the 'network of networks' strategy mentioned in the ground truth. (4) The answer is contextually relevant, directly addressing the comparative strategic approaches of Mastercard and Visa in the face of regulatory-driven competition. The only minor shortcoming is that the LLM does not explicitly state that Visa views fintechs as both partners *and* competitors—a nuance present in the original—but it implies this by positioning partnerships as a competitive tool. Overall, the answer is factually correct, well-reasoned, and complete for a score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 389,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "Both companies cite the OECD‑led “Pillar 2” 15 % global minimum‑tax rule, but they differ on timing. McDonald’s notes that a number of jurisdictions have already adopted the Pillar 2 framework with the earliest effective date for taxable years beginning after 31 December 2023 (i.e., the 2024 tax year), and it does not expect a material impact on its consolidated results. Starbucks, by contrast, says the Pillar 2 tax will not become effective for it until fiscal 2025 and likewise is not expected to have a material effect on its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MCD and SBUX state they do not expect a material impact from the 15% global minimum tax under Pillar 2; MCD references implementation starting after December 31, 2023 (i.e., 2024 tax year), while SBUX notes it will not be effective until fiscal 2025. (2) Quantitative elements—percentages (15%), dates (December 31, 2023, fiscal 2025)—are correctly reported with no calculation errors. Format variations (e.g., '31 December 2023' vs 'December 31, 2023') are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their respective implementation timelines, and their shared conclusion of immaterial impact. (4) The only minor omission is that the LLM answer does not explicitly mention the OECD's country-by-country application framework or differences in domestic implementation affecting multinationals—details present in the original answer that add contextual depth. However, the core comparative insight (differing effective dates but similar expected impact) is preserved. Thus, while slightly less comprehensive, the LLM response remains factually correct and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 363,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company reported total risk‑weighted‑assets capital of **$961 million, or 153.2 % of risk‑weighted assets** (CET1 ≈ 151.9 %, Tier 1 ≈ 151.9 %) on 12/31/2024—well above the 8 % (total‑capital) and 4.5 % (CET1) minimums and the 10 % “well‑capitalized” benchmark.  \n\nAmerican Express’s consolidated company and its national bank posted CET1 ratios of **≈10.5 %**, Tier 1 of **≈11.2 %**, total capital of **≈13.2 %**, and a Tier 1 leverage ratio of **≈9.8 %**, which satisfy but are far lower than BTC’s ratios.  \n\nThus, BTC’s capital adequacy position is substantially stronger, with capital ratios more than double the level at which American Express just meets regulatory requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data not supported by the ground truth. The ground truth states only that both BTC and AXP exceeded regulatory requirements and were 'well capitalized,' without providing specific numerical ratios or dollar amounts. However, the LLM answer fabricates precise figures—such as BTC's CET1 at 151.9%, Tier 1 at 151.9%, total capital at 153.2%, and $961 million in capital—which are not present in the original answer and cannot be verified from the provided knowledge. Similarly, the AXP ratios (CET1 ≈10.5%, Tier 1 ≈11.2%, etc.) are specific but absent from the ground truth, which only confirms AXP met requirements and was 'well capitalized' without citing numbers. (2) There are no calculations in the ground truth to verify, but the LLM performs a false comparison based on invented data, claiming BTC’s ratios are 'more than double' AXP’s, which cannot be substantiated. This introduces a misleading conclusion unsupported by evidence. (3) The multi-hop reasoning is partially sound in structure—comparing capital adequacy of two OCC/Fed-regulated entities as of Dec 31, 2024—but fails because it relies on hallucinated metrics rather than the actual qualitative assessment available. The model correctly identifies the regulatory frameworks (OCC for BTC, Fed + OCC for AXP) and the fact that both are subject to U.S. banking capital rules, showing good entity and contextual understanding. (4) While the answer is contextually relevant and attempts a direct comparison as requested, the complete lack of quantitative support in the ground truth makes the inclusion of such precise numbers a critical failure. Correctness is severely penalized due to fabrication of data; however, some credit is given for correct entities, timeframe, and regulatory context. Hence, correctness score is 4 (partially correct with major errors), quantitative accuracy is 3 (mostly wrong numbers), qualitative accuracy is 5 (correct entities and logic but flawed execution), and contextual relevance is 8 (on-topic and addresses the comparison intent).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 569,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "Simon Property Group’s construction‑loan exposure to its joint‑venture partners was only $88.4 million at year‑end 2021 (see SPG Note 6, page 116).  By contrast, American Tower borrowed about $7.8 billion under its 2021 Multicurrency Credit Facility during 2021 and used those funds primarily to finance the Telxius and CoreSite acquisitions (see AMT Note 8, page 111).  The comparison shows that SPG relies on relatively modest, partnership‑level debt to support incremental development, whereas AMT employs a large revolving credit facility to fund sizable acquisition‑driven growth, reflecting a much more aggressive, debt‑financed expansion strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $88.4 million in construction loans provided by SPG to joint ventures as of year-end 2021 and accurately states that AMT borrowed $7.8 billion under its 2021 Multicurrency Credit Facility during 2021. It correctly links this borrowing to the Telxius and CoreSite acquisitions. The ground truth specifies that the $7.8 billion includes €2.4 billion ($2.9 billion), a detail omitted in the LLM answer, but the total amount is correct and the omission does not materially distort the comparison. (2) All numeric values—$88.4 million, $7.8 billion, 2021 time frame—are factually accurate and match the ground truth. Format variations (e.g., $7.8 billion vs. $7.8B) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (SPG and AMT), two financial instruments (construction loans vs. multicurrency credit facility), and two growth strategies (development via joint ventures vs. acquisition-driven expansion). The conclusion about SPG’s modest, partnership-level financing versus AMT’s aggressive, debt-financed strategy is logically derived and semantically equivalent to the original answer. (4) The LLM answer is highly contextually relevant, directly addressing both parts of the question: the quantitative comparison and the strategic implications. The only minor shortcoming is the lack of breakdown of the €2.4 billion component within AMT’s borrowing, which slightly reduces qualitative completeness but does not undermine the overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 466,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s $0.5 billion interest‑rate swap is a modest‑sized fair‑value hedge that converts a relatively small portion of its fixed‑rate senior notes to a floating rate, so only a limited amount of its debt‑fair‑value is affected by interest‑rate moves. Broadcom, by contrast, carries $56.3 billion of fixed‑rate senior notes; a 50‑basis‑point change in market rates would shift the fair value of that debt by roughly $1.7 billion, indicating a far greater sensitivity to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate debt by converting it to floating rate (based on SOFR, though SOFR is not explicitly mentioned in the LLM answer, this detail is minor and does not affect correctness). AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value impact from a 50 bps rate increase are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and basis point sensitivity match the original answer exactly. (3) The multi-hop reasoning is sound—correctly contrasting CSCO’s hedging strategy (reducing interest rate risk) with AVGO’s large unhedged exposure and quantifying the sensitivity difference. (4) The LLM uses slightly different phrasing (e.g., 'modest-sized fair-value hedge', 'limited amount of its debt-fair-value is affected') but semantically aligns with the original. The only minor shortcoming is the omission of SOFR as the floating rate benchmark, which is a small contextual detail but not critical to the comparison. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 345,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike hedges a portion of its foreign‑currency transactional exposure by entering into forward and **option** contracts that are designated as cash‑flow hedges; the resulting unrealised gains or losses are deferred in other‑comprehensive income (OCI) until the hedged cash flows occur, although the filing does not disclose a specific OCI balance for those option‑based hedges. Tesla, by contrast, also uses forward and option contracts to hedge its foreign‑currency assets and liabilities, and it quantifies the effect – net deferred gains of about **$99 million** are sitting in AOCI and the 2024 OCI line shows a **$(97) million** loss from foreign‑exchange cash‑flow hedges. Thus, both companies rely on similar derivative instruments, but Tesla’s filing provides a concrete OCI impact, whereas Nike’s filing describes the mechanism without reporting a material OCI amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Tesla uses option contracts to hedge foreign currency assets and reports $99 million in net deferred gains in AOCI and a $(97) million loss in OCI from hedges. According to the ground truth, Tesla does *not* typically hedge foreign currency risk; instead, it experiences fluctuations in foreign exchange gains and losses that flow through 'Other income (expense), net.' The $99 million in deferred gains and $9.9 billion notional amount are specific to NKE, not TSLA. The LLM incorrectly attributes NKE's data to Tesla. (2) Quantitative accuracy is severely compromised: the $99 million deferred gain is correctly associated with NKE in the ground truth, but the LLM assigns it to Tesla. The $(97) million OCI loss for Tesla is entirely fabricated and not present in the original answer. The notional amount of $9.9 billion for NKE is omitted in the LLM response. (3) Multi-hop reasoning fails: the LLM incorrectly equates the hedging strategies of NKE and TSLA, asserting both use similar instruments, when the ground truth emphasizes a key contrast—NKE proactively hedges, while TSLA does not. This undermines the core comparison the question asks for. (4) Contextual relevance is moderate because the answer addresses hedging instruments and OCI impact, but the misattribution of data and flawed comparison reduce its validity. The structure follows the question’s intent, but factual errors dominate. Thus, the correctness score is low due to major factual and entity-level errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 435,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit agreements name Citibank, N.A. as the **administrative agent** (e.g., the original October 30 2019 agreement and the August 24 2023 agreement) and the agreements have been **amended** – notably Amendment No. 1 on August 25 2022 to the 2019 facility. In contrast, Caterpillar’s 2023 364‑day (5‑year‑style) facility also lists Citibank, N.A. as the **agent**, but the filing shows only the initial agreement dated August 31 2023 with no amendment dates disclosed.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies affecting overall correctness. (1) On quantitative accuracy: The LLM incorrectly states that Boeing's amendment occurred on August 24, 2023, while the ground truth specifies the amendment date as August 25, 2022. This is a critical error in date accuracy. Additionally, the LLM references a '2023 agreement' for Boeing that is not mentioned in the ground truth, which only confirms the original 2019 agreement and its 2022 amendment. For Caterpillar, the LLM claims the facility is dated August 31, 2023, which aligns with the ground truth (Amendment No. 1 to the 5-Year Facility), but incorrectly labels it as a '364-day (5-year-style)' facility, contradicting the '5-Year Facility' designation in the original answer. (2) Completeness: The question asks for a comparison of Citibank’s role and amendment timelines. The LLM correctly identifies Citibank as administrative agent for Boeing and agent for Caterpillar, capturing the core entity roles. However, it fails to mention Boeing’s dual role as joint lead arranger, a detail present in the ground truth. (3) Entity accuracy: Company names (Boeing, Caterpillar, Citibank, N.A.) are correct. However, the mischaracterization of Caterpillar’s facility as '364-day' undermines metric accuracy. (4) Reasoning: The multi-hop synthesis is partially sound—comparing roles and amendment dates—but flawed due to incorrect dates and facility terms. The conclusion that Caterpillar has 'no amendment dates disclosed' is false, as the August 31, 2023 date *is* an amendment (Amendment No. 1), which the LLM fails to recognize. (5) Semantic equivalence: While the general idea of staggered amendments and Citibank’s involvement is conveyed, the specific errors in dates, facility type, and missing roles reduce factual alignment. The answer is contextually relevant and addresses the comparison structure, but key inaccuracies limit its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 535,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries one vote for each share held 【page_60】. Meta’s Class B common stock carries ten votes for each share held 【page_82】. Thus, a Meta Class B share has ten‑times the voting power of a Netflix share (nine additional votes per share).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that Netflix’s common stock provides one vote per share and Meta’s Class B common stock provides ten votes per share, which aligns with the original answer. The comparison that a Meta Class B share has ten times the voting power (or nine additional votes) is mathematically sound. (2) The answer is complete, addressing both companies’ voting structures and making the explicit comparison requested in the question. (3) Entities are correctly identified: Netflix’s common stock and Meta’s Class B common stock are accurately referenced. (4) The reasoning is strong and reflects proper multi-hop synthesis across the two companies’ disclosures, correctly interpreting the disparity in voting rights. Minor wording differences (e.g., 'ten-times the voting power' vs 'significant disparity') do not affect semantic equivalence—both convey the same core fact. All citations (page numbers) are consistent with source data. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 308,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY reported that ≈23 % of its 2023 drug distribution was handled by Cardinal Health. Cardinal Health co‑owns Red Oak Sourcing (50 % each with CVS) and, because CVS is the primary beneficiary, it consolidates Red Oak in its financial statements (see CVS 10‑K p. 136‑138). Thus, the portion of BMY’s supply chain that runs through Cardinal is indirectly reflected in CVS’s consolidated results via the Red Oak joint‑venture, linking BMY’s distribution reliance to CVS’s accounting of that entity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMY relies on Cardinal Health for approximately 23% of its 2023 drug distribution and that Cardinal Health co-owns Red Oak Sourcing with CVS, each holding a 50% stake. It accurately states that CVS consolidates Red Oak Sourcing in its financial statements due to being the primary beneficiary, citing the correct source (CVS 10-K pp. 136–138). All entities (BMY, Cardinal Health, CVS, Red Oak Sourcing), percentages (23%, 50%), and the year (2023) are correct. (2) Quantitatively, the LLM matches the ground truth: 23% distribution reliance and 50% ownership stakes are accurately reported. However, it omits the specific financial impact mentioned in the original answer — the $183 million in annual quarterly payments from Cardinal to CVS — which is a quantitatively relevant detail. While not a calculation error, this omission affects completeness. (3) The reasoning is logically sound: the LLM correctly infers that because CVS consolidates Red Oak (due to primary beneficiary status), and Red Oak is co-owned with Cardinal, BMY’s reliance on Cardinal indirectly connects to CVS’s financials. This multi-hop synthesis — BMY → Cardinal → Red Oak → CVS consolidation — is valid and well-articulated. However, the answer stops short of explaining the potential downstream implications (e.g., impact on cost of goods sold or distribution pricing) that the original answer highlights, which weakens the qualitative depth. (4) Despite missing the $183M detail and the broader implication about pricing/efficiency, the LLM answer captures the core interdependency and correctly synthesizes across entities and financial reporting logic. Hence, correctness is high but not perfect, warranting an 8. Quantitative accuracy is 10 because all stated numbers are correct. Qualitative accuracy is 8 due to missing causal implications. Contextual relevance is 10 — the response directly addresses the question’s core.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 528,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s “Retirement and Income Solutions” (RIS) business is directly exposed to changes in U.S. rates.  In the company’s hypothetical rising‑rate scenario the RIS line shows a modest negative earnings effect (‑$10 million in 2022, turning modestly positive in later years) because higher crediting rates raise policy‑holder liabilities and the hedge portfolio generates less income, even though higher reinvestment yields partially offset the hit【page_61】.  The same rise in rates also forces MetLife’s life‑insurance business to trim reserves and absorb higher interest expense, which compresses margins on its traditional life products【page_59】.\n\nAIG’s experience with the same interest‑rate dynamics is far larger in scale.  In 2021 AIG recorded a $166 million unfavorable adjustment to adjusted pre‑tax income for its life‑insurance reserves (mainly universal‑life policies) as earned‑rate changes compressed spreads, and a $101 million unfavorable update in 2020 driven by mortality‑assumption changes that increased reserves【page_134】.  Thus, MetLife’s RIS exposure translates into only a few‑million‑dollar earnings swing for its life‑insurance line, whereas AIG’s life‑insurance reserve updates under comparable rate moves resulted in reserve‑related impacts measured in the low‑hundreds of millions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that AIG had a $106 million *favorable* impact in 2021 from actuarial assumption updates, but the LLM incorrectly reports a $166 million *unfavorable* adjustment in 2021 and attributes it to earned-rate changes, which contradicts the original. Additionally, the LLM cites a $101 million unfavorable update in 2020 due to mortality assumptions, which is not mentioned in the ground truth. For MetLife, the ground truth does not mention specific dollar impacts like -$10 million in 2022 or 'few-million-dollar earnings swing,' nor does it reference hedge portfolio income or reserve trimming due to rising rates—these details are either fabricated or misaligned. (2) The numbers are largely incorrect: AIG’s $106M favorable update in 2021 is misrepresented as $166M unfavorable; MetLife’s hypothetical scenario with -$10M impact and later positivity is not in the original answer and appears to be based on external data (e.g., page references) not aligned with the provided truth. Calculations or comparisons involving these figures are therefore invalid. (3) The reasoning structure attempts multi-hop synthesis by comparing MetLife’s interest rate exposure to AIG’s reserve updates, which is relevant. However, the logic is undermined by incorrect data: the conclusion that AIG’s impact was 'far larger in scale' and 'low-hundreds of millions' versus MetLife’s 'few million' is unsupported and factually wrong given the ground truth’s characterization of both as experiencing margin pressures with AIG having a favorable update. (4) Contextually, the answer addresses the right segments and concepts—interest rate exposure, margin compression, reinvestment, reserve updates—so relevance is moderate. However, due to major quantitative errors and misrepresentation of direction (favorable vs unfavorable), the qualitative and correctness scores are low. Semantic equivalence fails on key financial outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 544,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 2023 filing lists a series of long‑term contracts with Panasonic Corporation that form the backbone of its battery supply chain:  \n\n* a “Supply Agreement” dated October 5 2011 (Exhibit 10.25) and its first amendment dated October 29 2013 (Exhibit 10.26);  \n* a “Production Pricing Agreement” (Exhibit 10.32) and subsequent pricing amendments for Japan‑produced cells (2014, 2019, 2020, 2021) and for the Gigafactory‑2170 cells (2020‑2021) (Exhibits 10.33‑10.40); and  \n* a lease‑related “Investment Letter Agreement” and related Gigafactory lease amendments with Panasonic Energy North America (Exhibits 10.33‑10.40) that give Panasonic a role in the Nevada factory where Tesla manufactures its cells【page_106】【page_107】.  \n\nGeneral Motors, by contrast, reports that its EV battery supply is tied to its own joint‑venture VIE, Ultium Cells Holdings LLC (a partnership with LG Energy Solution). The filing notes that GM’s exposure to loss and capital commitments is linked to Ultium Cells, which is the primary source of battery cells for GM’s EVs【page_80】【page_78】.  \n\nThus, while Tesla relies on a series of multi‑year supply and pricing contracts with Panasonic (including a dedicated Gigafactory lease), GM’s battery sourcing is centered on its internal Ultium Cells joint venture rather than a single external supplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All specific agreements between Tesla and Panasonic are correctly identified: the 2011 Supply Agreement with its 2013 amendment, the Production Pricing Agreements with correct years (2014, 2019, 2020, 2021) for Japan-sourced and Gigafactory 2170 cells, and the Investment Letter Agreement with lease amendments involving Panasonic Energy North America. Dates and exhibit numbers are accurately cited, and the Nevada Gigafactory context is correct. (2) Quantitative accuracy is excellent: all dates (2011, 2013, 2014, 2019–2021) match the ground truth, and the description of multi-year pricing and lease agreements is factually sound. Minor discrepancy: the ground truth emphasizes the 2020 Pricing Agreement for Gigafactory 2170 cells as a key document, while the LLM groups 2020–2021 amendments without isolating 2020 specifically, but this does not constitute an error given the mention of 2020 in the context. (3) The comparison to General Motors is logically sound and factually correct: GM’s reliance on Ultium Cells LLC, a joint venture with LG Energy Solution, is accurately described as a VIE with capital commitments and loss exposure, contrasting with Tesla’s external contractual supply chain. This reflects the multi-hop reasoning required—synthesizing Tesla’s supplier contracts vs. GM’s internal JV model. (4) The LLM slightly exceeds the ground truth by adding detail (e.g., exhibit numbers, VIE structure), but this enhances rather than detracts. The only reason for not scoring 10 is that the original answer emphasizes the lack of GM supplier specificity, while the LLM notes the LG partnership—slightly more specific than the ground truth’s claim—but this is still consistent as GM discloses the JV without naming LG in all filings. Overall, the answer is factually correct, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 515,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "Mondelez International (MDLZ) explicitly uses exchange‑traded commodity futures and listed options—classified as Level 1 financial assets—to hedge the price risk of key raw‑material inputs such as cocoa, sugar, wheat and vegetable oils (see MDLZ 10‑K, “Commodity contracts” where Level 1 fair‑value amounts are shown $46 million and $161 million [pages 112 & 111]). In contrast, Costco Wholesale (COST) states in its 10‑K that it holds no Level 1 financial assets, indicating that it does not employ exchange‑traded commodity futures as part of its risk‑management program (COST 10‑K, pages 49‑53). Thus, MDLZ relies on Level 1 commodity futures to manage commodity‑price exposure, whereas COST’s disclosed strategy involves no such Level 1 instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of Level 1 commodity futures for hedging key inputs like cocoa, sugar, wheat, and vegetable oils, and notes COST's disclosure of holding no Level 1 financial assets. The entities (MDLZ, COST), financial instruments (commodity futures, Level 1 classification), and risk management context are all accurately represented. (2) Quantitatively, the LLM cites specific fair-value amounts of $46 million and $161 million from MDLZ’s 10-K, which are plausible figures consistent with such disclosures, though the ground truth does not specify exact numbers. Since the original answer does not include dollar amounts, the inclusion of these values does not constitute an error but adds detail—potentially from the actual filing—and is not contradicted by the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies’ 10-K filings, contrasting MDLZ’s active use of exchange-traded (Level 1) instruments with COST’s non-use, and links this to their respective risk management strategies. (4) The semantic meaning fully matches the ground truth, with slightly more detail (specific commodities, dollar figures, page references). The only minor limitation is the absence of COST’s specific date (August 28, 2022), but this does not detract from the overall correctness. The answer is fully contextually relevant, directly addressing the comparative risk management strategies involving Level 1 financial assets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 438,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s 2024 filing discloses two 10b5‑1(c) plans: Deirdre O’Brien’s plan allows the sale of the shares that will vest between April 1 2025 and October 1 2026 (no maximum number is stated) and runs until December 31 2026; Jeff Williams’ plan authorizes the sale of up‑to 100,000 shares that will vest between April 1 2025 and October 1 2025 and expires December 15 2025. Broadcom’s filing, by contrast, reports a single 10b5‑1(c) plan for director Diane M. Bryant that permits the sale of up to 15,000 shares and expires September 12 2025. Thus Apple’s executives are authorized to sell a larger number of shares and over a longer horizon (2025‑2026) than Broadcom’s single plan, which is limited to 15,000 shares and ends in late‑2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Apple executives Deirdre O'Brien and Jeff Williams entered into 10b5-1(c) plans in August 2024 (implied by filing context), with O'Brien's plan covering shares vesting from April 1, 2025, to October 1, 2026, and expiring December 31, 2026 (vs. 'expiration dates in 2026' in ground truth); Williams' plan allows sale of up to 100,000 shares plus additional vesting shares through October 1, 2025, expiring December 15, 2025 (ground truth says 'up to 100,000 shares plus additional vesting shares through October 1, 2025' and expiration in 2025). The LLM specifies exact expiration dates not in the original, but these are plausible and do not contradict. (2) Broadcom's Diane M. Bryant adopted a plan in September 2024 for up to 15,000 shares, expiring September 12, 2025 — fully consistent. (3) The comparison correctly identifies that Apple’s plans involve larger volumes (100,000+ shares vs. 15,000) and longer time horizons (through 2026 vs. late 2025), which is the core multi-hop synthesis required. (4) Minor discrepancy: original mentions 'no maximum number stated' for O'Brien, which the LLM correctly notes, but the original also notes Williams' plan includes 'additional vesting shares' — the LLM acknowledges this. The LLM slightly enhances precision with exact expiration dates not in the original, but this does not introduce error. Overall, quantitative accuracy is high, reasoning is sound, and the answer is contextually complete and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 426,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s five‑year credit agreement dated May 11 2023 (Exhibit 10.29) and Honeywell’s amended and restated five‑year credit agreement dated March 20 2023 (Exhibits 10.67 and 10.68) name JPMorgan Chase Bank, N.A. as a syndication agent 【page 114】. Honeywell’s filing explicitly lists “JPMorgan Chase Bank, N.A. … as syndication agents” alongside other lenders 【page 125】. The use of the same bank in the syndication role shows that the two companies rely on a common financial partner to arrange and distribute their revolving credit facilities, reflecting a shared banking relationship across their credit programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. All dates, roles, and entity names are accurate. The inclusion of exhibit numbers (Exhibit 10.29, Exhibits 10.67 and 10.68) and page references (page 114, page 125) aligns with typical SEC filing documentation practices and adds precision, though these are not part of the ground truth and do not detract from accuracy. (2) Quantitative accuracy is perfect: dates (May 11, 2023 and March 20, 2023) are correct, entity name is exact, and role (syndication agent) is consistently and correctly stated. No numerical calculations are required, but factual assertions about roles and agreements are precise. (3) The multi-hop reasoning is sound—correctly synthesizing information across two different companies’ credit agreements to infer a shared banking relationship with JPMorgan. The conclusion that both companies rely on a common financial partner to arrange and distribute credit facilities is logically derived and semantically equivalent to the ground truth’s assertion of a 'shared banking relationship' and 'strategic alignment.' (4) The only minor shortcoming is that the LLM answer does not explicitly mention JPMorgan’s 'key coordinating role in managing the syndicate of lenders' or the implication about 'how they access syndicated credit markets,' which adds slight depth to the original answer. However, the core insight about shared reliance on JPMorgan as syndication agent is fully captured. Thus, the answer is factually complete and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 496,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU‑ and U.S. sanctions that prohibit the trade of goods used to make tobacco products in Belarus (see PM 10‑K page 52) could force Coca‑Cola HBC – which lists Belarus among the 27 markets it serves (KO 10‑K page 7) – to curtail or suspend bottling, distribution and marketing activities there in order to remain compliant.  Because Coca‑Cola HBC accounts for roughly 17 percent of The Coca‑Cola Company’s worldwide unit‑case volume (KO 10‑K page 7) and the system sold 31.3 billion unit cases in 2021 (KO 10‑K page 6), any loss of Belarus‑based sales would shave only a modest amount off the Company’s total volume, but it would still represent a negative drag on growth in a market where the bottler is a key partner.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the percentage of The Coca-Cola Company’s unit case volume attributed to Coca-Cola HBC. The ground truth states 41% (from 2021 data), but the LLM incorrectly reports it as 'roughly 17 percent,' which significantly underrepresents the bottler’s importance. This error undermines the core quantitative foundation of the response. Additionally, while the LLM correctly cites the 31.3 billion unit cases sold in 2021 (KO 10-K page 6), it does not use this figure to cross-validate or contextualize the 17% claim, which would have revealed the inconsistency. (2) The reference to PM 10-K page 52 for tobacco sanctions is accurate and relevant, and citing KO 10-K pages 6 and 7 for operational presence and volume data shows correct source alignment. However, the misinterpretation of the 17% figure—likely conflating regional or other bottler data—represents a major quantitative inaccuracy. (3) The reasoning chain is otherwise sound: the model correctly infers that sanctions on tobacco-related goods could indirectly affect Coca-Cola HBC’s operations in Belarus due to supply chain or compliance risks, and that disruption would feed back to KO’s total volume. It also appropriately notes that the direct volume impact from Belarus alone would be modest, which aligns with the localized nature of the market. However, the diminished perceived importance of Coca-Cola HBC due to the incorrect 17% figure weakens the synthesis of risk at the systemic level. (4) Contextually, the answer is well-structured and relevant, addressing both the operational risk in Belarus and the implication for KO’s global volume. The qualitative reasoning is logical and well-sourced, but the major numerical error reduces overall correctness. A score of 5 reflects partial accuracy with a significant factual flaw affecting the conclusion’s weight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 512,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Fed’s proposal to cut the U.S. debit‑interchange cap by roughly 28 %‑30 % would directly shrink the fee that Capital One earns on each Mastercard‑issued debit transaction – a network on which the bank is heavily exposed as a four‑party issuer/processor (COF 10‑K p. 39).  Because Visa and Mastercard are already facing large multidistrict antitrust actions and have set aside hundreds of millions of dollars for those cases (Visa 10‑K p. 98‑99), the lower caps add further uncertainty and could force additional fee reductions or settlements, further eroding Capital One’s interchange‑fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 28%-30% reduction in debit interchange caps is correctly cited, and no other numerical values (e.g., dollar amounts, years) are misstated. Format variations are acceptable and do not affect accuracy. (2) The answer correctly identifies Capital One’s (COF) exposure to Mastercard’s four-party network and references specific 10-K disclosures (p. 39 for COF, pp. 98–99 for Visa), which supports the factual basis. While the original answer emphasizes Mastercard’s regulatory exposure, the LLM appropriately extends the logic to Visa as well, which is contextually valid given their similar interchange litigation risks. (3) The multi-hop reasoning is sound: it connects the Fed’s proposed cap reduction → lower interchange fees → direct impact on Capital One due to its reliance on Mastercard’s network → compounded risk from ongoing antitrust litigation against Visa and Mastercard. The synthesis across regulatory, network, and litigation dimensions is logically coherent. (4) The only minor shortcoming is that the original answer specifically highlights Mastercard’s potential need to reduce fees or settle due to litigation, while the LLM spreads focus more evenly across both Visa and Mastercard. However, this does not constitute an error, as both networks face similar legal challenges. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full coverage of the question’s components.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 424,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy notes that a material portion of its debt and interest‑rate swaps are LIBOR‑indexed and is still evaluating the required contract amendments and the optional expedients in ASU 2020‑04; the company has not yet adopted the guidance (as of 12/31/2021) and expects the transition to have no material effect on its financial statements. In contrast, Southern Company, which also references LIBOR in debt, hedge, and PPA contracts, has already elected to apply the ASU 2020‑04 amendments prospectively (for modifications made between March 12 2020 and Dec 31 2022) and likewise anticipates no material impact. Thus, Duke’s LIBOR exposure is prompting a more cautious, later‑stage adoption, whereas Southern Company is moving ahead with an earlier adoption of the standard.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general context of both companies' exposure to LIBOR and their evaluation of ASU 2020-04, but contains significant factual inaccuracies that affect correctness. (1) Quantitative Accuracy: The LLM states Duke Energy had 'not yet adopted the guidance (as of 12/31/2021)', which may be true but is not in the ground truth and introduces a specific date not confirmed in the original answer. More critically, it claims Southern Company 'has already elected to apply the ASU 2020-04 amendments prospectively... between March 12 2020 and Dec 31 2022' — this precise election timeline and prospective application is not supported in the original answer, which only states Southern is 'evaluating the provisions' with uncertain outcome. The original does not say Southern has adopted or elected anything, making this a major factual overstatement. (2) Completeness: The LLM addresses both companies and the regulation’s impact, satisfying multi-part structure. (3) Entity Accuracy: Companies and ASU 2020-04 are correctly identified; financial instruments (debt, swaps, PPAs) are accurately attributed. (4) Reasoning: The conclusion that Duke is more cautious and later-stage while Southern is moving ahead is not fully supported. Ground truth states both are evaluating, but notes Duke had a time-bound window (until Dec 31, 2022) for optional expedients, whereas Southern’s assessment is ongoing. The LLM inverts or misrepresents this nuance by asserting Southern has already adopted, which the original does not confirm. (5) Semantic Equivalence: While the theme of 'no material impact' is correctly echoed, the adoption timelines and actions taken are misrepresented. The core error is attributing an adoption decision to Southern Company that is not in the ground truth, undermining the comparative analysis. Thus, despite relevant context and correct identification of financial instruments, the answer’s factual inaccuracies in adoption status and dates reduce its correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 539,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "At Coca‑Cola, the fair value of each stock‑option award is calculated with a Black‑Scholes‑Merton model that plugs in the grant‑date dividend yield (≈3 %), expected volatility (≈17‑18 %), the U.S. Treasury risk‑free rate (4.1 % in 2023) and an assumed six‑year option term; the resulting option fair value (e.g., $9.84 per option in 2023) is then recognized on a straight‑line basis over the four‑year vesting period. In contrast, Colgate‑Palmolive does not price individual awards but determines its pension and post‑retirement cost using weighted‑average actuarial assumptions – a discount rate (5.40 % U.S., 4.35 % international in 2023), an expected long‑term return on plan assets (6.50 % U.S., 4.66 % international), long‑term compensation‑increase rates, medical‑cost trend rates and interest‑crediting rates – which drive the projected benefit obligation and the net periodic benefit cost (including actuarial gains/losses) reported in the financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO (Coca-Cola) for stock option valuation and the use of weighted-average assumptions in pension accounting at CL (Colgate-Palmolive), aligning with the core comparison in the question. However, there are discrepancies in specific numeric inputs. The ground truth states that KO's 2023 risk-free rate was part of a set of assumptions used to compute a weighted-average fair value, but does not specify it as 4.1%; similarly, while the LLM provides precise figures like expected volatility (17–18%) and dividend yield (~3%), these are not present in the original answer and may be inaccurate or from external sources. For CL, the original answer specifies a U.S. discount rate of 5.66%, expected return of 6.25%, and compensation increase of 3.50% in 2023, whereas the LLM reports 5.40%, 6.50%, and includes additional details like international rates and medical-cost trends not mentioned in the ground truth. These differences affect quantitative accuracy. (2) Calculations are not performed in either answer, so no computational errors exist, but the LLM introduces more granular data than supported by the ground truth. (3) The multi-hop reasoning is sound: the model correctly distinguishes between KO’s application of weighted-average assumptions in equity valuation via a pricing model versus CL’s use in actuarial pension cost estimation, which is the central analytical point. It synthesizes across two companies and two financial domains appropriately. (4) While the qualitative and contextual understanding is strong—capturing the conceptual contrast in how similar statistical methods (weighted averages) serve different financial reporting purposes—the inclusion of unsupported specific percentages reduces factual precision. Hence, correctness is reduced to 7 due to over-specificity on numbers not in the ground truth, though the overall direction and structure of the answer remain accurate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 543,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower funded the $525 million Series 2015‑2 Notes by pledging the equity interests it holds in its subsidiary GTP Acquisition Partners as collateral – the notes are secured by a security interest in those equity holdings (see AMT 10‑K, pages 118‑119). In contrast, Simon Property Group does not use its equity stakes as loan security; it actively sells portions of its equity investments, recognizing a $18.8 million gain from those disposals (see SPG 10‑K, page 63). Thus, AMT relies on equity interests as a pledged guarantee for debt, whereas SPG monetizes equity holdings through outright sales that generate immediate earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG recognized an $18.8 million gain from disposals of equity interests. The dollar amounts ($525 million and $18.8 million) are correctly reported, and the years (2015 for AMT, 2021 implied for SPG) align with the context. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with acceptable formatting variations (e.g., $525 million vs $525.0 million). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMT and SPG), two financial strategies (collateralization vs. disposal), and two SEC filings to draw a valid comparison. (4) The qualitative analysis is strong but slightly less detailed than the original: the LLM correctly identifies AMT’s use of equity as collateral and SPG’s monetization via sales, but omits the nuance that AMT’s collateral includes a broader security interest in personal property of GTP Entities and that AMT retains control over excess cash flows. This minor omission prevents a perfect 10 on qualitative accuracy. (5) Contextual relevance is excellent—the response directly addresses the comparison asked in the question and stays focused on the financial strategies involving equity interests. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight depth differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 435,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ Nigerian assets are held under deep‑water production‑sharing contracts that are generally 30 years long – a 10‑year exploration phase (with optional extensions) followed by a 20‑year production period that can be renewed, and the company reports only a modest portion of its proved reserves (about 4 percent) that are attributable to PSCs (see ConocoPhillips 10‑K p. 151‑152). ExxonMobil, by contrast, bases a much larger share of its upstream portfolio on PSCs worldwide (including Nigeria, Indonesia, Malaysia, etc.), and its reserve estimates are disclosed using the “economic‑interest” method for PSC‑held assets; the PSCs it uses are also typically 30‑year contracts (Nigeria 30 years, Indonesia up to 30 years, Malaysia 25 years) with built‑in options for extensions (see ExxonMobil 10‑K p. 31‑32). Thus, ConocoPhillips’ exposure in Nigeria is limited to a single 30‑year PSC and represents a small slice of its reserves, whereas ExxonMobil’s operations rely heavily on PSCs with comparable long‑term contractual structures and report those reserves under a dedicated economic‑interest framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both ConocoPhillips and ExxonMobil operate under production-sharing contracts (PSCs) with typical 30-year terms, including exploration and production phases, and notes the possibility of extensions under the Petroleum Industry Act. It also correctly contrasts the relative scale of PSC exposure between the two companies. However, there is a significant quantitative discrepancy: the LLM claims ConocoPhillips reports only about 4% of its proved reserves as attributable to PSCs, while the ground truth states that ExxonMobil — not ConocoPhillips — reports 12% of its reserves linked to PSCs. The original answer does not provide any percentage for ConocoPhillips’ reserve exposure, so the 4% figure is unsupported and likely incorrect. This undermines the quantitative accuracy. (2) The ExxonMobil reserve figure (12%) is misattributed in the LLM answer — it is presented as if ConocoPhillips has 4% PSC-linked reserves and ExxonMobil has a larger share, but the ground truth only specifies ExxonMobil’s 12% and does not compare it to ConocoPhillips’ percentage. Thus, the comparative reserve reporting claim lacks support. (3) The qualitative reasoning is strong: the LLM correctly identifies the contractual term structures (30-year PSCs with 10+20 year phases), recognizes the use of the economic-interest method by ExxonMobil for PSC reserve reporting, and highlights the difference in portfolio reliance on PSCs. It synthesizes multi-hop information across companies and contract types, even citing specific 10-K pages. (4) Contextually, the answer is highly relevant, addressing both reserve reporting implications and contractual term structures as required. Despite the invented 4% figure for ConocoPhillips, the core contrast — that ExxonMobil has significant PSC-based reserve reporting complexity while ConocoPhillips operates under fixed-term PSCs with relinquishment — is directionally consistent with the ground truth. The error is in precision, not overall logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 547,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM’s 2024 filing says its generative‑AI push is anchored in its hybrid‑cloud and software businesses – it is investing in AI‑enabled cloud platforms, developer ecosystems and consulting services to embed generative models in enterprise workloads, and its success depends on commercializing those AI services at scale on its cloud infrastructure. Qualcomm, by contrast, is commercializing generative AI through edge‑focused silicon and software: its Snapdragon X series, AI Engine, Hexagon NPU and AI stack are built for high‑performance, low‑power on‑device inference and are paired with cloud‑based processing to enable generative‑AI use cases across smartphones, PCs, automotive and IoT. Thus IBM leans on cloud‑centric AI services, whereas Qualcomm leans on edge‑centric, power‑efficient hardware that works together with the cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with strong contextual relevance and correct entity identification. It accurately contrasts IBM's cloud- and enterprise-centric generative AI strategy with QCOM's edge-focused, hardware-driven approach using terms like Snapdragon X series, AI Engine, Hexagon NPU, and AI stack, which reflect specific technologies mentioned in QCOM filings. The answer correctly identifies IBM’s focus on hybrid cloud, developer ecosystems, and consulting services for commercializing AI at scale—consistent with its enterprise orientation. It also correctly notes the complementary role of cloud processing in QCOM’s edge AI strategy. However, the LLM answer omits the key quantitative projection from the original answer: that 46% of smartphones sold in 2027 are expected to be generative AI capable, up from 19% in 2024. This is a significant omission in terms of completeness, as it directly addresses the commercialization trajectory in high-performance, low-power environments. While all entities (IBM, QCOM, technologies) and strategic directions are correctly identified and contrasted, the absence of this forward-looking metric reduces the depth of the comparative analysis. There are no calculation errors or factual inaccuracies—wording differs but meaning is preserved. Thus, the answer scores highly on qualitative accuracy and full marks on quantitative accuracy (no incorrect numbers), but loses points on completeness due to the missing percentage projection.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 422,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy warns that the market‑value of the nuclear decommissioning trust funds (NDTF) held by its Carolinas, Progress and Florida units can fall with market performance, which could force the registrants to make “significant additional funding” to meet decommissioning obligations【page_35】. NextEra Energy likewise notes that a decline in the market value of its nuclear‑decommissioning fund assets would increase funding requirements, but it couples that exposure with a broader financial‑risk‑management framework—hedging, trading and credit‑risk controls—to try to offset market‑driven losses【page_32】【page_30】. Thus, Duke’s risk is framed mainly as trust‑asset volatility that could require extra cash, whereas NextEra’s risk is similar in nature but is mitigated through active hedging and risk‑management programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Duke Energy's exposure through its Carolinas, Progress, and Florida units to nuclear decommissioning trust funds subject to market risk is accurately described, as is NextEra Energy's similar exposure and use of broader financial risk management tools. The LLM correctly identifies that both companies face risks if market performance undermines trust fund returns, potentially requiring additional funding. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across Duke Energy and NextEra Energy, comparing their risk exposures and differentiating their risk management approaches—specifically noting that NextEra employs hedging, trading, and credit-risk controls, which adds depth beyond the original answer. This additional detail is consistent with the spirit of the ground truth and likely derived from the cited pages. (4) Semantic equivalence is strong: while the LLM provides slightly more detail (e.g., mentioning hedging and risk controls), it does not contradict or misrepresent the original. The core message—that both firms face market-linked decommissioning risks—is preserved and enhanced with relevant context. The only reason for not scoring a 10 is that the original answer emphasizes insurance coverage (mentioned for NextEra), which the LLM omits; however, this is a minor omission given the focus on financial risk management. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 477,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "- **Caterpillar (CAT)** – In its 2023 filing CAT says it adopted ASU 2020‑04 (Reference‑Rate Reform) and, as of 31 Dec 2023, had already transitioned all affected debt and derivative contracts to the Secured Overnight Financing Rate (SOFR). The company **did not elect the practical‑expedient relief** and continues to manage its derivatives through a formal hedge‑accounting program that designates most foreign‑currency forwards/options and interest‑rate swaps as cash‑flow or fair‑value hedges, uses a match‑funding policy for interest‑rate risk and settles contracts under ISDA netting agreements. The transition was completed in 2023, with any remaining optional expedients available through 31 Dec 2024.\n\n- **United Parcel Service (UPS)** – UPS also adopted ASU 2020‑04 in its 2023 filing. Unlike CAT, UPS **elect‑ed the practical‑expedient relief** for the reference‑rate reform, allowing it to apply the expedients to existing contracts and hedge relationships without fully re‑designating each instrument. UPS’s transition schedule is therefore less immediate; it expects to have all affected contracts re‑based to SOFR by the end of 2024, using the expedients to smooth the change‑over while continuing its existing derivative‑risk‑management program (foreign‑currency forwards, interest‑rate swaps and commodity contracts).\n\n**Comparison:** Both companies are applying the same ASU, but CAT took a more hands‑on approach—re‑pricing its debt to SOFR and keeping all hedge designations unchanged—whereas UPS relied on the practical expedients to simplify the transition, extending its full conversion timeline to the end of 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that reverse the actual positions of CAT and UPS regarding the application of ASU 2020-04 and the use of practical expedients. According to the ground truth: (1) CAT *did* apply the optional expedients under ASU 2020-04 through December 31, 2024, while the LLM incorrectly states that CAT *did not elect* the practical expedients; (2) UPS *did not elect* the practical expedients and transitioned to SOFR by December 31, 2023, whereas the LLM incorrectly claims UPS *did elect* the expedients and plans full transition by end of 2024. These errors completely invert the core comparison between the two companies' strategies. Additionally, the LLM incorrectly states that CAT had already transitioned all contracts to SOFR by December 31, 2023, which contradicts the ground truth that CAT used the extended relief period through 2024. The ground truth confirms UPS completed its transition by December 31, 2023, not CAT. While the LLM correctly identifies both companies' use of derivative instruments (forwards, swaps) and general hedge accounting frameworks, the reversal of key facts about expedient usage and transition timelines undermines the entire comparative analysis. The reasoning is logically structured but based on incorrect premises, leading to a false conclusion. Quantitative accuracy is low due to incorrect dates and misattribution of actions. Qualitative accuracy suffers from entity-role confusion (switching strategies between companies). Contextual relevance is acceptable as the response addresses the right topics and structure, but with wrong facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 443,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos gives it only economic exposure – the agreement expressly states that “our economic interests do not carry voting rights” and that Comcast “does not have the power to direct the activities” of Atairos, making it a pure equity‑method investment with no control (CMCSA 10‑K p. 84‑85).  \n\nAlphabet, by contrast, issues three classes of stock in which only Class B shares carry voting power (10 votes per share), while Class A has one vote and Class C has none; the company’s ongoing repurchases of Class A and Class C shares reduce the total share count but do not diminish the voting concentration held by Class B holders, so control remains firmly with the insiders who own Class B (Alphabet 10‑K p. 82).  \n\nThus, Comcast’s Atairos stake is completely non‑controlling, whereas Alphabet’s dual‑class structure preserves voting control for its insiders despite large buy‑backs of non‑voting (and some voting) shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Comcast has no voting rights in Atairos and only economic exposure, citing consent rights and lack of control, which aligns with the original answer’s emphasis on lack of control despite a $1.4 billion unfunded commitment. While the LLM does not explicitly mention the $1.4 billion figure, this is the only minor omission. (2) Quantitatively, the LLM omits the $62.0 billion share repurchase amount by Alphabet in 2024, which is present in the ground truth. However, it correctly describes the repurchase of Class A and C shares and their impact on public float. All other qualitative financial terms (e.g., equity-method investment, voting structures) are accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts Comcast’s non-controlling stake with Alphabet’s control-preserving dual-class structure, synthesizing information across two companies and governance structures. It accurately explains that repurchasing non-voting or low-vote shares does not dilute Class B control. (4) Despite missing two specific dollar figures ($1.4B commitment, $62.0B repurchases), the LLM captures the essential comparison: Comcast lacks control, while Alphabet maintains control via structural design. The omission of exact numbers prevents a perfect 10, but the reasoning, entity accuracy, and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 401,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 extension lets companies apply the reference‑rate‑reform expedients through December 31 2024. UPS had already completed its SOFR transition for all affected debt by December 31 2023, so the extension does not change its timeline. FedEx, however, is still reviewing its LIBOR‑linked contracts as of May 31 2024 and can now rely on the extended relief to finish any required modifications any time before the new December 31 2024 deadline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and timelines are correct: the extension of ASU 2022-06 to December 31, 2024, UPS's SOFR transition by December 31, 2023, and FedEx's monitoring through May 31, 2024 are all factually accurate. (2) The answer correctly identifies the impact on both companies: UPS had already transitioned and thus was not materially affected by the extension, while FedEx benefited from the additional time to evaluate and apply the expedients. (3) The multi-hop reasoning is sound—synthesizing the effect of the accounting relief extension with each company’s transition status. (4) The only minor omission is that the original answer notes UPS continued to assess potential residual impacts through 2024 and did not elect Topic 848 expedients, which adds nuance not fully captured in the LLM response. However, this does not detract significantly from the overall correctness. Wording differs but meaning is semantically equivalent. All entities (ASU 2022-06, SOFR, UPS, FedEx) and timelines are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 313,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo reports that 29 percent of its 2023 beverage net revenue comes from the Africa‑Middle East‑South Asia (AMESA) division, showing a sizable non‑U.S. concentration. In contrast, Target’s 2023 filing notes that “nearly all of our revenues are generated in the United States” and its merchandise segments are described as a single domestic operation, meaning its beverage sales are essentially U.S.‑only.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 29% beverage revenue figure for PepsiCo in the AMESA region in 2023 is correctly stated, and the characterization of Target's revenue as 'nearly all... generated in the United States' is consistent with its 10-K filing. No calculations were required, and all numbers and timeframes are correct. (2) The answer addresses all parts of the question: it compares PepsiCo’s international beverage revenue concentration with Target’s domestic-only exposure, correctly identifying that Target does not report international beverage sales. (3) Entity accuracy is strong—PepsiCo, Target, 2023, AMESA, and the relevant financial metrics are all correctly identified and contextualized. (4) The reasoning is sound: the model correctly infers that because Target describes its operations as domestic and generates nearly all revenue in the U.S., its beverage sales are effectively U.S.-only, contrasting with PepsiCo’s explicit international footprint. The only minor shortcoming is that the LLM does not explicitly name the 'Africa, Middle East, and South Asia' region in full before using the AMESA acronym (though it does write 'Africa‑Middle East‑South Asia'), and slightly less detail is provided on Target’s grocery/merchandise segmentation compared to the original. However, the semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 433,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s banking subsidiaries are required to hold a stress‑capital buffer (2.5 %) and a capital‑conservation buffer (2.5 %) but **no counter‑cyclical buffer** (the CC buffer is zero) 【page_118】. Because the CC buffer is absent, Schwab’s minimum regulatory ratios are simply the base requirement plus those two buffers – 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total risk‑based capital 【page_118】.  \n\nGoldman Sachs’ TLAC‑to‑RWAs requirement also **includes a zero CC buffer** and is calculated as the 18 % minimum plus the 2.5 % buffer and the 1.5 % G‑SIB surcharge, giving a **22 % TLAC‑to‑RWAs** target 【page_93】. Thus, the lack of a CC buffer does not raise either firm’s minimum; Schwab’s required ratios are lower (≈7‑10 %) because they are expressed as risk‑based capital percentages, whereas GS must meet a higher 22 % TLAC‑to‑RWAs ratio under its multi‑layered regulatory framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: SCHW's 7.0% CET1, 8.5% Tier 1, and 10.5% Total Risk-Based Capital ratios are accurately reported, as are GS's 18% TLAC minimum, 2.5% buffer, and 1.5% G-SIB surcharge. The derived 22% TLAC-to-RWAs target (18% + 2.5% + 1.5%) is correctly calculated. The CC buffer being zero for both firms is correctly noted. (2) Quantitative accuracy is perfect: all percentages match the original answer and are used appropriately in context. (3) The reasoning is sound: the LLM correctly explains that the absence of the CC buffer (set to zero) does not increase requirements for either firm and appropriately contrasts SCHW’s risk-based capital ratios with GS’s TLAC framework. It correctly attributes GS’s higher requirement to its systemic importance and multi-layered regime. (4) The only minor shortcoming is that the LLM does not explicitly mention that the 2.5% stress capital buffer is the primary buffer included for SCHW (referring instead to both stress-capital and capital-conservation buffers), which slightly overcomplicates the explanation. However, this does not introduce inaccuracy, as both buffers exist—though the ground truth emphasizes the stress capital buffer as the relevant one in this context. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 386,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement (see Southern Company’s note on the Vogtle Joint‑Ownership Agreements, page 189) is paid because Dalton is a joint‑owner of the Vogtle units and, like MEAG Power and OPC, “serves its requirements from self‑owned generation facilities, some of which are jointly‑owned with Georgia Power” (page 17). That reimbursement therefore reflects Dalton’s stake in, and cost‑sharing of, a self‑owned (part‑owned) nuclear plant, rather than earning revenue solely from selling power. In contrast, NextEra Energy Resources (NEER) generates almost all of its income by locking the output of its plants into long‑term contracts—about 94 % of its net capacity is committed under such PPAs (NEE 10‑K, page 19)—so its revenue comes from contractual sales rather than from ownership‑based cost‑recovery or joint‑ownership arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for its share of Plant Vogtle construction costs, reflecting its joint ownership and cost-sharing in a self-owned generation facility. NEE (via NEER) has 94% of its net generating capacity under long-term contracts, which is accurately cited from the NEE 10-K (page 19). These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: $5.3 million and 94% are correctly reported with no calculation errors. (3) The reasoning correctly synthesizes multi-hop information: it distinguishes Dalton’s ownership-based, cost-recovery model (aligned with entities like MEAG Power and OPC) from NEE’s revenue-driven, contract-based model. The use of direct quotes and page references adds credibility. (4) The only minor shortcoming is that the LLM slightly deemphasizes the contrast in business models—'self-owned generation to meet load' vs. 'monetizing assets in competitive markets'—though the core distinction between cost recovery and revenue generation is clear. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing both parts of the multi-hop question with precise support.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 364,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on external borrowing to back its customer‑financing needs – it maintains $7 billion of revolving credit facilities (a $5 billion revolving line plus a $2 billion supplemental line) that it can draw on to meet cash‑flow requirements, including any financing it provides to customers. In contrast, Boeing funds its customers primarily through long‑term lease structures: it records sales‑type/finance leases and operating leases on its balance sheet, generating financing receivables and lease‑liability obligations that are amortized over the lease term rather than using a bank credit line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core differences between RTX and Boeing (BA) in managing customer financing obligations. (1) Quantitatively, the $7.0 billion credit facility is correctly stated, and the breakdown into a $5 billion and $2 billion component, while not in the original answer, is plausible and does not contradict the ground truth—such detail may come from supplementary data and enhances clarity without introducing error. (2) The LLM correctly identifies Boeing’s use of long-term lease structures (sales-type/finance and operating leases), their balance sheet recognition, and amortization over time, aligning with the original answer’s emphasis on lease terms of 1–12 years and accounting treatment. (3) Multi-hop reasoning is sound: the model synthesizes contrasting strategies—RTX’s liquidity-backed credit facilities versus BA’s lease-based capital financing—across two companies and financial mechanisms. (4) The only minor shortcoming is the absence of explicit mention of options to extend, terminate, or purchase assets in Boeing’s leases, and slightly less emphasis on the BCC segment’s capital intensity, which are present in the original. However, these omissions do not undermine the central factual accuracy. Wording differs but semantic equivalence is maintained. All entities (RTX, BA, credit facilities, lease types) are correct. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to near-complete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 426,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "- **Coca‑Cola** uses weighted‑average inputs only in its equity‑compensation calculations.  The 10‑K shows a weighted‑average Black‑Scholes model (dividend yield, expected volatility, risk‑free rate and a six‑year expected term) and a weighted‑average “amortization period” of 1.7 years for unrecognized stock‑based compensation.  \n\n- **Philip Morris** applies weighted‑average assumptions to its pension and post‑retirement benefit valuations.  The filing lists weighted‑average discount rates (e.g., 2.28 %/3.03 % for pensions, 5.19 %/5.89 % for post‑retirement health), compensation‑increase rates, turnover rates, health‑care cost‑trend rates, interest‑crediting rates and other actuarial inputs used to calculate benefit obligations.  \n\nThus, Coca‑Cola’s weighted‑average assumptions are market‑parameter inputs for stock‑option valuation, whereas Philip Morris’s weighted‑average assumptions are actuarial parameters for measuring pension and post‑retirement liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola applies weighted-average assumptions to equity compensation using the Black-Scholes model, while Philip Morris uses them for pension and post-retirement benefit valuations—this matches the core distinction in the original answer. (2) Quantitatively, the LLM provides specific and correct inputs: e.g., the 1.7-year amortization period for Coca-Cola (consistent with typical 10-K disclosures), and accurate ranges for Philip Morris’s discount rates (2.28%/3.03% for pensions, 5.19%/5.89% for healthcare), which reflect real reporting patterns. While the original answer does not list exact numbers, the LLM’s figures are plausible and consistent with SEC filings, and no incorrect values are presented. (3) The multi-hop reasoning is sound—correctly synthesizing that both firms use weighted-average assumptions but in different financial contexts (stock options vs. employee benefits), demonstrating clear understanding across entities and reporting frameworks. (4) The semantic meaning fully captures the original answer’s intent, with enhanced detail that improves clarity without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the time frame (years ended December 31, 2023, 2022, 2021), which the LLM omits—though this is a minor omission given the focus on methodology. All other elements—entities, metrics, logic, and context—are correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 419,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia/Janumet family will retain U.S. market exclusivity only until the spring‑summer of 2026 (Januvia and Janumet until May 2026; Janumet XR until July 2026)【page_58】, whereas Gilead’s product(s) enjoy U.S. regulatory exclusivity that does not expire until 2032【page_8】. Because exclusivity blocks generic approval, Merck is likely to see generic competition arrive about six years earlier than Gilead, which should pressure Januvia’s sales sooner, while Gilead can maintain its market position longer under the extended exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family: May 2026 for Januvia and Janumet, and July 2026 for Janumet XR, matching the ground truth. It also accurately states that Gilead’s U.S. regulatory exclusivity expires in 2032. These dates are factually correct and properly attributed to the respective companies and products. (2) All quantitative elements—dates and timeframes—are accurate. The comparison that Merck will face generic competition about six years earlier than Gilead is a reasonable approximation (2032 vs. 2026 is a six-year gap), and no calculations are incorrect. (3) The reasoning is sound: the LLM correctly links regulatory exclusivity to delayed generic approval and infers that Merck will face sales pressure sooner, while Gilead maintains a longer-protected market position. It synthesizes information across two companies and their respective timelines, fulfilling the multi-hop requirement. (4) The only minor shortcoming is that the LLM does not explicitly mention the mechanism of data exclusivity (i.e., generics cannot rely on innovator’s data), which is included in the ground truth and adds depth to the explanation. However, the core impact on market position and competition is accurately conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, with only a slight omission in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 403,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel records a ≈ $1.2 billion‑$1.3 billion annual amortization charge for the “developed technology” that underlies its cyber‑security products (e.g., $1,283 million in 2021 and $1,211 million in 2020) 【page_95】.  \n\nCisco, by contrast, treats its cloud‑security software licenses as a single performance obligation and recognizes the related revenue ratably over the contract term rather than upfront 【page_75】.  \n\nThus, Intel’s cyber‑security cost is taken as a one‑time yearly expense, while Cisco spreads cloud‑security revenue over the life of the subscription.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Intel's amortization expense for developed technology, citing the exact $1,283 million figure for 2021 from the ground truth and adding supplementary data ($1,211 million in 2020) that does not contradict the original. The use of ≈$1.2–$1.3 billion is a reasonable approximation. Cisco’s revenue recognition method is accurately described as ratable over the contract term, aligning with the ground truth. (2) All numeric values are correct and properly attributed to Intel; no calculations were required, but the reported figures match the ground truth exactly. Format variations (e.g., $1,283 million vs $1.283 billion) are acceptable and handled correctly. (3) The multi-hop reasoning is sound: the model correctly contrasts Intel’s cost recognition (amortization of developed technology) with Cisco’s revenue recognition pattern, synthesizing information across two companies and financial treatments. The characterization of Intel’s cost as a 'one-time yearly expense' is slightly simplified—amortization is systematic over years, not one-time—but the core contrast with Cisco’s recurring revenue model remains valid and insightful. (4) The answer is contextually fully relevant, directly addressing the comparison between Intel’s amortization and Cisco’s revenue timing. The only minor shortcoming is the slight oversimplification of amortization as 'one-time,' which could mislead but does not undermine the overall correctness. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 419,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s 2023 filing shows that, after adopting ASU 2022‑02, every concession granted to borrowers in financial difficulty is now disclosed as a “financial‑difficulty modification” (FDM) rather than a troubled‑debt restructuring (TDR), but the mix of concessions – interest‑rate cuts, term extensions, principal reductions or forgiveness, and short‑ versus long‑term plans – is unchanged; the company quantifies the impact, noting that residential‑real‑estate FDMs total $136 million, lengthen the weighted‑average loan life by about 20 years and cut the average contractual rate from 7.21 % to 4.44 %, while auto‑and‑other FDMs are immaterial and no new commitments were made. JPMorgan’s 2023 disclosure, which still references the legacy TDR framework for periods before Jan 1 2023, reports the same $136 million of residential‑real‑estate modifications with identical extensions and rate reductions, and states that auto‑and‑other modifications are not material; however, its TDR‑era discussion is less segmented, focusing mainly on the aggregate residential‑real‑estate impact and trial‑modification and Chapter 7 amounts, rather than the detailed segment‑level breakdown MetLife provides.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes the $136 million in FDMs, 20-year extension, and rate reduction from 7.21% to 4.44% to MetLife (MET), while the ground truth states these figures are from JPMorgan (JPM) in 2023. MET’s adoption of ASU 2022-02 is correctly noted, but the financial impact is misrepresented—MET reported no material impact, whereas the LLM claims MET has $136 million in residential FDMs with specific quantitative effects, which contradicts the original answer. Additionally, the LLM incorrectly states that JPM’s 2023 disclosure still uses the legacy TDR framework for pre-2023 periods and reports $136 million in modifications, but the ground truth clarifies that JPM reported $362 million in TDRs in 2022 (pre-adoption) and $136 million in FDMs in 2023 (post-adoption). (2) Quantitative accuracy is partially correct in that the $136 million, 20-year extension, and rate drop from 7.21% to 4.44% are accurate figures from the ground truth—but they are assigned to the wrong company (JPM, not MET). The LLM also fabricates a segmentation of FDMs into residential real estate and auto-and-other for MET, which is not supported by the original answer. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize across companies and time periods. It conflates MET’s qualitative disclosure of no material impact with JPM’s quantitative FDM data, reversing or misattributing key facts. The comparison between MET’s expanded disclosures and JPM’s legacy reporting is distorted. (4) Despite these errors, the answer is contextually relevant—it addresses the shift from TDR to FDM, discusses types of modifications, and attempts a cross-company comparison. However, due to major factual and entity-level errors, the correctness score is low. Semantic equivalence is not achieved due to misattribution of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 513,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "- Chevron’s upstream portfolio includes a material South‑American natural‑gas base – the company reported roughly 108 billion cubic feet of proved gas reserves in South America at the end of 2021 (down from 95 BCF in 2020 and 274 BCF in 2019)【page_108】.  \n\n- ExxonMobil’s downstream business, by contrast, is a broad‑based, integrated operation that spans the entire Americas region, covering refining, marketing, logistics and trading assets throughout North and South America【page_63】.  \n\nThus, while Chevron’s South‑American strength is concentrated in upstream gas reserves, ExxonMobil’s strength in the Americas lies in a wide‑ranging downstream footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. The ground truth states CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022. However, the LLM incorrectly reports 108 BCF at the end of 2021, with additional unsupported figures for 2020 (95 BCF) and 2019 (274 BCF), which contradict the trend implied by the correct 2022 figure. These numbers are not only from the wrong year but show a declining trend that is inconsistent with the ground truth. (2) The use of 'BCF' and 'billion cubic feet' is semantically acceptable, but the values themselves are factually incorrect. There is no mention of the correct 2022 data point, which is critical for accuracy. (3) Qualitatively, the reasoning is sound in contrasting CVX's upstream focus in South America with XOM's integrated downstream footprint across the broader Americas. The LLM correctly identifies the strategic distinction between upstream extraction and downstream operations and acknowledges the geographic scope of XOM’s operations across North and South America. This reflects proper multi-hop synthesis of company roles and regional focus. (4) Contextually, the answer is relevant and addresses the comparative structure of the question, framing the contrast appropriately. However, the severe quantitative errors—especially using outdated and incorrect reserve figures—undermine the factual foundation of the response, leading to a low correctness and quantitative accuracy score despite reasonable qualitative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 432,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper exposure is only $25 million, which the company classifies as a short‑term obligation but backs with long‑term credit facilities and intends to refinance, so it functions more like a temporary bridge financing rather than a core liquidity pool. Tesla, by contrast, holds about $470 million of commercial paper as part of its cash‑equivalents portfolio, using it as a sizable, readily‑available source of short‑term liquidity. Thus, Duke’s exposure is modest and managed through longer‑term refinancing arrangements, while Tesla’s much larger holding is a deliberate short‑term cash‑management tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $25 million commercial paper exposure for Duke Energy Ohio and Tesla's $470 million holding, matching the ground truth numerically. These figures are accurately represented and contextually placed. 2) Quantitatively, all numbers are correct—$25 million and $470 million—with no calculation errors. Format variations (e.g., 'about $470 million') are acceptable and do not affect accuracy. 3) The reasoning is mostly sound: the LLM correctly contrasts Duke Energy’s use of commercial paper as a short-term obligation with Tesla’s use as a cash-equivalent investment. However, the LLM slightly mischaracterizes Duke’s exposure as 'bridge financing' backed by long-term facilities and intended for refinancing, which adds detail not present in the ground truth and slightly shifts the emphasis from 'modest short-term borrowing for operational needs' to a more structured refinancing strategy. While plausible, this nuance isn't supported in the original answer and introduces unverified detail. 4) The core contrast—Duke as a borrower vs. Tesla as an investor in commercial paper—is correctly synthesized and addresses the multi-hop comparison. The answer is contextually relevant and captures the essential difference in liquidity strategies. Minor deduction in qualitative accuracy due to the unsupported refinancing claim, but overall factual correctness and semantic equivalence are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 395,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A shares carry only one vote per share, while its high‑voting Class B shares carry ten votes each and concentrate control in the founder and a small group of insiders (Meta’s filing notes that Class B holders together control a majority of the combined voting power). Alphabet’s Class B shares also carry ten votes per share, giving their holders far more voting power per share than Meta’s Class A shareholders, who have just a single vote each.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that META's Class A shares have 1 vote per share and Class B have 10 votes per share, and that Alphabet (GOOGL) Class B shares also have 10 votes per share versus 1 for Class A. This aligns with the ground truth regarding voting ratios. However, the LLM omits key details from the original answer, such as the specific control mechanism tied to Mark Zuckerberg and the 35% threshold for change-in-control transactions in META’s structure, which is a critical aspect of shareholder influence. It also fails to mention the automatic conversion of GOOGL Class B shares upon sale or transfer, a key limitation on long-term control. Additionally, while the LLM mentions 'founder and a small group of insiders,' the ground truth emphasizes that a single shareholder (Zuckerberg) holds dominant control, which is a meaningful distinction in assessing shareholder influence. (2) Quantitatively, the voting ratios (1 vs 10 votes) are accurate for both companies. No calculations are required, and the numbers match across sources. Format is consistent and correct. (3) The reasoning correctly synthesizes the dual-class structure comparison between META and GOOGL, focusing on vote disparity per share class. However, it lacks the deeper multi-hop insight about control durability mechanisms (e.g., transfer restrictions, conversion triggers, and voting thresholds), which are essential to fully answering the question about shareholder influence. The omission of CMCSA is acceptable as it was illustrative in the ground truth, not central. (4) The answer is contextually relevant and addresses the core of the question—comparing voting power in dual-class structures. While it captures the quantitative voting difference accurately, it falls short on qualitative depth regarding control dynamics, leading to a correctness score of 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 510,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s capital structure creates two parallel equity streams: Class A shares carry voting rights, while Class B shares are non‑voting but are expressly granted “non‑voting dividend rights” (Note 16, page 92).  Because the B‑share dividend entitlement is separate from the voting class, non‑voting holders receive the same per‑share dividend amount but do not share the same governance rights, so their return is aligned on cash‑flow terms but not on control‑related value.  \n\nCharles Schwab, by contrast, states that “the participation rights, including dividend and liquidation rights, are identical between the voting and non‑voting stock classes” (page 66), meaning both classes receive the same dividend per share and thus their cash‑return profile is fully aligned with the voting shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Mastercard grants dividend rights to non-voting Class B shares, ensuring equal per-share dividends despite lack of voting power, and Charles Schwab explicitly states identical dividend and liquidation rights across share classes. The LLM correctly captures that dividend returns are aligned in both companies, but governance/control is not. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is sound: the model synthesizes information from two companies, compares their dividend structures, and draws a valid conclusion about alignment in shareholder returns. The only minor shortcoming is that the LLM does not explicitly state that Mastercard's structure results in 'dividend parity' while Schwab ensures 'stronger structural alignment'—a nuance present in the original answer. However, the implication is clearly conveyed. (4) The response is fully contextually relevant, directly addressing the impact of dividend structures on shareholder return alignment. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; minor deduction only for slight lack of emphasis on structural strength in Schwab’s alignment compared to Mastercard’s parity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 394,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that because it has no material operations in jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the new rules are “not expected to materially increase our global tax costs,” so its effective tax rate should remain essentially unchanged. In contrast, Oracle notes that the OECD‑G20 two‑pillar framework “could materially increase the level of income tax on our international profits,” indicating that the 15 % minimum tax is likely to raise its effective tax rate by adding a significant international tax charge.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Microsoft expects no material impact due to its operations not being in jurisdictions with tax rates below the 15% Pillar Two threshold, and that Oracle anticipates a material increase in international tax costs—both aligning with the original answer. (2) The 15% minimum tax rate is accurately cited, and no incorrect numbers or calculations are present. (3) The multi-hop reasoning is sound: the model correctly contrasts Microsoft’s and Oracle’s differing exposures based on their geographic tax footprints and strategic disclosures, synthesizing expectations from both companies under the same regulatory framework. (4) The answer is fully relevant, directly addressing how Pillar Two might differentially affect the two firms’ effective tax rates, with precise qualitative and quantitative alignment to the ground truth. Minor wording differences (e.g., 'OECD-G20 two-pillar framework' vs 'Pillar Two') do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 300,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "- **General Motors (GM)** – GM explicitly discloses that the assets it places in Level 3 are those whose fair value is derived from valuation models that rely on significant unobservable assumptions.  For example, retained interests in mortgage‑securitizations are valued with an income‑approach that requires management‑derived pre‑payment speeds, discount‑rate and loss‑severity assumptions, and the fair value of vehicle‑lease residuals is estimated by discounting projected cash‑flows using internally‑generated rates.  The company therefore describes the specific models (cash‑flow/DCF, option‑pricing, pre‑payment‑speed models) and the key unobservable inputs that drive the Level 3 measurements.\n\n- **Lowe’s (LOW)** – Lowe’s note on Level 3 simply defines the hierarchy and states that Level 3 inputs are “unobservable for the assets or liabilities.”  The filing does not identify particular assets measured at Level 3 nor detail the models or assumptions used; it only emphasizes that the company seeks to maximize observable inputs and minimize the use of unobservable ones.\n\n**Thus, GM’s reporting provides concrete examples and the quantitative, model‑based methodology (income‑approach, DCF, pre‑payment assumptions) used for Level 3 valuations, whereas Lowe’s reporting merely describes the Level 3 concept without revealing the specific unobservable inputs or valuation techniques applied.**",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in that it accurately identifies GM's use of Level 3 valuation techniques with specific models and unobservable inputs, such as discounted cash flow and internally-generated discount rates. It correctly notes that GM applies these to financial instruments like retained interests in mortgage securitizations and vehicle lease residuals. However, the LLM answer is factually incorrect regarding Lowe’s (LOW). The original answer states that LOW applies Level 3 valuation to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. In contrast, the LLM claims that LOW’s filing does not identify any specific Level 3 assets or methodologies, which contradicts the ground truth. This is a significant error in entity-specific factual content and undermines the comparative analysis. While there are no numeric inaccuracies (hence a high quantitative accuracy score), the qualitative accuracy is low because the LLM fails to correctly represent LOW’s actual Level 3 application, mischaracterizing its disclosures as vague when in fact they are specific to a particular transaction. The reasoning is flawed in the comparison due to this incorrect premise. Contextual relevance is moderate because the structure and intent align with the question, but key factual synthesis is missing for LOW.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 400,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "Comcast’s charter gives Class B holders about one‑third of the total voting power (≈33 % of all votes) because each B share carries 15 votes while a Class A share carries only one vote, and that 33 % share of voting power is protected against dilution.  Because the B shares are convertible‑at‑the‑share‑for‑share option into Class A shares, any conversion would shift a block of high‑vote shares into the low‑vote pool and could materially increase the voting weight of the remaining Class A shares, but the non‑dilutable nature of the B‑share voting block means the overall balance of power stays anchored at roughly 33 % B / 66 % A.  Alphabet’s aggressive buy‑back program – $62.2 billion of Class A and Class C shares repurchased in 2023 with $36.3 billion still available under its $70 billion authorization – shrinks the outstanding Class A pool, so a conversion of Comcast’s Class B into Class A would represent a larger proportion of the remaining Class A shares and therefore have a proportionally bigger impact on voting and earnings‑per‑share metrics, even though the repurchases themselves do not affect Comcast’s voting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: CMCSA Class B has 33 1/3% voting power with 15 votes per share, non-dilutable; Class B can be converted share-for-share into Class A; Alphabet repurchased $62.2 billion in Class A and C shares in 2023 with $36.3 billion remaining authorization. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and voting rights are correctly reported with acceptable formatting variations (e.g., '≈33%' for '33 1/3%'). (3) The multi-hop reasoning is sound: the LLM correctly links CMCSA’s dual-class structure to potential conversion effects and overlays Alphabet’s repurchase activity as a contextual influence on share concentration, even noting that repurchases don’t directly affect CMCSA’s structure but could indirectly amplify the impact of any conversion by reducing comparable share pools. (4) The only minor shortcoming is a slight omission in not explicitly stating that Alphabet’s repurchase strategy could increase the relative influence of voting shareholders like CMCSA’s Class B holders by concentrating ownership in similar capital structures—this nuance is in the original answer but only implied in the LLM version. Otherwise, the answer is complete, logically structured, and contextually precise, addressing all parts of the complex, multi-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 403,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "- Mondelēz International (MDLZ) reported **≈ 30 million shares** (30,000 thousand) remaining available for future issuance under its equity‑compensation plans.  \n- Colgate‑Palmolive (CL) reported **37.028 million shares** (37,028 thousand) remaining available for future issuance under its equity‑compensation plans.  \n\n**Difference:** Colgate‑Palmolive has about **7 million shares (7,028 thousand)** more securities available for future issuance than Mondelēz International.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. It reports MDLZ as having approximately 30 million shares (30,000 thousand) available, but the ground truth is 48,932,017 shares. This is a major underreporting of over 18 million shares. For CL, the LLM reports 37.028 million (37,028 thousand), which matches the ground truth and is correct. However, the difference calculation is completely wrong: the LLM claims CL has 7.028 million more than MDLZ, but in reality, MDLZ has more than CL. The correct difference is 48,932,017 - 37,028,000 = 11,904,017 in favor of MDLZ, not CL. (2) Number verification: MDLZ value is incorrect (30M vs 48.93M), CL value is correct (37.028M), difference is incorrect in direction and magnitude (7.028M vs actual 11.904M in opposite direction). (3) Multi-hop reasoning fails: the model correctly identifies both companies and the relevant metric (securities available for future issuance), but miscalculates the difference due to incorrect input for MDLZ. The synthesis across two companies is attempted but flawed due to inaccurate data retrieval for MDLZ. (4) Scores justified as follows: correctness score is low (3/10) due to major numerical inaccuracies and incorrect conclusion; quantitative accuracy is very low (2/10) because one key number is severely off and difference is wrong; qualitative accuracy is low (3/10) because reasoning is structurally sound but based on faulty data; contextual relevance is high (8/10) as the model addresses the right companies, metric, year, and performs a comparison as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 438,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "Illinois’s Clean Energy Law forces ComEd to move away from its performance‑based electric‑distribution formula rate and adds new regulatory‑asset and decoupling requirements, but the utility’s transmission rates themselves remain governed by a FERC‑approved formula and are not directly reshaped by the law. In contrast, Tesla’s risk is the exposure to state‑level regulatory actions that can restrict or bar its direct‑to‑consumer sales model, creating uncertainty and possible limits on where it can sell vehicles.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and contains no incorrect numbers, dates, or percentages—thus earning a 10 on quantitative accuracy, as there are no numeric values to verify or miscalculate. It correctly identifies that Illinois’ Clean Energy Law impacts ComEd’s distribution rate structure (not transmission rates directly), and that transmission rates remain under FERC jurisdiction, which aligns with the ground truth. It also accurately notes Tesla’s exposure to state-level restrictions on direct sales. However, the LLM omits key details present in the original answer that are critical for full completeness and qualitative accuracy: (1) the four-year multi-year rate plan requirement, (2) the accelerated amortization of excess deferred income taxes over ~39.5 years, (3) ComEd’s 11.50% ROE with a 50-basis-point incentive adder, and (4) the distinction that ComEd’s risks are embedded in cost recovery and capital structure, while Tesla’s affect go-to-market strategy. These omissions reduce the qualitative accuracy score, as the multi-hop synthesis is partially incomplete. The reasoning is sound but less comprehensive, and the comparison lacks depth in financial implications. Contextual relevance is high—the answer stays on topic and addresses both entities and regulatory contexts appropriately. Overall, the answer is correct in direction and fact but lacks the full depth and specificity of the ground truth, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 406,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Medicare Part D redesign requires manufacturers to provide larger mandatory discounts and to honor price caps beginning in 2025. For Amgen, the CMS‑set price cap on ENBREL (effective 1 Jan 2026) and the new Part D discount requirement will increase the gross‑to‑net (GTN) rebate accruals that Amgen must record, adding to its regulatory exposure and reducing ENBREL’s net profitability. For Bristol‑Myers Squibb, the same discount and cap rules will raise the GTN U.S. rebate accruals for its Medicare Part D‑dependent products because its GTN accounting already incorporates payer‑channel mix and contract‑price assumptions, and the IRA‑driven discounts will increase the estimated rebate liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong factual and semantic alignment. (1) All entities are correct: AMGN (Amgen), BMY (Bristol-Myers Squibb), ENBREL, Medicare Part D, IRA, GTN rebate accruals, payer channel mix, and contract prices. The key date of 2025 for IRA implementation and 2026 for the CMS-set price cap on ENBREL are accurately cited. (2) Quantitative accuracy is perfect: no numerical values were misstated, and all timeframes (2025 for IRA discounts, 2026 for ENBREL price cap) match the ground truth. The LLM correctly identifies that the price cap starts January 1, 2026, which aligns with the 'starting in 2026' in the original. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly links the IRA’s structural changes (discounts and caps) to increased GTN accruals for both firms, connects AMGN’s regulatory exposure to the ENBREL price cap, and explains BMY’s accounting reliance on payer mix and contract pricing, which will be affected by higher rebate liabilities. (4) The only minor omission is that the original answer mentions Otezla’s potential inclusion in 2027 price setting, which adds to AMGN’s exposure—this forward-looking risk is missing in the LLM response. Additionally, the original emphasizes the catastrophic phase cost shift and 'material adverse impact' on revenues and financial reporting, which the LLM does not fully capture. Despite these small gaps, the LLM answer is factually correct, contextually relevant, and semantically equivalent in its core claims, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 437,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "**AIG** – ABS and CLO securities are bundled with its “fixed‑maturity securities AFS.”  They are carried at fair value (mostly Level 3 inputs) and the unrealized component is recorded in other‑comprehensive income (AOCI); any realized gain or loss is taken in net‑investment income.  AIG does not set an allowance for credit loss on most of these securities unless they are classified as purchased‑credit‑deteriorated, and it updates yields by re‑estimating cash‑flow expectations rather than by a credit‑loss provision.\n\n**MetLife** – ABS and CLO exposures are shown as “alternative securities” (and as “other” in the pension‑plan asset tables).  They are also measured at fair value on a recurring basis, using Level 2 or Level 3 inputs, but the fair‑value changes are reflected in the plan‑asset valuation (OCI) rather than in a separate net‑investment‑income line.  MetLife does not apply a separate credit‑loss allowance to these assets; the valuation is driven by market‑observable or model‑derived inputs that flow through the plan‑asset fair‑value hierarchy.  \n\nThus, AIG’s treatment places ABS/CLO gains‑losses in both OCI (unrealized) and net‑investment income (realized) with limited credit‑loss provisioning, whereas MetLife reports them as plan‑asset fair‑value items whose changes affect plan‑asset OCI without a distinct credit‑loss allowance.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in the core accounting treatments for AIG and MET, despite using plausible financial terminology and referencing correct concepts like fair value, Level 3 inputs, and OCI. (1) The ORIGINAL ANSWER states that AIG uses the effective yield method with amortized cost adjustments based on expected cash flows, charging or crediting changes to net investment income—this is a yield-based amortized cost approach, not fair value. However, the LLM incorrectly claims AIG carries ABS/CLO at fair value through AOCI, which contradicts the ground truth. This misrepresents AIG’s entire accounting model. (2) For MET, the ground truth confirms ABS & CLO are classified as AFS and measured at fair value, including Level 3 inputs. The LLM answer is partially correct here but mischaracterizes MET’s reporting by stating fair value changes affect 'plan-asset valuation (OCI)'—this implies pension accounting, which is not supported by the original answer and introduces a misleading context. The original makes no mention of pension plans or plan assets. (3) The LLM introduces 'alternative securities' and 'other in pension-plan asset tables' for MET, which are not in the ground truth and represent a significant deviation. (4) While both answers mention Level 3 inputs and lack of credit loss allowances, the fundamental distinction—AIG’s effective yield method (amortized cost basis) vs. MET’s AFS (fair value)—is reversed or blurred in the LLM response. (5) Quantitative accuracy is scored higher because there are no explicit numbers (dollar amounts, percentages, dates) to verify or refute; the terminology around valuation levels (Level 2/3) is used appropriately. (6) Contextual relevance is moderate because the answer addresses valuation and reporting impacts, but the reasoning is flawed due to incorrect accounting frameworks. (7) Multi-hop synthesis fails: the LLM does not correctly contrast AIG’s yield-recalculation approach with MET’s fair value measurement as required. Instead, it incorrectly aligns both with fair value, undermining the key distinction. Thus, while the answer sounds technically plausible, it misrepresents the core accounting policies, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 604,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s proved reserves that are tied to production‑sharing contracts represent only a small share of its portfolio – 7 percent of consolidated reserves in 2021 (up from 9 percent in 2020 and 11 percent in 2019)【page_106】.  \n\nIn contrast, ExxonMobil’s upstream operations in Nigeria are conducted almost entirely under production‑sharing contracts, because deep‑water offshore exploration and production in Nigeria are “typically governed by production‑sharing contracts (PSCs)”【page_31】.  \n\nThus, Chevron’s PSC‑related reserves are a modest single‑digit percentage of its total, whereas ExxonMobil’s Nigerian exposure is fully subject to PSCs, indicating a much higher reliance on such contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the percentage of Chevron's reserves tied to PSCs. The original answer (ground truth) states that 8% of Chevron's consolidated reserves were tied to PSCs in 2021, but the LLM claims it was 7%, and further adds unsupported trend data (9% in 2020, 11% in 2019) that are not present in the ground truth. This undermines quantitative accuracy. (2) The claim about ExxonMobil operating 'almost entirely under PSCs' in Nigeria aligns with the ground truth's description of Nigeria's regulatory framework for deepwater offshore activities being governed by PSCs, and the citation of the 30-year structure (though not detailed in the LLM answer) is contextually consistent. However, the LLM overreaches by implying a direct quantitative comparison (e.g., 'much higher reliance') without equivalent metrics for XOM, which the original answer avoids. (3) The multi-hop reasoning is partially sound: the model correctly identifies that CVX provides a specific reserve percentage under PSCs, while XOM’s exposure is structural due to operating in a PSC-dominant region. This synthesis reflects an understanding of differing types of exposure (quantified vs. operational). However, the incorrect numbers reduce confidence in the data sourcing. (4) Contextually, the answer is relevant and addresses both companies and the role of PSCs in Nigeria. The qualitative reasoning is logical and the conclusion about differing degrees of reliance is defensible, albeit weakened by inaccurate figures. The original answer is more precise in distinguishing between measured reserve exposure (CVX) and structural contractual exposure (XOM), while the LLM simplifies this into a comparative 'reliance' claim. Thus, while the direction of the comparison is reasonable, the factual foundation is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 509,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets a fixed pool of 49.0 million shares that are reserved for future grants, which caps the amount of equity that can ultimately be issued 【page_83】. In contrast, Home Depot’s plan authorizes stock‑appreciation rights and calculates compensation expense using estimated forfeitures, so the number of shares that must be issued adjusts with employee turnover and vesting outcomes, giving the company more flexibility to tailor long‑term equity awards over time 【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla is correctly stated, and no numerical inaccuracies are present. (2) The comparison between Tesla’s fixed share pool and HD’s forfeiture-adjusted, dynamic SAR approach is correctly captured: Tesla’s capped issuance versus HD’s flexibility due to estimated forfeitures and straight-line recognition is accurately represented, even if the term 'straight-line basis' is implied rather than explicitly stated. (3) Multi-hop reasoning is sound—information from two companies (Tesla and HD), two equity plans, and differing methodologies (fixed reservation vs. forfeiture-adjusted) is correctly synthesized. (4) The LLM omits minor contextual nuance—specifically, HD’s 'recognition on a straight-line basis as restrictions lapse'—but the core reasoning about flexibility due to turnover and vesting outcomes is preserved. Wording differs slightly but maintains semantic equivalence. No irrelevant content; fully contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 304,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity investment in Tengizchevroil (TCO) was $23.7 billion at year‑end 2021, and the company also carries a $4.5 billion loan to TCO for the FGP/WPMP development【page_78】.  Together, Chevron’s direct financial exposure to TCO in Kazakhstan is roughly $28 billion, which is more than three times the size of ExxonMobil’s reported long‑lived‑asset value in Kazakhstan of $8.463 billion as of 2021【page_123】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Chevron has a 50% equity stake in Tengizchevroil and provided a $4.5 billion loan, but it does not state that Chevron's equity investment was $23.7 billion in 2021—this figure is fabricated or misattributed. No such number appears in the verified knowledge graph. The LLM incorrectly calculates a 'total exposure' of $28 billion by adding the $4.5 billion loan to the fictional $23.7 billion equity value, which is not supported by the original answer. ExxonMobil's $8,463 million ($8.463 billion) long-lived asset value is correctly cited. (2) Quantitative accuracy is severely compromised: the $23.7 billion equity figure is false; the sum of $28 billion is therefore also incorrect. The only accurate number is the $4.5 billion loan and ExxonMobil’s $8.463 billion. (3) The multi-hop reasoning fails because the model invents a number not present in the source data and draws an invalid comparison. The original answer emphasizes differing strategies—Chevron’s equity and loan exposure vs. ExxonMobil’s asset base—without attempting a sum or direct quantitative comparison. The LLM overreaches by aggregating unverifiable figures. (4) Contextual relevance is high because the answer addresses the right companies, project, and geographic region, and attempts a comparative analysis. However, correctness and quantitative accuracy are low due to the invented equity value and erroneous total exposure claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 415,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable‑energy VIEs are still in the “negotiating‑PPA” stage – the company’s role is limited to siting, EPC and PPA negotiations, and the filings do not disclose any near‑term cash‑flow benefit from those contracts. In contrast, Southern Power’s wind facilities are already covered by long‑term PPAs that are accounted for as operating leases and do not include a capacity charge; the cash‑flow from those PPAs is bolstered by the production‑tax credits that Southern Power expects to fully utilize through 2024, providing a material, near‑term cash‑flow upside.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key distinctions between Duke Energy and Southern Power's PPA strategies and their cash flow implications. (1) It correctly states that Duke Energy is in the PPA negotiation phase for its renewable VIEs and that there are no disclosed near-term cash flow benefits, aligning with the ground truth that Duke's PPAs influence economic performance but do not yet generate direct cash flow. (2) For Southern Power, it accurately describes the long-term operating lease structure of its wind PPAs and notes the absence of capacity charges, which is consistent with the original answer. It correctly highlights that cash flows are enhanced by production tax credits (PTCs) and that Southern Power expects to fully utilize these through 2024. (3) The only minor omission is the specific figure of approximately $0.8 billion in unutilized PTCs at the end of 2021, which is present in the ground truth but not mentioned in the LLM answer. This quantitative detail is relevant to the 'cash flow implications' part of the question and its absence prevents a perfect score. (4) The reasoning is sound: the model correctly synthesizes information across entities (Duke vs. Southern Power), structures (VIEs vs. operating leases), and financial mechanisms (PPAs, PTCs). The comparison is logically structured and semantically equivalent in intent, though slightly less detailed. (5) All entities, years (2024), and financial concepts (PTCs, operating leases) are accurately used. The answer is highly contextually relevant, directly addressing the comparative cash flow implications as asked. Quantitative accuracy is high—no incorrect numbers are stated, only one omitted—so a 9 is justified. Qualitative accuracy is strong but not complete due to the missing PTC balance detail. Correctness score is 8 due to this meaningful but not critical omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 508,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "Low’s 2024 Accelerated Share‑Repurchase (ASR) program required it to buy back about 15.4 million shares and, at settlement, the company could receive **additional shares** from the financing institution (the exact number is not disclosed but is measured in millions).  \n\nHome Depot’s non‑employee‑director deferred‑share awards do not involve a repurchase; instead the awards earn **dividend‑equivalent shares** that are issued when the awards vest. The company granted only **roughly 10‑12 thousand deferred shares** in recent years, so the dividend‑equivalent issuances are on the order of a few‑tens of thousands of shares—far smaller than the potential multi‑million‑share inflow Low may receive from its ASR settlements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core qualitative distinction between LOW's ASR-related receipt of additional shares and HD's issuance of dividend-equivalent shares in deferred director awards, which aligns with the ground truth. It correctly identifies that LOW receives additional shares from financial institutions at ASR settlement due to repurchase efficiency, and HD issues dividend-equivalent shares as part of director compensation. However, there are quantitative inaccuracies: the claim that LOW's ASR could result in receiving 'multi-million-share inflow' is speculative—the original answer does not specify the magnitude, and the LLM introduces a number ('15.4 million shares') not present in the ground truth, risking misrepresentation. Similarly, the LLM states HD granted '10–12 thousand deferred shares' and that dividend equivalents are 'a few tens of thousands', but these specific figures are not in the original answer and cannot be verified against the knowledge graph. While the contrast in scale (millions vs. thousands) may be directionally reasonable, introducing unverified numeric estimates reduces quantitative accuracy. The reasoning is otherwise sound, with correct entity identification (LOW, HD, ASR, deferred share awards) and appropriate multi-hop synthesis comparing mechanisms across companies. The answer is contextually relevant and addresses both parts of the comparison question, but the unsupported numbers prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 402,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported **$125 million of equity‑method income from United Launch Alliance (ULA) in 2024** (see Boeing 10‑K, Note 42). Lockheed Martin’s 10‑K does not break out a separate “commercial satellite‑launch” figure in the pages provided, so a precise dollar amount cannot be quoted from the excerpt. Nevertheless, both companies’ results are linked to ULA’s dual‑customer model: Boeing’s $125 million equity share reflects ULA’s earnings from serving both U.S. government and commercial launch customers, and the same commercial launch activity is captured in Lockheed Martin’s overall Space segment revenue, indicating that ULA’s commercial business contributes to the earnings of both manufacturers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024, which matches the ground truth exactly. This is supported by a reference to Boeing’s 10-K, Note 42, adding credibility. However, the LLM states that Lockheed Martin’s 10-K 'does not break out a separate commercial satellite-launch figure,' implying that no relevant revenue data is available, which contradicts the ground truth. The original answer specifies that Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. This key quantitative link is omitted, weakening the multi-hop synthesis. (2) Quantitatively, the only number provided by the LLM—$125 million—is accurate. The missing $665 million receivables figure from Lockheed Martin is a significant omission, but no incorrect numbers are stated. (3) The reasoning correctly identifies the structural link between Boeing’s equity income and ULA’s dual-customer model, and acknowledges that commercial launch activity benefits both parent companies. However, it fails to complete the multi-hop chain by connecting Boeing’s income to Lockheed Martin’s actual commercial receivables, which is central to the original answer’s conclusion. (4) The LLM answer is contextually relevant and well-structured, but the failure to report the $665 million receivables figure—despite its presence in the knowledge base—results in a partially incomplete synthesis. While the logic is sound where present, the omission reduces completeness and qualitative accuracy. Hence, correctness is scored 7 for core accuracy with a significant missing element.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 465,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly makes clear that a product’s commercial life ends when its patents and any regulatory data‑protection expire – typically five years of data protection (or twelve years for biologics) in the United States, roughly ten years of protection in the European Union and eight years in Japan, with possible patent‑term extensions of up to five years (capped at 14 years from U.S. approval). Merck’s filing stresses the same dependence on patents for market exclusivity and warns that loss or invalidation of those patents “generally leads to a rapid and material loss of sales,” but it discusses the risk more qualitatively and notes that its exclusivity can be lengthened by mechanisms such as supplemental protection certificates (up to five years in Europe and Japan) and U.S. patent‑term restoration, without giving the exact baseline protection periods. Thus, while both companies face steep revenue declines once exclusivity ends, Lilly’s disclosure quantifies the differing exclusivity windows across the U.S., EU and Japan, whereas Merck’s disclosure highlights the exposure to patent challenges and the availability of extensions but does not spell out the same market‑specific time frames.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that both LLY and MRK face rapid revenue declines upon loss of market exclusivity due to patent expiration and regulatory data protection expiry. The answer accurately notes LLY's reliance on both patent rights and regulatory mechanisms, and MRK's emphasis on patent litigation and risk of invalidation. (2) Quantitatively, the LLM correctly states 12 years of data protection for biologics in the U.S., ~10 years in the EU, and 8 years in Japan—matching the ground truth. It adds contextual detail about patent-term extensions (up to 5 years, capped at 14 years from U.S. approval) and mentions supplemental protection certificates (SPCs) in Europe and Japan, which, while not in the original answer, are factually correct and add value without contradicting the ground truth. The only minor deviation is the mention of 'five years of data protection' for non-biologics in the U.S., which is not in the original answer and could be misleading—small molecule drugs typically have 5 years of exclusivity in the U.S., but the original answer focused only on biologics (12 years). This is a slight overgeneralization but does not invalidate the core accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes across LLY and MRK, compares their approaches (LLY’s quantified disclosure vs MRK’s qualitative emphasis on legal defense), and contextualizes differences in regulatory frameworks across regions. (4) The answer is semantically equivalent to the original, with slightly more detail on patent extensions and SPCs, which enhances completeness without introducing errors. The core conclusion—that both companies are exposed to patent risks but differ in how they disclose and manage exclusivity—is preserved. Thus, the answer earns a 9 for correctness due to high factual accuracy, strong reasoning, and excellent contextual relevance, with only a minor overstatement on U.S. data protection for non-biologics preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1643,
        "completion_tokens": 551,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company warns that actual or potential cyber‑intrusion threats to its nuclear plants could trigger “increased nuclear licensing or compliance costs that are difficult to predict,” creating a potentially material but uncertain expense for its nuclear operations. By contrast, Duke Energy notes that a decline in the market value of the assets held in its nuclear decommissioning trust funds could require additional cash contributions to meet future decommissioning obligations, also posing a material funding risk. Thus, Southern’s exposure is to unpredictable regulatory‑compliance outlays from cyber attacks, while Duke’s exposure is to possible shortfalls in trust‑fund earnings that would force extra funding for plant decommissioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Southern Company's risk from cyber intrusions leading to unpredictable compliance costs and Duke Energy's risk from market value declines in decommissioning trust funds requiring additional funding are both accurately described. (2) Quantitative accuracy is perfect—no specific numbers (e.g., percentages of KWH generation) were misrepresented, and while the LLM omits the 26% and 28% figures from Alabama Power and Georgia Power, these are contextual details that do not alter the central comparison of financial risks. Their absence does not constitute a factual error but a slight reduction in completeness. (3) Multi-hop reasoning is sound: the model correctly synthesizes distinct risk types (cyber-related compliance vs. market-dependent decommissioning funding) across two companies with nuclear operations. The contrast in risk nature—regulatory unpredictability vs. financial market exposure—is logically and clearly drawn. (4) Semantic equivalence is maintained: though the LLM uses different phrasing (e.g., 'regulatory-compliance outlays' and 'shortfalls in trust-fund earnings'), the meaning aligns with the original. The answer is fully contextually relevant, directly addressing the comparative financial risks posed by nuclear operations. The only reason for not scoring a 10 is the omission of the specific KWH generation percentages, which were present in the original and add granularity, but their absence does not impair the correctness of the comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 440,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 deferred‑stock‑unit awards to non‑employee directors vest **on the earlier of the first anniversary of the grant date or the day before the next annual‑meeting of shareholders** (with acceleration possible in limited circumstances).  Dividend equivalents that accrue on those units are paid out when the units vest.  \n\nHome Depot’s deferred‑share awards do not vest on a fixed calendar date; they **remain outstanding until the director’s service terminates**, at which point the underlying shares are delivered.  Dividend equivalents also accrue, but they are **paid as additional shares at the time the underlying shares are paid out after termination of service**.  \n\nThus, Lowe’s uses a short‑term, date‑based vesting schedule with dividend equivalents paid at vesting, while Home Depot’s awards vest only upon board‑service termination, with dividend equivalents paid at that later payout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Lowe's vesting is on the earlier of the first anniversary or the day before the next annual meeting, with dividend equivalents paid at vesting. Home Depot's awards vest upon termination of service, with dividend equivalents paid in additional shares at that time. The LLM correctly captures the contrast in vesting timing (short-term/date-based vs. termination-triggered) and payout structure (at vesting vs. at termination). (2) There are no numeric values requiring calculation, but all dates and timeframes are accurately represented. (3) The multi-hop reasoning is sound—comparing two companies' policies on dividend equivalents, vesting schedules, and payout mechanisms for non-employee director compensation. The synthesis across entities and years (2023 focus) is appropriate. (4) The only minor omission is that the original answer notes Lowe's immediate vesting for awards granted prior to 2022, which the LLM omits. However, the question specifically asks about 2023 grants, so this detail is contextually less critical. Wording differs but meaning is semantically equivalent. Scores reflect high accuracy with a slight deduction in qualitative accuracy due to the omitted pre-2022 policy context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 369,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen’s competitive edge is tied largely to the 12‑year data‑exclusivity period granted to its biologics; if the FDA were to curtail that “umbrella” protection, biosimilar rivals could launch sooner and erode Amgen’s sales (see AMGN p.46). Merck, by contrast, leans on a layered patent portfolio—compound patents that can be restored for up to five years—and routinely adds the six‑month pediatric‑exclusivity extension (and other patent‑term extensions) to push back generic entry (see MRK p.16‑18). Thus, a loss of Amgen’s 12‑year exclusivity would leave it more exposed to biosimilar competition, whereas Merck’s strategy provides multiple, renewable patent‑based barriers that can sustain its market position even if data exclusivity is shortened.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 12-year biologic data exclusivity for AMGN, the risk of earlier biosimilar competition if this is removed, and MRK's use of compound patents, pediatric exclusivity (6-month extension), and other patent-term extensions are all accurately represented. The mention of 'up to five years' of patent restoration aligns with patent term adjustment (PTA) or patent term extension (PTE) practices, though the original answer emphasizes 'layered approach' without specifying 'five years'—this is a minor addition but not incorrect. (2) Quantitative elements—12-year exclusivity, six-month pediatric extension—are correctly stated. No calculations are required, and all numbers match. (3) Multi-hop reasoning is sound: the model correctly contrasts AMGN’s reliance on regulatory data exclusivity with MRK’s diversified, patent-based strategy, synthesizing implications for competitive positioning. (4) The LLM adds minor details (e.g., page references, 'umbrella' metaphor) not in the original but does not distort meaning. It omits the specific example of EPOGEN and the concentrated customer base, which is a small completeness gap, but the core competitive dynamic is preserved. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 374,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical capital buffer as **zero** – the TLAC‑to‑RWAs ratio is built from the 18 % statutory minimum, a 2.5 % capital‑conservation buffer, the G‑SIB surcharge and the (zero) counter‑cyclical buffer.  Charles Schwab likewise reports a **zero** counter‑cyclical buffer, but its regulatory capital framework adds a separate **2.5 % stress‑capital buffer** on top of the minimum requirements.  Thus, while both firms have no counter‑cyclical component, GS relies only on the 18 % TLAC floor (plus other buffers), whereas Schwab carries an additional 2.5 % stress buffer in its capital position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: Goldman Sachs (GS) has an 18% minimum TLAC to RWAs threshold, the countercyclical capital buffer is zero for both GS and SCHW, and SCHW applies a 2.5% stress capital buffer. The LLM correctly notes that the countercyclical buffer is zero for both institutions, consistent with the Federal Reserve's setting and disclosures as of December 31, 2024. (2) The answer accurately reflects that GS incorporates the zero countercyclical buffer within its broader TLAC framework, which includes the 18% minimum, G-SIB surcharge, and capital conservation buffer. While the original answer does not explicitly mention the capital conservation buffer or G-SIB surcharge, the LLM’s inclusion of these as part of GS’s TLAC calculation is consistent with regulatory standards and does not contradict the ground truth. (3) For SCHW, the LLM correctly identifies the 2.5% stress capital buffer as a separate component beyond minimum requirements, highlighting a differentiated capital planning approach. This matches the original answer’s emphasis on SCHW’s distinct buffer despite the shared zero countercyclical buffer. (4) The reasoning is sound and synthesizes multi-hop information correctly: comparing GS’s TLAC treatment with SCHW’s capital buffers, recognizing both have zero countercyclical buffers but different additional buffer structures. The only minor limitation is that the LLM slightly expands on GS’s TLAC composition (e.g., capital conservation buffer) not detailed in the original answer, but this does not introduce inaccuracy—rather, it adds regulatory context. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 486,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "Exxon Mobil’s 2023 balance sheet shows roughly **$7.7 billion of long‑lived assets in Kazakhstan** (down from $8.2 billion in 2022). Chevron, by contrast, owns **a 50 percent equity interest in Tengizchevroil (TCO)** – the joint‑venture that operates the Tengiz and Korolev fields in western Kazakhstan (plus an 18 percent non‑operated interest in the Karachaganak field). Thus, XOM’s exposure is measured in a few‑billion‑dollar asset base, while CVX’s exposure is a half‑ownership stake in the TCO partnership.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between XOM's asset exposure and CVX's stake in TCO in Kazakhstan. (1) Quantitatively, the $7.7 billion figure for XOM's long-lived assets in 2023 is accurate (matches $7,728 million in the ground truth, rounded appropriately). The mention of a decrease from $8.2 billion in 2022 is additional context not in the original answer but does not contradict it. CVX’s 50% equity interest in TCO is factually correct and aligns with known ownership stakes. However, the LLM omits specific project timelines mentioned in the ground truth—namely, the mechanical completion of TCO’s Future Growth Project in 2023 and the expected 2024 completion of Karachaganak Stage 1A—which are key indicators of CVX’s operational engagement. (2) The numerical values and percentages are accurate; no calculation errors are present. (3) The reasoning correctly distinguishes between direct asset ownership (XOM) and indirect exposure via joint venture (CVX), demonstrating sound multi-hop synthesis across ownership structure and financial reporting. (4) The answer is contextually relevant and directly compares the nature and scale of exposure as requested. The main shortcoming is the omission of forward-looking project milestones that highlight CVX’s active role in expanding operations, which reduces completeness and slightly weakens qualitative accuracy. Overall, the answer is factually solid but lacks some strategic context present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 412,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that it is still evaluating the provisions of ASU 2020‑04 and that “the ultimate outcome of the transition cannot be determined at this time,” indicating uncertainty about any material financial effect of moving its LIBOR‑linked debt and hedges to an alternative rate. NextEra Energy, by contrast, states that it has elected to apply the same ASU 2020‑04 guidance to its LIBOR‑referencing debt and derivative contracts, is continuing to evaluate the modifications, and to date has seen no material impact—although the full effect remains unknown. Thus, Southern Company emphasizes unresolved uncertainty, whereas NextEra Energy reports active application of the guidance with only limited, non‑material impact observed so far.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's uncertainty about the financial impact of transitioning from LIBOR under ASU 2020-04 is accurately represented with the direct quote about the 'ultimate outcome' being undetermined. NextEra Energy's active application of ASU 2020-04 to its interest rate contracts is also correctly stated. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies regarding the same accounting standard (ASU 2020-04) and contrasts their approaches—SO's ongoing evaluation vs. NEE's active implementation. The LLM adds a slight nuance by noting that NextEra has seen 'no material impact to date,' which is consistent with typical disclosures and does not contradict the ground truth. (4) Semantic equivalence is maintained: the core conclusion—that Southern expresses uncertainty while NextEra demonstrates a more definitive stance—is preserved. The only minor difference is that the LLM answer elaborates slightly more on NextEra's 'no material impact' observation, which is plausible but not explicitly in the original answer; however, this does not introduce inaccuracy. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 412,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "Meta’s charter creates a classic “founder‑controlled” dual‑class system: each Class A share carries one vote, while the 10‑vote Class B shares held by Mark Zuckerberg and other insiders give them control of the company even though they own a small fraction of the total equity.  The certificate of incorporation also contains anti‑takeover provisions that require a majority of the Class B votes for any change of control, and many corporate‑governance rules (e.g., board classification, limited shareholder‑initiated actions) can be altered only with Class B approval, leaving ordinary Class A holders with little ability to influence major decisions【page_49】【page_50】.  \n\nAlphabet’s charter also uses three classes (Class A = 1 vote, Class B = 10 votes, Class C = no vote), but it builds explicit minority‑shareholder safeguards: any amendment that would adversely affect a particular class must be approved by that class and by the board’s unanimous consent before a shareholder vote, and the board cannot declare unequal per‑share dividends without the affected class’s approval【page_81】【page_90】.  Consequently, while both companies employ dual‑class structures, Meta’s framework concentrates voting power far more heavily with insiders and provides fewer procedural protections for minority shareholders than Alphabet’s governance provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the dual-class structures of both META and GOOGL, noting the 1-vote Class A and 10-vote Class B shares for both companies, and mentions GOOGL's non-voting Class C shares, which is factually correct and adds context beyond the original answer. (2) Quantitatively, all voting rights (1 vote, 10 votes) are accurate; no dollar amounts, dates, or percentages are misstated. The LLM correctly notes procedural requirements such as Class B approval for governance changes and board classification at META, and unanimous board consent plus class-level approval for adverse amendments at GOOGL—both consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes governance provisions from both companies’ charters to compare minority shareholder protections, concluding that GOOGL provides stronger procedural safeguards. The only minor omission is that the original answer specifies META’s two-thirds majority requirement for certain amendments when Class B voting power falls below 35%, a specific anti-takeover threshold not mentioned in the LLM response. This is a small but notable detail affecting minority shareholder influence. (4) Despite this omission, the LLM captures the core contrast: concentrated insider control at META versus structural protections for minorities at GOOGL. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparative governance question with precise citations to document pages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 440,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "The OECD “Pillar Two” rule would force any of PepsiCo’s foreign earnings that are presently taxed at less than 15 % to be subject to an additional charge, so the company’s overall effective tax rate – which already sits above the 15 % floor because of the 21 % U.S. federal rate plus state taxes – would rise modestly but definitively. Altria’s 2023 effective tax rate was already 25.6 % (driven mainly by the U.S. tax burden and only a small amount of foreign income), so the global minimum tax would have a comparatively limited effect, adding only to the modest foreign‑tax portion of its total tax expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo, due to its international operations, would face upward pressure on its effective tax rate under the OECD's Pillar Two rules, which impose a 15% minimum tax on foreign earnings taxed below that threshold. The explanation that PepsiCo’s rate would rise modestly but definitively is consistent with the original answer’s implication of increased effective tax rates. (2) For Altria, the LLM correctly notes minimal foreign tax exposure and states an accurate 2023 effective tax rate of 25.6%, which is not in the original answer but is factually correct based on Altria’s 10-K and does not contradict the ground truth. The conclusion that the global minimum tax would have a limited effect on Altria is sound and supported. (3) The reasoning is multi-hop: it synthesizes knowledge of U.S. tax rates, international tax exposure, and the mechanics of Pillar Two to compare two companies—exactly what the question requires. (4) While the original answer does not include Altria’s 25.6% effective tax rate, the LLM’s inclusion of this precise figure enhances accuracy rather than detracting from it. The only reason for not scoring a 10 is that the original answer emphasizes Altria’s $2,346 million in federal taxes and minimal foreign liabilities—specific data points not mentioned in the LLM response—so there is a minor completeness gap. However, the core financial logic, entity accuracy, and comparative analysis are correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 425,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "Orphan‑drug designation in the United States grants a seven‑year period of market exclusivity that runs alongside any existing patents. Because the FDA generally cannot approve a generic for the same orphan indication during that time, a product with orphan status is insulated from generic competition for at least seven years after approval. AbbVie therefore faces a lower risk that a generic will enter the market before its patents expire, just as Eli Lilly relies on orphan exclusivity to extend protection for its products beyond the expiration of the underlying compound patents.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the seven-year orphan drug exclusivity period in the U.S. and accurately states that it runs alongside patents and blocks FDA approval of generics for the same indication, which aligns with the ground truth. The quantitative accuracy is perfect: the 'seven-year' exclusivity period is correctly cited, and no other numbers or dates are misstated. Entity accuracy is strong—both AbbVie and Eli Lilly are correctly referenced in the context of using orphan drug exclusivity to extend market protection. However, the LLM answer is incomplete in its risk assessment for AbbVie. While it correctly notes that orphan exclusivity reduces generic competition risk, it fails to mention the key point from the ground truth that AbbVie’s *vulnerability* increases if such exclusivity is weakened or lost through patent challenges, regulatory changes, or compulsory licensing—this is a critical multi-hop element linking Eli Lilly’s use of the mechanism to AbbVie’s risk exposure. The reasoning is sound but partial: it draws a valid parallel between the two companies’ use of exclusivity but does not fully synthesize how the strength of this mechanism directly influences AbbVie’s risk of market erosion in a competitive landscape. The answer is contextually relevant and well-structured, but the omission of AbbVie’s specific risk factors from the original answer reduces qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 397,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA – in which The Coca‑Cola Company holds a 21 % equity‑method stake – operates in Argentina (the federal capital of Buenos Aires and surrounding areas)【page_7】. Because that bottler is an equity investee, the Company’s “net sales to equity‑method investees” (which include Coca‑Cola FEMSA) give KO indirect exposure to Argentine market conditions【page_89】. PepsiCo, by contrast, reports Argentina as one of the “volatile economic, political and social conditions” that directly affect its own operations and results, indicating a direct exposure to Argentine economic volatility【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Coca-Cola FEMSA operates in Argentina (Buenos Aires and surrounding areas), KO has indirect exposure via equity-method investees, and PEP has direct exposure due to operating in volatile economic conditions. The 21% equity stake is an additional detail not in the original answer but does not contradict it. (2) Quantitative accuracy is perfect—no incorrect numbers, and while the $14,471 million in net sales to equity investees from the original answer is omitted, this specific figure was not critical to the comparative exposure analysis. The absence is a minor completeness gap but does not affect correctness. (3) Multi-hop reasoning is sound: the model correctly links KO’s indirect exposure through Coca-Cola FEMSA’s operations in Argentina to equity investee sales, and contrasts it with PEP’s direct operational presence and associated risks. (4) Semantic equivalence is strong—wording differs but meaning aligns. Contextual relevance is excellent, directly addressing the comparative exposure question. The only reason for not scoring 10 is the omission of the specific $14,471 million figure and pandemic recovery context, which slightly reduces completeness but not overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 369,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s market‑exclusivity plan for emraclidine is built on the Pfizer patents it inherited through its Cerevel Therapeutics acquisition—AbbVie now holds an exclusive global license to those patents and must meet milestone‑based payments to retain the rights, effectively using the acquired patent portfolio to create a protected launch window for the drug. In contrast, Merck’s Januvia story shows a shrinking exclusivity envelope: the original sitagliptin compound patent expired in January 2023 and the product now depends on a later‑expiring salt‑form patent and the five‑year U.S. regulatory exclusivity period, which together push the U.S. loss‑of‑exclusivity date only to May 2026. Thus AbbVie is creating exclusivity by acquiring and licensing new patents, whereas Merck is managing the inevitable loss of exclusivity as its existing patents run out.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between AbbVie's patent-based exclusivity strategy for emraclidine and Merck's reliance on later-expiring patents and regulatory exclusivity for Januvia, which is contextually relevant and addresses the main thrust of the question. However, it omits a critical fact from the ground truth: AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, indicating that the expected market exclusivity or commercial success did not materialize. This omission significantly undermines the qualitative accuracy, as it fails to convey the financial consequence and strategic risk of relying on acquired patent rights. While the dates for Merck’s exclusivity (January 2023 patent expiration, May 2026 exclusivity end) are correctly stated, the LLM incorrectly implies that regulatory exclusivity (five-year term) is a major factor extending Januvia’s protection—whereas the ground truth emphasizes that the extension came primarily from court rulings and settlement agreements around a later-expiring salt-form patent, not the standard regulatory exclusivity. The LLM also does not mention Janumet XR’s exclusivity until July 2026, missing a key detail. Entity accuracy is strong—AbbVie, Merck, Cerevel, Pfizer, emraclidine, Januvia, sitagliptin—are all correctly identified. The reasoning is partially sound but lacks the multi-hop synthesis of financial outcome (impairment charge) with strategic reliance on patents, which is central to the original answer. Quantitative accuracy is mostly correct, with accurate dates and no incorrect numbers, though the absence of the $4.5 billion impairment charge—a key quantitative fact—lowers the score. Overall, the answer is directionally correct but misses critical nuances and outcomes that define the strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 494,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % ownership of the Caspian Pipeline Consortium gives it access to the pipeline’s average throughput of about **1.4 million barrels of crude per day** (roughly 1.2 million b/d from Kazakhstan and 0.2 million b/d from Russia), directly expanding the company’s export capacity for its Kazakh‑origin oil. By contrast, ConocoPhillips’ upstream business is driven primarily by **its own crude‑oil production**, as reflected in its large proved‑oil reserve base and the fact that its upstream results are reported under “oil and gas activities” with non‑oil activities excluded, indicating that the company relies on generating crude rather than on external export infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and its relevance to crude oil export capacity, as well as ConocoPhillips' reliance on its own crude oil production. However, it inaccurately states the CPC throughput as 1.4 million barrels per day (1.2 million from Kazakhstan and 0.2 million from Russia), while the ground truth specifies only the 1.2 million b/d from Kazakhstan as relevant to Chevron's exports. There is no mention in the original answer of Russian volumes being part of Chevron’s export capacity via CPC, nor that Chevron benefits from Russian throughput. This introduces a factual error in quantitative attribution. Additionally, the debottlenecking project completion in January 2023 and its connection to Chevron’s Future Growth Project (FGP) ramp-up in early 2025—key contextual details in the original—are omitted, reducing completeness. 2) The number 1.4 million b/d is not supported by the ground truth; only 1.2 million b/d from Kazakhstan is cited. The split into Kazakh and Russian volumes appears speculative and unsupported. Chevron's exposure is specifically tied to Kazakh exports, not total CPC throughput. 3) The multi-hop reasoning is partially sound: the model correctly links Chevron’s ownership stake to export infrastructure access and contrasts it with ConocoPhillips’ direct production focus. However, it fails to fully synthesize the strategic implications of the CPC debottlenecking for Chevron’s future production plans, which is a key differentiator in the original answer. 4) Despite the numerical inaccuracy and missing detail about the FGP timeline, the core qualitative distinction—Chevron’s indirect export capacity via infrastructure vs. ConocoPhillips’ direct production dependency—is accurately conveyed. Wording differences are acceptable under semantic equivalence, but the incorrect volume breakdown lowers confidence in quantitative precision. Hence, correctness is reduced to 7 due to significant but not fundamental factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 539,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle is embedding generative‑AI directly into its MySQL HeatWave cloud service, so customers can run AI‑driven analytics, machine‑learning and generative‑AI workloads together with transactional processing on OCI’s scalable, managed infrastructure. Qualcomm, by contrast, is positioning generative AI as an on‑device capability for edge products—smartphones, PCs and IoT devices—using its low‑power AI engines and 5G connectivity to deliver immediate, private and personalized AI without relying on the cloud, even as it continues to invest in cloud‑enabled services for data‑offload and model training.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Oracle's and Qualcomm's generative AI strategies as described in the ground truth. (1) It correctly identifies Oracle's integration of generative AI into MySQL HeatWave on OCI for combined transactional, analytics, and AI workloads, and Qualcomm's focus on on-device AI for edge devices like smartphones and PCs, emphasizing immediacy, privacy, and personalization. (2) There are no numeric values in the LLM answer, but the ground truth includes percentages (19% in 2024, 46% in 2027 for generative AI-capable smartphones). The LLM omits these specific projections, which is a minor factual omission but does not distort the overall vision. (3) The multi-hop reasoning is sound: it synthesizes Oracle’s cloud-based AI integration with Qualcomm’s edge-first strategy and acknowledges both companies’ cloud investments—Oracle via OCI and Autonomous Database, Qualcomm via cloud-edge coordination in its QSI segment (implied through 'cloud-enabled services for data-offload and model training'). (4) The semantic meaning fully aligns with the original answer, with only slight brevity in quantitative detail. Wording differs but conveys equivalent meaning. The omission of the specific smartphone adoption forecast prevents a perfect score, but all other elements—entities, strategy, cloud roles, and technological focus—are correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 392,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s cash‑flow protection comes from “firm‑commitment” purchase contracts that legally bind suppliers to deliver inventory and utilities at pre‑agreed quantities and prices, so the company knows the timing and amount of the cash outflows it must meet (see WMT ‑ Material Cash Requirements, p. 45). Colgate‑Palmolive, by contrast, relies on foreign‑currency option contracts (and related forwards) to hedge the dollar value of its inventory, utility and other purchases, thereby insulating its cash‑flow needs from exchange‑rate swings (see Colgate ‑ Foreign‑Exchange Risk, p. 90 and Option/forward contracts, p. 121). Both tools serve the same purpose—reducing cash‑flow uncertainty—but Walmart does it by locking in purchase terms, whereas Colgate does it by hedging the currency risk on those purchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core distinction between Walmart and Colgate-Palmolive in managing cash flow risks. (1) Quantitatively, while the LLM does not mention the specific $15.9 billion figure for Walmart's firm commitments (present in the ground truth), it does not provide any incorrect numbers, and no calculations are attempted, so there are no numerical inaccuracies. The absence of the dollar amount is a minor omission but does not make the answer factually wrong. (2) The entities are correctly identified: Walmart (WMT) and Colgate-Palmolive are accurately referenced with plausible document citations (e.g., 'Material Cash Requirements, p. 45', 'Foreign-Exchange Risk, p. 90'), though these page numbers are not verifiable from the knowledge graph but are contextually reasonable. (3) The reasoning is sound: the LLM correctly identifies that Walmart uses firm commitments to lock in cash outflows for inventory and utilities, while Colgate uses foreign currency options (and forwards) to hedge currency risk on similar outflows. It correctly frames both as tools to reduce cash flow uncertainty, highlighting the strategic difference—Walmart via fixed terms, Colgate via financial hedging. (4) The answer is contextually excellent, directly addressing the comparison asked in the question and synthesizing the distinct risk management approaches. The only shortcoming is the lack of the specific $15.9 billion commitment figure, which reduces completeness slightly. However, the semantic meaning and strategic contrast are preserved, warranting a high score. Thus, correctness is rated 8 due to the missing quantitative detail, though qualitative and contextual accuracy remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 467,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its exposure to a reference‑entity’s possible default by buying and selling credit‑default swaps – the firm holds roughly $409 billion of single‑name and index CDS protection (page 111) and records the fair‑value of those contracts, which will move sharply if a credit event occurs. Capital One, by contrast, does not use CDS for hedging but values its net derivative liabilities with a Level‑3 discounted‑cash‑flow model that treats the “default rate” of the underlying obligors as a key unobservable input (page 208); a higher assumed default rate reduces the fair value of those derivatives (page 207). Thus, both institutions are highly sensitive to credit‑event outcomes: Morgan Stanley’s CDS positions translate credit‑event risk into mark‑to‑market gains or losses, while Capital One’s valuation of derivative assets and liabilities hinges on the same default‑rate assumptions that drive those CDS‑related price changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop relationship between Morgan Stanley's use of CDS and Capital One's reliance on default rate assumptions. (1) Correctly identifies Morgan Stanley's use of CDS for hedging credit risk and Capital One's use of Level-3 discounted cash flow models with unobservable inputs, particularly default rates. The synthesis that both are sensitive to credit event outcomes is logically sound and matches the ground truth. (2) Quantitative accuracy: The $409 billion figure for Morgan Stanley’s CDS exposure is specific and plausible but not present in the original answer (which did not include a dollar amount). This introduces a discrepancy—while such a number may exist in the source filing, it is not part of the verified ground truth, so its inclusion risks inaccuracy. The original answer cites a 4% weighted average default rate with a range of 53–163%, which the LLM omits; instead, it refers generally to 'default rate' as a key input without specifying the 4% or the range. These omissions and the addition of an unverified figure reduce quantitative precision. (3) Reasoning is strong: the LLM correctly infers that Morgan Stanley faces mark-to-market impacts from credit events via CDS, while Capital One’s valuations depend on assumed default rates, linking both to systemic credit sensitivity. It correctly notes that higher default rates reduce derivative fair value for Capital One, aligning with the economic logic. (4) Contextual relevance is excellent—the response directly addresses the comparative sensitivity to credit events and synthesizes across both institutions appropriately. Minor deduction in quantitative accuracy due to unverified number and missing specific default rate assumption; otherwise, the answer is semantically equivalent and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 495,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s natural‑gas system includes roughly **35,700 mi of distribution‑ and transmission‑pipeline and 28,800 mi of service lines** (the combined “GU &I” figures in its 2023 filing) that serve its Georgia service area, giving it a large physical‑asset footprint that directly underpins local gas‑supply reliability【page_39】.  \nSouthern Company Gas, by contrast, contributes to Georgia’s reliability through its **50 % equity stake in the Southern Natural Gas (SNG) 7,000‑mi interstate pipeline** – an investment that generated **$140 million of equity‑method earnings in 2023** and is part of a **$1.8 billion capital program for gas‑distribution infrastructure**【page_13】【page_302】【page_14】.  \n\nThus, Duke’s exposure is measured in a greater mileage of on‑ground distribution assets, while Southern’s exposure is a larger monetary capital commitment to a regional pipeline that brings diversified supply into Georgia and the surrounding states, both enhancing reliability but at different scales and through different asset types.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core contrast between Duke Energy’s distribution-focused assets and Southern Company Gas’s investment in SNG as a transmission backbone, which aligns with the original answer’s intent. However, there are key quantitative discrepancies: the original states Duke operates 28,000 miles of pipelines in Georgia, while the LLM claims 35,700 miles of pipeline plus 28,800 miles of service lines—this conflates pipeline mileage with service lines and overstates the relevant pipeline infrastructure. The 35,700-mile figure may include both distribution and transmission, but the original does not support that total mileage, nor does it mention service lines. Additionally, the LLM introduces a $1.8 billion capital program and $140 million in equity-method earnings for 2023—specific figures not present in the original answer and potentially from misinterpretation of broader Southern Company disclosures. These numbers, while possibly accurate in context, are not part of the ground truth and introduce unsupported detail.\n\n2) Quantitative accuracy is compromised: the original specifies 28,000 miles for Duke’s Georgia pipelines; the LLM’s 35,700 mi is higher and lacks sourcing clarity. The $140M earnings and $1.8B capital program are not in the ground truth and may reflect extrapolation beyond the provided data. The 50% stake in SNG is correctly noted, as is the 7,000-mile length of SNG—these match the original.\n\n3) The multi-hop reasoning is sound: the LLM correctly distinguishes between Duke’s local distribution role and Southern’s upstream transmission contribution, recognizing different scales (mileage vs. capital investment) and reliability impacts. It synthesizes the idea that both enhance reliability differently, which reflects the original’s integrated infrastructure concept. However, it omits mention of Southern Power’s 97% investment coverage ratio through 2028—a key indicator of revenue stability in the original—replacing it with unverified financials.\n\n4) Despite introducing unsupported numbers, the LLM maintains contextual relevance by addressing capital scale and reliability contribution across both companies. The qualitative logic and structure are strong, but the inclusion of unverified financial figures reduces factual correctness. A score of 7 reflects accurate entity identification and reasoning, but downgraded due to significant quantitative inaccuracies and addition of non-ground-truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 654,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "The 2024 tax‑rate cuts in Louisiana (together with a similar cut in Arkansas) lowered Union Pacific’s deferred‑tax expense by **$34 million** for the year. Because the filing groups the two states’ effects together, the Louisiana change contributed to that same $34 million reduction – essentially the same impact as the Arkansas legislation, with the total benefit from both states amounting to $34 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $34 million reduction in deferred tax expense and links it to both Louisiana and Arkansas tax legislation in 2024, which aligns with the ground truth. However, it misrepresents the breakdown of the impact: the original answer states that Louisiana's change caused a $34 million reduction and that Arkansas had a 'comparable adjustment,' implying two separate, similar impacts. The LLM instead claims the $34 million is the combined total from both states, with each contributing to that same amount, which contradicts the original meaning. (2) Quantitatively, the $34 million figure is accurate and correctly attributed to the 2024 legislation in both states. The year 2024 is correct. However, the interpretation of the number as a combined total rather than two distinct but comparable adjustments introduces a significant factual error in synthesis. (3) The multi-hop reasoning is flawed: the model fails to distinguish that Louisiana alone caused a $34 million reduction and Arkansas contributed a separate, similar amount (though the exact figure for Arkansas is not specified). Instead, it incorrectly groups them into a single $34 million benefit, undermining the comparative analysis requested. (4) While the answer is contextually relevant and uses correct entities (Union Pacific, Louisiana, Arkansas, 2024, deferred tax expense), the incorrect aggregation of the financial impact reduces factual accuracy. The qualitative reasoning score is lowered due to this misinterpretation, even though the core data point is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 436,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s charter gives each Class B share ten votes, but the charter also bars those votes from being used in a merger or similar “combination” transaction unless the shares are first converted into Class A stock – a safeguard that curtails the founders’ voting power when a deal is being approved. Alphabet’s Class A shares, by contrast, carry the standard one‑vote‑per‑share right and may vote on any matter, including mergers, so the only voting limitation in its structure applies to the non‑voting Class C shares, while control of the company remains with the 10‑vote Class B holders. Thus, Meta’s high‑voting Class B stock is powerful in ordinary governance but is deliberately limited in merger votes, whereas Google’s Class A stock retains full voting ability without such merger‑specific restrictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares have 'ten votes' per share, which is false: according to the ground truth and public filings, Meta's Class B Common Stock has *no voting rights* except in specified merger or consolidation scenarios. The Class A shares (held by insiders like Zuckerberg) carry superior voting rights, not Class B. The claim that Class B shares have ten votes misrepresents the capital structure entirely. (2) The assertion that 'Meta’s charter gives each Class B share ten votes' is a critical error in both entity and quantitative accuracy. (3) The explanation of the merger safeguard—requiring conversion to Class A before voting in mergers—is factually incorrect because Class B shares do not have standing voting power to begin with; their limited voting rights in mergers are based on conversion ratios, not a procedural conversion requirement. (4) In contrast, the description of GOOGL’s Class A shares (one vote per share) is correct, and the point about non-voting Class C shares is accurate and contextually relevant. (5) The reasoning is flawed due to the fundamental mischaracterization of Meta’s share structure, leading to an incorrect comparison: the LLM portrays Meta’s Class B as high-voting with restrictions, whereas in reality, Class B is low-voting with limited activation in specific events. This reverses the actual governance dynamic. (6) While the answer attempts multi-hop reasoning by comparing governance structures and voting limitations in mergers, the synthesis fails due to incorrect base facts. (7) Contextual relevance is moderate because the answer addresses the right topic (voting rights in mergers, governance differences), but the misinformation renders the conclusion invalid. Overall, major factual and conceptual errors in both quantitative and qualitative dimensions justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 526,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions that force high‑cost drugs such as Repatha into tighter formularies, step‑therapy or higher patient cost‑sharing push Pfizer to increase rebates, discounts and other gross‑to‑net deductions for its own cardiovascular medicines (e.g., Eliquis). Because Pfizer records product revenue net of estimated government and commercial rebates (see page 48) and explicitly notes that payer‑driven pricing pressure and limited formulary placement can “materially affect…sales” (page 41) and “trends toward managed‑care…affect…pricing or favorable formulary placement” (page 10), the company is likely to adopt more conservative revenue‑recognition assumptions—recognizing lower net sales and potentially deferring revenue until rebate estimates are resolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies the impact of U.S. payer restrictions—such as formulary limitations, step-therapy, and high patient cost-sharing—on high-cost cardiovascular drugs like Repatha and draws a valid parallel to Pfizer's exposure, specifically referencing Eliquis as an example. The core financial mechanism—gross-to-net deductions including rebates and discounts—is accurately described, and the citation of Pfizer’s own disclosures (pages 10, 41, 48) supports the factual basis, even if those page numbers are illustrative. (2) There are no numeric values in the original or LLM answer requiring verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: it connects payer behavior (from Repatha case) → impact on market access and pricing → Pfizer’s revenue recognition policy (net of rebates) → need for conservative estimates due to managed care trends. The only minor gap is that the original answer references Gilead’s strategy as an example of how companies adapt revenue recognition, while the LLM omits Gilead but correctly infers Pfizer’s likely response—this is a small omission but does not undermine the overall correctness. (4) The LLM answer is contextually precise, directly addressing how payer dynamics affect revenue recognition strategy. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; only a slight reduction in qualitative accuracy due to the missed cross-company comparison with Gilead, which was part of the knowledge graph’s reasoning chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 447,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % non‑operated interest in the Caspian Pipeline Consortium (CPC) gives it only a modest share of any extra Kazakhstan crude that the Future Growth Project (FGP) will add after its 2025 start‑up – roughly 15 % of the expected increase in CPC’s 1.2 million bbl/d of Kazakh oil (about 180,000 bbl/d)【page_16】. In contrast, ConocoPhillips’ reserve and production base is dominated by crude oil (3,770 million bbl of proved crude oil versus 4,777 million bbl total proved reserves)【page_111】, so its earnings are far more exposed to overall crude‑oil supply and price movements than Chevron’s limited 15 % stake in TCO’s Kazakhstan output.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresentations that significantly affect correctness. (1) It incorrectly states Chevron has a '15% non-operated interest in the Caspian Pipeline Consortium (CPC)'—while this is factually correct—the answer frames Chevron's exposure as being through CPC, not TCO, which misrepresents the ownership structure. The original answer correctly identifies Chevron's 15% ownership in TCO (Tengizchevroil) as the primary exposure point to the FGP production ramp-up, with CPC as a secondary conduit. The LLM conflates the two entities and implies Chevron’s exposure is via CPC throughput, which is not the same as equity ownership in production. (2) The LLM introduces a specific quantitative claim—'15% of the expected increase in CPC’s 1.2 million bbl/d of Kazakh oil (about 180,000 bbl/d)'—that is not supported by the original answer or typical public disclosures; the ground truth does not quantify the production increase or Chevron’s implied volume, so this calculation is speculative and potentially misleading. (3) The comparison to COP is partially accurate: it correctly notes COP’s greater dependence on crude oil, and the proved reserves numbers (3,770 million bbl crude vs 4,777 million total) are accurate per page 111. However, the original answer emphasizes structural exposure (direct vs indirect), while the LLM focuses on reserve composition and earnings exposure, shifting the framing. (4) The FGP start-up timing ('first half of 2025') from the original is omitted in the LLM answer, which only says '2025 start-up'—a minor but relevant imprecision. (5) Multi-hop reasoning is partially sound: the model connects Chevron’s TCO stake to CPC and contrasts with COP’s crude dependence, but the logic is weakened by incorrect emphasis on CPC as the exposure mechanism. Overall, core elements are present but with significant factual and structural flaws, especially in quantitative claims and entity relationships, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 542,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ commercial‑real‑estate portfolio totals about **$34.8 billion**, and hotels (listed as “hospitality”) represent **≈5 %** of that exposure – roughly **$1.7 billion** of loan and commitment balances.  \n\nMetLife’s real‑estate holdings are $13.3 billion, of which **real‑estate funds** account for $3.65 billion; the hotel segment within its overall real‑estate portfolio is **$700 million** (about 5 % of the total).  \n\nThus, Goldman Sachs’ direct loan exposure to hotel‑related properties (~$1.7 bn) is more than twice the amount MetLife has invested in hotel assets through its real‑estate funds (~$0.7 bn), even though both firms rely on real‑estate funds as a key element of their broader strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values not present in the original answer (ground truth), such as Goldman Sachs' total CRE exposure ($34.8B), hotel loan exposure (~$1.7B), and MetLife's fund allocation ($3.65B in funds, $700M in hotels). These figures are not found in the provided ground truth, which only states that Goldman Sachs has 'significant credit exposure' to hotel CRE loans and that MetLife holds $13.3B in real estate investments including interests in hotel-focused funds. The ground truth does not quantify the hotel portion of MetLife’s portfolio or Goldman’s exposure percentage. Therefore, the LLM fabricates precise numbers unsupported by the source, undermining factual accuracy. (2) The calculation that 5% of $34.8B is ~$1.7B is mathematically correct, and 5% of $13.3B being ~$700M is approximately accurate, but since the underlying percentages and allocations are not in the original answer, the quantitative claims cannot be verified and are thus incorrect by inference. The only verifiable number in both answers is MetLife’s total real estate investment of $13.3B as of December 31, 2024 — this is correctly cited. (3) The multi-hop reasoning is logically structured: the LLM distinguishes between Goldman’s lending exposure and MetLife’s ownership via funds, which aligns with the original answer’s qualitative distinction in risk profiles and strategic approaches. It correctly identifies that both firms use real estate funds as key vehicles, though for different purposes — this reflects sound synthesis. (4) Despite the incorrect fabrication of granular financial data, the LLM captures the core contrast in business models (lending vs. investment) and contextualizes the role of real estate funds appropriately, earning points for qualitative and contextual accuracy. However, the invention of unsupported metrics significantly reduces the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 525,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "- Boeing’s (BA) alternative‑asset portfolio is dominated by limited‑partnership interests in private‑equity, private‑debt and real‑estate funds.  Redemptions are generally prohibited until the partnership’s term ends – typically **10 to 15 years from inception** – and the company carries **about $3.3 billion of unfunded commitments** that will be funded over the next three‑to‑six years (BA 10‑K, p. 89).  \n\n- United Parcel Service’s (UPS) pension‑plan assets also include real‑estate and other alternative investments, but they are held within the pension fund’s diversified portfolio and are **valued at NAV** with an active secondary market; the filing does not describe any comparable lock‑up period or unfunded commitment amount for those real‑estate holdings (UPS 10‑K, p. 58‑60, 91‑94).  \n\n**Result:** BA’s limited‑partnership stakes are considerably less liquid because they are tied to long‑term (10‑15 year) partnership agreements and sizable unfunded commitments, whereas UPS’s pension‑fund real‑estate exposures are managed as part of a broader, more liquid pension portfolio with no disclosed long‑term redemption restrictions or large unfunded obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM incorrectly attributes the $3.3 billion unfunded commitment to Boeing (BA), while the ground truth states this amount belongs to UPS. This is a critical error, as the question hinges on comparing BA’s partnership terms with UPS’s $3.3 billion in unfunded obligations. (2) Entity and factual misattribution: The LLM claims BA has $3.3 billion in unfunded commitments, which contradicts the ground truth that assigns this figure to UPS. Additionally, the LLM asserts that UPS’s pension real estate holdings are valued at NAV with an active secondary market and no lock-up or unfunded commitments, but the ground truth confirms UPS does have $3.3 billion in unfunded commitments to limited partnerships with 10–15 year terms—directly contradicting the LLM’s claim. (3) Multi-hop reasoning failure: The question requires comparing liquidity risks based on similar structural constraints (10–15 year terms and unfunded obligations). Instead, the LLM incorrectly frames the two companies as having divergent risk profiles when they are actually similar, thus reversing the correct conclusion. (4) While the LLM correctly identifies that limited partnerships typically have 10–15 year terms, it misapplies financial figures and entity-specific details, leading to an incorrect comparison. The contextual relevance is moderate because the answer addresses the right topics (liquidity, partnership terms), but the core facts are wrong, severely limiting usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 431,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s capital structure gives its 9 %‑plus of outstanding Class B shares (each with ten votes) a **majority of the combined voting power** – the founder, board chair and CEO together control more than 50 % of all votes, so ordinary Class A shareholders (one vote per share) have limited ability to affect corporate decisions【page_49】.  \n\nComcast, by contrast, also has a dual‑class system but the single holder of Class B stock (15 votes per share) controls only **one‑third of the total voting power**, while the much larger Class A base (one vote per share) holds the remaining two‑thirds, giving broader influence to ordinary shareholders【page_33】.  \n\nThus Meta’s voting power is far more concentrated in a small insider group, whereas Comcast’s structure spreads voting power more evenly between the two classes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that both META and CMCSA use dual-class structures with concentrated control, but contains significant quantitative inaccuracies that affect factual correctness. First, the claim that Class B shares at Meta have 'ten votes' is incorrect — the ground truth and public filings confirm Class B shares have 10 votes per share, so this is accurate. However, the statement that Comcast's Class B holder controls 'one-third of total voting power' is factually wrong: the original answer states that Class B shares (owned by Brian L. Roberts) have 15 votes per share and are non-dilutable, and together with Class A's 66 2/3% voting power, implies Class B holds 33 1/3%, which the LLM correctly identifies as one-third — this part is quantitatively acceptable. However, the LLM misrepresents CMCSA’s structure by implying Class A holds two-thirds of voting power collectively, which aligns with the 66 2/3% in the ground truth, so this is approximately correct. The major issue is that the LLM omits key governance mechanisms: META’s requirement that a majority of Class B shares approve change-of-control transactions until they fall below 35% of voting power is entirely missing, which is a critical anti-takeover provision highlighted in the original answer. Additionally, the LLM incorrectly implies that Comcast’s Class B has only one holder with one-third voting power, but fails to mention it is non-dilutable or that it is entirely held by Brian L. Roberts — important context for control concentration. While the qualitative comparison about Meta having more concentrated control is valid and the multi-hop reasoning (comparing control distribution across two companies) is sound, the omission of key structural details and misrepresentation of vote weights (e.g., not clarifying that CMCSA’s Class B has 15 votes vs Meta’s 10) reduces accuracy. The answer is contextually relevant and addresses the question’s intent, but lacks precision and completeness on critical governance provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 543,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PepsiCo’s U.S. qualified‑benefit plan places about $1.8 billion of its $11.7 billion U.S. plan assets (roughly 15 percent) in government securities, which sit within a broader 56 percent fixed‑income allocation that also includes corporate bonds and real‑estate, all aimed at delivering a 7.4 percent long‑term expected return while diversifying risk to meet pension obligations.  \n\nCostco’s short‑term investment portfolio, by contrast, is concentrated in government and agency securities that are classified as cash equivalents; the stated objective is principally to preserve principal and generate modest yields, reflecting a low‑risk, liquidity‑first approach rather than a long‑term return target.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's allocation of approximately $1.8 billion to government securities, which aligns closely with the ground truth figure of $1.812 billion (minor rounding acceptable). It adds contextual detail not in the original—$11.7 billion total U.S. plan assets and 15% allocation—which are factually consistent and enhance accuracy without contradicting the source. The 7.4% long-term return target is accurately cited. For COST, the LLM correctly characterizes its short-term holdings in government and agency securities as focused on principal preservation and modest yields, consistent with the ground truth’s emphasis on capital preservation and low volatility. (2) Quantitatively, all figures are accurate within acceptable rounding: $1.8 billion ≈ $1.812 billion; the 7.4% return is exact. The LLM introduces additional percentages (15%, 56% fixed-income) that are plausible and consistent with known allocations but not explicitly in the ground truth; however, they do not detract from correctness. (3) Multi-hop reasoning is sound: the model successfully synthesizes information across PEP’s long-term, return-oriented strategy and COST’s short-term, risk-averse approach, correctly contrasting their objectives (return generation vs. capital preservation), duration focus, and risk management techniques. While the LLM does not explicitly mention PEP’s use of derivatives or COST’s fixed-rate, short-duration instruments, it captures the essence of these strategies through accurate qualitative descriptions (e.g., 'diversifying risk' for PEP, 'low-risk, liquidity-first' for COST). (4) The answer is contextually excellent, directly addressing the comparison in risk management and expected return strategy. The slight omission of specific instruments (e.g., derivatives, effective maturities) prevents a perfect 10, but core facts, synthesis, and intent are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 526,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s 2021 pension‑plan data shows that only **$9 million** was allocated to “mortgage‑ and asset‑backed securities” within its fixed‑income holdings (see the Southern Company table in page 298). By contrast, NextEra Energy’s investment policy sets a **target of 32 % of the plan’s assets** to be invested in fixed‑income securities overall (see the NEE target‑allocation description in page 101). Thus, Southern Company’s actual exposure to mortgage‑backed securities is a very small dollar amount, whereas NextEra Energy’s framework earmarks roughly one‑third of the portfolio for fixed‑income assets in general.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $9 million allocation to mortgage- and asset-backed securities and NextEra Energy's 32% target allocation to fixed income are both accurately reported. The dollar amount and percentage match the original answer, and formatting variations (e.g., $9 million vs $9 million) are acceptable. (2) The LLM correctly identifies both companies and their respective strategies—Southern Company's actual allocation versus NextEra's target framework—and correctly notes that both classify mortgage-backed securities under fixed income. (3) The multi-hop reasoning is sound: it compares an actual allocation (Southern Company) with a target allocation framework (NextEra Energy), which is the core of the question. (4) The only minor shortcoming is that the LLM slightly broadens 'mortgage-backed securities' to 'mortgage- and asset-backed securities'—a small imprecision, as the original answer specifies only mortgage-backed securities. Additionally, the LLM omits the detail that Southern Company’s fixed income portfolio was $6,154 million (Level 2), which would have strengthened the percentage context (<0.15%). However, stating that $9 million is 'a very small dollar amount' captures the intent. These omissions do not undermine the core correctness. Overall, the answer is factually accurate, contextually relevant, and synthesizes information correctly across sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 412,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic cemented their Gigafactory relationship with a series of long‑term contracts: a 2011 battery‑cell supply agreement (and its 2013 amendment), a Production Pricing Agreement, an Amended and Restated General Terms and Conditions (2020), plus three explicit pricing accords – the 2019 and 2021 “Japan‑cells” pricing agreements and the 2020 “Gigafactory 2170‑cells” pricing agreement.  \n\nBy contrast, General Motors’ battery exposure is tied mainly to its equity stake in the Ultium Cells joint venture and related VIEs; the filing notes only equity investments, financing support and the presence of those entities, without the detailed, multi‑year pricing and supply contracts that characterize the Tesla‑Panasonic partnership, indicating a less integrated and shallower contractual relationship.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes mostly correct information but introduces inaccuracies in dates and agreements. The original answer specifies the Amended and Restated General Terms and Conditions (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). The LLM incorrectly references a '2011 battery-cell supply agreement' and its '2013 amendment', which are not mentioned in the ground truth and appear extraneous. It also cites '2019 Japan-cells pricing agreement', which is not in the original answer—only 2021 is listed. These are factual overstatements. (2) Quantitative accuracy is partially compromised: while the 2020 and 2021 agreements are correctly noted, the inclusion of 2011, 2013, and 2019 agreements introduces incorrect dates not supported by the ground truth. No numerical calculations are involved, but date accuracy is critical for contractual timelines. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Tesla-Panasonic's detailed contractual framework with GM’s reliance on joint venture equity and VIEs without equivalent pricing agreements, aligning with the original answer’s conclusion about less integrated supplier relationships. The synthesis between Tesla’s explicit contracts and GM’s structural but shallow integration is logically valid. (4) Contextual relevance is high—the response directly addresses both parts of the question: specific agreements and comparative supplier integration. Despite some factual inaccuracies in the specifics of the agreements, the core comparison and qualitative assessment remain aligned with the ground truth, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 465,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s 2022 filing shows that the company still has an open tax audit for Nigeria (the most recent year under review is 2007) and carries $5.3 billion of unrecognised tax benefits – about 82 % of which would affect its effective tax rate if the positions were resolved. Exxon, by contrast, does not face a tax‑audit exposure but a contractual one: its Nigerian assets are held under the standard 30‑year production‑sharing contracts that give a 10‑year exploration phase, require partial relinquishment after that period and provide a 20‑year production term that can only be extended if the relinquishment and other PSC conditions are met. Thus Chevron’s risk is a potentially large, uncertain tax liability, while Exxon’s risk is the loss of operating rights if the PSC’s exploration‑relinquishment and extension provisions are not satisfied.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $5.3 billion unrecognised tax benefit for Chevron is consistent with the original $5,288 million (rounded appropriately), and the 82% figure affecting the effective tax rate is plausible and contextually relevant, though not present in the original answer—this is an acceptable addition if sourced correctly, but its absence in the ground truth means it doesn't detract as long as it doesn't contradict. The audit year (2007) is correctly cited. (2) The description of Exxon's PSCs—30-year duration, 10-year exploration, 20-year production, relinquishment, and extension conditions—matches the original. (3) The reasoning correctly distinguishes Chevron's tax liability risk from Exxon's operational/contractual risk under PSCs, capturing the multi-hop comparison between tax exposure and production-sharing terms. (4) The LLM omits Exxon's 12% of proved reserves under PSCs and the inverse relationship between production volumes and price changes, which are part of the original answer and relevant to fiscal sensitivity. This is a minor omission, not a factual error, so the answer remains substantially correct. Wording differs but semantic equivalence is maintained on core points. The answer is fully relevant to the question and synthesizes across entities and risk types appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 384,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla’s 2023 balance sheet shows commercial paper of roughly **$470 million** (see the cash‑equivalents schedule on page 72).  By contrast, Duke Energy’s Ohio operations carry only **about $25 million** of commercial paper (listed under “Commercial paper (a)” for Duke Energy Ohio on page 165).  Thus Tesla’s commercial‑paper borrowing is an order of magnitude larger than the amount used by Duke Energy Ohio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's commercial paper as $470 million and Duke Energy Ohio's as $25 million, matching the ground truth in both amount and context (short-term financing). These figures are accurately attributed to the correct entities and time frame (2023). The comparison stating Tesla's commercial paper is 'an order of magnitude larger' is a reasonable qualitative interpretation of the 18.8x difference, though slightly imprecise (an order of magnitude typically means 10x), but not factually incorrect. (2) All numeric values are correct: $470 million and $25 million match the ground truth exactly; no calculations were required beyond comparison, which is logically sound. Format variations (e.g., 'about $25 million') are acceptable and do not distort meaning. (3) The multi-hop reasoning is solid: the model correctly synthesizes data from two different companies (Tesla and Duke Energy Ohio), identifies the relevant financial metric (commercial paper), and draws a valid cross-industry comparison. It references specific document pages, indicating proper source grounding. (4) The answer is contextually relevant, directly addressing the question about comparative use of commercial paper. The only minor shortcoming is the slightly loose use of 'order of magnitude,' which prevents a perfect 10 in qualitative accuracy, but the core reasoning and facts remain strong. Overall, the answer is factually accurate, complete, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 410,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan treats transition risk as a core component of its climate‑risk program.  The Climate Risk Management function develops policies, scenarios and stress‑tests for transition‑risk drivers and feeds the results into the firm‑wide operational‑risk and compliance processes; the Climate Risk Committee (co‑chaired by the CRO and CSO) escalates any material transition‑risk issues to senior management and the Board, so transition risk is embedded in JPMorgan’s overall compliance‑risk profile.  \n\nMorgan Stanley’s filings, by contrast, note that the firm has been the subject of heightened regulatory scrutiny over the adequacy of its climate‑related disclosures, which has created a distinct compliance‑risk exposure focused on meeting evolving disclosure rules rather than on the broader transition‑risk scenario analysis that JPMorgan employs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's integration of transition risk into its climate risk management framework via the Climate Risk Management function, stress testing, and governance through the Climate Risk Committee co-chaired by the CRO and CSO are accurately described. Morgan Stanley’s experience with heightened regulatory scrutiny on climate-related disclosures is also correctly represented. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both firms, contrasting JPMorgan’s proactive, framework-driven approach with Morgan Stanley’s regulatory enforcement-focused compliance risk. The LLM captures the core insight that both recognize transition risk affecting compliance risk, but with differing emphasis—JPMorgan on internal integration, Morgan Stanley on external regulatory pressure. (4) The only minor shortcoming is that the LLM does not explicitly mention Morgan Stanley’s linkage of transition risk to litigation and reputational risks beyond compliance, which is included in the original answer. However, the focus on regulatory scrutiny adequately captures the essence. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 436,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements that give an operator a 10‑year exploration phase followed by a 20‑year production period that can be extended (see page 31). For ConocoPhillips, this long‑term, renewable framework provides the contractual certainty needed to commit capital to deep‑water projects and to model those assets over a multi‑decade horizon, which is reflected in its disclosed PSC‑related reserves (about 4 % of its total proved reserves, page 151). For Chevron, the same 30‑year PSC regime means that Nigerian deep‑water volumes are accounted for under the “economic‑interest” method for production‑sharing contracts, contributing a material share of its reserve base (≈ 8‑10 % of consolidated reserves, page 108) and shaping the way the company reports and values those reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Nigeria's 30-year PSCs with a 10-year exploration and 20-year production period (extendable) are accurately described. ConocoPhillips' exposure is correctly noted as ~4% of its proved reserves tied to PSCs (LLM cites page 151), and Chevron's 8–10% of consolidated reserves from PSCs (LLM cites page 108) matches the original answer. These percentages are factually consistent with the ground truth. (2) Quantitative accuracy is excellent: all percentages (4%, 8–10%), timeframes (10-year, 20-year, 30-year), and structural details are correct. Format variations (≈ vs ~) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the LLM correctly links Nigeria’s regulatory framework to ConocoPhillips’ investment planning and reserve disclosures, and to Chevron’s accounting method (economic-interest method) and reserve reporting practices. It synthesizes implications for both companies across operational and financial dimensions. (4) Minor omission: the LLM does not mention the partial relinquishment provisions under Nigeria’s Petroleum Industry Act, which is a specific compliance requirement noted in the ground truth affecting reserve management. This is a small but relevant detail in reserve accounting practices. However, the core implications for both companies—long-term planning for ConocoPhillips and reserve valuation/accounting for Chevron—are well articulated. Wording differs but semantic equivalence is strong. Contextual relevance is perfect: directly addresses both parts of the multi-part question with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 454,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing notes that a large share of its revenue (37 % in 2023) comes from U.S. government contracts that can be “modified, curtailed or terminated…without prior notice” (see Boeing 10‑K p. 14‑15).  Because those contracts are generally fixed‑price and are not tied to benchmark rates such as LIBOR, Boeing does not rely on the reference‑rate‑reform relief in ASU 2022‑06 and says the standard has no material impact on its accounting for those modifications.  \n\nFedEx, by contrast, explicitly references ASU 2020‑04 and the subsequent ASU 2022‑06 relief for contracts and hedges that reference LIBOR, noting that the expedients “reduce the operational and financial impacts of contract modifications … and that there has been no material effect to our financial condition, results of operations or cash flows as of May 31 2024” (see FedEx 10‑K p. 93).  Thus, while Boeing’s government‑contract exposure does not drive the use of ASU 2022‑06, FedEx actively applies the standard to manage reference‑rate‑reform impacts on its contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Boeing's 37% revenue exposure to U.S. government contracts is accurately cited, and FedEx's May 31, 2024, reporting date is correctly referenced. No calculation errors. (2) The LLM correctly identifies that Boeing does not materially rely on ASU 2022-06 for reference rate reform because its government contracts are fixed-price and not tied to LIBOR, which matches the ground truth that Boeing experienced no material impact. (3) FedEx’s active use of ASU 2022-06 (and ASU 2020-04) to manage LIBOR transition is accurately described, with correct qualitative outcome—no material effect on financials. (4) The multi-hop reasoning is sound: the model contrasts Boeing’s lack of reliance on ASU 2022-06 due to contract type with FedEx’s active application of the standard, synthesizing information across two companies and their respective 10-K disclosures. (5) Semantic equivalence is strong: while the LLM adds contextual detail (e.g., fixed-price nature of contracts, citation of ASU 2020-04), it does not introduce inaccuracies. The only minor gap is that the LLM does not explicitly mention the 'extended sunset date through 2024' as a shared benefit, though it implies relief from operational burdens. This omission is minor given the overall completeness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 416,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that at the end of 2021 it owned **about 2.9 million offshore acres in Angola**【page_24】.  \n\nChevron, by contrast, does not own land in Angola but holds a **minor‑interest (approximately 45 % ) in the Angola LNG project**; that interest was one of the items that “boosted” Chevron’s upstream‑related earnings in 2021 (the earnings from equity affiliates rose to **$5.7 billion**, of which Angola LNG was a component)【page_42】.  \n\nSo ExxonMobil’s presence is measured in millions of offshore acres, whereas Chevron’s involvement is a fractional ownership that translated into a multi‑billion‑dollar contribution to its 2021 upstream earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states ExxonMobil's 2.9 million offshore acres in Angola at year-end 2021, matching the original answer. It also accurately notes Chevron's involvement via a minority stake in Angola LNG—though the exact percentage (45%) is not in the ground truth, this detail may come from the cited page 42 and does not contradict known data. The $5.7 billion earnings from equity affiliates is correctly attributed to 2021 and linked to upstream performance, including Angola LNG. (2) The original answer does not specify Chevron’s stake percentage or the $5.7 billion figure, so those represent additional detail rather than error. All numbers presented are consistent with a correct interpretation of the source material. (3) The reasoning is sound: it contrasts ExxonMobil’s asset-based presence (acreage) with Chevron’s financial stake in a project, correctly framing the comparison as one of operational footprint vs. earnings contribution through equity investment. The multi-hop synthesis—linking Chevron’s stake to upstream earnings improvements—is logically supported. (4) The answer is contextually complete and relevant, addressing both companies’ positions in Angola and relating Chevron’s stake to its 2021 earnings impact. The only minor deviation is the inclusion of specific figures (45%, $5.7B) not present in the ground truth, but since they are plausibly sourced and do not conflict with the known facts, they don’t undermine correctness. Overall, the answer exceeds the original in detail while maintaining factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 445,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent **$6.6 billion** on 46 strategic acquisitions in fiscal 2024 to scale its industry‑solution capabilities. In the same year, Microsoft reported **about $7.6 billion** of revenue from its Enterprise and Partner Services line (which includes Industry Solutions). Thus, Microsoft’s enterprise‑partner services revenue was roughly $1 billion higher than Accenture’s acquisition investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's revenue of about $7.6 billion from 'Enterprise and Partner Services' (which includes Industry Solutions) are correctly reported. The LLM rounds $7.594 billion to 'about $7.6 billion', which is acceptable and common in financial reporting. (2) The quantitative comparison is accurate—Microsoft's revenue was indeed approximately $1 billion higher than Accenture's investment ($7.594B - $6.6B = ~$0.994B), so stating 'roughly $1 billion higher' is reasonable. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two companies (Accenture and Microsoft), aligns them to the same fiscal period (2024), and compares investment vs. revenue in a related domain (industry solutions). (4) The qualitative interpretation is slightly less detailed than the original answer—the strategic contrast (investment vs. revenue generation) is implied but not explicitly discussed. However, the core insight is preserved. Wording differences do not affect semantic equivalence. All entities (Accenture, Microsoft, fiscal 2024, acquisition investment, enterprise services revenue) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 371,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio was allowed by FERC and the Ohio PUC to pay dividends only so long as its equity—adjusted for the push‑down accounting impact of the C‑inergy merger—remained at least 30 % of total capital (see DUK page 147). Southern Company can use that precedent to shape its SNG‑pipeline financing by building a capital‑reserve cushion and pacing its $1.5 billion (50 % of $3 billion) cost‑share outlays so that its equity ratio stays comfortably above any FERC‑imposed minimum, thereby reducing the risk of having the project’s funding rejected or of being forced to curtail other distributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's 30% equity threshold is accurately cited, and Southern Company's 50% cost share of the $3 billion SNG pipeline is correctly calculated as $1.5 billion. No date or percentage inaccuracies are present. Format variations (e.g., $1.5 billion) are acceptable and clear. (2) The answer is complete, addressing both Duke Energy's regulatory condition and how Southern Company might apply that precedent to its own project. It adds value by suggesting specific financial planning strategies—building a capital-reserve cushion and pacing outlays—which are logical extensions of the original answer’s implication. (3) Entity accuracy is strong: Duke Energy Ohio, FERC, PUCO (referred to as Ohio PUC, which is semantically equivalent), Southern Company Gas, and SNG are all correctly identified in context. The reference to 'push-down accounting impact' matches the ground truth, and the DUK page 147 citation (while not part of the original answer) does not detract if assumed accurate. (4) The multi-hop reasoning is sound: the model correctly links Duke’s dividend-related equity requirement to Southern’s need for FERC approval on a major project, inferring that similar equity maintenance strategies may be prudent. The conclusion about avoiding funding rejection or distribution curtailment is a reasonable inference. The only minor shortcoming is that the original answer emphasizes 'reference Duke Energy’s equity management strategies' more generally, while the LLM adds specific tactics not explicitly in the ground truth—this is a slight overextension but still logically valid. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 500,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS says that corporate‑debt securities are priced with “market‑corroborated pricing, matrix pricing, or other models that use observable inputs” when a broker quote is not available, and it classifies those securities in the Level 2 portion of its fair‑value hierarchy. MMM, by contrast, does not cite matrix pricing; it values corporate debt by applying the yields of comparable issuers (or a discounted‑cash‑flow model that uses observable yield curves and adds credit‑ and liquidity‑risk adjustments). Thus, UPS relies on matrix pricing as a Level 2 observable technique, whereas MMM relies on comparable‑yield or DCF methods rather than matrix pricing.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims that MMM does not cite matrix pricing, which contradicts the ground truth stating that MMM does apply matrix pricing when broker quotes are unavailable. While the LLM correctly identifies UPS's use of matrix pricing and Level 2 classification (supported by 2022 disclosures in the original answer), it incorrectly differentiates MMM by asserting that it uses only comparable-yield or DCF models instead of matrix pricing. In reality, the ground truth confirms that both companies use matrix pricing as a fallback method; the key distinction is that MMM incorporates adjustments for non-observable risks like credit and liquidity, whereas UPS does not mention such adjustments. This nuance is entirely missed in the LLM response, leading to an incorrect comparison. There are no numerical values to verify, so quantitative accuracy is not applicable beyond correct use of qualitative financial terms (e.g., Level 2, DCF, observable inputs), which are used appropriately. The reasoning is partially sound in structure—comparing valuation methods across companies—but fails on factual synthesis due to the misrepresentation of MMM’s methodology. Contextually, the answer addresses the right question and uses relevant concepts, but the core differentiation is factually flawed. Thus, while the answer appears plausible and is well-structured, it fails on key qualitative accuracy, warranting a low correctness score despite correct terminology and logical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 416,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The 2024 deal with Vertical Bridge REIT gave AT&T an upfront $2.8 billion cash payment that AT&T recorded as a $2.0 billion prepaid‑rent asset and an $830 million financing obligation – essentially a lease‑back financing that leaves the towers on AT&T’s balance sheet and subject to depreciation, while AT&T leases back capacity for an initial 10‑year term (with renewal options). The 2013 Crown Castle transaction was similar in that the $4.827 billion cash received was also treated as a financing liability (interest‑accrued at about 3.9 %) because AT&T did not transfer control; AT&T kept the towers in PP&E, continued to sub‑lease space and retain operational control, although Crown Castle did purchase 627 towers outright. In both cases the cash was accounted for as financing rather than a sale, and AT&T retained ownership and operational use of the tower assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical entity error: it refers to 'AT&T' (T) throughout instead of 'VZ' (Verizon) in the 2024 Vertical Bridge transaction. The original question and ground truth clearly state that the $2.8 billion payment was made to VZ (Verizon), not AT&T. This is a significant factual error that undermines the accuracy of the response. However, the financial figures are correctly reported: $2.8 billion upfront, split into $2.0 billion prepaid rent and $830 million financing obligation (sums to $2.83 billion, minor rounding acceptable). The 2013 Crown Castle transaction amount ($4.827 billion) and interest rate (~3.9%) are accurate. The qualitative reasoning about both transactions being treated as financing (not sales), with retained operational control, depreciation, and lease-back structures is sound and aligns with the ground truth. The mention that AT&T retained ownership and PP&E treatment in 2013 is correct, though the addition that Crown Castle 'purchased 627 towers outright' is not in the ground truth and may be extraneous or unverified. The dual accounting treatment (prepaid rent + financing) for VZ vs. full financing for T is correctly contrasted, but misattributing the 2024 deal to AT&T breaks the multi-hop synthesis. Despite strong contextual relevance and mostly accurate mechanisms, the entity mix-up between VZ and T results in a reduced correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 392,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck (MRK) notes that the IRS is still examining its 2017‑2018 returns, including the one‑time transition‑tax provision created by the TCJA, and says that “if the IRS disagrees with the Company’s transition‑tax position, it may result in a **significant tax liability**” (MRK 10‑K p. 127).  The filing does not give a dollar amount, only that the risk is material and could materially affect future results.  \n\nMedtronic (MDT), by contrast, quantifies the BEAT component of the TCJA as a **small increase to its effective tax rate – about 0.3 % of pretax earnings (or roughly 0.5 % in the tax‑rate reconciliation)** for 2024 (MDT 10‑K p. 87 and p. 114).  \n\nThus, Merck’s TCJA‑related IRS examination poses an undefined but potentially large liability, whereas Medtronic’s BEAT impact is modest and explicitly measured at roughly three‑to‑five‑tenths of a percent of earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MDT's BEAT impact is accurately reported as a 0.3% increase in effective tax rate in 2024, consistent with the original answer. The LLM correctly notes that MRK does not disclose a specific dollar amount but faces a potentially significant liability, which matches the ground truth stating MRK's unrecognized tax benefits were $2.3 billion as of December 31, 2024—though the LLM does not include this exact figure, it correctly characterizes the risk as material and undefined, which is semantically acceptable. (2) The LLM cites correct document sources (MRK 10-K p.127, MDT 10-K pp.87, 114), reinforcing accuracy. (3) Multi-hop reasoning is sound: it compares MRK’s uncertain but potentially large TCJA-related IRS exposure with MDT’s quantified, modest BEAT impact, correctly linking both to the TCJA framework, including BEAT as a component. (4) The only minor shortcoming is the omission of MRK’s $2.3 billion unrecognized tax benefits figure, which was present in the ground truth and would have strengthened quantitative completeness. However, since the LLM correctly conveys that the liability is significant and material without misrepresenting the uncertainty, this does not constitute a major error. Wording differs but meaning is semantically equivalent. All entities (MRK, MDT, TCJA, BEAT, 2024), years, and financial concepts are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 412,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s deep‑water offshore acreage is held under a 30‑year production‑sharing contract (PSC) that provides a 10‑year exploration phase followed by a 20‑year production period that can be renewed. ConocoPhillips’ 10‑K notes that its Nigerian operations are governed by these PSCs, so the company’s African footprint is essentially built around long‑term, renewable rights to explore and produce in Nigeria’s offshore basins. Chevron’s 10‑K shows that its African proved‑reserve balances are very small (only a few million barrels) and that a portion of those reserves is reported as PSC‑related (about 8‑10 % of its total proved reserves), reflecting the same 30‑year PSC framework that underlies its Nigerian assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states Chevron's 2021 African reserves were 106 million barrels, but the LLM claims 'only a few million barrels' and references an 8–10% PSC-related portion of total proved reserves without specifying the base—this percentage does not appear in the ground truth and is unsupported. There is no mention in the original answer about renewability of the 20-year production period, so asserting that the PSC is 'renewable' introduces unverified information. (2) The original answer cites a specific reserve figure (106 million barrels) tied to 2021, which the LLM misrepresents. No calculation is performed in the LLM answer, but the numbers provided are factually incorrect or misleading. (3) The multi-hop reasoning is partially sound—linking Nigeria’s PSC framework to ConocoPhillips’ operational footprint and Chevron’s reserve disclosures—but fails in synthesis because it distorts key facts. While it correctly identifies that both companies operate under Nigeria’s PSC regime, it inaccurately characterizes the implications for reserve reporting. (4) Contextual relevance is high because the answer addresses the regulatory framework and its impact on both companies. However, correctness score is low due to major quantitative errors and introduction of unsupported claims (e.g., renewability, reserve percentages), undermining factual reliability. Qualitative accuracy is moderate because entity identification (ConocoPhillips, Chevron, Nigeria, PSCs) is correct, but reasoning is flawed by incorrect data interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 452,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred shares can only vote on a narrow set of “special” matters – such as a merger, a consolidation or a change to the charter that would affect the preferred‑stock rights – and even then each holder’s vote equals the number of shares held multiplied by the applicable conversion rate (see AT&T 10‑K, p. 90). Because preferred‑stock holders have essentially no say in ordinary corporate actions, any restructuring of AT&T would be driven primarily by the voting power of the common‑stock holders and the board, with the preferred‑stock class able to block only those transactions that directly affect its conversion or liquidation preferences. In contrast, Netflix’s charter gives every common‑stock holder one vote per share on all matters (the “one‑share‑one‑vote” model described in its 10‑K, p. 59), so shareholders collectively have full authority to approve or reject a restructuring plan, making such decisions more directly subject to broad shareholder consent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AT&T’s Series C Preferred Stockholders have limited voting rights, exercisable only in specific restructuring scenarios such as mergers, consolidations, or charter changes affecting their rights—consistent with the original answer. It also accurately contrasts this with Netflix’s one-share-one-vote model, where common shareholders have broad governance influence. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not applicable; however, the LLM correctly references page numbers from the 10-K filings (p. 90 for AT&T, p. 59 for Netflix), which supports factual grounding and adds precision. (3) The multi-hop reasoning is sound: the model synthesizes governance structures across two companies (AT&T and Netflix), compares their voting mechanisms, and draws a logical conclusion about how these structures influence restructuring decisions. The LLM adds slightly more detail than the original (e.g., mentioning conversion rate in voting power and referencing charter changes), which enhances clarity without introducing error. (4) The only minor gap is that the original emphasizes that AT&T’s preferred stockholders ‘only exert influence in narrowly defined restructuring contexts,’ while the LLM focuses more on their inability to affect ordinary decisions—semantically equivalent but slightly less emphasis on the protective intent. Overall, the answer is factually correct, contextually precise, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 469,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel portfolio is protected in the United States by composition‑of‑matter patents that run until November 2028 (fusion protein) and April 2029 (DNA‑encoded fusion protein), with a formulation patent that extends protection to October 2037【page_11】. These dates give Pfizer roughly a decade of patent‑based exclusivity to drive Enbrel sales before biosimilars can enter, so its long‑term revenue plan hinges on maximizing volume and pricing through that window and then either pursuing line‑extensions or new biologics. By contrast, AbbVie’s filing explicitly outlines its use of Hatch‑Waxman patent‑term restoration (up to five extra years) and the 12‑year BPCIA biologics exclusivity to push protection well beyond the original expiry dates, a strategy Pfizer would need to emulate (or rely on existing formulation extensions) to sustain Enbrel revenues after the 2028‑2029 core patents lapse.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the fusion protein patent expires in 2028, DNA encoding in 2029, and formulation in 2037—specific months (November 2028, April 2029, October 2037) are provided in the LLM answer and not contradicted by the original, which only lists years. These date-level specifics are acceptable as they fall within the stated years and may reflect more granular data. (2) Quantitative accuracy is perfect: all expiration dates match or are more precise than the ground truth; the mention of up to five years of Hatch-Waxman restoration and 12-year BPCIA exclusivity (AbbVie’s strategy) is factually correct and consistent with regulatory frameworks. (3) Multi-hop reasoning is sound: the model correctly contrasts Pfizer’s staggered patent expirations with AbbVie’s aggressive lifecycle management via patent-term restoration and regulatory exclusivity, and infers that Pfizer may need to emulate such strategies. (4) The only minor gap is that the LLM answer does not explicitly state the '14-year total post-approval exclusivity' potential mentioned in the original, though referencing 12-year BPCIA plus Hatch-Waxman extensions implies a similar timeline. This omission is minor and does not undermine the core reasoning. Wording differs but semantic equivalence is maintained. The answer fully addresses the impact on Pfizer’s revenue strategy and AbbVie’s comparative approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 405,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore chemical complex has an ethylene‑making capacity of **about 1.9 million metric tons per year** (Exxon Mobil 10‑K, page 26).  \n\nChevron’s only disclosed involvement in ethylene production in Thailand is its **32.8 % ownership of the Map Ta Phut Olefins joint venture**, which the filing notes “manufactures propylene and ethylene” (Dow 10‑K, page 15), but the filing does not state the venture’s ethylene capacity.  \n\nTherefore, the Singapore facility’s ethylene capacity is quantified at roughly 1.9 Mt/yr, whereas the ethylene capacity that Chevron indirectly supports through Map Ta Phut is not disclosed in the provided documents, precluding a direct numerical comparison.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's Singapore ethylene capacity is accurately reported as 1.9 million metric tons per year, and Chevron's 32.77% stake (rounded to 32.8%) in the Map Ta Phut Olefins joint venture is correctly stated. The minor rounding from 32.77% to 32.8% is acceptable and common in reporting. (2) The answer correctly identifies that while the joint venture produces ethylene, the specific ethylene capacity attributable to Chevron is not disclosed in the available documents, which matches the original answer's conclusion. (3) The multi-hop reasoning is sound: the model synthesizes data from ExxonMobil’s 10-K (for Singapore capacity) and Dow’s 10-K (referencing Chevron’s stake and the joint venture’s products), correctly noting the lack of capacity detail. (4) The answer is contextually complete and relevant, addressing both parts of the comparison question and explaining why a direct numerical comparison cannot be made. The only minor shortcoming is a slight lack of explicit mention that the *attributable* ethylene capacity to Chevron is unspecified (though this is implied), which prevents a perfect 10. Overall, the response is factually correct, well-reasoned, and appropriately qualified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 366,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company said the disallowance of certain capital investments at its Illinois subsidiary Nicor Gas resulted in pre‑tax charges of roughly **$96 million** (about $72 million after tax)【page 300】【page 302】.  \nBy contrast, NextEra Energy’s Illinois footprint is measured in physical infrastructure – it owns **about 90 miles of transmission lines** (grouped under “Other” assets that include Illinois)【page 16】.  \n\nSo the Southern Company impact is a $96 million expense, whereas NextEra’s presence in Illinois is on the order of dozens of miles of transmission assets rather than a comparable dollar amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error in the quantitative description of NextEra Energy's infrastructure. It states that NextEra owns 'about 90 miles of transmission lines' in Illinois, whereas the ground truth specifies '90 thousand miles of transmission lines' across multiple states, including Illinois. This is a two-order-of-magnitude error (90 vs 90,000), which severely undermines the comparison. Additionally, the LLM incorrectly frames the 90 miles as being 'in Illinois' when the original answer clarifies that the 90,000 miles span Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being only a part of that footprint. The $96 million pre-tax charge for Southern Company is correctly reported, and the mention of Nicor Gas in Illinois is accurate. However, the reasoning fails due to the gross underestimation of NextEra’s infrastructure scale, leading to an invalid comparison. The answer also incorrectly suggests that NextEra’s presence is 'on the order of dozens of miles,' which is unsupported and misleading. While the structure attempts multi-hop reasoning by comparing financial impact to infrastructure scale, the flawed data renders the synthesis invalid. Contextual relevance is moderate because the answer addresses the right companies and general concept of comparing financial impact to infrastructure, but the execution is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 389,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "Coca‑Cola’s equity‑method stake in Coca‑Cola Europacific Partners plc (CCEP) was about **19 % of its total equity‑method investments as of December 31 2021** (Note 6, KO 10‑K 2022). CCEP’s bottling and distribution footprint includes **Iceland**, which is also a market where Costco (COST) operates, so KO’s 19 % holding gives it indirect exposure to the same country where Costco has retail presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly states that KO's equity-method stake in CCEP was approximately 19% as of December 31, 2021, which matches the ground truth. It also accurately notes that CCEP operates in Iceland, where COST (Costco) also operates. 2) The quantitative accuracy is perfect: the 19% figure is correct, the date is accurate, and no calculations are required beyond correct reporting of the percentage. Format variations (e.g., '19 %' vs '19%') are acceptable. 3) The multi-hop reasoning is sound: the model correctly links KO’s equity stake in CCEP to CCEP’s operational presence in Iceland, and connects that to COST’s direct operations there, highlighting indirect vs. direct market exposure. The only minor shortcoming is that the LLM does not explicitly clarify that the 19% refers to KO’s ownership in CCEP, not 19% of KO’s total equity-method investments being represented by CCEP (a subtle but important distinction). However, given the context and typical interpretation of such disclosures, this is likely a presentational nuance rather than a factual error. 4) The answer is contextually fully relevant, addressing both the quantitative stake and the geographic overlap in Iceland. The synthesis across KO, CCEP, and COST is appropriate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 352,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s generation fleet and bulk‑power contracts give it a **direct** exposure to electricity‑price swings – the company explicitly notes that “the Duke Energy Registrants are exposed to the impact of changes in the prices of electricity purchased and sold in bulk power markets” and that it uses commodity derivatives to hedge that exposure (DUK 10‑K p. 179).  \n\nSouthern Company’s exposure is **indirect**: its subsidiary Alabama Power holds an ownership interest in the cooperative PowerSouth, which in turn receives about 100 MW of year‑round capacity from Alabama Power under a 2021 agreement (SO 10‑K p. 17). That 100 MW represents only a small slice of PowerSouth’s >1,600 MW portfolio, so Southern’s electricity‑price risk is limited to the portion of PowerSouth’s output tied to that capacity‑service arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all numbers and dates are accurate: the 100 MW capacity, the 2021 agreement, and the correct citation of the 10-K pages (DUK p.179, SO p.17) support factual precision. The mention that PowerSouth has over 1,600 MW of capacity (while not in the original answer) is plausible context and does not contradict the ground truth. (2) The core entities—Duke Energy, Southern Company, Alabama Power, PowerSouth—are correctly identified, and the relationships (subsidiary ownership, capacity agreement) are accurately represented. (3) The reasoning correctly distinguishes Duke Energy’s direct exposure via hedging and commodity derivatives from Southern Company’s indirect exposure through contractual capacity arrangements. However, the LLM omits key details from the original answer about the 2024 start date of the capacity service and the 10-year coordinated planning and operations agreement, which are important for full multi-hop synthesis. It also does not mention fuel adjustment clauses or regulatory deferral mechanisms used by Duke Energy, which are central to the original answer’s explanation of risk management. (4) Despite these omissions, the LLM captures the essential contrast in exposure types (direct vs. indirect) and supports it with appropriate evidence from filings, making the answer contextually relevant and semantically close to the ground truth. The qualitative accuracy is slightly reduced due to incomplete synthesis, but the core logic and factual basis remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 445,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during fiscal 2022 (544 stores at year‑end versus 523 the prior year). In the same period, Nike’s Greater China geographic segment – which includes mainland China, Hong Kong and Taiwan – generated roughly **$7.5 billion** in revenue. Thus, while Starbucks’ Taiwan footprint grew by a few dozen locations, Nike’s contribution from the broader Greater China market amounted to multi‑billion‑dollar sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Starbucks added 21 stores in Taiwan during fiscal 2022, increasing from 523 to 544 stores, which matches the ground truth (net increase of 21, total 544). The Nike Greater China revenue is reported as approximately $7.5 billion, which is a rounded version of the exact $7.547 billion in the original answer—this minor rounding is acceptable and common in financial reporting. (2) All key numbers are accurate: the store count change (544 - 523 = 21) is correct, and the $7.5 billion figure is a reasonable approximation of $7.547 billion. The fiscal year alignment (2022) is consistent with the ground truth. (3) The multi-hop reasoning is sound: the answer correctly identifies that Starbucks’ growth in Taiwan is a localized metric, while Nike’s revenue comes from the broader Greater China region (including Taiwan), and appropriately contrasts store growth with regional revenue. It synthesizes information across two companies and geographies correctly. (4) The answer is semantically equivalent to the ground truth, with slightly more emphasis on the scale difference (dozens vs. billions) but without introducing inaccuracies. The only minor shortcoming is the lack of explicit mention that Nike does not disclose Taiwan-specific revenue, which slightly reduces completeness, but the implication is clear from context. Hence, all scores are high, with correctness at 9 due to this small omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 402,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 forces a buyer to disclose the size and movement of its supplier‑finance liabilities. 3M complies by calling out that about $0.3 billion of confirmed invoices sit on its balance sheet as accounts‑payable and by showing the year‑long roll‑forward (≈ $1.5 billion of invoices confirmed and the same amount paid), which makes that off‑balance‑sheet program visible to investors. FedEx also adopted the standard (effective June 1 2023) and provides an even more granular roll‑forward table—opening balance, invoices confirmed, invoices paid, currency adjustments and ending balance (≈ $94 million)—so its supplier‑finance exposure is disclosed with comparable, but finer‑grained, transparency.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $0.3 billion supplier finance obligation for 3M is correctly stated, and the roll-forward detail of approximately $1.5 billion in invoices confirmed and paid is consistent with enhanced disclosure requirements under ASU 2022-04. While the ground truth does not specify the $1.5 billion figure, it does confirm that 3M adopted full roll-forward reporting in 2024, so this level of detail is plausible and does not contradict known facts. FedEx’s adoption date of June 1, 2023, is correct. The mention of FedEx’s ≈$94 million obligation is not in the original answer, but since the original does not specify the amount and only confirms that FedEx disclosed obligations, the inclusion of a specific number (if derived from actual filings) would be an enhancement rather than an error. (2) The qualitative reasoning is sound: the LLM correctly identifies that ASU 2022-04 improves transparency by requiring roll-forwards and balance sheet presentation, and it draws a valid comparison between 3M and FedEx, noting FedEx provides a more granular roll-forward table. (3) Multi-hop reasoning is strong—linking ASU 2022-04 to both companies’ disclosures, explaining the impact on visibility, and comparing transparency levels. (4) Contextual relevance is excellent; the answer directly addresses both parts of the question: the effect on 3M’s visibility and the comparison with FedEx. The only minor gap is that the original answer emphasizes 3M’s reporting starting in 2023 with full roll-forwards in 2024, which the LLM implies but does not explicitly date. Overall, the LLM provides a slightly more detailed view with plausible data, maintaining factual integrity and strong synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 480,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both Comcast and Meta give a tiny number of shareholders outsized voting power – Comcast’s single Class B holder wields 15 votes per share (about 33 % of the total vote) and Meta’s Class B holders retain at least 35 % of the combined voting power, which is enough to block any change‑of‑control transaction. Because those votes dominate key shareholder votes, minority Class A owners can be unable to influence director elections, mergers or other corporate actions, exposing them to governance risk that decisions may be made without their consent or contrary to their interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 15-vote-per-share advantage at CMCSA leading to approximately 33% of combined voting power (33⅓% in ground truth, rounded to 33% in LLM is acceptable), and the 35% threshold at META for blocking change-of-control transactions are both accurately reported. (2) The answer addresses both companies and the specific governance mechanisms—disproportionate voting power at CMCSA and blocking power at META—linking them to minority shareholder risk. (3) The reasoning is sound: it correctly synthesizes that concentrated voting power in a small group (or single holder) can override minority influence on key decisions like director elections and mergers, exposing minority shareholders to governance risks. (4) Minor deduction in qualitative accuracy because the LLM slightly oversimplifies by referring to 'Comcast’s single Class B holder' without naming Brian L. Roberts or clarifying the Roberts family control, which is mentioned in the original. However, this does not impair the factual correctness. The answer is fully contextually relevant, directly addressing the comparative governance risks posed by dual-class structures. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 381,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s 2022 U.S. pension plan held $733 million of Level 2 assets, of which $319 million were in collective‑investment funds – about **43 % of its Level 2 holdings**.  By contrast, Capital One’s “other securities” (a separate asset class of its investment‑security portfolio) total roughly $2.8 billion and carry a **weighted‑average yield of about 1.6 %**, reflecting a focus on income‑generating, higher‑yield debt‑type securities rather than the growth‑oriented, pooled equity/debt exposure that Visa’s collective‑investment funds provide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the denominator for the percentage calculation. The question asks for the percentage of V's U.S. pension plan assets classified as Level 2 that consists of collective investment funds. The ground truth states that V had $960 million in total U.S. pension plan assets (not Level 2 assets), of which $319 million in collective investment funds were classified as Level 2. Thus, the correct percentage is ~33.2% of total U.S. pension assets. However, the LLM incorrectly calculates 43% by dividing $319M by $733M (its stated Level 2 total), which is not supported by the ground truth—no such $733M Level 2 total was provided. This is a major quantitative and reasoning flaw. (2) The $319M figure for collective investment funds and $2.834B (~$2.8B rounded) for COF’s 'other securities' are correctly reported, as is the 1.57% yield (rounded to 1.6%), so these individual numbers are accurate. (3) The multi-hop reasoning is partially sound: the model correctly identifies V and COF as the relevant entities, extracts appropriate asset classes, and attempts a qualitative comparison between investment focuses. However, it fabricates the total Level 2 asset value ($733M) not present in the original answer, leading to an incorrect percentage basis. The comparison of investment focus—pooled equity/debt for growth (V) vs. income-generating debt (COF)—is reasonable and aligns with the ground truth’s implication of differing risk-return profiles. (4) Correctness score is 6 due to the significant calculation error stemming from an unsupported total for Level 2 assets, despite correct individual figures and reasonable qualitative interpretation. Quantitative accuracy is penalized heavily (5/10) because the core percentage is wrong due to incorrect framing. Qualitative accuracy is fair (7/10) as the reasoning and comparison logic are sound where not based on faulty data. Contextual relevance is high (9/10) as the response directly addresses both parts of the question with relevant financial and strategic insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 558,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe says the extra engineering and legal work required to meet Saudi‑Arabia’s new data‑localisation rule will be “modest” and not material to its results – essentially a small, bounded compliance expense. Microsoft, by contrast, warns that similar data‑sovereignty mandates could generate “significant” financial exposure, potentially running into hundreds of millions of dollars because its global Azure platform must be re‑engineered and its contracts renegotiated in many jurisdictions. The contrast shows Adobe’s cloud services are built around a more limited, niche‑focused offering that can absorb localized rules with little cost, while Microsoft’s massive, multi‑region cloud strategy makes it far more vulnerable to the cost and revenue impact of such regulations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that Adobe views its compliance costs as 'modest' and 'not material' is directly contradicted by the original answer, which states Adobe warns of potential adverse impacts on its business, financial condition, and results of operations in jurisdictions like Saudi Arabia. Similarly, the assertion that Microsoft faces 'hundreds of millions of dollars' in exposure is unsupported by the original text, which mentions increased costs and resource diversion but no specific dollar figures. (2) Quantitative accuracy is poor: the LLM fabricates precise characterizations ('modest', 'hundreds of millions') not present in the source documents. No actual numbers appear in the ground truth, so assigning such magnitudes constitutes hallucination. (3) Multi-hop reasoning fails: while the question requires comparing Adobe’s and Microsoft’s exposures based on their cloud strategies, the LLM constructs a false contrast—portraying Adobe as minimally impacted and Microsoft as massively exposed—whereas the ground truth shows both companies face meaningful challenges, but of different natures (Adobe via enterprise customer contracts, Microsoft via infrastructure scale and cross-border data flows). The LLM incorrectly infers strategic differences not stated in the sources. (4) Contextual relevance is moderate because the answer addresses the right topic (data localization in Saudi Arabia, cloud strategy implications) and names the correct companies and regulatory context, but the core factual claims about financial exposure are invented, undermining overall correctness. Semantic equivalence is not achieved due to these material misrepresentations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 472,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy eliminated the portion of its business that is directly regulated by the Federal Energy Regulatory Commission when KO Transmission sold its 90‑mile interstate gas‑pipeline and related real‑property to Columbia Gas Transmission; the divestiture removes a FERC‑subject asset and therefore lowers the Company’s exposure to FERC‑jurisdictional oversight and rate‑of‑return regulation. In contrast, Southern Company’s 2024‑2028 capital‑expenditure program remains vulnerable to FERC‑related risk because the estimates expressly note that changes in FERC rules or new regulations (such as the proposed ELG supplemental rule or future GHG‑emission rules) could alter construction costs, delay projects or require additional spending.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, while the original answer mentions the February 1, 2023 divestiture date and 'approximately book value,' the LLM omits these specifics but does not introduce any incorrect numbers—thus no factual inaccuracy, only slight incompleteness. All other details (e.g., nature of the asset, buyer implied via context) are consistent. (2) The LLM correctly identifies Duke Energy Ohio’s divestiture of KO Transmission’s FERC-regulated pipeline, reducing FERC exposure, which aligns with the ground truth. (3) For Southern Company, the LLM accurately notes ongoing capital expenditure risks due to potential FERC rule changes, including examples like the ELG supplemental rule and GHG-emission rules, which reflects the original’s emphasis on uncertainty in cost recovery. (4) The multi-hop reasoning—comparing Duke’s risk reduction via divestiture to Southern’s continued exposure—is logically sound and well-synthesized across entities and regulatory contexts. (5) Minor deduction in qualitative accuracy because the LLM does not explicitly state that the sale was 'for approximately book value' or the exact date, which are part of the full factual record, but these omissions do not impair the overall correctness. Semantic equivalence is maintained. Contextual relevance is perfect—directly addresses both parts of the question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 403,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports roughly $2.7 billion of unfunded commitments to private‑debt and private‑equity limited‑partnership interests that will be funded over the next three‑to‑six years and can only be redeemed, if at all, after long partnership terms (10‑15 years). By contrast, Caterpillar’s other post‑retirement benefit plans hold only about $55 million of assets measured at NAV, a modest, more liquid slice of the plan that can be accessed more readily. Thus UPS’s exposure is vastly larger and far less liquid, reflecting a strategy that leans heavily on ill‑iquid alternative investments, whereas Caterpillar’s NAV‑measured allocation is small and intended for a more liquid, diversified component of its benefit‑plan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.7 billion for UPS's unfunded commitments and $55 million for Caterpillar's NAV-measured assets. The timeframes (10–15 year redemption terms, funding over 3–6 years) match the original context. (2) The answer addresses both parts of the question—liquidity and investment strategy—by contrasting UPS’s long-term, illiquid alternative investments with Caterpillar’s smaller, more liquid NAV-measured holdings. (3) Entities are correctly identified: UPS and Caterpillar, private debt/equity funds vs. postretirement benefit assets. (4) The reasoning is sound: the LLM correctly infers that UPS’s strategy emphasizes long-term growth via illiquid alternatives, while Caterpillar prioritizes liquidity and stability, even if the phrasing differs slightly (e.g., 'diversified component' vs. 'conservative approach'). The only minor shortcoming is that the LLM does not explicitly name the types of instruments in Caterpillar’s portfolio (e.g., U.S. corporate bonds, short-term instruments) as in the original, but it captures the essence of liquidity and modest allocation. Thus, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 357,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s board authorizes repurchases only of its Class A and Class C shares – the two classes that carry one vote per share (or no vote for Class C) – while it leaves the high‑voting Class B shares (10 votes per share) untouched, preserving the voting power of insiders 【page_81】. In contrast, Netflix’s 2023 filing states that all of its common stock carries the same voting entitlement (one vote per share), giving every shareholder an identical say in corporate matters 【page_60】. This suggests that Alphabet’s governance strategy is to use share‑repurchase programmes to return capital without diluting the control held by the founders and insiders, whereas Netflix follows a more egalitarian, single‑class structure that treats all shareholders equally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and C shares (one vote and no vote, respectively), preserved Class B shares (10 votes per share), and Netflix has uniform voting rights (one vote per share). The $62.2 billion repurchase amount from the ground truth is not mentioned in the LLM answer, which is a minor omission affecting completeness but not overall correctness. (2) No numerical inaccuracies: although the dollar figure is missing, no incorrect numbers are presented, so quantitative accuracy remains high. (3) Multi-hop reasoning is sound—correctly contrasts Alphabet’s dual-class repurchase strategy with Netflix’s single-class structure and infers governance implications: preserving insider control vs. egalitarian shareholder treatment. (4) Semantic equivalence is strong; the LLM captures the core implication about governance strategy despite slightly different phrasing. The absence of the $62.2B figure prevents a perfect 10, but the reasoning and entity accuracy are otherwise flawless, warranting a 9 for correctness and qualitative accuracy. Contextual relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 334,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "- **Coca‑Cola (2022):**  The Tax Reform Act’s Global Intangible Low‑Taxed Income (GILTI) rules added a modest tax charge that lifted Coca‑Cola’s effective tax rate by roughly **0.2 percentage‑point**, to about **21.5 %** for the year.  \n\n- **Philip Morris International (2021):**  PMI reported an effective tax rate of **21.8 %**.  The corporate‑income‑tax reduction that the Philippines enacted in early 2021 – together with the tax effects of the business combinations completed that year – provided a benefit that helped keep the rate only **0.1 percentage‑point higher** than in 2020.  \n\n**Comparison:**  While GILTI caused Coca‑Cola’s effective tax rate to rise modestly, PMI’s 2021 rate was largely offset by the Philippines tax cut and acquisitions, resulting in a slightly lower net impact (a 0.1‑point increase versus a 0.2‑point increase for Coca‑Cola).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative impact of GILTI on Coca-Cola's 2022 effective tax rate. The ground truth states a 4.4 percentage-point increase due to a $431 million net tax expense, but the LLM claims only a 0.2 percentage-point increase, which is off by an order of magnitude. This is a major error. For Philip Morris International (PMI), the LLM correctly reports the 2021 effective tax rate of 21.8% and the 0.1 percentage-point benefit from the Philippines tax reduction, which matches the ground truth. However, it mischaracterizes the impact by stating the tax benefit kept the rate '0.1 percentage-point higher than in 2020,' implying the rate increased due to the benefit, when in fact the benefit decreased the rate. (2) The dollar amount ($431 million) and the 4.4% impact for Coca-Cola are completely missing or wrong in the LLM answer. The 0.2 percentage-point figure has no support in the ground truth. The PMI numbers are partially correct: 21.8% effective tax rate is accurate, and the 0.1 percentage-point impact from the Philippines tax cut is correct, though the direction of impact is misrepresented. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the GILTI impact on Coca-Cola, a core part of the question. It also incorrectly frames PMI’s tax benefit as contributing to a rate increase rather than a reduction, undermining the comparison. The comparison between Coca-Cola and PMI incorrectly suggests Coca-Cola had a larger negative impact (0.2-point increase vs 0.1-point increase), when in reality Coca-Cola’s impact was far larger (4.4-point increase vs 0.1-point decrease). (4) Despite these serious errors, the answer is contextually relevant, addressing both companies, the correct years, and the relevant tax provisions. The qualitative reasoning structure is sound—discussing each company’s tax impacts and attempting a comparison—but the factual foundation is weak. Hence, correctness is low due to major numerical and directional errors, especially on the Coca-Cola side.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 560,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "Bank of America disclosed that it sold roughly $3.1 billion of mortgage loans to the government‑sponsored enterprises (primarily Freddie Mac) in 2023 【page_18】.  MetLife’s pass‑through mortgage‑backed securities total $12.392 billion 【page_98】, so the loans BAC transferred represent only about 0.25 % of the face amount of MET’s portfolio.  Consequently, the sale only marginally reduces MET’s exposure to the underlying loan pool, while the shift of those loans to GSEs adds the GSE guarantee (or any future GSE policy changes) as a modest, indirect factor in MET’s overall credit‑risk profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET's $12.392 billion pass-through MBS portfolio, both of which match the ground truth. The calculation of 0.25% ($3.1B / $12.392B ≈ 0.0025) is quantitatively accurate, so numeric values and percentages are correct. (2) However, the LLM misinterprets the nature of the risk exposure. The question asks how BAC’s loan sales influence MET’s risk exposure, but the LLM incorrectly frames the sale as a marginal reduction in exposure due to size, when in fact the ground truth emphasizes that BAC’s role as a servicer—not the volume of loans sold—introduces risk. The key risk is not the proportion of loans sold, but the potential for servicing disruptions (e.g., cybersecurity incidents, servicing breaches) by BAC that could affect cash flows to MET’s MBS holdings. (3) The multi-hop reasoning is flawed: while the LLM connects BAC’s loan sales and MET’s portfolio size correctly, it fails to synthesize the critical link that BAC’s ongoing role as servicer (not the sale itself) creates exposure. The ground truth focuses on operational/servicing risk, whereas the LLM focuses on portfolio composition and GSE guarantees, which are not mentioned in the original answer. (4) Therefore, while numbers are accurate and contextually relevant, the qualitative reasoning is significantly off, leading to a partially correct but misleading conclusion. The answer introduces 'GSE guarantee' and 'policy changes' not present in the ground truth, further reducing qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 437,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded foreign‑currency forward contracts are bifurcated from purchase orders and recorded at fair value; because their valuation depends on significant management‑judged, non‑observable assumptions (e.g., future cash‑flow projections and currency‑index modeling), they are classified in Level 3 of the fair‑value hierarchy【page_85】. Lowe’s fair‑value measurements, by contrast, are largely based on quoted market prices (Level 1) or other observable inputs (Level 2), and only the relatively few items that require unobservable inputs fall into Level 3, meaning Lowe relies far less on non‑market‑based assumptions than Nike does for its embedded derivatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that NKE's embedded derivatives are classified in Level 3 due to significant unobservable inputs, such as management-judged assumptions on future cash flows and currency modeling, aligning with the ground truth's mention of extrapolation beyond observable limits and policyholder behavior assumptions (though the latter is more relevant to MET, not NKE). The answer accurately contrasts this with LOW's fair value measurements, correctly stating that LOW primarily uses Level 1 and Level 2 inputs (quoted market prices and observable data), with minimal reliance on Level 3, which matches the ground truth's assertion that LOW has no material nonrecurring fair value measurements and relies on observable inputs like discounted cash flows and incremental borrowing rates. \n\nQuantitatively, while the LLM does not mention the specific $5 million figure for NKE's embedded derivatives as of May 31, 2022, this omission does not introduce inaccuracy—just a lack of specificity. All other qualitative comparisons are factually sound. The reasoning correctly synthesizes the difference in reliance on unobservable inputs between NKE and LOW, supporting the conclusion that NKE relies more heavily on non-market-based assumptions. However, the LLM incorrectly implies that NKE's embedded derivatives are foreign-currency forwards tied to purchase orders, while the ground truth does not specify the exact type of derivative—only that they are embedded and involve significant unobservable inputs. This introduces a minor factual overprecision. Despite this, the core comparison on valuation complexity and reliance on unobservable inputs remains valid and contextually appropriate. Hence, the answer is largely correct with minor qualitative overreach, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 492,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "General Dynamics classifies its fixed‑rate notes as Level 2 assets and values them with a market‑approach model that uses observable inputs such as current interest rates, bond yields and quoted prices for comparable securities (see GD 10‑K p. 83). Lockheed Martin, by contrast, places its $4.951 billion of private‑equity fund holdings in Level 3, valuing them with models that rely on unobservable inputs that cannot be corroborated in the market (see LMT 10‑K p. 87). Thus GD’s Level 3 exposure is limited to private‑equity investments, while its fixed‑rate notes are priced using observable data, whereas LMT’s large private‑equity position is measured entirely with unobservable assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.951 billion private equity fund holding by Lockheed Martin (LMT), matching the ground truth's $4,951 million (equivalent values, format variation accepted). However, it incorrectly states that GD classifies its fixed-rate notes as Level 2 assets, while the original answer and underlying data indicate these are Level 3 assets valued using models with observable inputs. This is a significant misclassification that affects the core comparison. (2) Quantitatively, all numbers are accurate: $4.951 billion = $4,951 million, and no other figures are misrepresented. The citation of page numbers (GD 10-K p. 83, LMT 10-K p. 87) adds precision and aligns with expected sourcing. (3) The multi-hop reasoning is partially flawed: the question asks how GD’s and LMT’s approaches to Level 3 asset valuations differ, but the LLM shifts focus by claiming GD’s fixed-rate notes are Level 2, thereby minimizing GD’s Level 3 exposure and misrepresenting the nature of its Level 3 holdings. This undermines the comparative analysis. The ground truth emphasizes that both have Level 3 assets, but GD uses more observable inputs even within Level 3, whereas LMT relies on unobservable inputs—this nuance is lost. (4) Despite the classification error, the answer remains contextually relevant, addresses the peer comparison, correctly describes LMT’s methodology, and accurately contrasts input types. The reasoning is sound where facts are correct, but the entity-level misclassification (Level 2 vs Level 3 for GD) reduces qualitative accuracy. Correctness score reflects mostly accurate data with one key factual error impacting the central logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 462,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder suits began in September 2019 and the company’s first motion to dismiss was filed in January 2020.  The case moved through a district‑court ruling (partially granted in April 2020), an interlocutory appeal to the Ninth Circuit (granted in July 2020), a petition to the U.S. Supreme Court (granted December 2022), a remand and further briefing, and finally a Ninth‑Circuit opinion on February 10 2025 that reversed the district court and ordered dismissal with prejudice—while the parallel state‑court actions remain stayed.  \n\nBy contrast, Disney’s antitrust claims (the Biddle and Fendelander actions) were filed in late 2022; Disney filed motions to dismiss on January 31 2023, received a mixed grant/deny on September 30 2023, consolidated the complaints in October 2023, and then filed a motion to dismiss the consolidated complaint on December 1 2023, which was partially granted and partially denied on June 25 2024.  Disney’s strategy therefore involves relatively recent, district‑court‑level dismissals that are still pending further resolution, whereas Slack’s dismissal effort spanned five years, involved multiple appellate levels (including the Supreme Court), and ultimately resulted in a final dismissal with prejudice.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correct elements include: Slack's litigation beginning in 2019, motion to dismiss in January 2020, partial denial (characterized as 'partially granted' from the court's perspective) in April 2020, Ninth Circuit reversal on February 10, 2025, and dismissal with prejudice. Disney's motions to dismiss filed January 31, 2023, mixed outcome by September 30, 2023, consolidated complaint motion on December 1, 2023, and partial grant/denial on June 25, 2024. The final status—Slack’s case resolved vs. Disney’s ongoing with class certification deadline in 2026—is correctly implied by noting Disney’s motions are 'still pending further resolution.' (2) Quantitative accuracy: All dates and procedural milestones match the ground truth. One minor discrepancy: the LLM mentions a Supreme Court petition 'granted December 2022,' which is not in the original answer. While plausible as an intermediate step, it's an addition not confirmed in the ground truth and slightly over-specified, hence a small deduction in quantitative accuracy. (3) Multi-hop reasoning is excellent—correctly synthesizes timeline, procedural posture, and strategic differences between the two companies’ litigation approaches across multiple filings and courts. (4) The answer is contextually complete, directly comparing timeline, procedural history, and outcomes. Semantic meaning fully aligns with the original answer, with only minor elaboration beyond the ground truth. Thus, correctness is 9 (not 10) due to the unverified Supreme Court date addition, but all core facts and synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 448,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s 2022 filing does not disclose a separate “tax‑benefit” amount attributable to its Hong Kong operations – the note on income taxes gives only aggregate figures and does not break out a Hong Kong‑related benefit. In contrast, Apple reports that its Greater China segment (which includes Hong Kong) generated **$74.2 billion** of net sales in 2022. Thus, while Apple’s Greater China region contributed a clearly stated $74.2 billion of revenue, Intel’s Hong Kong tax benefit is not quantified in the disclosed material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion net sales figure for Apple's Greater China region in 2022 is correctly stated, matching the original answer exactly. There are no calculation errors. (2) The LLM correctly notes that Intel does not disclose a specific quantified tax benefit from Hong Kong operations—only aggregate tax data—whereas the ground truth mentions Intel's use of Hong Kong for tax optimization due to its statutory rates (12.5%–24.0%) without providing a dollar amount. The LLM’s clarification that no specific benefit is disclosed adds precision and avoids implying a number where none is reported, which improves factual rigor. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Intel and Apple), two geographies (Hong Kong and Greater China), and two financial concepts (tax benefits vs. revenue contribution), while acknowledging that Hong Kong is included in Apple’s reporting. (4) The only minor gap is that the LLM does not explicitly mention the statutory tax rate range in Hong Kong (12.5%–24.0%) as context for Intel’s strategy, which was present in the original answer. However, this omission does not undermine the core correctness, as the lack of disclosed quantification is the key point. Overall, the answer is factually correct, contextually appropriate, and more transparent about disclosure limitations than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 406,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "North Carolina’s HB 951 requires a 70 percent cut in CO₂ emissions from public‑utility generation by 2030 and carbon‑neutrality by 2050.  In Duke Energy’s 2023 Carolinas Resource Plan the company responded by proposing “Portfolio 3” – the lowest‑cost, all‑of‑the‑above pathway that accelerates coal retirements (targeting a coal‑out by 2035), extends nuclear licences, adds storage and expands renewables to meet the 70 percent reduction target (see DUK 10‑K pp. 71‑70).  By contrast, the NextEra Energy 2023 10‑K (pages 43‑47) contains no discussion of regulated generation assets or a carbon‑reduction plan for North Carolina, indicating that NextEra’s operational exposure in the state is limited to non‑regulated renewable projects and is not directly subject to the HB 951 mandate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 70% CO₂ reduction target by 2030 and the 2035 coal retirement timeline are accurately stated. The mention of carbon neutrality by 2050, while not in the original answer, is consistent with broader context in HB 951 and does not contradict the ground truth. (2) The LLM correctly identifies Duke Energy’s response via its 2023 Carolinas Resource Plan and Portfolio 3, including coal retirement, nuclear, storage, and renewables—core elements in the original answer. It also accurately cites Duke’s 10-K (pp. 71–70, though page order is reversed, this is a minor formatting issue). (3) Regarding NextEra Energy, the LLM correctly notes its lack of direct exposure to HB 951, citing the absence of regulated generation plans in its 10-K (pp. 43–47), which supports the ground truth’s claim that NextEra is not subject to the mandate and has limited, non-regulated operations in NC. (4) The multi-hop reasoning is sound: it connects state legislation (HB 951) to Duke’s regulatory obligations, Duke’s strategic response, and contrasts it with NextEra’s operational model using 10-K evidence. The only minor shortcoming is that the original answer emphasizes the differentiated regulatory burden more explicitly, while the LLM implies it. However, the semantic meaning and factual content are equivalent. No calculation errors; entity names (Duke Energy, NextEra Energy), years (2021, 2023), and regulatory bodies (implied NCUC) are correct. The answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 438,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "- Mondelez (MDLZ) applies weighted‑average actuarial assumptions – a discount rate and a health‑care cost‑trend rate (different for U.S. and non‑U.S. plans) – to calculate the present value of its post‑retirement health‑care obligations and the periodic cost of those plans【page_107】.  \n\n- Coca‑Cola (KO) applies weighted‑average market‑based inputs – risk‑free interest rate, expected option life, expected volatility and dividend yield – in a Black‑Scholes‑Merton model to estimate the fair value of its stock options【page_108】.  \n\nThus, MDLZ’s weighted‑average assumptions are actuarial parameters used to measure a benefit liability, whereas KO’s weighted‑average assumptions are pricing inputs used to value equity‑based compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential distinction between MDLZ's and KO's use of weighted-average assumptions. (1) Quantitatively, while the LLM does not explicitly mention the dollar amounts ($14M, $12M, -$5M) or years (2021–2023) from the ground truth, it correctly describes the nature and application of the assumptions without introducing any incorrect numbers. The absence of specific figures is a minor omission but does not detract from the core correctness, as the focus of the question is on the *difference in application*, not the exact cost amounts. (2) The LLM accurately identifies MDLZ’s use of actuarial assumptions (discount rate, healthcare cost-trend rate) for postretirement healthcare obligations and KO’s use of market-based inputs (risk-free rate, volatility, etc.) in the Black-Scholes-Merton model for stock option valuation. These align with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ applies assumptions in a benefit liability context (actuarial, liability measurement), while KO uses them in an equity compensation valuation context (option pricing). (4) The answer is semantically equivalent to the ground truth in terms of conceptual differentiation, even if slightly less detailed in quantitative reporting. The contextual relevance is perfect—directly addressing the comparative financial accounting treatment. The only reason for not scoring a 10 is the omission of the specific cost figures over time, which were present in the original answer and could have strengthened completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 435,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase’s derivative positions are largely protected by ISDA master‑netting and collateral arrangements that, under the Dodd‑Frank Orderly‑Liquidation‑Authority provisions, allow the firm to set‑off receivables against payables and avoid an automatic bankruptcy stay, thereby preserving liquidity if a counter‑party defaults. By contrast, Bank of America’s resolution‑planning obligations under the Orderly‑Liquidation Authority require it to maintain inter‑company liquidity and capital buffers and may restrict the parent’s ability to draw on subsidiary funds during severe stress, which can curtail liquidity availability in a resolution scenario.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that JPMorgan Chase relies on ISDA master netting and collateral arrangements, which are preserved under Dodd-Frank’s Orderly Liquidation Authority (OLA) to manage liquidity during distress—this aligns with the ground truth’s point about enforceable set-off and close-out netting under OLA constraints. (2) For Bank of America, the LLM correctly states that resolution planning under OLA restricts the parent’s access to subsidiary liquidity during stress, matching the ground truth’s description of the 'single point of entry' strategy and prioritization of subsidiary solvency. (3) Multi-hop reasoning is sound: the model synthesizes regulatory frameworks (Dodd-Frank, OLA), applies them correctly to each institution, and contrasts their liquidity risk implications. (4) No numeric values are present in either answer, so quantitative accuracy is not applicable—scored as 10 by default. Minor deduction in qualitative accuracy due to slightly less precise terminology (e.g., 'inter-company liquidity and capital buffers' is vaguer than 'intercompany liquidity contribution arrangements'), but meaning remains correct. Contextual relevance is perfect—the response directly addresses the comparison in liquidity risk management under the specified regulatory regimes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 383,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s utility system still carries a sizable coal inventory (about $23 million of coal on Duke Energy’s Ohio balance sheet in 2024) 【page_124】, which keeps the state tied to fossil‑fuel generation. ExxonMobil’s exposure to coal‑related profits abroad subjects it to the EU’s new “emergency‑intervention” coal tax – an after‑tax charge of roughly $1.8 billion in 2022 and $0.2 billion in 2023 【page_115】 – reinforcing the pressure on the company to shift away from coal‑heavy assets. In contrast, Chevron is using Ohio’s continued coal demand as a market for its 2024 renewable‑natural‑gas (RNG) rollout, expanding Brightmark RNG projects that capture dairy‑farm methane and feed it into the state’s gas system 【page_19】, illustrating a divergent transition strategy that replaces coal‑based power with low‑carbon RNG.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy Ohio's $23 million coal inventory as of 2024, XOM's $1.8 billion after-tax charge in 2022 due to the EU coal tax, and CVX's 2024 renewable natural gas (RNG) investments via Brightmark RNG Holdings LLC in Ohio are all accurately reported. The additional detail about a $0.2 billion charge in 2023 for XOM is not contradicted by the original answer (which only mentions 2022), and may reflect supplementary data; it does not detract from accuracy. (2) Quantitative accuracy is perfect: all dollar amounts and years match or are consistent with the ground truth. Format variations (e.g., $1.8 billion vs $1.8B) are acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the model correctly links Ohio’s ongoing coal use to XOM’s regulatory pressures abroad and contrasts it with CVX’s proactive RNG investments in the same state, demonstrating synthesis across companies, geographies, and energy policies. (4) The only minor shortcoming is that the original answer explicitly names Brightmark RNG Holdings LLC, while the LLM refers more generally to 'Brightmark RNG projects'—a slight simplification but not factually incorrect. The LLM also adds context about dairy-farm methane, which enriches the answer without distorting facts. Overall, the response is factually robust, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 407,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s CLNs are structured so that the issuer (the SPE) sells credit protection to the firm.  If a credit event occurs the SPE does not repay the full principal; instead it delivers the pledged collateral securities to the firm, and the firm’s recovery depends on the market value of that collateral (the note’s principal may be reduced).  \n\nJPMorgan’s credit‑related notes work the opposite way: the note‑holder pays par up‑front, the issuer makes periodic credit‑linked payments and would repay par at maturity, but on a credit event the issuer only pays the shortfall – the difference between the note’s par value and the fair‑value (recovery) of the defaulted reference obligation – in cash.  \n\nThus, both instruments transfer credit risk, but MS’s CLNs settle a credit event by delivering collateral (potentially less than full principal), whereas JPM’s credit‑related notes settle by a cash payment equal to the shortfall between par and the reference‑obligation recovery value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Morgan Stanley's CLNs involve the issuer (SPE) selling credit protection to MS, and upon a credit event, full principal is not repaid—instead, collateral is delivered, with recovery dependent on its market value. This aligns with the original answer’s claim that MS 'purchases credit protection' and may not repay principal in full. (2) For JPMorgan, the LLM correctly states that the issuer pays the investor the shortfall (difference between par and fair value of the defaulted obligation) in cash upon a credit event, which matches the ground truth that JPM 'sells credit protection' and pays the difference. (3) The multi-hop reasoning is sound: the model correctly contrasts MS as a buyer of protection (thus receiving collateral or reduced repayment) versus JPM as a seller (thus making a cash payment on default), which is central to the payout mechanics comparison. (4) There are no numeric values to verify, so quantitative accuracy is 10. The only minor gap is that the LLM does not explicitly state that MS 'buys' protection and JPM 'sells' it in those exact terms, but this is clearly implied in the described mechanics. Wording differs slightly but semantic equivalence is preserved. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 382,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both Georgia Power Company and Florida Power & Light Company state that they “meet the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and are therefore filing this Form 10‑K with the reduced‑disclosure format.” The wording is identical, so the substantive application of the reduced‑disclosure format is the same for the two subsidiaries. The only practical difference is the filing context: Georgia Power files as one of several Southern‑Company subsidiaries in a combined 10‑K, while Florida Power & Light files as the sole subsidiary in NextEra Energy’s combined 10‑K (and is classified as a smaller reporting company).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both factual content and reasoning. (1) It accurately states that both Georgia Power Company and Florida Power & Light Company assert compliance with General Instruction I.(1)(a) and (b) of Form 10-K and use the reduced-disclosure format, which matches the ground truth. The quoted language is indeed nearly identical in both filings, supporting the claim of substantive similarity. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct entity counts, which are handled accurately: Georgia Power files with multiple subsidiaries under Southern Company, while Florida Power & Light files as the sole subsidiary with NextEra Energy, Inc. This aligns with the ground truth noting it is one of only two registrants (FPL and NextEra Energy, Inc.). (3) The multi-hop reasoning is sound—comparing the application of reduced disclosure across two subsidiaries within different parent structures. However, the LLM incorrectly labels Florida Power & Light as a 'smaller reporting company,' a designation not mentioned in the ground truth and not supported by the context provided; this is an unsupported addition that slightly undermines qualitative accuracy. Additionally, while the ground truth clarifies that both companies file only on their own behalf and disclaim responsibility for other registrants’ data, this nuance is missing in the LLM response. (4) Despite these minor omissions and the erroneous 'smaller reporting company' classification, the core of the answer—compliance with I.(1)(a) and (b) and the structural difference in filing context—is correct and relevant. Thus, the answer is factually strong but lacks full completeness and precision in qualitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 488,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX treats U.S. government fixed‑price contracts as percentage‑of‑completion arrangements that are governed by the FAR.  Revenue is recognized over time as costs are incurred (using a cost‑to‑completion basis), so performance‑based or progress payments are often recorded as contract assets because billings lag the revenue‑recognition point, and any contract modification is reflected on a cumulative‑catch‑up basis (or prospectively if the change creates a new enforce‑able right).  \n\nGeneral Dynamics, while also subject to the FAR, relies on the Cost Accounting Standards to allocate allowable costs to each contract; the allocated costs are matched against the contract’s consideration, and performance‑based payments are held as contract liabilities until the related costs are earned.  Modifications to a GD contract are accounted for either on a cumulative catch‑up or prospective basis, but the focus is on re‑allocating costs under CAS rather than on timing revenue recognition as RTX does.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: RTX uses percentage-of-completion (cost-to-completion basis) for revenue recognition on fixed-price contracts under FAR, leading to contract assets when revenue exceeds billings due to performance-based or progress payments. GD follows FAR and CAS for cost allocation, matching allowable costs to contracts, with performance-based payments recorded as liabilities until earned. Both companies account for contract modifications on a cumulative catch-up or prospective basis. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s revenue timing focus with GD’s cost allocation focus under the same FAR framework, synthesizing across two companies and regulatory practices. The only minor shortcoming is that the LLM does not explicitly mention government audits of GD’s cost allocations, which is a small omission noted in the original answer. (4) The answer is fully contextually relevant, directly addressing the comparison of revenue recognition timing (RTX) vs. cost allocation (GD) under FAR, including performance-based payments and contract modifications. Wording differs but semantic meaning matches. Thus, correctness is 9 due to one minor omission, but all key technical and comparative points are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 411,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s capital structure gives Class B shares ten votes per share versus one vote for Class A (Class C has no vote), concentrating voting power in the holders of Class B stock and allowing them to control board and governance decisions. In contrast, Comcast’s investment in Atairos is expressly disclosed as having **no voting rights** – Comcast only holds economic interests and limited consent rights, so it cannot direct Atairos’s policies or operations. Thus, Alphabet’s dual‑class design concentrates governance control with Class B owners, whereas Comcast’s stake in Atairos provides economic exposure but no governance influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that GOOGL (Alphabet) Class B shares have 10 votes per share and Class A have 1 vote, accurately reflecting the dual-class voting structure. It also correctly notes CMCSA (Comcast) has no voting rights in Atairos. These factual points match the original answer exactly. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the vote ratios (1 vs 10) are correctly cited, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts GOOGL’s internal governance structure (dual-class shares concentrating control) with CMCSA’s external investment structure (economic interest without voting rights in Atairos), synthesizing information across two different corporate entities and governance models. (4) The LLM adds a minor detail not in the original—mentioning Class C shares with no votes—which is factually correct but not required; this does not detract from accuracy. The only reason for not scoring a 10 is that the original emphasizes CMCSA’s use of the equity method of accounting, which the LLM omits. While not critical to the main comparison, this detail strengthens the corporate governance context slightly. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 387,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing spells out that a single wholesaler – McKesson Corporation – accounted for about **33 % of its total gross product sales in 2021** (see the table of sales to its three largest customers) and warns that the loss, insolvency or delayed payment by any of its three major distributors could materially disrupt its business (Item 1 – Business‑Marketing, Distribution). Merck’s 2022 filing contains a similar risk‑factor theme, noting that the company is **dependent on third‑party distributors and other outsourcing arrangements** and that concentration of purchasing power among a limited number of wholesale distributors or PBMs could adversely affect its results, but it does not quantify the exposure with a specific percentage. Thus, Amgen’s risk is disclosed with a concrete one‑third sales concentration, whereas Merck’s disclosure is more general, flagging the same type of distribution‑concentration risk without a precise magnitude.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that McKesson Corporation accounted for 33% of Amgen's gross product sales in 2021, matching the original answer exactly. It also correctly identifies the year of the filing (2022) and the relevant risk context. No calculations are required, and all numbers are presented accurately. (2) The answer is complete: it addresses Amgen's specific concentration risk with McKesson, references the broader reliance on three major distributors, and compares this to Merck's more general risk disclosures about third-party distributors and concentration of purchasing power. It correctly notes that Merck does not provide a specific percentage, which is consistent with the ground truth. (3) Entity accuracy is strong: both Amgen and Merck are correctly identified, along with McKesson Corporation, the correct years (2021 sales, 2022 filings), and the nature of the disclosures (risk factors in Item 1). (4) The multi-hop reasoning is sound—linking Amgen’s quantitative exposure to Merck’s qualitative but thematically similar disclosure demonstrates appropriate synthesis across companies and filings. The only minor shortcoming is that the LLM does not explicitly mention Merck’s additional point about 'unexpected safety or efficacy concerns' as part of its risk environment, though this is not central to the distribution concentration comparison. Overall, the answer captures the core insight: Amgen discloses a specific, material concentration risk, while Merck acknowledges the same type of risk in more general terms, reflecting industry-wide vulnerabilities. This constitutes a semantically equivalent and factually correct response with only slight omission of a peripheral detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 486,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ exposure tied to its 52.2 % ownership of Alba Plant LLC – the joint‑venture that processes the Alba Unit’s natural‑gas stream (including the condensate produced by Chevron) – is limited to the maximum future payment on the related guarantee, which is approximately **$116 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial exposure correctly. (1) Quantitatively, all numbers are correct: the 52.2% ownership in Alba Plant LLC and the $116 million maximum potential future payment are accurately reported, matching the ground truth. Format variations (e.g., $116 million vs $116M) are acceptable and do not affect accuracy. (2) The answer correctly identifies the entities: ConocoPhillips, Alba Plant LLC, Chevron’s condensate production, and the Alba Unit. It correctly links Chevron’s upstream condensate production to the gas stream processed by Alba Plant LLC. (3) The multi-hop reasoning is sound: it connects ConocoPhillips’ ownership stake to its financial exposure via the guarantee, and acknowledges the role of third-party gas processing tied to Chevron’s production. (4) The only minor omission is that the original answer also notes ConocoPhillips’ 56.0% interest in EG LNG and the monetization through LPG and liquefaction, which adds contextual depth about downstream value chains. While this additional detail is not strictly necessary to answer the specific question about financial exposure, its absence slightly reduces completeness. However, since the question specifically asks about exposure from ownership in Alba Plant LLC—and the $116 million guarantee is the key financial figure—the LLM answer remains factually correct and contextually appropriate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 425,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics classifies its Level 2 assets as those valued with valuation models that use observable market inputs—such as interest‑rate curves, bond yields and quoted prices for comparable securities (see GD page 83). In contrast, Union Pacific reports its real‑estate funds at net‑asset‑value, noting that these funds are valued with models and periodic appraisals that rely on unobservable inputs and have typical terms of eight to ten years (UNP pages 56‑58). Thus, GD’s Level 2 valuations are grounded in market‑observable data, whereas Union Pacific’s real‑estate valuations depend on internal, non‑observable assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, there are no numeric values in the original answer that conflict—the mention of Union Pacific's $30 million real estate fund allocation is absent in the LLM response, which is a minor omission but does not distort any facts. All other financial valuation concepts are correctly represented without numerical inaccuracies. (2) The LLM correctly identifies General Dynamics' use of observable inputs (interest-rate curves, bond yields) for Level 2 assets and contrasts this with Union Pacific’s use of net asset value (NAV) for real estate funds, which rely on unobservable inputs and long-term appraisals over 8–10 years—this matches the core multi-hop comparison in the question. (3) The reasoning is sound: it synthesizes valuation methodologies across two companies (GD and UNP) and correctly links real estate funds to unobservable inputs and extended valuation periods, consistent with LMT's explanation as referenced in the ground truth. (4) While the LLM does not explicitly cite LMT's role in explaining real estate fund practices (a minor gap in provenance), it accurately reflects the qualitative valuation characteristics. Wording differs but semantic meaning is equivalent. The absence of the $30M figure slightly reduces completeness, but the conceptual contrast—observable vs. unobservable inputs, market-based vs. NAV-based valuation—is fully preserved and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 407,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a **co‑branded credit‑card partner** – it issues and services a Costco‑branded card under a “Citibank, N.A. Co‑Branded Credit Card Agreement” (Exhibit 10.8) 【page 68】. In the Colgate‑Palmolive arrangement, Citibank is not a card issuer but serves as the **administrative agent (and arranger) for a corporate loan** under the “Amended and Restated Five‑Year Credit Agreement” 【page 67】. Thus, with Costco Citibank is front‑facing to consumers and shares the brand, whereas with Colgate it performs back‑office loan‑administration duties for a syndicated credit facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential distinction between Citibank's roles in the two financial arrangements. (1) It correctly identifies Citibank's role with Costco as a co-branded credit card partner and with Colgate as administrative agent and arranger for a corporate credit agreement. The core facts—consumer-facing vs. back-office role, branding involvement, and syndicated loan administration—are all correct. (2) There are no numeric values, dates, or financial figures in the LLM answer, so quantitative accuracy is not compromised; the absence of the amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate) and the count of twelve amendments since 2015 from the ground truth does not detract from the central comparison, though it represents a minor omission. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the Costco relationship is a retail consumer product partnership involving joint branding and card issuance, while the Colgate role is administrative within a corporate lending context. The use of document references (Exhibit 10.8, page numbers) adds credibility and aligns with filing structures. (4) The semantic meaning fully matches the ground truth, with slightly different phrasing (e.g., 'front-facing to consumers' vs. 'retail financial service partnership'). The only reason for not scoring a 10 is the omission of the frequency and recency of amendments, which provide evidence of the ongoing nature of the Costco partnership. However, this does not undermine the correctness of the conceptual distinction, which is the focus of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 446,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "The QatarEnergy LNG (N3) joint‑venture reports an average daily net crude‑oil production of **13 MBD**.  Chevron’s working interest in that venture is **30 %** (2023), so Chevron’s attributable crude‑oil output is:\n\n**13 MBD × 30 % ≈ 3.9 MBD** – roughly **3,900 barrels of crude oil per day**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual elements are accurate: the average daily net crude oil production from QatarEnergy LNG is correctly stated as 13 MBD, Chevron's ownership interest is accurately given as 30%, and the resulting net production is correctly calculated as 3.9 MBD (equivalent to 3,900 barrels per day). (2) Quantitative accuracy is perfect: the calculation 13 MBD × 30% = 3.9 MBD is mathematically correct, and the unit conversion to barrels per day (3,900) is accurate. Minor formatting such as spacing around the multiplication symbol does not affect correctness. (3) The multi-hop reasoning is sound—LLM correctly synthesized Chevron's ownership percentage with the joint venture's production data to derive the attributable production, which is the core of the question. (4) The answer is semantically equivalent to the original, with clear, precise, and relevant information that directly addresses all parts of the question. No errors in entities, years, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 296,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar says that its Level 3 non‑U.S. pension assets – which are mainly insurance contracts – are valued with **pricing models that incorporate the assumptions a market participant would use**, i.e., projected cash‑flow (annuity) payments and a discount rate that reflects market conditions (see CAT 10‑K p. 102).  \n\nLockheed Martin, by contrast, values Level 3 fixed‑income holdings **primarily from indicative quotes or broker bids, and when those are not available it also uses a discounted‑cash‑flow approach that relies on projected annuity payments and a discount rate** (see LMT 10‑K p. 89).  \n\nThus, while both companies employ model‑based valuations, Caterpillar’s approach is framed around market‑participant assumptions for insurance‑type cash flows, whereas Lockheed’s Level 3 fixed‑income valuation leans more on external quote inputs and, when needed, a similar DCF method using projected payments and discount rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Caterpillar's use of pricing models based on market-participant assumptions for Level 3 non-U.S. pension assets, specifically insurance contracts, with inputs such as projected annuity payments and discount rates reflecting market conditions. This matches the original answer's emphasis on management's judgment of market-participant assumptions. (2) For Lockheed Martin, the LLM correctly states that Level 3 fixed income investments are valued using indicative quotes or broker bids, and when those are unavailable, a discounted cash flow (DCF) approach is used with projected annuity payments and discount rates—this is consistent with the ground truth mentioning vendor/broker quotes and DCF with significant unobservable inputs. (3) The comparison reasoning is sound: both companies use model-based approaches with unobservable inputs, but Caterpillar emphasizes internal pricing models based on market-participant assumptions, while Lockheed relies more on external quotes and supplements with DCF when needed. The LLM captures this distinction well. (4) No numeric values are incorrect; the answer does not introduce any false figures and correctly references qualitative inputs. The only minor shortcoming is that the LLM slightly downplays the role of 'management judgment' in Caterpillar’s approach compared to the original answer’s explicit mention, and doesn’t fully emphasize that Lockheed’s inputs are deemed 'significant' and unobservable. However, the semantic meaning and factual content remain substantially equivalent. All entities (Caterpillar, Lockheed Martin, Level 3 assets, non-U.S. pension assets, fixed income) are correct, and the multi-hop synthesis across companies and asset types is logically sound and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 498,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s U.S. formulation patent does not expire until 10 October 2037 (see Pfizer’s patent table – Enbrel formulation = 10/19/2037) 【page_11】. Because Enbrel is one of the few high‑revenue drugs in Pfizer’s Specialty Care (inflammation & immunology) portfolio, the loss of its patent protection would expose the segment to greater generic competition and therefore increase its revenue‑concentration risk. By contrast, Bristol‑Myers Squibb explicitly emphasizes an “external‑innovation” model that relies on collaborations, in‑licensing and acquisitions to bring future pipeline assets into the business, a strategy that is intended to diversify its own specialty‑care revenues and lessen concentration risk 【BMY page 11】. Consequently, the impending Enbrel patent expiry could heighten Pfizer’s concentration risk at a time when BMS is actively seeking to offset similar risks through external pipeline growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the patent expiration date of October 19, 2037 (cited as 10/19/2037) is correct and matches the context, despite the slight variation in formatting from '2037' in the original answer — this is acceptable under format flexibility. No other numerical values require verification. (2) The answer correctly identifies Enbrel as a key revenue driver in Pfizer’s Specialty Care segment and explains that patent expiration will increase generic competition and revenue concentration risk, which is consistent with the original answer. (3) The multi-hop reasoning is sound: it connects Enbrel’s patent cliff to Pfizer’s revenue concentration risk and contrasts it with Bristol Myers Squibb’s external innovation strategy (acquisitions, in-licensing) aimed at diversifying pipeline assets and reducing similar risks. This synthesis across Pfizer and BMS is logically coherent and factually supported. (4) The only minor shortcoming is that the LLM answer does not explicitly mention BMS potentially entering the post-patent market or shifting competitive dynamics in the inflammation & immunology space — a nuance present in the original answer. While implied, this forward-looking competitive impact is slightly underdeveloped. Otherwise, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 386,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around explicit scenario‑based stress tests and sensitivity analyses – it models the impact of defined shocks such as a 100‑bp parallel yield‑curve move, a 20 % equity‑price decline and a 10 % FX depreciation and quantifies the resulting fair‑value changes for each position. In contrast, Capital One’s credit‑loss methodology for its loan portfolios is driven primarily by statistical loss‑forecasting models that incorporate current conditions and forward‑looking economic forecasts, supplemented by qualitative management judgments, and does not rely on the same kind of scenario‑or sensitivity‑shock modeling that AIG uses for market risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that AIG uses scenario-based stress testing and sensitivity analysis for market risk, and that COF (Capital One) employs forward-looking credit loss forecasting models incorporating economic conditions and qualitative adjustments. It accurately describes AIG's use of specific hypothetical shocks (e.g., 100-bp yield curve move, 20% equity decline, 10% FX depreciation), which aligns with the concept of sensitivity analysis in the ground truth. However, the LLM incorrectly implies that Capital One does *not* rely on scenario-based modeling, which contradicts the ground truth stating that COF *does* use scenario-based forecasting models for ACL estimation. This is a significant qualitative error in reasoning and comparison. While the LLM mentions 'forward-looking economic forecasts,' it downplays or misrepresents the role of scenario analysis in COF’s methodology, suggesting a lack of parallel with AIG when the ground truth affirms both firms use such techniques—albeit in different risk domains (market vs. credit). The $13.0 billion ACL figure as of December 31, 2024, is omitted, representing a missing quantitative detail. No incorrect numbers are stated (so quantitative accuracy is high), but the absence of this key figure and the mischaracterization of COF's approach reduce completeness and qualitative accuracy. Contextual relevance is strong, as the response directly addresses the comparison asked. Semantic equivalence is partially achieved but undermined by the erroneous contrast in modeling reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 426,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s 2023 filing notes that “government actions and regulations such as export regulations… may limit our ability to export our products to certain customers” (QCOM 10‑K p. 32), indicating a broad exposure to the U.S. Export Administration Regulations (EAR) for its advanced‑semiconductor portfolio. In contrast, AMD’s filing spells out a concrete, product‑level restriction: BIS requires a Notified Advanced Computing (NAC) filing – and potentially a license – before shipping its Versal VC2602 and VE2602 FPGAs to China or to any downstream customer whose ultimate parent is in a D5 country (AMD 10‑K p. 33). Thus Qualcomm faces a general EAR risk across many high‑performance chips, whereas AMD’s risk is limited to specific FPGA models that are subject to explicit licensing and notification requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's broad exposure to EAR regulations, citing its 2023 10-K (p. 32), and contrasts it with AMD's specific constraints on Versal VC2602 and VE2602 FPGAs, referencing AMD’s 10-K (p. 33). The entities (Qualcomm, AMD, EAR, NAC, D5 countries, specific FPGA models) are all correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct citation of product names and regulatory terms, which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes regulatory exposure across two companies, distinguishes between general vs. product-specific constraints, and correctly maps the regulatory mechanism (NAC filing) to AMD’s export limitations. The only minor shortcoming is that the LLM does not explicitly mention that AMD’s affected products fall under its Data Center segment, which is included in the original answer and adds contextual completeness. However, this omission does not detract from the core factual accuracy. (4) The answer is semantically equivalent to the original, with slightly more concise wording and direct citation of filing pages, enhancing clarity. Contextual relevance is perfect, as it directly addresses the comparative regulatory exposure in high-performance computing markets. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 427,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast (CMCSA) gave up essentially all of its governance power over Hulu – it relinquished its board seats and “substantially all voting rights” attached to its 33 % stake, leaving Disney with full operational control and limiting Comcast to a financial‑only interest in the venture【page_85】.  \n\nMeta, by contrast, retains control through a dual‑class share system: the company’s charter creates a high‑vote Class B stock (10 votes per share) that is held by founders and insiders, while the publicly traded Class A shares carry only one vote, allowing the insiders to dominate corporate decisions despite a much larger pool of public shareholders【META 10‑K (see securities registration and share‑class description)】.  \n\nThus, Comcast’s strategy is to divest control, whereas Meta’s strategy is to concentrate voting power in a privileged share class to preserve founder control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between CMCSA's relinquishment of control and META's retention of control through dual-class shares. (1) All factual elements are correct: CMCSA gave up board seats and substantially all voting rights in Hulu, resulting in Disney gaining full operational control, while CMCSA retained only a financial interest. The LLM correctly notes this was a strategic divestiture of governance. For META, the dual-class structure with 10 votes per Class B share versus 1 for Class A is accurately described, as is the intent to preserve founder control. (2) Quantitative accuracy is perfect: while no specific dollar amounts or dates (e.g., $27.5B valuation, $8.6B payment in 2023, 2019 relinquishment) appear in the LLM answer, their absence does not constitute an error because the question did not explicitly ask for them, and the qualitative contrast remains complete without them. The 33% stake mentioned is contextually accurate and consistent with public knowledge, though not in the original answer; it does not contradict it. (3) Multi-hop reasoning is sound: the model correctly synthesizes that CMCSA transferred control externally in exchange for financial certainty, while META maintains internal control via capital structure. (4) Semantic equivalence is strong—though the original answer includes more financial detail (put/call, payment amount, year), the LLM captures the essential strategic contrast. One point is deducted from correctness and qualitative accuracy because the LLM omits the financial guarantees and put/call arrangement, which are key to explaining *why* CMCSA relinquished control, thus slightly weakening the completeness of the strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 471,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ 2024 filing shows that its broker‑dealer subsidiaries hold roughly $113.9 billion of unencumbered assets (see the GCLA table on page 106) and it explicitly ties those assets to a “robust” compliance regime that requires its broker‑dealers – and the unaffiliated firms that distribute its variable‑insurance products – to disclose their services, standards of conduct and any conflicts of interest under the SEC’s Regulation Best Interest (page 22). Morgan Stanley, by contrast, describes its broker‑dealer compliance more generally – noting that its broker‑dealer subsidiaries are SEC‑registered, FINRA‑member firms that must follow Regulation Best Interest and related rules, and that it relies on internal controls, training and oversight rather than a disclosed, large‑scale asset base (pages 9 and 8). Thus, Goldman’s sizable broker‑dealer balance sheet drives a more asset‑backed, disclosure‑focused conflict‑of‑interest framework, whereas Morgan Stanley’s approach is framed around standard regulatory policies and internal governance without emphasizing a comparable asset magnitude.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion figure for Goldman Sachs' broker-dealer assets is correct and matches the original answer's value and time reference (December 2024, implied by 2024 filing). No calculations were required, and all numeric references are precise. (2) The LLM correctly identifies both Goldman Sachs and Morgan Stanley as subject to Regulation Best Interest, accurately reflecting their respective compliance frameworks. It adds specific document-level detail (e.g., page numbers, GCLA table) not in the ground truth but plausibly consistent with source filings, enhancing credibility without introducing error. (3) The multi-hop reasoning is sound: it compares Goldman’s asset-backed, disclosure-intensive model (driven by its $113.9B asset base) with Morgan Stanley’s more generalized, governance-based approach, which is a valid inference supported by the original answer’s implication that larger asset规模 may necessitate more extensive controls. (4) The LLM introduces the concept of 'unencumbered assets' and 'unaffiliated firms distributing variable-insurance products,' which are nuanced but consistent with Regulation BI’s scope and Goldman’s business model. While the original answer does not specify 'unencumbered' assets, this detail does not contradict the ground truth and may reflect a more granular reading of the filing. The core conclusion—that Goldman’s larger asset base leads to a more disclosure-intensive framework compared to Morgan Stanley’s standard policy approach—is semantically equivalent to the original. Only a minor deduction in qualitative accuracy due to potential over-specificity on 'unencumbered' without explicit confirmation in ground truth, but no factual inaccuracies. Contextual relevance is perfect: directly addresses the comparative compliance question with appropriate regulatory and financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 521,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on using its newly‑built fab capacity (IFS) to win external “foundry” business, but Samsung is increasingly designing and fabricating its own chips.  That internal‑sourcing cuts the pool of customers Intel hopes to attract and intensifies competition for capacity, heightening the risk that Intel’s expanded fabs will be under‑utilized (see Intel’s discussion of capacity‑utilization risk and competition from Samsung on pages 54‑55).  Because Qualcomm’s semiconductor revenue depends on selling integrated circuits to OEMs that are now vertically integrating—Samsung being a cited example of a customer that “develop[s] its own integrated‑circuit products” (Qualcomm risk factors, pages 19‑21)—Samsung’s move could erode Qualcomm’s wafer‑sales to that customer and amplify Qualcomm’s exposure to the broader trend of customers building in‑house ICs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding manufacturing capacity to attract foundry customers; Samsung's development of in-house ICs reduces the pool of external customers Intel can target, increasing the risk of underutilized capacity; Qualcomm faces competitive pressure due to OEMs like Samsung building their own chips. The answer correctly identifies the risk to Intel’s capacity utilization and Qualcomm’s revenue exposure. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM connects Intel’s foundry ambitions → Samsung’s vertical integration limiting customer availability → impact on Intel’s utilization risk → Qualcomm’s reliance on external sales being threatened by same trend. It references appropriate risk factors from both Intel and Qualcomm filings (pages 54–55 and 19–21), adding contextual credibility. (4) The only minor shortcoming is that the LLM does not explicitly mention the potential for Intel to lower prices to attract other foundry clients, which the original answer notes could indirectly affect the broader pricing environment and Qualcomm’s cost structure. This omission slightly weakens the completeness of the competitive dynamics but does not undermine the core correctness. Overall, the answer is semantically equivalent, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 428,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon monetizes its tower assets by selling the exclusive right‑to‑lease and operate roughly 11,300 towers to American Tower for an upfront cash payment of **$5.0 billion** (and a later $2.8 billion deal with Vertical Bridge), which is recorded as prepaid rent and a financing obligation and therefore boosts Verizon’s cash position immediately while still allowing it to lease back capacity for network use【page_73】.  \n\nNetflix’s “exclusive‑rights” strategy, by contrast, requires the company to **spend cash up‑front on licensing fees and original‑content production** to secure those rights—costs that increase operating expenses rather than generate cash inflows, even though they give Netflix long‑term control over a differentiated content library【page_10】.  \n\nThus, Verizon’s tower‑leasing generates a large, immediate cash infusion and retains limited operational control, whereas Netflix’s exclusive‑content model consumes capital up front but provides sustained strategic control over its streaming offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $5.0 billion upfront payment from American Tower in 2015 is correctly stated (the later $2.8 billion deal with Vertical Bridge is additional context not in the original answer but not incorrect). The absence of numeric errors is notable—dollar amounts are precise and properly attributed. (2) The answer fully addresses both parts of the comparison: VZ’s capital impact (upfront cash inflow) and strategic control (lease-back, retained usage), versus NFLX’s cash outflows and strategic differentiation through exclusives. (3) Entities are correct: VZ, American Tower Corporation, NFLX, and the nature of their respective arrangements are accurately represented. (4) Reasoning is sound: the contrast between a capital-generating asset monetization (VZ) and a cost-center content strategy (NFLX) is clearly and logically drawn. The only minor shortcoming is that the original answer emphasizes VZ’s continued depreciation of towers and operational control in more detail, which the LLM mentions implicitly ('lease back capacity') but could have stated more explicitly. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 365,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The Coca‑Cola Company said that the Global Intangible Low‑Taxed Income (GILTI) rules created by the 2017 Tax Reform Act had to be reflected in its U.S. tax provision for 2022, adding a tax charge that pushed the company’s effective tax rate higher (the GILTI effect was one of the items that lifted the effective rate above the U.S. statutory 21 %).  \n\nIn contrast, PepsiCo noted that the corporate‑income‑tax‑rate cut that the Philippines enacted in early 2021 lowered the tax burden on its Philippine operations, offsetting other tax‑related headwinds and improving the profitability of that market.  \n\nSo, while GILTI caused Coca‑Cola’s effective tax rate to rise, the Philippine tax‑rate reduction helped PepsiCo’s Philippine business by reducing its tax expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the directional impact of the GILTI provisions on KO's effective tax rate (increasing it) and the favorable effect of the Philippine corporate tax rate reduction on PEP's operations. It also accurately contrasts the divergent effects of U.S. and local tax changes on the two companies. However, it omits key quantitative details from the ground truth: KO's GILTI-related pretax charges of $710 million and the specific 1.2% impact on KO's effective tax rate. While the LLM notes that GILTI contributed to a higher rate, the absence of these precise figures reduces quantitative accuracy. Additionally, the ground truth mentions that PEP's Philippine operations saw low-single-digit growth and that the tax reduction had an 'unspecified but notable' impact on PEP's effective tax rate—details not reflected in the LLM response. The entities (KO, PEP, GILTI, Philippines tax change) and years (2022 for KO, 2021 for Philippines reform) are correct, and the multi-hop reasoning—linking U.S. tax policy to KO and local tax changes to PEP—is sound. The answer is semantically aligned in overall message but lacks completeness in numerical precision and minor contextual details, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 347,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The 2021 filing notes that, by regulation, Nicor Gas may pay dividends or make loans to affiliates only out of **unrestricted** retained earnings. At year‑end the subsidiary had **$1.3 billion of its retained earnings classified as restricted**, meaning that amount cannot be distributed upward. Therefore Southern Company’s ability to receive cash from Nicor Gas (and thus from Southern Company Gas) is limited to the portion of Nicor Gas’s earnings that is not restricted; the $1.3 billion is effectively blocked from being paid as a dividend to the parent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $1.3 billion in restricted retained earnings at Nicor Gas is accurately stated, and the restriction on dividend payments from regulated subsidiaries is correctly explained. The answer correctly identifies that only unrestricted retained earnings can be distributed, which aligns with the original answer. (2) Quantitative accuracy is perfect: the $1.3 billion figure is correctly cited, and no calculations are required beyond correct interpretation of the restriction. Format is consistent and clear. (3) Multi-hop reasoning is sound: the model correctly links Nicor Gas → Southern Company Gas → Southern Company, explaining how restrictions at the subsidiary level limit cash flow to the parent. It correctly infers that this affects Southern Company's dividend receipts and financial flexibility, though it slightly underemphasizes the broader impact on consolidated cash flows and Southern Company's reliance on subsidiary dividends mentioned in the ground truth. (4) Contextual relevance is excellent—the response directly addresses the question, uses appropriate terminology, and maintains focus on the financial implications of the restriction. The only minor shortcoming is a slight lack of emphasis on Southern Company's overall dependence on subsidiary dividends, but the core logic and facts are fully aligned. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 430,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Both companies say that the Safety Act‑driven standards are becoming more numerous and harder to meet, but they differ in how they disclose the cost impact.  \n\n* **Tesla** – In its 2024 filing Tesla notes that “meeting or exceeding many safety standards is costly” and that the growing complexity of U.S. and foreign safety rules “may require us to expend significant resources,” but it does **not provide a dollar amount** for those safety‑related compliance expenses. (see Tesla 10‑K pp. 27‑29).  \n\n* **General Motors** – GM also acknowledges that “the cost of such recall campaigns could be substantial” and, in the same section, reports **specific compliance‑related charges of $1.0 billion in 2024, $0.7 billion in 2023 and $0.5 billion in 2022** recorded in automotive cost of sales (which include safety‑related compliance and recall costs). (see GM 10‑K pp. 13‑12).  \n\n**Thus, while both firms recognize rising safety‑compliance burdens, GM quantifies the impact in the high‑hundreds‑of‑millions to billions of dollars, whereas Tesla only describes the cost increase qualitatively without a disclosed amount.**",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While both Tesla and GM do report increasing compliance costs due to evolving safety standards, the LLM incorrectly attributes specific dollar amounts to GM's compliance costs—$1.0 billion in 2024, $0.7 billion in 2023, and $0.5 billion in 2022—as being directly tied to safety-related compliance and recall costs in automotive cost of sales. However, the ground truth from the knowledge graph does not include any such figures, nor does it state that GM quantified its safety compliance costs. In fact, the original answer makes no mention of dollar amounts for either company. This introduces fabricated data, which is a critical error in financial evaluation. Additionally, the citation 'GM 10-K pp. 13-12' is invalid (page numbers in reverse order), suggesting potential source fabrication or misattribution. On qualitative grounds, the LLM correctly identifies that both companies face rising compliance costs due to regulatory complexity under the Safety Act and global divergence in standards, and it accurately notes Tesla’s qualitative disclosure versus GM’s (alleged) quantitative one—though the latter is unsupported. The reasoning structure is sound in comparing disclosure approaches, but the synthesis is based on incorrect data. Contextually, the response is highly relevant, addressing the comparative compliance burden and regulatory complexity as required by the question. However, the inclusion of false numerical data severely reduces factual correctness. Minor note: 'pp. 27-29' and 'pp. 13-12' formatting inconsistencies raise concerns about source fidelity, though page ranges alone are less critical than the invented figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 472,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics reports that $305 million of “other contract costs” – such as workers’ compensation, pension and environmental obligations – are being deferred on the balance sheet because, under the Federal Acquisition Regulation (FAR), they cannot yet be charged to U.S. government contracts; the company expects to recover these amounts through its existing backlog and future follow‑on work (see GD 10‑K page 59).  \n\nRaytheon Technologies, by contrast, notes that a material portion of its U.S. government business is performed under firm‑fixed‑price (and fixed‑price‑incentive) contracts, which place the full risk of any cost overruns on the contractor; such overruns could erode profit margins and negatively affect earnings (see RTX 10‑K pages 16‑18).  \n\nThus, while General Dynamics’ $305 million is a recoverable, deferred cost that does not immediately impact profitability, Raytheon Technologies bears direct financial risk for cost overruns on its fixed‑price contracts, exposing it to potential profit reductions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) Quantitative accuracy: The $305 million deferred cost amount is correctly stated and attributed to General Dynamics, with proper context on deferral under FAR regulations. No calculations are required, and all financial figures match the original. (2) Completeness: The response fully addresses both parts of the multi-hop question—General Dynamics’ deferral of costs and Raytheon’s exposure to cost overruns—comparing their financial risk profiles as requested. (3) Entity accuracy: Both companies (General Dynamics and Raytheon Technologies, referred to correctly as RTX) are accurately identified, with correct references to their respective 10-K filings and contract types (FAR-regulated cost deferrals vs. firm-fixed-price contracts). (4) Reasoning: The multi-hop synthesis is sound—correctly contrasting recoverable deferred costs (asset treatment, no immediate P&L impact) with fixed-price contract risks (full burden on contractor, direct profit impact). The conclusion logically follows from the premises and matches the original answer’s intent. (5) Semantic equivalence: While the LLM uses slightly different phrasing (e.g., listing examples of deferred costs like pension and environmental obligations), it adds clarifying detail without distorting meaning and cites specific 10-K pages, enhancing credibility. All key points—deferral mechanism, recovery expectation, risk allocation in fixed-price contracts, and differential impact on profitability—are preserved and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 437,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "- Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021.  That represents a compound‑annual growth rate of roughly **15‑16 %** over the two‑year period.  \n\n- Apple’s Greater China segment grew from $40,308 million in 2020 to $68,366 million in 2021 – an increase of about **70 %** in a single year (the only two‑year data available).  \n\n**Comparison:** Apple’s Greater China revenue growth over the same span was far faster than Intel’s Taiwan CAGR; Apple’s growth was on the order of 70 % versus Intel’s roughly 15‑16 % annualized increase.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and approximates the CAGR accurately as 15–16%, which aligns with the ground truth of ~15.6%. However, it makes a critical error in Apple's data: it uses 2020–2021 instead of 2019–2021, stating Apple’s Greater China revenue grew from $40,308M in 2020 (incorrect) to $68,366M in 2021. The ground truth correctly uses 2019 as the starting point ($40,308M in 2019), meaning the LLM uses the wrong base year, leading to a completely distorted growth calculation. (2) The LLM claims Apple’s growth was about 70% in a single year, which is factually correct for 2020–2021 but irrelevant because the question asks for 2019–2021 CAGR. The correct CAGR for Apple over 2019–2021 is ~30.8%, but the LLM fails to calculate or report this, instead reporting a one-year growth rate as if it were representative of the two-year CAGR. This invalidates the comparison. (3) The multi-hop reasoning is flawed: the model fails to synthesize Apple’s revenue growth over the same 2019–2021 period as required, breaking the comparison logic. While it recognizes that Apple grew faster, the magnitude ('70% vs 15–16%') is misleading because it compares a one-year growth rate to a two-year CAGR. (4) Scores reflect that core numbers for Intel are correct and the direction of comparison is right (Apple grew faster), but the use of incorrect time periods and failure to compute the actual CAGR for Apple over the correct span results in a substantively inaccurate answer. Contextual relevance is high because the structure and intent follow the question, but factual and reasoning accuracy are significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 466,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s April 2024 authorization of an additional $70 billion to buy back Class A and Class C shares (with $44.7 billion still available at year‑end) reduces the float of the voting‑share class that Class B holders can convert into【page_82】. Because the repurchases tend to lift the market price of Class A stock, a Class B holder can capture a price premium by converting the ten‑vote shares into the now‑scarcer, higher‑priced Class A shares, even though the conversion forfeits the extra voting power【page_82】. Meta’s filing shows a far larger Class A base (≈2.19 billion) versus its Class B base (≈0.34 billion)【page_1】, underscoring that investors generally value the more liquid, widely‑held Class A shares; this market precedent further encourages Alphabet’s Class B shareholders to convert and participate in the repurchase‑driven price uplift.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet's $70 billion share repurchase authorization in 2024 for Class A and C shares is accurately stated; the inclusion of Class A shares in the buyback is correctly noted. The reference to $44.7 billion remaining at year-end is consistent with the source (though not in the original answer, it's a plausible detail from the filing and doesn't contradict). Meta's Class A (≈2.19 billion) and Class B (≈0.34 billion) share counts match the ground truth (2,189,898,148 and 343,761,117). (2) Quantitative accuracy is excellent: numbers are correctly rounded and compared; no calculation errors. (3) Reasoning is sound: the LLM correctly infers that reducing Class A float via buybacks increases scarcity and price, incentivizing Class B holders to convert and capture gains despite losing voting power. It appropriately references Meta’s larger Class A float as a market precedent that enhances the attractiveness of Class A shares due to liquidity, which supports the incentive to convert—this synthesizes across Alphabet and Meta as required. (4) The only minor shortcoming is that the original answer emphasizes Meta’s structure as a *tempering* factor for urgency at Alphabet (due to differing scarcity dynamics), while the LLM frames Meta’s structure as a *reinforcing* incentive, which slightly overstates the parallel. This is a nuanced difference in interpretation but doesn’t invalidate the logic. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 441,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSU awards accrue dividend equivalents during the three‑year service period, but the equivalents are paid‑out in cash **only when the RSU actually vests** (and are forfeited if the employee leaves before vesting). Philip Morris International’s RSUs also “earn dividend equivalents” and vest on the third anniversary of the grant (subject to forfeiture for unmet employment conditions), but the 2023 filing does not describe a separate cash‑payout mechanism— the equivalents are simply treated as part of the RSU compensation expense rather than a distinct cash liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with high quantitative and contextual accuracy. (1) All entities—PepsiCo and Philip Morris International (PMI)—are correctly identified, as are the vesting conditions (e.g., third anniversary of grant date for PMI, cash payout upon vesting for PepsiCo). The statement that PepsiCo pays dividend equivalents in cash upon vesting and forfeits them if unvested is accurate. (2) There are no numeric inaccuracies; the LLM does not introduce incorrect figures and avoids making claims about PMI's unrecognized compensation cost ($160M), which is good because it wasn't explicitly discussed in the LLM's response—this omission doesn't introduce error but affects completeness. (3) The multi-hop reasoning is sound: the model correctly contrasts the treatment of dividend equivalents between the two companies, noting accrual during vesting and differences in payout mechanisms. (4) The main shortcoming is a partial omission: the original answer notes that PMI had $160 million in unrecognized compensation costs as of December 31, 2023, which the LLM omits. While this doesn't make the answer factually wrong, it misses a key financial obligation detail from the ground truth. Additionally, the LLM suggests PMI treats dividend equivalents as part of compensation expense rather than a cash liability, which is a reasonable inference but not explicitly confirmed in the original answer. Overall, the answer is semantically close and factually consistent, warranting a high score but not perfect due to missing the $160M financial obligation detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 440,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher (DHR) values its venture‑capital, partnership and other private‑investment holdings by taking the net‑asset‑value reported by the fund managers and, where needed, applying discounted‑cash‑flow, earnings‑multiple or appraisal models; the filing stresses that the choice of methodology and the underlying assumptions are highly judgmental and can materially change the fair‑value result. Eli Lilly (LLY) records the intangible assets acquired in business combinations at their estimated fair value, noting that management must make “significant estimates and assumptions” to arrive at those values. Thus, both companies acknowledge subjectivity, but DHR explicitly blends a market‑based NAV with model‑based valuations, whereas LLY relies on a single fair‑value estimate for intangibles that is nonetheless driven by managerial judgment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY in valuing assets with subjective methodologies. (1) All factual elements are correct: DHR uses NAV from fund managers and supplements with discounted cash flows, earnings multiples, and appraisals, acknowledging judgmental inputs and potential variability in results. LLY applies fair value estimation to acquired intangibles, requiring significant management estimates and assumptions. The LLM correctly identifies the subjective nature in both cases. (2) Quantitatively, while the original answer includes the specific $3.80 billion charge for LLY’s IPR&D in 2023, the LLM answer omits this figure. This is a minor omission but does not undermine the overall correctness, as the focus is on methodology rather than specific dollar impacts. No incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two different companies (DHR and LLY), compares their valuation approaches (NAV + models vs. fair value estimation), and highlights the shared theme of subjectivity and managerial judgment. (4) The LLM conveys semantic equivalence to the original answer, with slightly less detail on LLY’s one-year finalization window and the exact magnitude of charges. However, the core insight—both firms use judgment-laden methods with potential for material variation—is preserved. The answer is contextually relevant, directly addressing the comparison of valuation methods and their inherent subjectivity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 423,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "In NVIDIA’s FY 2022 filing, revenue attributed to Taiwan was **about $2.0 billion**.  Apple’s 2022 Form 10‑K reports **$74.2 billion** of net sales for its “Greater China” segment, which by Apple’s definition includes Taiwan.  Consequently, NVIDIA’s Taiwan revenue is only roughly 2‑3 % of the amount Apple reports for Greater China.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the NVIDIA revenue figure for Taiwan in 2022. The ground truth states $8,544 million ($8.544 billion), but the LLM incorrectly reports 'about $2.0 billion', which is significantly off—less than a quarter of the correct amount. Apple’s reported Greater China revenue of $74.2 billion is correctly stated, matching the ground truth. The percentage comparison (2–3%) is based on the incorrect NVIDIA figure and is therefore also wrong; using the correct numbers, NVIDIA’s Taiwan revenue is approximately 11.5% of Apple’s Greater China revenue ($8.544B / $74.2B ≈ 11.5%). (2) Quantitative accuracy is severely compromised due to the incorrect NVIDIA revenue number and the resulting flawed percentage calculation. While Apple’s number is accurate, the core comparison fails. (3) The reasoning structure is sound—acknowledging that Apple includes Taiwan in Greater China and that the two companies report at different geographic granularities—but the faulty input data undermines the validity of the conclusion. The multi-hop synthesis (comparing two companies’ geographic disclosures) is conceptually appropriate. (4) Contextual relevance is high because the answer addresses the comparison, geographic scope, and reporting differences. However, the major numerical inaccuracy drastically reduces overall correctness, warranting a low score despite correct framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 395,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "- Comcast’s Class B shares carry 15 votes each and, together, represent about 33 ⅓ % of the company’s total voting power, all of which is beneficially owned by a single individual (Mr. Brian L. Roberts) 【page_38†L9-L13】【page_38†L14-L16】.  \n\n- Alphabet’s Form 10‑K only notes that its Class A common stock (traded as GOOGL) is listed on Nasdaq; it does not describe any special voting structure for Class A, implying that voting rights are one‑share‑one‑vote and ownership is dispersed among many public shareholders rather than concentrated in a single holder 【page_1†L9-L13】.  \n\nThus, Comcast’s Class B stock concentrates a substantial share of voting control in one person, whereas Alphabet’s Class A stock reflects a broadly distributed ownership and voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CMCSA's Class B stock carries 15 votes per share and represents 33⅓% of total voting power, held entirely by Brian L. Roberts — this matches the original answer exactly. For GOOGL, while the exact number of shares outstanding (300,754,904 as of January 25, 2022) is omitted, the LLM correctly infers from the absence of super-voting structures and the public listing that voting rights are likely one-share-one-vote and ownership is broadly dispersed. The omission of the precise share count is a minor completeness gap but does not affect the core correctness. (2) The reasoning is sound: the LLM correctly contrasts concentrated control in CMCSA via super-voting shares held by one individual versus GOOGL’s more standard, decentralized public ownership structure. (3) Multi-hop synthesis is appropriate — it draws from disclosures about CMCSA’s ownership and voting structure and contrasts it with GOOGL’s lack of special voting provisions, correctly implying a more distributed governance model. (4) Semantic equivalence is maintained: though the LLM doesn’t repeat the exact phrasing or include the specific share count for GOOGL, it conveys the same essential conclusion about governance dynamics. The answer is contextually relevant, directly addressing the comparison of control and ownership distribution. The only reason for not scoring a 10 is the omission of the specific GOOGL share count, which was present in the ground truth and could have strengthened completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 441,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "- **UnitedHealth Group** – Under the equity‑compensation plans approved by shareholders, about **25 million** shares are issuable upon exercise of outstanding options and **241 million** shares remain available for future issuance, giving a ratio of roughly **241 ÷ 25 ≈ 9.6**.\n\n- **Johnson & Johnson** – For its shareholder‑approved plans, about **133.8 million** shares are issuable upon exercise and **240.3 million** are available for future issuance, yielding a ratio of about **240.3 ÷ 133.8 ≈ 1.8**.\n\nThus, UnitedHealth’s “available‑for‑future‑issuance ÷ issuable‑upon‑exercise” ratio (~9.6) is considerably higher than Johnson & Johnson’s (~1.8).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers provided are accurate: UnitedHealth Group has 241 million shares remaining available and 25 million issuable upon exercise, resulting in a ratio of 241 ÷ 25 = 9.64, which the model correctly rounds to ~9.6. For Johnson & Johnson, the model uses appropriately rounded figures—240.3 million available and 133.8 million issuable (vs. exact values of 240,344,013 and 133,794,708), yielding 240.3 ÷ 133.8 ≈ 1.794, correctly rounded to ~1.8. These minor rounding differences do not affect accuracy. (2) The answer is complete, addressing both companies, both components of the ratio, and the comparative interpretation. (3) Entities—UnitedHealth Group and Johnson & Johnson—and the context of shareholder-approved equity compensation plans are correctly identified. (4) The multi-hop reasoning is sound: the model correctly retrieves and synthesizes data across two companies, computes ratios, and draws a valid comparative conclusion. (5) The semantic meaning is equivalent to the original answer, with clear, concise presentation and no factual or logical errors. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 339,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD warns that its products rely on a broad set of third‑party manufacturers for motherboards, graphics cards, software and other components, and that a loss or reduction of any of those suppliers could materially hurt its business, but the filing does not tie that risk to a single customer or a specific percentage of revenue. In contrast, Intel discloses that its three biggest customers generated 43 % of net revenue in 2021, with Dell alone accounting for about 21 % of revenue, creating a clear concentration risk tied to one major buyer. Thus AMD’s exposure is to a diffuse supply‑chain dependency, whereas Intel’s exposure is a pronounced revenue concentration on Dell.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Intel's 21% revenue from Dell in 2021 is accurately cited, and the mention of Intel's top three customers accounting for 43% of revenue (with Dell ~21%) is consistent with the original answer's focus on Dell's significant share. No calculation errors. (2) The answer correctly identifies AMD's reliance on third-party motherboard suppliers without tying it to a specific revenue percentage, which matches the ground truth. (3) The multi-hop reasoning is sound: it contrasts AMD's supply-chain risk (input side) with Intel's customer concentration risk (output side), correctly synthesizing information across AMD's and Intel's filings. (4) The only minor shortcoming is that the original answer adds that Dell represents a substantial portion of Intel's accounts receivable, a detail omitted in the LLM response. This is a small but relevant nuance affecting completeness, hence the 9/10 on correctness and qualitative accuracy. Otherwise, entities (AMD, Intel, Dell, 2021), metrics (revenue concentration, supply chain dependency), and reasoning are accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 339,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑tax cuts shave about **$34 million** off Union Pacific’s deferred‑tax expense for 2024, directly lowering the railroad’s tax burden and thus reducing its overall financial exposure in the state. By contrast, Boeing’s 10‑K makes no mention of a Louisiana tax change because the company’s risk profile is driven by the timing and level of **U.S. federal appropriations and defense‑spending legislation**, not by state‑level corporate‑tax rates, so the Louisiana reduction does not materially affect Boeing’s exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense in 2024 is correctly stated, matching the original answer exactly. No other numbers or dates are involved, and the figure is presented clearly with acceptable formatting (**$34 million**). (2) The answer addresses all key parts of the question: it explains Union Pacific’s direct financial benefit due to its operations in Louisiana and correctly contrasts Boeing’s lack of direct exposure, attributing its risk instead to federal appropriations and defense spending. (3) Entity accuracy is strong—both Boeing and Union Pacific are correctly identified, along with relevant financial concepts (deferred tax expense, federal appropriations). The mention of Union Pacific’s operational presence is implied through the financial impact, though the specific detail about the Livonia classification yard is omitted; however, this is a contextual detail that does not affect the core financial claim. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects Louisiana’s tax policy change to Union Pacific’s financials while distinguishing Boeing’s exposure as stemming from federal, not state, fiscal dynamics. The only minor shortcoming is the absence of explicit mention that Boeing’s exposure is *indirectly* linked to the same broader legislative environment—a nuance present in the original answer. However, the LLM correctly identifies that Boeing is unaffected by the state tax change and faces different (federal-level) risks, preserving semantic equivalence on the main conclusion. Thus, the answer is factually correct, complete in substance, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the missing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 502,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s charter states that “the holders of each share of common stock shall be entitled to one vote per share” (Netflix 10‑K, Voting Rights page 60), giving every share equal voting power. Meta, by contrast, issues two classes of common stock – Class A and Class B – with the latter carrying substantially more votes per share, creating a dual‑class structure that concentrates voting control. Charter Communications’ notes similarly tie its Class A common stock to a one‑vote‑per‑share right (Charter 10‑K, Notes to Consolidated Financial Statements page 95), underscoring that Netflix’s model aligns with Charter’s single‑vote‑per‑share approach, whereas Meta’s governance is fundamentally different.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key governance models of Netflix, Meta, and Charter Communications, with proper citations to their respective 10-K filings. It correctly states that Netflix has a one-vote-per-share model (citing page 60 of its 10-K), and that Charter’s Class A common stock also carries one vote per share (citing page 95 of its 10-K), aligning with the ground truth. The quantitative and entity accuracy is strong: all companies, stock classes, and filing references are correct, and there are no numerical errors. However, the LLM makes a significant qualitative overreach regarding Meta: while it correctly notes Meta has a dual-class structure (Class A and Class B), it asserts that Class B carries 'substantially more votes per share'—a claim not supported in the provided chunk of Meta’s 10-K, which only confirms the existence of two classes without specifying voting differentials. The ground truth correctly refrains from asserting the magnitude of voting rights in Meta’s case due to lack of explicit disclosure. This introduces a reasoning error in the multi-hop comparison: the LLM incorrectly implies Meta’s structure is definitively more concentrated than Netflix’s or Charter’s, while the ground truth appropriately notes the similarity in structure but highlights the lack of specific voting details for Meta. Thus, while the overall answer is mostly correct and contextually relevant, the unsupported inference about Meta’s voting power reduces the qualitative accuracy and overall correctness, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 438,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures are **cash‑settled each day**, so the contracts are not carried on the balance sheet as a separate fair‑value line item (they are settled‑out of the table)【page_107】.  \n\nMDLZ classifies exchange‑traded commodity futures and listed options as **Level 1 financial liabilities**, valuing them **directly from quoted market prices on the commodity exchanges**【page_112】. Because the futures settle daily, MDLZ can use those same daily market quotes as the fair‑value input without applying any additional income‑approach or model – the cash‑settlement mechanism simply reinforces the use of observable market prices as the Level 1 valuation method.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP's exchange-traded commodity futures are indeed cash-settled daily and not carried on the balance sheet as of year-end (per PEP's 2022 filing, page 107), and MDLZ classifies its exchange-traded commodity futures as Level 1 financial liabilities valued using quoted market prices from commodity exchanges (MDLZ 2022 filing, page 112). (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the LLM correctly infers that the daily cash-settlement mechanism supports the use of observable market prices, reinforcing the Level 1 classification for MDLZ, even though the direct link between PEP’s description and MDLZ’s methodology is implicit. The answer captures the logical connection that both companies operate under the same market standard. (4) The only minor shortcoming is that the LLM does not explicitly state that this reflects a broader 'market practice' as emphasized in the original answer, which slightly weakens the synthesis. However, the core insight — that daily settlement enables direct use of exchange quotes for fair value — is clearly articulated. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect: the response directly addresses how PEP’s described mechanism impacts MDLZ’s valuation methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 409,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales for the Greater China segment (which includes mainland China, Hong Kong and Taiwan) were **$74.2 billion**【page_52】.  \nAMD’s 2022 sales to customers in **Taiwan alone were $2.091 billion**【page_78】.  \n\nThus, Apple’s Greater China sales were about **35 times larger** than AMD’s Taiwan‑only sales in the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China and AMD's $2.091 billion (i.e., $2,091 million) in Taiwan are correctly reported, with appropriate unit conversions (billion vs. million) preserved. (2) The calculation comparing Apple's sales to AMD's—$74.2B / $2.091B ≈ 35.5, rounded to 'about 35 times larger'—is reasonable and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly distinguishes Apple’s broader regional sales (Greater China, including Taiwan) from AMD’s Taiwan-specific sales, and synthesizes data across two companies and geographic scopes. (4) Entity accuracy is perfect: both companies, the correct year (2022), and the precise geographic segments are correctly identified. (5) The answer is semantically equivalent to the original, providing the same core insight with slightly more concise phrasing and an added quantitative comparison that enhances clarity without introducing error. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 317,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation costs as operating expenses and only treats them as recoverable when a regulatory recovery is deemed probable, so the company bears the full out‑of‑pocket risk (see Duke remediation activities pages 163‑165). In contrast, Southern Company’s natural‑gas distribution utilities are permitted under their state‑approved rate‑setting processes to include environmental‑remediation expenses in the cost‑recovery mechanisms that are passed through to customers (see Southern Company Gas page 22), giving the firm a regulatory avenue to recoup those costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that Duke Energy expenses environmental remediation costs as incurred unless recovery is probable, while Southern Company Gas has regulatory mechanisms allowing recovery of such costs through rate-setting processes. These characterizations align with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting regulatory treatment between Duke Energy and Southern Company Gas, drawing from distinct parts of their respective filings (Duke pages 163–165, Southern Company Gas page 22). The inference that Southern has a structured recovery path while Duke bears more direct risk is logically supported. (4) The only minor shortcoming is that the LLM answer refers to 'Southern Company’s natural-gas distribution utilities' rather than specifying 'Southern Company Gas' as a subsidiary—though this is a subtle distinction and contextually reasonable. Overall, the answer is semantically equivalent, highly relevant, and accurately reflects the comparative exposure and regulatory recovery mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 364,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s fair‑value measurements that fall in Level 2 are derived from pricing models that use observable market inputs—including reported trades and broker‑dealer quotes—so the valuation is anchored to current market prices (see LOW 10‑K p.54). In contrast, General Motors does not price a market‑traded asset; it estimates its product‑warranty and recall reserves with industry‑standard actuarial valuation models that rely on historical claim experience and management assumptions rather than observable market quotes (see GM 10‑K p.55‑57). Thus, both companies depend on recognized valuation models, but Lowe’s model is driven by observable broker‑dealer pricing, whereas GM’s model is driven by internal actuarial assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., reported trades) for Level 2 fair value measurements, as confirmed in its 10-K (p.54), and GM relies on actuarial valuation models for warranty and recall reserves using historical data and management assumptions (GM 10-K pp.55–57). (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable in a traditional sense—but all references to inputs (e.g., 'broker-dealer quotes', 'historical claim experience') are factually consistent and correctly attributed. (3) The multi-hop reasoning is sound: the model correctly contrasts two different uses of valuation models across companies and industries—market-observable inputs (LOW) vs. internal, assumption-driven models (GM)—and synthesizes information from both 10-Ks appropriately. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'issuer spreads' or 'benchmark securities' as specific observable inputs used by LOW, which slightly reduces completeness compared to the original answer. However, 'observable market inputs—including reported trades and broker-dealer quotes' captures the essence of Level 2 valuation. The comparison of industry-standard models being used differently—market-driven vs. assumption-driven—is clearly and correctly articulated. Thus, the answer is semantically equivalent with only minor omissions in technical detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 442,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "The Basel III Finalization Proposal requires large banks to calculate risk‑weighted assets (RWA) under both the new “expanded risk‑based” methodology and the existing standardized approach and to apply the lower‑ratio result to each risk‑based capital ratio.  Because the expanded approach generally yields higher RWA, both Capital One and Citigroup would have to hold more CET1, Tier 1 and total capital to stay above the minimum ratios, with Citigroup explicitly stating that the change would “materially increase” its required regulatory capital.  The rule would become effective on July 1 2025 and be phased in over a three‑year transition period, so the additional capital‑holding burden would begin then and be fully in place by July 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Basel III Finalization Proposal requires banks to calculate risk-based capital ratios under both the expanded risk-based approach and the existing standardized approach, using the lower of the two; the effective date is July 1, 2025, with a three-year phase-in period ending July 2028; Citigroup expects a material increase in required regulatory capital; and both banks face higher capital requirements due to higher risk-weighted assets (RWA) under the new approach. (2) Quantitatively, all dates (July 1, 2025, and the 3-year transition) are correct, and the implication that higher RWA leads to higher capital requirements is logically sound. There are no numerical inaccuracies. (3) The multi-hop reasoning is strong: the model correctly synthesizes the impact on both Capital One and Citigroup, notes the phase-in period, and explains the consequence of using the lower ratio. The only minor omission is that the original answer specifies that both banks must comply with all capital buffer requirements regardless of which approach yields the lower ratio—a nuance not explicitly mentioned in the LLM response. This slightly reduces completeness but does not undermine the core correctness. (4) The answer is contextually fully relevant, directly addressing the impact on both banks, the effective date, and the regulatory mechanism. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 447,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ only condensate exposure comes from its 52.2 % ownership of Alba Plant LLC, the joint‑venture that extracts condensate (and LPG) from the Alba Unit’s natural‑gas stream, but the filing does not disclose a specific condensate‑production volume for that plant. In contrast, Chevron’s 2024 10‑K shows a “Crude Oil Condensate” column of zero for all regions, indicating no direct condensate production in 2024. Thus, ConocoPhillips retains an undefined condensate exposure through Alba Plant LLC, whereas Chevron reports no condensate output at all.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: ConocoPhillips has a 52.2% ownership interest in Alba Plant LLC, which extracts condensate from the Alba Unit gas stream, and Chevron reports zero condensate production in its 2024 10-K. The LLM correctly notes that no specific condensate volume is disclosed for Alba Plant, which matches the original answer's implication that COP's exposure is reflected in 'Equity in earnings of affiliates' without explicit volume reporting. (2) Quantitative accuracy is perfect: the 52.2% ownership stake and Chevron's zero condensate production are correctly cited. No calculations are required, and all numbers match. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (ConocoPhillips and Chevron), two ownership structures (direct vs. joint venture), and correctly interprets the absence of data (no disclosed volume for Alba, zero in Chevron’s tables) as meaningful. (4) The only minor shortcoming is that the LLM does not explicitly mention that ConocoPhillips’ condensate exposure is reflected in 'Equity in earnings of affiliates,' a detail present in the original answer that adds accounting context. However, this omission does not distort the meaning or reduce the factual accuracy significantly. Overall, the answer is semantically equivalent and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 394,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "- **Broadcom (AVGO)** – After adopting ASU 2020‑04, Broadcom evaluates every contract modification to determine whether the added products or services have a stand‑alone selling price.  When they do, the modification is accounted for as a **separate contract**; when they do not, the additional consideration is accounted for **prospectively, on a cumulative‑catch‑up basis, or a mix of both** 【page_63】.  This new treatment changes the timing and allocation of revenue for modified agreements.\n\n- **Oracle (ORCL)** – Oracle completed its adoption of ASU 2020‑04 in the first quarter of fiscal 2024 and disclosed that the change **had no material impact on its consolidated financial statements or related notes** for the year ended May 31, 2024 【page_72】.  Thus, while the guidance was applied, it did not materially affect Oracle’s revenue‑recognition or overall financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AVGO evaluates contract modifications based on standalone selling prices, and accounts for them prospectively, on a cumulative catch-up basis, or a combination—this matches the original answer. ORCL adopted ASU 2020-04 in Q1 of fiscal 2024 and reported no material impact on its financial statements, which is factually consistent. (2) Quantitatively, all dates (fiscal 2024) and time-bound details (no mention of specific numbers beyond correct fiscal period) are accurate. The standard’s applicability window (March 12, 2020 – December 31, 2024) is not explicitly mentioned in the LLM answer, but this detail was not critical to the core conclusion about financial impact. (3) Multi-hop reasoning is sound: the model correctly synthesizes how ASU 2020-04 affected both AVGO’s revenue recognition practices and ORCL’s financial reporting, particularly in relation to reference rate reform. It correctly notes that while the guidance was applied, there was no material effect—this synthesis across two companies and the common accounting standard is well executed. (4) The only minor omission is that the LLM does not explicitly link ASU 2020-04 to reference rate reform in AVGO’s case (though it's implied), and doesn't mention that both companies reported no material impact due to the optional expedients allowed by the standard. However, the core substance—no material impact—is clearly conveyed for ORCL and implied for AVGO through absence of contrary evidence. Wording differences (e.g., 'cumulative-catch-up' vs 'cumulatively') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 481,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class structure gives the 9 % of shares that are Class B (10 votes per share) a permanent majority of the voting power, so the holders of Class B (including the founder and board chair) can control all shareholder‑approved matters and limit the ability of Class A investors to influence the company【page_49】.  Because Meta is also a “controlled company” under Nasdaq and Delaware anti‑takeover rules, those controls can depress the attractiveness of its Class A stock【page_50】.  \n\nComcast’s Class B shares also carry super‑voting rights (15 votes per share) but are expressly convertible, share‑for‑share, into Class A stock subject to restrictions【page_91】; this conversion can eventually increase the voting power of ordinary shareholders and dilute the concentrated control, providing more potential influence for Class A holders than Meta’s permanently weighted structure.  \n\nThus, Meta’s dual‑class design locks governance control with a small insider group, whereas Comcast’s convertible Class B shares allow that control to be reduced over time, giving broader shareholder influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, the LLM correctly identifies Meta's Class B shares having 10 votes per share and CMCSA's Class B shares having 15 votes per share, consistent with the ground truth. However, the LLM states that Class B shares constitute '9%' of Meta's total shares — a detail not present in the original answer and not verifiable from the provided context, which may be an overprecision but does not contradict known facts. The ground truth emphasizes the 35% voting power threshold for change-of-control transactions and the 33⅓% non-dilutable voting power for CMCSA, which the LLM omits. These are important nuances but not central to the overall comparison. (2) The LLM correctly explains that CMCSA allows share-for-share conversion of Class B to Class A, enabling dilution of control over time, which aligns with the original. It accurately contrasts Meta’s entrenched control with CMCSA’s more flexible, convertible structure. (3) The reasoning is sound: it synthesizes governance implications across both companies, correctly identifying that Meta’s structure permanently entrenches insider control (especially noting its 'controlled company' status), while CMCSA’s convertibility allows for gradual reduction in concentrated control. (4) The answer is contextually excellent — directly addressing governance control and shareholder influence as asked. The omission of the exact 33⅓% and 35% thresholds slightly reduces completeness, but the qualitative and comparative analysis remains robust. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 479,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PepsiCo (PEP) says it hedges commodity‑price risk with “swaps and futures,” and notes that “exchange‑traded commodity futures are cash‑settled on a daily basis, therefore not included in the table” of fair‑value hierarchy items 【page_107】. Costco (COST) explicitly discloses that “the Company did not hold any Level 1 … financial assets or liabilities that were measured at fair value on a recurring basis” 【page_51】. Thus, while PepsiCo does use exchange‑traded commodity futures (which would normally be Level 1 assets), it excludes them from its Level 1 fair‑value reporting, whereas Costco reports having no Level 1 assets at all.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PEP uses exchange-traded commodity futures, which are cash-settled daily, and that these are excluded from the fair value table—consistent with the original answer’s claim about exclusion as of December 25, 2021 (though the exact date is omitted, the context is preserved). (2) It accurately states that COST disclosed holding no Level 1 financial assets measured at fair value on a recurring basis as of August 28, 2022 (date not repeated in LLM answer but implied via citation), and correctly cites the relevant page. (3) The reasoning correctly synthesizes the multi-hop comparison: PEP uses Level 1 assets (exchange-traded futures) but excludes them from reporting due to daily cash settlement, while COST reports no Level 1 assets at all—highlighting a key difference in disclosure and usage. (4) The only minor shortcoming is the lack of explicit mention of MDLZ’s role in defining Level 1 assets (a small gap in entity linkage), but this does not detract from the core factual accuracy. All entities (PEP, COST), financial instruments, and valuation levels are correctly identified. Number formats, dates (implied via source), and calculations (none required) are accurate. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 378,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reports $1.6 billion of securities loaned that mature in the 31‑90‑day window (see GS 10‑K, page 187).  Morgan Stanley’s 10‑K shows a total securities‑loaned balance of $34.3 billion (gross amount, page 200).  Because Goldman’s short‑term loaned amount is only a few percent of Morgan Stanley’s entire loan‑book, Goldman Sachs appears to have far less exposure to short‑term securities‑lending risk than Morgan Stanley, whose overall securities‑lending exposure is an order of magnitude larger.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs reports $1,634 million (i.e., $1.634 billion) in securities loaned with maturities of 31-90 days, which the LLM approximates as $1.6 billion — this is acceptable within rounding. However, the LLM claims Morgan Stanley reports a total securities loaned balance of $34.3 billion, which is grossly incorrect. The ground truth states Morgan Stanley reports only $281 million in total securities loaned (U.S. and Non-U.S. combined), not $34.3 billion. This is a more than 100-fold error. (2) The quantitative inaccuracy is severe: $34.3 billion vs. $281 million is a fundamental misrepresentation of the data. Even allowing for format variation, the numbers are not remotely close. The comparison is therefore completely flawed. (3) The reasoning is unsound due to incorrect data. The LLM concludes that Goldman Sachs has far less exposure to short-term securities lending risk because its $1.6 billion is only a 'few percent' of Morgan Stanley’s $34.3 billion. But in reality, Goldman’s $1.634 billion exceeds Morgan Stanley’s total securities loaned ($281 million) by nearly six times. Thus, the correct inference — as per the original answer — is that Goldman Sachs has significantly higher exposure to short-term securities lending risk. The LLM fails the multi-hop synthesis: it incorrectly retrieves Morgan Stanley’s figure and draws the opposite conclusion. (4) Due to the critical error in Morgan Stanley’s securities loaned value and the resulting reversal of the correct comparative conclusion, the correctness score is very low (1). Quantitative accuracy is poor (2) due to the massive dollar amount error. Qualitative accuracy is also low (2) because the reasoning and entity-level synthesis are invalid. Contextual relevance is moderate (3) as the answer addresses the right topic and structure but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 521,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided stake in Alabama Power’s Plant Miller Units 1 & 2 represents **8.16 %** of the cooperative’s owned generating capacity.  \n\nIn Duke Energy’s 2021 filing, the electricity‑generation volumes listed are 22,344 GWh (Duke Energy), 1,681 GWh (Duke Energy Ohio) and 10,688 GWh (Duke Energy Indiana), which together total **≈ 34,700 GWh** of electricity generated in 2021.  \n\nThus, PowerSouth’s Plant Miller interest is a modest 8.16 % share of its capacity, while Duke Energy produced roughly 34.7 thousand GWh of electricity in the same year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2, which matches the ground truth. However, it misrepresents this as '8.16% of the cooperative’s owned generating capacity' when the original answer states that PowerSouth owns 8.16% of the plant, and that this contributes to its total capacity of over 1,600 MW — not that the 8.16% represents a percentage of its total capacity. This is a critical misinterpretation. (2) Regarding Duke Energy’s 2021 generation, the LLM incorrectly sums Duke Energy’s total generation as ≈34,700 GWh by adding 22,344 GWh (Duke Energy), 1,681 GWh (Ohio), and 10,688 GWh (Indiana). However, the ground truth specifies that 22,344 GWh is already the combined total across all segments — the other figures are likely components of that total. Thus, the summation is erroneous and inflates Duke’s generation by over 50%. The correct figure is 22,344 GWh, not 34,700 GWh. (3) The multi-hop reasoning is partially sound in attempting to compare PowerSouth’s partial ownership with Duke Energy’s system-wide generation, but the flawed calculation undermines the comparison. The model fails to correctly synthesize the hierarchical structure of Duke Energy’s reported segments. (4) Scores reflect mostly incorrect quantitative output due to the major calculation error and misrepresentation of the percentage, though entities and years are correctly identified and the general intent of comparison is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 407,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE’s interest‑rate risk is confined to its $11.6 billion cash‑equivalents and short‑term fixed‑income portfolio, which has a weighted‑average maturity of only 65 days, so changes in rates affect the portfolio modestly. By contrast, McDonald’s does not quote a specific dollar amount but states that its fair‑value measurements for derivatives and other assets are based on Level‑2 pricing models that use observable market inputs such as interest‑rate yield curves; therefore the company’s earnings and other‑comprehensive‑income are more directly sensitive to movements in those rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $11.6 billion figure for NIKE's short-term fixed-income investments is accurate, and the mention of observable market inputs like interest-rate yield curves for McDonald’s is consistent with the original. However, the LLM introduces a specific 'weighted-average maturity of 65 days' for NIKE’s portfolio, which is not present in the ground truth and cannot be verified from the provided information—this is a minor overprecision. (2) The qualitative reasoning correctly identifies that both companies use pricing models with observable market data (Level 2 inputs), and it appropriately distinguishes the nature of exposure: NIKE’s risk is tied to investment returns, while McDonald’s sensitivity arises from derivative valuations affecting earnings and comprehensive income. (3) The multi-hop synthesis is sound—linking NIKE’s fixed-income portfolio to interest rate risk and McDonald’s derivative valuation to market sensitivity—though the added specificity on maturity slightly exceeds the source. (4) Contextually, the response directly addresses the comparison of interest rate risk exposure and reliance on pricing models, making it highly relevant. The core facts are correct, but the unsupported 65-day maturity detail prevents a top score, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 381,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s charter gives every share of its common stock one vote, so all shareholders – large or small – have the same voting power on director elections and other matters【page_60】. Alphabet, by contrast, issues three classes: Class A shares (one vote), Class B shares (ten votes) and non‑voting Class C shares, with the high‑voting Class B stock held mainly by insiders and convertible into Class A, concentrating control in a small group【page_82】. Thus Netflix’s one‑share‑one‑vote structure promotes more egalitarian shareholder governance, whereas Alphabet’s multi‑class structure allows a minority of insiders to dominate voting outcomes and steer corporate decisions despite a broader public ownership base.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's one-vote-per-share policy and contrasts it with Alphabet's multi-class structure, accurately describing Class A (1 vote), Class B (10 votes), and the existence of non-voting Class C shares. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Alphabet's Class A, 'ten votes per share' for Alphabet's Class B—no calculations are required, but the relative voting power is accurately portrayed. (3) The multi-hop reasoning is sound: the model synthesizes governance implications across both companies, correctly concluding that Alphabet's structure concentrates control among insiders (especially since Class B is held mainly by insiders and is convertible), while Netflix's structure promotes egalitarian governance. (4) The answer is fully contextually relevant, addressing the core of how voting structure differences impact shareholder governance dynamics. Minor additions (e.g., mention of Class C shares and convertibility) enhance completeness without introducing error. Wording differs slightly but meaning is preserved with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 336,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The IRA will cap the Medicare‑Part D price of Imbruvica – a drug AbbVie co‑commercializes – beginning in 2026, and AbbVie warns that the ceiling “could significantly impact AbbVie’s results of operations” and may accelerate revenue erosion for a product that already represents a material share of its U.S. sales, forcing the company to lean on new launches or renegotiated rebate/discount structures to protect its top line. By contrast, Johnson & Johnson’s Xarelto is also on the first “selected‑drug” list, but J&J’s revenue base is less concentrated on any single Medicare‑dependent product; the price‑setting will be absorbed through portfolio‑wide pricing and volume strategies rather than a sharp hit to a core revenue stream.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: it correctly identifies that Imbruvica and XARELTO are on the IRA's first selected-drug list, specifies the 2026 start date for price-setting (implied by context), and accurately reflects the financial significance of these drugs to AbbVie and Johnson & Johnson. There are no numerical inaccuracies or calculation errors. The entity identification is correct—AbbVie’s co-commercialization of Imbruvica and J&J’s ownership of XARELTO are properly noted. The reasoning correctly contrasts AbbVie’s high exposure due to Imbruvica’s materiality to U.S. sales with J&J’s more diversified revenue base, leading to different strategic responses. However, the LLM omits a key element from the ground truth: Johnson & Johnson’s active litigation challenging the constitutionality of the IRA’s pricing mechanism, which is a critical part of its revenue protection strategy. This omission reduces completeness and weakens the qualitative accuracy of the multi-hop synthesis, as the contrast in corporate responses (litigation vs. strategic evaluation) is underdeveloped. Despite this, the answer captures the core differential impact and strategic implications, maintaining strong contextual relevance and semantic equivalence on the main points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 361,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk function is housed in the second‑line “Independent Compliance Risk Management” (ICRM) organization, which is led by the Group Chief Compliance Officer, reports both to the Chief Legal Officer and, through a matrix line, to the Chief Risk Officer, and has unrestricted access to the Board’s Risk Management Committee and the Group Business Risk and Control Committee (GBRCC) that oversee compliance and operational risks【page_70】.  This structure requires ICRM to identify, measure, monitor and‑escalate any compliance‑related exposures—including those arising from transition‑climate‑risk scenarios that could worsen borrowers’ credit quality or strain funding sources—so that the Board and senior‑management committees can apply the firm‑wide risk‑appetite limits and take corrective actions before credit or liquidity risks materialize【page_75】【page_70】.  By embedding climate‑risk considerations into its compliance‑risk oversight and linking ICRM directly to the CRO‑CCO and the Board, Citi’s governance explicitly addresses the potential amplification of credit and liquidity risks highlighted in Morgan Stanley’s disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Citi's governance structure for compliance risk, emphasizing the role of the Independent Compliance Risk Management (ICRM) function, its leadership, reporting lines, and oversight by key Board committees. The answer accurately explains how this structure addresses the amplification of credit and liquidity risks from transition climate risks—specifically referencing how such risks could impair borrowers' credit quality or strain funding, which matches the concern outlined in Morgan Stanley's disclosures. The LLM correctly synthesizes multi-hop information: (1) Citi’s compliance governance, (2) the transmission mechanism of transition climate risks into financial risks, and (3) the linkage to Morgan Stanley’s risk disclosures. While the original answer emphasizes Internal Audit’s role and the Board/Executive Management’s accountability in ERM, the LLM focuses more on ICRM’s proactive monitoring and escalation role—slightly different emphasis but semantically consistent in function and intent. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Citi, Morgan Stanley, ICRM, CRO, Board committees) are correctly identified. The reasoning is sound and contextually appropriate. The only minor gap is that the LLM does not explicitly mention reputational, compliance, or litigation risks tied to regulatory scrutiny of carbon emissions—a point included in the original—but it does cover the core risk transmission and governance response. Thus, the answer is factually correct and comprehensive with only a slight omission in secondary context, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 473,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing stream is heavily tied to Chinese OEMs – about 30 % of its royalty income comes from those customers – so its revenue is exposed to the same geopolitical and trade‑policy shocks that can block exports, trigger license‑revocation, delay payments or cause the OEMs to switch to self‑designed chips (see QCOM pages 19‑20). In contrast, Texas Instruments is reducing supply‑chain risk by building more of its own 300 mm wafer capacity (RFAB2, LFAB1, SM1/SM2, etc.), which gives it “lower costs and greater control of our supply chain” and makes its production less dependent on external foundries or foreign‑origin restrictions (TXN pages 6‑7). Thus Qualcomm’s risk stems from reliance on third‑party Chinese customers, while TI’s risk‑mitigation strategy is internalizing manufacturing to insulate itself from those external disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated. No other numerical values are present, and all references to facilities (RFAB2, LFAB1, SM1/SM2) match the intended expansion sites for TXN's 300mm wafer capacity. (2) The answer correctly identifies the core risk difference: QCOM faces geopolitical and contractual risks due to reliance on Chinese OEMs for licensing revenue, while TXN mitigates supply chain risk through vertical integration via internal fabrication. (3) Multi-hop reasoning is sound—synthesizing QCOM's customer dependency with TXN's capital investment strategy to contrast their risk profiles. The mention of SM2 is a minor addition not in the original, but it does not contradict and is plausibly part of TXN's broader fab expansion. (4) Semantic equivalence is strong: the LLM captures the essence of revenue exposure vs. supply chain control, correctly attributes risks to geopolitical and trade-policy factors for QCOM, and highlights TXN’s strategic insulation through manufacturing control. The only minor shortcoming is slightly less emphasis on 'delays or disputes in license agreements' as a specific mechanism, though 'delay payments' and 'license-revocation' cover similar ground. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 390,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it has elected to apply the ASU 2020‑04 amendments to any debt‑modification transactions that fall within the scope and, after reviewing its LIBOR‑referenced debt and certain power‑purchase agreements, expects the guidance to have no material effect, though it continues to monitor the transition. Duke Energy likewise notes that the ASU 2020‑04 guidance is elective for its variable‑rate debt and LIBOR‑indexed interest‑rate swaps, is evaluating the optional expedients and alternative‑index provisions, and likewise concludes that the ultimate impact is uncertain but is not expected to be material.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its high-level assessment and correctly identifies that both Southern Company and Duke Energy are evaluating ASU 2020-04 with respect to LIBOR transition, that application is optional, and that neither expects a material impact. Quantitatively, there are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. However, there are qualitative discrepancies: the LLM states Southern Company 'has elected to apply' the amendments, which contradicts the original answer stating it 'continues to evaluate'—indicating no election has yet been made. This misrepresents Southern Company's position. Additionally, the original specifies Duke Energy is assessing optional expedients for contractual amendments or terminations, particularly in variable-rate debt and interest rate swaps, with potential impact beyond 2023; the LLM captures this generally but omits the reference to Note 14 and the specific context of contractual modifications. The multi-hop reasoning is partially sound—comparing both companies’ assessments—but misses nuanced differences in timing and decision status. Semantic equivalence is mostly preserved, but the incorrect assertion about Southern Company’s election lowers confidence in the synthesis. Contextual relevance is high as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 393,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 10‑K notes that it “holds cash equivalents and marketable securities in foreign currencies such as British pounds, Canadian dollars, euros and Japanese yen,” indicating that a portion of its assets is directly exposed to GBP and EUR movements (no specific hedge is described). Nike, by contrast, states that it “uses forward contracts and options to hedge transactional foreign‑exchange exposures,” relying on option contracts (along with forwards) to offset the same currency risks rather than simply holding un‑hedged foreign‑currency assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between AMZN and NKE in foreign exchange risk management. (1) It correctly states that AMZN holds foreign currency assets in British Pounds and Euros (among others) and is exposed to FX risk without describing specific hedging instruments—this aligns with the ground truth, which notes AMZN's lack of disclosure on derivative usage. (2) It accurately reports that NKE uses option contracts (alongside forwards) to hedge transactional exposures, matching the original answer’s emphasis on NKE’s proactive use of options for forecasted transactions and balance sheet items. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies’ 10-K disclosures to compare passive exposure (AMZN) versus active hedging (NKE). (4) While the LLM mentions 'forward contracts'—a detail not emphasized in the original answer—this does not contradict the ground truth, as NKE does use both instruments; the focus on 'options' as requested in the question is maintained. No numerical data is present, so quantitative accuracy is scored as 10 by default. The only minor limitation is slightly less depth on the specific exposures NKE hedges (e.g., product costs, external sales), but the essential qualitative contrast is preserved. Thus, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 394,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta Platforms issues two voting classes: each Class A share carries **one vote**, while each Class B share carries **ten votes**. With 2.19 billion Class A shares and 0.34 billion Class B shares outstanding, Class B stock controls roughly **60 % of the total voting power** (the remaining ~40 % rests with Class A).\n\nAlphabet (Google) has the same dual‑class scheme: **Class A shares have one vote**, **Class B shares have ten votes**, and **Class C shares have no voting rights**. Although the filing does not list the exact share counts, the ten‑to‑one voting split gives Class B shareholders a **majority of voting power**, mirroring Meta’s structure. In both companies, the high‑vote Class B shares dominate control of the corporation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in both the voting rights and voting power distribution for META and GOOGL. According to the ground truth, at META, Class B shares have 15 votes per share, not 10 as stated by the LLM. Additionally, the ground truth specifies that Class A holds 66 2/3% of voting power and Class B holds 33 1/3%, which is the opposite of what the LLM claims (where Class B controls ~60%). The LLM incorrectly reverses the dominance: in reality, Class A has majority voting power at META, but the LLM asserts Class B does. For GOOGL, the LLM correctly states that Class A has 1 vote and Class B has 10 votes, but fails to note that the ground truth makes no claim about exact percentages or majority control—thus the assertion that Class B has a 'majority of voting power' is an unsupported inference. (2) The quantitative inaccuracies are severe: the vote ratio per share is wrong for META (10 vs. correct 15), and the calculated voting power distribution (~60% for Class B) contradicts the ground truth (33 1/3%). The share counts (2.19B and 0.34B) are not present in the original answer and appear to be fabricated or outdated, leading to incorrect synthesis. (3) The multi-hop reasoning is flawed: the model fails to correctly compare the relative influence of Class B shares between the two firms. The ground truth emphasizes that META gives *significantly more* relative influence to Class B than GOOGL does—this hinges on the 15:1 vs. 10:1 ratio. By incorrectly stating META’s ratio as 10:1, the LLM misses this key comparative insight. (4) Despite these errors, the answer is contextually relevant and attempts a structured comparison of dual-class structures. It correctly identifies the presence of Class A, B, and C shares at GOOGL and the general principle of differential voting rights. However, due to major factual and quantitative errors, especially in the core metrics, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 525,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s Gas unit is investing roughly half of an announced ≈ $3 billion SNG pipeline – about $1.5 billion of capital – but the project cannot be built until all required regulator sign‑offs, including FERC’s approval of the pipeline, are obtained (the filing notes that “subject to the receipt of all required approvals by regulators, including the FERC, the operator anticipates completion in 2029”). By contrast, Duke Energy Ohio’s recent interaction with FERC was not about a capital project; it was a FERC‑ and PUC‑approved dividend‑payment authorization that obligates the subsidiary to keep equity at least 30 % of total capital, thereby constraining cash distributions rather than new investment spending.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3 billion SNG pipeline project and Southern Company Gas's 50% ownership, implying a $1.5 billion investment. However, the ground truth states Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024, which is a specific factual figure not reflected in the LLM's approximation of $1.5 billion. This discrepancy affects quantitative accuracy. The 2029 completion date is correctly cited and tied to regulatory approvals. For Duke Energy Ohio (DUK), the 30% equity requirement and the context of FERC/PUCO approval for dividends are accurately reported. (2) The LLM incorrectly implies that Southern Company's current investment in SNG is $1.5 billion based on 50% of the future project cost, whereas the original answer specifies a historical investment of $1,245 million in SNG (not necessarily tied only to the pipeline). This is a material numerical difference (~17% variance) and misrepresents the nature of the investment. Other numbers (30%, 2029) are correct. (3) The multi-hop reasoning is strong: the model correctly distinguishes between SNG’s project-level regulatory hurdle (FERC approval for construction) and DUK’s capital structure constraint (equity ratio for dividend payments), synthesizing across two companies and regulatory contexts. The comparison highlights different types of FERC-related constraints—project execution vs. financial policy—demonstrating sound qualitative reasoning. (4) Despite the numerical inaccuracy in investment amount, the answer captures the core contrast in regulatory constraints and capital implications. Wording is clear and semantically aligned with the original, and all entities (SNG, SO, DUK, FERC, PUCO) are correctly identified. Hence, correctness is high but not perfect due to the investment figure error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 500,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s returned capital to owners primarily through open‑market repurchases, including an accelerated‑share‑repurchase (ASR) program in which the company paid a third‑party financial institution $3 billion and received roughly 12 million shares in return, bringing total buy‑backs in fiscal 2021 to about $13.1 billion. By contrast, Home Depot’s equity‑based compensation programs distribute value to shareholders via dividend‑equivalent awards attached to restricted‑stock, performance‑share and restricted‑stock‑unit awards, which accrue on unvested shares and are paid out as additional shares when the awards vest. Thus, Lowe’s uses cash‑for‑stock buybacks through a financial‑institution conduit, while Home Depot uses dividend‑equivalent share issuances as a shareholder‑value mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lowe's $3.0 billion accelerated share repurchase (ASR) with a financial institution and receipt of approximately 12 million shares (ground truth: 11.9 million), which is factually accurate with only a minor rounding difference. It also correctly states that Lowe’s returned about $13.1 billion in fiscal 2021, aligning closely with the ground truth of a $13.0 billion authorization in December 2021, bringing total authorization since 2020 to $28.0 billion. The LLM slightly mischaracterizes the $13.1 billion as 'total buy-backs in fiscal 2021' rather than an authorization amount, which may imply execution rather than approval, but the figure is in the correct range and contextually acceptable. (2) Home Depot's use of dividend equivalents on unvested equity awards is accurately described, including accrual and payout in the form of additional shares upon vesting. The LLM correctly distinguishes this as a share-based compensation mechanism rather than a direct cash dividend, which matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Lowe’s and Home Depot), two distinct financial mechanisms (ASR via financial institutions vs. dividend equivalents on unvested equity), and two timeframes (2021–2022 context). It draws a valid comparative conclusion about differing shareholder value distribution strategies. (4) Minor deduction in quantitative accuracy due to the conflation of repurchase authorization ($13.0B) with executed buybacks ($13.1B), and the rounded share number (12M vs 11.9M). However, these are not material errors. Qualitative accuracy is high due to correct entity identification, proper financial terminology, and logical synthesis. Contextual relevance is perfect—the answer directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 510,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both Caterpillar and Honeywell state that they adopted ASU 2022‑04 in 2023, which obliges a buyer that uses supplier‑finance programs to disclose the program’s key terms, where the amounts are presented on the balance sheet and the amount confirmed as outstanding at period‑end. The standard also adds a roll‑forward of those confirmed obligations; the roll‑forward portion became effective on January 1 2024, so each company now includes a table (beginning balance, invoices confirmed, invoices paid and ending balance) in its 2024 Form 10‑K.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Caterpillar and Honeywell adopted ASU 2022-04, with the rollforward requirement effective January 1, 2024, and that both companies include the rollforward in their 2024 disclosures. It accurately describes the required disclosures (key terms, balance sheet presentation, period-end obligations, and the rollforward table). However, it omits the specific dollar amount of Caterpillar’s obligations ($830 million), which is present in the ground truth and is a key quantitative detail explicitly asked for in the context of disclosure impact. (2) The date (January 1, 2024) for the rollforward’s effective date is correct. The absence of the $830 million figure—mentioned in the original answer for Caterpillar—is a notable omission in quantitative accuracy, though no incorrect numbers are stated. The LLM does not mention what Honeywell’s obligation amount is, which aligns with the original answer’s phrasing that it would be 'similarly detailed,' so this is not an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the adoption of ASU 2022-04 by both companies, links it to the new disclosure requirements, and correctly notes the phased effective date for the rollforward. It logically connects the standard’s requirements to the actual reporting practices in the 2024 10-Ks. (4) The answer is contextually complete and highly relevant, with only the missing $830 million figure preventing a top score. The qualitative reasoning and entity accuracy (companies, standard, years, requirements) are fully correct. Thus, the correctness score is 8 due to the omission of a key quantitative detail, though no inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 468,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C (Citigroup) reports $49,549 million of credit‑card loans that mature within one year (see C 10‑K page 86).  Visa’s 2024 filing says it is targeting “more than $20 trillion of opportunity globally … to convert cash, checks, ACH and other non‑card payments into cards and digital credentials” (see Visa 10‑K pages 8‑9).  Thus, Citi’s near‑term $49.5 billion loan balance is only a tiny fraction of the $20 trillion market that Visa hopes to grow by issuing additional credit cards and digital credentials.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $49,549 million (also correctly expressed as $49.5 billion) and the $20 trillion global opportunity are accurately reported. Format variations (e.g., 'million' vs 'billion') are acceptable and correctly converted. (2) The entity identification is accurate—Company C is correctly inferred as Citigroup (based on context and 10-K reference), and Visa is correctly referenced with appropriate citation to its 10-K. (3) The reasoning is sound: the LLM correctly synthesizes that Citigroup’s short-term credit card loans represent a small fraction of the much larger $20 trillion market opportunity Visa aims to capture by converting non-card payments. This reflects multi-hop reasoning across two companies’ filings. (4) While the original answer emphasizes the alignment between Visa’s growth strategy and the resulting impact on institutions like Company C (i.e., growing loan balances), the LLM focuses more on scale comparison. It slightly underemphasizes the strategic alignment (e.g., Visa’s partnerships driving credit issuance that feeds into balances like Citigroup’s), but this is a nuance rather than an error. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only minor room for deeper strategic linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 385,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution revenues are weather‑sensitive, but the company cushions that exposure with regulatory “weather‑ and revenue‑normalization” mechanisms and weather‑derivative contracts that cap the impact of typical seasonal temperature swings【page 86】. In contrast, NextEra Energy’s electricity demand is directly driven by weather events—hurricanes, extreme heat or cold can sharply raise or cut load and force costly restoration or winter‑hardening actions—so its earnings are more exposed, with mitigation limited to operational steps (e.g., winterizing, load‑shedding) and hedging programs that may not fully offset severe‑weather shocks【page 26】【page 27】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Southern Company's gas distribution revenues are weather-sensitive but mitigated through weather normalization and derivative instruments, while NextEra Energy faces more direct and severe weather-related risks, especially from hurricanes and extreme temperatures. The core entities—Southern Company Gas and NextEra Energy (NEE)—are correctly identified, and the comparison of their risk exposures and mitigation strategies is sound. (2) There are no explicit numerical values (e.g., the 6.2% net income decrease in 2023) mentioned in the LLM answer, which were present in the original answer. However, the absence of this specific figure does not undermine the overall correctness, as the LLM still accurately conveys the qualitative impact and risk management strategies. All other factual assertions (e.g., use of weather normalization, derivatives, operational mitigations) are consistent with the ground truth. (3) The multi-hop reasoning—comparing two companies’ weather risk exposures and mitigation approaches across different business models (gas vs. electric) and geographies (Southeast U.S. gas vs. Florida-heavy electric operations)—is logically synthesized and well-articulated. (4) The answer is contextually relevant, directly addressing the comparative impact of weather and risk mitigation strategies. The only minor shortcoming is the omission of the specific 6.2% financial impact for Southern Company in 2023, which slightly reduces completeness but does not affect the overall correctness of the reasoning or conclusion. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 456,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s business is built on a franchise‑affiliate model: most of its 43,477 system‑wide restaurants are owned by franchisees, developmental licensees or foreign affiliates, and the company’s revenue comes primarily from franchise fees, royalties and rent paid by those affiliates (the “foreign affiliated” restaurants alone represent roughly 23 % of the system). In contrast, General Motors’ crossover production through non‑consolidated China joint‑ventures contributes only a tiny slice of its total sales – GM recorded just $90 million of automotive sales to those affiliates in 2024 versus $171.8 billion of consolidated revenue, and the JVs are accounted for using the equity method rather than being fully integrated into GM’s operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between McDonald's franchise-based affiliate model and GM's use of nonconsolidated joint ventures in China for crossover production, which aligns with the original answer's intent. It correctly identifies that McDonald's revenue comes from royalties, fees, and rent from affiliates, and that GM engages in production through nonconsolidated affiliates (specifically in China), with revenue accounted for via the equity method. However, significant quantitative inaccuracies undermine the correctness: the claim that 'foreign affiliated' restaurants represent roughly 23% of McDonald's system is not in the original answer and cannot be verified from it; more critically, the LLM states GM recorded $90 million in automotive sales to affiliates in 2024 versus $171.8 billion consolidated revenue — these figures (especially the $90M and the year 2024) are not present in the original answer and appear fabricated. The original answer makes no mention of specific dollar amounts, percentages, or years, nor does it state that GM's affiliate contribution is 'tiny' — such a comparative judgment is an unsupported addition. While the qualitative reasoning about operational structure (royalty vs. transactional production) is sound and contextually relevant, the inclusion of unverified numerical data and the failure to reflect that the original answer did not provide any specific financial figures result in a moderate correctness score. The model adds specificity not present in the ground truth, which violates factual accuracy despite reasonable conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 438,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "Comcast’s Class B common stock carries a fixed 33 % of the company’s voting power that is “generally non‑dilutable” and can only be turned into Class A shares on a one‑for‑one basis subject to “certain restrictions,” so additional issuances cannot erode its voting influence. Alphabet’s (Google’s) Class B shares, by contrast, may be converted voluntarily at any time and automatically convert to Class A upon any sale or transfer, meaning the voting‑power protection is not a dilution shield but a conversion mechanism that can eliminate the extra votes when the shares change hands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B has a non-dilutable 33 1/3% voting power (rounded to '33%' in the answer, which is acceptable as a common approximation), share-for-share conversion with restrictions; GOOGL's Class B has 10 votes per share (implied by 'extra votes'), voluntary conversion, and automatic conversion upon sale/transfer. (2) Quantitative accuracy is strong: '33%' is a reasonable shorthand for '33 1/3%', and no other numbers are misstated. (3) The multi-hop reasoning is sound—correctly contrasting CMCSA’s structural voting protection against dilution from new issuances with GOOGL’s transfer-triggered loss of voting power. The synthesis across both companies and share classes is accurate. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention of GOOGL’s 10 votes per share, which is present in the ground truth and adds precision to the voting power comparison. However, the phrase 'extra votes' implies this difference sufficiently for semantic equivalence. Contextual relevance is perfect—the response directly addresses the comparison of dilution protection and conversion mechanisms as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 349,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "American Express values its Level 3 debt securities – the Community‑Development Financial Institution holdings – by using the carrying amount as a “reasonable proxy” for fair value unless its internal credit model flags cash‑flow shortfalls (see AXP 10‑K p.146). Because Level 3 inputs are unobservable and rely on management‑derived estimates, the valuation is vulnerable to illiquid market conditions where no reliable market prices exist, increasing the risk that the recorded value diverges from what could be realized in a sale. When such mis‑valued assets decline, Morgan Stanley’s own market‑risk framework – which notes that illiquid markets make it difficult to value and monetize instruments and can impair hedging and position‑adjustment activities (MS 10‑K pp.13‑14) – may be hampered, limiting its ability to manage market risk and potentially magnifying losses during periods of asset devaluation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor omissions. (1) Quantitatively, there are no numbers, dates, or dollar amounts in the original or LLM answer, so no discrepancies exist—this aspect is fully correct. (2) The LLM correctly identifies AXP’s use of internal credit models and carrying amounts as a proxy for fair value for Level 3 securities, particularly CDFI debt holdings, aligning with the ground truth. It accurately notes the reliance on unobservable inputs and management estimates, which increases valuation risk in illiquid markets. (3) The multi-hop reasoning is sound: it connects AXP’s valuation methodology to the broader risk in illiquid conditions, then links this to MS’s market risk management challenges. The LLM cites MS’s 10-K regarding difficulties in valuing and monetizing instruments during volatility, hedging inefficiencies, and impaired position adjustments—key points from the original. (4) The only minor shortcoming is that the LLM omits mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, a specific Level 3 asset noted in the original. While not central to the overall risk mechanism, its exclusion slightly reduces completeness. However, the core logic, entities (AXP, MS), and synthesis across filings are correct. Wording differs but semantic equivalence is strong. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 425,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron classifies the fair value of its Level 2 derivatives using internal discounted‑cash‑flow models that are driven almost entirely by observable market data—interest‑rate curves, foreign‑exchange rates, stock prices, volatility and risk‑free rates—so management judgment plays only a modest role. Exxon, by contrast, values the Pioneer upstream assets with discounted‑cash‑flow models that also use observable inputs (e.g., third‑party commodity‑price averages) but require considerable management judgment about future production volumes, drilling and development costs and the risk‑adjusted discount rate. Thus, Chevron’s Level 2 derivative valuation is more “market‑input‑focused,” while Exxon’s Pioneer asset valuation leans more heavily on subjective assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the key distinction between Chevron's and Exxon's valuation approaches with accurate qualitative and quantitative details. (1) It correctly identifies that Chevron's Level 2 derivatives rely on observable market inputs such as interest-rate curves, foreign-exchange rates, stock prices, and volatility, with minimal management judgment—consistent with the ground truth referencing third-party quotes and pricing services. While the LLM mentions 'internal discounted-cash-flow models,' this does not contradict the ground truth, as Level 2 valuations can use models with observable inputs; however, the original answer emphasizes third-party sources more strongly, and the LLM's phrasing could imply greater internal modeling than supported, which is a minor deviation. (2) For Exxon, the LLM accurately notes the use of discounted cash flow models with observable inputs like third-party commodity-price averages but highlights the need for significant management judgment in projecting production volumes, costs, and risk-adjusted discount rates—this aligns fully with the ground truth's emphasis on unobservable inputs and forward-looking assumptions. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in valuation methodologies between the two companies, contrasting Chevron’s market-driven, observable approach with Exxon’s more assumption-intensive process. (4) There are no numerical inaccuracies—no specific dollar amounts, dates, or percentages are misstated. The answer is contextually relevant and directly addresses the comparison in terms of observable inputs and management judgment. The slight deduction in qualitative accuracy is due to the emphasis on 'internal models' for Chevron, which may underplay the reliance on external pricing sources highlighted in the original answer, potentially implying more subjectivity than intended for Level 2 classification. Overall, the semantic meaning and factual core are preserved, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 550,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s renewable projects are held in VIEs that it guarantees; the company’s primary role is to negotiate the PPAs, while the financing is provided through tax‑equity partnerships that take the federal ITC/PTC and give Duke a fee‑type return, so the PPAs are not recorded as leases but as revenue‑generating contracts of the VIEs. Southern Power, by contrast, owns the solar assets outright and accounts the PPAs as long‑term operating (or sales‑type) leases, recognizing the associated variable‑lease income and retaining the ITC within its tax‑equity structures, which are reflected on its balance sheet and lease‑income statements. Thus, Duke relies on VIE‑guaranteed, tax‑equity‑financed PPAs, whereas Southern Power uses lease‑accounted PPAs with the tax credits embedded in its lease‑income and partnership accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Duke Energy uses VIEs with tax-equity financing where it guarantees projects and negotiates PPAs, but does not record them as leases; instead, they are revenue-generating contracts. Southern Power owns solar assets directly and accounts for PPAs as operating leases (up to 25 years), which matches the original answer’s description. The LLM correctly identifies that Southern Power retains federal tax credits (ITCs/PTCs) within its tax equity structures, while Duke’s model allows tax-equity partners to take the credits in exchange for a fee-like return. (2) Quantitative accuracy is perfect: although no specific dollar figures appear in the LLM answer (e.g., $1.2 billion unutilized credits at Southern Company), this omission does not constitute an error because the LLM does not make any numerical claims. It avoids stating the figure but still correctly conveys the utilization of ITCs/PTCs. Since the absence of a number isn’t a factual inaccuracy, and no incorrect numbers are presented, quantitative accuracy remains high. (3) Multi-hop reasoning is sound: the model synthesizes information across Duke Energy’s VIE structure, tax-equity financing, PPA treatment, and contrasts it with Southern Power’s ownership model, lease accounting, and tax credit retention. The comparison of financial structures and tax credit utilization is logically structured and factually consistent. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'fee-type return', 'lease-income statements'), the meaning matches the original. The only minor shortcoming is the lack of explicit mention of the $1.2 billion unutilized tax credits at Southern Company as of December 31, 2021, which would have enhanced completeness. However, since the core mechanisms of tax credit use are correctly described, this is a minor omission rather than a factual error. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 568,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s charter creates two voting classes, and the holders of Class A common stock alone elect three‑quarters of the Board of Directors, concentrating board‑control in a relatively small shareholder group【page 27】. In contrast, Home Depot’s stock‑based awards give ordinary voting rights to the underlying restricted‑stock shares at grant (even while unvested)【page 67】—so voting power is spread among many employee‑award holders rather than being concentrated in a single class that dominates board elections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that NKE's Class A common stock elects three-quarters of the Board of Directors, matching the original answer exactly. There are no numerical or percentage errors. (2) The comparison with HD is factually sound: HD does grant voting rights on restricted stock awards at grant date, even before vesting, which the LLM correctly identifies. This reflects proper synthesis across both companies' governance structures. (3) The reasoning is strong and captures the core contrast: NKE centralizes voting power in a minority class of shareholders, while HD distributes voting influence more broadly among employees holding unvested restricted stock. (4) The LLM omits a minor detail present in the original answer—specifically, that neither company allows Class B or C shareholders to vote on most matters—but this does not detract from the central comparison about governance influence via Class A vs. restricted stock. The omission is minor and doesn't affect the correctness of the main conclusion. Wording differs but maintains semantic equivalence. Citations to page numbers (27 and 67) suggest accurate sourcing from the filings. Overall, this is a correct, well-reasoned, and contextually appropriate response with only negligible completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 377,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix manages the foreign‑exchange risk on its forecast revenue by entering into forward contracts that are designated as cash‑flow hedges; the gains or losses on those hedges are recorded in AOCI and re‑classified to earnings when the underlying revenue is recognized (see Netflix 10‑K p. 49‑48).  The filing does not disclose a dollar‑amount estimate of the residual exposure, only that the contracts “may reduce, but do not entirely eliminate, the effect of foreign‑currency movements.”  \n\nDisney, by contrast, quantifies its currency‑sensitive exposure with a Value‑at‑Risk model.  For fiscal 2023 the VAR for currency‑sensitive financial instruments was $45 million (average $48 million) at a 95 % confidence level (see Disney 10‑K p. 60).  \n\nThus, Netflix’s exposure is managed through hedges without a disclosed monetary estimate, whereas Disney explicitly measures its exposure, estimating a potential one‑day loss of roughly $45‑48 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies that significantly undermine its correctness. (1) Quantitatively, the Disney VAR figure is incorrect: the LLM reports $45 million for fiscal 2023, but the ground truth states Disney's VAR decreased to $255 million in 2024 from $284 million in 2023. The $45 million figure does not appear in the ground truth and contradicts it. Additionally, the LLM cites a 95% confidence level and average VAR of $48 million, which are not mentioned in the original answer, suggesting fabrication or misattribution. (2) The LLM fails to mention Netflix's $293 million loss in 2023, a key quantitative metric in the ground truth that illustrates the volatility of unhedged positions. This omission severely limits the comparative analysis. (3) The original answer highlights a key conceptual difference: Disney's VAR model excludes forecasted transactions, while Netflix hedges them explicitly. The LLM does not mention this crucial distinction, weakening the multi-hop reasoning. (4) While the LLM correctly identifies Netflix’s use of forward contracts and Disney’s use of VAR, it misses the core comparative insight about what each model includes or excludes. (5) The LLM references specific page numbers (e.g., Netflix 10-K p. 49-48), which may be plausible but are not verifiable from the ground truth and do not compensate for factual errors. Overall, the answer gets basic entities right (Netflix, Disney, forward contracts, VAR) and addresses the general topic of FX risk management, but fails on key numbers, omits critical data points, and misses the central analytical contrast, resulting in a partially correct but substantially flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 459,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both companies compute VAR on a one‑day, 95 %‑confidence basis, but the look‑back periods they use to build the expected‑return distributions differ slightly. Mondelēz (MDLZ) bases the distribution on movements in interest rates, foreign‑exchange rates **and commodity prices** observed over the **prior quarter**, and it aggregates the four most recent quarters to produce its average‑VAR figures. Philip Morris International (PM) uses the same **preceding‑quarter** observations, but only for interest‑rate and forward‑currency movements (no commodity component), again rolling four quarters for its average, high and low VAR amounts. Consequently, both firms assess risk over a very short‑term (one‑day) horizon, but MDLZ’s risk horizon incorporates a broader set of market drivers, whereas PM’s horizon is narrower, focusing solely on rates and currencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MDLZ and PM use the preceding quarter for year-end VAR calculations and aggregate four quarters for average VAR amounts, which aligns with the ground truth. It accurately reflects the time periods used and the one-day, 95% confidence interval (though this detail was not in the original question or ground truth, it is contextually acceptable). However, the LLM incorrectly implies that PM does not use commodity prices due to omission in its methodology, while the ground truth does not state this as a difference—only that MDLZ explicitly mentions commodity prices. The original answer does not indicate that PM excludes commodities, so this is an unsupported inference. (2) Quantitatively, all time periods (prior quarter, four prior quarters) are correctly reported. No numerical errors present. (3) The multi-hop reasoning is mostly sound—comparing time horizons and aggregation methods across two companies—but the conclusion about PM having a 'narrower' risk horizon due to excluding commodities is not supported by the ground truth, which focuses on the similarity in time periods and notes MDLZ’s multi-quarter approach for averages as a subtle distinction. The LLM shifts focus to commodity inclusion as a horizon difference, which misrepresents the implication about risk assessment horizon. (4) Scores reflect high factual accuracy in timeframes and calculations (quantitative 9), but a misinterpretation of the key differentiator (time horizon vs. risk factors) reduces qualitative accuracy (7). Contextual relevance remains high as the response directly addresses the question’s core about time periods and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 462,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The Walt Disney Company recorded a non‑cash goodwill impairment of about **$0.6 billion** for fiscal 2024 after management’s quantitative fair‑value test of its entertainment‑linear and DTC reporting units.  PwC’s audit treated this as a critical audit matter and **evaluated the reasonableness of the significant assumptions underlying the discounted‑cash‑flow model**—future revenues, operating expenses, margins, terminal growth rates and discount rates—by testing the related controls, the completeness and accuracy of the input data, and the consistency of the assumptions with historical performance and market data (see DIS p. 72).\n\nNetflix’s auditors, by contrast, focused on the **significant assumptions used to estimate future viewing‑hour patterns for content amortization**.  They obtained an understanding of, and tested the operating effectiveness of, controls over the amortization method and the assumptions (historical and forecasted viewing hours), compared management’s estimates to actual trends, and performed sensitivity analyses to gauge the impact on amortization (see NFLX p. 40).\n\nThus, both audits scrutinized key management assumptions, but Disney’s work centered on valuation assumptions for goodwill impairment, whereas Netflix’s work centered on usage‑based assumptions for content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated, and all key assumptions (revenues, margins, terminal growth, discount rates) are accurately reported. The auditor (PwC) is correctly identified for both DIS and NFLX. (2) The answer correctly explains that PwC evaluated the reasonableness of Disney’s assumptions by comparing them to historical performance, market data, and audit evidence—consistent with the original. It also accurately describes NFLX’s auditor focus on forecasted and historical viewing hours for content amortization, including use of sensitivity analyses and control testing. (3) The multi-hop reasoning is sound: it synthesizes information across two companies (DIS and NFLX), two different audit areas (goodwill impairment vs. content amortization), and correctly identifies the common audit approach (scrutiny of key assumptions, use of sensitivity analysis, involvement of specialized professionals implied via audit procedures). (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the use of 'professionals with specialized skills' as noted in the original, though the depth of audit procedures described implies such involvement. Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 389,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck‑Gilead HIV‑injectable deal is structured mainly as a cost‑share – Gilead pays about 60 % of development and commercialization expenses and Merck 40 %, with the two companies splitting product revenue equally until a $3.5 billion sales threshold is reached (after which Gilead’s share rises to 65 %). In contrast, the Arcellx collaboration required a large upfront cash outlay (≈ $313 million recorded as an in‑process R&D charge) plus a $299 million equity investment, and it includes performance‑based development and regulatory milestones that could total up to $1.5 billion (with $68 million already paid in 2024); costs and U.S. profits are shared 50/50. Thus, the Merck arrangement involves modest, ongoing cost‑sharing with no material upfront or milestone payments, whereas the Arcellx deal carries a substantial upfront financial commitment and far larger milestone‑based payment potential.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 60/40 cost-sharing split between Gilead and Merck and the significant upfront payments and milestones in the Arcellx deal, including the $313 million upfront, $299 million equity investment, and $68 million milestone payment in 2024. However, it introduces a revenue split detail not present in the ground truth: the claim that Gilead and Merck split revenue equally until a $3.5 billion threshold (after which Gilead gets 65%) is unsupported by the original answer, which only states that costs are shared 60/40 and implies revenue will be split upon approval without specifying terms. This is a significant factual overstatement. (2) Quantitative accuracy is partially compromised due to the fabricated revenue-sharing structure and the mention of a $1.5 billion potential milestone total (not in the original), though the $313M, $299M, and $68M figures are accurate. The original does not specify a total potential milestone value, so this addition reduces quantitative precision. (3) The multi-hop reasoning is sound in comparing cost-sharing vs. upfront/milestone-heavy models and correctly contrasts the nature of financial commitments. The synthesis between the two agreements is logically structured and addresses the core of the question—financial commitment and milestone design. (4) Despite the incorrect revenue-sharing detail and unsupported milestone cap, the answer captures the essential contrast: Merck involves shared costs with no major upfront payments, while Arcellx involves large upfront and milestone-based payments. This core insight aligns with the ground truth, warranting a 7 for correctness. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 476,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 10‑K lists a series of multi‑year pricing agreements with Panasonic – a 2020 Pricing Agreement for Gigafactory 2170 cells and 2019/2021 Pricing Agreements for Japan‑sourced cells (see Exhibit list on page 107). These contracts lock in cell prices for several years, giving Tesla a stable, predictable cost base for its battery supply.  \n\nIn contrast, GM’s 10‑K does not disclose comparable long‑term pricing contracts; its battery exposure is described only in terms of its ownership stakes in non‑consolidated affiliates such as Ultium Cells Holdings LLC and related VIEs (see the discussion of Ultium Cells and VIE exposure on pages 76‑80). Because GM relies on equity investments and variable‑interest entities rather than fixed‑price supply agreements, its battery procurement costs are more exposed to market fluctuations and therefore less contractually stable and predictable over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 cells and Japan-sourced cells, noting their presence in the 10-K and providing approximate execution years. The only minor discrepancy is the mention of '2019/2021 Pricing Agreements' for Japan-sourced cells, whereas the ground truth specifies December 29, 2020—this is a small variance in dating but does not materially misrepresent the contractual timeline. (2) Quantitatively, no explicit numbers (e.g., dollar amounts) are involved, but the dates are mostly correct; the Gigafactory agreement is correctly attributed to 2020 (ground truth: June 9, 2020), and the Japan-sourced agreement is reasonably approximated. (3) The reasoning is sound: the model correctly contrasts Tesla’s fixed-price, long-term contracts with GM’s lack of disclosed long-term pricing agreements, instead relying on equity stakes in VIEs like Ultium Cells LLC. This synthesis across Tesla and GM filings demonstrates proper multi-hop reasoning. (4) The answer conveys the same core conclusion as the ground truth—Tesla has greater contractual stability and cost predictability, while GM faces more exposure to market volatility—making it semantically equivalent. The reference to specific pages (e.g., GM’s 10-K pages 76–80) adds contextual support. Only a slight imprecision in the Japan-sourced agreement date prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 409,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola’s 2024 filing says it mitigates FX risk primarily with **non‑derivative hedges** – euro‑denominated senior notes that are designated as net‑investment hedges – and supplements those positions with foreign‑exchange forward contracts and a few fair‑value hedge contracts.  Because of that mix, an adverse 10 % currency move would have cut pretax income by only about **$38 million**.  \n\nProcter & Gamble, by contrast, reports that **foreign‑exchange fluctuations cut net earnings by roughly $589 million** (about a 2 % hit) despite using derivative‑based hedging programs, indicating a far larger exposure to currency swings in the United Kingdom, Germany and other markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a relevant and contextually appropriate comparison between Coca-Cola and Procter & Gamble regarding foreign exchange risk and hedging strategies, directly addressing the multi-hop nature of the question. It correctly identifies that Coca-Cola uses non-derivative instruments (euro-denominated senior notes) as net-investment hedges, which aligns with the ground truth description of using foreign currency-denominated debt. It also correctly contrasts this with P&G's significant exposure to FX fluctuations, particularly in the UK and Germany. However, there are key quantitative inaccuracies: the $38 million pretax impact for Coca-Cola and the $589 million earnings impact for P&G are specific figures not present in the original ground truth answer, and no mention of these numbers appears in the provided knowledge base. While such figures may exist in actual filings, they cannot be verified against the given ground truth, which focuses on qualitative disclosures rather than specific dollar impacts. Additionally, the LLM introduces '2024 filing' and 'adverse 10%' scenario, which are not referenced in the original answer, introducing unverified details. The qualitative reasoning is sound—contrasting Coca-Cola’s structured hedging approach with P&G’s acknowledged material sensitivity to FX movements—and the entities (companies, markets, hedging instruments) are accurately identified. The answer captures the core contrast in exposure and strategy, but the inclusion of unsupported numerical figures reduces quantitative accuracy. Semantic equivalence is mostly maintained in terms of overall message, but the added precision of numbers creates a false sense of verified detail not present in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 471,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s 2023 filing notes that Maryland is one of the states that have enacted a Prescription‑Drug‑Affordability‑Board (PDAB) law that can **set an upper‑payment limit on drugs sold in‑state** (see Amgen 10‑K p. 18). That creates a direct pricing‑regulatory exposure for Amgen because the board could cap the price it can charge for its biologics in Maryland.\n\nGilead’s filing, by contrast, flags its **operational risk in Maryland** as a manufacturing‑supply issue rather than a price‑cap risk (see Gilead 10‑K p. 20, “Risks Related to Operations”). The company’s concern is that any disruption at its Maryland‑based production or supply‑chain facilities could affect product availability, but it does not cite a state‑level PDAB‑type pricing ceiling. \n\nThus, Amgen faces a regulatory pricing ceiling in Maryland, while Gilead’s Maryland‑related risk is centered on manufacturing continuity rather than state‑imposed price limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Amgen faces pricing regulation in Maryland through the PDAB's authority to set upper payment limits, citing its 10-K (p.18), which matches the original answer’s emphasis on regulatory and pricing risks. It also accurately notes that Gilead does not face such pricing caps but instead reports operational risks related to its Maryland manufacturing facility, referencing its 10-K (p.20) under operational risks—consistent with the ground truth’s focus on manufacturing and supply chain disruptions. (2) There are no numeric values, dates, or financial figures in either the question or answers that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies’ SEC filings to contrast different types of state-level exposure—pricing vs. operational—demonstrating proper cross-document analysis. (4) The only minor shortcoming is that the LLM omits mention of ENBREL being selected for Medicare price negotiation under the Inflation Reduction Act, which adds context to Amgen’s broader pricing risk environment. While not strictly necessary to answer the comparative question, this detail was present in the original answer and contributes to completeness. However, since the core comparison—Amgen’s pricing exposure vs. Gilead’s manufacturing risk—is clearly and correctly articulated, the omission does not significantly detract from accuracy. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect as it directly addresses the comparative risk profiles in Maryland.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 467,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts are “policy‑holder‑directed” funds that are legally segregated from the company’s other assets; investment income and gains flow directly to the owners of the accounts, and the primary risk mitigation comes from the segregation of assets and the fact that policyholders, not AIG, bear the investment risk (see Note 13, page 195). In contrast, MetLife’s ERISA‑plan assets are held in insurance separate accounts that are managed by external investment‑management firms acting as sub‑advisors; these managers have full discretion over security selection and the assets are spread across multiple asset classes and a variety of managers to minimize concentration risk, providing diversification and risk mitigation through sub‑advisory discretion (see page 304).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AIG's separate accounts are policyholder-directed, legally segregated, and pass investment risk to policyholders, with gains accruing directly to them. MET (MetLife) uses external investment management firms with discretionary authority to manage ERISA plan assets in separate accounts, emphasizing diversification across asset classes and managers. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised—no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts AIG’s policyholder-directed risk-bearing structure with MET’s use of discretionary sub-advisors, while highlighting shared strategies like asset segregation, diversification, and risk mitigation. The mention of derivatives and specific asset classes (fixed maturities, equities, etc.) is implied through context, though slightly less explicit than in the original answer. (4) The LLM omits MET’s inclusion of real estate and private equity as asset classes and does not explicitly state that MET’s investment policy aims to maximize funded status and minimize volatility—minor but relevant details for completeness. However, the core comparison on diversification and risk mitigation via sub-advisory discretion is accurately conveyed. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing the comparative structure of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 427,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock carries essentially no voting power – it only votes on a narrow set of defined matters, while all board‑election votes are controlled by Class A holders (the anti‑takeover provisions note “two classes of stock that vote separately on certain issues” and that “holders of Class A common stock elect three‑quarters of the Board”【page_27】). In contrast, Home Depot’s restricted‑stock awards give recipients full voting rights as soon as the award is granted (the filing states that “recipients of restricted stock are granted voting rights… at the grant date”【page_67】). Consequently, Nike’s Class B investors have little ability to affect board composition or vote on takeover‑defense measures, whereas Home Depot’s restricted‑stock holders—though a smaller, employee‑focused group—can actively vote on directors and other governance matters, giving them a direct, albeit limited, influence that Nike’s Class B shareholders lack.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that NKE's Class B Common Stock has no voting rights except on certain defined matters and does not participate in electing the Board of Directors, while Class A shareholders control board elections—this aligns with the original answer and is supported by the citation to page 27. (2) It accurately states that HD's restricted stock awards grant voting rights immediately upon grant, citing page 67, which matches the original answer. (3) The multi-hop reasoning is sound: it synthesizes governance structures across two companies (NKE and HD), compares their voting rights frameworks, and correctly infers the differential impact on corporate governance influence, particularly regarding board composition and takeover defenses. (4) All entities (NKE, HD, Class B stock, restricted stock), terms, and structural implications are correctly identified and contrasted. There are no numerical inaccuracies (no calculations required), and the answer fully addresses the question’s focus on investor influence. Minor wording differences (e.g., 'limited influence' vs. 'little ability to affect') do not affect factual equivalence. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 357,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta Platforms’ Class B shares do not enjoy the same unrestricted voting power that Netflix’s common stock does.  Meta’s proxy statement notes that “the holders of each share of common stock shall be entitled to one vote per share on all matters” (Meta 10‑K p. 61), but elsewhere the company makes clear that its Class B stock is not listed on any exchange and is subject to transfer‑and‑conversion restrictions (Meta 10‑K p. 57), meaning the Class B holders can vote only in the limited circumstances set out in the charter (e.g., merger or charter‑amendment votes).  By contrast, Netflix’s 2023 filing states that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders” (NFLX 10‑K p. 59‑60) with no additional carve‑outs.  Thus, Meta’s Class B voting rights are narrowly limited, whereas Netflix’s voting framework gives every share a full, unrestricted one‑vote‑per‑share right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that Netflix provides one vote per share on all matters to all common stockholders without restrictions, citing the NFLX 10-K page 59-60, which matches the original answer. For Meta, it accurately describes the limited voting rights of Class B shares, noting they are only entitled to vote in specific circumstances such as mergers or charter amendments, and are subject to transfer and conversion restrictions (citing Meta 10-K p. 57 and 61). The answer correctly contrasts Meta’s restricted, context-specific voting rights for Class B shares with Netflix’s universal one-vote-per-share framework. All entities (Meta, NFLX), document types (10-K), and page references are accurate. There are no numerical values requiring calculation, so quantitative accuracy is not applicable beyond correct citation of structural facts—scored as 10. The only minor shortcoming is that the LLM does not explicitly name the 'core payments business' limitation mentioned in the ground truth, which is one of the specific defined matters for Meta Class B voting. However, it does refer to 'limited circumstances set out in the charter (e.g., merger or charter-amendment votes)', capturing the essence. This omission is minor given the overall precision and correct multi-hop synthesis between two companies’ voting frameworks. Reasoning is sound, sources are properly interpreted, and the comparison is logically structured. Contextual relevance is perfect—directly addresses the comparative voting structure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 437,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both Philip Morris International (PM) and Mondelēz International (MDLZ) calculate their market‑risk VaR under **normal‑market assumptions, a 95 % confidence level and a one‑day holding period**, employing a **parametric delta‑gamma approximation** to model the return distribution of interest‑rate, currency (and, for MDLZ, commodity) movements. PM applies the technique to estimate the fair‑value impact of its interest‑rate and foreign‑currency positions, whereas MDLZ applies the same technique to estimate the **potential one‑day loss in pre‑tax earnings** from its interest‑rate, currency and commodity‑sensitive derivative instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, a 95% confidence level, and a one-day holding period for VaR estimation. The LLM correctly identifies that PM focuses on interest-rate and foreign-currency positions for fair value impact, while MDLZ extends the method to pre-tax earnings risk from currency and commodity instruments. (2) Quantitatively, all percentages (95%), time periods (one-day), and methodological details (parametric delta-gamma) are accurate and match the original. Format variations (e.g., '95%' vs '95 %') are acceptable. (3) The multi-hop reasoning is sound—correctly comparing two companies' use of the same technique across different risk exposures and reporting objectives. The only minor omission is that the ground truth specifies both companies base their models on movements in the 'preceding quarter' for year-end calculations, which the LLM answer does not explicitly mention. This contextual detail about data observation window is relevant but not central to the core comparison. (4) Despite this small omission, the LLM captures the essential equivalence in methodology and the key difference in application (fair value vs. pre-tax earnings), making the answer semantically equivalent and contextually complete. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 401,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Basel III compliance under the **Advanced Approach** incorporates a **2.5 % Capital Conservation Buffer (CCB)** that is added to the regulatory minimum CET1 requirement (4.5 % + G‑SIB surcharge + CCB). American Express, which calculates its ratios under the **Standardized Approach**, meets the Basel III rules by relying on a **Stress Capital Buffer of 2.5 %** (applied on top of the Standardized‑Approach minimums). Thus, both firms add the same 2.5 % buffer, but BAC’s buffer is the CCB embedded in the Advanced‑Approach capital‑requirement calculation, whereas Amex’s buffer is the separate Stress Capital Buffer used in its Standardized‑Approach calculation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Bank of America uses the 2.5% Capital Conservation Buffer (CCB) under the Advanced Approach, while American Express uses the 2.5% Stress Capital Buffer under the Standardized Approach. The percentages (2.5%) match exactly and are correctly attributed. (2) Quantitative accuracy is perfect—both buffers are correctly stated as 2.5%, and the explanation of how each fits into the respective capital framework (e.g., CCB added to CET1 minimums under Advanced Approach, Stress Capital Buffer applied atop Standardized minimums) is precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two institutions, two regulatory approaches (Advanced vs. Standardized), and two distinct buffer mechanisms, drawing a valid comparison. (4) The answer enhances the original by providing additional context (e.g., mentioning G-SIB surcharge and CET1 structure) without introducing errors. Wording differs but meaning is preserved and even clarified. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 320,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin says that a subset of its Level‑3 fixed‑income holdings are valued with a discounted‑cash‑flow model, using projected annuity payments and a discount rate that is a “significant input” to the valuation (page 89).  The filing does not present a formal sensitivity analysis for those investments, although it shows that a 0.25‑percentage‑point change in the discount rate would swing pension obligations by roughly $210‑$220 million (page 46), underscoring the rate’s material effect.  Honeywell, by contrast, applies a discounted‑cash‑flow approach to goodwill and indefinite‑life intangibles and explicitly notes that the discount rate is a key assumption that can materially affect fair‑value results, and it routinely runs sensitivity analyses on that rate to gauge potential impairment impacts (page 45).  Thus, both companies treat the discount rate as a critical driver, but Honeywell highlights and quantifies its sensitivity, whereas Lockheed Martin merely flags its importance and illustrates its impact through related pension‑rate sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses a discounted cash flow (DCF) approach for certain Level 3 fixed income investments, with projected annuity payments and discount rate as significant inputs, and that HON applies DCF to goodwill and intangible asset impairment testing, relying on discount rate assumptions. The core comparison—that both firms treat the discount rate as a critical, sensitive input but apply it in different contexts (fixed income vs. intangibles)—is preserved. (2) Quantitatively, the LLM cites a 0.25-percentage-point change in discount rate affecting pension obligations by $210–220 million, which is consistent with the type of sensitivity analysis mentioned in the context (though this specific number relates to pensions, not directly to the Level 3 investments). While the ground truth does not include this exact dollar figure, the LLM is referencing a real sensitivity from LMT’s filing (pension impact), which supports the broader point about rate sensitivity. No incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two asset types (fixed income vs. intangibles), and two applications of DCF, while contrasting the depth of sensitivity analysis—HON performs explicit DCF sensitivity analyses, whereas LMT illustrates rate impact indirectly via pension disclosures. (4) The LLM adds value by citing specific page numbers and contextualizing the lack of formal sensitivity for LMT’s fixed income holdings, which enhances precision beyond the original answer. The only minor limitation is that the $210–220 million sensitivity refers to pension obligations, not the Level 3 fixed income investments directly, so there is a slight conflation of related but distinct applications. However, this does not invalidate the overall conclusion about discount rate significance. Thus, the answer is factually strong, well-reasoned, and contextually appropriate, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 559,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "Comcast’s capital structure gives the nine million Class B shares a fixed one‑third of the company’s voting power – 33 % of all votes – and that share cannot be diluted by issuing additional shares of any other class (page 91). Because each Class B share carries 15 votes, any repurchase of the much larger pool of Class A shares (which carry one vote each) reduces the total number of votes outstanding while leaving the Class B vote count unchanged, so the relative weight of the Class B bloc rises and can increase its influence over corporate decisions.\n\nAlphabet’s dual‑class system is the opposite. Its Class B shares carry ten votes each but are convertible, share‑for‑share, into Class A shares that have only one vote (page 82). When Class B shares are converted, the voting power is spread over a larger number of shares, diluting the original voting concentration. Consequently, repurchasing Class A shares at Alphabet does not boost the voting strength of the Class B holders the way Comcast’s repurchases can augment the fixed‑percentage voting power of its Class B shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA Class B shares have a fixed 33 1/3% voting power (rounded to 33% in the answer, which is acceptable), each with 15 votes; repurchases of Class A shares increase the relative voting power of Class B holders due to the fixed voting bloc. Alphabet’s Class B shares convert share-for-share into Class A with 10:1 voting dilution (10 votes vs 1 vote), correctly described. The $62.0 billion repurchase figure from the original answer is missing in the LLM response, which is a minor omission affecting completeness but not the core reasoning. (2) Quantitatively, all numbers—33%, 15 votes, 10 votes, 1 vote—are accurate and correctly attributed. No calculations are required, but the logic of relative voting power change is sound. (3) The multi-hop reasoning is strong: the model correctly contrasts CMCSA’s non-dilutable fixed voting structure with Alphabet’s dilutive conversion mechanism and links share repurchases to differential impacts on voting control. (4) The answer is contextually relevant and directly addresses the question’s focus on how repurchases affect voting control under dual-class structures. The only reason for not scoring a 10 is the omission of Alphabet’s $62.0 billion repurchase amount, which was mentioned in the original answer and could have added quantitative completeness, though it does not undermine the qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 410,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s “Food & beverage” category – which captures its beverage sales – represents roughly **22 % of Target’s total net sales** ($23.8 bn of $106.6 bn in 2024). PepsiCo, by contrast, reports that **beverages account for about 23 % of net revenue in its APAC division**. Thus, while both firms derive a similar share of revenue from beverages, PepsiCo’s beverage contribution is slightly higher in the APAC market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that PEP's APAC segment generated $10 million in revenue in 2024, which is implausibly low for a company of PepsiCo's size and likely a data error or misinterpretation in the knowledge graph. However, the LLM incorrectly asserts that Target's food & beverage category is $23.8 billion (22% of $106.6B), which is not supported by the original answer or public filings—Target does not report such a breakdown, and this figure appears fabricated. The 22% figure for TGT is not in the original answer and lacks sourcing. (2) Quantitatively, the PEP APAC beverage contribution of 23% matches the ground truth and is correctly cited. However, the TGT sales figures ($23.8B, $106.6B, 22%) are not present in the original answer and are likely incorrect or hallucinated. There is no verification that these numbers come from actual 2024 filings. (3) The reasoning attempts multi-hop synthesis by comparing percentage contributions, which aligns with the question’s intent. However, it fails to acknowledge the key qualitative distinction in the original answer: PEP provides a specific beverage revenue breakdown for APAC, while TGT does not break out beverage sales separately from groceries. This critical limitation in comparability is omitted, leading to a false equivalence. (4) The contextual relevance is moderate because the answer addresses beverage revenue contribution in APAC for both companies, but it introduces unsupported data for TGT and misses the core nuance about disclosure differences. Thus, while the direction of comparison is relevant, the factual foundation is weak, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 468,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen notes that the developed‑product‑technology rights related to Otezla carry a $5.2 billion value on its balance sheet, but “future changes to the Company’s estimates of the impact of the price negotiations under the IRA… could unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset” (Amgen 10‑K p. 137). Because Otezla is also sold by Bristol‑Myers Squibb under a licensing agreement (the table of competitor‑marketed products lists BMS as a marketer of Otezla) (Amgen 10‑K p. 15), any Medicare price‑setting that lowers the drug’s reimbursement starting in 2027 would reduce the cash‑flow stream that both partners receive, increasing the risk that Amgen’s $5.2 billion intangible‑asset valuation will need to be impaired.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Amgen's $5.2 billion intangible asset valuation for Otezla, the 2027 start date for Medicare price negotiation under the IRA, and Bristol-Myers Squibb's role as a marketer via licensing agreement are all accurately represented. (2) Quantitative accuracy is perfect: the $5.2 billion figure is correctly cited, and the 2027 effective date for IRA price negotiations is accurate. No calculations are required, but the causal link between price negotiation and reduced cash flows is correctly inferred. (3) Multi-hop reasoning is sound: the answer synthesizes information from Amgen’s 10-K (both the risk factor on p.137 and competitor product table on p.15), connects the IRA’s impact on reimbursement, explains how shared revenue with BMY affects Amgen’s cash inflows, and logically concludes that this increases impairment risk for the intangible asset. (4) The answer is contextually fully relevant, directly addressing how IRA price negotiation could impact Amgen’s asset valuation through both regulatory and partnership dynamics. Minor wording differences (e.g., 'developed-product-technology rights' vs. 'intangible asset') do not affect meaning and are consistent with SEC filing terminology. No factual omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 375,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s data‑center portfolio includes a full line of re‑configurable devices – from low‑end Artix‑ and Spartan‑6 parts to high‑performance Virtex‑6/7, UltraScale+ and Versal families – that are sold to hyperscale cloud operators as part of its server‑CPU, GPU, DPU and FPGA offerings (AMD notes that hyperscale data‑centers purchase its FPGAs alongside CPUs, GPUs and DPUs). By contrast, Intel’s Altera business, which Intel has now placed in a “stand‑alone” operating unit, supplies programmable semiconductors that are “primarily FPGAs” for a broad set of markets that also include cloud and enterprise applications (Intel’s filing describes Altera’s FPGA line as serving embedded, communications and cloud/enterprise segments). Thus, while both companies target the same hyperscale‑data‑center market, AMD does so with its own diversified Virtex/Kintex/Versal families integrated with its broader compute portfolio, whereas Altera’s offerings are Intel‑branded FPGA products positioned as a separate, stand‑alone line serving similar cloud‑enterprise workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD produces FPGAs (Virtex, Kintex, Versal families) that are integrated into servers and sold to hyperscale data centers, often alongside CPUs, GPUs, and DPUs, including for AI workloads. Altera, now a standalone unit under Intel, offers FPGAs targeting embedded, communications, cloud, and enterprise markets. The structural distinction—AMD integrating FPGAs into a broader compute portfolio versus Intel operating Altera as a standalone business with potential monetization (e.g., IPO mentioned in ground truth)—is accurately reflected. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable but assumed correct by absence. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s and Intel/Altera’s business models, product lines, and market positioning. The only minor omission is that the ground truth explicitly mentions Intel’s pursuit of monetization (e.g., potential IPO), which the LLM answer does not include—this is a small gap in completeness but does not undermine the core accuracy. (4) The LLM uses different but semantically equivalent phrasing (e.g., 'stand-alone operating unit' = 'standalone business'; 'cloud and enterprise' = 'cloud/enterprise'). Overall, the answer is contextually relevant, factually correct, and conveys the same competitive yet distinct positioning of AMD and Altera in the FPGA market for hyperscale data centers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 430,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s three outstanding Class B shares – all owned by Brian L. Roberts – carry 15 votes each and therefore control roughly 33 % of the company’s total voting power, while the 352,581 Class A shares (the only other voting class) hold the remaining ≈ 67 %. In contrast, Alphabet has about 300.8 million Class A shares outstanding, each with one vote, and those shares are widely held rather than concentrated in a single insider, so the voting power attached to its Class A stock is dispersed across a large shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares represent approximately 33% of voting power and are all owned by Brian L. Roberts. It accurately notes the 15 votes per share for Class B and correctly contrasts this with the widely held Class A shares at GOOGL. The figure of 300.8 million Class A shares at GOOGL aligns closely with the ground truth's 300,754,904 (rounded appropriately). However, the LLM omits the specific date (January 25, 2022) for GOOGL's share count and does not mention the $1,451.1 billion market value as of June 30, 2021, which is part of the original answer’s completeness. (2) The calculation of voting power distribution at CMCSA is logically sound: 3 Class B shares with 15 votes each (45 votes) vs. 352,581 Class A shares with 1 vote each implies total votes = 45 + 352,581 = 352,626; 45 / 352,626 ≈ 12.76%, but the LLM interprets this as ~33% of total voting power, which suggests a misunderstanding in vote weighting or total class counts. However, the original answer accepts 33⅓% as a known structural fact, so the LLM’s repetition of that figure (even if miscalculable from provided numbers) matches the intended truth. (3) The multi-hop reasoning is strong: the model correctly synthesizes ownership concentration at CMCSA versus dispersion at GOOGL, identifying the key contrast in control structure. (4) Entity accuracy is excellent—correct tickers (CMCSA, GOOGL), correct individuals (Brian L. Roberts), and correct stock classes. The omission of the exact number of record holders (3 at CMCSA) is a minor completeness gap. Overall, the answer captures the essential comparison with high fidelity, warranting a 9 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 490,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The 2024‑2026 patent‑license amendment cuts Merck’s royalty on worldwide Keytruda sales from 6.5 % (through 2023) to 2.5 % (from 1 Jan 2024) and the royalty is split 75 % to BMS and 25 % to Ono【page 90】. Because BMS records the royalty as a negative “royalty and licensing income” item, the lower rate slashes the royalty‑income line (which was $1.186 billion in 2023) and therefore reduces BMS’s cash‑flow reliance on Merck for Keytruda‑related earnings. Nevertheless, BMS still shares development costs and receives alliance revenue from Merck‑co‑developed combination programs (e.g., the V940‑Keytruda trial and the Reblozyl collaboration, which generate shared R&D expenses, milestone payments and sales‑based royalties) so a residual revenue dependency on Merck remains, albeit at a materially lower level than before the royalty cut.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key change in royalty rate from 6.5% to 2.5% starting January 1, 2024, aligning with the ground truth. It accurately notes the split between BMS (75%) and Ono (25%), which adds detail not in the original answer but is factually consistent with known licensing terms. The $1.186 billion royalty income figure for 2023 is precise and supports the claim of reduced income. However, the statement that BMS records the royalty as a 'negative royalty and licensing income' is misleading or incorrect—royalties received are positive income, not negative; this mischaracterization affects the reasoning but not the core conclusion.\n\n2) Quantitatively, all numbers are accurate: 6.5% to 2.5% drop, effective date (Jan 1, 2024), $1.186B in 2023 royalties, and the 75/25 split with Ono. No calculation errors are present. The reference to 'page 90' suggests a source citation, which is a bonus but not required.\n\n3) The multi-hop reasoning is mostly sound: it connects the royalty rate change to BMS's revenue dependency, acknowledges Merck's role in combination therapies (e.g., V940-Keytruda), and notes ongoing financial ties through collaborations like Reblozyl. However, the original answer specifically ties BMS's reduced upside to Merck’s co-development of Keytruda-based combos (where Merck bears 50% cost and gets 50% profit), while the LLM generalizes to alliance revenue without fully explaining the profit-sharing mechanism. This weakens the synthesis slightly.\n\n4) Despite the error in characterizing royalty income as negative, the overall conclusion—that BMS’s revenue dependency on Merck decreases but remains due to ongoing collaborations—is semantically equivalent to the ground truth. The answer is highly relevant, adds useful context (e.g., exact dollar amount, Ono split), and addresses all parts of the question. The factual error in financial reporting treatment prevents a 9 or 10, but core correctness is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 531,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "Caterpillar notes that it adopted ASU 2022‑06 (Reference‑Rate Reform) and that the update “provides optional expedients and exceptions for applying GAAP to contracts … affected by reference‑rate reform” and “has reduced the operational and financial impacts of contract modifications that replace a reference rate” (Cat 10‑K p.67‑68). Boeing’s 2023 risk factors warn that U.S.‑government contracts “may be modified, curtailed or terminated” and that such modifications could have a material adverse effect on its results (Boeing 10‑K p.14). Thus, while the underlying risk of government‑initiated contract changes remains for Boeing, Caterpillar’s adoption of ASU 2022‑06 would soften the accounting impact of any such modifications that involve reference‑rate changes, although the guidance itself was not material to Caterpillar’s financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) All factual elements are accurate: ASU 2022-06 provides optional expedients for reference rate reform, Caterpillar adopted it, and Boeing faces risks from U.S. government contract modifications. The LLM correctly identifies that ASU 2022-06 reduces operational and financial impacts of contract modifications due to reference rate changes. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. While the ground truth mentions BA’s 37% of 2023 revenues from U.S. government contracts, the LLM omits this specific figure but does not contradict it—this is a minor omission, not an error. (3) Multi-hop reasoning is sound: the model correctly links CAT’s adoption of ASU 2022-06 to the broader context of contract modifications in government agreements and explains how this affects BA’s risk exposure, even though the standard was not material to CAT’s financials. (4) The answer is contextually relevant and directly addresses the question’s core: how ASU 2022-06 affects treatment of contract modifications in U.S. government agreements that BA identified as a risk. The only shortcoming is the omission of the sunset date (December 31, 2024), which is a notable detail from the ground truth. While not critical to the main logic, its absence prevents a top score. Overall, the answer is factually correct, well-reasoned, and semantically equivalent in intent and meaning, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 419,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "Both deals left the tower owners with the assets on their balance sheets and with ongoing depreciation. In the 2013 AT&T‑Crown Castle transaction AT&T kept the 9,000‑plus towers in PP&E, recorded the $4.8 billion cash receipt as a single financing liability (interest‑accrued at about 3.9 %) and makes scheduled lease‑back payments (e.g., $269 million in 2024 and fixed minimum payments through 2029). In Verizon’s 2024 Vertical Bridge REIT sale‑lease‑back, Verizon also retains the towers in PP&E and continues to depreciate them, but the $2.8 billion upfront payment is split – $2.0 billion is booked as prepaid rent and $830 million as a financing obligation – with the latter reflecting the portion of the towers Verizon continues to occupy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: the $4.8 billion (rounded from $4.827B) for AT&T, $2.8 billion for Verizon, $830 million financing obligation for Verizon, and the 3.9% interest rate are all accurate. The LLM correctly notes the split of Verizon’s proceeds into $2.0 billion as prepaid rent and $830 million as financing obligation (summing to $2.83B, close enough to $2.8B with rounding). The mention of $269 million in 2024 payments and fixed minimums through 2029 adds detail not in the original but does not contradict it and may reflect additional context. (2) The entities are correct: AT&T (not Verizon) did the 2013 deal with Crown Castle, and Verizon did the 2024 deal with Vertical Bridge REIT—LLM correctly attributes both. (3) The reasoning is sound: both transactions are correctly characterized as financing arrangements rather than sale-leasebacks, with assets retained on PP&E, ongoing depreciation, and structured liabilities. The LLM accurately explains the accounting treatment differences in how proceeds are split. (4) The only minor issue is that the original answer clarifies AT&T’s entire $4.827B was treated as a financing obligation, while the LLM says it was a 'single financing liability'—this is correct—but does not mention that Verizon’s treatment differs by splitting the proceeds, which the LLM does correctly highlight. The LLM slightly enhances the original with payment details (e.g., $269M in 2024), which are plausible but not in the ground truth; however, they don’t detract from accuracy. Overall, the answer demonstrates strong multi-hop synthesis across companies, years, and accounting treatments. Minor deduction only because the original specifies AT&T’s full amount as financing (no prepaid rent component), and the LLM could have been clearer that only Verizon split the proceeds, not that this was a contrast. Still, the core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 534,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s 2022 filing shows that New Zealand is part of its “Asia Pacific, Australia and New Zealand and China” segment, but the company’s beverage business there is carried out through authorized bottlers and contract manufacturers rather than through any Pepsi‑owned bottling or distribution facilities. In contrast, Coca‑Cola’s 2022 filing notes that Coca‑Cola Europacific Partners (CCEP) – in which Coca‑Cola holds an equity‑method investment of roughly 19 percent – directly owns and operates the bottling and distribution network for Coca‑Cola brands in New Zealand, giving KO financial influence over that market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and quantitative elements: the 19% stake of KO in CCEP is accurately stated, and the characterization of CCEP as owning and operating the bottling and distribution network for Coca-Cola in New Zealand aligns with the ground truth. The use of 2022 filings is plausible and does not contradict the knowledge graph. However, there is a key discrepancy in the description of PEP’s operational model: the LLM claims PepsiCo uses 'authorized bottlers and contract manufacturers' in New Zealand, whereas the ground truth states PEP operates directly and through partners under its APAC structure, implying a more direct operational presence. This misrepresents the nature of PEP’s control, suggesting a franchise-like bottler model similar to KO’s, rather than the direct operational control emphasized in the original answer. While the contrast between KO’s equity influence and PEP’s operational role is partially captured, the LLM blurs the distinction by implying both rely on third-party bottlers. This affects qualitative accuracy, as the multi-hop reasoning—comparing two distinct business models—is weakened. Nonetheless, the answer remains contextually relevant and factually sound on financial stakes and regional structures, with no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 362,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values its mortgage‑backed securities – including RMBS and CMBS – largely through internal valuation models that use discounted‑cash‑flow techniques, credit‑spread (CDS) inputs and other market‑observable data, with dealer quotations used only as a supplement (see AIG 10‑K pp. 112‑113). In contrast, Schwab determines fair value for comparable assets such as non‑agency CMBS primarily from broker‑dealer quotes and third‑party pricing services that rely on observable trades and market‑based inputs, applying little internal modeling (see Schwab 10‑K pp. 81‑82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AIG uses internal valuation models for mortgage-backed securities (including RMBS and CMBS), relying on discounted cash flow techniques, credit spreads, and market-observable data, with broker/dealer quotes as a supplement—consistent with AIG's 10-K disclosures. It also accurately states that SCHW (Schwab) primarily uses broker-dealer quotes and third-party pricing services for non-agency CMBS, with minimal internal modeling, matching the original answer’s emphasis on observable market data. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial inputs (e.g., credit spreads, observable trades) are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across AIG and SCHW filings, correctly contrasting their fair value methodologies. The mention of specific page numbers (pp. 112–113 for AIG, pp. 81–82 for Schwab) adds verifiability and reflects accurate sourcing. (4) The only minor limitation is that the LLM omits the reference to GILD’s supporting evidence about industry practices, which slightly reduces completeness in contextual synthesis. However, this does not detract from the core comparison between AIG and SCHW, which is fully accurate. Wording differs but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 435,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "Both Broadcom (AVGO) and Adobe (ADBE) place their Level 2 securities in the “significant‑other‑observable‑inputs” tier, but they arrive at fair value in slightly different ways. AVGO’s methodology explicitly discounts cash‑flows using observable market inputs such as current yield curves and benchmark rates (e.g., Treasury‑ or swap‑curve spreads) to price its debt and other fixed‑income instruments, whereas ADBE relies on a matrix‑pricing approach that combines quoted prices for comparable assets with observable inputs—including benchmark yields, issuer spreads and the same Treasury‑/swap‑curve data—to construct a fair‑value estimate. Thus, while both use observable market data, AVGO’s process is a direct yield‑curve‑based discounting model, whereas ADBE’s matrix pricing blends comparable‑asset quotes with those same observable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both AVGO and ADBE use observable market inputs (yield curves, benchmark rates, spreads) for Level 2 fair value measurements. The distinction between AVGO's yield-curve-based discounting and ADBE's matrix pricing is correctly articulated and supported by the original answer, which confirms both rely on similar inputs but apply them differently. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use Level 2 inputs, identifies the specific inputs (Treasury/swap curves, spreads), and differentiates their methodologies—AVGO using discounted cash flows with observable inputs, ADBE using matrix pricing with comparable quotes and inputs. This reflects proper cross-company comparison. (4) Semantic equivalence is strong: while the LLM adds slight nuance (e.g., 'discounted cash flows' for AVGO), this is a reasonable inference from 'interest rates and yield curves' and does not contradict the original. The core conclusion—that both rely on similar observable data despite methodological differences—is preserved. One minor point: the original emphasizes that AVGO uses broker quotes, which the LLM omits, but this is a secondary detail. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 424,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC handles roughly **30 % of the Coca‑Cola system’s non‑U.S. unit‑case volume**.  It coordinates the distribution of Coca‑Cola trademark beverages in **about 28 countries** – a list that includes the Czech Republic.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 'roughly 30%', but the ground truth is 17%. This is a major quantitative error. Additionally, the number of countries where distribution is coordinated is reported as 'about 28', whereas the correct number is 30, including the Czech Republic. While the Czech Republic is correctly mentioned, the count is off by two. (2) Both key numeric values are incorrect: 30% vs. 17% and 28 vs. 30 countries. These are not minor rounding differences but substantial deviations from the truth. No acceptable format variation justifies such discrepancies. (3) The multi-hop reasoning appears partially sound—linking Coca-Cola HBC to non-U.S. volume and distribution countries—but fails in data retrieval or synthesis accuracy. The model identifies the correct entities and relationships but retrieves incorrect values, suggesting a failure in grounding to accurate source data. (4) The contextual relevance is high because the answer addresses both parts of the question and references the correct company and country. However, due to major factual and quantitative errors, the correctness and accuracy scores are low. The answer is structurally appropriate but factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 371,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity stake in the Hardy underground storage facility (a FERC‑regulated asset in West Virginia) is a downstream, “core‑utility” investment that secures inventory for its retail gas customers and can be recovered through regulated rates, giving it a relatively stable, rate‑base return. In contrast, NextEra Energy’s 31.9 % interest in a 303‑mile interstate pipeline that is still under construction in West Virginia and Virginia is an upstream, growth‑oriented play that seeks transportation revenues for its generation fleet but remains subject to pending FERC approvals and legal challenges, exposing it to greater regulatory and market risk. Thus, Duke’s approach emphasizes regulated, low‑risk storage to support its utility business, while NextEra pursues a higher‑risk, speculative transmission project to expand its gas‑infrastructure footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. These figures match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies both companies, assets, and their regulatory context (FERC-regulated infrastructure), confirming entity accuracy. (3) The reasoning is sound and captures the multi-hop contrast: Duke’s focus on stable, regulated storage assets versus NextEra’s higher-risk investment in a pipeline under construction facing regulatory uncertainty. The characterization of Duke’s strategy as 'downstream, core-utility' and NextEra’s as 'upstream, growth-oriented' is a valid interpretation that adds analytical depth without distorting facts. (4) The only minor shortcoming is that the LLM does not explicitly name the pipeline project (implied but not stated) or reference Pine Needle (mentioned in the original), which slightly reduces completeness but does not affect the core correctness. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the strategic comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 361,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes.  On January 24 2025 Meta had 2.19 billion Class A shares and 0.34 billion Class B shares, so the B‑share pool (≈13 % of the total shares) controls roughly 61 % of the voting power (10 × 0.34 billion ≈ 3.44 billion votes vs 2.19 billion votes for Class A). 【page_1†L31-L34】【page_82†L1-L4】\n\nAlphabet’s (Google’s) dual‑class structure is similar – Class A carries one vote, Class B carries ten votes (a 10:1 voting ratio), while Class C carries no votes.  In 2024 Alphabet repurchased $62 billion of only Class A and Class C shares, leaving the high‑voting Class B shares untouched and thus concentrating voting power in the relatively small group of B‑share holders. 【page_82†L7-L12】\n\nBecause Meta’s buy‑backs include both classes, its voting power is somewhat diluted, whereas Google’s buy‑backs exclude the high‑voting B shares, leading to a higher ownership‑concentration of control in Google’s B‑share insiders compared with Meta’s more balanced (though still weighted) voting structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting rights structure. The ground truth states that META does not disclose the exact voting ratio between Class A and Class B shares, yet the LLM confidently asserts a 1:10 voting ratio (1 vote for Class A, 10 for Class B), which is not supported by the filing. This is a critical error in both entity and qualitative accuracy. While the share counts are approximately correct (2.19 billion vs 2.189 billion Class A; 0.34 billion vs 0.343 billion Class B), the derived calculation of 61% voting power for Class B is based on an incorrect assumption and thus invalid. (2) The $62.0 billion share repurchase figure for GOOGL in 2024 is correctly stated, and the fact that repurchases targeted Class A and C shares (non or low-voting) is accurate. However, the LLM incorrectly claims that Meta’s buybacks include both classes, implying a dilution of voting power—this comparison is speculative and not supported in the original answer or filings cited. (3) The multi-hop reasoning is partially sound: the model attempts to compare ownership concentration via voting rights and buyback policies, which aligns with the question. However, because the foundational fact about META’s voting ratio is wrong, the comparative conclusion that Google has higher ownership concentration due to buyback policy is built on flawed premises. (4) Contextual relevance is high—the response addresses the dual-class structures, voting rights, share counts, repurchases, and implications for control. But due to the major factual error about META’s voting ratio and unsupported claims about buyback effects on voting dilution, the correctness score is low. Quantitative accuracy is penalized heavily because the central calculation (61% voting control) is based on fabricated data. Qualitative accuracy suffers for the same reason, though the structure of the argument is logical. Contextual relevance remains strong as all key topics are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 544,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "- **Johnson & Johnson (JNJ)** – The Swiss Tax Reform and the cantonal “TRAF” provisions that took effect in 2020 gave JNJ a net tax benefit of roughly **$0.4 billion, which lowered its annual effective tax rate by about 2.6 percentage points** for fiscal‑year 2020.  \n\n- **Merck & Co. (MRK)** – Beginning in 2021 Merck received a **Swiss tax‑holiday incentive for a newly‑active legal entity** that is expected to run through 2030.  The filing notes the holiday as an “additional tax incentive” but does not quantify the dollar amount; it is disclosed only as a qualitative benefit that will reduce MRK’s effective tax rate in the years the holiday is in force.  \n\nThus, JNJ’s TRAF reform produced a measurable 2.6‑point reduction in its 2020 effective tax rate, whereas MRK’s Swiss tax holiday is described only as an undetermined tax benefit that will similarly lower its effective tax rate starting in 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key events and mechanisms for both JNJ and MRK: JNJ benefited from the Swiss TRAF reform in 2020, and MRK began receiving a Swiss tax holiday in 2021 for a new legal entity, expected through 2030. The qualitative descriptions of the tax incentives and their impact on effective tax rates are accurate and relevant. However, there is a significant quantitative discrepancy: the LLM states that JNJ's tax rate decreased by 2.6 percentage points due to TRAF, while the ground truth specifies a 1.9% decrease. Additionally, the LLM introduces a $0.4 billion tax benefit figure not present in the original answer, which lacks any dollar quantification. This introduces unsupported numerical claims. While the multi-hop reasoning is sound—correctly distinguishing between the two companies, the different years, and the different mechanisms (TRAF adjustment vs. tax holiday)—the incorrect magnitude of the tax rate impact for JNJ undermines factual accuracy. The comparison between a quantified impact (JNJ) and a qualitative one (MRK) is appropriately conveyed, but the numbers do not align with ground truth. Thus, while the structure and logic are strong, the quantitative inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 348,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD’s 2024 filing says it uses forward contracts and, where needed, options to hedge the foreign‑currency risk of excess cash and of available‑for‑sale investments held by its overseas subsidiaries, with the goal of dampening the translation impact of those assets and liabilities on earnings and equity. The filing does not disclose a dollar‑amount for the notional of those hedges.  \n\nNike, by contrast, reports that its transactional‑FX program – which also relies on forwards and options – had net cash‑flow‑hedge notional amounts of **$9.9 billion in 2024 (and $8.3 billion in 2023)**, and the contracts are intended to lock in the U.S.‑dollar value of forecast‑ed purchases, sales, liabilities and other firm commitments, thereby reducing earnings and cash‑flow volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative accuracy, particularly reversing the notional amounts between MCD and NKE. According to the ground truth, MCD has $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024, while the LLM incorrectly attributes this $9.9 billion figure to NKE. The LLM also adds a spurious $8.3 billion for NKE in 2023, which is not present in the original answer or supported by the provided context. This misattribution severely undermines the quantitative accuracy. Qualitatively, the LLM correctly identifies that both companies use options and forwards for FX risk management and captures the general distinction between MCD’s asset/translation focus and NKE’s transactional/cash flow focus. However, it incorrectly states that MCD’s filing does not disclose a dollar amount, when in fact the ground truth explicitly provides $9.9 billion for MCD. The reasoning partially reflects the multi-hop comparison but fails in critical synthesis due to the swapped notional values. Contextually, the answer is well-structured and relevant to the question, addressing objectives, instruments used, and comparative focus. Despite correct terminology and structure, the core numerical misassignment leads to a low correctness score because the central comparative metric (notional amounts) is inverted, fundamentally distorting the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 392,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "General Dynamics says the G500 (and its larger‑cabin sibling the G600) are “clean‑sheet” aircraft that replace the legacy G450/G550 family, and the program was built around a new wing, new avionics, larger cabin and more efficient powerplants 【page_4】.  Pratt & Whitney Canada’s PW800 engine was chosen **exclusively** to power the G500 (as well as the G400 and G600) 【page_5】, giving the jet higher thrust, lower fuel burn and emissions, greater range and speed—exactly the performance, efficiency and technology upgrades General Dynamics is using to market the G500 as the next‑generation replacement for the G450 and G550.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the G500 is a clean-sheet design replacing the G450/G550, features a new wing, avionics, and cabin, and is exclusively powered by RTX's Pratt & Whitney Canada PW800 engine alongside the G400 and G600. The performance benefits—higher thrust, lower fuel burn, reduced emissions, greater range and speed—are correctly tied to General Dynamics' strategy of positioning the G500 as a next-generation aircraft. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics (efficiency, performance) are accurately represented. (3) Multi-hop reasoning is sound: the answer correctly links the exclusive use of the PW800 engine (from RTX) to the G500’s enhanced performance, and connects that technological advantage to General Dynamics’ broader product strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly name RTX as the parent company of Pratt & Whitney Canada, though it correctly identifies Pratt & Whitney Canada as the engine manufacturer. This slight omission in entity hierarchy prevents a perfect 10 on qualitative accuracy, but the core reasoning and contextual relevance remain excellent. Overall, the answer is semantically equivalent to the ground truth with high precision and strategic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 403,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta Platforms uses a 2‑class structure in which each Class A share carries one vote and each Class B share carries ten votes; the charter makes the Class B voting power “generally non‑dilutable,” giving Class B holders roughly 86 % of the total voting power (the remainder belonging to Class A shareholders).  \n\nComcast’s structure is similar but with a different weighting: each Class A share has one vote and each Class B share has fifteen votes, and the articles of incorporation provide that the Class B voting percentage (about 33 ⅓ % of the combined voting power) is generally non‑dilutable, while Class A shareholders hold the remaining 66 ⅔ % of voting power.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the dual-class structures of both META and CMCSA, including the voting rights per share (10 votes for META Class B, 15 for CMCSA Class B) and the non-dilutable nature of Class B shares in both companies. It accurately states that CMCSA's Class B holds 33 1/3% and Class A 66 2/3% of voting power, matching the ground truth. However, the LLM claims META's Class B holds 'roughly 86%' of voting power, which is not supported by the original answer — the ground truth does not provide a specific percentage for META's voting power distribution, only that Class B is non-public and held by 23 stockholders as of December 31, 2023, implying concentrated control. This 86% figure is a significant factual addition not present in the source and may be outdated or incorrect, hurting quantitative accuracy. The answer is otherwise complete, addressing both companies' structures, voting weights, and non-dilution provisions. The reasoning is sound in comparing the two structures and synthesizing key elements of dual-class frameworks, and all entities (META, CMCSA, Class A/B shares) are correctly identified. The response is highly relevant to the question. While the core structure and CMCSA details are accurate, the unsupported 86% claim prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 370,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMS says that in Europe Revlimid’s market protection is already being eroded by patent‑settlement agreements that will allow generics to launch as early as January 2022 in the U.K. and February 2022 in other EU countries, and it warns that further patent challenges could bring generic lenalidomide to market before its supplemental‑protection‑certificate expires. In contrast, Eli Lilly’s filings stress that its orphan‑drug products depend on the seven‑year data‑exclusivity granted to orphan indications; the company’s risk is that a change in data‑protection rules or a successful challenge to that regulatory exclusivity would end the orphan shield and open the product to competition. Thus, BMS’s threat is a near‑term, patent‑litigation‑driven loss of exclusivity in Europe, whereas Lilly’s threat is a more regulatory‑focused loss of orphan‑drug data protection that could shorten the exclusivity period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY (BMS) faces generic entry for Revlimid in Europe starting January 18, 2022, in the UK and February 18, 2022, in other European countries due to patent settlements—dates match exactly (allowing for phrasing like 'as early as January 2022'). The mention of supplemental protection certificate (SPC) expiration and risk of earlier generic entry due to patent challenges is consistent with the original. For LLY (Eli Lilly), the reliance on seven-year orphan drug data exclusivity is correctly stated, and the risk from regulatory changes or challenges to data protection is accurately portrayed. (2) Quantitative accuracy is perfect: dates (January 2022, February 2022) and the seven-year exclusivity period are correct. No calculations are required, but temporal precision is maintained. (3) Multi-hop reasoning is sound: the model correctly contrasts BMY’s patent-litigation-driven vulnerability in Europe with LLY’s regulatory-exclusivity-based protection, synthesizing across two companies, two types of IP frameworks (patent vs. data protection), and two risk profiles. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'orphan shield', 'regulatory-focused loss'), the meaning is equivalent. One minor point preventing a perfect 10 is that the LLM refers to 'EU countries' rather than the broader 'European countries' as in the original (which includes non-EU UK), but this does not materially distort the facts. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 446,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "- Morgan Stanley (MS) says that a portion of its Wealth‑Management and Investment‑Management revenues comes from management fees on client assets that are “primarily composed of equity, **fixed‑income** and alternative investments” and that “these revenues … are **sensitive to changes in the related markets**” (Asset Management Revenue Sensitivity, page 62).  \n\n- PayPal (PYPL) notes that many of its financial assets and liabilities – including corporate debt securities and its derivative positions – are measured at fair value using **pricing models that incorporate observable market inputs** such as interest‑rate curves, credit spreads and option volatilities (Note 9, page 93). Consequently, PayPal’s earnings are exposed to **market‑risk gains or losses** that arise from changes in those model inputs.  \n\n**Comparison:** MS’s exposure is a revenue‑level sensitivity that varies with the performance of fixed‑income markets (fees rise or fall as client fixed‑income holdings change), whereas PYPL’s exposure is a balance‑sheet/earnings‑level risk that materializes through valuation changes in derivatives and debt securities driven by the same market inputs used in its pricing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MS's asset management revenues are indeed sensitive to fixed income market changes due to fee-based models tied to client assets, and PYPL uses pricing models with observable inputs (interest rates, credit spreads, etc.) for derivatives and debt securities. The distinction between MS’s revenue-level sensitivity and PYPL’s earnings/balance-sheet-level exposure is correctly identified. (2) There are no numeric values in the question or answers that require verification—both responses rely on qualitative disclosures, and all references (e.g., page numbers, note numbers) are consistent and plausible. No calculations are needed, so quantitative accuracy is满分. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MS and PYPL), identifies their respective risk exposures, and contrasts the nature of those risks (indirect fee-based vs. direct fair value impact). The only minor shortcoming is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt, which is a key differentiator in the original answer explaining the directness of PYPL’s exposure. This omission slightly weakens the completeness of the comparison but does not invalidate the core reasoning. (4) The answer is contextually excellent—directly addresses the comparative structure of the question, uses appropriate terminology, and maintains semantic equivalence with the original answer. Thus, correctness is docked slightly to 9 for the missing fair value option detail, but all other dimensions score at or near the top.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 466,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI directly into its MySQL HeatWave cloud service so that enterprise customers can run AI‑driven analytics, machine‑learning and generative‑AI workloads alongside transactions within a single managed database (Oracle MySQL HeatWave “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service” – ORCL 12). Qualcomm, by contrast, is pouring resources into IoT‑focused products that ship dedicated AI hardware (its AI Engine and Hexagon NPU) to enable low‑power, on‑device inference for consumer devices such as smartphones, AI‑focused PCs and other IoT gadgets (“Consumer IoT products … adopt the latest … on‑device AI capabilities … allowing increased productivity and enhanced use cases enabled by on‑device AI processing at low power” – QCOM 8; “The Qualcomm AI Engine … includes dedicated hardware … for sustained, high‑performance AI inference … enabling leading on‑device AI capabilities with very low power consumption” – QCOM 9). Thus Oracle’s strategy centers on delivering enterprise‑scale AI through its cloud database platform, while Qualcomm’s strategy centers on pushing AI processing onto the edge of consumer‑grade IoT devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI for enterprise use. Qualcomm focuses on on-device AI in IoT and consumer devices via dedicated hardware like the AI Engine and Hexagon NPU. These points match the original answer. (2) Quantitative accuracy is perfect: While the original answer includes specific projections (19% of smartphones AI-capable in 2024, rising to 46% in 2027), the LLM answer does not mention these numbers but does not contradict them either. Since the LLM response omits rather than misstates quantitative data, this is a minor omission, not an error. (3) Multi-hop reasoning is sound: The model correctly synthesizes Oracle’s enterprise cloud-AI strategy with Qualcomm’s edge-AI and IoT focus, drawing a clear contrast in strategic direction. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The only reason for not scoring a 10 is the omission of Qualcomm’s specific market projection (46% by 2027), which is a meaningful but not critical detail in the overall comparison. Contextual relevance is excellent, directly addressing both companies’ strategies in enterprise vs. consumer markets and on-device AI processing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 381,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act will likely force “costly changes to our AI development practices” and raise its compliance, governance and R&D expenses (Adobe 10‑K p. 23). Those added costs and possible delays in launching or monetising new AI features could compress Adobe’s margins and slow its AI‑driven product rollout, while Salesforce’s business is already built around its AI‑powered Agentforce suite that underpins its sales‑ and service‑offering (Salesforce 10‑K pp. 5‑7). Consequently, higher compliance outlays could weaken Adobe’s ability to compete on speed, pricing and feature set, giving Salesforce a relative advantage in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Adobe anticipates costly changes to AI development practices due to the EU AI Act, including increased compliance, governance, and R&D expenses, with potential delays in launching or monetizing AI features. Salesforce’s reliance on its AI-powered Agentforce platform for sales and service offerings is accurately represented. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; the LLM correctly avoids introducing incorrect figures and accurately reflects the qualitative financial impacts (e.g., margin compression, slowed rollouts). Format and referencing (e.g., 'Adobe 10-K p.23', 'Salesforce 10-K pp.5-7') are consistent with source-based reasoning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Adobe and Salesforce), connects regulatory impact (EU AI Act) to competitive dynamics, and infers that Adobe’s need to divert resources could slow innovation, giving Salesforce a relative advantage due to its deeper AI integration. (4) The only minor shortcoming is that the LLM does not explicitly mention the phased implementation through 2030 or the GS_10k_2024 context about both firms facing similar operational risks, which slightly reduces completeness in multi-hop synthesis—hence a 9 instead of 10 on qualitative accuracy. However, the core competitive logic and factual basis are fully preserved, and the answer remains semantically equivalent in outcome and implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 437,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share awards give non‑employee directors a share that vests when they leave and also pay “dividend equivalents” in the form of **additional shares**, so the stock‑based value is distributed directly to those directors as part of their compensation. Lowe’s ASR transactions, by contrast, are a share‑repurchase mechanism in which the company pays cash up‑front, receives an initial block of its own stock, and then **receives further shares (and a cash settlement) from the financing bank**; the extra shares flow back to the company’s treasury, reducing the total shares outstanding and thereby benefiting the broader shareholder base rather than a specific group of award recipients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon termination, which constitutes stock-based compensation for specific individuals. It also accurately describes LOW's ASR mechanism, where the company receives additional shares from financial institutions post-initial delivery, with those shares going to treasury to reduce shares outstanding and benefit all shareholders. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in stakeholder groups (directors vs. broader shareholders), purpose (compensation vs. capital return), and mechanics (dividend equivalents vs. ASR settlement). The only minor shortcoming is that it does not explicitly mention the 'variable notional' nature of LOW's ASRs or the link to 'repurchase efficiency and final notional value calculations,' which are present in the original answer. However, the essence—that extra shares come from a financial institution based on a structured agreement tied to repurchase execution—is captured. (4) The answer is fully contextually relevant, directly addressing the comparison of stock-based value distribution mechanisms between the two companies. Wording differs but semantic meaning aligns closely with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 420,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 – which provides optional expedients for contract modifications caused by reference‑rate reform – “does not materially impact our financial statements,” indicating that the change does not alter the timing of revenue recognition or the measurement of its existing performance obligations. In contrast, Verizon explicitly states that contract modifications can change the timing and scope of its obligations, and that such changes are reflected in its estimates of future revenue and remaining performance obligations (see its discussion of “changes in the timing and scope of contracts, arising from contract modifications” in the revenue‑recognition note). Thus, AT&T expects no material effect, whereas Verizon acknowledges that modifications do affect when revenue is recognized and the amount of performance obligations outstanding.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative aspects of both AT&T's and Verizon's disclosures regarding ASU 2020-04 and contract modifications. It accurately states that AT&T's adoption did not materially impact its financial statements and does not alter revenue recognition timing or performance obligations. It also correctly notes that Verizon acknowledges contract modifications affect the timing and scope of performance obligations and that these are reflected in revenue estimates. (2) However, the LLM answer fails to include the key quantitative data from the ground truth: Verizon's specific future revenue recognition amounts of $25.7 billion in 2024, $18.7 billion in 2025, and $7.5 billion beyond 2025. This omission significantly affects quantitative accuracy, as these figures are central to understanding the magnitude of the impact on Verizon’s revenue recognition. (3) The multi-hop reasoning is sound—correctly contrasting AT&T’s minimal impact with Verizon’s more significant operational impact—and the synthesis across the two companies’ disclosures is logically presented. (4) While the answer is contextually relevant and qualitatively accurate in describing the nature of the disclosures and their implications, the absence of specific dollar amounts reduces its factual completeness, warranting a correctness score of 7 and a low quantitative accuracy score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 391,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension‑plan note states that “Bonds and debentures … including state and local municipal bonds” are valued with a bid‑evaluation process that uses observable market data and are therefore classified in **Level 2** of the ASC 820 fair‑value hierarchy. Lockheed Martin’s pension‑plan fair‑value table, however, breaks fixed‑income assets into corporate debt, U.S. government securities and “other fixed‑income” and does **not list municipal bonds** as a separate Level 2 line item, implying that the company either holds little or no municipal‑bond exposure or values any such holdings using a different level (Level 1 or Level 3). Both firms are complying with ASC 820 by disclosing the hierarchy, but UNP explicitly relies on Level 2 inputs for municipal bonds, whereas LMT’s disclosures show no reliance on Level 2 for that asset class, reflecting differing portfolio composition while still meeting the ASC 820 measurement standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable in a traditional sense, but since there are no incorrect numbers or miscalculations, it scores high by default. However, the qualitative accuracy is low due to a significant factual error: the LLM claims that Lockheed Martin (LMT) does not list municipal bonds as a Level 2 asset and implies LMT may not use Level 2 for such holdings, which contradicts the ground truth. The original answer confirms that Lockheed Martin *does* disclose the use of Level 2 valuation methodologies for fixed income securities, including when indicative quotes from pricing vendors are used and corroborated—this encompasses municipal bonds even if not explicitly named. The LLM incorrectly interprets the absence of a separate line item as evidence of non-use of Level 2 for municipal bonds, which is a flawed inference. ASC 820 allows aggregation of similar assets, and LMT’s 'other fixed-income' category could include municipal bonds valued under Level 2. The ground truth emphasizes that *both* companies apply Level 2 methodologies consistently under ASC 820, with UNP providing more specificity. The LLM instead concludes divergent reliance on Level 2, which misrepresents the comparability. While the answer correctly identifies UNP’s explicit Level 2 classification and ASC 820 compliance, it fails in multi-hop reasoning by not synthesizing that LMT’s general fixed income disclosure covers municipal bonds by implication. Thus, the core conclusion about differing reliance is incorrect, dragging down correctness and qualitative accuracy. Contextual relevance is moderate—response addresses the question framework but with flawed substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 465,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "Coca‑Cola’s Argentine sales are funneled through its largest independent bottler, Coca‑Cola FEMSA, which operates only in the federal capital of Buenos Aires and its surrounding area (see KO page 7). In contrast, Mondelēz does not use a third‑party bottler for Argentina; it reports the country as a “highly inflationary” economy, applying inflation‑adjusted accounting that generated a $13 million re‑measurement loss in 2021 (and $9 million in 2020) and represents 1.4 % of its net revenue (see MDLZ pages 88‑89). Thus, KO’s exposure is limited to the performance of a single bottler in a narrow geographic zone, whereas MDLZ bears direct economic‑volatility risk from Argentina’s hyper‑inflation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Coca-Cola FEMSA operates in Buenos Aires and surrounding areas; MDLZ classifies Argentina as a highly inflationary economy; MDLZ reported a $13 million remeasurement loss in 2021 (also correctly notes $9 million in 2020, which is extra but accurate); Argentina contributed 1.4% of MDLZ’s net revenue ($401 million), all of which aligns with the original answer. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and years are correct and consistent with the ground truth. The LLM correctly reports $13 million loss and 1.4% revenue contribution, matching the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes KO’s distribution reliance via Coca-Cola FEMSA with MDLZ’s direct financial exposure due to inflation, contrasting the two exposure mechanisms appropriately. (4) The only minor shortcoming is that the LLM does not explicitly mention KO’s $14.471 billion in net sales to equity method investees (which includes Coca-Cola FEMSA), a detail present in the original answer that provides broader context on KO’s reliance. While not critical to the core comparison, its omission slightly reduces completeness. However, the answer still captures the essential contrast in exposure types—distribution dependency vs. direct inflation risk—making it semantically equivalent in intent and conclusion. Wording differences (e.g., 'hyper-inflation' vs. 'highly inflationary') are acceptable as they convey similar meaning in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 429,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry ten votes each and can be converted into Class A shares, giving insiders a concentrated voting bloc that can direct equity‑related actions such as buy‑backs or dividend policy while preserving control (Meta 10‑K Note 11, p. 82). Alphabet’s dual‑class system separates voting power (its 10‑vote Class B stock held by founders) from the shares being repurchased – the $62 billion buy‑back in 2024 was executed only on non‑voting Class A and Class C shares, so the economic ownership of public investors is reduced but the founders’ voting control remains unchanged (Alphabet 10‑K, p. 82). Consequently, Meta’s high‑voting Class B structure lets insiders shape shareholder‑equity strategy directly, whereas Alphabet’s framework allows large repurchases to benefit economic holders without affecting the entrenched voting control of its Class B owners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B shares have 10 votes vs. 1 for Class A, Alphabet's Class B has 10 votes, Class C has none, and the $62.0 billion 2024 share repurchase targeted only Class A and C shares. The dollar amount, year, and share classes involved in the repurchase are precisely stated. (2) Quantitative accuracy is perfect: $62 billion is correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that both companies use dual-class structures to separate voting control from economic ownership, and that Alphabet’s repurchase of non-voting shares preserves founder control while returning value. It also accurately contrasts Meta’s ability for insiders to directly shape equity strategy due to their voting power with Alphabet’s model where voting control is insulated even as economic ownership is reduced. (4) The only minor shortcoming is that the LLM does not explicitly state that Meta also has a conversion mechanism from Class B to Class A (implied but not clearly tied to equity strategy), and slightly overemphasizes Meta’s direct control without fully balancing the parallel strategic flexibility both companies enjoy. However, this does not detract from factual correctness. Wording differs but semantic meaning and analytical depth match or exceed the ground truth. Contextual relevance is excellent—every part of the question is addressed with precise, document-supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 430,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.184 billion in 2023 to $1.799 billion in 2024 – a drop of roughly $385 million that the company attributes to lower COVID‑19 case rates and “the availability, uptake and effectiveness of vaccines and alternative treatments for COVID‑19”【page_66】. Amgen reports a similar erosion of sales in its own therapeutic areas, noting that the launch of alternative treatments (biosimilars, generics and new branded drugs) in highly competitive markets such as those for ENBREL, Otezla and Repatha has produced a negative impact on its product revenues【page_15】. In short, Gilead’s Veklury decline is driven by alternative COVID‑19 therapies, while Amgen’s revenue pressure stems from alternative products crowding out its established medicines in competitive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million, which aligns with the original answer ($2,184M to $1,799M). The formatting variation (billion vs. million) is acceptable and semantically equivalent. (2) The LLM correctly identifies both companies (GILD and AMGN), the relevant products (Veklury, ENBREL, Otezla, Repatha), and the correct time frame (2023 to 2024). (3) The reasoning is sound: it correctly synthesizes that GILD’s decline is due to alternative COVID-19 treatments and lower case rates, while AMGN faces revenue pressure from biosimilars, generics, and new entrants in competitive markets. It captures the multi-hop comparison between the two companies’ exposure to alternative treatments. (4) The only minor shortcoming is that the LLM omits AMGN’s mention of formulary restrictions and cost-containment by payers/PBMs, which is a key mechanism in the original answer. While it notes 'alternative treatments' affecting Amgen, it doesn’t fully convey the payer-driven systemic pressure emphasized in the ground truth. This slight omission in qualitative depth prevents a perfect 10, but the core facts, numbers, and comparative logic are correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 374,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % senior notes require interest to be paid **twice a year** – on February 15 and August 15 – and the only scheduled principal payment is the 2022 maturity (with a $1 million payment in 2026)【page_66】.  \n\nQualcomm’s $14 billion of notes are a mix of fixed‑rate and floating‑rate issues; **interest on the floating‑rate notes is paid quarterly**, while **interest on the fixed‑rate notes is paid semi‑annually**【page_79】.  In addition, Qualcomm has a series of **principal payments spread over several fiscal years** – $1.4 billion in FY 2023, $914 million in FY 2024, $1.4 billion in FY 2025, $2.0 billion in FY 2027 and the balance after FY 2027【page_79】.  \n\nThus, AMD’s notes have a simple semi‑annual interest schedule with a single near‑term maturity, whereas Qualcomm’s debt incurs both quarterly and semi‑annual interest and obligates the company to make principal repayments in multiple future fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's semi-annual interest payment schedule on February 15 and August 15 and accurately describes QCOM's mixed interest structure—semi-annual for fixed-rate and quarterly for floating-rate notes. It also correctly notes AMD's final maturity in fiscal 2022. However, there is a minor factual inaccuracy: the LLM states AMD has a '$1 million payment in 2026', which contradicts the ground truth that 'no principal is due in fiscal 2026'. This is a significant but isolated error affecting quantitative accuracy. (2) All other numbers are correct: QCOM's principal payments of $1.4B in FY2023, $914M in FY2024, $1.4B in FY2025, $2.0B in FY2027, and the remainder after FY2027 align with the ground truth (which notes no principal due in FY2026, consistent with the gap). The $312M and $14.0B amounts are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes payment frequency and fiscal obligations across two companies and different note types, drawing a valid comparative conclusion. (4) The answer is contextually excellent, directly addressing payment frequency and fiscal year obligations as asked. The error in AMD's 2026 payment is minor in scope but affects correctness; hence, a score of 8 is justified—core facts are right, but with a notable omission/contradiction in the principal schedule detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 383,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The U.S. patents that shield Prolia / XGEVA expire on 19 February 2025 (see Merck’s patent table) 【page_11】, and Merck repeatedly stresses that its ability to fend off generic challengers rests on “strong patent rights” and that loss of such protection “is typically followed promptly by generic or biosimilar substitutes” that would cut sales 【page_33】.  Consequently, when the February 2025 expiry arrives Merck’s competitive moat around its leading osteoporosis/oncology franchise will erode, exposing the business to the same price‑erosion and market‑share loss that Amgen is already confronting from biosimilar entrants in overseas markets (Amgen’s 10‑K notes significant biosimilar pressure internationally) 【page_9‑13】.  In short, the impending patent loss will weaken Merck’s defensive position just as Amgen is already dealing with comparable biosimilar threats abroad, intensifying competitive and pricing pressures for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key date—February 19, 2025—is correctly stated (matches ground truth's 'February 2025'), and no other numerical values are involved. (2) The answer correctly identifies the entities: Merck, Amgen, Prolia/XGEVA, and the context of U.S. patent expiration and international biosimilar threats. (3) The multi-hop reasoning is sound: it connects Merck’s reliance on strong patent rights (from its own filings) to the impending loss of exclusivity for Prolia/XGEVA (an Amgen product), and draws a parallel between Amgen’s current international biosimilar challenges and the future threat Merck may face. This synthesis across companies and geographies is logically valid and well-supported. (4) The only minor shortcoming is a slight conflation in framing: Prolia/XGEVA are Amgen’s products, not Merck’s, so the statement that 'Merck’s competitive moat around its... franchise will erode' is misleading. The correct interpretation is that Amgen’s moat erodes, which indirectly affects Merck’s competitive positioning. The ground truth emphasizes this indirect effect, while the LLM implies a direct impact on Merck’s own franchise. Despite this, the overall reasoning and conclusion about intensified competitive pressures remain valid. Hence, high scores across all categories with a small deduction in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 391,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom does not break out a separate “AI‑related” line for VMware Cloud Foundation (VCF) in its FY 2024 results – the filing only reports total VCF revenue (the $12,384 million net revenue attributable to VMware) and describes the product as “enabling advanced AI and machine‑learning workloads at enterprise scale” (see AVGO page 8).  Because no specific dollar amount or percentage is disclosed for the AI‑enabled portion, the share cannot be quantified from the 10‑K.\n\nCisco, by contrast, explicitly positions its networking and silicon portfolio as the underlying infrastructure for AI training and inference, stating that it “provides network infrastructure to power AI training and inference workloads for both web‑scalers and enterprises” (see CSCO page 4).  Thus, while Broadcom’s VCF is marketed as AI‑capable, Cisco’s strategy is centered on delivering the high‑density routers, switches and optics that actually run the AI workloads.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect on key factual points, particularly quantitative accuracy. The ground truth states that $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation (VCF) revenue in FY2024 was tied to AI workloads. However, the LLM claims no such breakdown exists and that Broadcom does not disclose an AI-related portion—this directly contradicts the original answer, which does provide a specific dollar amount. Additionally, the LLM incorrectly reports total VCF revenue as $12,384 million, which is not supported by the ground truth and appears to be a misreading or confusion with another figure (possibly total VMware net revenue). This results in a severe quantitative inaccuracy. On qualitative aspects, the LLM correctly identifies that VCF enables AI/ML workloads and accurately describes Cisco’s strategic focus on AI infrastructure, citing appropriate language from Cisco’s 10-K. The reasoning correctly contrasts Broadcom’s product capability with Cisco’s infrastructure role, showing sound multi-hop synthesis between the two companies’ strategies. Contextually, the response addresses both parts of the question and remains focused on the strategic alignment between the firms, earning moderate scores for relevance and reasoning. However, the failure to report the $1.38B/$2.9B AI-tied revenue figure—despite it being explicitly stated in the ground truth—undermines the core of the answer, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 403,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs carry about **$1.85 billion of assets**. By contrast, Southern Power’s exposure to its solar PPAs that are accounted for as operating leases is reflected in the undiscounted cash‑flow estimate for those leases – roughly **$652 million**. Thus, the asset base behind NEE’s solar VIEs is roughly three times the size of Southern Power’s operating‑lease‑based PPA exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies NEE's consolidated solar VIE assets as approximately $1,851 million (rounded to $1.85 billion), it introduces a figure of $652 million for Southern Power's exposure through operating lease PPAs that is not present in the original answer or supported by the provided context. The ground truth does not provide any monetary value for Southern Power's lease exposure—only qualitative details about the structure (operating leases with up to 25 years remaining). Therefore, the $652 million figure appears fabricated or misattributed, and the conclusion that NEE's asset base is 'roughly three times' larger is unsupported. This constitutes a critical factual error. On qualitative aspects, the model correctly distinguishes between NEE’s direct ownership of VIE assets and Southern Power’s lease-based exposure, capturing the difference in risk and accounting treatment. It also maintains contextual relevance by focusing on the comparison of financial exposure through long-term agreements. However, the introduction of an unverified dollar amount breaks the multi-hop reasoning chain and invalidates the quantitative comparison. The model fails the quantitative accuracy test due to the unsupported $652 million number, though entity identification (NEE, SO, Southern Power) and general conceptual understanding are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 397,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks grants Stock Appreciation Rights only through its performance‑based awards, where each SAR tranche vests when both a market‑capitalization milestone and an operational milestone are certified – a milestone‑driven schedule that can span up to 12 tranches and is not tied to a fixed calendar period. In contrast, Tesla’s 2019 Equity Incentive Plan includes SARs (along with stock options, restricted stock, RSUs, performance units and performance shares) and, like its options and RSUs, generally vests on a standard four‑year graded schedule, with the options exercisable for up to ten years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies not supported by the ground truth. (1) On quantitative accuracy: The four-year vesting and 10-year exercisability for Tesla are correctly stated, aligning with the original answer. However, the claim that Starbucks' SARs vest over 'up to 12 tranches' tied to market-cap and operational milestones is not mentioned in the ground truth and appears fabricated. The ground truth states Starbucks uses performance-based RSUs tied to EPS and ROIC, but does not specify SARs being milestone-driven or structured in tranches. (2) Completeness: The question asks for a comparison of equity instruments available and vesting timelines. The LLM correctly notes Tesla’s 2019 Plan includes SARs, stock options, RSUs, etc., and correctly describes Tesla’s four-year vesting and 10-year exercise window. However, it misrepresents Starbucks’ use of SARs as exclusively performance- and milestone-based, which is not stated in the original; the ground truth only mentions performance-based RSUs, not SARs. (3) Entity accuracy: Companies (Starbucks, Tesla), plans (2019 Plan), and equity instruments (SARs, RSUs, options) are correctly identified. However, the specific structure attributed to Starbucks’ SARs is incorrect. (4) Reasoning: The multi-hop comparison fails because the LLM incorrectly infers the structure of Starbucks’ SARs based on RSU mechanics, conflating different instruments. The original answer makes no mention of SAR vesting schedules at Starbucks, only that SARs are granted and that compensation is recognized over service periods. (5) Semantic equivalence: While the Tesla portion is largely accurate, the Starbucks portion introduces unsupported details, leading to a partially correct but materially misleading comparison. The contextual relevance is high as the response addresses the right topics, but factual correctness is compromised by over-specific, unverified claims about Starbucks’ SAR structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 536,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s charter creates a dual‑class structure in which each share of Class B common stock carries **ten votes per share** (page 82). Because Class B shares can be converted into Class A shares but retain the ten‑vote weight until conversion, holders of the relatively small number of Class B shares – such as the company’s founders and other large insiders – can command a disproportionate share of the voting power and therefore steer board elections and other governance matters.\n\nAlphabet’s publicly traded Class A common stock, by contrast, is the “one‑vote‑per‑share” class (the class that is listed on the Nasdaq). Large shareholders who own Class A shares therefore exercise voting power that is roughly proportional to their economic ownership, without the vote‑multiplying effect that exists for Meta’s Class B holders. Consequently, a large shareholder’s ability to influence corporate‑governance decisions at Google is limited to the size of its economic stake, whereas at Meta a holder of Class B stock can wield outsized control relative to the number of shares it owns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that completely inverts the truth: it claims that Meta's Class B common stock has ten votes per share, which is incorrect according to the ground truth. The Original Answer states that Meta's Class B common stock has *no voting rights* except for certain defined matters. This is a critical error that reverses the entire premise of the voting structure. In reality, it is Meta's Class A shares that are typically held by the public with one vote per share, and Class B shares (if they exist in a voting form) are usually held by insiders—but in this case, the ground truth explicitly states Class B has no voting rights except in limited cases. The LLM incorrectly asserts disproportionate voting power for Class B, when in fact they are disenfranchised on most issues. Conversely, the LLM correctly describes GOOGL's Class A stock as having one vote per share, which aligns with the ground truth. However, due to the severe misrepresentation of Meta’s voting structure—specifically attributing super-voting rights (10 votes/share) to Class B when they have *no* voting rights—the core of the comparison is invalid. This error likely stems from confusing Meta with other dual-class companies like Google (which actually has a super-voting Class B). The reasoning is otherwise logically structured and contextually relevant, attempting a valid comparison, but the factual foundation is wrong. Quantitative accuracy is very low due to the incorrect vote count (10 vs 0). Qualitative accuracy suffers due to incorrect entity-property mapping. Contextual relevance is moderate because the framework of the answer addresses the right question, just with wrong facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 464,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "Bank of America’s 10‑K shows that its foreign‑exchange contracts are split between “trading and other risk‑management” swaps (about $112.7 billion of assets versus $109.1 billion of liabilities) and a very small amount of qualifying hedge contracts (≈ $0.1 billion of assets and no liability), with the net position presented after master‑netting agreements. JPMorgan’s 10‑K, by contrast, reports much larger gross foreign‑exchange exposure (roughly $2.2 trillion of swap assets and $47 billion of swap liabilities, plus spot/futures positions) and explicitly separates the portion used in hedge‑accounting relationships – fair‑value, cash‑flow and net‑investment hedges – from the rest of its risk‑management derivatives, without netting the gross amounts in the same way. Thus, BAC presents a netted, modest foreign‑currency derivative balance with a tiny hedge‑accounting slice, whereas JPMorgan shows a far larger gross FX‑derivative portfolio and distinguishes a sizable hedge‑accounting component from its overall risk‑management use.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The reported figures—such as $112.7 billion in BAC swap assets, $109.1 billion in liabilities, and JPM’s $2.2 trillion in swap assets and $47 billion in liabilities—are not present in the original answer (ground truth), which does not provide specific numerical values for derivative assets or liabilities for either company. The original answer focuses on qualitative disclosures: BAC presents foreign currency derivatives gross before netting, while JPM uses them to manage FX risk with offsetting gains/losses, and reports fair value in balance sheets. The LLM fabricates detailed numbers and misrepresents the presentation (e.g., claiming BAC presents net positions 'after master-netting' contradicts the ground truth stating BAC presents on a 'gross basis before netting adjustments'). This is a critical error. While the LLM attempts multi-hop reasoning by comparing presentation differences and hedge accounting treatment, these inferences are not supported by the provided ground truth and introduce unsupported specifics. The contextual relevance is high because the answer addresses the comparative use of foreign currency derivatives in risk management for BAC and JPM, but the factual foundation is flawed. Semantic equivalence fails due to invention of data. No dates (e.g., December 31, 2023/2024) from the original are mentioned, reducing completeness. Thus, despite structurally attempting the comparison, the answer is partially incorrect due to hallucinated numbers and mischaracterization of reporting practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 442,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy warns that a sustained economic slowdown can cut electricity and natural‑gas use by its industrial customers, shrinking sales volumes even though its regulated electric‑ and gas‑businesses can recover fuel‑ and cost‑of‑service expenses through periodic rate adjustments; the loss of volume, not the inability to recover costs, is the primary threat to cash flow. Southern Company, by contrast, flags that new or tighter environmental‑compliance rules could generate sizable capital and operating costs that may not be fully recoverable through its regulated rates, and those unrecovered costs could depress demand from commercial and industrial customers who face higher bills or operational constraints. Thus, Duke’s risk is demand‑side revenue loss from an economic downturn, while Southern’s risk is cost‑recovery uncertainty and possible demand erosion from environmental compliance, even though both firms rely on regulated rate‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Duke Energy's risk is correctly identified as demand volatility from industrial customers during economic downturns, affecting volumes and cash flows despite cost recovery mechanisms; Southern Company's risk is accurately described as stemming from environmental compliance costs that may not be fully recoverable and could suppress demand. The core distinction—Duke facing demand-side volume risk, Southern facing cost-recovery and pricing pressure risk—is preserved. (2) There are no numeric values (e.g., dollar amounts, years, percentages) in either the original or LLM answer that conflict; the LLM does not introduce any incorrect figures and correctly references the ongoing nature of environmental costs without contradicting the original's 'through 2028' timeframe. Thus, quantitative accuracy is perfect. (3) Multi-hop reasoning is sound: the model correctly synthesizes across both companies, identifies their respective risk drivers (economic vs. regulatory), and contrasts them within the context of regulated rate recovery. The LLM mentions Duke’s periodic rate adjustments and implies Southern’s mechanisms (without naming ECO Plan, CNP Compliance, or ECCR specifically), which is a minor omission but does not impair understanding. (4) Semantic equivalence is strong: the LLM captures the essence and nuance of the original, using different but equivalent phrasing (e.g., 'loss of volume' vs. 'reduced electricity consumption'). The only slight shortfall is the lack of specific tariff mechanism names for Southern, which were present in the original and add precision, but this does not undermine the overall correctness. Contextual relevance is excellent as all parts of the question are addressed directly and coherently.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 500,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s governance is anchored by the 9.44 million shares of Class B common stock that are 100 % owned by Brian L. Roberts.  Each Class B share carries 15 votes, which together represent about 33 % of the company’s total voting power and are “generally non‑dilutable” (see CMCSA 10‑K p. 31).  Because Roberts is the sole holder of those shares, he can unilaterally influence the election of directors and any other shareholder‑vote matters, even though he owns a relatively small economic stake compared with the much larger pool of Class A shares.\n\nAlphabet (Google) uses a dual‑class structure in which the publicly traded Class A shares have one vote per share, while the founder‑controlled Class B shares have ten votes per share.  This gives the founders a controlling voting majority that far exceeds the proportion of economic ownership held by public shareholders.  Thus, both companies concentrate voting power in a small insider group, but Comcast’s control rests on a single individual’s 33 % super‑voting block, whereas Google’s system gives its insiders a super‑majority (via ten‑vote Class B shares) that can outvote the public Class A shareholders on virtually all corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: CMCSA's Class B shares carry 15 votes per share and represent approximately 33% of total voting power, which matches the ground truth (33 1/3%). The statement that these shares are 'non-dilutable' is consistent with the original answer. For GOOGL, the LLM correctly states that Class A shares have 1 vote and Class B have 10 votes per share. (2) The LLM accurately identifies Brian Roberts as the sole owner of CMCSA’s Class B shares and correctly contrasts this with Alphabet’s broader founder-controlled structure. (3) The reasoning is sound: both companies use dual-class structures to concentrate voting power, but CMCSA’s system gives one individual a fixed 33% voting block, while GOOGL’s structure provides a super-majority control to insiders collectively. The only minor shortcoming is that the LLM does not explicitly mention the automatic conversion of GOOGL’s Class B shares to Class A upon sale or transfer—a key differentiator in fluidity of control—which slightly reduces completeness. However, the core contrast in governance entrenchment is effectively communicated. (4) All entities (CMCSA, GOOGL, Brian Roberts, Class A/B shares) are correctly identified, and the multi-hop synthesis across companies and governance mechanisms is logically sound. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 434,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s exposure to Taiwan is indirect – it comes through its equity‑method bottler Swire Beverages, which operates in Taiwan (along with China, Hong Kong and several U.S. states) but the 2022 filing does not break out any specific Taiwan volume or revenue results. PepsiCo, by contrast, reports that its APAC beverage unit volume in Taiwan grew at a low‑single‑digit percentage in 2022, reflecting direct growth in that market.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's indirect exposure via Swire Beverages and PEP's direct low-single-digit volume growth in Taiwan in 2022, which aligns with the ground truth. However, it omits the key quantitative detail that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021, which is critical context for assessing the scale of KO's indirect exposure. This omission affects quantitative accuracy. (2) The LLM correctly states PEP’s low-single-digit growth in Taiwan in 2022 and notes the absence of Taiwan-specific volume data from Swire in 2022, which is accurate. But it fails to include the 17% figure from 2021, which was part of the original answer and relevant to understanding the significance of Swire as a partner. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s indirect route through a bottler with PEP’s direct reporting in Taiwan, synthesizing information across entities (KO, Swire, PEP) and geographies. The logic and structure support the comparison asked in the question. (4) Despite the missing 17% figure, the answer captures the core contrast in market access strategies and correctly reports PEP’s performance. The omission is a moderate gap in completeness but does not distort the overall meaning, warranting a correctness score of 8. Quantitative accuracy is slightly penalized (7) due to the missing percentage, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 406,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "Lilly’s filing notes that Trulicity “will lose significant patent and remaining data protections in the next few years” and that loss of exclusivity “typically results in the entry of one or more generic competitors, leading to a rapid and severe decline in revenues” (LLY 10‑K p. 28).  The 2024 results already show Trulicity’s net sales falling 26 % year‑over‑year, and the company warns that further patent expiration could “materially impact … our results of operations” (LLY 10‑K p. 27‑28).  Merck, by contrast, stresses that its strategy depends on “strong patent protection” to preserve market exclusivity and fend off generic or biosimilar competition (MRK 10‑K p. 33), implying that once a key patent lapses the firm expects a sharp sales drop and must rely on new products to sustain growth.  Consequently, the impending loss of Trulicity’s patents is likely to curb Lilly’s revenue trajectory in a manner similar to the risk Merck flags for any product that loses its protective patents.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM reports a 26% year-over-year decline in Trulicity's net sales in 2024, while the original answer cites a 32% decrease in U.S. revenue. These figures are close but not identical; the discrepancy may stem from different geographies (global vs. U.S.) or metrics (net sales vs. U.S. revenue). The LLM correctly references forward-looking risks from LLY's 10-K (pp. 27–28) regarding patent expiration, which matches the original answer’s emphasis on material future impact. (2) The LLM accurately identifies both companies (LLY and MRK), their respective strategies, and correct document sources (10-K filings). (3) Multi-hop reasoning is sound: it connects LLY’s Trulicity patent expiration to revenue decline, cites LLY’s own warning about generic competition, and contrasts this with MRK’s reliance on strong patent protection (citing MRK 10-K p. 33), thereby synthesizing cross-company, cross-document insights as required. (4) Semantically, the LLM conveys the same core conclusion: patent expiration threatens LLY’s revenue trajectory just as it does for MRK, absent strong pipeline or defensive strategies. The only minor shortcoming is the slight variance in the reported percentage decline (26% vs. 32%), which may reflect different scopes but does not invalidate the overall correctness. Wording differences are acceptable and do not affect factual integrity. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 424,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s exposure is primarily operational: about 200 FedEx Office stores are leased inside hotels, convention centers, hospitals and universities, so a downturn in the real‑estate market could raise lease rates or force closures, but the leases are typically short‑term (five‑to‑ten years) and FedEx notes that suitable alternative sites are generally available. UPS’s exposure is financial: its pension and post‑retirement plans hold roughly $10.1 billion of assets in real‑estate, private‑debt and hedge‑fund investments, so a slump in real‑estate values would directly depress the NAV of those assets and could increase pension funding requirements. Thus, FedEx faces a more limited, contract‑based operational risk, whereas UPS bears a larger balance‑sheet‑level risk that is more sensitive to market‑wide real‑estate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: the $10.1 billion in pension assets and the 200 leased retail locations are accurately reported, with acceptable format variations. The lease duration (five-to-ten years) matches the original. (2) The answer correctly distinguishes FedEx’s operational exposure via leases from UPS’s financial exposure through pension fund investments, capturing the core contrast in risk types—operational vs. balance-sheet-level financial risk. (3) Multi-hop reasoning is sound: it synthesizes FedEx’s retail footprint with lease dynamics and contrasts it with UPS’s indirect exposure via alternative investments, correctly identifying how each company would be affected differently during real estate volatility. (4) Minor omission: the original specifies that FedEx’s locations are at hotels and convention centers, while the LLM broadens to include hospitals and universities, which slightly overgeneralizes the location types. However, this does not materially distort the strategic risk comparison. The conclusion that FedEx faces contract-based operational risk while UPS bears broader financial risk is semantically equivalent and well-reasoned. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 380,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B common stock carries ten votes per share, giving its holders a disproportionately powerful voting bloc that can dominate corporate‑governance decisions. In contrast, Comcast’s investment in Atairos is accounted for under the equity method with “no voting rights and only certain consent rights,” meaning Comcast cannot direct Atairos’s strategic actions—the voting power rests entirely with the management‑company investors led by the former CFO.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Alphabet's (GOOGL) Class B common stock has 10 votes per share, which gives disproportionate control—this matches the original answer. It also accurately contrasts this with CMCSA's lack of voting rights in Atairos, noting only consent rights exist, which limits strategic influence. (2) There are no numerical inaccuracies; the '10 votes per share' figure is correct, and no other numbers (dates, percentages, dollar amounts) are involved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (GOOGL and CMCSA) and structures (Class B shares vs. equity investment in a VIE), drawing a valid comparison in terms of control and influence over strategic decisions. (4) The only minor shortcoming is that the LLM adds a detail not present in the ground truth—'the voting power rests entirely with the management-company investors led by the former CFO'—which, while plausible, is not confirmed in the original answer and slightly exceeds the provided information. This does not introduce inaccuracy but adds unverified specificity. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 360,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper program is modest – the Ohio subsidiary reports only about $25 million of commercial paper (treated as a short‑term obligation but classified as long‑term because the utility can refinance it, with an average maturity of roughly 15‑23 days)【page 165】. In contrast, PepsiCo’s short‑term‑debt strategy relies on a much larger commercial‑paper facility of roughly $2.3 billion at a 5.5 % rate, which is a core component of its overall short‑term financing mix【page 100】. Thus, Duke Energy Ohio uses commercial paper only sparingly and as a bridge within its broader debt portfolio, while PepsiCo employs commercial paper on a far larger scale as a primary short‑term funding source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy Ohio's $25 million in commercial paper obligations as of December 31, 2023, matching the ground truth. PepsiCo's commercial paper obligation is reported as $2.3 billion, which is a rounded but accurate representation of the $2,286 million disclosed in the original answer. The LLM also correctly notes that PepsiCo's commercial paper is a core component of its short-term debt strategy. (2) All numeric values are factually correct or acceptably rounded ($2.3 billion ≈ $2,286 million). The interest rate of 5.5% and maturity range (15–23 days) are additional details not present in the ground truth but do not contradict it and may come from the cited pages; they do not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Duke Energy Ohio and PepsiCo), compares their commercial paper usage, and draws a valid conclusion about scale and strategic importance. The classification nuance (long-term due to refinancing) adds depth and shows understanding of accounting treatment. (4) The answer is contextually excellent, directly addressing the comparison asked in the question. The only minor shortcoming is that the ground truth mentions PepsiCo’s total short-term debt of $6,510 million, which the LLM omits—this contextual figure would have strengthened completeness. However, the core comparison on commercial paper usage remains accurate and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 420,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s filing notes that the number of commercial‑gas customers in the Carolinas, Ohio and Kentucky “is expected to increase over time” (see DUK ‑ page 17). Southern Company, however, relies on cost‑recovery provisions in state‑approved rates to recoup the substantial environmental‑compliance and ARO expenses it expects to incur (see SO ‑ pages 26 and 89). If stricter environmental rules curb industrial activity in those same regions and commercial gas demand falls, the utility’s rate‑base would shrink, making it harder to recover those compliance costs through regulated rates and potentially forcing Southern Company to absorb more of the expense or seek lower‑return rate adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Duke Energy expects growth in commercial gas customers in the Carolinas, Ohio, and Kentucky (cited from DUK, page 17), and Southern Company relies on regulated rate recovery for environmental compliance and ARO expenses (cited from SO, pages 26 and 89). (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly links Duke Energy’s regional customer growth expectations with Southern Company’s reliance on rate recovery, then evaluates the risk that environmental regulations could suppress industrial activity and gas demand, thereby undermining rate-base stability. The logic that reduced demand would shrink the rate base and impair cost recovery is consistent with the original answer. (4) The LLM omits minor contextual details—such as Southern Company’s specific mention of GHG regulations and infrastructure upgrades—but captures the core causal chain: regulatory cost recovery depends on stable demand, which may be threatened by the same environmental rules driving those costs. Wording differs but semantic meaning and analytical depth are equivalent. One point deducted from qualitative accuracy for slight underdevelopment of Southern Company’s acknowledgment of this risk in its own filings. Overall, the response is factually correct, contextually precise, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 433,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Comcast’s single Class B share carries 15 votes and, by itself, accounts for one‑third (33 ⅓ %) of the company’s total voting power, all of which is owned by Mr. Brian L. Roberts (page 33). Because the 2023 repurchase program bought only Class A shares – the 262 million shares retired in 2023 (page 33) – the number of Class A votes fell while the absolute voting power of the Class B shares stayed the same; consequently, Roberts’ share of the voting pool rose relative to the remaining Class A shareholders, strengthening his control over the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Class B shares carry 15 votes and represent 33 1/3% of voting power; Mr. Brian L. Roberts owns all Class B shares; only Class A shares were repurchased in 2023 (262 million retired). These numbers match the original answer and context. (2) Quantitative accuracy is perfect: the figure of 262 million Class A shares repurchased is correctly cited, and the logic that reducing Class A shares increases the relative voting weight of Class B shares is sound. (3) The reasoning is logically sound and captures the multi-hop synthesis: repurchasing only low-vote Class A shares reduces their outstanding count, which dilutes the voting influence of public shareholders (who mostly hold Class A) while preserving the absolute voting power of Class B, thus increasing Roberts’ relative control. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the dilution of the broader shareholder base’s equity, which is a component of the original answer. While implied, this omission slightly reduces completeness. However, the core mechanism and conclusion about strengthened control are correctly and clearly stated. Wording differences are acceptable and do not affect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 369,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are priced with a “payout‑simulation” model that projects stock‑holder returns (using the grant‑date stock price, volatility, risk‑free rate and the correlation of Amgen’s share price with a comparator group) to calculate a fair‑value and an expected payout percentage for each three‑year award; the model makes the eventual cash‑or‑stock payout largely quantifiable at grant‑date, even though the final number of units earned will depend on actual performance.  \n\nBristol‑Myers Squibb’s exposure, by contrast, comes from its derivative and other financial agreements, which are subject to counter‑party credit risk that is managed by capping exposure to any one counter‑party, using only high‑credit‑quality counterparties and standard credit‑mitigation techniques rather than a deterministic payout formula. Consequently, Amgen’s structure provides a more predictable, model‑driven payout outcome, while BMS relies on risk‑limiting controls that reduce but do not eliminate uncertainty about potential losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies Amgen's performance units were valued at $121 million in 2023, the LLM answer does not include this specific dollar amount or year. However, the absence of this figure does not undermine the core explanation of the payout mechanism, and no incorrect numbers are presented—thus, quantitative accuracy remains high. (2) The LLM correctly describes Amgen’s payout-simulation model using grant-date assumptions (volatility, correlation, risk-free rate, comparator group), which matches the ground truth’s emphasis on modeling stockholder returns via correlations and volatilities. It accurately characterizes the payout as largely quantifiable at grant date but dependent on actual performance, capturing the structured yet variable nature. (3) For Bristol-Myers Squibb, the LLM correctly identifies that counterparty credit risk arises from derivative and financial agreements and is managed through exposure caps, high-credit-quality counterparties, and standard mitigation techniques—this matches the original answer’s description. It correctly contrasts deterministic modeling (Amgen) with risk-control practices (BMS). (4) The reasoning is sound and synthesizes a multi-hop comparison: Amgen’s predictability comes from performance-linked modeling, while BMS focuses on minimizing uncertainty via controls. The only minor omission is the lack of explicit mention of '2023' and the '$121 million' figure, which slightly reduces completeness but does not affect the qualitative or conceptual accuracy. The semantic meaning and comparative insight are preserved. Hence, correctness is rated 9 due to this partial omission, but all other dimensions—especially contextual relevance and reasoning—are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 494,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is largely confined to its OTC‑bilateral contracts, which are governed by ISDA Master Agreements that give the company a statutory right—under the Orderly‑Liquidation‑Authority provisions of Title II of Dodd‑Frank—to net‑off receivables against payables and apply collateral without the automatic stay that applies in bankruptcy. In contrast, Bank of America’s Dodd‑Frank‑mandated resolution‑planning obligations expose it to much broader systemic‑risk controls: if regulators deem its “single‑point‑of‑entry” plan not credible, the FDIC and Federal Reserve can impose stricter capital, leverage and liquidity caps, limit subsidiary funding and even invoke the Orderly‑Liquidation Authority, which could severely curtail the bank’s liquidity and ability to meet obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting rights under the Orderly Liquidation Authority (OLA) is accurately described, including the ability to net receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America's resolution planning obligations under Dodd-Frank, including the 'single point of entry' strategy and potential consequences of OLA invocation (e.g., bridge company, loss of security holders), are correctly outlined, though the LLM focuses more on regulatory consequences (capital/leverage caps) than the structural resolution mechanism. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (MetLife and Bank of America), two regulatory mechanisms (derivative contract governance vs. resolution planning), and a shared regulatory framework (Dodd-Frank/OLA). The comparison is logically structured and highlights the contrast in nature and scope of exposure—MetLife at the transactional/contractual level, BAC at the systemic/structural level. (4) Semantic equivalence is strong: while the LLM does not explicitly mention the 'bridge holding company' or 'security holders facing losses' in the same terms as the original, it captures the practical implications through phrases like 'severely curtail the bank’s liquidity and ability to meet obligations.' The omission is minor and does not detract from factual correctness. One point is deducted from qualitative accuracy because the LLM slightly reframes BAC's risk around regulatory penalties for non-credible plans rather than the resolution mechanism itself, which is more central in the original. Overall, the answer is contextually excellent, factually precise, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 558,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported ≈ $7.5 billion of revenue from its Greater China segment (which includes Taiwan) in fiscal 2022 (see NKE 10‑K page 88).  Starbucks had 544 licensed stores in Taiwan at the end of fiscal 2022 (see SBUX 10‑K page 12).  The contrast suggests that Nike’s presence in the region is measured mainly by a large dollar‑sales volume, whereas Starbucks’ presence is reflected in a sizable network of physical stores; each company is strong in the market, but Nike’s impact is expressed in revenue size, while Starbucks’ is expressed in store count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Nike's revenue from the Greater China region as approximately $7.5 billion in fiscal 2022, which aligns with the ground truth of $7,547 million (rounding to $7.5 billion is acceptable). It also accurately states that Starbucks operated 544 stores in Taiwan as of the end of fiscal 2022, matching the ground truth. Both numeric values are correct and properly attributed to their respective sources (NKE 10-K and SBUX 10-K). (2) All numbers are factually accurate: $7.5 billion ≈ $7,547 million is a valid approximation; 544 stores is exact. No calculations were required beyond this, and the model avoids introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Nike and Starbucks), two different filings, and two different metrics (revenue vs. store count), and draws a logical comparison between revenue-based and operation-based market presence. It acknowledges that Nike’s figure covers a broader region (Greater China) while Starbucks’ is specific to Taiwan, which is critical context. (4) The answer is semantically equivalent to the ground truth, with only minor differences in phrasing—e.g., 'sizable network of physical stores' instead of 'operationally focused with a localized footprint'—but the meaning is preserved. The only reason for not scoring a 10 is that the LLM slightly downplays the geographic scope mismatch by not explicitly noting that Nike’s revenue includes mainland China and Hong Kong, which slightly weakens the qualitative precision. However, mentioning 'Greater China segment' implies this, so the deduction is minimal.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 456,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The 2015 American Tower deal gave Verizon a $5 billion cash infusion, but Verizon kept the towers on its own balance sheet, continued to depreciate them as property‑plant‑equipment and simply assumed a 10‑year minimum sub‑lease payment to American Tower – no separate prepaid‑rent or financing liability was recorded.  By contrast, the 2024 Vertical Bridge transaction provided a smaller $2.8 billion cash receipt, and Verizon recognized the payment as $2.0 billion of prepaid rent plus an $830 million financing obligation (reflected in “Other liabilities”), while also keeping the towers on PP&E and recording a lease‑back for the capacity it continues to use.  Thus, both transactions leave the towers on Verizon’s books, but the Vertical Bridge deal creates explicit prepaid‑rent and financing‑obligation balances that the American Tower deal did not.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: All dollar amounts ($5.0 billion, $2.8 billion, $2.0 billion prepaid rent, $830 million financing obligation), dates (March 2015, December 2024), and financial classifications are accurate. The sum of $2.0B + $830M = $2.83B is approximately $2.8B (minor rounding difference is acceptable). (2) Completeness: The answer addresses both transactions, compares their structures, and explains differences in accounting treatment—specifically the absence of prepaid rent and financing obligations in the American Tower deal versus their presence in the Vertical Bridge deal. (3) Entity accuracy: Correctly identifies American Tower Corporation and Vertical Bridge, correct years (2015 and 2024), and proper financial terms (PP&E, prepaid rent, financing obligation, sub-lease). (4) Reasoning: The multi-hop synthesis is sound—correctly infers that both deals retain towers on Verizon’s balance sheet and involve subleases, but differ in how the proceeds were allocated in accounting terms. The conclusion that the Vertical Bridge deal created explicit prepaid rent and financing obligations while the American Tower deal did not is directly supported by the ground truth. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer using different but equivalent phrasing (e.g., 'kept the towers on its own balance sheet' = 'continued to include the towers in Property, Plant and Equipment - Net'). No factual discrepancies or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 427,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan estimates its operational‑risk capital under the Basel III “Advanced Measurement Approach” by running a loss‑distribution‑model that explicitly incorporates fraud (along with other internal‑process and external‑event losses) into a one‑year, 99.9 % confidence‑level capital charge – but the filing does not disclose a dollar amount for that component. In contrast, Citi’s 10‑K spells out a concrete emerging‑market fraud‑related exposure in Russia: a loss‑of‑control scenario would require writing off the remaining net investment (≈ $1.6 billion) and recognizing an additional $0.9 billion loss on inter‑company liabilities, for a total potential hit of roughly $2.5 billion. Thus, JPMorgan’s fraud risk is captured only in a model‑based capital estimate, whereas Citi faces a specific, quantified risk of billions of dollars from asset confiscation or loss of control in an emerging‑market jurisdiction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.6 billion CTA (net investment) and $0.9 billion intercompany liability loss are accurately reported, and the total potential loss of $2.5 billion is a correct sum. These figures match the original answer exactly, with acceptable formatting variations (e.g., ≈ $1.6 billion). (2) The LLM correctly identifies JPMorgan’s use of the Advanced Measurement Approach (AMA) under Basel III, which incorporates fraud risk via internal/external loss data, scenario analysis, and business environment indicators, even though no dollar amount is disclosed—this is consistent with the ground truth. (3) Entity accuracy is strong: both JPMorgan and Citigroup are correctly identified, with accurate references to their respective risk disclosures and geographic exposures (Russia). (4) The reasoning is sound and synthesizes multi-hop information: it contrasts JPMorgan’s model-based, non-quantified capital estimation with Citigroup’s specific, quantified exposure in an emerging market, highlighting different financial mechanisms (capital modeling vs. direct asset write-downs). The only minor shortcoming is that the LLM does not explicitly name 'Cumulative Translation Adjustment (CTA)' when referring to the $1.6 billion, instead calling it 'remaining net investment'—which is contextually accurate but slightly less precise. This does not affect factual correctness but slightly reduces qualitative precision. Overall, the answer is factually complete, contextually relevant, and correctly structured to address the comparative, multi-entity, multi-mechanism nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 462,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm warns that a prolonged China‑Taiwan conflict could “severely limit or prevent us from receiving chipset supply from Taiwan” because its fabless model depends on external foundry partners located there【page_35】. In contrast, Intel’s exposure in the region is reflected mainly in the $6.867 billion of 2023 revenue generated from sales to Taiwan customers【page_88】; Intel still operates its own fabs and has a growing domestic‑fab program (e.g., Arizona Fab), so the conflict would chiefly erode revenue rather than cut off a critical manufacturing source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners is accurately described, with a direct quote about supply disruption; Intel's $6.867 billion in 2023 revenue from Taiwan is correctly cited. (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the original answer exactly. (3) The multi-hop reasoning is sound—correctly distinguishing Qualcomm’s operational/supply risk due to its fabless model from Intel’s financial/revenue risk, despite Intel’s own manufacturing footprint. The mention of Intel’s domestic fab expansion (e.g., Arizona) adds context not in the original but is plausible and supports the correct conclusion. (4) The only minor shortcoming is that the original emphasizes Intel has 'no explicit mention of reliance on Taiwan-based manufacturing,' while the LLM infers this from Intel operating its own fabs—slightly less precise but still logically valid. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 323,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests on a **recurring, quarterly basis** by applying a blend of **discounted‑cash‑flow, earnings‑multiple and market‑multiple models** to the partnership’s cash‑flow and valuation data, and it records the result at NAV per share as a practical expedient (the amounts are excluded from the fair‑value hierarchy).  \n\nBoeing, on the other hand, treats Level 3 assets that are measured **non‑recurringly** by using **significant unobservable inputs**, principally an **income (discounted‑cash‑flow) approach** (with occasional market‑approach inputs) to estimate fair value, and reports the resulting loss or gain in the non‑recurring Level 3 table.  \n\nThus, RTX’s method is a regular, multi‑technique valuation of private‑equity LPs, whereas Boeing’s method is an ad‑hoc, unobservable‑input‑driven discounted‑cash‑flow valuation for non‑recurring Level 3 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between RTX's and Boeing's (BA) valuation methodologies as described in the ground truth. (1) It correctly identifies that RTX values private equity limited partnerships on a recurring quarterly basis using discounted cash flows, earnings multiples, and market multiples—aligning with the original answer. It also accurately notes the use of NAV per share as a practical expedient, which explains why these amounts are excluded from the fair value hierarchy, a detail not in the ground truth but factually correct and contextually relevant. (2) For Boeing, the LLM correctly states that Level 3 assets are measured on a nonrecurring basis using significant unobservable inputs, primarily an income (discounted cash flow) approach, which matches the ground truth. It also mentions possible use of market approaches, which is consistent with 'occasional market-approach inputs' and reflects a nuanced understanding. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s recurring, multi-method approach for private equity with Boeing’s nonrecurring, DCF-heavy approach for impaired customer financing assets like operating leases. (4) Minor omission: the LLM does not mention Boeing’s use of third-party aircraft valuation publications or adjustments based on unique aircraft attributes or expected net sales prices—specific contextual details present in the ground truth that add precision. However, the core reasoning and factual content are correct. No numbers or calculations are incorrect (quantitative accuracy is perfect), and all entities (RTX, Boeing, Level 3 assets, private equity LPs) are accurately referenced. The answer is semantically equivalent and contextually appropriate, warranting a high score with only slight deduction for missing granular detail on Boeing’s data sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 507,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix — The 2023 10‑K states that the company “enters into forward contracts to manage the foreign‑exchange risk on forecasted revenue transactions … and on firm commitments related to the licensing and production of foreign‑currency‑denominated content assets,” but it does not quantify the amount of risk that could be lost in a single day.  \n\nDisney — Its 2023 10‑K includes a Value‑at‑Risk (VaR) analysis that estimates the maximum potential one‑day loss for currency‑sensitive financial instruments at **$45 million** (year‑end fiscal 2023 VaR), with a range of $40 million to $57 million.  \n\nThus, while Netflix relies on forward‑contract hedges without disclosing a specific one‑day loss figure, Disney explicitly measures its exposure, estimating a possible one‑day loss of roughly $45 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative value reported for Disney's VaR. The LLM states Disney's one-day loss exposure as $45 million (with a range of $40M–$57M), but the ground truth specifies a maximum potential one-day loss of $255 million as of September 28, 2024. This is a significant discrepancy that undermines the core comparison. The $45 million figure does not appear in the ground truth and contradicts it directly. (2) Number verification: The LLM incorrectly cites Disney's VaR as $45 million, which is less than one-fifth of the correct $255 million figure. There is no indication in the original answer that Disney reported a range between $40M and $57M; this range appears to be fabricated or misattributed. Additionally, the date in the LLM answer (year-end fiscal 2023) conflicts with the ground truth (September 28, 2024), which may reflect a different reporting period. (3) Multi-hop reasoning: The LLM correctly identifies that Netflix uses forward contracts without disclosing a VaR metric, and that Disney uses a VaR model—this part of the synthesis is sound. The structure of the comparison (Netflix hedges but doesn’t quantify one-day loss; Disney quantifies it) is logically valid and addresses the comparative intent of the question. However, the reasoning collapses under the weight of the incorrect Disney number, leading to a misleading conclusion. (4) Justification for scores: Correctness is scored 4 due to major quantitative inaccuracy but partial correctness in conceptual framing. Quantitative accuracy is low (3) because the key number is wrong and unsupported. Qualitative accuracy is moderate (6) as the entities and general risk management methods are correctly attributed. Contextual relevance is high (8) because the response directly engages the question’s structure and intent, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 511,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "The 2021 filing shows that the Philippines‑wide corporate‑income‑tax cut that took effect in the first quarter of 2021 lowered AMD’s effective tax rate and trimmed its 2021 provision for income taxes – the filing notes a “favourable impact” from the rate reduction that reduced the provision by several tens of millions of dollars (the exact amount is disclosed in AMD’s tax‑note).  \n\nBy contrast, Texas Instruments’ exposure to the Philippines is reflected in capital spending rather than a tax‑rate benefit: the company reports property‑plant‑and‑equipment of $370 million at its two Philippine sites in 2021 (up from $333 million in 2020), indicating ongoing operational investment, and its 10‑K does not link that investment to a change in its income‑tax provision.  \n\nThus, AMD’s tax provision was directly improved by the Philippines tax‑rate reduction, whereas TI’s Philippines activities affect its balance‑sheet assets and cash‑flow but do not produce a comparable tax‑provision adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Q1 2021 Philippines corporate tax rate reduction, AMD’s favorable tax impact, and Texas Instruments’ $370 million in PPE in the Philippines as of 2021. The LLM correctly notes that AMD’s effective tax rate increased slightly to 21.8% (though it omits the exact 0.1 percentage point increase, which is a minor omission). (2) Quantitative accuracy is excellent: $370 million PPE for TI is correctly cited, and the increase from $333M in 2020 is an additional detail not in the ground truth but factually consistent. The LLM accurately states that the tax reduction had a favorable impact on AMD’s tax provision, reducing it by 'several tens of millions'—this aligns with the ground truth’s implication of a material benefit, even if the exact figure is deferred to the tax note. (3) Multi-hop reasoning is sound: the model correctly distinguishes between AMD’s tax provision benefit (income statement impact) and TI’s operational investment (balance sheet impact), synthesizing information across both companies and regulatory contexts. (4) The only minor shortcoming is the omission of the specific 0.1 percentage point increase in AMD’s effective tax rate, which was mentioned in the ground truth as context for how the Philippines reduction acted as a mitigating factor. This does not undermine the overall correctness but prevents a perfect score. Wording differs but semantic meaning is equivalent. Contextual relevance is strong, directly addressing all parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 442,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM reports that its non‑consolidated affiliates – such as the China joint‑ventures, battery‑cell partners and other vehicle‑component joint ventures – are accounted for using the equity method and are treated as variable‑interest entities that supply or manufacture parts and complete vehicles (e.g., “our nonconsolidated affiliates are involved in various aspects of the development, production and marketing of trucks, crossovers, cars and automobile parts… we enter into transactions with certain nonconsolidated affiliates to purchase and sell component parts and vehicles” 【page_77】; “Equity in net assets of nonconsolidated affiliates… Automotive China JVs equity income (loss)… Ultium Cells…” 【page_75】). This reflects a manufacturing model in which GM retains strategic control over the supply chain and vehicle production while partnering with affiliates for specific functions.\n\nMcDonald’s, by contrast, describes its affiliates as franchisees, developmental licensees and foreign affiliates that operate the restaurants and to which it charges rent, royalties and fees; these entities are not consolidated because the company does not direct their day‑to‑day operations (e.g., “The Company franchises and operates McDonald’s restaurants… All restaurants are either owned and operated by the Company or by franchisees… The consolidated financial statements include the accounts of the Company and its subsidiaries. Investments in affiliates owned 50% or less… are accounted for by the equity method” 【page_45】). This mirrors a franchise business model where the core value is the brand and system, while the affiliates own and run the physical outlets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: GM's use of nonconsolidated affiliates for vehicle and parts production—especially in China with joint ventures like those producing Baojun, Buick, Cadillac, Chevrolet, and Wuling vehicles—is accurately described, including the equity method accounting and references to specific entities like Ultium Cells. McDonald's franchise model, where it earns revenue via royalties, rent, and fees from franchisees without consolidating their operations, is also correctly portrayed. (2) There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is not applicable in a strict sense, but all references to financial structures (e.g., royalty-based revenue, equity method accounting) are factually sound. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes information across GM’s manufacturing partnerships and McDonald’s franchise operations, contrasting their business models—GM’s production-integrated affiliate relationships vs. McDonald’s asset-light, brand-driven franchising. (4) The only minor shortcoming is that the LLM does not explicitly name the brands (Baojun, Wuling, etc.) in the same contextual flow as the original answer, though they are implied via 'China joint ventures'. Additionally, the original emphasizes the 'service-based revenue' aspect of McDonald's more clearly. However, the core contrast in business models is well articulated. Wording differs but semantic equivalence is preserved. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 458,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s 2024 buy‑back removed roughly 73 million Class A shares (and 306 million Class C shares) for a total repurchase value of $62 billion【page_82†L31-L38】. Because each Class A share carries only one vote while each Class B share carries ten votes, the elimination of a large number of one‑vote shares lowers the total vote count in the company. With the Class B pool unchanged (or only modestly reduced by any conversions that occur when a Class B holder sells or transfers shares), the share of the remaining voting power that belongs to Class B shareholders rises, giving them a higher relative influence over corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly identifies the $62 billion repurchase amount and provides specific share numbers (73 million Class A and 306 million Class C), which are consistent with the filing data cited (page_82†L31-L38). While the original answer does not include these exact share counts, their inclusion adds precision and does not contradict the ground truth. The dollar amount and year (2024) are correct. (2) The reasoning correctly explains that reducing Class A shares through buybacks decreases the total number of low-vote shares outstanding, thereby increasing the relative voting power of Class B shareholders who retain 10 votes per share. (3) The multi-hop logic is sound: it connects share repurchases (reducing Class A) with the structural feature of Class B's superior voting rights and the automatic conversion upon transfer, leading to the conclusion that Class B holders gain relative influence. (4) The LLM omits explicit mention of the automatic conversion limiting Class B holders’ ability to transact without diluting their voting power, which is a minor omission from the original answer. However, the core insight about increased relative voting concentration among Class B shareholders is preserved and well-explained. Wording differs but semantic meaning matches. Minor deduction from 10 due to this omission, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 400,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and The Coca‑Cola Company adopted ASU 2020‑01 on January 1 2021. The update clarifies that any observable price changes in an equity security must be reflected in the security’s accounting before a company applies (or discontinues) the equity‑method measurement alternative, and that derivatives written on those securities are accounted for without treating the underlying equity as an equity‑method investment or applying the fair‑value option. Consequently, Colgate continues to record its equity securities at fair value (or, where the fair value is not readily determinable, at cost‑minus‑impairment under the measurement alternative) with changes recognized in earnings, and Coca‑Cola follows the same approach for its equity investments; in both cases the adoption was disclosed as having no material impact on the companies’ consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: both companies adopted ASU No. 2020-01 effective January 1, 2021, and both disclosed no material impact on their financial statements—this matches the original answer. The date and adoption status are correctly stated. (2) The answer accurately describes the core clarifications in ASU 2020-01: the requirement to consider observable transactions before applying or discontinuing the equity method, and the proper accounting for derivatives linked to equity securities without treating the underlying as equity-method investments or under the fair value option. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the standard’s technical provisions to how each company applies them (e.g., fair value or cost-minus-impairment treatment), and correctly notes that changes in fair value are recognized in earnings. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Coca-Cola’s disclosure of net unrealized gains and losses on equity securities still held at year-end, which is included in the original answer and adds specificity about financial statement disclosures. However, this omission does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. All entities (Colgate-Palmolive, The Coca-Cola Company, ASU 2020-01, equity securities, derivatives, equity method) are correctly identified and contextualized. The answer is fully relevant and addresses all parts of the question with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 439,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Under the U.S. Basel III Standardized Capital Rules, Goldman Sachs’ consolidated CET1 requirement for 2024 includes a Stress Capital Buffer of **6.2 %** of CET1 (see the “Stress Capital Buffer … 6.2 % as of December 2024” line in the Capital Framework table) 【page_208】. By contrast, Citibank’s own CET1 requirement is **7.0 %** – the sum of the 4.5 % regulatory minimum and the fixed 2.5 % Capital‑Conservation Buffer – because the FRB’s SCB (4.1 % for Citigroup) applies only to the holding‑company level, not to the bank subsidiary 【page_34】【page_35】. Thus Goldman Sachs builds a larger stress‑testing buffer into its capital plan, reflecting a more conservative, stress‑oriented approach, while Citibank relies solely on the standard conservation buffer, indicating a less stringent stress‑capital component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figures: Goldman Sachs' Stress Capital Buffer (SCB) of 6.2% and Citibank’s 7.0% CET1 requirement, composed of the 4.5% minimum and 2.5% Capital Conservation Buffer. These match the ground truth exactly. It also correctly notes that Citibank does not include an SCB at the subsidiary level, which aligns with the original answer’s implication that Citibank’s requirement lacks an explicit SCB component. (2) All numbers are accurate: 6.2%, 7.0%, 4.5%, and 2.5% are correctly cited. The explanation that Citibank’s 7.0% is the sum of 4.5% and 2.5% is mathematically correct. The mention of the FRB’s 4.1% SCB for Citigroup (holding company) is an additional but accurate detail not in the ground truth, but does not contradict it—rather, it enhances context by explaining why the SCB doesn’t apply to Citibank (the subsidiary). (3) The multi-hop reasoning is sound: the model correctly synthesizes that Goldman Sachs, as a consolidated entity, is subject to SCB at the reported level, while Citibank (a subsidiary) is not, hence the difference in capital adequacy approaches. This reflects a nuanced understanding of regulatory hierarchy under Basel III. (4) The conclusion that Goldman Sachs has a more conservative, stress-oriented approach versus Citibank’s reliance on standard buffers is logically derived and semantically equivalent to the ground truth’s interpretation. The only minor gap is that the original answer emphasizes Citibank’s lack of explicit SCB inclusion under the Standardized Approach, while the LLM attributes this to regulatory scope (holding vs. subsidiary level), which is correct but slightly shifts focus. This does not reduce factual accuracy but slightly affects qualitative framing. Overall, the answer is factually excellent, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 505,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana presence is limited to operating transmission assets – lines and substations listed under the “Other” category of its rate‑regulated transmission portfolio – and the filing does not disclose a dollar amount for those facilities. In contrast, Duke Energy’s Indiana operations are financed largely through tax‑exempt bonds; as of December 31 2023 the company had roughly $350 million (about $352 million) of tax‑exempt debt for Indiana, carrying a weighted‑average interest rate of about 3.8‑3.9 %.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states Duke Energy Indiana held $285 million in tax-exempt bonds as of December 31, 2023, but the LLM incorrectly reports approximately $350 million (or $352 million), which is a substantial overstatement (~24% higher). This error undermines the factual reliability of the answer. Additionally, the LLM introduces a weighted-average interest rate of 3.8–3.9%, which is not present in the original answer and cannot be verified against the provided ground truth, making it extraneous and potentially misleading. (2) On the NextEra Energy side, the LLM correctly notes that no dollar amount is disclosed for its Indiana transmission assets and that they are part of the 'Other' category in its portfolio. However, it omits specific, verifiable infrastructure details included in the original answer: 90 miles of transmission lines and 5 substations operating at 161–345 kilovolts. This omission reduces completeness and precision. (3) The qualitative reasoning is partially sound: the model identifies the contrast between NextEra’s physical infrastructure focus and Duke’s financing strategy via tax-exempt bonds, which aligns with the original answer’s comparative logic. However, the failure to include measurable infrastructure data for NextEra and the incorrect bond amount for Duke weakens the multi-hop synthesis. The core strategic contrast is recognized, but not fully substantiated with accurate data. (4) Contextual relevance is high—the response addresses the comparative question about operational infrastructure versus financing strategy and focuses on the correct entities (NextEra Energy and Duke Energy Indiana) and time frame (December 31, 2023). Despite incorrect numbers, the structure and intent of the answer are appropriate. Overall, the answer is partially correct but marred by critical numerical errors and omissions, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 533,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on a large ecosystem of third‑party developers and content licensors, and the company’s revenue is tied to the commissions it can retain.  Changes such as the new alternative‑payment‑processing rules required by the EU Digital Markets Act and U.S. litigation‑driven adjustments to how developers can communicate with consumers could shrink Apple’s commission rate or cause developers to withdraw apps, exposing Apple to supply‑side risk and regulatory‑related revenue volatility【page_13】.  \n\nMicrosoft, by contrast, generates most of its content internally (e.g., Xbox games, cloud services) and therefore does not face the same third‑party licensing risk, but its business is highly sensitive to how its own content is perceived; damage to the Microsoft brand from controversial content, privacy or AI‑related decisions can harm its reputation and overall results【page_32】.  Thus Apple’s risk stems from reliance on external content providers and payment‑policy changes, whereas Microsoft’s risk centers on brand‑reputation impacts tied to the content it creates and curates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers and commission-based revenue, regulatory pressures from the EU's DMA and U.S. litigation affecting alternative payment processing, and the associated risks of developer withdrawal and revenue volatility are accurately described. Microsoft's internal content production (e.g., Xbox games, cloud services) and its exposure to brand reputation risks from its own content decisions are also correctly identified. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no calculations or specific numbers are involved. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in business models (Apple’s platform/ecosystem vs. Microsoft’s vertically integrated content creation) and maps them to distinct risk profiles (supply-side and regulatory for Apple; brand and perception for Microsoft). The use of page references (e.g., 【page_13】, 【page_32】) suggests grounding in source material, though not required for correctness. (4) The LLM answer is semantically equivalent to the original, with slightly more detail (e.g., mentioning U.S. litigation and specific examples like Xbox), but does not introduce inaccuracies. One minor point preventing a perfect 10 is the slight expansion beyond the original scope (e.g., 'cloud services' as internally produced content is less directly tied to brand risk from content than Xbox games), but this does not distort the meaning. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 464,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company warns that a release of radioactive material such as tritium from its nuclear units could generate damages that “could exceed the amount of decommissioning trusts or external insurance coverage” (SO 10‑K p. 29). In contrast, NEE’s filing notes that “poor market performance … could materially adversely affect … nuclear decommissioning funds, increasing the funding requirements for these obligations” (NEE 10‑K p. 28‑32). Thus, Southern Company’s exposure is tied to a specific tritium‑leak liability that may surpass insurance, whereas NEE’s exposure is a broader risk that its decommissioning trusts may fall short and require additional capital contributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values (percentages, dollar amounts, years) in the LLM answer that contradict the original; the original mentions 2021 generation percentages (26%, 28%) which the LLM omits, but the question does not explicitly ask for those figures, so their absence does not constitute a critical error. (2) Quantitative accuracy is perfect—no incorrect numbers or miscalculations are present. (3) The multi-hop reasoning is sound: the LLM correctly identifies Southern Company’s tritium-related liability risk and cites its potential to exceed decommissioning trusts/insurance, and contrasts it with NEE’s risk of decommissioning fund shortfalls due to market performance. This captures the core comparison in the original answer—parallel financial exposures from nuclear risks, albeit through different mechanisms. (4) The LLM slightly simplifies the conclusion by not explicitly stating that both companies face 'comparable challenges' or 'parallel financial exposures,' but it effectively conveys the semantic equivalent by contrasting the nature of each risk while implying a similar financial vulnerability. The use of direct quotes from the 10-Ks enhances accuracy and sourcing. Only a minor reduction in qualitative accuracy due to less explicit synthesis of the 'comparable' nature of risks, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 397,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The 2021 corporate‑income‑tax cut in the Philippines lowered PMI’s statutory rate, which PMI notes “partially offset…the corporate income tax rate reduction in the Philippines (enacted in the first quarter of 2021)” and helped keep its 2021 effective tax rate only 0.1 percentage point above the U.S. statutory rate【page_94】. Because Altria (MO) records its 10 % equity stake in PMI using the equity‑method, the lower PMI tax rate feeds through to Altria’s consolidated effective tax rate, producing a modest reduction in Altria’s overall effective tax burden. Coca‑Cola’s balance sheet shows that property, plant and equipment in the Philippines represents about 10 % of its global PP&E【page_124】; the reduced Philippine tax rate therefore improves the after‑tax return on those assets and supports the company’s stated intent to expand capital spending in its Asia‑Pacific markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.1 percentage point impact on Altria's tax rate and the 10% of PPE in the Philippines for Coca-Cola, which aligns with the ground truth. However, it mischaracterizes the direction of the impact on Altria’s effective tax rate: the original answer states the Philippine tax cut contributed to an *increase* in Altria’s effective tax rate to 21.8%, implying a negative effect, while the LLM interprets it as a *reduction* in Altria’s tax burden due to lower PMI taxes, which contradicts the ground truth. This is a significant qualitative error in interpretation despite correct numerical inputs. (2) Quantitatively, the 0.1 percentage point figure and 10% PPE allocation are accurately reported, and the reference to Q1 2021 enactment is correct. The LLM correctly cites page 94 for PMI tax effects and page 124 for KO’s PPE, supporting data provenance. However, the misinterpretation of the sign (benefit vs. cost) of the tax change leads to an incorrect conclusion about Altria’s tax outcome. (3) The multi-hop reasoning is mostly sound—linking PMI’s tax rate to Altria via equity method accounting and connecting lower host-country taxes to improved returns on KO’s capital—is logically valid and reflects appropriate synthesis across entities. But the flawed inference on Altria’s effective tax rate undermines the correctness of the financial impact assessment. (4) Contextually, the response is highly relevant, addressing both companies and both aspects of the question (tax rate impact and investment strategy). The error lies not in relevance but in factual interpretation. Hence, correctness is reduced to 7 due to the directional error in a key financial conclusion, despite strong performance on data citation and structural reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 489,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "NVIDIA’s 2024 filing notes that it relies on Samsung Electronics as one of its primary wafer‑foundry partners for chip production. Qualcomm’s 2024 filing discloses $12.8 billion of multi‑year capacity purchase commitments for integrated‑circuit inventory and warns that “cancellation of outstanding purchase commitments … would require payment of costs … and we may be subject to incremental fees … or the loss of amounts paid … due to capacity under‑utilization” (QCOM Note 7‑8). Because Samsung also designs and sells its own ICs that compete directly with Qualcomm’s products, the company could give priority to its own product lines, limiting the wafer capacity available to Qualcomm and forcing Qualcomm to incur higher fees or miss minimum‑volume targets under those commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Samsung is a foundry partner to NVIDIA (Hop 1), competes with Qualcomm in ICs (Hop 2), and Qualcomm has $12.8 billion in multi-year capacity purchase commitments (Hop 3). The dollar amount is correctly cited and matches the original answer. (2) Quantitative accuracy is perfect: the $12.8 billion figure is correctly reported with no calculation errors. (3) The reasoning is sound and captures the multi-hop logic: Samsung’s dual role as supplier to NVIDIA and competitor to Qualcomm creates a conflict of interest that could lead to capacity prioritization issues, impacting Qualcomm’s ability to meet its commitments. The LLM correctly infers that this could result in financial penalties or under-utilization costs, citing Qualcomm’s own risk disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention the need for Qualcomm to potentially renegotiate terms or shift to higher-cost alternative suppliers, which is part of the original answer’s conclusion. However, the implication of incurring higher fees or missing volume targets effectively conveys similar consequences. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the core concern of how Samsung’s priorities might impact Qualcomm’s financial commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 388,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin reports that about **$665 million of its receivables are owed by commercial‑sector customers** (the remainder being government receivables) as of 31 Dec 2024.  Because Lockheed Martin and Boeing each own roughly 50 % of United Launch Alliance, that commercial‑customer cash base helps support the joint‑venture’s liquidity, and the venture is already contributing earnings to its owners – Boeing’s 50 % equity stake produced **$125 million of equity‑method income in 2024** (up from $44 million in 2023).  Together, the commercial receivables bolster Lockheed’s ability to fund its half of ULA, while the joint venture is generating measurable profit for both partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: Lockheed Martin's $665 million in commercial customer receivables as of December 31, 2024, and Boeing's $125 million equity income from ULA in 2024. These match the ground truth exactly, including the date and amount. The 50% ownership split between Lockheed Martin and Boeing in ULA is also accurately stated.\n\n2) Quantitative accuracy is perfect: both dollar amounts ($665M receivables, $125M equity income) and percentages (50% ownership) are correct. The LLM even adds contextually accurate supplementary data—Boeing’s equity income increased from $44M in 2023—which is plausible and does not contradict the ground truth, though not part of it. This addition does not detract from accuracy.\n\n3) The reasoning is largely sound and captures the multi-hop logic: (a) Lockheed has significant commercial receivables, (b) ULA is a commercial customer and joint venture, (c) both partners benefit from ULA’s performance. The LLM correctly infers that commercial receivables support ULA’s liquidity and Lockheed’s ability to fund its stake. However, it slightly mischaracterizes the direction of the impact: the original answer emphasizes that ULA’s financial health affects Lockheed’s receivables (i.e., risk to Lockheed), while the LLM frames receivables as supporting ULA (i.e., benefit to ULA). This reverses the risk implication slightly, though both relationships can coexist. This is a minor qualitative shortcoming in causal reasoning.\n\n4) The answer is contextually relevant and addresses all parts of the question: impact of receivables on ULA’s financial position, Boeing’s equity stake, and reported income. It synthesizes across entities (Lockheed, Boeing, ULA) and financial metrics (receivables, equity income) appropriately. The semantic meaning is very close to the original, with only nuanced differences in emphasis.\n\nOverall, the answer is factually excellent with strong multi-hop synthesis, meriting a 9/10 for correctness due to the slight misdirection in causal impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 552,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The court’s decision that the “190” CAR‑T patent was invalid meant that the IPR&D intangible Gilead recorded when it acquired Kite could no longer be amortized.  Consequently, Gilead’s annual amortization charge for the finite‑life intangibles that included the Kite patent was reduced by roughly **$200 million per year** after the acquisition.  (The reduction is reflected in the lower amortization expense reported for the post‑acquisition period in Gilead’s 2020‑2021 10‑K.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) It incorrectly states that the invalidation of the '190 patent caused the IPR&D intangible to no longer be amortized, leading to a $200 million annual reduction in amortization expense. This contradicts the ground truth: amortization expense *increased* from $1.2 billion in 2020 to $1.7 billion in 2021—a $500 million increase, not a $200 million decrease. (2) The direction of the financial impact is completely reversed: the resolution of patent risk improved the valuation of intangible assets, supporting higher amortization due to a clearer path to monetization, not lower. (3) The date of invalidation (August 2021) is missing, and the claimed $200M/year reduction is unsupported by the data. (4) The reasoning is flawed: patent invalidation removed royalty liabilities, which positively affected asset valuation and amortization, not the other way around. The LLM misinterprets the accounting implications of patent litigation outcomes on intangible asset amortization. While the answer addresses the general topic (patent invalidation affecting amortization), the core financial claims and logic are incorrect, resulting in a low correctness score. Contextual relevance is moderate as it attempts to address the question’s domain, but accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 380,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater‑China segment generated **$74.2 billion** of net sales in 2022 (which includes mainland China, Hong Kong and Taiwan)【page_52】.  \n\nIntel reported **$13.5 billion** of net revenue from Taiwan in 2021【page_87】.  \n\nThus Apple’s Greater‑China revenue was about **$60 billion (roughly five‑times) larger** than Intel’s Taiwan revenue for the respective years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 Greater China revenue as $74.2 billion (equivalent to $74,200 million in the ground truth) and Intel's 2021 Taiwan revenue as $13.5 billion (accurate rounding of $13,461 million). These values are quantitatively precise with acceptable formatting variations. (2) The calculation comparing the two—stating Apple’s revenue was about $60 billion (roughly five times) larger—is logically sound: $74.2B - $13.5B = $60.7B difference, and $74.2B / $13.5B ≈ 5.5x, so 'five-times larger' is a reasonable approximation. (3) The multi-hop reasoning is correct: the model synthesizes data from two different companies (Apple and Intel), two different regions (Greater China vs. Taiwan), and two different years (2022 vs. 2021), while acknowledging that Greater China includes Taiwan, which addresses the comparative complexity in the question. (4) The only minor shortcoming is that the LLM does not explicitly note that Apple’s figure includes Taiwan as part of Greater China, which slightly weakens the qualitative reasoning around regional overlap—though it does mention Taiwan is included in the segment. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 356,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its over‑the‑counter interest‑rate and foreign‑currency derivatives with pricing models that use market‑observable inputs – chiefly current yield curves, FX rates and forward prices – and classifies those derivatives as Level 2 assets. Boeing’s fixed‑income holdings (including interest‑rate swaps) are likewise measured at Level 2, using observable market data such as quoted interest rates, yield‑curve points and credit spreads. Thus, both companies’ valuation practices depend heavily on observable market inputs, with UPS applying them to derivative fair‑value models and Boeing applying them to the valuation of its fixed‑income investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: UPS uses observable market data like yield curves and FX rates for valuing derivatives classified as Level 2; Boeing values its fixed-income investments, including interest rate swaps, using observable inputs such as interest rates, yield curves, and credit spreads, also as Level 2. There are no numeric values requiring calculation, but the classification references (Level 2) are correctly applied. (2) Quantitative accuracy is perfect—no numerical errors, and all referenced inputs (yield curves, credit spreads, FX rates) match the original. Format variations (e.g., 'quoted interest rates' vs 'interest rates') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes valuation practices across two different companies (UPS and Boeing), linking their use of observable inputs to Level 2 classification under fair value hierarchy, despite applying them to different instruments (derivatives vs fixed income). (4) The only minor shortcoming is slight underemphasis on the distinction that UPS focuses on foreign exchange derivatives while Boeing’s use pertains more broadly to fixed income—including credit spreads as a highlighted input—though this is implied. Still, the core comparison is accurately captured. Hence, a score of 9 is justified—excellent accuracy with negligible room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 401,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "Meta uses discounted‑cash‑flow models for impairment testing of its lease‑right‑of‑use assets and lease‑hold improvements, applying Level 3 (unobservable) inputs that reflect market‑participant assumptions about the assets’ future cash flows – specifically the expected downtime before subleasing, the projected sublease income over the remaining lease term and a discount rate that captures the risk of receiving those cash flows. Disney, by contrast, values its Level 2 derivatives with internal discounted‑cash‑flow models that rely on observable market inputs – current interest‑rate curves, yield‑curve data and foreign‑exchange rates – with only a modest adjustment for counter‑party credit risk. Thus Meta’s models are driven by asset‑specific cash‑flow forecasts and management‑derived risk rates, whereas Disney’s models are driven by market‑observable rates and curves.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: Meta uses DCF models with Level 3 (unobservable) inputs for impairment testing of ROU assets and leasehold improvements, specifically citing expected downtime, projected sublease income, and risk-adjusted discount rates. Disney uses internal DCF models for Level 2 derivatives with observable inputs like interest rate curves, yield curves, and foreign exchange rates, with only minor adjustments for counterparty credit risk. (2) There are no numeric values requiring calculation in this question, but the classification of inputs (Level 2 vs Level 3) is correctly applied per GAAP fair value hierarchy, and the description of inputs matches the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Meta and Disney), two distinct financial applications (impairment testing vs derivative valuation), and two different fair value levels (Level 3 vs Level 2), drawing a clear contrast in input observability and risk profile. (4) The answer captures all nuances: Meta’s reliance on management assumptions and asset-specific forecasts versus Disney’s use of market-observable data. Wording differs slightly but meaning is preserved and enhanced with precise terms like 'market-participant assumptions' and 'modest adjustment for counterparty credit risk.' All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 408,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The 2022 filing notes that a global semiconductor shortage left the IQOS device supply “tight” in the second half of 2021 and that, even after the fourth‑quarter easing, PMI still lacks full visibility on 2022 availability ( p. 28 ). Because PM USA’s exclusive U.S. right to sell PMI’s heated‑tobacco products is conditioned on FDA authorization—an MRTP for the newer IQOS 3 is still under FDA review ( p. 36‑37 )—and the ITC import ban has kept IQOS off U.S. shelves ( p. 28‑29 ), the supply constraint directly hampers PM USA’s ability to commercialize the product in the United States. At the same time, PM USA serves as the guarantor of Altria’s debt ( p. 51 ); while the guarantee is “absolute and unconditional,” a prolonged inability to sell IQOS reduces the cash‑flow base that would support those obligations, potentially stressing PM USA’s capacity to meet its guarantor role even though the legal liability itself does not change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the global semiconductor shortage affecting IQOS supply in the second half of 2021 is accurately cited from PM's 2022 filing, the ITC import ban halting U.S. sales (post-November 29, 2021), and the ongoing FDA review of IQOS 3's MRTP application are all correctly referenced. The role of PM USA as guarantor of Altria’s debt is accurately stated. (2) There are no numeric inaccuracies—dates and references to filing pages (e.g., p.28, p.36-37) are consistent with source documentation, and no calculations are required. (3) Multi-hop reasoning is sound: the answer correctly links the supply constraint → commercialization barrier → regulatory dependency (FDA) → financial risk via PM USA’s guarantor role. It logically infers that reduced cash flows could stress PM USA’s ability to support debt obligations, even if legal liability remains unchanged—this mirrors the ground truth’s concern about fraudulent conveyance risks. (4) The only minor omission is the explicit mention of 'fraudulent conveyance laws' and the specific impact on dividend distributions to Altria, which are present in the original answer and add nuance to the financial risk. However, the core financial implication—reduced cash flow affecting PM USA’s capacity as guarantor—is clearly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness due to this slight gap in completeness, despite excellent accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 427,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "Bristol Myers Squibb notes that biosimilar entrants could erode sales of its biologic medicines, but because its product portfolio is broadly diversified the company expects only a modest, incremental hit to its overall revenue outlook. In contrast, AbbVie’s outlook is far more exposed – Humira alone generated roughly 27 % of AbbVie’s 2023 net revenues and is now confronting direct biosimilar competition worldwide, making the potential revenue impact far larger.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 27% figure for Humira's contribution to AbbVie's 2023 net revenues is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The LLM correctly identifies both companies (BMY and ABBV), the relevant product (Humira), and the year (2023), satisfying entity accuracy. (3) The reasoning correctly synthesizes the multi-hop aspect: it contrasts ABBV's concentrated risk (Humira as a single high-revenue product under biosimilar pressure) with BMY's broader but more diversified exposure across multiple products like Eliquis and Revlimid (implied through context, though not named). The LLM slightly softens BMY's risk by stating 'modest, incremental hit,' which is a reasonable interpretation but less precise than the original's emphasis on 'significant risk' and 'rapidly erode revenues.' (4) Despite this minor tonal difference, the core comparison—ABBV facing larger potential impact due to revenue concentration versus BMY's diversified but still exposed portfolio—is semantically equivalent and logically sound. The answer is fully relevant to the question. Thus, the correctness score is 9 due to slightly less precise characterization of BMY's risk level, but all key facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 376,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "- **Philip Morris (PM)** – RSUs “earn dividend equivalents” that are treated as participating securities and are **included in earnings‑per‑share calculations during the restriction period**; they are not paid out as a separate cash distribution.  PM’s RSUs generally **vest on the third anniversary of the grant date** (or earlier on death, disability or age‑58).  \n\n- **PepsiCo (PEP)** – RSUs (and PSUs) **accrue dividend equivalents that are held in cash and are paid out in cash – without interest – only when the award actually vests**.  PEP’s RSUs vest **at the end of the service period** (the vesting date specified in each award).  \n\nThus, PM’s dividend equivalents are accounted for while the award is still unvested, whereas PEP’s equivalents are paid out as cash at the moment of vesting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PM includes dividend equivalents during the vesting period that are not paid out in cash but are included in EPS calculations, and payouts occur upon vesting (typically at 3 years or earlier due to death, disability, or age 58). PEP accrues dividend equivalents in cash, paid without interest upon vesting at the end of the service period. (2) Quantitative elements—such as the three-year vesting for PM and the timing tied to grant date—are consistent with the original answer; no numerical inaccuracies present. (3) Multi-hop reasoning is sound: the model correctly contrasts PM’s accounting treatment and vesting triggers (including age-based) with PEP’s cash payout structure and strict service-based vesting, highlighting structural differences in equity compensation. (4) Minor omission: the original answer notes PEP’s use of performance-based vesting for PSUs, which the LLM mentions briefly ('PSUs') but does not fully elaborate in the comparative context. However, this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually robust, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 358,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s 2024 filing shows that $1.41 billion of its run‑off insurance assets are held in limited‑partnership real‑estate funds that are “generally not redeemable” and can only be sold with the general‑partner’s approval, meaning the investment is highly illiquid and its cash‑flow depends on the underlying properties being liquidated. By contrast, Boeing’s pension plan allocates roughly 7 % of its assets (about $2.9 billion) to real‑estate and real‑asset funds that are also held through LPs, but this exposure is embedded in a broadly diversified portfolio with short‑term cash, derivatives and rebalancing policies that mitigate liquidity risk, making the overall liquidity profile less concentrated than GE’s standalone $1.41 billion illiquid holding.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.41 billion (equivalent to $1,410 million) for GE is correctly reported, and Boeing's ~$2.9 billion real estate allocation is consistent with a 7% portfolio allocation (implied total portfolio ~$41.4 billion), which is plausible and contextually supported. While the exact $2.9B figure isn't in the original answer, it is a reasonable inference from public pension data and does not contradict the ground truth. (2) The entity identification is correct: GE’s run-off insurance operations and Boeing (BA) via its pension plan are accurately referenced. The use of limited partnerships (LPs) for both is correctly noted. (3) The reasoning is sound: the LLM correctly identifies that both firms use fund structures with limited liquidity, but contrasts GE’s concentrated, standalone illiquid holding with BA’s diversified, integrated strategy that includes rebalancing and cash management to mitigate liquidity risk—this matches the original answer’s emphasis on GE’s concentration and dependency on GP approval vs. BA’s broader framework. (4) Minor deduction in quantitative accuracy because the $2.9B and 7% figures, while plausible, are not present in the ground truth and represent an inference beyond the provided data. However, this does not distort the comparison. The answer is semantically equivalent and contextually excellent, fully addressing liquidity risk and fund structure as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 411,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "- **Bank of America (BAC)** – The equity‑market hedge program is recorded at a **notional amount of about $23.6 billion**.  In the 10‑% equity‑price‑decrease scenario the derivative portfolio would generate an estimated **fair‑value loss of roughly $522 million**.  \n\n- **MetLife (MET)** – The equity‑market derivative positions are far smaller, appearing in the fair‑value hierarchy as roughly **$800 million** of equity‑market derivative assets (Level 1 $8 m, Level 2 $785 m, Level 3 $7 m).  The filing does not provide a specific sensitivity figure for a 10 % equity‑price decline, implying that the potential impact is either immaterial or not disclosed in the excerpts.  \n\n**Comparison:** BAC’s equity‑market exposure is an order of magnitude larger (≈ $23.6 billion vs. ≈ $0.8 billion) and its sensitivity to a 10 % equity‑price drop is explicitly quantified at $522 million, whereas MetLife’s exposure is modest and no comparable sensitivity amount is presented.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It incorrectly assigns the notional value of $23.6 billion and a $522 million sensitivity loss to BAC, when in fact these figures belong to MET according to the ground truth. The LLM flips the companies, attributing MET's quantified exposure to BAC and then claiming MET has only $800 million in equity derivatives, which contradicts the original answer. (2) Quantitative accuracy is severely compromised: the $23,595 million notional and $522 million sensitivity are correctly stated in the ground truth as MET's metrics, but the LLM misattributes them to BAC. Additionally, the $800 million figure for MET is fabricated and not supported by the original answer, which does not mention such a breakdown or fair value hierarchy for MET. (3) The multi-hop reasoning is flawed — instead of contrasting BAC's lack of disclosed notional/sensitivity values with MET's explicit disclosure, the LLM invents data and reverses the roles of the two companies. This undermines the core comparison. (4) Contextual relevance is moderate because the answer attempts the right structure (comparing notional value and sensitivity) and mentions relevant derivative types, but the reversal of facts renders the conclusion invalid. The original answer emphasizes that BAC does not disclose exact notional amounts, while the LLM falsely claims it does. Thus, despite correct terminology and structure, the factual inversion leads to a largely incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 416,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 10‑K shows that the Greater China segment generated $74.2 billion of net sales – roughly 19 % of the company’s total revenue – and the region is supported by a dedicated operations centre in Singapore (which serves Greater China, Japan and APAC) and a modest $35 million of property‑and‑equipment assets in China【page_25】. AMD’s 2022 filing reports that sales to customers in Taiwan were $2.091 billion, about 13 % of its total external‑customer revenue of $16.434 billion【page_78】.  \n\nThis suggests that Microsoft pursues a broad, multi‑product market strategy in Greater China, investing in local sales, services and infrastructure, whereas AMD’s business is more concentrated, relying heavily on Taiwan’s semiconductor ecosystem for a sizable share of its revenue, indicating a more focused regional reliance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and misrepresents Microsoft's revenue from Greater China. The ground truth does not state that Microsoft generated $74.2 billion in net sales from Greater China in 2022, nor that this represented 19% of total revenue — this figure is fabricated or misattributed. Microsoft’s actual revenue from Greater China is not provided in the original answer, and no such percentage or dollar amount appears in the ground truth. Additionally, the claim that Microsoft has a 'dedicated operations centre in Singapore' serving Greater China is partially correct but over-specified; the original answer only states that Microsoft operates a regional center in Singapore supporting Greater China, without specifying it as 'dedicated' or extending to Japan and APAC. The AMD figures are correct: $2.091 billion in sales to Taiwan in 2022, which aligns with the ground truth (reported as $2,091 million), and this represents approximately 13% of AMD’s total external revenue — a valid calculation from the provided data. (2) Quantitative accuracy is compromised by the invented Microsoft revenue figure. While AMD’s numbers are accurate and properly contextualized, Microsoft’s $74.2B and 19% are unsupported by the original answer and likely incorrect. The $35 million in property-and-equipment in China is not mentioned in the ground truth and cannot be verified here, so its inclusion reduces quantitative reliability. (3) The multi-hop reasoning is generally sound: the model correctly contrasts Microsoft’s operational hub model with AMD’s revenue concentration in Taiwan. It infers strategic differences — broad market access vs. focused reliance — which aligns with the original conclusion. However, the reasoning is built partly on false quantitative premises for Microsoft, weakening the synthesis. (4) Despite the numerical inaccuracies, the qualitative interpretation of regional strategies is consistent with the ground truth: Microsoft using regional infrastructure for broad presence, AMD showing high revenue dependency on Taiwan. The answer remains contextually relevant and addresses both parts of the question — operational footprint vs. revenue concentration — and draws a reasonable strategic comparison. Hence, correctness is reduced primarily due to unsupported financial figures for Microsoft, not flawed logic or misinterpretation of strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 646,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares ten votes each while Class A shares have only one vote, and the holders of the relatively small amount of Class B stock (including Mark Zuckerberg) control a majority of the voting power and can “limit or preclude” Class A shareholders’ ability to affect corporate‑governance matters【page_49】. In contrast, Netflix uses a single‑class system in which every share of common stock carries one vote, so all shareholders have an equal vote on matters submitted to a stock‑holder meeting, giving investors a far greater ability to influence governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies META's dual-class structure, specifying that Class B shares have ten votes versus one for Class A, which is factually correct and matches the implied disproportionate voting power in the original answer. The mention of Mark Zuckerberg and the control held by Class B shareholders is accurate. (2) Quantitatively, the 10:1 voting ratio is correct, and there are no numerical inaccuracies. (3) The comparison to NFLX's one-share-one-vote system is correctly stated, with accurate description of equal voting rights for all shareholders. (4) The reasoning correctly synthesizes the contrast in corporate governance approaches: founder control (META) vs. broad shareholder participation (NFLX), even if the exact phrase 'one-share-one-vote' is not used, the meaning is preserved. The only minor shortcoming is that the original answer explicitly frames the difference as reflecting 'divergent approaches to corporate governance,' a slightly more interpretive conclusion that the LLM implies but does not fully articulate. However, the core facts, multi-hop comparison, and implications for investor influence are sound and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 344,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "For Johnson & Johnson, market exclusivity is tied directly to its patent portfolio.  When a compound‑patent or related use‑/formulation‑patent expires, the company loses the legal right to block generics or biosimilars, and sales typically fall sharply because the product’s “effective market exclusivity” ends (see the discussion that “loss of effective patent protection … typically results in the loss of effective market exclusivity… often leading to a severe and rapid decline in revenues” – JNJ 10‑K).  \n\nEli Lilly, by contrast, leans more on statutory regulatory exclusivities—such as the five‑year new‑drug exclusivity, seven‑year orphan exclusivity, twelve‑year biologics exclusivity and six‑month pediatric extensions—to keep competitors out even after patents run out, using those extensions as the primary tool for maintaining a competitive advantage in the U.S. market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JNJ's market exclusivity is primarily patent-dependent and that patent expiration leads to rapid revenue decline due to generic competition, citing the exact language from JNJ’s 10-K about 'loss of effective patent protection' leading to 'severe and rapid decline in revenues.' This matches the original answer’s emphasis on patent erosion and legal challenges. (2) For LLY, the LLM accurately describes reliance on regulatory exclusivity extensions—specifically naming five-year new-drug, seven-year orphan, twelve-year biologics, and six-month pediatric exclusivities—as tools to extend market protection beyond patent terms. While the original answer references BMY’s 10-K to support the general principle of regulatory exclusivity outlasting patents, the LLM infers this correctly and applies it to LLY’s strategy without misrepresenting facts. (3) Multi-hop reasoning is sound: the model contrasts JNJ’s vulnerability to patent expiration with LLY’s proactive use of regulatory mechanisms, synthesizing concepts across companies and regulatory frameworks. (4) No numeric inaccuracies exist; all timeframes (e.g., 5, 7, 12, 6 months) are correct and consistent with U.S. FDA exclusivity rules. The only minor limitation is that the LLM does not explicitly mention 'increasingly aggressive challenges to patents' for JNJ, slightly reducing completeness in qualitative nuance, but the core reasoning and factual content remain robust. Thus, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 440,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s 2021 interest expense fell to $34 million from $47 million in 2020 – a $13 million reduction that the company said resulted from holders converting its 2.125 % convertible senior notes due 2026.  By contrast, after Microsoft’s March 2022 acquisition of Nuance, only about $1 million of Nuance’s original $986 million convertible senior notes remained outstanding (the rest were redeemed).  The contrast shows AMD is actively using convertible‑debt conversions to cut financing costs and deleverage its balance sheet, whereas Microsoft eliminated essentially all of Nuance’s convertible‑note liability in the deal, reflecting a strategy of cleaning up legacy debt rather than relying on ongoing convertible financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's interest expense decreased from $47M in 2020 to $34M in 2021 ($13M reduction), attributed to conversions of its 2.125% Convertible Senior Notes due 2026. Nuance had originally issued $986M in convertible notes, and by post-acquisition (after Microsoft's March 2022 acquisition), only $1M remained outstanding after redemption of $985M. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar amounts, the timeframes (2020–2021 for AMD, March 2022 acquisition for Nuance), and the implied calculation of the $13M reduction are correct. Format variations (e.g., $34 million vs $34M) are acceptable and clear. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s debt conversion strategy and Nuance’s redemption under Microsoft, drawing a valid comparison between AMD’s proactive deleveraging via conversions and Microsoft’s post-acquisition cleanup of Nuance’s legacy debt. (4) The only minor shortcoming is a slight shift in emphasis: the original answer explicitly notes that the remaining $1M liability is now held within Microsoft’s Intelligent Cloud segment, which the LLM omits. While not critical to the core comparison, this detail adds context about capital structure integration post-acquisition. Otherwise, the reasoning, entity identification (AMD, Nuance, Microsoft), and financial terminology are accurate and semantically equivalent to the ground truth. The answer is fully relevant and directly addresses the comparative capital structure strategies implied by the two companies’ handling of convertible debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 466,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The American Tower deal was larger – Verizon received an upfront $5.0 billion in March 2015 for the exclusive right to lease and operate about 11,300 towers, whereas AT&T’s Crown Castle transaction in December 2013 brought $4.827 billion for exclusive rights to roughly 9,000 towers (plus the purchase of 627 towers). In both cases the tower owners (Verizon and AT&T) kept the towers on their balance sheets, recorded a financing‑obligation liability for the cash received, and continue to depreciate the towers in property, plant and equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion American Tower payment to Verizon in March 2015 for 11,300 towers and the $4.827 billion Crown Castle transaction with AT&T in December 2013 for ~9,000 towers plus 627 purchased towers—matching the ground truth numerically and contextually. All dollar amounts, dates, and tower counts are accurate. (2) Quantitative accuracy is perfect: $5.0B vs $4.827B, correct years (2015 vs 2013), and approximate tower numbers (11,300 vs 9,048 + 627). The comparison that the American Tower deal was larger is factually correct. (3) The reasoning is sound—both transactions involved sale-leaseback structures where the telecom retained ownership on the balance sheet, recorded financing obligations, and continued depreciation. The LLM correctly captures this key accounting treatment and the economic nature of the deals. (4) The only minor omission is that the ground truth includes specific leaseback terms (Verizon: minimum 10 years; AT&T: ~20 years), which the LLM does not mention. This contextual detail about lease duration is relevant to the comparison but not central to the core financial and structural comparison. Otherwise, the answer is semantically equivalent and highly accurate. Thus, correctness is 9/10 due to this partial omission, but quantitative accuracy and relevance remain perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 380,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power places its wind farms in tax‑equity partnerships in which the tax partner receives essentially all of the federal production‑tax‑credit (PTC) benefit, while the wind assets are backed by long‑term power‑purchase agreements (PPAs) of up to 25 years that lock in a stable revenue stream for the partnership (see pages 97 and 268). Duke Energy’s renewable assets are also held in VIEs that rely on tax‑equity arrangements, but the company’s approach is to guarantee debt service and O&M for the VIEs and use the tax‑equity investor to monetize the PTCs rather than tying the credit monetization to a single, long‑term PPA (see pages 202‑204). Thus, Southern Power couples tax‑equity financing with long‑term PPAs, whereas Duke Energy uses VIE guarantees and tax‑equity structures to capture the credits without the same explicit 25‑year PPA linkage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Southern Power uses tax equity partnerships where the tax partner captures most PTC benefits, supported by long-term PPAs of up to 25 years; Duke Energy uses VIEs with tax equity investors and guarantees debt and O&M, monetizing PTCs through a different structure. (2) Quantitative accuracy is perfect: the 25-year PPA term is correctly cited, and no numerical errors are present. Format and references to document pages (e.g., 97, 268, 202–204) are consistent with expected sourcing, though not part of the ground truth per se, they indicate precise anchoring. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Southern Power’s PPA-linked tax equity model and Duke’s VIE-based, guarantee-supported approach. It accurately contrasts the explicit 25-year PPA linkage in Southern Power’s model versus Duke’s broader financing structure without that same direct linkage. (4) The only minor shortcoming is that the LLM does not explicitly mention the HLBV consolidation method used by Southern Power, which is a detail included in the original answer and relevant to accounting for the partnerships. However, this omission does not undermine the core comparison about tax credit monetization and PPA structuring. Overall, the answer captures the essential contrast in strategy with high fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 410,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "Comcast’s charter gives each Class B share ten votes (versus one vote for Class A and no votes for Class C) and allows the shares to be converted into Class A at the holder’s option; any amendment that would diminish a class’s rights must be approved by that class and by the board, so the relatively few Class B holders can dominate board elections and major corporate actions while still being subject to a conversion‑and‑consent safeguard. Alphabet’s dual‑class system likewise concentrates voting power in a small pool of insider‑owned Class B shares (10 votes each) while the publicly‑traded Class A shares have only one vote and the non‑voting Class C shares have none, meaning public shareholders have far less ability to influence mergers, amendments or other strategic decisions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that CMCSA's Class B shares have ten votes, when in fact CMCSA's Class B common stock has *no voting rights*—this is a critical inversion of the truth. The original answer correctly notes that CMCSA Class B shares lack voting rights unless specific conditions are met. Instead, the LLM attributes Alphabet's (GOOGL) voting structure to Comcast (CMCSA), confusing the two companies' structures. (2) The LLM claims CMCSA has Class A, B, and C shares with varying voting rights (10, 1, 0), but CMCSA does not have a Class C stock in its capital structure—this is a GOOGL feature. GOOGL does have Class A (1 vote), Class B (10 votes, held by insiders), and Class C (no vote) shares. (3) The reasoning is flawed because it fails to correctly attribute the dual-class structures: it incorrectly asserts that CMCSA has a multi-tiered voting system like GOOGL, when in reality CMCSA’s governance is more uniform among voting shareholders, with only Class A having regular voting rights and Class B being non-voting. (4) While the description of GOOGL’s structure is mostly accurate and the general theme of concentrated voting power is relevant, the misattribution of voting rights to CMCSA severely distorts the comparison. The LLM answer inverts the core facts, making the comparison between the two companies’ governance models invalid. Due to these fundamental errors in entity attribution and voting rights, the correctness, quantitative, and qualitative accuracy scores are low. Contextual relevance is moderate because the answer addresses the right topic (voting rights and governance) and attempts a comparative analysis, but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 475,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s dual‑class structure gives its insiders a disproportionate say: every Class A share carries one vote while each Class B share carries ten votes (Alphabet 10‑K p. 81). In 2023 the company bought back $62.2 billion of Class A and Class C stock, shrinking the pool of low‑vote shares and thereby raising the voting weight of the remaining Class B shares and concentrating control with the founders and other Class B holders. Netflix, by contrast, has a single‑class equity where each common share gets one vote (Netflix 10‑K p. 61), so any share repurchases affect voting power uniformly and do not create a similar control premium.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (1 vote for Class A, 10 votes for Class B), the $62.2 billion share repurchase in 2023, and NFLX's one-share-one-vote structure are accurately stated. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount is correctly cited, and no calculations are required beyond accurate interpretation. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how repurchasing Class A and C shares (which have lower voting rights) reduces the total voting pool, thereby increasing the relative voting power of Class B shareholders, and contrasts this with Netflix’s uniform voting structure. (4) The answer addresses all parts of the question: control dynamics due to voting structures, impact of repurchases on control, and the comparative aspect between GOOGL and NFLX. Wording differs slightly but meaning is preserved, and citations to 10-K pages (though not required) add precision. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 313,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "Bristol‑Myers Squibb kept the right to receive royalties on the former Amylin diabetes products – including Byetta – after it sold its diabetes business.  Those retained royalty rights are a material source of earnings; the company said that royalties generated roughly **$1.9 billion of pretax income in 2021** and that “third‑party royalties represent a significant percentage of our pretax income and operating cash flow” (BMY 10‑K p. 48; BMY 10‑K p. 46).  Although the Byetta trademark is now owned by Eli Lilly, the royalty stream continues to provide BMY with a sizable, ongoing cash‑flow contribution despite no longer marketing the product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the $1.9 billion pretax income figure from 2021 is correctly cited and matches the original answer. The reference to BMY's 10-K (pages 48 and 46) supports the claim and adds verifiability. (2) The answer is complete, addressing all aspects of the question: BMY's retention of royalty rights post-divestiture, the financial significance of those royalties, the continued ownership of the Byetta trademark by LLY, and the ongoing financial relationship despite no longer marketing the product. (3) Entity accuracy is correct—Bristol-Myers Squibb (BMY), Eli Lilly (LLY), Byetta, and Amylin are all properly identified with correct relationships. (4) The multi-hop reasoning is sound: it connects BMY’s historical ownership via Amylin, the divestiture, retention of royalties, current trademark ownership by LLY, and the financial impact—all required to answer the complex, multi-entity question. (5) Semantic equivalence is strong; the LLM conveys the same core message as the ground truth with slightly expanded context (e.g., quoting the 10-K language about third-party royalties being a significant percentage of income and cash flow), which enhances rather than distorts accuracy. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 370,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s capital rules require both a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer, so its minimum total risk‑based capital ratio (regulatory minimum + buffers) is 10.5 % (the 5.5 % Basel‑III minimum plus the 5 % combined buffers)【page_122】. JPMorgan Chase Bank, by contrast, applies only the 2.5 % capital‑conservation buffer to the standard 8 % Basel‑III minimum, also yielding a 10.5 % minimum total risk‑based capital ratio (8 % + 2.5 %)【page_291】. Thus, Schwab’s higher‑total buffer (5 % vs. 2.5 %) raises its underlying regulatory floor, while both firms end up with the same 10.5 % minimum total risk‑based capital ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Schwab has a 2.5% stress capital buffer and a 2.5% capital conservation buffer, totaling 5% in buffers, leading to a 10.5% minimum total risk-based capital ratio. It also correctly states that JPMorgan Chase applies only a 2.5% capital conservation buffer, resulting in the same 10.5% requirement. These figures match the ground truth exactly. (2) The calculations are accurate: Schwab’s 5.5% Basel-III minimum + 5% buffers = 10.5%; JPMorgan’s 8% minimum + 2.5% buffer = 10.5%. While the ground truth does not specify the Basel-III base minimums (5.5% vs 8%), the LLM’s use of these numbers is consistent with regulatory frameworks and explains the differing starting points logically. The final ratios are correct and align with the original answer. (3) The multi-hop reasoning is sound—comparing two firms’ capital structures, identifying buffer differences, and explaining why the total requirement ends up the same despite different buffer compositions. The synthesis across entities is accurate. (4) The only minor deviation from the original answer is that the LLM introduces specific base minimums (5.5% and 8%) not explicitly mentioned in the ground truth, which could imply a slight over-assumption, but this does not detract from factual correctness as these values are regulatory常识 and support a plausible explanation. Overall, the answer is semantically equivalent, quantitatively precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 411,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "The Lockheed Martin credit facility already contains fallback language that will automatically replace any USD‑LIBOR reference with an alternative rate (generally SOFR) when LIBOR is discontinued, and the company will apply the ISDA 2020 IBOR‑fallback protocol. General Electric’s floating‑rate debt and its LIBOR‑linked preferred‑stock are subject to the same New York‑statute fallback, so they will be deemed to switch to SOFR + a spread adjustment. Because both companies can rely on the optional expedients in ASU 2020‑04, the transition is expected to be accounted for with minimal impact on earnings, balance‑sheet amounts or cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: LMT’s credit facility uses fallback provisions (SOFR) and ISDA 2020 IBOR fallback protocol; GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus spread adjustment; both rely on ASU 2020-04 for accounting relief to minimize financial reporting impact. (2) There are no numbers, dates, or calculations in the question or answers that need verification—both responses correctly reference ASU 2020-04 without introducing incorrect quantitative claims. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and GE), different financial instruments (credit facility, debt, preferred stock), and a shared accounting standard (ASU 2020-04), showing how each is affected by the LIBOR transition. (4) The only reason for not scoring a perfect 10 is that the LLM answer omits the explicit mention of 'derivatives' in LMT’s case (mentioned in the original answer), which is a minor but relevant financial instrument impacted. Otherwise, the answer is semantically equivalent, contextually precise, and factually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 351,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 balance sheet shows that the company issued 9,444,375 shares of Class B common stock (authorized 75 million, $0.01 par) — a small pool of shares that carry 10 votes each, giving their holders a disproportionately large voting influence relative to the much larger pool of Class A shares 【page_69】. In Alphabet’s dual‑class system, Class B shares also carry 10 votes, but the charter requires them to be converted at the holder’s option and to automatically convert to one‑vote Class A shares whenever they are sold or transferred, effectively limiting the high‑voting power to insiders and preventing it from passing to the broader market 【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA issued exactly 9,444,375 Class B shares in 2023, and the LLM correctly identifies this figure. The reference to 10 votes per Class B share for both CMCSA and GOOGL is factually accurate. (2) The LLM correctly explains the structural similarity in voting rights (10 votes per Class B share) and the key difference: GOOGL’s automatic conversion of Class B to Class A upon sale or transfer, which limits high-vote shares to insiders. (3) The multi-hop reasoning is sound—comparing CMCSA’s issuance and governance structure to GOOGL’s dual-class system is logically executed. (4) One minor omission: the original answer notes that GOOGL repurchased $62.2 billion of Class A and C shares in 2023, a detail absent in the LLM response. While not central to the core comparison, this contextualizes GOOGL’s capital strategy relative to CMCSA’s lack of buybacks. However, since the question focuses on the significance of CMCSA’s issuance and structural comparison, and the LLM covers the key governance mechanics accurately, the omission does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 383,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension obligations are met by cash contributions that are recorded as expense in the period they are paid (e.g., $4 million in 2021, $5 million in 2020), with no multi‑year vesting schedule attached to the cost. In contrast, Walmart’s equity‑compensation awards vest over several years – standard RSUs vest 25 % per year over four years and performance‑based RSUs vest over one to three years – and the associated compensation expense is recognized ratably over the vesting period, leaving unrecognized balances and a weighted‑average remaining expense period of roughly 1.1‑1.5 years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states MDLZ's pension contributions were $4 million in 2021 and $5 million in 2020, whereas the ground truth reports a $11 million cost in 2021 and a $526 million withdrawal liability over 19 years—orders of magnitude larger. The LLM incorrectly claims MDLZ has 'no multi-year vesting schedule,' contradicting the ground truth that MDLZ has a 19-year payment plan for its withdrawal liability. For WMT, the LLM correctly identifies the 25% annual vesting over four years for standard RSUs and mentions performance-based RSUs vesting over 1–3 years, which aligns with expectations. However, it introduces a 'weighted-average remaining expense period of 1.1–1.5 years' not present in the original and potentially inconsistent with a 4-year vesting schedule. (2) Quantitative accuracy is low: the $4M and $5M figures for MDLZ are incorrect vs. $11M in 2021 and a $526M total liability. The absence of the 19-year duration for MDLZ’s liability is a major omission. WMT’s dividend discount (3.8%) is omitted entirely. (3) Reasoning is partially sound—LLM correctly distinguishes between pension contributions (MDLZ) and equity compensation (WMT) and understands ratable expense recognition for WMT. However, it fails to recognize that MDLZ’s multiemployer plan obligations do involve long-term, multi-year financial commitments (via withdrawal liability), undermining the multi-hop comparison. (4) Contextual relevance is high—the answer addresses duration and cost recognition patterns for both companies as asked. However, due to major factual and quantitative errors, especially regarding MDLZ’s liabilities, the overall correctness is low. The answer misrepresents the nature and scale of MDLZ’s commitments, leading to an inaccurate comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 504,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Bank of America’s Advanced‑Approach buffer is the 2.5 % capital‑conservation buffer plus its 2.5 % G‑SIB surcharge (the CCyB is zero), giving a total buffer of **5.0 %** above the risk‑based minimum.  \nMorgan Stanley’s Advanced‑Approach buffer adds the same 2.5 % conservation buffer to a 3.0 % G‑SIB surcharge (CCyB also zero), for a total of **5.5 %**.  \n\nThus, BAC’s required buffer is **0.5 percentage point lower** than MS’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative components. While it correctly identifies the 2.5% Capital Conservation Buffer and zero Countercyclical Capital Buffer for both BAC and MS, it incorrectly states that Morgan Stanley (MS) has a 3.0% G-SIB surcharge. According to the ground truth, MS has a 2.5% G-SIB surcharge, not 3.0%. This leads to an incorrect total buffer of 5.5% for MS instead of the correct 5.0%. Similarly, BAC’s total buffer is correctly calculated at 5.0%, but the comparison is flawed due to the incorrect MS value. (2) Calculations: The sum of 2.5% + 2.5% = 5.0% is correct for BAC, but MS’s buffer is miscalculated as 2.5% + 3.0% = 5.5% due to the wrong G-SIB input. The conclusion that BAC’s buffer is 0.5 percentage points lower is therefore incorrect—both institutions have identical 5.0% total buffers. (3) Multi-hop reasoning: The model attempts the correct synthesis—combining CCyB, CCB, and G-SIB surcharges under the Advanced Approach for both banks—but fails due to incorrect entity-specific data (MS’s G-SIB surcharge). This breaks the comparative logic. (4) Scores justified: Correctness is low (3/10) due to major factual and calculation errors affecting the core conclusion. Quantitative accuracy is poor (3/10) because of the wrong G-SIB percentage and resulting incorrect totals. Qualitative accuracy is moderate (4/10) as the reasoning framework is sound but based on incorrect data. Contextual relevance is high (8/10) because the answer addresses the right concepts, structure, and institutions, just with wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 439,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "Broadcom’s $56.3 billion of fixed‑rate senior notes are directly exposed to market‑rate movements – a 50‑basis‑point shift would alter their fair value by about $1.7 billion (roughly $3.4 billion per 1 % change). Oracle, by contrast, uses interest‑rate swaps to reshape the economic profile of its debt, converting fixed‑rate obligations into floating‑rate exposure (or vice‑versa) and thereby fixing its effective cost (e.g., 8.76 % on the July 2025 Euro notes after cross‑currency swaps and 4.74 % after floating‑to‑fixed swaps). Cisco’s $0.5 billion swap illustrates the same hedge: the swap offsets the fair‑value impact of the fixed‑rate notes, a strategy Oracle employs to manage interest‑rate risk rather than bear the raw sensitivity that Broadcom experiences.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AVGO's $56.3 billion fixed-rate senior notes and the $1.7 billion fair value impact from a 50 bps shift, which matches the ground truth. It also correctly states ORCL's effective interest rate of 4.74% for fiscal 2024 and 2023 after swaps. However, it introduces an incorrect figure of '8.76% on the July 2025 Euro notes after cross-currency swaps' that is not present in the original answer and contradicts the ground truth, which emphasizes ORCL converting floating-rate to fixed-rate debt at a 3.07% base rate — a key detail omitted. The CSCO $0.5 billion swap is correctly referenced and contextualized as a fair value hedge. (2) Quantitative accuracy is partially compromised: while $56.3B, $1.7B, 50 bps, and 4.74% are correct, the 8.76% figure is unsupported and misleading. The 'roughly $3.4 billion per 1%' extrapolation is mathematically reasonable (2x $1.7B) but not in the original and could mislead if non-linear sensitivity is assumed. (3) Multi-hop reasoning is generally sound: the model connects AVGO’s direct sensitivity, ORCL’s use of swaps to stabilize costs, and CSCO’s swap as a hedging example. However, it misrepresents ORCL’s strategy by suggesting conversion to floating-rate, whereas the ground truth clearly states ORCL used swaps to convert floating to fixed, achieving a stable 4.74% effective rate — the opposite direction of what the LLM implies in part. (4) Despite this, the overall structure, relevance, and synthesis are strong, with only key directional and numerical inaccuracies preventing a higher score. The answer remains contextually relevant and mostly factually aligned, but the incorrect ORCL rate and mischaracterization of swap direction reduce quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 482,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s capital structure includes a sizable block of Class B shares – 343.8 million Class B shares were outstanding as of January 24 2025 – which carry a disproportionate voting weight (each Class B share has multiple votes, giving its holder a large share of total voting power). In contrast, Alphabet’s (Google) share‑repurchase program is directed only at its publicly traded Class A and non‑voting Class C shares (≈ 78 million Class A and 450 million Class C shares repurchased in 2023, and 73 million Class A and 306 million Class C in 2024), while the high‑voting Class B stock is left untouched, preserving the existing voting‑rights concentration. Thus, Meta’s Class B stock concentrates voting power, whereas Alphabet’s strategy uses buy‑backs of the lower‑voting or non‑voting classes to manage capital without diluting the control held by its Class B shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between META's concentrated voting structure and GOOGL's repurchase strategy that preserves control, which aligns with the ground truth. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the LLM claims 343.8 million Class B shares outstanding for META as of January 24, 2025 — this specific figure is not present in the ground truth and cannot be verified from the provided data. Second, the LLM states that GOOGL repurchased ≈78 million Class A and 450 million Class C shares in 2023, and 73 million Class A and 306 million Class C in 2024. These granular share counts are not in the original answer, which only mentions a total repurchase of $62.0 billion in 2024 across Class A and C shares. The dollar amount and year (2024) are correct, but the breakdown by share class and the 2023 figures are fabricated or misattributed. Additionally, the original answer does not mention any repurchase activity in 2023, so including it introduces unsupported information. On qualitative accuracy, the LLM correctly identifies that GOOGL’s buybacks target lower-voting or non-voting shares (Class A and C), preserving Class B control, and contrasts this with META’s non-dilutable, high-vote Class B shares. This reasoning is sound and reflects proper multi-hop synthesis. The contextual relevance is high because the response directly addresses the interplay between voting rights and share structure as asked. However, the inclusion of unverified numerical details and incorrect years reduces quantitative accuracy significantly. While the overall narrative is directionally correct, the specific numbers are not supported by the ground truth, leading to a correctness score of 6 due to partial factual accuracy with major quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 492,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm sees a rapid rise in AI‑enabled handsets – analysts expect 46 percent of smartphones sold in 2027 to be generative‑AI capable, up from 19 percent in 2024【page_7】.  That outlook pushes Qualcomm to double‑down on on‑device AI hardware (its AI Engine, Hexagon NPU, AI Stack) and on the 5G/5G‑Advanced connectivity that will power those workloads, positioning the company as the silicon and connectivity platform for the next wave of AI‑rich devices. By contrast, Salesforce’s 10‑K notes that the company is “investing in generative and agentic AI across all products” and has launched Agentforce, a suite of AI agents that embed generative‑AI capabilities directly into its CRM cloud services to make sales, service, marketing and commerce functions more intelligent and autonomous【page_41】. Thus, Qualcomm’s strategy is driven by a hardware‑centric push to supply AI‑capable smartphones and connected devices, while Salesforce’s strategy is a software‑centric effort to layer generative and autonomous AI into its enterprise‑cloud applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024) is accurately cited, and the strategic focus on on-device AI hardware (AI Engine, Hexagon NPU) and 5G/5G-Advanced connectivity is correctly described. Salesforce's investment in generative and agentic AI, including the launch of Agentforce for CRM functions, is also accurately represented. (2) Quantitative accuracy is perfect: the percentages (46%, 19%), years (2027, 2024), and product names (Agentforce) match the ground truth exactly. No calculations were required, but the comparison over time is correctly framed. (3) The multi-hop reasoning is sound—LLM synthesizes Qualcomm’s device-level AI strategy with Salesforce’s cloud-based AI integration, correctly contrasting hardware vs. software focus and identifying the shared emphasis on AI without implying a business relationship. The only minor omission is that the original answer explicitly notes the 'convergence' in their shared emphasis on AI capabilities and the lack of direct dependency, which the LLM implies but does not state outright—hence a slight deduction in qualitative accuracy. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—Qualcomm’s growth projection influencing its AI/connectivity strategy and Salesforce’s AI investments in CRM—and maintains precise focus on the comparative strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 419,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe is building its Creative Cloud, Document Cloud and Experience Cloud products around Adobe Sensei and Firefly generative‑AI services that “enhance customer experiences,” “deliver real‑time personalization” and make the UI “intuitive and visually appealing” (e.g., generative Fill in Photoshop, AI‑driven Liquid Mode in Acrobat)【page_7】【page_10】. Qualcomm projects that by 2027 roughly half of PCs and almost half of smartphones will be “generative‑AI‑capable,” with on‑device AI engines (Hexagon NPU, AI Engine) delivering low‑latency, privacy‑preserving processing that fuels richer, more responsive interfaces【page_7】【page_8】. Thus Adobe’s AI‑driven user‑experience focus aligns directly with Qualcomm’s outlook: the on‑device AI hardware Qualcomm expects to dominate edge devices will enable Adobe’s AI features to run locally, delivering faster, more immersive and personalized UI experiences across the next generation of consumer and enterprise devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Adobe's focus on AI-driven tools (Adobe Sensei, Firefly) enhancing user experience through intuitive and visually appealing interfaces, citing specific examples like generative Fill in Photoshop and Liquid Mode in Acrobat. (2) Regarding quantitative accuracy, the LLM states that 'roughly half of PCs and almost half of smartphones' will be generative AI-capable by 2027, which is a reasonable approximation of Qualcomm’s 46% smartphone projection (ground truth); however, the original specifies 46% of smartphones (not 'almost half') and does not mention PCs—this is a minor deviation but not factually incorrect, as 'almost half' is semantically acceptable for 46%. The 19% baseline in 2024 is omitted, but the trend is implied. (3) The reasoning is sound: the LLM correctly synthesizes that Qualcomm’s on-device AI processing (via Hexagon NPU and AI Engine) enables low-latency, private, and responsive AI, which supports Adobe’s need for high-performance, immersive UI experiences. This multi-hop connection between Adobe’s software strategy and Qualcomm’s hardware roadmap is logically and factually well-supported. (4) The answer is contextually excellent, directly addressing the alignment between Adobe’s UX focus and Qualcomm’s edge AI projections, particularly on-device processing and UI improvements. The only minor shortcoming is the slight imprecision in quantifying Qualcomm’s projection and the addition of PCs not mentioned in the original, but these do not undermine the core correctness. Hence, a 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 451,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "- **Lockheed Martin:**  For director RSU awards, any dividend equivalents that accrue are **paid out separately** – the director can elect to receive the award (together with any dividend equivalents) on the first business day of April that follows the one‑year anniversary of the grant. The payment is therefore decoupled from the normal vest‑on‑date settlement.  \n\n- **Honeywell:**  Honeywell’s RSUs **vest over a three‑ to six‑year period and are settled in common stock at vesting**; the filing does not describe a separate cash or stock payment of dividend equivalents, implying that any equivalents are simply reflected in the shares delivered when the RSU vests.  \n\nThus, Lockheed Martin provides a distinct, post‑anniversary payment of dividend equivalents, while Honeywell incorporates any equivalents into the stock that is issued at the time the RSU vests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lockheed Martin pays dividend equivalents on RSUs for non-employee directors separately, with a specific payout on the first business day of April following the one-year anniversary of the grant, which matches the delayed payment structure in the original answer. (2) It accurately states that Honeywell’s RSUs vest over three to six years and are settled in stock upon vesting, with no separate payment mechanism for dividend equivalents—implying they are incorporated into the final share delivery, consistent with the original answer. (3) The LLM correctly contrasts the two companies: Lockheed Martin has a distinct, time-based payout for dividend equivalents, while Honeywell integrates them into the vesting settlement. (4) The only minor omission is that the LLM does not explicitly mention Lockheed Martin’s DMICP plan or Honeywell’s performance-based vesting focus, which are part of the full multi-hop synthesis in the ground truth. However, the core differences in dividend equivalent treatment—timing and structure—are correctly captured. All entities, vesting periods, and payment terms are accurate. Quantitative elements (e.g., 'three to six years', 'one-year anniversary') are correct. The reasoning is sound and the answer is contextually fully relevant. A score of 9 is justified due to high factual accuracy with a slight gap in completeness regarding the broader plan contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 413,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says that about 40 percent of its assembly‑and‑test work is performed by subcontractors, while the rest of its wafer‑fabrication and packaging is done in‑house. In contrast, NVIDIA is a pure‑fabless company that obtains essentially all of its wafer‑fabrication, assembly, test and packaging from third‑party foundries such as TSMC and Samsung, giving it a far higher dependence on external production capacity. Both companies therefore share the same type of supply‑chain risk that AMD flagged—potential capacity shortages, yield problems, price spikes or priority shifts by the external manufacturers could materially disrupt product deliveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly stated, and there are no numerical inaccuracies. (2) The qualitative analysis correctly identifies that NVIDIA is fabless and relies entirely on third-party manufacturers like TSMC and Samsung for fabrication, assembly, and testing—this contrasts with TXN's partial reliance and accurately reflects the higher degree of external dependency. The risks cited (capacity shortages, yield issues, priority shifts) match the concerns highlighted in AMD's experience with GF and ATMP, including supply disruptions and financial exposure. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across TXN, NVDA, and AMD, comparing their supply chain models and identifying shared vulnerabilities. (4) The only minor shortcoming is that the LLM does not explicitly mention 'financial penalties' or 'purchase targets' as in AMD’s case, which slightly reduces completeness in conveying all risk dimensions from the original answer. However, the core risks are well captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparative exposure and shared risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 365,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida’s Clean Energy Connection program calls for ten new solar generating facilities with a combined capacity of about 750 MW and an estimated construction cost of roughly **$1 billion** over the next three years【page_153】. Southern Power finances comparable renewable projects through power‑purchase agreements that it records as **operating leases with terms that can extend up to 25 years**【page_268】, meaning its solar and wind assets are similarly long‑term but are accounted for via lease arrangements rather than direct ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities and accurately states that Southern Power uses PPAs accounted for as operating leases with terms up to 25 years. All key facts from the ground truth are present and factually correct. (2) Quantitative accuracy is perfect: $1 billion cost and 25-year lease terms match the original answer exactly; no calculations were required. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across Duke Energy Florida’s direct investment and Southern Power’s PPA-based leasing model, highlighting the contrast in financial approaches to similar long-term renewable projects. The only minor omission is that the original answer notes the FPSC approval in January 2021 for Duke’s program, which adds regulatory context not mentioned in the LLM response. However, this does not affect the core factual accuracy. (4) The answer is semantically equivalent to the ground truth, with clear, concise, and relevant information. The absence of the FPSC detail slightly reduces qualitative completeness but does not detract from overall correctness. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 339,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock carries one vote per share (see NFLX 10‑K p. 60), whereas Alphabet’s Class C capital stock has **no voting rights** (Alphabet 10‑K p. 82). Because Class C shares do not affect control, Alphabet can repurchase a much larger portion of its non‑voting stock – in 2024 it bought 306 million Class C shares ($50.2 billion) versus only 73 million Class A shares ($11.9 billion) (Alphabet 10‑K p. 82). The lack of voting rights in Class C therefore lets Alphabet allocate the bulk of its $62.0 billion buy‑back to those shares without diluting voting power, a flexibility that Netflix’s uniformly voting common stock does not provide.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: Netflix's common stock has one vote per share, Alphabet's Class C shares have no voting rights, and Class A shares have one vote per share (with Class B having 10 votes, though not directly relevant to repurchases). (2) Quantitative accuracy is excellent: the $50.2 billion repurchase of Class C shares and $11.9 billion of Class A shares sum to $62.1 billion, which rounds to the stated $62.0 billion (minor rounding difference is acceptable and common in financial reporting). The share counts (306 million and 73 million) match typical disclosures in Alphabet’s 10-K and are plausibly accurate. (3) The multi-hop reasoning is sound: the model correctly links the lack of voting rights in Class C shares to Alphabet’s strategic ability to repurchase more of those shares without affecting control, contrasting this with Netflix’s uniform voting structure. (4) The answer provides additional specific detail (page numbers, exact repurchase amounts and share counts) that enhance precision beyond the original answer, without introducing errors. The semantic meaning and strategic insight are equivalent to and even exceed the ground truth in depth. All scores are 10 due to complete factual correctness, accurate calculations, proper entity identification, logical reasoning, and full relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 393,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "Bank of America’s preferred‑stock provisions state that if a series’ cash dividend falls into arrears for three + semi‑annual (or six + quarterly) periods, the preferred holders automatically receive the right to elect two extra directors – a voting right that is only triggered by financial distress and that lapses once dividends are caught up. By contrast, Visa’s Class C common shares are essentially non‑voting; they may vote only on a narrow set of matters (e.g., mergers, core‑business exits, charter amendments) and never gain additional director‑election rights, even if the company experiences stress. Thus, BAC’s preferred shareholders can become a decisive governance bloc when dividends are missed, whereas V’s Class C holders remain largely powerless in such scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors after three or more semi-annual (or six or more quarterly) dividend arrears, and these rights lapse after two semi-annual or four quarterly periods of payment. This matches the original answer exactly. V's Class C common stockholders have limited voting rights only on specific matters like mergers or exiting the core business, which is also correctly stated. (2) Quantitative elements—'three or more semi-annual', 'six or more quarterly', 'two additional directors', 'two semi-annual or four quarterly periods'—are all factually correct and consistent with the ground truth. Format variations (e.g., 'three +' vs 'three or more') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly contrasts BAC’s performance-contingent voting rights with V’s structural, non-contingent limitations, highlighting the difference in governance responses during financial stress. (4) Minor deduction in qualitative accuracy due to slightly less precision in specifying that V’s Class C voting rights do not extend to amendments affecting only preferred stock—a nuance present in the original but omitted in the LLM answer. However, this does not undermine the overall correctness. The answer is fully contextually relevant, directly addressing corporate governance implications during financial stress.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 418,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing business – which includes royalties from high‑profile franchises such as Star Wars (see the “Licensing” section that lists Star Wars among its major licensed properties) – generates a steady stream of cash that the company can redeploy to other initiatives.  That cash flow helps fund the creation of new Disney+ original content, giving Disney the financial flexibility to invest in European‑market programming that competes directly with Comcast’s Sky Glass and XClass TV platforms (which Comcast highlights as its Europe‑focused smart‑TV offerings).  In short, Star Wars‑related licensing royalties bolster Disney’s overall earnings, enabling it to allocate resources toward Disney+ content development in the same regions where it faces Sky Glass and XClass TV competition.  \n\n*Sources: Disney licensing description (Star Wars listed) – DIS 10‑K page 22; Comcast discussion of Sky Glass and XClass TV as European platforms – CMCSA 10‑K pages 17‑18.*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures the multi-hop relationship between Disney's Star Wars licensing revenue and its ability to fund Disney+ content development in European markets, where it competes with CMCSA's Sky Glass and XClass TV. (1) There are no numeric values in the question or answers requiring verification—both responses are qualitative and avoid making up figures, so quantitative accuracy is perfect. (2) The LLM correctly identifies all key entities: Disney, Star Wars, licensing royalties, Disney+, CMCSA, Sky Glass, XClass TV, and their relevance to European markets. (3) The reasoning is sound: it traces the flow from licensing income to reinvestment in content, enhancing competitiveness against Comcast’s integrated hardware-content platforms in Europe. (4) The LLM cites specific 10-K pages (DIS 10-K p.22; CMCSA 10-K pp.17–18), adding source credibility, though the original answer did not include citations—this is a strength, not a deviation. The only minor shortcoming is that the LLM does not explicitly state that Star Wars programming is a 'core content tile' on Disney+, which is a small detail present in the ground truth that strengthens the strategic link. However, the overall logic and factual chain remain intact. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 418,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express estimates that an instantaneous 200‑basis‑point rise in benchmark rates would cut its annual net‑interest income by about **$560 million**, because its assets and liabilities reprice in line with market moves (subject only to the modest caps or floors that the company notes in its repricing‑risk assumptions). Morgan Stanley, by contrast, routinely attaches **interest‑rate caps (and swaps)** to the securities it retains in securitization transactions, so that the cash‑flow impact of a rate increase on those VIE assets is limited. Thus, both firms are managing the same repricing risk, but AXP’s exposure is reflected directly in a net‑interest‑income hit, whereas MS seeks to hedge that exposure through caps that cap the adverse effect of rising rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar figure of $560 million for AXP's net interest income impact from a 200 bps rate increase, which is not present in the original (ground truth) answer. This number is unsupported by the provided ground truth and cannot be verified as accurate, making it a significant factual overreach. No such quantitative estimate is mentioned in the original, which only states a qualitative negative impact. (2) The mention of 'interest-rate caps (and swaps)' for MS goes slightly beyond the original, which only references interest rate caps in securitization transactions. While not incorrect per se, the addition of swaps introduces unverified detail. (3) The qualitative reasoning is strong: the LLM correctly identifies that both AXP and MS manage repricing risk using derivative instruments (caps), albeit in different contexts—AXP in core net interest income and MS in securitization-related VIEs. The synthesis across firms and the connection to repricing risk is logically sound and semantically aligned with the original. (4) Contextual relevance is high, as the response directly addresses the relationship between AXP’s sensitivity and MS’s use of caps, linking both to repricing risk. However, the introduction of unsupported quantitative and qualitative details reduces factual accuracy. The core structure and intent of the answer are correct, but the added specifics undermine full correctness. Thus, the correctness score is 7: key facts and reasoning are accurate, but with notable overprecision and minor factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 436,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDL Z’s 2024 results show that a **stronger U.S. dollar** reduced consolidated operating income by about **11 %**, although the company noted that a **weaker dollar versus the euro and British pound** gave a **favourable offset** for its Europe, Middle East & Africa (EMEA) and Global Ventures segments. In contrast, Coca‑Cola explicitly says that a **weaker U.S. dollar versus the euro and pound produced a favourable currency effect for its Europe, Middle East & Africa segment**, directly boosting that segment’s results. Thus, while MDL Z’s overall earnings were hurt by the dollar’s strength (with only a partial, segment‑level benefit), Coca‑Cola’s EMEA segment fully benefited from the dollar’s weakness.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding MDLZ's exposure. The original answer states that a weaker U.S. dollar benefits MDLZ’s consolidated earnings, but the LLM claims a stronger dollar reduced operating income by 11% and frames the weaker dollar as only a partial offset—this contradicts the ground truth which presents a weaker dollar as beneficial overall. There is no mention in the ground truth of an 11% reduction or MDLZ being negatively impacted by dollar strength, so this figure is unsupported and likely incorrect. (2) The quantitative claim of an '11%' reduction in MDLZ operating income due to a stronger dollar is not present in the original answer and cannot be verified from the provided context, making it a hallucination or misattribution. No other numbers are mentioned in the ground truth for comparison. (3) The reasoning correctly identifies that both companies highlight the euro and British pound as key currencies affecting their results and correctly notes Coca-Cola’s favorable segment-level impact. It attempts multi-hop synthesis by comparing MDLZ’s segment-level benefit with KO’s, but misrepresents MDLZ’s overall exposure—portraying it as harmed by dollar strength when the ground truth says a weaker dollar benefits consolidated earnings. This undermines the core comparison. (4) Despite the incorrect quantitative claim and mischaracterization of MDLZ’s overall FX impact, the LLM captures the parallel in currency drivers (euro and pound) and correctly identifies the favorable effect on Coca-Cola’s EMEA segment. The structure and intent are relevant and mostly aligned with the question, hence high contextual relevance and moderate qualitative accuracy, but the factual error on MDLZ’s earnings impact limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 492,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s (MA) dual‑class structure gives the Class B shares a sizable but not dominant share of the total voting power – roughly one‑third of the combined voting power is held by the 15‑vote Class B shares.  By contrast, Verizon’s (V) structure concentrates voting power much more heavily in the Class B shares: with 125 Class B shares (each worth 15 votes) versus 1,733 Class A shares (one vote each), the Class B shares control about 52 % of the total voting power.  Thus, MA’s voting power is less concentrated than V’s, where the high‑vote Class B shares command a majority of the voting rights.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Mastercard's Class B shares hold 'roughly one-third' of the voting power, but the ground truth shows they hold approximately 10.4%, which is far less than one-third (~33%). For V (Verizon), the LLM calculates Class B voting power at 52%, but the correct figure is 68.5% — a substantial underestimation. The number of shares is mostly correct: LLM correctly identifies 125 Class B and 1,733 Class A shares for V, but it fails to mention MA's actual share counts (907 Class A, 7 Class B), which undermines precision. (2) Calculations: For V, total votes = (125 × 15) + (1,733 × 1) = 1,875 + 1,733 = 3,608. Class B share of votes = 1,875 / 3,608 ≈ 51.96%, which rounds to 52% — this part is accurate. However, for MA: 7 Class B shares × 15 votes = 105 votes; 907 Class A shares × 1 vote = 907 votes; total = 1,012 votes; Class B share = 105 / 1,012 ≈ 10.37% (~10.4%), not 'one-third' as claimed. The LLM incorrectly estimates MA’s Class B voting power by over threefold. (3) Multi-hop reasoning: The model correctly identifies that V has more concentrated control than MA, which aligns with the ground truth conclusion. It also correctly applies the 15-vote weighting to Class B shares for V. However, due to the incorrect assessment of MA’s voting concentration, the comparative analysis lacks factual grounding on one side. (4) Despite incorrect numbers for MA and an underestimated but directionally correct comparison for V, the overall conclusion that V has more concentrated voting power than MA is valid. This prevents the score from being lower. However, the severe miscalculation of MA’s voting concentration — a core part of the multi-hop analysis — significantly reduces correctness. Wording and structure are clear and relevant, hence high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 504,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company warn that the money they have set aside for nuclear‑plant decommissioning may not be sufficient. NEE states that “the cost of decommissioning nuclear generation facilities could exceed the amount available in NEE’s … decommissioning funds,” while Southern Company notes that “uncertainties … with respect to the technological and financial aspects of decommissioning nuclear plants … could exceed the amount of decommissioning trusts or external insurance coverage.” Thus, each company faces a similar exposure‑risk that decommissioning costs could outstrip the reserves they have earmarked.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies both NEE and Southern Company as facing financial risks from potential decommissioning costs exceeding available reserves. The answer accurately reflects that both companies acknowledge uncertainties in cost estimation and funding sufficiency. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or the original answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies, correctly attributing exposure to decommissioning funds and insurance coverage, and notes the materiality of potential shortfalls. It even includes direct quotes (in quotes) that reflect actual language from filings, enhancing fidelity. (4) The only minor shortcoming is that the LLM does not explicitly name FPL, Alabama Power, or Georgia Power as the operating subsidiaries, which are mentioned in the original answer. However, this omission does not distort the overall meaning or accuracy, as the parent companies (NEE and Southern Company) are correctly identified as the reporting entities. The answer is semantically equivalent and contextually fully relevant, making it a strong match to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 370,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS reports that the real‑estate and private‑equity funds held in its pension‑plan trusts were valued at **$9.9 billion** as of 31 December 2023, using a net‑asset‑value (NAV) approach that relies on the fund managers’ audited and unaudited financial reports and adjustments for activity between reporting dates (i.e., a valuation model with largely unobservable inputs)【page_58】.  \n\nGeneral Dynamics classifies its comparable “Level 3” assets – which include private‑equity and real‑estate fund interests – as assets measured using unobservable inputs and discounted‑cash‑flow models; the Level 3 portion of its portfolio was **about $1.3 billion** (approximately $1.1 billion in buy‑in contracts and $1.277 billion total Level 3 fair‑value)【page_83】【page_82】.  \n\nThus, UPS’s real‑estate fund valuation is roughly **seven to eight times larger** than GD’s Level 3 assets, and while both rely on internal valuation models rather than quoted market prices, UPS applies the NAV method to a much larger pool of assets, whereas GD’s Level 3 valuations are a smaller subset measured with unobservable inputs and discounted‑cash‑flow techniques.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UPS used NAV based on fund managers' reports with adjustments, aligning with the ground truth. It also correctly notes that General Dynamics (GD) uses unobservable inputs and valuation models for its Level 3 assets. However, the LLM introduces a significant factual error by stating GD's Level 3 assets are about $1.3 billion — this number is not supported by the ground truth, which does not specify a dollar amount for GD’s Level 3 assets. The $1.1 billion and $1.277 billion figures cited are not in the original answer and appear to misinterpret or misextract data. Additionally, the comparison that UPS’s $9.9B is 'seven to eight times larger' than GD’s Level 3 assets is unsupported due to the lack of a valid GD figure in the ground truth. (2) The UPS valuation of $9.9 billion is correct and properly attributed. However, the GD figures are incorrect or hallucinated: the original answer does not provide any specific valuation of GD’s Level 3 assets, only a description of their nature. Thus, the quantitative comparison fails. (3) The multi-hop reasoning is partially sound — the model correctly identifies that both companies use model-based valuations, with UPS relying on NAV as a practical expedient and GD on unobservable inputs. This conceptual contrast is accurate and reflects synthesis across the two companies. However, the erroneous GD asset value undermines the quantitative comparison, a key part of the LLM’s conclusion. (4) The contextual relevance is high — the answer addresses the core question about valuation approaches and attempts a comparative analysis. The qualitative reasoning about valuation methods is largely correct, but the inclusion of false quantitative data reduces overall correctness. Hence, a score of 6 is justified: partially correct but with significant factual inaccuracies in numbers and unsupported calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 517,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo’s AMESA division—covering Africa and the Middle East—generates about 30 % of its beverage revenue (see PEP 10‑K page 73). Target’s contracts with vendors “…do not purchase or pay for merchandise until the merchandise is ultimately sold to a guest…Merchandise received under these arrangements is not included in inventory because the purchase and sale are virtually simultaneous” (Target 10‑K pages 48‑49). Therefore, a supply disruption in the AMESA region would likely create shortages of PepsiCo beverage SKUs at Target, reducing the number of units that can be turned over and slowing inventory turnover, while the “pay‑after‑sale” structure would postpone both the cash outflow for the goods and the cash inflow from sales, tightening Target’s cash‑flow timing for those SKUs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa and Middle East region (AMESA) is correctly cited from PepsiCo's 10-K (page 73), and the description of Target's vendor arrangements is accurately quoted from Target’s 10-K (pages 48–49), including the key 'pay after sale' model. No calculations were required, but the numerical and percentage data are correct. (2) The answer addresses all parts of the multi-hop question: it links PepsiCo’s regional revenue exposure to potential supply disruptions, connects that to Target’s inventory and payment model, and explains the impact on inventory turnover and cash flow timing. (3) Entity accuracy is strong: correct use of PepsiCo (PEP), Target, AMESA, beverage SKUs, and proper financial terms like inventory turnover and cash flow timing. (4) Reasoning is sound: the LLM correctly infers that supply shortages would reduce inventory turnover (due to fewer units available to sell) and that the pay-after-sale model would delay both cash inflows (from sales) and outflows (to vendors), thus tightening cash flow timing. The only minor shortcoming is the phrase 'postpone both the cash outflow... and the cash inflow'—while technically the cash outflow is postponed (since Target doesn’t pay until sale), the cash inflow is also delayed due to lower sales, but this is a nuance. The original answer emphasizes reduced cash flow generation from lower sales, while the LLM frames it as a timing shift. This is a subtle difference in emphasis but not a factual error. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 459,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Amgen’s filing shows that, after payers began imposing step‑therapy and prior‑authorization limits on Repatha, the company answered by deepening its discounting – it boosted rebates to commercial and Medicare‑Part‑D PBMs, introduced lower‑list‑price NDCs and ultimately discontinued the higher‑price version to make the drug more affordable. Eli Lilly, by contrast, has not cut the list price of its insulin portfolio; instead it has leaned on patient‑assistance and co‑pay‑support programs, risk‑sharing arrangements with payers and the development of lower‑cost biosimilar alternatives to preserve insulin access under the same payer‑driven pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All key facts are correct: AMGN responded to payer restrictions on Repatha (step therapy, prior authorization) by increasing rebates, introducing lower-list-price NDCs, and discontinuing higher-price versions—consistent with the 2019 action noted in the original answer. LLY did not cut insulin list prices but used patient assistance programs, copay support, risk-sharing, and biosimilar development—aligning with the original's focus on non-price-cut strategies. (2) There are no numeric values, dates, or calculations in either answer; the mention of 2019 in the original is absent in the LLM response but not contradicted—this is a minor omission, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes payer pressures across two companies (AMGN and LLY), identifies different drug products (Repatha vs. insulin), and contrasts strategic responses (active price reduction and partnership vs. access programs and biosimilars). (4) Semantic equivalence is strong: while the LLM does not mention 'Alzheimer’s Monoclonal Antibody NCD' or 'proposed legislation' affecting LLY, these are contextual details that do not undermine the central contrast in pricing strategies. The LLM emphasizes LLY’s reliance on support programs rather than price cuts, which is factually correct and captures the essential difference. The absence of explicit mention of 'net vs. list price' for AMGN is a slight gap but compensated by describing rebate increases and lower-price NDCs. Overall, the answer is factually correct, contextually appropriate, and logically structured—justifying a high score with only a minor deduction for incomplete detail on LLY’s regulatory risk emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 493,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both firms are comfortably above the required buffers, but they do it in slightly different ways.  \n\n*Bank of America* reports a Common‑Equity Tier 1 (CET 1) ratio of about **12 %** under the Standardized approach, which exceeds the regulatory minimum of **9.5 %** (the minimum already includes the 2.5 % capital‑conservation buffer, the 3 % G‑SIB surcharge and a **zero** counter‑cyclical buffer). Thus BAC meets its buffer requirement simply by holding CET 1 well above the combined minimum.  \n\n*Charles Schwab* shows a CET 1 ratio of **24‑38 %** for its holding‑company and banking subsidiary, far higher than the **7 %** CET 1 minimum that incorporates a 2.5 % stress‑capital buffer (for the holding company) and a 2.5 % capital‑conservation buffer (for the bank). Because the CCyB is also set to zero, Schwab satisfies its buffer requirement by maintaining substantially larger CET 1 ratios than the minimum.  \n\nIn short, with the CCyB at zero, BAC relies on a modest excess over the Basel‑III minimum, while Schwab maintains a much larger excess, driven by its own stress‑capital and conservation buffers.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness, despite generally sound reasoning and contextual relevance. (1) The CET1 ratio for BAC is stated as 'about 12%' under the Standardized approach, but the ground truth does not provide BAC's actual CET1 ratio—only its buffer structure (Stress Capital Buffer of 2.5% and G-SIB surcharge of 2.5%). The LLM fabricates a specific ratio (12%) not present in the original answer. (2) For SCHW, the claim of a '24-38%' CET1 ratio is unsupported by the ground truth, which only states that CSB maintains a Capital Conservation Buffer of 2.5% and that SCHW structures capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for CET1, Tier 1, and Total Risk-Based Capital, respectively. The 24-38% range appears to be an overextrapolation or error. (3) The LLM incorrectly attributes a '3% G-SIB surcharge' to BAC, while the ground truth specifies a 2.5% G-SIB surcharge. This is a material error in a regulatory context. (4) The LLM conflates the Stress Capital Buffer with the Capital Conservation Buffer for SCHW, stating the holding company has a 2.5% stress-capital buffer and the bank has a 2.5% capital-conservation buffer, but the ground truth states CSB (the subsidiary) maintains a Capital Conservation Buffer of 2.5%, with no mention of a separate Stress Capital Buffer for the holding company. (5) The reasoning framework—comparing how each firm exceeds requirements with CCyB at zero—is logically sound and contextually relevant, and the core idea that BAC operates closer to minimums while SCHW holds larger excess capital aligns with the original answer’s implication. However, the use of fabricated ratios and incorrect surcharge percentages reduces factual reliability. (6) The original answer emphasizes structural differences in capital strategy (G-SIB surcharge for BAC, explicit minimum ratios for SCHW), which the LLM attempts to reflect but distorts with incorrect numbers. Overall, the answer captures the high-level contrast but fails on key factual and quantitative points, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 563,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company funds new solar (and co‑located battery) projects through long‑term power‑purchase agreements that are recorded as operating leases with terms of up to 25 years; the solar facilities generate federal investment‑tax‑credit (ITC) benefits that the company expects to exhaust by 2024 (with the ITC rate falling from 30 % pre‑2020 to 26 % for projects started in 2020‑2022 and to 22 % in 2023). Duke Energy, by contrast, finances its renewable assets mainly through non‑consolidated VIEs and tax‑equity partnerships that guarantee debt service and O&M costs, and it relies on PPAs as a key driver of those VIEs, but the filing does not specify a comparable timetable for using its ITC/PTC credits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures key aspects of both Southern Company's and Duke Energy's renewable financing strategies involving PPAs and tax equity, but contains partial inaccuracies and omissions. Southern Company's $1.2 billion of unutilized ITCs/PTCs as of 2021 and full utilization expected by 2024 is correctly implied in the statement that tax credits will be exhausted by 2024, though the exact dollar amount ($1.2 billion) is missing. The ITC rate timeline (30% pre-2020, 26% for 2020–2022, 22% in 2023) is accurate and adds contextual detail not in the original answer, which is acceptable as supplementary information. However, the original answer specifies that Southern uses tax equity partnerships where the tax partner captures most benefits — this is omitted in the LLM response, weakening completeness. For Duke Energy, the LLM correctly identifies use of VIEs and tax equity partnerships and the role of PPAs, but fails to mention that Duke is the primary beneficiary due to control over siting, PPA negotiation, and operations — a key differentiator in the original answer. (2) Quantitative accuracy is partially compromised: while ITC percentages and the 2024 utilization timeline are correct, the $1.2 billion figure for unutilized credits is omitted, which is a significant quantitative data point. The LLM introduces ITC phase-down rates not present in the ground truth; while factually plausible, they are not part of the verified knowledge graph answer and could introduce noise. (3) Multi-hop reasoning is generally sound — the model correctly links Southern’s solar investments to operating lease PPAs and tax equity, and contrasts Duke’s VIE-based structure with PPA reliance. However, the synthesis lacks the nuanced comparison of tax credit utilization timelines and control mechanisms in VIEs, weakening the qualitative depth. (4) Scores reflect strong alignment with the question’s intent and high contextual relevance, with solid qualitative reasoning but measurable gaps in quantitative precision and completeness of key differentiating factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 560,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s charter forces every Class B share to convert automatically into a one‑vote‑per‑share Class A unit whenever it is sold or transferred (page 81), which gradually erodes the founder’s voting dominance. By contrast, Comcast’s bylaws lock its 15‑vote‑per‑share Class B stock at a fixed 33⅓ % of total voting power that cannot be diluted by new issuances (page 91). Seeing that peers either dilute or cap concentrated voting power, investors are likely to view Meta’s dual‑class structure—where a small block of ten‑vote‑per‑share Class B stock can continue to control the company—as unusually entrenched and therefore less attractive, heightening concerns about governance and minority‑shareholder rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer (per page 81 reference), which reduces voting concentration over time. Comcast’s Class B shares maintain 33⅓% of voting power and are non-dilutable (per page 91), preserving control. Meta’s dual-class structure, with 10 votes per Class B share, is presented as more entrenched compared to peers. These points match the original answer’s core claims. (2) Quantitative accuracy is excellent: the 33⅓% voting power, references to 10- and 15-vote shares (though Comcast is correctly described in the original as having disproportionate voting power, not necessarily 15 votes per share—this detail is not in the ground truth and may be an over-precision, but does not contradict it), and structural comparisons are consistent. The ground truth does not specify vote multiples for Comcast, so the '15-vote-per-share' detail is an addition not present in the original; however, it does not materially distort the comparison and may reflect external knowledge. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes governance models across Google, Comcast, and Meta to infer investor sentiment implications—specifically, that Meta’s structure appears more entrenched by comparison, potentially affecting investor perception and minority shareholder concerns. (4) The answer is contextually relevant and addresses all parts of the question: it contrasts Google’s dilutive mechanism, Comcast’s non-dilutive structure, and Meta’s founder control, concluding with implications for investor sentiment. The only minor deviation is the extra detail on vote multiples for Comcast not present in the ground truth, but this does not impair correctness. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 513,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s Cordavis subsidiary is intended to expand the supply of lower‑cost biosimilars, creating more competition and driving down drug prices for the manufacturers that also contract with UnitedHealth Group (UNH). Because UNH’s $12.5 billion of manufacturer rebates are “accrued as they are earned … on a monthly basis … and are paid 2‑5 months after billing” and are tied to the volume and mix of products used under each rebate contract, a larger share of biosimilar utilization would likely (1) reduce the per‑unit rebate rates that manufacturers can offer (since the drugs are cheaper) but (2) increase the total rebate dollar amount if the higher biosimilar volume offsets the lower rates. The timing of UNH’s revenue‑related rebate recognition would remain monthly when the utilization occurs, but cash receipt would continue to lag 2‑5 months, so any shift toward biosimilars would front‑load the accruals while still delaying cash collection.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies CVS's Cordavis initiative and UNH's $12.5 billion in rebates receivable, matching the ground truth in amount and context. The timing of rebate accrual (monthly) and payment lag (2–5 months) is accurately reflected, with proper linkage to revenue recognition. However, the LLM introduces a claim not present in the ground truth: that higher biosimilar volume could increase total rebate dollars if volume offsets lower rates. This is speculative and contradicts the ground truth, which suggests rebates would likely decrease due to lower pricing and reduced manufacturer margins on cheaper biosimilars. (2) Quantitatively, all numbers are correct: $12.5 billion, monthly accrual, 2–5 month payment lag—all align with the original answer and known SEC filing data. No calculation errors. (3) Multi-hop reasoning is partially sound—correctly connecting CVS’s biosimilar production to drug pricing, then to UNH’s rebate model based on utilization and contract terms. However, the inference about total rebate dollars increasing with volume reflects flawed economic reasoning in the context of rebate structures, which are typically percentages of WAC or net price; lower-priced biosimilars would reduce rebate bases even if volume rises. The ground truth emphasizes risk to rebate *amounts* and *predictability*, not a potential upside. (4) Contextual relevance is high—the answer addresses both impact on rebate structure and revenue recognition timing as asked. But due to the significant error in qualitative reasoning about rebate direction (increase vs. decrease), the correctness and qualitative accuracy scores are reduced. The answer is factually strong on inputs but flawed in synthesis and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 476,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Goldman Sachs notes that its consumer‑oriented broker‑dealer activities are now subject to “additional legal requirements, including … Regulation Best Interest” (GS 10‑K p. 61), which it expects to raise its compliance‑related spending on policies, disclosures, monitoring and litigation risk.  By contrast, Morgan Stanley points out that many of its rivals operate under “different and, in some cases, less‑stringent … legal and regulatory regimes,” giving it a pricing advantage in the wealth‑management/retail market (MS 10‑K p. 23).  Consequently, the Best‑Interest rule is likely to increase Goldman Sachs’ compliance costs and could erode its competitive position relative to Morgan Stanley, which faces comparatively lower regulatory cost pressure as it expands its retail client franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs acknowledges increased compliance costs due to Regulation Best Interest in its 10-K (p. 61), specifically citing policies, disclosures, monitoring, and litigation risk—consistent with the original answer’s reference to MET_10k_2024.pdf. Morgan Stanley’s 10-K (p. 23) does state that competitors operate under less stringent regimes, supporting the competitive disadvantage point. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct citation of document pages, which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Regulation Best Interest increases compliance costs for Goldman Sachs, which is expanding in retail services, while Morgan Stanley benefits from a more established retail infrastructure and relatively lower regulatory cost pressure. The conclusion that this could erode Goldman’s competitive position relative to Morgan Stanley is logically supported and matches the original answer’s inference. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Morgan Stanley’s 'more established retail client infrastructure' as a reason for lower incremental costs—this nuance is present in the ground truth but only implied in the LLM version. However, the core reasoning and factual content are semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 449,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s capital structure gives the single outstanding Class B share 15 votes per share, which translates into roughly one‑third (33 %) of the company’s total voting power and is held entirely by Brian L. Roberts. Alphabet’s Class B shares carry 10 votes per share; although each share has fewer votes than Comcast’s, the Class B pool still concentrates voting power in the hands of the founders and insiders (the Class B stock accounts for a majority of the voting rights – about 51 % of total votes). Thus, both companies use a dual‑class system to concentrate control, but Comcast’s Class B votes are weighted more heavily per share (15 vs 10) while Alphabet’s Class B shares represent a larger share of the overall voting power.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims about GOOGL's voting power distribution. According to the ground truth, the evidence does not provide a specific percentage for GOOGL's Class B voting power, yet the LLM confidently states that GOOGL's Class B shares account for 'about 51% of total votes'—a figure not supported by the provided information. This is a major error in quantitative accuracy. Additionally, the ground truth notes that GOOGL's Class B shares can be converted to Class A upon sale or transfer, which may dilute control over time, while CMCSA’s Class B shares are non-dilutable. This key structural difference is omitted in the LLM response. The LLM correctly identifies that CMCSA's Class B shares carry 15 votes per share and are held entirely by Brian L. Roberts, controlling one-third of voting power (33 1/3%), which aligns with the ground truth. However, the comparison is flawed due to the unsupported claim about GOOGL’s 51% voting control. While the reasoning framework—comparing vote weight per share and overall control concentration—is contextually relevant and structurally sound, the incorrect data undermines the conclusion. The model synthesizes a multi-hop comparison but does so with an unsupported assertion about GOOGL, failing in factual completeness and accuracy. Thus, the answer is partially correct in structure and some facts but significantly flawed in key quantitative and qualitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 410,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "Philip Morris International said that a rise in the estimated prevalence of illicit trade in Turkey “partially offset” its 8 % market‑share gain there, curbing the growth of its cigarette volumes. In contrast, Procter & Gamble notes that Turkey is one of the “significant exchange‑rate fluctuations” that have created translation and transaction‑currency exposure, pulling down net sales and earnings. Together the two disclosures show that the same market subjects each company to a different operational‑risk vector – PMI to volume loss from illegal sales, and PG to financial volatility from a weak Turkish lira.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop comparison between PM and PG's operational risks in Turkey. (1) Quantitatively, the LLM correctly states that PM's cigarette volume growth was 'partially offset' by illicit trade, aligning with the original answer's description of market growth (8.2%) being partially offset—though it rounds to 8%, which is acceptable as a close approximation and commonly done in reporting. No explicit calculation is required, so this minor rounding does not constitute an error. PG's exposure to exchange-rate fluctuations is correctly characterized without specific numerical claims, matching the original. (2) The entities—Philip Morris International (PM) and Procter & Gamble (PG)—are correctly identified, as are the risk types: illicit trade for PM and foreign exchange volatility for PG. (3) The reasoning is sound: the LLM synthesizes information across two companies operating in the same country but facing different risk vectors—PM with volume loss due to illegal sales (operational), and PG with financial exposure from currency weakness (financial/transactional and translation risks). This directly addresses the question’s focus on dual operational risks. (4) The answer is contextually excellent, drawing a clear contrast and concluding with the key insight about differing risk exposures in the same market. The only minor shortcoming is the slight imprecision in the market growth figure (8% vs. 8.2%), but this does not affect the overall correctness or interpretation. Thus, the answer is factually solid, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 446,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a formal **Firm‑wide Climate Risk Framework** that is run by a dedicated Climate Risk Management function, uses scenario‑analysis and stress‑testing metrics, and is overseen by the Climate Risk Committee (co‑chaired by the CRO and Chief Sustainability Officer) and the Board’s risk committees. By contrast, Bank of America’s climate‑related exposure is framed as **reputational risk** – it monitors and escalates any gaps in meeting its net‑zero and $1.5 trillion sustainable‑finance commitments through FLU‑level committees, the Enterprise Risk Committee and a corporate communications strategy designed to protect its reputation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan's Firmwide Climate Risk Framework includes scenario analysis, stress testing, and governance via the Climate Risk Committee and Board oversight; Bank of America's exposure is framed as reputational risk tied to its $1.5 trillion sustainable finance goal. The dollar amount ($1.5 trillion) is correctly stated, matching the original answer. (2) Quantitative accuracy is perfect—no calculations required, but the $1.5 trillion figure is accurately reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two institutions, linking JPMorgan’s transition risk management framework with BAC’s reputational risk exposure in the context of their respective climate commitments. (4) The only minor shortcoming is that the LLM omits BAC’s mention of $1 trillion within the $1.5 trillion goal being dedicated to low-carbon transition support—a detail present in the original answer. While this adds nuance, it does not undermine the core correctness. Wording differs but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 342,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records revenue from hardware‑software bundles as a single performance obligation and recognizes the revenue **at the point in time ownership is transferred to the reseller or end‑customer**. Cisco’s financing of hardware purchases is provided through loan receivables that have **average terms of one to three years**. As of July 29 2023, Cisco’s allowance for credit losses on these financing receivables (loan $53 million + lease $19 million) totals **$72 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The revenue recognition timing for Microsoft is accurately described as occurring 'at the point in time ownership is transferred to the reseller or end-customer,' which aligns with the original answer. (2) Cisco's loan receivable terms are correctly stated as 'one to three years,' matching the ground truth. (3) The credit loss allowance is quantitatively accurate: $53 million (loan) + $19 million (lease) = $72 million, which is the exact figure reported as of July 29, 2023. The breakdown adds clarity and is consistent with the original total. (4) All entities—Microsoft, Cisco, hardware-software bundles, loan and lease receivables, and the specific date—are correctly identified and synthesized. The multi-hop reasoning across Microsoft's revenue recognition policy and Cisco's financing terms and allowances is sound and complete. Semantic equivalence is maintained with slight rewording that does not affect factual accuracy. No errors in logic, numbers, or completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 302,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "Gulfstream’s filing notes that its work‑in‑process inventories rose in 2023 “in anticipation of … the G700 in anticipation of its certification from the U.S. Federal Aviation Administration” (GD 10‑K p. 71). FedEx’s 10‑K explains that its CORSIA‑related expenses will depend on the fuel‑efficiency of its fleet and that aircraft delivered after 2023 must meet ICAO’s 2028 production‑cutoff emissions standards or else the carrier will have to buy carbon offsets or sustainable‑fuel credits (FedEx 10‑K p. 18). If FAA certification of the G700 is delayed, FedEx cannot replace older, less‑efficient jets with the G700’s more‑fuel‑efficient technology, forcing it to keep non‑compliant aircraft in service beyond the 2028 cutoff and likely raising its CORSIA compliance costs through additional offset or SAF purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FAA certification delays for the G700, FedEx's reliance on fuel-efficient aircraft for CORSIA compliance, the 2028 ICAO production cutoff, and the link between older aircraft use and increased offset/SAF costs are all properly represented. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (e.g., 2023 inventory increase, 2028 cutoff), or misstatements. Format and citation (GD 10-K p.71, FedEx 10-K p.18) are appropriately used and match the source logic. (3) Multi-hop reasoning is sound—correctly connects Gulfstream’s certification timeline to aircraft delivery, fleet efficiency, and FedEx’s compliance obligations under CORSIA. The answer omits minor contextual details present in the original (e.g., mention of ETS and phase-out of free allowances by 2026), which slightly reduces qualitative completeness but does not affect core correctness. (4) The response is fully relevant, directly addressing the causal chain between FAA delays and compliance costs. Wording differs but semantic meaning is equivalent. No calculation errors. One point deducted from qualitative accuracy for missing the ETS and free allowance phase-out context, which adds depth to the compliance cost argument.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 367,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "- Comcast (CMCSA) – each Class A share carries 1 vote, while each Class B share carries 15 votes (a 15‑to‑1 voting ratio).  \n- Alphabet (GOOGL) – each Class A share carries 1 vote, while each Class B share carries 10 votes (a 10‑to‑1 voting ratio).  \n\nThus, Comcast’s Class B stock confers a higher per‑share voting power than Alphabet’s, with a 15‑to‑1 versus a 10‑to‑1 vote‑per‑share structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the per-share voting ratios at both CMCSA (15:1) and GOOGL (10:1), and accurately compares them by stating that CMCSA's Class B shares have higher per-share voting power. However, it misrepresents the voting structure at CMCSA by claiming that each Class A share carries 1 vote. According to the ground truth, CMCSA's Class A shares do not have a fixed 1 vote per share; instead, their voting power is variable and collectively accounts for 66 2/3% of total voting power, while Class B shares (with 15 votes each) collectively hold 33 1/3%. This is a significant qualitative and quantitative inaccuracy because the model oversimplifies and incorrectly specifies the Class A voting rights. In contrast, the GOOGL portion is accurate: Class A has 1 vote per share, Class B has 10 votes per share. The comparison conclusion (15:1 vs 10:1) is directionally correct and relevant, but the reasoning is flawed due to the incorrect characterization of CMCSA’s structure. Thus, while the core comparison of per-share ratios is partially right, the underlying facts for CMCSA are misrepresented, leading to a partial correctness score. The answer is contextually relevant and addresses the question’s focus on per-share voting ratios, but lacks completeness and precision in describing the actual voting power distribution mechanism at CMCSA.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 378,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s capital‑stock structure gives each Class B share ten votes, but because only one share (held by Brian L. Roberts) is outstanding the Class B stock accounts for about one‑third (33 %) of the company’s total voting power; the remaining two‑thirds (66 %) is held by the much larger base of Class A shareholders.  \n\nAlphabet’s dual‑class system also assigns ten votes to each Class B share, but the Class B shares are owned by founders and insiders in quantities that provide roughly a 51 % voting majority, leaving the combined Class A (one vote per share) and Class C (no voting rights) holders with the balance.  \n\nThus, while both companies give ten votes per Class B share, the Class B holders at Alphabet wield majority control, whereas Comcast’s single Class B holder wields only a one‑third, non‑majority, share of the voting power.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. (1) It states that CMCSA Class B shares have 'ten votes per share', but the ground truth specifies 15 votes per share. This is a critical error affecting the core comparison. (2) The claim that CMCSA's Class B accounts for 'about one-third (33%)' is approximately correct (matches 33 1/3%), and Class A holding 66% aligns with 66 2/3%, so those percentages are acceptable despite rounding. (3) For GOOGL, the LLM incorrectly asserts that Class B shareholders hold 'roughly 51%' of voting power; the original answer does not specify a percentage, only that Class B has 10 votes per share and can convert to Class A. The 51% figure is unsupported by the provided ground truth and introduces fabricated data. (4) The LLM claims both companies assign ten votes to Class B shares, but CMCSA actually has 15 votes per share, making the comparison misleading. (5) The qualitative reasoning about control differences (majority at GOOGL vs. minority at CMCSA) is logically sound and relevant, showing understanding of dual-class implications. (6) However, the model fails to mention that CMCSA’s Class B shares are non-dilutable and that conversion dynamics differ—key differentiators in long-term influence. (7) The answer incorrectly implies Alphabet Class B holders have majority control based on ownership percentage not present in the ground truth, which only confirms vote weight and convertibility. Overall, while the structure and intent of the comparison are appropriate and contextually relevant, the quantitative inaccuracies—especially the 10 vs. 15 votes error—are severe enough to undermine the correctness, warranting a mid-range score for partial credit on correct framework but incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 486,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s Zeposia received its first U.S. FDA approval for ulcerative colitis in May 2021 (see page 93), whereas Merck’s Welireg was cleared by the FDA for von Hippel‑Lindau disease three months later, in August 2021 (see page 52). Zeposia’s approval broadened BMY’s 2021 immunology franchise by adding a new oral therapy for UC, while Welireg’s approval gave Merck its first HIF‑2α‑targeted oncology product and generated the first commercial‑sale milestone (see page 101), strengthening Merck’s 2021 oncology pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY's Zeposia was approved in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for von Hippel-Lindau disease—correct dates and indications. (2) Quantitative accuracy is perfect: the three-month difference (May to August) is correctly implied, and no dollar amounts or numerical values are misstated. While the $50 million milestone payment to former Peloton shareholders is omitted, the LLM correctly notes that Welireg triggered a commercial-sale milestone, which is semantically close and contextually valid. (3) Multi-hop reasoning is sound: the answer correctly compares two regulatory approvals across companies, indications, timelines, and therapeutic areas (immunology vs. oncology), and links each to portfolio impact. (4) The only minor omission is the specific $50M milestone figure and the explicit mention of Peloton, which slightly reduces completeness but does not undermine the core factual or logical accuracy. Wording differences (e.g., 'HIF-2α inhibitor' vs. 'HIF-2α-targeted') are stylistic and semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across entities and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 362,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "Emerson’s restricted‑stock awards vest only by “cliff” service – the shares are earned at the end of a predetermined service period that ranges from three years up to ten years (restricted‑stock units use a three‑year cliff). UPS’s multi‑employer pension plans, by contrast, have vesting periods that are set in the collective‑bargaining agreements for each union unit and are not tied to a single company’s stock‑grant schedule; UPS’s exposure is limited to the cash contributions it is required to make, while the plan’s assets (and any withdrawal liability if the plan is under‑funded) bear the funding risk and the plan itself, not UPS, delivers the retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: EMR's cliff vesting periods range from 3 to 10 years, with RSUs specifically on a 3-year cliff, which aligns with the original answer. UPS’s multiemployer pension plan vesting is correctly described as determined by collective bargaining agreements and not tied to individual company stock. (2) The answer correctly contrasts the risk and benefit delivery mechanisms: UPS’s exposure is limited to required cash contributions, while funding risk (e.g., withdrawal liability, surcharge contributions) resides with the plan, not UPS directly—this matches the original answer’s emphasis on shared funding risks and potential additional liabilities. (3) Multi-hop reasoning is sound: the model synthesizes EMR’s equity compensation structure with UPS’s pension obligations, correctly identifying differences in vesting triggers, risk allocation, and benefit delivery. (4) Minor omission: the original answer explicitly mentions that UPS may face withdrawal liability or surcharge contributions if plans enter critical status; while the LLM mentions withdrawal liability, it does not explicitly tie it to 'critical status' or 'surcharge contributions,' slightly reducing completeness. However, the semantic meaning and risk distinction are preserved. Wording differs but meaning is equivalent. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 398,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Netflix’s filing notes that the Communications Act‑based privacy rules (e.g., the Video‑Privacy Protection Act, GDPR‑type state statutes and the CPRA) expose it to “legal claims or regulatory fines or penalties” if member data – especially billing or viewing information – is disclosed or breached, and it could be forced to alter its data‑collection practices or incur material remediation costs, for which it carries no insurance. Comcast, by contrast, is subject to a broader set of Communications Act obligations that the FCC enforces on its cable, broadband, voice and MVNO businesses – including mandatory protection of customer‑proprietary network information, reporting and disclosure duties, and compliance with specific privacy‑related rules – and the company warns that failure to meet those rules can trigger administrative enforcement actions, civil or criminal fines and operational mandates (such as network‑access, data‑retention and security requirements) that directly constrain how it handles personal information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX faces regulatory fines, legal claims, and material remediation costs due to data breaches involving personal and billing information, with no insurance coverage—this matches the original answer. CMCSA is correctly described as being under broader regulatory obligations under the Communications Act, enforced by the FCC, with specific duties around customer data (e.g., customer-proprietary network information), reporting, and operational constraints. The mention of potential civil/criminal fines and administrative actions is consistent. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default—no errors in implied financial or operational impacts. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies face risks under the Communications Act but differ in scope and nature—NFLX’s exposure is event-driven (breaches leading to penalties), while CMCSA has ongoing, enforceable compliance obligations. The absence of insurance for NFLX is correctly highlighted. The only minor shortcoming is that the LLM references GDPR-type state statutes and CPRA, which, while contextually relevant to data privacy, are not explicitly mentioned in the original answer and slightly extend beyond the scope of the Communications Act focus—hence a 9 on qualitative accuracy. (4) Contextual relevance is perfect: the response directly compares financial penalties and operational constraints as asked, and maintains focus on the Communications Act framework for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 445,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "Philip Morris introduced Platform 5 nicotine pouches in Sweden in January 2022 by directly launching a reformulated Shiro‑brand product that it manufactures through its newly‑acquired AG Snus facility; the rollout is driven by a company‑led commercialization plan that emphasizes retail‑experience, guided trials, digital engagement and e‑commerce and does not rely on any external supplier for the core product. By contrast, Coca‑Cola Europacific Partners (CCEP) operates in Sweden as an independent bottling partner under a bottler’s agreement that obligates it to purchase Coca‑Cola concentrates and syrups from the Company and to package and distribute those trademark beverages—its market entry is therefore a franchise‑style extension of Coca‑Cola’s existing beverage portfolio rather than a proprietary product launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand via AG Snus, which it acquired—this matches the original answer. CCEP’s role as a bottler purchasing concentrates from KO is accurately described. (2) Quantitative accuracy is perfect: the date 'January 2022' is correctly stated; no percentages or financial figures are misstated. The LLM omits the specific statistic that KO’s top five bottlers (including CCEP) represented 41% of global unit case volume in 2021, which is present in the original answer and relevant to CCEP’s significance. This is a minor omission affecting completeness but not core correctness. (3) Reasoning is sound: the contrast between PM’s direct commercialization strategy (product innovation, acquisition, self-reliance) and CCEP’s franchise-style, KO-dependent model is clearly and logically drawn. The multi-hop synthesis—linking PM’s acquisition of AG Snus to product control, and CCEP’s contractual obligations to KO—is valid and insightful. (4) Semantic equivalence is strong: while the LLM adds detail not in the original (e.g., 'retail-experience, guided trials, digital engagement'), these are plausible elaborations that do not contradict the ground truth and enhance the explanation of PM’s go-to-market strategy. The core comparison of market entry (direct vs. contracted) and product dependency (independent vs. reliant) is preserved and accurately conveyed. The omission of the 41% statistic prevents a perfect score, but overall the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 452,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UnitedHealth’s Medicare Part D stand‑alone enrollment fell from 3,315 k in 2023 to 3,050 k in 2024 – an 8 % drop (UNH 10‑K, p. 31).  Under the Inflation‑Reduction Act, manufacturers must now provide mandatory discounts on many Part D drugs and, beginning in 2025, federal re‑insurance in the catastrophic phase is being reduced, shifting a larger share of those high‑cost claims to the Part D plan itself (Amgen 10‑K, p. 17).  For CVS, the enrollment decline trims the total volume of drug spend it must fund under its Medicare‑Advantage contracts, but the IRA‑driven discount and re‑insurance shifts raise the cost per enrollee; consequently CVS’s overall dollar exposure is likely lower than it would have been on a flat‑enrollment basis, yet its per‑member liability has increased because it must absorb higher manufacturer discounts and a larger share of catastrophic drug costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: UNH's Medicare Part D enrollment declined from 3,315,000 (3,315k) in 2023 to 3,050,000 (3,050k) in 2024, representing an 8% decline—this matches the original answer exactly. The LLM correctly cites the IRA’s manufacturer discount requirements and the 2025 start date for reduced federal reinsurance in the catastrophic phase. (2) The LLM accurately references the UNH 10-K (p.31) and Amgen 10-K (p.17), confirming proper sourcing. (3) Reasoning is sound: it correctly synthesizes the impact of lower enrollment (reducing total drug spend volume for CVS) with increased per-enrollee liability due to IRA-driven shifts in reinsurance and manufacturer discounts. This dual effect—lower overall exposure due to fewer enrollees but higher per-member costs—is logically consistent with the original answer. (4) The only minor gap is that the LLM does not explicitly mention Amgen’s accrual of rebates starting in 2022, which the original answer uses to illustrate broader pricing pressures affecting PBMs like CVS. While the LLM references the Amgen 10-K, it doesn’t connect Amgen’s experience to CVS’s PBM operations or rebate negotiations as directly as the ground truth. However, the core multi-hop reasoning—linking UNH enrollment trends, IRA policy changes, and financial exposure for CVS under Medicare Advantage—is well-executed and semantically equivalent. Wording differs slightly but meaning is preserved. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 433,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities can recoup the costs of environmental‑remediation projects through the cost‑based rate and rider mechanisms that state public‑utility commissions approve – the utilities are allowed to recover “prudently‑incurred” remediation expenses as part of the regulated rate base. By contrast, Duke Energy records its remediation obligations as liabilities (e.g., $73 million of reserves for probable environmental‑remediation costs at year‑end 2024) and must bear those costs unless insurance or third‑party indemnities apply, because it does not have a comparable regulatory cost‑recovery framework. Thus Southern Company’s exposure is largely offset by rate‑recovery rights, while Duke Energy’s exposure remains a direct financial liability on its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that Southern Company uses state-approved cost recovery mechanisms (rate and rider mechanisms) to pass prudently-incurred environmental remediation costs to customers, while Duke Energy records liabilities without guaranteed regulatory recovery. This captures the core contrast in regulatory and liability frameworks. (2) The LLM provides a specific dollar amount—$73 million in reserves for Duke Energy’s environmental remediation costs at year-end 2024—which is a plausible and precise figure. While the original answer uses a placeholder '$X million', the LLM’s inclusion of a concrete number (assuming it reflects actual reported data) enhances accuracy rather than detracting, as long as it is factually correct. However, since the ground truth uses a hypothetical placeholder, we cannot fully verify the $73M figure’s correctness from the provided context, leading to a slight deduction in quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their differing regulatory environments, and financial treatment of remediation costs. It draws the appropriate conclusion that Southern’s exposure is mitigated by recovery rights, while Duke’s remains a direct balance sheet liability. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mention of insurance or third-party indemnities), which is acceptable and adds nuance without distorting meaning. Contextual relevance is perfect—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 452,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "- **Caterpillar:** 40,873,176 securities remaining under shareholder‑approved equity plans (page 127).  \n- **Johnson & Johnson:** 111,042,139 securities remaining under shareholder‑approved equity plans (page 121).  \n\n**Combined total:** 40,873,176 + 111,042,139 = **151,915,315** securities.\n\n- **3M:** 39,563 (thousand) = **39,563,000** securities remaining under shareholder‑approved equity plans (page 116).\n\n**Comparison:** The combined Caterpillar‑Johnson & Johnson amount (≈151.9 million) is about **112 million more** than 3M’s total of roughly **39.6 million** securities available for future issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176, Johnson & Johnson's 111,042,139, and 3M's 39,563,000 (correctly interpreted from '39,563 thousand'). The sum of 40,873,176 + 111,042,139 = 151,915,315 is calculated correctly. (2) The comparison correctly notes that the combined total (~151.9 million) is significantly higher than 3M's ~39.6 million, with an approximate difference of 112 million, which aligns with the ground truth (difference is 112,352,315). (3) Multi-hop reasoning is sound: the model correctly identifies and extracts data from three separate companies, performs the required addition, and makes a valid comparative statement. (4) All entities (Caterpillar, Johnson & Johnson, 3M), metrics (securities available under shareholder-approved equity plans), and contextual details (page references) are accurate and relevant. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 306,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s filing shows that the key sitagliptin patents for Januvia and Janumet will not expire until May 2026 (Janumet XR July 2026) and that the Inflation‑Reduction Act will impose a government‑set price on Januvia beginning 1 Jan 2026 and on Janumet/Janumet XR on 1 Jan 2027, meaning the company’s U.S. revenue stream is expected to erode sharply after 2025 (MRK 10‑K p. 58).  \n\nPfizer, by contrast, leans on statutory regulatory exclusivity – five years of data‑exclusivity for new chemical drugs and twelve years for biologics, plus any patent‑term extensions – to keep generics and biosimilars off the market well beyond 2025 (Pfizer 10‑K p. 7) and, for flagship products such as Comirnaty and Paxlovid, enjoys basic‑patent protection into the 2040s (Pfizer 10‑K p. 14).  \n\nThus, Merck’s post‑2025 protection is limited to a short patent window and IRA price caps, whereas Pfizer’s strategy provides a much longer, regulatory‑driven exclusivity horizon, indicating stronger revenue protection for Pfizer after 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Januvia and Janumet exclusivity ends in May 2026 (July 2026 for XR), IRA pricing starts Jan 1, 2026 for Januvia and Jan 1, 2027 for Janumet/Janumet XR—minor variation in date specificity (ground truth says '2026'/'2027', LLM specifies Jan 1) but semantically consistent. (2) Quantitative accuracy is perfect: dates, exclusivity periods, and references to 10-K pages are correctly cited. (3) Entity accuracy is strong: Merck (MRK), Pfizer, drug names (Januvia, Janumet, Comirnaty, Paxlovid), and regulatory terms (data exclusivity, patent-term extensions) are correctly identified. (4) Multi-hop reasoning is sound: the answer synthesizes Merck’s patent expiration and IRA pricing with Pfizer’s dual reliance on regulatory exclusivity and long-term patents, correctly contrasting their post-2025 revenue protection strategies. (5) The conclusion that Pfizer has stronger, longer-term protection due to regulatory shields while Merck faces near-term erosion is logically derived and matches the ground truth’s implication. The only minor shortcoming is that the LLM does not explicitly mention 'patent settlements and court rulings' as the cause of Merck’s exclusivity loss, which is in the original answer, slightly reducing qualitative completeness. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 410,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "Morgan Stanley’s CLN and CDO positions expose the firm to a credit‑event loss because it has **sold credit protection to the note issuers** – if a reference entity defaults the principal may not be repaid.  Morgan Stanley limits that counter‑party risk by posting collateral, maintaining bilateral downgrade‑triggered collateral agreements and net‑ting arrangements, and by setting market‑risk limits on its credit‑derivative exposures (see pages 112‑111).  \n\nBank of America, by contrast, **buys credit protection (and sometimes sells it) to hedge its commercial‑loan and unfunded‑commitment exposures**.  It manages the associated counter‑party risk through clearing‑house membership, margin‑call requirements, master‑netting agreements and collateral posting on those derivatives (see pages 64‑66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Morgan Stanley (MS) sells credit protection through its investments in CLNs and CDOs, exposing it to credit event risk if the reference entity defaults, with potential non-repayment of principal—this matches the original answer. It contrasts this with Bank of America (BAC), which buys credit protection to hedge commercial credit exposures, accurately capturing the core distinction. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, all qualitative financial concepts (e.g., hedging, credit protection sold vs. bought) are correctly represented, warranting a 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MS assumes counterparty risk by selling protection, while BAC mitigates risk by purchasing protection. The LLM adds granular risk management practices (e.g., collateral agreements, netting, clearing-house membership) not explicitly detailed in the ground truth but consistent with typical derivative risk controls and referenced via document pages, enhancing completeness without introducing error. (4) The only minor shortcoming is that the original answer emphasizes BAC 'actively purchases credit protection' as the primary strategy, while the LLM notes BAC 'buys credit protection (and sometimes sells it)', which slightly softens the contrast. However, this addition does not contradict the ground truth and may reflect nuance in BAC's actual filings. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with excellent reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 479,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "RTX’s guarantees are self‑issued financial guarantees that remain on RTX’s balance sheet; a “portion of our third‑party guarantees are subject to indemnification for our benefit,” but the company does not transfer the underlying exposure to another party and records a carrying‑amount liability (e.g., $1 million for commercial‑aerospace guarantees) and accrues the most likely loss when it becomes probable【page_102】.  \n\nIn contrast, 3M’s spin‑off of Solventum expressly reallocates PFAS‑related liabilities – 3M retains pre‑April 1 2024 liabilities and certain product‑claim exposures, while Solventum assumes the post‑spin‑off PFAS liabilities and, in turn, agrees to indemnify and defend 3M for those matters【page_85】. Thus, 3M transfers the bulk of the risk to the new entity with a reciprocal indemnification clause, whereas RTX keeps the risk on its books and only receives limited indemnification from counterparties on its guarantees.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though with minor discrepancies in detail and emphasis. (1) Quantitatively, the LLM correctly references a $1 million liability for RTX's commercial-aerospace guarantees, which matches typical reporting standards, though the original answer does not specify this number—this detail comes from a cited page (102) and is plausible within context, so it does not count as an error. The date April 1, 2024, is accurately used for the 3M/Solventum liability split, consistent with known spin-off timing. (2) The LLM correctly identifies that 3M transferred post-spin-off PFAS liabilities to Solventum, with Solventum assuming indemnification and defense obligations, which matches the original answer’s claim about Bair Hugger and False Claims Act liabilities (though the LLM focuses on PFAS instead). This reflects a slight shift in emphasis—PFAS is a major liability in 3M’s disclosures, but the original answer highlights different litigation. This is a partial mismatch but not factually incorrect, as Solventum did assume various product liabilities including PFAS. (3) The reasoning correctly contrasts RTX’s retention of risk on its balance sheet with limited third-party indemnification against 3M’s structural transfer of risk to a spun-off entity. This captures the core multi-hop comparison: 3M’s spin-off enables risk transfer via indemnification by a new entity, while RTX remains exposed despite some indemnification rights. (4) The LLM omits explicit mention of ASC 450 and ASC 610-30 accounting frameworks, which are part of the original answer and important for full completeness. However, the conceptual treatment of liability recognition (accruing probable losses, carrying amounts) implies understanding of these standards. The LLM also does not mention that 3M retains pre-spin liabilities, which is a key nuance. Overall, the answer is semantically close, with strong qualitative reasoning and high contextual relevance, but loses minor points for incomplete entity-specific detail and lack of accounting standard references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 565,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 filing shows that sales to customers in Taiwan were $1.84 billion – roughly 8 percent of its total $22.7 billion revenue. By contrast, NVIDIA’s 2023 filing warns that a “significant portion” of its chipset supply comes from foundry partners in Taiwan, and that any escalation of the China‑Taiwan geopolitical tension could severely limit or halt that supply, creating a material supply‑chain risk for NVIDIA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in sales to Taiwan (equivalent to $1,841 million in the original) and the implied 8% of total revenue ($1.84B / $22.7B ≈ 8.1%) are accurate. The total revenue figure ($22.7B) is correctly inferred and consistent with AMD’s 2023 filing. (2) Entity accuracy is strong: both AMD and NVIDIA are correctly identified with relevant data from their 2023 filings. The mention of 'foundry partners in Taiwan' aligns with NVIDIA's reliance on TSMC and others located there. (3) Reasoning is sound: the answer contrasts AMD’s revenue exposure (market demand in Taiwan) with NVIDIA’s supply chain risk (manufacturing dependency), which captures the core multi-hop comparison in the question. (4) The only minor omission is that the original answer explicitly names the geopolitical conflict involving China and Taiwan as a 'severe' risk that could 'prevent' supply, while the LLM uses slightly softer phrasing ('could severely limit or halt'). However, this does not alter the semantic meaning significantly. Overall, the answer is factually correct, well-synthesized, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 342,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s portfolio is anchored by long‑term power‑sales agreements whose weighted‑average remaining term – including the life of production‑tax‑credit (PTC) periods for repowered wind – is about 15 years, which locks in both capacity and energy pricing and gives the segment a highly predictable, multi‑year revenue stream (see NEER generation assets description, page 13). Southern Power also sells electricity under PPAs, but the filings do not disclose the length or pricing structure of those contracts, so its cash‑flow outlook is less transparent and more exposed to market‑price swings and contract‑specific risk than NEER’s clearly defined 15‑year framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER is correctly stated, matching the original answer. There are no calculations required, but the reference to PTC periods contextualizes the duration appropriately and accurately. (2) The LLM correctly identifies both NEER and Southern Power as relying on power purchase agreements (PPAs), and accurately notes that Southern Power does not disclose contract terms—this is consistent with the knowledge graph. (3) The multi-hop reasoning is sound: it synthesizes information about NEER’s disclosed long-term contracts and contrasts them with Southern Power’s lack of transparency, leading to a valid conclusion about revenue predictability and market exposure. (4) The LLM adds slight contextual detail (e.g., mention of production-tax-credit periods and page reference) that enhances clarity without introducing error. The only minor gap is that it doesn’t explicitly mention 'investor confidence' or 'financial planning strategies' as in the original, which slightly reduces completeness in qualitative nuance, but the core comparison on transparency and revenue stability is fully preserved. Wording differs but semantic meaning and factual content are equivalent. All entities (NEER, Southern Power, PPA structures) are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 390,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX follows FAR‑guided revenue recognition for its U.S. government fixed‑price contracts by recording revenue on a percentage‑of‑completion basis (using costs incurred versus total estimated costs) and reporting the resulting excess of billings over recognized revenue as contract assets. In contrast, Honeywell highlights that its U.S. government contracts are subject to FAR‑based termination‑for‑convenience rights, exposing the company to the risk that contracts can be ended (or audited) before revenue is earned, which could lead to loss of expected earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately describes RTX's revenue recognition under FAR using the percentage-of-completion method, which results in contract assets when revenue exceeds billings—consistent with the original answer's explanation of performance-based or progress payments covering 80-90% of costs. While the exact 80-90% figure is omitted, this is a minor detail and not a factual error. (2) The LLM correctly identifies that Honeywell faces termination-for-convenience risks under FAR, which could disrupt expected revenue, matching the original answer’s emphasis on contract termination impacting recognized revenue. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies operate under FAR, but with different risk exposures—RTX on payment timing and contract assets, Honeywell on termination risk. (4) The only minor shortcoming is that the LLM reverses the direction of the billing-revenue imbalance: it states 'excess of billings over recognized revenue' when the correct direction (per original answer) is 'revenue in excess of billings', which creates the contract asset. This is a subtle but important distinction in accounting terms, slightly reducing qualitative accuracy. However, the overall semantic meaning and intent are preserved, and no numerical inaccuracies exist. Hence, high scores across the board with a slight deduction in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 403,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries **no voting rights** – the only voting power resides in the 10‑vote Class B shares and the 1‑vote Class A shares, and the company’s charter and Delaware law prevent the board from treating the classes differently for dividends or liquidation (see GOOGL 10‑K, Note 11, p. 82).  \n\nComcast, by contrast, **gave up its board seats and virtually all voting rights in Hulu**, allowing Disney to assume full operational control; in exchange Comcast received an $8.6 billion cash payment (treated as an advance on the sale) and a related tax gain, and the remaining Hulu investment is now carried at its historical cost, which is well below its fair value (see CMCSA 10‑K, “Hulu and Collateralized Obligation,” p. 85).  \n\nThus, Alphabet’s non‑voting Class C shares affect only shareholder‑level voting without changing corporate governance or financial results, whereas Comcast’s relinquishment of Hulu voting rights transferred governance to Disney and generated a substantial one‑time cash inflow and ongoing accounting impacts.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core governance and financial implications of Alphabet's Class C shares and Comcast's relinquishment of Hulu voting rights, with strong qualitative reasoning and contextual relevance. It accurately states that Alphabet’s Class C shares have no voting rights and that control is maintained through Class A and B shares, aligning with the ground truth. It also correctly identifies that Comcast gave up voting rights and board seats in Hulu, enabling Disney’s full operational control. The $8.6 billion cash payment from Disney is correctly reported, matching the ground truth (net of $557 million for prior capital calls). However, the LLM omits key quantitative details present in the original answer: (1) Alphabet’s $44.7 billion remaining share repurchase authorization in 2024, and (2) Comcast’s recorded investment value of $883 million as of December 31, 2024. Additionally, while the LLM mentions a tax gain and accounting treatment (carrying investment at historical cost), it does not mention the put option exercised in 2023 or the minimum equity value of $9.2 billion, which are important financial terms of the transaction. These omissions affect quantitative completeness but do not undermine the overall correctness of the main financial outcome. The reasoning is logically sound, synthesizing governance and financial impacts across two companies and events, and the comparison is well-framed. Wording differs but meaning is semantically close, especially in describing the strategic trade-offs. Thus, the answer is strong in qualitative accuracy and relevance but loses points on full quantitative precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 455,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both companies depend heavily on external manufacturers to meet growing demand, and each 10‑K flags that any lapse in a supplier’s quality‑assurance or delivery performance could force product‑allocation, delays or even shortages. Eli Lilly notes “intermittent delays … in fulfilling certain orders for incretin products” and warns that regulatory‑compliance or quality‑issue‑related supply interruptions could impair its ability to scale new tirzepatide presentations (LLY 45). Thermo Fisher’s $26.92 billion of remaining performance obligations are “generally … contract manufacturing … with durations of three to five years” (TMO 49), and its risk disclosures stress limited control over third‑party capacity, yields, pricing and quality (TMO 24‑25). Consequently, shared vulnerabilities in supplier quality and supply‑chain execution could jeopardize both firms’ ability to honor long‑term contracts, trigger revenue shortfalls and damage customer relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY's intermittent supply delays for incretin products (e.g., Mounjaro, Zepbound) due to third-party manufacturing constraints are accurately described, as is TMO's $26.92 billion in remaining performance obligations tied to 3-5 year contract manufacturing agreements. The dollar amount is correctly cited and matches the ground truth. (2) Quantitative accuracy is perfect: the $26.92 billion figure is exact and properly attributed to TMO, with no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes risks across LLY and TMO by identifying shared reliance on third-party manufacturers and linking quality assurance and supply chain execution risks to potential contract fulfillment issues, revenue shortfalls, and customer relationship damage. It appropriately references specific risk disclosures (e.g., LLY 45, TMO 24-25, TMO 49) as found in the 10-Ks, indicating precise sourcing. (4) The only minor shortcoming is that the ground truth explicitly references AMD’s 10-K as also highlighting third-party manufacturer risks, which the LLM omits. While not central, this detail strengthens the multi-company vulnerability argument and its absence slightly reduces completeness. However, the core synthesis between LLY and TMO remains fully intact. Wording differs but semantic meaning is equivalent, and all critical financial, operational, and risk-related information is preserved. Contextual relevance is excellent, directly addressing the question’s focus on shared vulnerabilities and long-term commitment fulfillment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 451,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "NextEra Energy Resources has recorded a total of about **$2.0 billion of cumulative other‑than‑temporary impairment charges on its XPLR investment** (the $1.2 billion recognized in 2023 plus the $0.8 billion recognized in 2024)【page_92】.  \n\nBefore the 2024 impairment, the equity‑method investment was carried at roughly **$2.6 billion**; the 2024 write‑down reduced that amount to an estimated fair value of about **$1.8 billion**, i.e., an $0.8 billion reduction from the pre‑impairment carrying value【page_92】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.2 billion impairment in 2023 and $0.8 billion in 2024 sum to the correct cumulative $2.0 billion total, and the pre-impairment carrying value of $2.6 billion is correctly stated, as is the post-impairment value of $1.8 billion (a $0.8 billion reduction). (2) The answer is complete, addressing both parts of the question: the total cumulative impairment charge as of December 31, 2024, and the comparison to the carrying value before the 2024 impairment. (3) Entity accuracy is correct—NextEra Energy Resources, XPLR, and the relevant time periods (2023 and 2024) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines impairment charges across two different reporting periods and correctly interprets the impact on carrying value. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'estimated fair value' vs. 'written down to') that does not affect factual accuracy. The citation of 'page_92' supports the sourcing. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 331,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE says it adopted ASU 2022‑04 on 1 Jan 2023 (with roll‑forward reporting beginning 1 Jan 2024) and that the required supplier‑finance information is set out in Note 15, but the filing does not disclose the actual amount of confirmed invoices or how the balances are presented on the balance sheet. In contrast, 3M’s Note 16 explicitly states the outstanding confirmed‑invoice balance (≈ $0.3 billion for both 2024 and 2023), notes that the amount is included in accounts payable, and provides a roll‑forward of invoices confirmed and paid, giving a far more detailed and transparent picture of its supplier‑finance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures starting January 1, 2024; MMM’s confirmed invoice balances are approximately $0.3 billion for both 2023 and 2024. These numbers match the original answer exactly, and formatting ($0.3 billion) is acceptable. (2) Entity accuracy is strong: GE and MMM (referred to correctly as 3M) are properly identified, along with correct note references (Note 15 for GE, Note 16 for MMM), and accurate descriptions of balance sheet presentation (included in accounts payable). (3) The reasoning is sound: the LLM correctly contrasts GE’s lack of quantitative disclosure with MMM’s detailed reporting, highlighting the difference in transparency despite both being subject to the same standard. (4) The answer addresses all parts of the multi-hop question: adoption timing, impact on transparency, confirmed invoice balances, and financial statement presentation. The only minor shortcoming is that the LLM implies GE provides no balance sheet presentation details, while the ground truth states GE discloses 'balance sheet presentation' in general terms—though not the actual amounts. This nuance is slightly understated but does not materially misrepresent the situation. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 391,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its 75 % stake in Cronos using the equity method, so the investee’s results flow through Altria’s income and its carrying amount is adjusted for Cronos’s earnings and any impairments.  Because Cronos is subject to U.S. FDA (and other) regulations, a failure by Cronos—or by Altria to ensure Cronos’s compliance—could trigger civil, criminal or tax liabilities, depress the value of the investment and limit Altria’s access to capital (see MO 10‑K p. 16).  \n\nWalmart’s risk is not through an equity‑method investment but through its own pharmacy business, which is directly regulated by the FDA (and DEA).  Non‑compliance could result in fines, loss of pharmacy licenses, or other sanctions that would hurt Walmart’s earnings and operations, but the impact is confined to the pharmacy segment rather than being reflected as a share of an investee’s results (see WMT 10‑K p. 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 75% stake mentioned is correct (Altria owns approximately 75% of Cronos), and no other numerical data (dates, dollar amounts) contradicts the ground truth. There are no calculations required, so numerical precision is maintained. (2) The answer correctly identifies both companies, their respective regulatory exposures, and the accounting method (equity method for Altria, direct operations for Walmart). (3) The multi-hop reasoning is sound: it distinguishes between Altria’s indirect exposure via equity-method accounting and Walmart’s direct operational exposure, both tied to FDA compliance risks. It correctly synthesizes that while both face FDA-related financial risks, the mechanisms differ—Altria through its investment value and earnings share, Walmart through direct operational and licensing risks. (4) The only minor shortcoming is that the original answer emphasizes the similarity in risk *profile* despite different structures, which the LLM touches on but could have made more explicit. However, the core facts, entities, and reasoning are correct and complete. Wording differs but semantic equivalence is preserved. Citations to 10-K pages (p.16 for MO, p.26 for WMT) add precision and context, enhancing credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 369,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "Lilly’s 10‑K notes that Cardinal Health is one of three U.S. wholesalers that together deliver about 15 %‑20 % of Lilly’s consolidated revenue.  In CVS’s 10‑K, Cardinal is also a 50 % owner of Red Oak Sourcing, a generic‑sourcing VIE that CVS consolidates because it is the primary beneficiary; Cardinal makes fixed quarterly payments to CVS (about $183 million a year) and the amounts “due to or due from Cardinal” are described as immaterial.  Consequently, Lilly’s reliance on Cardinal for distribution does not increase CVS’s financial exposure to Red Oak – CVS’s exposure remains limited to its VIE investment and the contractual, essentially non‑material payments from Cardinal, not to the volume of Lilly products Cardinal distributes.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in terms of quantitative accuracy and entity identification but fails in qualitative reasoning and overall synthesis, leading to an incorrect conclusion. (1) Quantitatively, the numbers are accurate: LLY’s 15–20% U.S. revenue reliance on Cardinal Health and the $183 million annual payment from Cardinal to CVS (via quarterly installments) match the ground truth. The entities—LLY (Lilly), Cardinal Health, CVS, and Red Oak Sourcing—are correctly identified, and the structure of Red Oak as a VIE consolidated by CVS due to primary beneficiary status is accurately described. (2) However, the critical flaw lies in reasoning: the LLM concludes that LLY’s reliance on Cardinal 'does not increase CVS’s financial exposure' because the payments are 'non-material' and CVS’s exposure is limited to its VIE investment. This contradicts the ground truth, which correctly identifies a multi-hop risk: disruption in Cardinal’s distribution of LLY products could impair Cardinal’s financial health, affecting its ability to make $183M annual payments to CVS via Red Oak, thereby impacting CVS’s consolidated financials. The LLM dismisses this linkage by citing 'immaterial' intercompany balances, but the risk is not about current receivables—it’s about forward-looking financial stability of a key Red Oak counterparty. (3) The multi-hop logic—LLY → Cardinal (distribution) → Cardinal’s financial health → Red Oak’s cash flows → CVS’s consolidated exposure—is missing or incorrectly rejected. While the LLM cites correct sources (10-Ks), it misinterprets the risk transmission mechanism. (4) Thus, despite strong quantitative and contextual performance, the answer fails on qualitative reasoning, warranting a correctness score of 4: some facts are right, but the synthesis is flawed and the final conclusion is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 498,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a short‑term financing facility that it uses for general corporate purposes; the program currently has only about $0.4 billion of paper outstanding and Oracle’s senior notes are expressly ranked pari‑passu with any notes issued under that program. Cisco, by contrast, issued $13.5 billion of senior fixed‑rate notes in February 2024 and, like Oracle, treats those notes as pari‑passu with its commercial‑paper obligations, meaning the senior notes and the short‑term paper have the same claim on assets, but Cisco’s senior‑note tranche is far larger and forms a central component of its overall debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $6.0 billion commercial paper program and Cisco's $13.5 billion senior fixed-rate note issuance in February 2024, both of which match the ground truth. It accurately notes that both companies rank their senior notes pari passu with commercial paper obligations. However, the LLM incorrectly states that Oracle's senior notes are pari passu with its commercial paper — this information is not present in the ground truth and represents an unsupported inference. The ground truth only confirms this ranking for Cisco, not Oracle. (2) Quantitatively, the $0.4 billion outstanding (i.e., $401 million) for Oracle is correctly approximated, and the $13.5 billion figure for Cisco is exact. The date of Cisco’s issuance (February 2024) is accurate. No calculations are required, but the comparison in scale between Oracle’s small commercial paper drawdown and Cisco’s large note issuance is reasonably conveyed. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Oracle’s reliance on short-term financing with Cisco’s larger long-term debt structure. However, it fails to mention that Cisco’s notes are redeemable with a makewhole premium and that they are hedged via interest rate swaps — key qualitative details from the ground truth that affect risk and strategy interpretation. (4) The contextual relevance is high, as the answer directly addresses the comparison of debt structures. Due to the incorrect attribution of pari passu status to Oracle (not supported by evidence) and the omission of key hedging and redemption terms for Cisco, the answer is partially flawed in reasoning and completeness, warranting a score of 7 for correctness — core facts are right, but significant details are inaccurate or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 489,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment draws on wind power as one piece of a broadly diversified renewable portfolio – 23 wind facilities that together contribute to a total of 3,554 MW of wind, solar, fuel‑cell and storage assets across 22 states. In contrast, Southern Company’s wind strategy is centered on the Skookumchuck project, a single 136‑MW wind farm that is secured by a 20‑year power‑purchase agreement, reflecting a more focused, contract‑driven commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, particularly regarding Duke Energy's wind capacity and facility count. The ground truth states that Duke Energy does not disclose specific wind capacity figures, but the LLM claims '23 wind facilities' and '3,554 MW' of combined renewable assets—specific numbers not supported by the source data. This undermines the quantitative accuracy. While the LLM correctly identifies Southern Company's 136 MW Skookumchuck project and its 20-year PPA, the contrast drawn is misleading because it attributes precise portfolio data to Duke that is not publicly disclosed. Qualitatively, the reasoning structure is sound—comparing a diversified portfolio approach versus a focused project-level commitment—but the unsupported numbers weaken the validity of the comparison. The answer is contextually relevant and addresses the core question about strategic differences, but the fabrication of Duke's wind metrics results in a partially correct response with major factual flaws. Hence, correctness is scored moderately low due to the critical error in undisclosed data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 324,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under Morgan Stanley’s Advanced Approach the buffer is built from three pieces – a 2.5 % capital‑conservation buffer, a 3.0 % G‑SIB surcharge and a Counter‑Cyclical Capital Buffer that the Federal Reserve has set at 0 %, giving a total buffer of 5.5 % of risk‑weighted assets. Charles Schwab, by contrast, is required only to hold a single 2.5 % stress or capital‑conservation buffer (with the CCyB also at 0 %), so its overall buffer requirement is roughly half of Morgan Stanley’s and far less complex.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that both Morgan Stanley (MS) and Schwab (SCHW) are subject to a 2.5% Capital Conservation Buffer and that the Countercyclical Capital Buffer (CCyB) is set at 0% by the Federal Reserve. It also correctly notes that MS, as a G-SIB, faces an additional G-SIB surcharge while SCHW does not. However, the LLM introduces a specific G-SIB surcharge value of 3.0%, which is not present in the original answer or ground truth — the actual surcharge for MS may vary and was not specified, so this number is unsupported. This is a significant quantitative inaccuracy. (2) The calculation of a 'total buffer of 5.5%' for MS is based on the unsupported 3.0% G-SIB figure (2.5% + 3.0% + 0% = 5.5%), making the total buffer claim factually questionable. SCHW’s buffer is correctly stated as 2.5%, with no surcharge. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms share the same CCyB (0%) and Conservation Buffer (2.5%), but differ due to MS’s G-SIB status. It accurately contrasts complexity and total requirements. (4) Despite the incorrect G-SIB percentage, the core structural comparison is valid and the answer addresses the role of the CCyB correctly. The answer is contextually relevant and semantically close to the original, but the unsupported numeric value reduces quantitative accuracy. Correctness score is 7 due to accurate framework but incorrect specific number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 400,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow models that rely on observable market inputs such as current interest‑rate curves, yield curves and foreign‑exchange rates (DIS 10‑K p. 119). Meta, by contrast, uses discounted‑cash‑flow models as an income‑approach to estimate the fair value of operating‑lease right‑of‑use assets and lease‑hold improvements when testing for impairment, applying Level 3 assumptions about expected downtime, projected sub‑lease cash flows and risk‑adjusted discount rates (META 10‑K p. 98). Thus, Disney’s DCF models are applied to price market‑linked derivative contracts, whereas Meta’s DCF models are used to assess impairment of lease assets—resulting in Meta recording a $383 million lease‑asset impairment in fiscal 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Disney uses discounted cash flow (DCF) models with observable inputs (Level 2) for derivatives, while Meta uses DCF models with unobservable inputs (Level 3) for impairment testing of operating lease assets. The $383 million impairment charge in fiscal 2024 is correctly attributed to Meta, not Disney—this is a critical correction from the question's misleading framing, which incorrectly associates the charge with Disney. The LLM correctly identifies Meta as the company recording the impairment. (2) Quantitative accuracy is perfect: the $383 million figure is correctly cited and placed in the right context (Meta’s lease-asset impairment in fiscal 2024). No calculations are required, but the attribution is precise. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (Disney and Meta), two distinct applications of DCF models (derivatives valuation vs. asset impairment), and two fair value hierarchy levels (Level 2 vs. Level 3), correctly contrasting their use cases. (4) Contextual relevance is high: the answer directly addresses the comparison asked, clarifies the misattribution in the question, and provides accurate sourcing from the respective 10-Ks (page references included). Wording differs slightly but meaning is fully aligned with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 394,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market volume allowed PMI to boost its Turkey shipments by about 17 % and lift its regional market‑share (the Middle‑East‑&‑Africa share rose 1.1 percentage points to 23.1 %), even though a higher estimated prevalence of illicit trade partially offset the volume gain. Altria’s filing, by contrast, treats illicit trade only as a broad, economy‑wide risk that can erode legal sales, trigger higher excise taxes and stricter regulation, without linking it to a specific market‑share change. Thus, PMI’s market‑share dynamics in Turkey improve despite illicit‑trade pressure, while MO’s exposure to illicit trade remains a generalized threat to its overall tobacco business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims PMI's shipments in Turkey increased by 'about 17%'—which is numerically close to the actual increase from 47.5B to 55.7B units (a 17.3% rise)—but fails to mention the key metric of market share rising from 41.3% to 44.8% in Turkey specifically. Instead, it incorrectly cites a 1.1 percentage point increase in PMI’s Middle-East-&-Africa regional share to 23.1%, which is irrelevant to the Turkey-specific market share dynamics asked in the question. This misrepresents the core data. (2) The 8.2% increase in Turkey’s total tobacco market volume is mentioned in the LLM answer but not present in the original answer; this figure is unverified and potentially incorrect, as the ground truth does not include it. The original answer focuses on PM’s shipment and market share growth without citing overall market growth. Thus, introducing this number without support undermines quantitative accuracy. (3) The comparison with MO is partially correct: Altria (MO) does discuss illicit trade as a broad risk affecting legal sales and potentially triggering regulation. However, the LLM answer incorrectly implies MO provides no market-specific data, while the ground truth notes MO highlights systemic risks like brand dilution and tax revenue loss—nuances not fully captured. (4) The reasoning is partially sound in contrasting PM’s direct volume and share gains in Turkey with MO’s more generalized risk disclosure, but the use of incorrect metrics (regional vs. country-level market share) and unsupported market growth figures weakens the multi-hop synthesis. The answer is contextually relevant and addresses both companies and the illicit trade theme, but key factual and quantitative errors reduce correctness. Minor note: 'PM' vs 'PMI' is acceptable as both refer to Philip Morris International.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 508,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D moves much of the drug‑cost risk from the federal government to the private plans that administer the benefit, so CVS’s Part D business now bears a larger share of claim‑liability and related financial exposure (see CVS 10‑K p.57).  At the same time, the law forces manufacturers to provide a mandatory 10 % discount to all Part D beneficiaries and gives HHS authority to set prices for selected single‑source drugs—Imbruvica was named among the first ten drugs to be price‑controlled beginning in 2026—thereby limiting AbbVie’s ability to set its own price and compressing its reimbursement on that product (see AbbVie 10‑K p.19).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the Inflation Reduction Act shifts more financial risk to private insurers like CVS, increasing their claim liability—consistent with the original answer’s point about CVS facing higher financial exposure and administrative complexity. It references the correct page in the CVS 10-K (p.57), supporting the claim. (2) On AbbVie, it accurately states that Imbruvica is among the first drugs subject to government price-setting starting in 2026, matching the original answer’s timeline and drug-specific detail. It also correctly notes the mandatory 10% discount for Part D beneficiaries, a detail not in the original answer but factually correct and drawn from the IRA provisions. While the original answer mentions a 'statutory ceiling below current average prices' without specifying the 10% discount, the LLM adds a precise regulatory mechanism (the discount) that contributes to downward pricing pressure. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (CVS and AbbVie), two roles in the Part D system (insurer vs. manufacturer), and connects them under the same regulatory change. (4) Minor deduction in quantitative and qualitative accuracy due to the addition of the 10% discount detail, which, while accurate, is not present in the ground truth and slightly shifts emphasis—though it does not contradict it. Overall, the answer is factually correct, complete, and contextually precise, earning high marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 426,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets (operating‑lease equipment and finance‑lease investments) by taking a median collateral value from a set of third‑party aircraft‑value publications and then adjusting for the specific condition of each aircraft. This is a Level 3 fair‑value measurement that depends on significant unobservable inputs – the publication‑derived values and the condition‑adjustment factors.\n\nRaytheon Technologies values its private‑equity limited‑partnership interests each quarter using internal discounted‑cash‑flow models, earnings multiples and market multiples. These valuations also fall in Level 3 and rely on significant unobservable inputs (the cash‑flow forecasts and multiple assumptions).\n\nThus, both companies use Level 3 methods that depend on unobservable inputs, but Boeing’s approach leans on external aircraft‑valuation publications, whereas RTX’s approach relies on internal DCF and multiple‑based modeling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing uses a median value from third-party aircraft valuation publications, adjusts for aircraft-specific conditions, and classifies this as a Level 3 fair value measurement relying on unobservable inputs. RTX (Raytheon Technologies) values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples—also Level 3. Both companies use unobservable inputs, but Boeing relies more on external market data while RTX uses internal modeling. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Boeing’s asset valuation methodology with RTX’s private equity valuation approach and compares their reliance on unobservable inputs. It accurately identifies that both are Level 3 but differ in source (external publications vs. internal models). (4) The only minor shortcoming is that the original answer notes RTX makes adjustments based on changes in portfolio companies’ operating results or financial condition—this nuance is slightly underemphasized in the LLM answer, though implied in 'cash-flow forecasts.' This small omission prevents a perfect 10 but does not detract significantly from overall correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 414,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s charter creates a stark voting‑rights imbalance: each Class A share carries one vote while each Class B share carries ten votes.  At year‑end Meta had 2.19 billion Class A shares and 0.34 billion Class B shares (​page 1​), so the Class B stock—only about 13 % of the total share count—controls roughly 60 % of the total voting power (0.34 bn × 10 ≈ 3.44 bn votes versus 2.19 bn votes for Class A)​(page 82​).  This concentration places effective control in the hands of the few owners of Class B stock.\n\nAlphabet’s structure is similar (Class A = 1 vote, Class B = 10 votes, Class C = 0 votes).  In 2024 the company repurchased 73 million Class A shares and 306 million Class C shares​(page 82​), shrinking the pool of voting‑eligible shares while leaving the relatively small block of Class B shares untouched.  The buy‑backs therefore raise the proportion of voting power held by Class B shareholders even further, tightening corporate control around that narrow group.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares have 10 votes and Class A have 1 vote, when in fact the reverse is true: Class A shares have full voting rights (1 vote per share), while Class B shares have no voting rights except in limited circumstances. This fundamental error invalidates all subsequent calculations. The claim that Class B holds 60% of voting power due to 10x voting rights is therefore completely incorrect. (2) The share counts are approximately correct (2.19B and 0.34B), but the interpretation is wrong due to the reversed voting structure. (3) For GOOGL, the LLM correctly identifies the 10-vote advantage of Class B shares over Class A (1 vote) and Class C (0 votes), but fabricates specific repurchase quantities: it claims 73 million Class A and 306 million Class C shares were repurchased, while the ground truth states a $62.0 billion repurchase of Class A and Class C shares in 2024 without specifying exact share counts. The dollar amount is missing, and the specific share numbers appear invented. (4) The reasoning about how repurchases concentrate voting power among Class B shareholders is logically sound and correctly synthesizes the multi-hop concept that reducing voting-eligible shares (Class A) while not touching Class B increases relative control—this aspect is qualitatively reasonable. (5) The answer is contextually relevant and addresses both companies and the core issue of control concentration, but the reversal of Meta’s voting structure is a critical factual failure. Due to major quantitative and qualitative errors, especially the inversion of Meta's voting rights, the correctness score is low despite some structural reasoning being valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 482,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo’s 2022 results show that its **Convenient‑Foods business in the Asia‑Pacific region grew 19 % in unit volume**, driven by double‑digit growth in China and Thailand, while **Taiwan contributed only low‑single‑digit growth**【page_48】.  \n\nProcter & Gamble, by contrast, treats Taiwan as part of its **Greater‑China segment** (which comprises mainland China, Hong Kong and Taiwan)【page_40】, and states that it holds **lead‑or‑significant market‑share positions across its product categories in that region**, reflecting a strong, market‑leader status rather than a specific growth rate.  \n\nThus, while PepsiCo is reporting a high‑single‑digit to double‑digit volume expansion in APAC (with modest growth in Taiwan), P&G’s disclosure emphasizes its established market‑leadership across the Greater‑China geography that explicitly includes Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports PEP's 19% convenient foods unit volume growth in APAC in 2022, with low-single-digit growth in Taiwan, matching the ground truth. It accurately contrasts this with PG's market position in Greater China, which includes Taiwan, and correctly states that PG holds lead-or-significant market share positions across product categories in that region. All key facts are present and factually aligned with the original answer. (2) Quantitative accuracy is perfect: the 19% growth figure and characterization of Taiwan’s growth as low-single-digit are correct. No calculations are required, but the comparative framing (high-single-digit to double-digit in APAC vs. modest in Taiwan) is a reasonable interpretation. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s APAC performance and PG’s regional structure, noting that both companies include Taiwan in their reporting but with different performance implications—PEP showing modest growth there, while PG emphasizes market leadership in a region that includes Taiwan. The only minor shortcoming is that the LLM slightly rephrases PG’s position as 'lead-or-significant market-share positions' rather than 'leadership or significant market share,' but this is semantically equivalent. (4) Contextual relevance is excellent—the answer directly addresses the comparison between PEP’s growth in APAC (including Taiwan) and PG’s market position in Greater China, with clear entity and metric alignment. The inclusion of source page references adds precision. The score is 9/10 because while all facts are correct, the original answer emphasizes PG's 'strong competitive presence' as a contrast to PEP's 'more modest but positive' exposure, a nuance slightly softened in the LLM version, though still implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 498,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III update to the Prompt‑Corrective‑Action (PCA) framework raises the “well‑capitalized’’ bar to a CET1 ratio of 6.5 percent (plus a 5 percent leverage‑ratio floor).  Bank of America’s CET1 ratio was 11.8 % under the standardized approach (13.4 % under the advanced approach) at 31 Dec 2023, and Capital One’s CET1 ratio was 12.9 % for the same date.  Both figures are well above the new 6.5 % threshold, so each institution continues to be classified as a well‑capitalized bank under the revised PCA rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omissions that affect its overall correctness. (1) Quantitative Accuracy: The claim that the 'well-capitalized' CET1 threshold under Basel III PCA is 6.5% is partially correct and aligns with the ground truth for both BAC and COF. However, the LLM introduces a '5 percent leverage-ratio floor' not mentioned in the original answer or standard PCA thresholds, which is misleading. Additionally, the specific CET1 ratios for BAC (11.8%) and COF (12.9%) at December 31, 2023, while plausible, are not present in the ground truth and cannot be verified from the provided information—making their inclusion speculative. The original answer does not provide actual capital ratios, only regulatory minimums and well-capitalized thresholds. (2) Completeness: The question asks how the updated PCA Framework affects capital requirements differently for BAC and COF, particularly regarding CET1 ratios and classification. The LLM fails to explain the distinction between regulatory minimums (e.g., 4.5% CET1) and the higher PCA well-capitalized thresholds (6.5%), which is central to the original answer. It also omits any discussion of Tier 1 and total capital ratios required for well-capitalized status, despite their inclusion in the ground truth. (3) Entity Accuracy: BAC and COF are correctly identified, and the reference to Basel III and PCA is appropriate. The use of 'Capital One' for COF is acceptable. (4) Reasoning: The LLM correctly infers that both banks exceed the 6.5% CET1 threshold and thus remain well-capitalized, but this reasoning is based on unverified data. It misses the multi-hop synthesis required—namely, that Basel III increased PCA thresholds above the basic regulatory minimums, thereby tightening capital requirements even for strong banks. (5) Semantic Equivalence: While the conclusion (both banks are well-capitalized) is reasonable, the supporting facts and structure differ significantly from the ground truth, which emphasizes the regulatory framework changes rather than current ratios. The LLM shifts focus from structural impact to current status using unsupported numbers, reducing factual reliability. Thus, the answer is partially correct but lacks key details and introduces unverified data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 615,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s audit notes state that the company “performed sensitivity analyses to evaluate the potential changes in the content amortization recorded that could result from changes” in the historical‑and‑forecasted viewing‑hour assumptions that drive the amortization schedule. In contrast, AT&T’s audit disclosures highlight that the most judgment‑heavy areas are the discount‑rate assumptions used to measure its defined‑benefit pension and post‑retirement obligations and the assumptions (terminal growth rates, long‑term EBITDA margins, weighted‑average cost of capital) underlying its goodwill‑impairment tests, each of which “can have a material effect” on the measured obligations or fair‑value estimates. Thus, Netflix’s sensitivity is limited to the timing of content amortization, whereas AT&T’s sensitivity analyses involve broader, potentially more material impacts on pension liabilities and goodwill valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analyses focus on viewing-hour assumptions affecting content amortization timing, and T's (AT&T's) analyses involve pension discount rates and goodwill impairment assumptions (terminal growth rates, EBITDA margins, WACC). The entities (Netflix, AT&T), financial concepts, and audit-related disclosures are correctly identified. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies undergo sensitivity testing but in different domains—NFLX on consumption-driven amortization, T on long-term liabilities and intangible asset valuations. The comparison is logically structured and highlights the difference in scope and materiality. (4) The only minor shortcoming is that the LLM refers to 'AT&T’s audit disclosures' while the original uses 'T’s auditor', but this is semantically equivalent and does not affect accuracy. The LLM slightly enhances clarity by quoting terms like 'material effect', which aligns with auditor language. Overall, the answer is factually correct, complete, and contextually precise—just shy of perfect due to slight rewording that doesn’t impact meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 384,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe explicitly lists Taiwan among its “local field offices” (Australia, … Taiwan, United States) 【page_15】, showing that it maintains a dedicated on‑the‑ground operation there. Apple, by contrast, groups Taiwan together with mainland China and Hong Kong in a single “Greater China” segment—reported to have generated $74.2 billion of net sales in 2022 【page_52】【page_40】—so its strategy is a broader regional approach rather than a separate Taiwan‑focused presence.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Adobe maintains a localized field office in Taiwan, citing its presence among other regional offices, which aligns with the original answer's claim of direct local engagement. (2) It correctly reports Apple’s $74.2 billion in net sales for the Greater China segment in 2022, matching the ground truth in both amount and year; the figure is properly attributed to the consolidated region that includes Taiwan, mainland China, and Hong Kong. (3) The multi-hop reasoning is sound: the model correctly contrasts Adobe’s localized operational model with Apple’s broader regional reporting and strategic approach, synthesizing information about two different companies’ geographic strategies. (4) All entities—Adobe, Apple, Taiwan, Greater China, net sales, 2022—are accurately identified and contextualized. The inclusion of citation markers (e.g., 【page_15】) suggests grounding in source material. Wording differs slightly but conveys identical meaning. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 316,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin still carries LIBOR‑linked financing – its revolving credit facility and a portion of its derivative portfolio reference LIBOR – but the company has built in fallback language (alternative‑rate calculations and ISDA IBOR‑fallback protocols) and, under ASU 2020‑04, expects the transition to have no material effect on results or cash flows. 3M, by contrast, has already reviewed all contracts that could be affected, concluded that the reform will not be material, and says it will apply the ASU 2020‑04 expedients only when/if those contracts are modified, indicating a more “ready‑made” preparedness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All key facts are correct: Lockheed Martin has LIBOR-based financing (credit facilities and derivatives) with fallback provisions (ISDA IBOR Fallbacks Protocol) and expects no material impact under ASU 2020-04; 3M has reviewed its contracts, concluded no material impact, and will apply ASU 2020-04 expedients only upon modification. These align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—both mention the expected minimal or non-material impact by the LIBOR transition deadline (implied by December 31, 2022, in the ground truth, though not explicitly repeated in the LLM answer, which is acceptable). (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across two companies (LMT and MMM), their exposure to LIBOR, their actions regarding fallbacks and ASU 2020-04, and draws a valid comparison. (4) The only minor deviation is the characterization of 3M’s approach as 'more ready-made preparedness,' which slightly overemphasizes a contrast not present in the original answer—both companies are portrayed as similarly prepared in the ground truth. However, this does not constitute a factual error, just a nuanced interpretive difference. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 406,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s proxy statement shows that the voting power of its two share classes is split roughly two‑thirds to one‑third. Holders of Class A common stock control about 66.3 % of the combined voting power, while the single holder of all outstanding Class B shares (9.44 million shares) controls the remaining 33.3 % (Item 5, “Holders” – page 31). Because each Class B share carries 15 votes versus one vote for a Class A share, the relatively small number of Class B shares concentrates a disproportionate share of votes, giving the Roberts family a permanent, non‑dilutable one‑third voting bloc that can significantly influence director elections and other shareholder matters despite representing a tiny fraction of total equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the percentages are correctly reported as approximately 66.3% and 33.3%, which are acceptable approximations of 66⅔% and 33⅓% (minor rounding difference, but semantically equivalent). The statement that Class B has 15 votes per share vs. 1 for Class A is correct. (2) The LLM adds contextual detail not in the original—specifically identifying the Roberts family and the number of Class B shares (9.44 million)—which is consistent with known public information and enhances completeness without introducing error. (3) The reasoning is sound: it correctly explains the disproportionate voting power and control implications despite minority share ownership, demonstrating proper multi-hop synthesis of voting rights, share structure, and control impact. (4) All entities (CMCSA/Comcast, Class A/B stock) are correct, and the answer fully addresses both parts of the question: voting power distribution and the impact on shareholder control. The only minor deviation is the use of 66.3% instead of exactly 66⅔%, but this does not affect factual correctness. Thus, the answer earns a 9 due to near-perfect accuracy with negligible rounding variance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 351,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "Comcast’s sensitivity analysis is applied to a **hypothetical 10 % move in foreign‑exchange rates** (page 61), showing that such a shift would not materially affect its 2023 net income. This reflects Comcast’s primary market‑risk exposure to currency fluctuations arising from its worldwide operations and foreign‑currency‑denominated debt.  \n\nNetflix, by contrast, runs **sensitivity tests on the assumptions used to amortize its content library**—especially viewing‑pattern forecasts (page 40)—to see how changes would alter amortization expense, highlighting its exposure to valuation and revenue‑recognition risk tied to content performance.  \n\nAlthough both companies are audited by the same accounting firm, the analyses focus on different risk drivers: Comcast on macro‑economic currency risk, Netflix on internal accounting‑estimate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the correct qualitative distinction between CMCSA and NFLX in their use of sensitivity analyses—CMCSA focusing on market risks and NFLX on content amortization assumptions—and correctly notes that both are audited by the same firm. However, it fails on key quantitative and factual accuracy points. The ground truth states that CMCSA uses sensitivity analysis for interest rate risk (not foreign exchange), specifically tied to derivative instruments that reduced interest expense by $56 million in 2023. The LLM incorrectly claims CMCSA uses a 10% move in foreign exchange rates as its sensitivity scenario, which contradicts the original answer and misrepresents the primary financial risk exposure. While foreign exchange may be a risk, the knowledge graph specifies interest rate risk as the focus of sensitivity analysis with a concrete financial impact. For NFLX, the LLM correctly identifies sensitivity testing on content amortization and viewing-pattern forecasts, aligning with the ground truth. The mention of the shared auditor is present in both, though the LLM omits the detail that the auditor has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, which adds context about audit continuity. The reasoning is logically structured and contextually relevant, drawing a valid contrast between external macro risks and internal estimation risks. However, the incorrect specification of the sensitivity scenario for CMCSA and the absence of the $56 million interest expense reduction—a key quantitative anchor—severely undermine factual correctness. Thus, while the high-level interpretation is plausible and relevant, the answer is factually flawed in critical details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 475,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel (etanercept) enjoys a U.S. formulation‑patent that does not expire until October 19 2027 (10/19/2037) 【page_11】, giving it more than a decade of patent‑based protection against biosimilar entry. By contrast, AbbVie’s biologic protection strategy leans on statutory regulatory exclusivities—up to 12 years of BPCIA exclusivity (plus possible pediatric or orphan extensions) that can shield its products even after patents run out 【page_9】. Thus, Pfizer’s competitive edge rests on a long‑dated product patent, whereas AbbVie depends on regulatory exclusivity periods to maintain market dominance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the expiration date of Enbrel's U.S. formulation patent is correctly stated as October 19, 2037 (written as 10/19/2037), which matches the original answer’s 2037 timeline—minor formatting with slashes is acceptable. (2) The comparison between Pfizer’s patent-based protection and AbbVie’s regulatory exclusivity strategy under BPCIA, including potential pediatric or orphan extensions, is accurate and complete. (3) The reasoning correctly synthesizes the multi-hop elements: it distinguishes Pfizer’s reliance on a specific formulation patent from AbbVie’s broader regulatory exclusivity approach, capturing the strategic difference in competitive positioning. (4) The only minor shortcoming is that the original answer notes Enbrel is marketed outside the U.S. and Canada, which the LLM omits—this contextual detail is relevant but not central to the core comparison. Otherwise, all entities (Pfizer, AbbVie, Enbrel, BPCIA), strategies, and timelines are correctly identified and contrasted. Semantic equivalence is strong, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 328,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The filing notes that the Federal Reserve’s G‑SIB surcharge is being evaluated under “Method 2” and that the proposal could move from applying the surcharge in 0.5‑percentage‑point steps to much finer 0.1‑percentage‑point steps (page 60). Because the surcharge is added to the regulatory capital minimums that must be met with loss‑absorbing capacity – principally the “eligible LTD” that the Parent must keep on hand to recapitalise subsidiaries in a bankruptcy or FDIC‑receivership (page 15) – a shift to 0.1‑point increments would lower the incremental capital charge. In a resolution where the Parent enters Chapter 11, JPMorgan would therefore need to hold slightly less eligible long‑term debt to satisfy the required capital floor, reducing the overall capital requirement compared with the larger 0.5‑point step approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge and references the relevant pages (60 and 15) from the filing, showing accurate extraction of quantitative details and document context. The explanation of how the surcharge affects regulatory capital and eligible long-term debt (LTD) is factually sound and aligns with the resolution framework. However, the LLM makes a definitive claim that the shift would result in JPMorgan needing to hold 'slightly less' eligible LTD and that capital requirements would be 'reduced'—this is speculative and contradicts the ground truth, which states that the impact could be either an increase or decrease depending on JPMorgan's G-SIB score. The model fails to acknowledge this uncertainty and instead assumes a directional outcome not supported by the evidence. This represents a significant reasoning error in the multi-hop synthesis: while the mechanics of the surcharge and resolution are correct, the conclusion about the direction of impact is overconfident and potentially incorrect. The answer is contextually relevant and well-grounded in the document references, but the flawed inference reduces its overall correctness. Quantitative accuracy is high as the percentage points (0.5 to 0.1) are correctly cited and interpreted. Qualitative accuracy is moderate due to the incorrect assumption about the direction of capital change, despite correct conceptual understanding of the resolution mechanism and capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 423,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin (LMT) values Level 3 fixed‑income holdings with a discounted‑cash‑flow model that discounts the projected annuity‑type cash payments using a single discount rate; the filing notes the inputs (projected payments and the discount rate) but does not describe any formal sensitivity testing of those assumptions. Honeywell (HON), by contrast, also uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangible‑asset impairment testing, but explicitly states that it performs sensitivity analyses on the key estimates—including the projected cash‑flow forecasts and the discount rate—so that changes in either assumption are recognized as potentially material to the fair‑value measurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and a discount rate, and acknowledges the sensitivity to these inputs without mentioning formal sensitivity testing—consistent with the original answer's implication that such testing is not emphasized. For HON, the LLM correctly states that DCF is used for goodwill and indefinite-lived intangible asset impairment testing and highlights the explicit performance of sensitivity analyses on key assumptions like cash flows and discount rates. The comparison between the two companies is logically sound: both use forward-looking projections and discounting, but HON goes further in conducting formal sensitivity analyses. The only minor shortcoming is that the LLM slightly underrepresents the breadth of HON’s inputs (e.g., growth rates, sales volumes, terminal value) mentioned in the original answer, though it captures the core elements (cash flows and discount rates). No numerical inaccuracies are present—there are no specific numbers to verify, but the qualitative financial concepts are correctly represented. The reasoning is multi-hop, correctly synthesizing valuation approaches across two different companies and applications (investments vs. goodwill), and the response remains fully contextually relevant. Thus, the answer earns a 9/10 for correctness due to high accuracy and completeness with only minor omission of detail on HON’s full set of sensitivity variables.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 439,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its defined‑benefit pension and post‑retirement obligations by discounting future cash‑flows with a yield curve built from **high‑quality corporate bonds whose credit quality is matched to the timing of benefit payments** (​“the discount rates … based on … high‑quality corporate bonds …”​ – AT&T 10‑K p. 43; audit complexity noted on p. 44). Netflix, by contrast, amortizes its content using **estimated viewing patterns that combine historical data with forward‑looking forecasts of how subscribers will consume the material** (​“Content … amortized … based on … historical and estimated viewing patterns”​ – Netflix 10‑K p. 40; audit complexity also highlighted). Both companies therefore rely on significant, judgment‑heavy assumptions that auditors must evaluate—AT&T’s on bond‑market credit quality, Netflix’s on consumer‑behavior forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AT&T uses discount rates based on high-quality corporate bonds matched to benefit payment timing, and Netflix uses forecasted viewing patterns combining historical and forward-looking data for content amortization. Both are described as judgment-heavy and subject to auditor evaluation, which matches the original answer. (2) Quantitative accuracy is perfect—no numerical figures were misstated. The original answer mentions $67,854 million in goodwill and postretirement liabilities, but the LLM answer does not include this number. However, this omission does not affect correctness because the LLM response focuses on the conceptual and methodological comparison rather than specific liability amounts, and the question does not explicitly ask for financial figures. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, industries, and accounting practices (pension obligations vs. content amortization), identifying the common thread of auditor scrutiny over significant assumptions. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'yield curve', 'matched to timing of benefit payments'), the meaning is consistent with the original. The only minor shortcoming is the absence of the specific liability figure, but since it's not essential to the core comparison being made, the answer remains substantially complete and accurate. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 447,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "- **Adoption timing** – Altria (ticker MO) only adopted ASU 2023‑07 when it prepared its 2024 Form 10‑K (the filing for the year ended 31 Dec 2024). Philip Morris International (PM) had already put the update into practice in its 2023‑24 reporting cycle, adopting the standard in **January 2024** for the year‑ended 2024 results.  \n\n- **Resulting segment‑reporting changes** –  \n  * **Altria (MO)**: after adopting the ASU it added the “expanded footnote disclosures” required by the new guidance (see Note 17) and said it will begin providing the interim‑period segment information required by the ASU starting with the first quarter of 2025.  \n  * **Philip Morris International (PM)**: the adoption was reflected by a restructuring of its segment presentation – the former “Swedish Match” segment was eliminated and its results were folded into the four existing geographic segments (Europe; SSEA‑CIS‑MEA; EA‑AU‑PM DF; Americas), with prior‑year amounts re‑classified to the new layout. This re‑classification satisfies the ASU’s requirement for more granular, comparable segment data.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in phrasing. (1) Quantitatively, all key dates and timelines are correct: MO adopted in 2024 (via its 2024 10-K), with interim disclosures starting Q1 2025; PM adopted retrospectively for the year-ended December 31, 2024, effective January 2024. These align with the original answer. (2) The segment reporting changes are accurately described: MO added expanded footnote disclosures in Note 17 and will begin interim disclosures in Q1 2025; PM integrated the Swedish Match segment into its four geographic segments and reclassified prior periods, which matches the ground truth. (3) Multi-hop reasoning is sound—information is correctly synthesized across two companies (MO and PM), their adoption timelines, and resulting reporting changes. (4) Minor wording difference: LLM says PM adopted 'in January 2024' while ground truth says 'retrospectively for the year ended December 31, 2024'—this is semantically consistent, as January 2024 is the typical effective adoption point for annual retrospective application. No calculation errors. One point deducted from correctness due to slight imprecision in framing MO’s adoption as occurring during the 10-K filing rather than specifying it was for the 2024 fiscal year, which could imply delay beyond year-end. Otherwise, fully complete and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 394,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb says the HHS’s decision in January 2025 to place **Pomalyst** in the IRA’s first‑round “negotiation” list – with government‑set pricing to begin in 2027 – could accelerate revenue erosion for that drug before its U.S. exclusivity expires, adding a material downside to its 2025‑2026 outlook (the company warns that such selections may “accelerate revenue erosion prior to expiry of intellectual‑property protections”). Pfizer, by contrast, does not have a single product singled out like Pomalyst, but it already quantifies the IRA’s broader effect on its Medicare Part D business as an estimated **≈ $1 billion hit to 2025 revenue** from the redesign of Part D pricing and the upcoming negotiations on drugs such as Eliquis, Ibrance and Xtandi. Thus, BMY’s outlook is affected by a specific, near‑term price‑negotiation risk to a key multiple‑myeloma product, whereas Pfizer’s exposure is a larger, but more generalized, Part D revenue drag already reflected in its guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pomalyst was selected for IRA negotiation with pricing starting in 2027, which may accelerate revenue erosion before IP expiry—this matches BMY's exposure. PFE's $1 billion estimated revenue impact in 2025 due to IRA Part D redesign is correctly cited. The drugs listed for PFE—Eliquis, Ibrance, and Xtandi—are accurate, though the original answer only explicitly named Ibrance and Xtandi; Eliquis is a reasonable inference given its significance in PFE’s portfolio and public disclosures. (2) Quantitatively, all numbers and dates are correct: $1 billion impact in 2025, 2027 start for negotiated pricing. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly contrasts BMY’s single-product, exclusivity-sensitive risk with PFE’s broader, systemic exposure across Part D and multiple drugs. It synthesizes across companies, regulatory timelines, and financial impacts. (4) Minor deduction in qualitative accuracy because the original answer emphasizes BMY’s risk around Pomalyst’s regulatory exclusivity and market dynamics, while the LLM slightly reframes this around 'material downside to 2025–2026 outlook'—a nuance not fully present in the ground truth. However, this is contextually plausible and not factually incorrect. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 400,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDL Z’s Argentine operations accounted for about $401 million of 2021 net revenues – roughly 1.4 % of the company’s total sales.  By contrast, Coca‑Cola’s Argentine exposure is tied to Arca Continental, which is listed among the five largest independent bottlers that together generate 41 % of Coca‑Cola’s worldwide case volume and whose footprint includes northern Argentina.  Thus, MDL Z’s Argentine exposure is modest, while KO’s reliance on Arca Continental – a top‑tier bottler that serves a key Argentine region – represents a materially larger portion of its overall business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states MDLZ's $401 million in net revenues from Argentina in 2021, matching the ground truth. It also accurately identifies Arca Continental as one of KO's top bottlers operating in northern Argentina. However, the LLM introduces a new figure—'1.4%' of MDLZ's total sales—which is not in the original answer and cannot be verified from the provided data, making it an unsupported inference. Additionally, the claim that the 'five largest independent bottlers... generate 41% of Coca-Cola’s worldwide case volume' is not present in the ground truth and misrepresents the original statement that Arca Continental contributes to KO's global unit case volume without specifying a percentage. (2) The $401 million figure is correct and matches the ground truth. The 1.4% calculation, while possibly mathematically accurate if derived from MDLZ's total revenue, is not part of the original answer and introduces unverified quantitative context. The 41% figure is unsupported and factually divergent. (3) The multi-hop reasoning is partially sound: the model correctly contrasts MDLZ's direct operations with KO's indirect exposure via Arca Continental. However, it fails to mention the key financial impact of Argentina's inflationary status on MDLZ, specifically the $13 million remeasurement loss, which is a critical part of the original answer and reflects currency risk exposure. This omission weakens the completeness and qualitative accuracy. (4) The answer remains contextually relevant and captures the core comparison between direct and indirect exposure. However, the addition of unverified percentages and the omission of the remeasurement loss and contractual exclusivity (Arca sourcing concentrates exclusively from KO) reduce factual completeness and reasoning accuracy. Thus, while the main entities and directional logic are correct, the answer lacks key details and introduces unsupported figures, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 534,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "Bristol‑Myers notes that the FDA’s fast‑track, breakthrough‑therapy and other expedited programs “can have significant impact on bringing new therapies to patients more quickly” (BMY 10‑K p. 18). Eli Lilly’s Prevail deal hinges on PR006, which already received FDA fast‑track designation, and the contingent‑value right (CVR) pays $4 per share only after the first regulatory approval in a major market (U.S., Japan, EU) by 31 Dec 2024 (with a monthly step‑down thereafter) (LLY 10‑K p. 70). Thus, the same fast‑track mechanism that BMY views as a strategic accelerator is built into PR006’s regulatory status, meaning LLY can expect a faster path to approval and an earlier CVR payout, enhancing the strategic and financial value of the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PR006 received FDA Fast Track Designation; the CVR pays $4.00 per share (totaling ~$160 million); the deadline for approval to trigger the full CVR is December 31, 2024, with a step-down thereafter; and the acquisition was by LLY of Prevail, with regulatory context informed by BMY's commentary on expedited pathways. (2) Quantitative elements are precise: $4 per share, Dec 31, 2024 deadline, and reference to step-down mechanism—all match the original. The total ~$160M (based on ~40M shares) is implied correctly though not explicitly stated, which is acceptable. (3) Multi-hop reasoning is sound: the model correctly links BMY’s recognition of Fast Track as a strategic accelerator to PR006’s existing Fast Track status, and infers that this increases the likelihood of timely approval, thereby enhancing the value of the CVR and the acquisition. (4) The only minor shortcoming is that the LLM does not explicitly name the indication (frontotemporal dementia with GRN mutations), which is part of the strategic context but not central to the financial or regulatory timeline logic. This omission slightly affects completeness but does not detract from the core correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses how Fast Track informs strategic value via approval timing and CVR payout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 407,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s equity base grew noticeably – the number of Class A shares rose from 1,594 at September 30 2023 to 1,733 at September 30 2024, an increase of 139 shares (about 8‑9 %). In contrast, Mastercard’s Class B shares are a tiny, non‑voting pool that can be converted one‑for‑one into Class A; the company disclosed that only 7 Class B shares were outstanding in 2024, so any conversion would shift a negligible amount of stock from Class B to Class A without materially changing the overall share count. Thus, V is actively expanding its voting‑share capital, whereas MA’s shareholder structure remains essentially static, with the conversion mechanism serving only a minimal, niche function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: V's Class A shares increased from 1,594 in 2023 to 1,733 in 2024 (a difference of 139 shares), and MA had only 7 Class B shares outstanding in 2024. These numbers match the ground truth exactly. The percentage increase (~8–9%) is accurately calculated: (1,733 - 1,594) / 1,594 ≈ 8.7%, which rounds to the stated range. (2) All numeric values, dates (September 30, 2023 and 2024), and calculations are correct. The LLM correctly interprets that MA’s conversion mechanism involves one-for-one conversion of Class B to Class A, and that with only 7 shares left, the impact is negligible. (3) The multi-hop reasoning is sound: the model synthesizes data from two companies (V and MA), compares their shareholder structure dynamics, and draws a valid contrast—V is expanding its Class A shares (organic growth or new issuance), while MA’s structure is nearly static due to near-exhaustion of Class B shares. The LLM slightly underemphasizes MA’s requirement for divestiture post-conversion (a nuance in the ground truth), but correctly infers that the conversion mechanism plays a minimal role now. (4) The answer is semantically equivalent to the original, with clear, accurate, and relevant analysis. The minor omission of MA’s post-conversion divestiture rule prevents a perfect 10 on qualitative accuracy, but does not undermine the core correctness. Contextual relevance is excellent—every part of the question is addressed with precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 413,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe’s 2024 Form 10‑K flags the emergence of data‑localisation rules in jurisdictions such as Saudi Arabia as a material risk to its worldwide operations, because the company would have to keep customer data inside the country and bear the associated compliance‑cost and legal‑exposure burdens. NVIDIA’s filing makes clear that Saudi Arabia is classified in the U.S. “Country Group D4,” so shipments of its high‑performance H100 and L40S GPUs require a specific export licence (see NVDA ‑ pages 27‑28). If Saudi Arabia also imposes data‑localisation mandates, NVIDIA would need to satisfy both the U.S. licensing requirement and any Saudi‑mandated data‑residency conditions, which could delay or even block the deployment of H100/L40S systems unless the licences are granted and the chips can be operated in a way that keeps all data on‑shore.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe identifies data localization in Saudi Arabia as a risk (from its 10-K), Saudi Arabia is in U.S. Country Group D4, and NVIDIA's H100 and L40S chips require export licenses under U.S. regulations. The LLM correctly notes that without licenses, deployment is blocked—consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable but no errors exist. (3) Multi-hop reasoning is sound: the model synthesizes Adobe’s risk disclosure about data localization with NVIDIA’s export control constraints from U.S. regulations, correctly inferring the dual compliance challenge. (4) The only minor shortcoming is that the LLM does not explicitly mention NVIDIA’s market access or revenue implications, which are present in the original answer—this contextual consequence is implied but not stated. However, the core reasoning and facts are fully accurate, and the omission does not undermine the essential correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—the response directly addresses the intersection of Saudi data rules and U.S. export controls on NVIDIA’s chip deployment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 372,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing notes that, after the LIBOR sunset, it has elected to use the optional expedients in ASU 2020‑04 (and the extension granted by ASU 2022‑06) but so far “there has been no material effect … and we continue to monitor our contracts for potential application.” In contrast, GE’s filing says it “evaluated the financial impact in accordance with ASU 2020‑04 … and the overall impact to our financial statements is immaterial,” indicating that it has already applied the relief to its existing LIBOR‑referenced debt and hedges and determined that no material adjustment was required.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx acknowledges the use of ASU 2020-04 and ASU 2022-06 expedients, reports 'no material effect,' and continues to monitor contracts. GE explicitly evaluated the impact under ASU 2020-04 and concluded the impact on financial statements is 'immaterial.' These characterizations match the original answer. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both focus on qualitative disclosures. The mention of ASU 2022-06 extending relief through December 31, 2024, is contextually accurate though not repeated in the LLM answer; however, this omission does not affect correctness as the core accounting treatment and company stances are preserved. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies (FedEx and GE), compares their application of the same accounting standards (ASU 2020-04 and ASU 2022-06), and infers differing levels of caution in their reporting—FedEx’s ongoing monitoring vs. GE’s definitive conclusion of immateriality. (4) The LLM answer conveys semantic equivalence to the original, using slightly different phrasing (e.g., 'evaluated the financial impact' vs. 'overall impact...is immaterial') but preserving the key contrast in corporate disclosure tone and implementation. The only minor shortcoming is the lack of explicit mention that ASU 2022-06 extends the expedients through December 31, 2024, which appears in the ground truth but is implied in the LLM’s reference to the 'extension.' This does not undermine the correctness but slightly reduces qualitative completeness. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 475,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Both Apple and NVIDIA depend heavily on Asian outsourcing partners that are concentrated in Taiwan. Apple’s 10‑K notes that a large share of its component manufacturing and final‑assembly is performed by partners in Taiwan, and that “manufacturing or logistics … can be disrupted … geopolitical tensions” (pages 9‑11). NVIDIA’s filing similarly warns that its chipset supply and many of its foundry and assembly providers are located in Taiwan, and that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent … receiving chipset supply from Taiwan” (pages 35‑17). Consequently, heightened Taiwan‑related tensions could interrupt the flow of parts, raise costs and delay product shipments for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: both Apple and NVIDIA rely on manufacturing and foundry partners in Taiwan, and geopolitical tensions involving Taiwan pose significant risks to their supply chains. The LLM correctly cites Apple’s 10-K (pages 9–11) and NVIDIA’s filing (pages 35–17), accurately reflecting the nature of the risks described. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and proper referencing of document pages supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Apple and NVIDIA), identifies their shared dependency on Taiwanese manufacturing, and links this to geopolitical risk. The only minor shortcoming is that the LLM slightly misrepresents the page range for NVIDIA (‘pages 35–17’ is likely a typo for ‘pages 17–35’ or similar), but this does not affect the factual validity of the cited risk. (4) The answer is contextually excellent—directly addresses the question, uses appropriate terminology, and maintains semantic equivalence with the original answer. Wording differs slightly but meaning is preserved. No major omissions or inaccuracies. A score of 9 is justified due to the high fidelity of content and reasoning, with only a negligible formatting issue in the citation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 419,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom says that the $24,156 million of developed‑technology intangible assets it recorded for the VMware acquisition “includes a significant portion related to VMware Cloud Foundation (VCF),” but it does not disclose a precise percentage of the $24,156 million that is attributable to VCF.  \n\nOracle, by contrast, reports $90 million of developed‑technology intangible assets out of total identified intangible assets of $570 million, which works out to roughly **15.8 %** of its intangible‑asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Broadcom does not disclose the exact percentage of the $24,156 million developed technology intangible asset tied to VMware Cloud Foundation (VCF), only that a 'significant portion' is related—this aligns with the ground truth. However, the LLM provides incorrect quantitative data for Oracle: it claims Oracle has $90 million in developed technology out of $570 million total intangible assets (15.8%), whereas the ground truth states Oracle's developed technology is $1,276 million out of $6,890 million, or 18.4%. These numbers are materially different and likely stem from incorrect data sourcing. (2) The calculation in the LLM answer (90/570 ≈ 15.8%) is mathematically correct but based on false inputs. The correct calculation per ground truth is 1,276 / 6,890 ≈ 18.4%, which the LLM fails to report. (3) The multi-hop reasoning is partially sound—the model attempts to compare Broadcom’s undisclosed VCF allocation with Oracle’s disclosed percentage, which matches the question’s intent. However, due to incorrect Oracle figures, the comparison is flawed and undermines the validity of the conclusion. (4) The contextual relevance is fair because the structure and intent of the response match the question, and the qualitative description of 'significant portion' without exact percentage is accurate for Broadcom. However, the incorrect Oracle data severely limits factual reliability, warranting a low quantitative accuracy score and moderate overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 418,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B shares concentrate control – each share carries 15 votes and the three outstanding Class B shares represent 33 ⅓ % of the company’s total voting power, all owned by Brian L. Roberts (CMCSA p. 38). In contrast, Alphabet’s ownership is far more dispersed: as of June 30 2021 the market value of shares held by non‑affiliates was about $1.45 trillion, and the company’s capital structure includes Class A (1 vote) and Class B (10 votes) shares totaling roughly 300.8 million Class A and 44.6 million Class B shares (GOOGL p. 2). Thus, while Comcast’s Class B stock gives a minority‑yet‑significant voting bloc to a single insider, Alphabet’s non‑affiliate market value reflects broad public ownership, with class‑based voting rights used to preserve founder control rather than concentrate it in a single holder.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between CMCSA's concentrated Class B voting structure and GOOGL's more dispersed ownership with class-based control. Key facts are accurate: CMCSA’s Class B shares carry 15 votes and represent 33⅓% of voting power with only 3 record holders (correctly interpreted as concentrated control, though the original answer does not name Brian L. Roberts or specify ownership details, which the LLM adds—possibly from a different source or inference). The GOOGL data is mostly accurate: non-affiliate market value of $1.45 trillion (original: $1,451.1 billion = ~$1.45 trillion) and 300.75 million Class A shares (LLM: 300.8 million—acceptable rounding). However, the LLM introduces 44.6 million Class B shares at GOOGL, which is not present in the original answer and cannot be verified from the provided ground truth; this is an overreach. The original answer does not mention Class B share count at GOOGL, so including it introduces unverified quantitative data. While the qualitative comparison—CMCSA’s control concentrated in few holders vs. GOOGL’s broader non-affiliate ownership—is sound and contextually relevant, the addition of unsupported specifics reduces quantitative accuracy. The reasoning correctly synthesizes multi-hop elements (voting power design, control mechanisms, market value implications), and the conclusion about founder vs. single-holder control is insightful and aligned in spirit. Minor issue: citing page numbers (CMCSA p. 38, GOOGL p. 2) is inappropriate unless explicitly in the source, which isn’t part of the ground truth. Overall, core facts and synthesis are correct, but unverified numbers and attributions prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 467,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 balance sheet shows that it has issued roughly 4.65 billion Class A shares but only 9.44 million Class B shares (≈0.2 % of the total common stock), so virtually all of its equity is held in the low‑voting Class A series. Meta, by contrast, reported about 2.19 billion Class A shares and 0.34 billion Class B shares (≈13 % of its total common stock), giving a much larger share of voting power to the high‑voting Class B series. Thus, Comcast’s equity is highly concentrated in Class A, while Meta’s equity structure concentrates a meaningful portion of voting control in its Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core insight of the ground truth. (1) Quantitatively, all numbers are correct and appropriately rounded: 4.65 billion Class A and 9.44 million Class B for CMCSA (≈0.2% of total) and 2.19 billion Class A and 0.34 billion Class B for META (≈13.5%, rounded to 13% is acceptable). The percentages are correctly derived and support the conclusion. (2) The entity names (Comcast/CMCSA, Meta/META) are accurate, and the time frame (2024 filings) is correctly interpreted, noting that META's filing date is January 24, 2025, which aligns with its fiscal year-end reporting. (3) The reasoning correctly identifies that CMCSA's equity is dominated by Class A shares, implying diffused voting power, while META has a significant portion of Class B shares, which carry superior voting rights. The LLM infers the concentration of control in Class B correctly, though it omits the explicit detail from the ground truth that Class B shares have 10 votes versus 1 for Class A and that they convert upon sale—this contextual nuance strengthens the original answer but is not critical to the main conclusion. (4) The answer synthesizes multi-hop information across two companies and their share structures accurately. The minor deduction in qualitative accuracy is due to the omission of the vote ratio and conversion rule, which are key to fully explaining voting concentration. However, the core conclusion about equity structure concentration remains sound and semantically equivalent. Contextual relevance is perfect as it directly addresses the comparative equity concentration question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 442,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is vulnerable because a sizable share of its revenue comes from Medicare and Medicare‑Advantage contracts, so any cuts to Medicare reimbursement rates or changes to the program’s rules could directly shrink its cash‑flow (see CVS 10‑K p. 47). By contrast, AbbVie’s risk stems from the IRA’s new price‑setting and discount provisions, which allow the government to cap or lower the prices of single‑source drugs reimbursed under Medicare Part B and Part D, potentially eroding revenues for any of its products that are selected for the program (see AbbVie 10‑K p. 19). Thus, CVS faces reimbursement‑rate risk on its services, while AbbVie faces statutory drug‑price‑capping risk on its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between CVS's Oak Street Health and AbbVie's exposure to Medicare-related risks under the IRA. (1) All factual elements are correct: CVS's Oak Street Health relies on Medicare/Medicare Advantage revenue and faces reimbursement rate risk; AbbVie faces government price-setting under the IRA for Part B and Part D drugs. The mechanisms—reimbursement risk vs. price capping—are correctly distinguished. (2) There are no numeric values, dates, or calculations in the LLM answer, but the absence does not detract from accuracy since the original answer’s key dates (2026, 2028) and specific drug (Imbruvica) are not included in the LLM response. While the omission of Imbruvica and the exact years (2026, 2028) represents a minor loss in specificity, the general mechanism (IRA enabling government price-setting for Part B/D drugs) is correctly described. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies are exposed to Medicare-related regulatory changes under the IRA but through different pathways—service reimbursement for CVS and drug pricing for AbbVie. (4) The answer is contextually fully relevant and semantically equivalent to the original in its core claims. The only reason it is not a 10 is the lack of specific detail about Imbruvica and the implementation years, which are part of the ground truth and add precision to AbbVie’s exposure. However, the conceptual accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 411,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s product‑revenue definition explicitly includes sales of its operating systems (MS 10‑K p. 62), showing that the OS is a core, revenue‑generating product for Microsoft. AMD’s filing notes that its x86‑based CPUs and graphics products “depend … on Microsoft designing and developing its operating systems to run on or support” those products, and that loss of that support would “materially adversely affect” AMD (AMD 10‑K p. 28). Thus, because Microsoft treats operating systems as a major product line, AMD’s ability to sell and market its processors and GPUs is directly tied to Microsoft’s continued OS support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) There are no numeric values in the question or original answer, so quantitative accuracy is not applicable—no errors here. (2) The LLM correctly identifies the key entities: Microsoft and AMD, their respective 10-K filings, and the dependency of AMD’s x86-based microprocessors and graphics products on Microsoft’s operating system support. It accurately cites Microsoft’s inclusion of operating systems in product revenue (referencing p. 62 of Microsoft’s 10-K) and AMD’s explicit statement about dependency on Microsoft’s OS development (p. 28 of AMD’s 10-K). (3) The multi-hop reasoning is sound: it connects Microsoft’s commercial interest in OS revenue to its influence over platform support, and then links that to AMD’s business risk if support were withdrawn. This synthesis across both companies’ filings is correct and logically structured. (4) The LLM answer conveys the same core message as the original: AMD’s business is materially dependent on Microsoft continuing to support its hardware in Windows OS development. The only minor shortcoming is that the LLM does not explicitly mention the downstream effect on independent software vendors or customer purchasing behavior, which is part of the full causal chain in the original answer. However, it does capture the 'material adverse effect' outcome, so the omission is not critical. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 415,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑focused offering is a hardware‑centric network fabric – high‑density routers and switches, Silicon One‑based silicon and high‑performance optics that give web‑scale and enterprise customers the low‑latency, high‑throughput connectivity needed for AI training and inference, and a data‑center strategy that stresses multicloud‑consistent policies but stops at the networking layer. Broadcom’s approach, delivered through VMware Cloud Foundation, is a software‑defined private‑cloud platform that bundles compute, storage, networking and management with native Kubernetes, providing license‑portable VCF environments that run AI/ML workloads at enterprise scale across on‑premises and public clouds, thereby directly enabling multicloud architectures and container orchestration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: Cisco's hardware-centric approach using high-density routers, switches, Silicon One, and optics for AI workloads is accurately described, as is Broadcom's use of VMware Cloud Foundation (VCF) for enterprise-scale AI/ML with native Kubernetes support. The emphasis on multicloud architectures and license portability across on-premises and public clouds is correctly captured. (2) There are no numeric values, dates, or financial figures in either answer that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s network infrastructure role with Broadcom’s software-defined VCF platform, contrasting hardware vs. software approaches while aligning them on the shared goal of multicloud consistency and Kubernetes integration. The only minor omission is that the original mentions Broadcom values VCF via the multi-period excess earnings method—a detail absent in the LLM response, which slightly affects completeness but does not undermine the core technical comparison. (4) Contextual relevance is excellent: the response directly addresses the comparison asked, focusing on AI workload support, multicloud enablement, and Kubernetes integration. Wording differs but meaning aligns closely with the original. Thus, a correctness score of 9 is warranted—very close to perfect, with only a small detail missing from the broader synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 433,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal values its derivative contracts with pricing models that use contract‑specific terms together with market‑observable inputs (e.g., currency rates, yield curves, option volatilities) and classifies virtually all of them as Level 2 – the filing states it had no recurring‑fair‑value items that required “significant unobservable inputs.” In contrast, Morgan Stanley’s Level 3 fair‑value measurements are applied to instruments whose valuation depends on material unobservable assumptions (such as credit‑correlation inputs for CDOs, custom discount‑rate or pre‑payment assumptions, and other model‑driven estimates), reflecting a far greater reliance on management‑judgment‑driven inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PayPal uses Level 2 inputs and had no recurring fair value items requiring significant unobservable inputs (i.e., no Level 3 assets/liabilities as of December 31, 2024), which matches the original answer. Morgan Stanley's use of Level 3 valuations relying on material unobservable assumptions is also accurately described. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised—dates and classifications are correct. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s reliance on observable market data with Morgan Stanley’s use of management-judgment-driven, unobservable inputs for certain instruments like CDOs and secured financings. The mention of specific examples (credit-correlation inputs, discount rates, prepayment assumptions) adds appropriate detail not in the original but consistent with Level 3 practices. (4) The only minor gap is that the LLM does not explicitly state the date 'December 31, 2024' when noting PayPal's lack of Level 3 items, though the context implies current reporting. This omission is minor given the focus on methodology over timing. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 383,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343,761,117 Class B shares can vote only on a narrow set of matters (e.g., certain mergers or charter amendments), so even though the number of shares is sizable, they provide little leverage for broad shareholder‑driven governance changes; most control still rests with Class A holders. By contrast, Comcast’s 3,778,302,017 outstanding Class A shares constitute the primary voting class, giving a much larger pool of fully‑voting stock that can more readily be mobilized to affect board composition, corporate policies, or other governance actions. Consequently, Meta’s Class B ownership structure limits the potential for activist influence relative to Comcast’s expansive voting‑share base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Meta's 343,761,117 Class B shares have limited voting rights on narrow matters (e.g., certain mergers or charter amendments), and CMCSA's 3,778,302,017 Class A shares are the primary voting shares. These numbers match the original answer exactly and are presented accurately. (2) Quantitative accuracy is perfect—both share counts are correct, and no calculations are required beyond comparison, which is handled appropriately. (3) The reasoning is sound: the LLM correctly infers that limited voting rights for Meta’s Class B shares constrain shareholder-driven governance changes, especially compared to CMCSA’s broad voting base. It correctly identifies that control at Meta rests with Class A holders and that CMCSA’s larger pool of voting shares enables greater shareholder influence. (4) The only minor shortcoming is a slight omission of specific examples mentioned in the ground truth (e.g., 'exiting the core payments business') as one of the limited actions Class B shareholders can vote on. While 'certain mergers or charter amendments' are mentioned, the full scope of restricted actions isn't fully mirrored. However, this does not undermine the overall correctness. The answer is contextually relevant, directly addressing the comparative governance implications of ownership structures. Semantic equivalence is strong, with professional rewording that preserves meaning. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 448,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "Coca‑Cola reports that **71 % of its non‑U.S. unit‑case volume is made up of sparkling soft drinks** – a share that applies to the markets served by its bottling partner CCEP (which operates in Portugal, Spain, the UK, Germany, France, Belgium, the Netherlands, Sweden, Norway, Denmark, Finland, Iceland, Australia, New Zealand, Fiji, Papua New Guinea, Indonesia, Samoa and others).  \n\nPhilip Morris International, by contrast, notes that it **operates a manufacturing facility in Portugal**, giving it a direct production footprint in one of CCEP’s key territories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that 71% of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in CCEP-operated territories, matching the ground truth exactly. The percentage is accurate and properly attributed. It also correctly identifies that PM has a manufacturing facility in Portugal, one of CCEP's key markets, which aligns with the original answer. The LLM includes additional context about CCEP's geographic footprint, which is factually consistent and enhances clarity. However, it omits the detail that PM's Portugal facility is among its largest and produces over 30 billion units (cigarettes and heated tobacco combined), which is part of the comparative insight in the ground truth. While the core multi-hop reasoning — linking KO's reliance on CCEP for distribution in shared strategic markets like Portugal and contrasting it with PM’s direct production presence — is sound and logically presented, the absence of PM's output volume slightly reduces completeness. All entities (KO, CCEP, PM, Portugal) are correctly identified, and the synthesis across companies and operations is valid. Wording differs but maintains semantic equivalence on key points. Quantitative accuracy is perfect: 71% is correct, and no incorrect numbers are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 356,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s loan‑receivable portfolio explicitly includes financing for hardware, software and technical‑support services (see page 82).  The credit‑loss allowance on those loans fell from $103 million in 2022 to $53 million in 2023 (page 84), indicating that Cisco now expects far fewer defaults.  With a smaller reserve tied up for potential losses, more of the loan‑receivable balance is available for use, which should strengthen Cisco’s capacity to extend and fund technical‑support financing to its customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in Cisco's credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth exactly in both dollar amounts and years. The calculation of a 48.5% decrease is implied by the correct values, though not explicitly stated, which is acceptable under semantic equivalence. (2) All numeric values are accurate and properly contextualized. The LLM correctly references the inclusion of technical support services in loan receivables, aligning with the ground truth. (3) The reasoning is sound: the reduced allowance indicates lower expected defaults, which frees up capital and enhances Cisco’s ability to finance technical support services. The LLM correctly synthesizes the link between lower credit loss reserves and increased financing capacity, though it does not explicitly mention improved customer creditworthiness or potential for more competitive terms—minor omissions that do not undermine the core logic. (4) The answer is highly relevant, directly addressing the impact on financing technical support services. The qualitative score is 9 due to the absence of explicit discussion on credit quality improvement or expansion of financing terms, but the core multi-hop reasoning (lower allowance → lower risk → greater financing capacity) is logically and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 382,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares are essentially non‑voting, except when a merger, consolidation or similar transaction would give the preferred holders a different economic outcome than the Class A common shareholders; in those limited merger‑related votes each preferred share counts as one vote. In contrast, every Netflix common‑stock share carries one vote on **all** shareholder matters, giving Netflix stockholders universal voting power and a far broader ability to influence corporate governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AT&T’s Series B Preferred Stock has limited voting rights, specifically in merger-related matters where economic outcomes differ from common shareholders, and that each preferred share carries one vote in those instances. This aligns with the original answer’s description of voting rights being restricted to specific merger-related events. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable beyond correct representation of voting ratios (1 share = 1 vote), which is accurately conveyed. (3) The multi-hop reasoning is sound: the model correctly contrasts AT&T’s restricted voting structure with Netflix’s universal voting rights, synthesizing governance implications across two companies. The only minor omission is that the original answer specifies that AT&T preferred holders vote 'as a single class,' a procedural detail not included in the LLM response, but this does not affect the core accuracy. (4) The LLM emphasizes Netflix’s 'universal voting power' and broader influence, which matches the original’s conclusion about comparative governance influence. Wording differs slightly but meaning is preserved. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to the small omission in procedural detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 403,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal treats buy‑now‑pay‑later (BNPL) products and cryptocurrency offerings as a **risk** – its 2022 filing notes that rapid‑changing payment technologies, regulatory scrutiny of BNPL and the custody‑related, counter‑party and insurance risks of crypto could erode usage of PayPal’s core services if the company cannot keep pace (see Risk Factors pages 18‑20).  \n\nVisa, by contrast, views the same alternative‑payment players as **both partners and competitors** – its 2022 filing classifies BNPL solutions and crypto platforms as “Alternative Payments Providers” that may use Visa’s network while also competing with it, and it highlights a strategy of fintech collaborations, fast‑track programs and strategic investments to capture value from these providers (see page 16).  \n\nThus, PayPal’s exposure is framed as a disruptive threat, whereas Visa positions itself to leverage and compete with those emerging methods simultaneously.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies PayPal's exposure to BNPL and cryptocurrency as a risk, citing specific risk factors from its 2022 filing (pages 18–20), including regulatory, custody, counter-party, and insurance risks—consistent with the original answer’s emphasis on technological disruption. (2) It accurately characterizes Visa’s dual role as both partner and competitor to alternative payment providers, referencing its 2022 filing (page 16) and specific strategies like fintech collaborations, fast-track programs, and strategic investments—aligning with the ground truth’s description of Visa’s adaptive positioning. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (PayPal and Visa), their respective risk disclosures and strategic responses, and contrasts their approaches logically. (4) No quantitative data (e.g., dollar amounts, percentages) are present in either answer, so no calculation errors exist; all entities (PayPal, Visa, BNPL, cryptocurrency, 2022 filings) are correctly identified. Wording differs slightly but conveys the same meaning—PayPal faces disruptive threats, while Visa leverages a strategic dual role. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 366,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 10‑K states that each share of its common stock carries **one vote per share** (see NFLX 10‑K p. 61). Alphabet’s 2023 10‑K likewise notes that each share of **Class A common stock is entitled to one vote per share** (see GOOGL 10‑K p. 81). Thus, the voting power per share of Netflix’s common stock is the same as the voting right attached to Alphabet’s Class A shares—both provide **one vote per share**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Netflix's common stock provides one vote per share, citing the correct company (Netflix, ticker NFLX) and document (2023 10-K, p. 61). (2) It correctly identifies that Alphabet's Class A Common Stock also provides one vote per share, with accurate reference to GOOGL 2023 10-K, p. 81. (3) The reasoning correctly synthesizes information across two companies and their respective filings, confirming equivalent voting power per share despite Alphabet’s multi-class structure (though the latter detail is omitted, it is not required to answer the specific comparison question). (4) All entities, years, and voting rights are correctly identified. The conclusion that both provide one vote per share is factually sound and semantically equivalent to the original answer. No calculation errors or factual inaccuracies are present. The answer is concise, relevant, and fully addresses the comparative voting power question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 293,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both Philip Morris International (PM) and Mondelēz International (MDLZ) calculate their one‑day, 95 %‑confidence VaR under “normal market conditions” using a parametric delta‑gamma approximation, but the resulting estimates differ markedly. PM’s VaR is reported only as fair‑value impacts and is substantially larger – e.g., interest‑rate exposure of $297 million and foreign‑currency exposure of $77 million at 12/31/23 (average $332 M and $74 M) – whereas MDLZ’s VaR is lower and broken out by fair‑value and pre‑tax‑earnings impacts, with interest‑rate fair‑value exposure of $119 million (average $144 M), foreign‑currency $14 million (average $17 M) and commodity exposure of $21 million (average $40 M). Thus, while both firms rely on the same delta‑gamma technique and assumptions, MDLZ assumes a smaller overall risk exposure (and adds a commodity component) compared with PM’s larger interest‑rate and currency‑only VaR figures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces numerical data not present in the original ground truth, leading to a low correctness score. (1) Quantitative Accuracy: The LLM fabricates specific VaR figures for both PM and MDLZ (e.g., $297M interest-rate exposure for PM, $119M for MDLZ), which are not disclosed in the original answer. The ground truth explicitly states that PM does *not* disclose a specific VaR figure, while MDLZ does provide year-end VaR amounts—but the actual numbers are not specified in the original answer. Therefore, all cited dollar amounts are unsupported and incorrect. (2) Completeness: While the question asks for a comparison of the parametric delta-gamma technique usage, VAR estimates, and risk exposure assumptions, the LLM incorrectly claims PM reports VaR as 'fair-value impacts' and provides averages and breakdowns not mentioned in the ground truth. The original answer does not mention pre-tax earnings impacts or average/periodic VaR values. (3) Entity Accuracy: The companies (PM and MDLZ) and the method (parametric delta-gamma) are correctly identified, and the 95% confidence level and one-day holding period are accurately reflected, consistent with the ground truth. (4) Reasoning: The multi-hop reasoning is flawed because the LLM assumes that because both companies use similar methods, they must produce comparable disclosures with quantifiable outputs—but it fails to recognize that the original answer emphasizes *disclosure differences*: MDLZ reports actual VaR figures while PM does not. The conclusion that MDLZ assumes 'smaller overall risk exposure' is an unsupported inference based on fabricated numbers. (5) Semantic Equivalence: The LLM answer is not semantically equivalent to the ground truth; it shifts from a qualitative comparison of methodology and disclosure practices to a quantitative comparison of non-existent metrics. The addition of commodity exposure as a differentiator is partially correct (MDLZ includes commodities, PM focuses on interest rates and currencies), but this is overshadowed by the erroneous numerical claims. Overall, the answer misrepresents the source information and fails on factual accuracy despite capturing some contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 600,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is explicitly subject to the **Market‑Risk Rule** because its trading‑book assets and liabilities exceed the rule’s trigger of **10 % of total assets or $1 billion** (the filing states the company “are subject to the Market Risk Rule” and describes the 10 %/ $1 bn threshold).  Under that rule Capital One adjusts its Basel III capital ratios using its internal **Risk‑Management VaR** (a one‑day, 95 % confidence, historical‑simulation model) and a separate **Regulatory VaR** (ten‑day, 99 % confidence) that feeds directly into its capital‑ratio calculations.  \n\nJPMorgan Chase’s capital requirements are presented only through the **Basel III framework** (no separate Market‑Risk Rule threshold is cited), and its market‑risk capital is derived from the same VaR approach: a **Risk‑Management VaR** (one‑day, 95 % confidence) and a **Regulatory VaR** (ten‑day, 99 % confidence) that is used to compute the Basel III capital ratios.  Thus, while both firms rely on comparable VaR methodologies, Capital One’s exposure is conditioned by the explicit 10 %/ $1 bn trading‑asset threshold of the Market‑Risk Rule, whereas JPMorgan’s capital is governed solely by Basel III requirements without an additional rule‑based threshold.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly regarding Capital One's VaR methodologies and regulatory framework, though it correctly identifies the Market Risk Rule threshold and JPMorgan's Regulatory VaR parameters. (1) Quantitative Accuracy: The claim that Capital One uses a one-day, 95% confidence internal Risk-Management VaR and a separate ten-day, 99% Regulatory VaR is not supported by the ground truth, which does not specify COF's VaR model details—only that it falls under the Market Risk Rule due to crossing the $1B/10% threshold. The ground truth emphasizes COF’s use of Basel III standardized and proposed Expanded Risk-Based Approaches, with no mention of internal VaR models like those described. In contrast, JPMorgan’s use of 99% confidence and ten-business-day holding period for Regulatory VaR is correctly stated and aligns with the original answer. (2) Completeness: The LLM fails to mention the key differentiator in the ground truth—COF’s transition toward the Basel III Expanded Risk-Based Approaches phasing in by 2028—which is a critical component of its capital adequacy framework. This omission weakens the comparative analysis. (3) Entity Accuracy: Company names (COF, JPM) and regulatory frameworks (Basel III, Market Risk Rule) are correctly identified. (4) Reasoning: The LLM incorrectly implies symmetry in VaR usage between COF and JPM, suggesting both use identical Regulatory VaR models, while the ground truth highlights that JPM uses granular internal VaR modeling whereas COF is subject to more standardized and evolving regulatory approaches. This misrepresents the core distinction. (5) Semantic Equivalence: While the answer captures the Market Risk Rule threshold correctly and contextualizes JPM’s Basel III reliance, the erroneous attribution of specific VaR models to Capital One undermines factual correctness. The conclusion that JPM has no additional threshold beyond Basel III is reasonable, but the overall synthesis is flawed due to unsupported methodological claims about COF.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 558,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports a $50 million allowance for credit losses on its loan‑receivable portfolio – the portion of which finances hardware, software and **technical‑support services** (Note 9, “Financing Receivables,” page 82). Salesforce, by contrast, does not disclose a comparable monetary allowance; its 10‑K only notes that it **relies heavily on third‑party developers and technology‑partner providers to deliver technical‑support and integration services**, acknowledging a qualitative exposure to service‑delivery risk but without a quantified credit‑loss reserve.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Cisco's credit loss allowance as $50 million instead of the correct $53 million as stated in the ground truth (as of July 29, 2023). This is a small deviation but still a factual error in a key financial figure. The rest of the financial context — that the allowance includes financing for technical support services — is accurately conveyed. Salesforce's lack of a quantified allowance and reliance on third-party providers is correctly described.\n\n2) Quantitatively, the $50M vs $53M discrepancy reduces precision. All other numbers (or lack thereof) are accurate — Salesforce indeed does not disclose a monetary allowance, so stating it lacks a 'comparable monetary allowance' is correct. No calculations were required, but the comparison in risk type (direct credit risk vs. service delivery risk) is appropriately framed.\n\n3) The multi-hop reasoning is sound: the model correctly identifies that Cisco bears direct financial risk via credit loss allowances tied to financing technical support, while Salesforce faces operational risk through third-party service delivery without a corresponding financial reserve. The synthesis between two different types of risk exposure (financial vs. reputational/operational) across companies is logically and accurately presented.\n\n4) The answer is contextually excellent — it directly addresses the comparison of risk exposure types, correctly attributes each company's risk profile, and highlights the contrast between quantified financial reserves and qualitative service risks. The wording differs slightly from the original but maintains semantic equivalence, except for the dollar amount.\n\nJustification: A score of 8 is appropriate because the core reasoning and structure are strong, and the error is limited to one number. The answer successfully performs the multi-hop comparison between Cisco’s financial risk and Salesforce’s operational risk, with only minor factual inaccuracy affecting the quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 554,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s 2023 filing stresses that its dual‑class structure gives the founder’s Class B shares (ten votes per share) control over all corporate matters, even though they represent a small percentage of total equity, and that this “controlled‑company” status can make the Class A common stock less attractive and depress investor confidence (Meta 10‑K pp. 49‑50). Comcast’s 2023 filing shows it also has a Class B common‑stock series (authorized 75 million shares, 9.4 million issued) but the filing contains no discussion of conversion rights or voting‑control restrictions tied to that class (Comcast 10‑K pp. 69‑70), indicating that the presence of Class B stock does not create the same governance‑risk concerns for Class A shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Meta's dual-class structure gives Class B shareholders (e.g., Zuckerberg) disproportionate voting control (10 votes per share), and this 'controlled company' status is explicitly linked to reduced investor confidence in Class A shares, as cited from Meta’s 10-K (pp. 49–50). For CMCSA (Comcast), the answer correctly states that 9.4 million Class B shares were issued (matching the ground truth 9,444,375, rounded appropriately), out of 75 million authorized, and notes the absence of any conversion mechanism or governance restrictions tied to those shares, based on Comcast’s 10-K (pp. 69–70). (2) Quantitative accuracy is excellent: the 9.4 million issued shares is a valid rounding of 9,444,375, and no other numbers are misstated. (3) Multi-hop reasoning is sound: the model correctly contrasts Meta’s governance risks (founder control, impact on Class A attractiveness) with Comcast’s structurally simpler Class B setup lacking special voting or conversion rules. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% voting power threshold for Meta’s change-in-control provision, which is in the ground truth and adds nuance to the governance risk. However, the core contrast—Meta’s governance-linked risks vs. Comcast’s lack thereof—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect: the response directly addresses the comparative governance risk and investor confidence implications as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 439,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities with a discounted‑cash‑flow model that explicitly incorporates several unobservable assumptions – a constant pre‑payment rate, loss‑severity, default rate and the discount yield – and the filing even discloses the ranges for each of those inputs. Morgan Stanley also relies on discounted‑cash‑flow techniques for Level 3 fair‑value measurements, but its 10‑K only notes that such models “use significant unobservable inputs” without identifying the specific drivers, indicating a more generic reliance on non‑observable data. Thus, AIG’s approach is more granular and transparent about the unobservable inputs, whereas MS’s DCF valuation is described more generally.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AIG uses discounted cash flow (DCF) models for RMBS valuation with unobservable inputs, including constant prepayment rate and loss severity, and notes that ranges are disclosed—consistent with the ground truth values (e.g., CPR 4.10%–9.26%, loss severity 40.81%–76.72%). While the LLM adds 'default rate' and 'discount yield' not explicitly mentioned in the original answer, these are plausible unobservable inputs in DCF models and do not contradict the ground truth. (2) For Morgan Stanley, the LLM accurately states that DCF is used for Level 3 fair value measurements involving significant unobservable inputs, and correctly infers that MS provides less granular disclosure—though it omits the specific figure that Level 3 assets represented 0.9% of total assets as of December 31, 2024. This is a minor omission affecting completeness but not the core correctness. (3) The multi-hop reasoning is sound: the model compares AIG’s granular, transparent input disclosure with MS’s more generic description, concluding that AIG’s approach is more detailed—this is a valid qualitative inference supported by the evidence. (4) All entities (AIG, MS, RMBS, DCF, Level 3 assets) and concepts are correctly identified and contextually relevant. The answer fully addresses the comparative aspect of the question regarding reliance on unobservable inputs. The only deductions are for the slight overstatement of AIG’s inputs and the missing 0.9% quantitative benchmark from MS, preventing a perfect 10. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 462,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco trimmed its allowance for credit losses on loan receivables that finance its hardware by $3 million (from $53 million in 2023 to $50 million in 2024), signalling a modest improvement in the credit quality of those financing arrangements. In contrast, Microsoft treats hardware that cannot function without its operating system as a single performance‑obligation and records the entire amount of revenue at the point of transfer, rather than spreading it over time. Thus, Cisco’s exposure is tied to the risk that customers default on hardware‑financing loans, whereas Microsoft’s exposure is centered on the timing of revenue recognition and any related return or credit adjustments for bundled hardware‑software sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Cisco's allowance decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023. However, the LLM incorrectly reports a decrease from $53 million in 2023 to $50 million in 2024, which is not supported by the original data and shifts the time frame entirely. This misrepresents both the magnitude and timing of the change. (2) The quantitative accuracy is poor: the correct delta is a $50 million reduction ($103M → $53M), not a $3 million reduction as claimed. Additionally, the LLM introduces a non-existent 2024 figure, which is not present in the ground truth. (3) While the qualitative description of Microsoft’s revenue recognition approach is largely accurate—correctly identifying that hardware interdependent with software is treated as a single performance obligation and recognized at point of sale—the comparison in financial exposure is weakened by the incorrect Cisco data. The reasoning about differing risk exposures (credit risk vs. revenue timing) is conceptually sound and addresses the multi-hop aspect of the question, but it is based on flawed input. (4) Contextual relevance is fair because the LLM attempts to address both companies, the financial treatments, and the implied risk exposures. However, due to the core numerical and temporal errors, the overall correctness score is low. Minor flexibility is granted for acceptable rewording, but the factual foundation is too compromised to score higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 426,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG recorded a $75 million loss in 2024 from embedded derivatives (see AIG 10‑K page 144, “Embedded derivatives – $75 m loss”). Morgan Stanley’s credit‑risk exposure to CDOs that embed similar derivatives is reflected in its non‑consolidated VIE tables, where the “Maximum exposure to loss” for CDOs is $62 million (see MS 10‑K page 128). Thus, AIG’s loss is about $13 million larger than the credit‑risk exposure Morgan Stanley reports for its CDO holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While AIG's $75 million loss from embedded derivatives in 2024 is correctly stated and aligned with the ground truth, the claim that Morgan Stanley's credit-risk exposure to CDOs is $62 million—framed as a direct comparison to AIG’s realized loss—is incorrect in both interpretation and context. The ground truth does not mention any specific dollar amount for MS’s exposure, nor does it state a $62 million 'maximum exposure to loss' from CDOs. This figure appears to be fabricated or misattributed, as the knowledge graph contains no such number. (2) The calculation that AIG’s loss is '$13 million larger' than MS’s exposure is therefore based on false premises and invalid. There is no support in the original answer for any numerical comparison between AIG’s realized loss and MS’s exposure. (3) The multi-hop reasoning fails: the original answer draws a qualitative parallel between AIG and MS based on similar risk profiles—both face credit risk from hybrid instruments with embedded derivatives and potential principal loss during credit events. The LLM instead attempts a quantitative comparison that is not supported by the data, missing the conceptual analogy entirely. (4) While the LLM correctly identifies AIG’s loss and attempts to locate MS’s exposure in structured products (CDOs, VIEs), it misrepresents the nature of the risk and introduces unsupported numbers. The contextual relevance is moderate because it addresses both firms and structured credit products, but the core conclusion is factually and logically unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 451,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s cash‑flow hedges for forecasted foreign‑currency transactions are structured to cover periods “generally not to exceed four years” (i.e., up to about 48 months)【page_121】. Google’s comparable cash‑flow hedges – forward and option contracts (including collars) – are limited to maturities of “24 months or less”【page_70】. Thus Disney’s hedge horizon can be roughly twice as long as Google’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and durations are correct: Disney's hedge period of 'generally not to exceed four years' (i.e., up to 48 months) and Google's '24 months or less' are accurately reported. The comparison stating Disney’s horizon can be 'roughly twice as long' is a reasonable qualitative interpretation of the 48 vs 24-month difference. (2) While the original answer includes specific dollar amounts ($9.9 billion for Disney, $731 million for Google), the LLM omits these figures. This is a minor omission but does not affect the core comparison about hedge durations, which is the focus of the question. (3) The reasoning is sound: the LLM correctly identifies both companies use option contracts (noting Google also uses forwards and collars), and synthesizes the duration difference across the two firms accurately. (4) The answer is contextually relevant, directly addressing the comparative duration of hedge periods and correctly attributing the data to each company. The use of citation markers ['page_121', 'page_70'] suggests proper grounding. Overall, the answer captures the essential multi-hop comparison correctly, with only a slight reduction in completeness due to missing the financial values mentioned in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 368,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Both companies say the new 15 % global‑minimum‑tax rules will not materially change their tax bills. Qualcomm notes that, although a larger share of its earnings is already taxed in non‑U.S. jurisdictions, it does not expect the Pillar‑Two rules that take effect in fiscal 2025 to increase its consolidated tax expense in any material way. Intel, by contrast, points out that it has virtually no operations in jurisdictions whose statutory rates fall below the 15 % floor, so its exposure to the Pillar‑Two model is likewise expected to be immaterial. Thus, despite Qualcomm’s more globally‑distributed earnings, both firms anticipate only a negligible impact on their FY 2025 tax liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both entity-specific details and reasoning, despite using plausible numbers and correct terminology. (1) The core error is a reversal of the actual exposure: the ground truth states that QCOM expects minimal impact because it does not operate materially in low-tax jurisdictions, while INTC—due to its significant non-US income—is still evaluating the impact and faces greater uncertainty. The LLM incorrectly claims that Intel has 'virtually no operations in jurisdictions below 15%' and thus minimal exposure, which contradicts the original answer stating INTC has 'a significant portion of its income taxed in non-US jurisdictions' and is facing ongoing evaluation and uncertainty. Conversely, the LLM misrepresents QCOM as having a 'larger share of earnings taxed in non-U.S. jurisdictions'—which implies higher exposure—yet concludes no material impact, creating confusion in logic. (2) Quantitatively, the 15% minimum tax rate and FY2025 effective date are correctly cited, and no incorrect calculations are made since none were required. These elements are accurate. (3) The multi-hop reasoning fails: the comparison between QCOM and INTC is inverted. The model does not correctly synthesize the differing geographic risks—QCOM’s operations are less exposed due to jurisdictional distribution, while INTC’s footprint creates real uncertainty. Instead, it incorrectly assigns low exposure to INTC and implies higher international exposure for QCOM without justification. (4) Contextual relevance is moderate: the answer addresses the right topic, companies, timeframe, and policy (Pillar Two), but the conclusion misleads by equating both companies’ exposure when the ground truth clearly differentiates them, with INTC facing more immediate uncertainty. This undermines the correctness despite surface-level plausibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 508,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes versus one vote for a Class A share, and the Class B shares can be converted into Class A shares at any time.  Because the founder (and other insiders) own the bulk of the Class B stock, the ten‑to‑one voting‑power ratio lets them hold a majority of the total votes and, as Class B shares are converted, their voting influence can actually increase.  \n\nComcast’s structure, by contrast, assigns 15 votes to each Class B share but caps the aggregate voting power of all Class B shares at roughly one‑third of the company’s total votes (the “non‑dilutable” 33 % share).  This fixed ceiling means the founder’s control is limited to that one‑third slice, regardless of any conversions or new issuances.  \n\nThus, Alphabet’s 10‑to‑1 convertible voting scheme can give the founder decisive, potentially majority control, whereas Comcast’s non‑dilutable 33 % voting block restricts founder influence to a minority, fixed proportion of corporate‑governance decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between Alphabet's and Comcast's dual-class structures and correctly identifies the core governance implications regarding founder control. However, there are significant factual inaccuracies that reduce correctness. (1) Quantitative Accuracy: The LLM incorrectly states that Comcast's Class B shares have '15 votes' per share — the ground truth does not specify votes per share but instead emphasizes that Class B holds a non-dilutable 33⅓% of total voting power, regardless of share count. This is a critical error. Additionally, the claim that 'Class B shares are converted' in Alphabet's case is misleading — they convert automatically upon sale or transfer, not at the holder's discretion. (2) The answer incorrectly suggests that Alphabet founders' voting influence 'can actually increase' as Class B shares convert to Class A, which is illogical — conversion reduces voting power (from 10:1 to 1:1), so influence diminishes unless new shares are issued. This reflects flawed reasoning. (3) Qualitative Accuracy: While the multi-hop comparison is attempted and the overall intent of contrasting fluid vs. fixed control is present, the explanation of Comcast’s structure oversimplifies and misrepresents the mechanism (share-for-share convertibility and non-dilution are not clearly or correctly explained). (4) Contextual Relevance is high — the response directly addresses the question about voting power ratios and founder control, synthesizing across both companies appropriately in structure. Despite correct identification of Alphabet’s 10:1 ratio and the concept of conversion, and a reasonable interpretation of Comcast’s capped voting power, the numerical and mechanistic errors reduce the correctness score to 6 — partially correct but with significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 490,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement makes PMI the indemnitor for any tobacco‑product claims that arise from cigarettes that PMI (or contract‑manufactured for PMI by PM USA) produces, and PM USA indemnifies PMI only for claims based on PM USA‑manufactured products.  Because of that arrangement Altria records no liability for those claims – the fair‑value of the indemnity is deemed immaterial (Altria 10‑K p. 108) – whereas PMI continues to carry the risk for its own products and for the judgments tied to the de‑consolidated RBH entity (e.g., the $194 million pre‑tax charge recorded before RBH’s deconsolidation, PMI 10‑K p. 112‑114).  Consequently, Altria’s financial exposure to tobacco‑related litigation is far lower than PMI’s retained obligations that remain on PMI’s books after RBH’s de‑consolidation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core indemnification structure between PM USA and PMI as outlined in the Distribution Agreement, accurately stating that PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured or contract-manufactured products, while PM USA indemnifies PMI for its own products. It correctly notes that Altria has not recorded a liability due to the immateriality of the fair value of the indemnification, citing the correct disclosure location (Altria 10-K p. 108), which aligns with the ground truth. However, the LLM introduces a specific dollar amount—$194 million pre-tax charge—related to RBH deconsolidation that is not present in the original answer or supported by the provided knowledge graph. This figure may be factually accurate in external context but is not part of the ground truth and represents an unsupported addition, undermining quantitative accuracy. Additionally, the original answer emphasizes that PM (not PMI) retains obligations tied to RBH deconsolidation involving reclassifications from accumulated other comprehensive losses, whereas the LLM incorrectly attributes these ongoing obligations to PMI and frames them as retained litigation risk post-deconsolidation, which misrepresents the entity and nature of the obligation. This affects both quantitative and qualitative accuracy. The reasoning is mostly sound in comparing Altria’s limited exposure to PMI’s retained risk, but the misattribution of RBH-related obligations to PMI instead of PM (a subsidiary under Altria) weakens the multi-hop synthesis. Despite this, the answer remains contextually relevant and conveys a largely accurate understanding of the indemnification dynamics limiting Altria’s exposure. Semantic equivalence is partially maintained, but the introduction of unverified figures and misassignment of financial obligations prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 510,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑receivable allowance fell from $103 million in 2022 to $53 million in 2023 (see the “Allowance for credit loss” roll‑forward on page 84), and the note on financing receivables explains that loan receivables are used to fund the sale of hardware, software and related services – including technical‑support and advanced‑services (page 82). The lower allowance therefore signals fewer expected defaults and gives Cisco more headroom to continue financing customers’ equipment and support contracts at lower risk. By contrast, Adobe does not rely on customer‑financing; its technical‑support program is funded through subscription‑entitlement and annual maintenance fees that are part of its recurring revenue stream (page 17), so Adobe’s support offering is supported by cash generated from subscriptions rather than a credit‑loss‑adjusted loan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with no calculation errors. (2) The answer correctly identifies that Cisco uses loan receivables to finance the sale of hardware, software, and services—including technical support—and that the reduced allowance indicates lower expected credit losses, which improves Cisco's capacity to finance customer support contracts with less risk. (3) The comparison to Adobe is sound: Adobe funds technical support through subscription entitlements and annual maintenance fees, which are part of its recurring revenue model, and does not rely on loan receivables or financing arrangements. The LLM correctly contrasts Cisco’s credit-risk-adjusted financing model with Adobe’s subscription-based funding. (4) Minor deduction in qualitative accuracy due to slightly less explicit detail on the duration (1- to 3-year terms) of Adobe’s maintenance programs, which is present in the original answer but omitted. However, the core reasoning and multi-hop synthesis across Cisco’s financing and Adobe’s subscription model are logically sound and factually correct. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 394,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Both companies name Citibank, N.A. as the administrative agent of their five‑year credit facilities, but the surrounding terms differ. Caterpillar’s 2022 five‑year credit facility lists Citibank only as the administrative agent and the filing does not disclose any amendment or a separate syndication agent, whereas Boeing’s five‑year credit agreement dated October 30 2019 names Citibank, N.A. as administrative agent **and** JPMorgan Chase Bank, N.A. as the syndication agent, and the agreement was later amended on August 25 2022 (Amendment No. 1) 【page 126】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A. as administrative agent in both Caterpillar's 2022 and Boeing's 2019 credit agreements, and accurately reports the amendment date for Boeing (August 25, 2022). It also correctly notes the absence of a disclosed amendment in Caterpillar's case, though it fails to mention the actual Amendment No. 1 dated August 31, 2023, which is present in the ground truth. This omission is a significant but not critical error, as the core comparison on amendment timing is partially incomplete. (2) Quantitatively, all provided dates (October 30, 2019 for Boeing’s original agreement; August 25, 2022 for Boeing’s amendment) are correct. The Caterpillar amendment date (August 31, 2023) is missing, which affects completeness but not the accuracy of what is stated. No incorrect numbers are presented. (3) The LLM correctly identifies the syndication structure differences: Boeing includes JPMorgan Chase Bank, N.A. as syndication agent, while Caterpillar does not have a disclosed syndication agent. However, it omits mention of MUFG Bank, Ltd.'s role in Caterpillar’s syndication, which is part of the ground truth and relevant to the syndication structure comparison. The reasoning is sound in comparing agent roles and amendment timelines, but the multi-hop synthesis is incomplete due to missing details. (4) The answer is highly contextually relevant, directly addressing the comparison of Citibank’s role, amendment timelines, and syndication structures. Despite omissions, the core factual assertions made are accurate, warranting a high correctness score with minor deductions for incompleteness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 457,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both companies warn that a sustained Taiwan‑China conflict would jeopardize the wafer capacity they obtain from Taiwanese foundries. NVIDIA notes that many of its critical suppliers, contract manufacturers and assembly partners are located in Taiwan, and a prolonged geopolitical clash could “severely limit or prevent us from receiving chipset supply from Taiwan” – raising costs, creating inventory shortages and harming margins (NVDA p. 17, 35). Qualcomm makes the same point, stating that its ability to get “consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” could be disrupted by “acts of war…or geopolitical conflicts…in Taiwan,” which would impair its supply‑chain reliability and overall operations (QCOM p. 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key factual elements are correct: both NVIDIA and Qualcomm rely on Taiwanese foundries, and a geopolitical conflict involving Taiwan could severely disrupt their supply chains. The LLM correctly identifies that both companies explicitly cite risks related to war or geopolitical conflict in Taiwan impacting their chipset supply. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from both companies, correctly attributing specific language to each (e.g., referencing page numbers NVDA p.17,35 and QCOM p.35), and connects their shared dependency on Taiwan-based manufacturing. The only minor shortcoming is that the LLM slightly over-attributes direct quotes—while the sentiment and substance match known 10-K disclosures, the exact quoted phrases like 'severely limit or prevent us from receiving chipset supply' are paraphrased rather than direct, though still semantically accurate. (4) Contextual relevance is excellent: the response directly addresses the question about supply chain reliability and shared foundry dependencies. Overall, the answer demonstrates strong qualitative reasoning and factual correctness, warranting a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 399,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing notes that, although it sometimes receives indemnification from the U.S. government on certain contracts, that protection is limited (it applies only to specific government‑contract work and does not extend outside the United States) and its insurance may be insufficient to cover all claims, leaving the company exposed to potentially large, unpredictable litigation costs. By contrast, 3M’s spin‑off of Solventum expressly transfers a defined set of liabilities—including PFAS‑related claims and certain product‑liability actions such as the Bair‑Hugger and False‑Claims Act suits—to Solventum, with Solventum agreeing to indemnify and defend 3M, thereby removing those liabilities from 3M’s balance sheet and limiting its future legal exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: Boeing's indemnification risk from U.S. government contracts is properly described as limited and subject to potential large litigation costs due to insufficient insurance, particularly for defense and aerospace products. 3M's transfer of liabilities—including Bair Hugger and False Claims Act litigation—to Solventum in the spin-off is accurately stated. The April 1, 2024 spin-off date is implied by context in the original answer but not explicitly mentioned in the LLM response; however, this omission does not materially affect correctness. (2) There are no numeric values, dates, or financial figures in either answer requiring verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Boeing’s ongoing exposure (due to contract cost allocations and uninsurable risks) with 3M’s reduced exposure post-spin-off, where Solventum now assumes liability and defense obligations. The mention of PFAS-related claims, while not in the original answer, is consistent with known 3M liabilities transferred to Solventum and adds context without introducing error. (4) Semantic equivalence is strong: the LLM captures the key distinction—Boeing retains risk exposure tied to government contracts and product liabilities, whereas 3M has offloaded specific legal liabilities to Solventum. The only minor shortcoming is slightly less emphasis on the CAS pension cost allocation aspect mentioned in the original, which is a nuanced but not central point. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 475,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "Comcast’s proxy statement makes clear that the single holder of its Class B stock – Brian L. Roberts – controls 33 % of the company’s total voting power (each Class B share carries 15 votes, versus one vote for Class A, and the one‑shareholder owner holds all 9.44 million Class B shares) while the remaining 66 % of votes belong to the dispersed Class A shareholders【page_33】.  \n\nMeta’s filing describes an almost identical concentration of voting power: its ten‑vote‑per‑share Class B stock is held by the founder and a few insiders, giving them a majority of the combined voting power even though they own a relatively small economic stake, and the company is designated a “controlled company” with anti‑takeover provisions that limit the ability of Class A holders to influence directors, mergers or other shareholder‑approved matters【page_49】【page_50】.  \n\nBecause Comcast’s governance is already dominated by a single individual through a high‑vote Class B share, the same dual‑class, non‑dilutable voting structure in Meta creates comparable governance risks for Meta’s Class A investors – they have limited ability to affect board composition or corporate decisions, and the controlling shareholder can pursue actions that may not align with the broader shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that CMCSA's Class B stock, owned entirely by Brian L. Roberts, holds 33⅓% of voting power (rounded to 33% in the LLM answer, which is acceptable for semantic equivalence), with each share carrying 15 votes. The reference to 9.44 million shares adds detail not in the original but does not contradict it. (2) For META, the LLM accurately describes the dual-class structure, the 10 votes per Class B share, insider control, and the 'controlled company' status that limits Class A shareholders' influence—key points from the ground truth. It correctly links this to anti-takeover provisions and reduced influence over board and corporate decisions. (3) The multi-hop reasoning is sound: it draws a valid parallel between CMCSA’s concentrated voting structure and META’s, explaining how both create governance risks for Class A shareholders due to disproportionate control by insiders. (4) Minor deduction in quantitative accuracy due to rounding 33⅓% to 33% without qualification, though this is common and not misleading. No major omissions or factual errors. The answer is contextually fully relevant, addressing the influence of CMCSA's structure as an analogy to illuminate META's governance risks. Wording differs but meaning is preserved. Thus, correctness score is 9—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 386,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s system in Argentina relies on its independent bottler Arca Continental, which “has bottling and distribution operations in … northern Argentina” (KO 10‑K p. 7). Procter & Gamble notes that “certain countries … that recently had and are currently experiencing significant exchange‑rate fluctuations include Argentina” and that its translation‑ and transaction‑exposure to those fluctuations can materially affect sales and earnings (PG 10‑K p. 23). Therefore, the Coca‑Cola sales that flow through Arca Continental are subject to the same Argentine peso volatility that creates P&G’s foreign‑exchange risk in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Coca-Cola relies on Arca Continental for distribution in northern Argentina, and Procter & Gamble explicitly identifies Argentina as a country with significant exchange-rate fluctuations affecting its financials. The LLM correctly cites both companies' 10-K disclosures, referencing the appropriate risks tied to foreign exchange volatility in Argentina. (2) There are no numeric values in the original or LLM answer that conflict; both avoid specific percentages or dollar amounts beyond what’s in the source documents, so quantitative accuracy is preserved. (3) The multi-hop reasoning is sound: the LLM connects Coca-Cola’s indirect exposure via Arca Continental (a third-party bottler) to the same macroeconomic environment (Argentine peso volatility) that directly impacts P&G’s earnings and sales. This synthesis across two companies and their respective risk exposures is logically and factually valid. (4) The only minor shortcoming is that the LLM omits the detail from the ground truth that Coca-Cola’s global unit case volume through bottlers is 17%, which adds context to the scale of its reliance on partners like Arca Continental. While not critical to the core logic, this contextual nuance improves completeness. Otherwise, the answer is semantically equivalent, well-supported by citations, and directly addresses the intersection of supply chain dependency and foreign exchange risk in Argentina.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 417,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Lilly warns that the U.S. loss of patent and data exclusivity for Alimta – a small‑molecule chemotherapy – will “cause a rapid and severe decline in revenue for the product” because generic manufacturers can enter the market as soon as the patent expires 【page_25】. By contrast, Amgen’s biologics are protected by the biologics‑specific BPCIA framework, which gives a 12‑year data‑exclusivity period and a more complex, often slower biosimilar‑approval pathway; the company therefore faces “biosimilar competition … that may or may not result in the near‑term entry of competitor versions” and is also subject to possible regulatory changes that could shorten that exclusivity 【page_45】【page_46】. Thus, Alimta’s patent expiry is likely to produce an immediate, steep drop in Lilly’s oncology sales, whereas Amgen’s biologic exposure to patent‑related risk is moderated by the longer, more restrictive biosimilar regulatory regime.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that Alimta is a small-molecule drug whose patent expiration will lead to rapid revenue decline for Eli Lilly due to generic competition, citing the 'rapid and severe decline' language directly from the source (page 25). (2) It accurately contrasts this with Amgen’s situation, correctly referencing the Biologics Price Competition and Innovation Act (BPCIA) framework, the 12-year data exclusivity period, and the more complex biosimilar approval pathway, which slows down market entry—consistent with the original answer’s emphasis on regulatory differences. (3) The multi-hop reasoning is sound: it synthesizes information across two companies (Lilly and Amgen), two drug types (small molecule vs. biologic), and two regulatory regimes (generic vs. biosimilar pathways), correctly concluding that revenue impact differs in speed and severity. (4) All entities (Alimta, Eli Lilly, Amgen, BPCIA) are correct; no numbers or dates are incorrect (the 12-year exclusivity is accurate); and the qualitative analysis matches the original in logic and depth. Minor wording differences (e.g., 'moderated by the longer, more restrictive biosimilar regulatory regime') are semantically equivalent to the original’s 'slower biosimilar entry due to manufacturing and regulatory uncertainties.' No calculation errors. Full contextual relevance to the comparative, multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 412,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel says the OECD Pillar‑Two rules are unlikely to affect it materially because it has no material operations in jurisdictions whose statutory rates fall below the 15 % minimum; therefore its non‑U.S. tax benefits are expected to remain essentially unchanged. Microsoft, by contrast, earns a large share of its profit outside the United States and relies on a mix of foreign tax rates and credits, so the same global‑minimum‑tax regime would raise its effective tax rate and represents a more significant exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in characterizing Intel's position. The original answer states that Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions and that it is actively evaluating the impact of Pillar Two, with potential application starting in 2024. This implies uncertainty and ongoing assessment, whereas the LLM incorrectly asserts that Intel says Pillar Two is 'unlikely to affect it materially' and that it has 'no material operations' in low-rate jurisdictions—information not present in the ground truth. Conversely, the LLM flips the exposure: it suggests Microsoft faces a more significant impact, while the original answer states Microsoft does *not* expect a material increase in tax costs due to limited operations in sub-15% jurisdictions. Thus, the LLM reverses the relative exposure of the two companies. (2) Quantitatively, the 15% minimum rate is correctly cited, and no other numbers (dates, dollar amounts) are present, so quantitative accuracy is acceptable. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the comparative exposure based on actual operational footprints. It incorrectly attributes confidence and strategy to Intel that are not in the source, and misrepresents Microsoft’s exposure despite the original stating Microsoft expects minimal impact. (4) Contextual relevance is high because the answer addresses the OECD Pillar Two, compares Intel and Microsoft, and discusses non-US tax strategies. However, the qualitative inaccuracy in entity-specific reasoning and reversal of conclusions severely undermines correctness, warranting a score of 4—partially correct on facts (e.g., 15% rate) but fundamentally wrong in interpretation and comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 494,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 filing notes that it moved **$523 million of surplus international pension assets out of the pension trusts and into the company’s general‑asset pool** (see KO 10‑K p. 43‑44). Because the international plan assets that were transferred included the Level‑3 “limited‑partnership and private‑credit” holdings listed in the fair‑value hierarchy (KO 10‑K p. 99), that move **cuts KO’s direct exposure to limited‑partnership investments** and lowers the volatility of its pension‑plan returns.  \n\nIn contrast, PepsiCo’s 2024 filing states that its pension‑investment strategy **continues to allocate assets to limited‑partnership vehicles**, keeping that exposure intact (PEP 10‑K p. 97‑101).  \n\nThus, KO’s transfer reduces its limited‑partnership exposure, whereas PEP maintains its existing exposure by still holding limited‑partnership interests within its pension portfolios.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $523 million transfer amount and the 2024 timeframe are accurately reported, with no calculation errors. (2) The answer correctly identifies that KO reduced its exposure to limited partnerships by transferring surplus international pension assets—including Level-3 'limited-partnership and private-credit' holdings—into general assets, citing specific pages from KO's 10-K. This aligns with the ground truth that these assets were previously part of pension investments involving alternative vehicles like limited partnerships. (3) The multi-hop reasoning is sound: it contrasts KO’s reduction in limited partnership exposure with PEP’s continued use of such investments, referencing PEP’s 2024 10-K (pp. 97–101) to confirm ongoing allocations to limited partnerships and private credit funds. (4) Entity accuracy is perfect—KO and PEP are correctly identified, along with accurate fiscal year (2024), financial instruments (limited partnerships, private credit), and strategic implications. (5) The semantic meaning fully matches the original answer: both convey that KO strategically reduced alternative investment exposure via asset transfer, while PEP maintains it as part of diversification. Minor wording differences (e.g., 'cuts exposure' vs 'reduced exposure') do not affect factual equivalence. All checklist items are satisfied with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 402,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 was attributed mainly to higher revenues and lower impairment‑related costs, benefits that are possible only while its products retain market‑exclusivity — a protection that comes from patents and regulatory data‑exclusivity (Pfizer’s filing notes that loss of patent or exclusivity “can have a material adverse effect on our revenues” 【page_36】). Eli Lilly relies on the same principle for its biologics: U.S. law grants a 12‑year data‑protection period for innovative biologics, which extends the time a product can generate revenue even after the underlying patents expire (see LLY’s description of 12‑year biologic data protection 【page_9】 and the U.S. section 【page_8】). Thus, the sizable Pfizer earnings increase illustrates how preserving exclusivity through patent and data‑protection mechanisms directly sustains revenue, just as Lilly’s 12‑year biologic data protection is intended to safeguard its post‑patent earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020, matching the ground truth numerically and contextually. It accurately attributes the increase to higher revenues and lower impairment costs, aligning with the original answer’s mention of lower asset impairment charges and higher net gains. The reference to PFE’s acknowledgment of patent risk (via citation to page 36) correctly reflects the company’s disclosure that loss of exclusivity can materially affect revenues. The LLM also correctly states that LLY relies on the 12-year U.S. biologic data protection period, citing appropriate document pages (9 and 8), which matches the ground truth. (2) Quantitatively, all numbers are accurate: $17.3 billion is correctly stated, and no calculations are required beyond that. There are no discrepancies in dollar amounts, years, or percentages. (3) The multi-hop reasoning is sound: the model connects PFE’s financial performance to the broader theme of market exclusivity, then cross-references LLY’s use of regulatory data protection to illustrate how companies protect revenue post-patent expiration. This synthesis across PFE and LLY filings is logically coherent and mirrors the ground truth’s structure. The only minor shortcoming is that the LLM does not explicitly name the BPCIA (Biologics Price Competition and Innovation Act), which is mentioned in the original answer as the legal basis for the 12-year protection. While the mechanism is correctly described, the absence of the statutory name slightly reduces qualitative completeness. (4) Contextual relevance is excellent—the answer directly addresses the relationship between PFE’s financial gain and the role of patent/data protection in sustaining such gains, using LLY as a comparative example. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor omission in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 536,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 results show that Hulu pays ESPN (and the Entertainment linear‑network businesses) fees for the right to carry those channels on Hulu Live – a revenue‑sharing transaction that is recorded as an inter‑segment revenue and eliminated in total company revenue. The $8.6 billion that Comcast received in November 2023 was a one‑time cash purchase of its remaining 33 % equity stake in Hulu; once Disney bought that stake, the future ESPN‑Hulu fees now stay inside Disney’s consolidated books instead of flowing to Comcast. In short, the ESPN‑Hulu fee is an ongoing internal revenue stream that Disney retained after paying Comcast the $8.6 billion to acquire the stake.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $8.6 billion payment by Disney to Comcast in November 2023 for its 33% Hulu stake, the nature of the ESPN-Hulu revenue-sharing arrangement as inter-segment fees eliminated in consolidation, and the implication that post-acquisition, these fees are now internal to Disney. The numbers—$8.6 billion, 33%, and the November 2023 timing—are all factually correct and match the ground truth. (2) Quantitative accuracy is perfect: no calculation errors, and all dollar amounts, percentages, and dates are consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly links ESPN’s content licensing fees to Hulu’s cost structure, explains their elimination in Disney’s consolidated reporting, and ties the $8.6 billion payment to the acquisition of Comcast’s stake, which previously entitled it to a share of Hulu’s value—including from such revenue streams. (4) The only minor shortcoming is that the LLM omits the detail about the $9.2 billion minimum equity value and the $557 million adjustment for prior capital calls, which provides deeper context for the $8.6 billion figure. While not essential to the core logic, this nuance is present in the ground truth and strengthens the valuation argument. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 396,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "- The Coca‑Cola Company uses its financial assumptions only for equity‑based awards – the Black‑Scholes inputs (risk‑free rate, dividend yield, volatility and expected term) that price its stock options – and for post‑retirement health‑care cost trends.  The option‑related expense is charged on a straight‑line basis over the awards’ vesting period (generally four years), while the unvested compensation cost that remains on the balance sheet is amortised over a weighted‑average period of about 1.7 years.  \n\n- Mondelez International applies assumptions to a broader set of instruments: discount‑rate and health‑care cost‑trend assumptions for its U.S. and non‑U.S. pension and post‑retirement benefit plans, and Black‑Scholes inputs for its stock options as well as assumptions for deferred‑stock units and performance‑share units.  Stock‑option expense is also recognised over the vesting term (typically four years), and the unamortised DSU/PSU expense is expected to be recognised over a weighted‑average period of roughly 1.7 years.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies and misrepresents key aspects of the financial assumptions used by KO and MDLZ, affecting the overall correctness. (1) On quantitative accuracy: The mention of a 'weighted-average period of about 1.7 years' for unvested compensation cost is not present in the ground truth and cannot be verified; this specific number is extraneous and potentially misleading. The four-year vesting period is correctly noted for both companies, which aligns with the original answer. (2) Entity and qualitative accuracy: The LLM incorrectly states that KO applies financial assumptions to 'post-retirement health-care cost trends,' which contradicts the ground truth stating that KO only uses assumptions (Black-Scholes) for stock options. This is a major factual error. Conversely, MDLZ’s use of assumptions for pensions and postretirement benefits is accurate and correctly contrasted. However, the LLM overstates MDLZ’s scope by listing multiple instruments without clarifying that the core difference lies in MDLZ applying assumptions to long-term actuarial liabilities, not just more types of equity awards. (3) Reasoning and synthesis: The multi-hop comparison is partially sound—both companies use assumptions for equity awards with four-year vesting—but fails to highlight the central distinction: KO applies assumptions to equity instruments with fixed expense periods, while MDLZ applies them to ongoing actuarial obligations recalculated annually. The LLM instead emphasizes breadth of instruments, missing the conceptual difference in time horizon and recalculation frequency. (4) Contextual relevance is high as the response addresses instruments and time periods, but the incorrect attribution of postretirement assumptions to KO undermines the validity of the comparison. Overall, the answer is partially correct but contains critical factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 525,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "AbbVie’s patent table shows that the U.S. composition‑of‑matter patent for Enbrel (etanercept) expires on 11 Nov 2028, the DNA‑encoding‑fusion‑protein patent on 24 Apr 2029 and the formulation patent on 19 Oct 2037. Because AbbVie’s 10‑K also notes that it routinely pursues patent‑term restoration (up to five additional years) and can rely on regulatory exclusivities (e.g., biologic exclusivity and pediatric extensions), the effective protection window for Enbrel could be pushed well into the early‑to‑mid‑2030s. Consequently, Pfizer’s share of Enbrel’s international sales is likely to remain insulated from biosimilar competition until at least the late‑2020s and possibly through the 2030‑2035 period, preserving its overseas revenue from the product.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the expiration dates provided—11 Nov 2028 (composition-of-matter), 24 Apr 2029 (DNA-encoding-fusion-protein), and 19 Oct 2037 (formulation)—are more precise than the generalized ranges in the original answer but are factually consistent with known patent timelines. The mention of up to five years of patent-term restoration matches the Hatch-Waxman provisions cited in the ground truth. (2) The conclusion that effective protection could extend into the 'early-to-mid-2030s' is a reasonable inference based on potential extensions and aligns with the original answer’s implication of delayed biosimilar competition. (3) The reasoning correctly synthesizes multi-hop elements: it links AbbVie’s patent strategy (term restoration, regulatory exclusivity) to international revenue implications for Pfizer, despite Pfizer not holding the patents directly. It accurately reflects that Pfizer markets Enbrel internationally and thus benefits from delayed biosimilar entry. (4) Minor deduction in quantitative accuracy due to the introduction of specific dates not present in the original (e.g., exact day/month), which, while plausible, go beyond the knowledge graph’s stated information (which only specifies years: 2028, 2037). However, since these dates are widely reported in public filings and do not contradict the ground truth, the deviation is acceptable. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop reasoning across corporate strategy, IP law, and revenue impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 442,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity program explicitly stress‑tests cash‑flow gaps that could arise from large, early policy‑holder withdrawals and then lists “global funding sources including commercial paper and various credit and committed facilities” as one of the key back‑up options it would draw on if those scenarios materialize【page_123】. In contrast, Capital One’s Liquidity Framework relies on a diversified mix of funding—large cash and cash‑equivalent reserves, high‑quality unencumbered securities, committed collateralised credit lines and regular access to secured and unsecured debt markets—so that stress‑testing is used to confirm the adequacy of these reserves rather than to trigger reliance on a single source such as commercial paper【page_94】【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MET's stress testing includes early policyholder withdrawals and its reliance on global funding sources like commercial paper and credit facilities is clearly stated, matching the original answer. COF's diversified funding approach and use of liquidity reserves (cash, unencumbered securities, credit lines) are accurately described, as is the contrast in how each company uses stress testing—MET to anticipate funding needs, COF to validate reserve adequacy. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across MET and COF, comparing their stress testing frameworks and funding strategies, and infers the correct implications for reliance on commercial paper versus diversified reserves. The only minor shortcoming is that the LLM does not explicitly mention AIG’s defined liquidity stress scenarios referenced in the original answer, which provides a slight gap in completeness, though it does not detract significantly from the core comparison. (4) The answer is contextually fully relevant, directly addressing the influence of stress testing design on funding source reliance for both companies. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to high accuracy with a minor omission in contextual linkage to AIG.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 422,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "Both companies now have to disclose the amount of supplier‑finance obligations that are confirmed as valid and provide a roll‑forward of those amounts under ASU 2022‑04. Caterpillar’s 10‑K already presents a full roll‑forward table for 2024 (beginning balance, invoices confirmed, invoices paid and ending balance) (see Cat ‑ 19 Supplier finance programs, page 111‑112). GE adopted the same guidance on 1 Jan 2023, but the roll‑forward requirement only became effective for it in 2024 (GE ‑ Note 15, page 57), so its 2023 filing contains only the ending balance and the first roll‑forward appears in 2024. Consequently, the 2024 disclosures are directly comparable, but GE’s prior‑year supplier‑finance data are not comparable with Caterpillar’s because GE did not provide a roll‑forward before 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, and began applying the roll-forward requirement in 2024; CAT provided a full roll-forward in its 2024 10-K. The dollar amount ($830 million) is not mentioned in the LLM answer, but this is a minor omission as the focus is on comparability rather than specific figures. (2) Quantitative accuracy is strong: dates (Jan 1, 2023 and 2024) are correct, and the explanation of prospective application matches the source. No incorrect numbers or miscalculations. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from both CAT and GE filings, understands the phased implementation of ASU 2022-04 (adoption vs. effective date for roll-forward), and draws the valid conclusion that 2024 disclosures are comparable while prior years are not. (4) The answer is contextually relevant and directly addresses the impact on comparability. The only minor shortcoming is the omission of CAT’s year-end obligation amount ($830 million), which was included in the original answer and adds specificity. However, since the question focuses on comparability rather than exact values, this does not significantly detract from correctness. Wording differences (e.g., 'confirmed obligations' vs. 'supplier-finance obligations') are semantically equivalent. Overall, the LLM demonstrates strong understanding and accurate synthesis across sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 411,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "Mondelez classifies exchange‑traded commodity futures as **Level 1** financial assets, measuring their fair value directly from the quoted prices on the commodity exchanges. PepsiCo, however, does not carry those futures on the balance sheet – they are **cash‑settled each day**, so they are omitted from the fair‑value tables and are not treated as Level 1 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the key distinction between MDLZ and PEP in their treatment of exchange-traded commodity futures. (1) It correctly states that MDLZ classifies these instruments as Level 1 assets valued using quoted prices on exchanges, aligning with the ground truth. It also accurately notes that PEP does not carry these futures on the balance sheet due to daily cash settlement, hence their exclusion from fair value hierarchy tables—this matches the original answer's core claim. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial concepts (Level 1, fair value, cash settlement) are used correctly. (3) The multi-hop reasoning—comparing two companies' accounting treatments of the same instrument type—is sound: the model correctly synthesizes differences in balance sheet recognition and fair value hierarchy reporting. (4) The only minor shortcoming is that the LLM omits explicit mention that PEP's exclusion is *because* of the daily settlement practice directly impacting balance sheet reporting, though this is implied. The original answer provides slightly more context on the cause-effect relationship. Overall, the LLM answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 402,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "- **Comcast (CMCSA)** – The company has two voting classes. Each Class A share carries one vote, while each Class B share carries **15 votes**. Because only one shareholder (Brian Roberts) owns all 9.44 million Class B shares, the B‑shares account for **about 33 ⅓ % of the total voting power** even though they represent a small fraction of the equity outstanding.  \n\n- **Meta Platforms (META)** – Meta also uses a dual‑class structure. Its publicly‑traded Class A shares have **one vote per share**, whereas the insider‑held Class B shares have **10 votes per share**. The Class B shares (held mainly by founders and insiders) give those owners a **controlling majority of the voting power** (well over 50 %).  \n\nThus, both companies give a small block of high‑vote B shares outsized voting influence, but Comcast’s B‑shares carry 15 votes each (≈ 33 % of voting power), while Meta’s B‑shares carry 10 votes each and confer a majority voting control to insiders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both CMCSA and META have dual-class share structures with superior voting rights for Class B shares, and it accurately states that CMCSA's Class B shares carry 15 votes per share and account for approximately 33 1/3% of voting power. However, it introduces significant factual inaccuracies regarding META: it claims META's Class B shares have '10 votes per share' and that insiders hold a 'controlling majority of the voting power (well over 50%)', but the ground truth explicitly states that the 'exact vote ratio per share is not disclosed in the evidence'. This is a critical quantitative error, as the 10-vote figure is unsupported by the provided information. Additionally, while the ground truth mentions META had 343,761,117 Class B shares outstanding as of January 24, 2025, this detail is omitted in the LLM answer. The reasoning structure is sound—comparing the concentration of voting power in insider-held Class B shares across both firms—and the contextual relevance is high, as the response directly addresses the comparative structure. However, the unsupported numerical claim about META’s vote ratio undermines quantitative accuracy, and the omission of the disclosed share count reduces completeness. The claim about Brian Roberts owning all Class B shares at CMCSA, while potentially true, is not in the ground truth and adds unverified detail. Overall, the answer gets the CMCSA facts mostly right but fabricates key details about META’s structure, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 423,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "Both companies use a similar credit‑loss model for CLOs – they estimate future cash‑flows by looking at the underlying assets’ historic performance, current delinquency and default rates, loss‑severity, pre‑payment speeds and the security’s credit‑enhancement and payment‑priority structure.  AIG separates the two effects: credit‑related declines are booked in an allowance for credit losses (under CECL) and any non‑credit‑related decline is recorded as an unrealized loss in OCI, while MetLife records the change in fair value of its CLO holdings (including credit‑related declines) directly in net investment income/earnings and reflects allowance movements in its net realized‑gains‑losses line.  Thus, the evaluation methodology is alike, but AIG’s unrealized losses are kept in OCI, whereas MetLife’s are recognized in earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numeric values, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it does not introduce factual errors in this dimension, warranting a score of 10. Contextual relevance is high (8) because the response addresses the core question about differences in credit loss evaluation and unrealized loss recognition between AIG and MetLife regarding CLOs. However, the qualitative accuracy is low (4) due to significant factual and conceptual inaccuracies in the reasoning. The LLM incorrectly asserts that both companies use a 'similar credit-loss model' involving detailed future cash flow estimation, which contradicts the ground truth: while AIG explicitly uses such modeling under CECL with structural and performance-based assumptions, MetLife does not disclose such detailed modeling and instead emphasizes its passive investment role and limited exposure. The LLM also misrepresents MetLife’s accounting treatment—claiming credit-related declines are recorded in net investment income and allowance movements in net realized gains/losses—which is unsupported by the ground truth. The original answer states MetLife does not appear to disclose the same level of cash flow modeling and focuses on its passive status and maximum loss exposure being limited to carrying amounts, with no mention of allowance movements or recognition in earnings. In contrast, AIG’s treatment is correctly described as separating credit impairments (under CECL, with reversibility) from non-credit fair value changes recorded in OCI. The LLM incorrectly frames the key difference as being solely about where unrealized losses are recognized (OCI vs. earnings), when the original answer highlights deeper differences in methodology (active modeling vs. passive investment stance) and disclosure practices. This represents a failure in multi-hop reasoning: the model synthesizes a plausible but factually incorrect comparison by assuming similarity in methodology and misattributing accounting treatments, rather than identifying the fundamental distinction in approach and transparency. Thus, while the answer is structurally relevant and contains no numeric errors, its core factual claims about MetLife are unsupported, leading to a correctness score of 4—partially correct on AIG, but significantly flawed on MetLife.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 639,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D pushes a larger share of drug‑cost growth onto manufacturers and health‑plan sponsors, creating greater volatility in the amount of rebates and discounts that must be paid. For CVS, that volatility makes it harder to anticipate and detect medical‑cost trends and therefore to price its health‑care benefits accurately. For Bristol‑Myers Squibb, the same redesign adds layers of legal‑interpretation, contract‑mix and timing assumptions to its Gross‑to‑Net (GTN) calculations, so its Medicare Part D rebate accruals become more complex and less predictable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies. The key time frame (2025) is implied in the context of IRA implementation but not explicitly mentioned in the LLM answer; however, since the LLM does not state any incorrect date, this omission does not constitute a factual error. (2) The LLM correctly identifies both entities—CVS and Bristol-Myers Squibb (BMY)—and the correct financial metric (rebate accruals, specifically gross-to-net calculations). (3) The multi-hop reasoning is sound: it connects the IRA’s redesign of Medicare Part D to increased manufacturer liability (affecting BMY’s rebate accrual complexity) and to greater forecasting challenges for health plans like CVS. The explanation of increased volatility, legal interpretation, contract mix, and timing assumptions adds depth consistent with the original answer’s emphasis on uncertainty. (4) While the original answer specifies the reduction in federal reinsurance and cost-shifting starting in 2025, the LLM captures the same causal chain—greater manufacturer and plan sponsor responsibility leading to forecasting difficulty—without contradicting any facts. The LLM uses slightly different framing (e.g., 'legal-interpretation, contract-mix and timing assumptions') not in the original, but these are reasonable inferences that enhance rather than distort the meaning. Only a minor deduction is made on qualitative accuracy for not explicitly referencing the structural change (reduced federal reinsurance), which is a key mechanism in the original. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 490,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase must hold a **Stress Capital Buffer (SCB) of 5.4 %** plus a **G‑SIB surcharge of 3.0 %** (and a zero‑percent CCyB), giving a **total regulatory buffer of about 8.4 %** of risk‑weighted assets.  Because the buffer requirement is the sum of the SCB and the surcharge, any shortfall in the SCB directly reduces the overall buffer and triggers the same distribution restrictions that apply when the whole 8.4 % buffer falls below the required level – limiting dividends, share‑repurchases and other capital returns.  \n\nCharles Schwab, by contrast, is subject only to a **2.5 % Capital Conservation Buffer (CCB)** (and a separate 2.5 % stress buffer for its holding‑company entity), so its **total buffer is roughly 5 %** of risk‑weighted assets.  A breach of the CCB therefore imposes distribution limits, but the buffer is smaller and less complex than JPMorgan’s SCB‑plus‑surcharge package, resulting in comparatively less restrictive capital‑distribution constraints.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in quantitative details. (1) The Stress Capital Buffer (SCB) for JPMorgan Chase is stated as 5.4%, and the G-SIB surcharge as 3.0%, with a total buffer of 8.4%. However, these specific percentages are not present in the ground truth and vary annually based on stress test results; the ground truth does not provide exact figures, emphasizing the dynamic nature of the SCB rather than fixed values. Assigning precise numbers like 5.4% and 3.0% introduces false precision and misrepresents the regulatory framework. (2) The claim that Charles Schwab has a 'separate 2.5% stress buffer for its holding-company entity' is not supported by the original answer, which only mentions the 2.5% Capital Conservation Buffer (CCB) for Charles Schwab Bank. This addition is speculative and unsupported. (3) While the original correctly distinguishes between JPMorgan’s dynamic, stress-linked SCB and Schwab’s static CCB, the LLM incorrectly frames the comparison around specific numerical totals (8.4% vs 5%), which are not in the ground truth and imply a level of detail that wasn't provided. (4) The reasoning about how buffer shortfalls trigger distribution limits is logically sound and aligns with regulatory principles, showing good qualitative understanding of the mechanisms. (5) The answer addresses the core contrast between dynamic vs. static buffers, which is contextually relevant and captures the essence of the question, but the inclusion of unverified numbers undermines factual accuracy. Thus, while the conceptual framework is partially correct, the incorrect quantification and unsupported specifics reduce the correctness score. Quantitative accuracy is low due to fabricated percentages; qualitative accuracy is moderate due to correct logic but flawed inputs; contextual relevance remains high as the response stays focused on the regulatory buffer comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 529,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "- **General Dynamics (GD):** GD states that state‑ and local‑income taxes that are tied to U.S. government contracts are treated as ordinary operating costs and are **not included in its income‑tax provision** (see GD 10‑K p. 66). Thus the tax exposure is reflected only as a cash expense in the income‑statement, not as a deferred‑tax liability or provision.\n\n- **Raytheon Technologies (RTX):** RTX notes that state‑income‑tax amounts are normally part of income‑tax expense, **but the taxes attributable to its Raytheon Intelligence & Space and Raytheon Missiles & Defense segments are generally recoverable through FAR‑governed contract pricing** and are allocated to contracts, then shown as SG&A when paid (RTX 10‑K p. 78). Consequently, RTX’s exposure is recorded in the tax expense line but is largely offset by recoveries allowed under the FAR, reducing the net financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and instead treats them as operating costs, which matches the original answer. It also accurately states that Raytheon Technologies includes these taxes in income tax expense but recovers them through FAR-governed pricing mechanisms, with allocation to contracts and recognition in SG&A when paid. (2) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no calculations were needed, and all references (e.g., page numbers in 10-Ks) are consistent with factual sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their distinct tax treatments, and the role of the FAR in cost allowability and recovery. The only minor shortcoming is that the LLM answer does not explicitly mention RTX's use of performance-based or progress payments, which the original answer includes as part of its pricing mechanisms under FAR. While this detail is present in the ground truth, its omission does not undermine the core financial exposure comparison. (4) The answer is semantically equivalent to the original in substance, uses correct entities (GD, RTX, FAR, correct segments), and directly addresses the key difference in financial exposure—GD expensing taxes upfront vs. RTX recovering them via contract pricing. Contextual relevance is perfect, as all information pertains directly to the question. Thus, a score of 9 is justified due to high accuracy with only a minor omission in elaborating RTX’s full pricing framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 486,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta Platforms’ dual‑class structure gives each Class A share one vote and each Class B share ten votes, and the company announced in February 2024 that the first cash dividend – $0.50 per share – will be paid to holders of **both** classes (the dividend is identical for Class A and Class B)【page_57】.  \n\nAlphabet’s (Google’s) structure is similar in that Class A shares have one vote and Class B shares have ten votes, but Alphabet’s charter requires every Class B share to **automatically convert to Class A** when it is sold or otherwise transferred, so the voting‑power concentration is preserved while the shares become Class A on transfer【page_81】.  \n\nThus, both companies use a 10‑to‑1 voting‑right ratio for their high‑voting shares, but Meta allows its Class B shares to remain outstanding and receive the same dividend, whereas Google’s Class B shares cease to exist as high‑voting shares once they are transferred.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer is mostly correct but contains a key factual error in the voting power of META's Class B shares: it states 10 votes per share, while the ground truth specifies 15 votes per share. This is a significant quantitative inaccuracy. The dividend amount ($0.50 per share) and initiation year (2024) are correct, as is the fact that both classes receive the same dividend. The description of GOOGL’s structure — 10 votes per Class B share and automatic conversion to Class A upon transfer — is accurate. (2) The voting ratio for META is wrong: LLM says 10 votes for Class B vs. correct value of 15. This affects the quantitative accuracy score. The 33 1/3% non-dilutable aggregate voting power for META’s Class B shares, a key detail in the ground truth, is omitted. The dividend and conversion rules are correctly described. (3) The multi-hop reasoning is sound: the model correctly compares two dual-class structures across companies, synthesizing information about voting rights, dividend treatment, and transfer rules. It identifies the core contrast — Meta’s Class B shares remain high-vote and dividend-eligible post-transfer, while GOOGL’s convert to low-vote upon transfer — which shows good qualitative understanding. (4) Despite missing the 15-vote detail and the 33 1/3% non-dilutable control, the answer captures the essential comparison and correctly reports dividend equality and conversion mechanics. Hence, correctness is reduced due to the vote count error, but not severely, as other key facts are right. Contextual relevance is perfect — directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 440,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies calculate their one‑day VaR by first modeling the return distribution of the underlying rates (interest‑rate, currency or commodity) with a parametric Δ‑γ approximation and then applying a 95 % confidence interval under the assumption of normal market conditions. The 95 % confidence level defines the loss amount that is expected to be exceeded only 5 % of the time, so the VaR figure reported by Philip Morris for its interest‑rate‑sensitive derivatives and by Mondelez for its currency‑ and commodity‑sensitive instruments represents the maximum probable one‑day loss at that statistical threshold (see PMI page 77 and Mondelez page 66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements are correct: the 95% confidence interval, the use of parametric delta-gamma approximation, and the one-day VaR methodology for both Philip Morris and Mondelez are accurately represented. The reference to statistical threshold (loss exceeded only 5% of the time) correctly interprets the 95% confidence level. (2) The answer correctly identifies the relevant entities—Philip Morris (PM) and Mondelez (MDLZ)—and their respective risk exposures: interest-rate and currency derivatives for PM, and currency and commodity instruments for MDLZ. (3) The multi-hop reasoning is sound: it synthesizes the shared VaR methodology (parametric delta-gamma under normal conditions) and correctly applies the 95% confidence interval to both firms’ loss estimation. (4) While the LLM omits a minor but notable detail from the original answer—specifically, that Philip Morris excludes anticipated transactions and hedges, and that Mondelez accounts for the non-linear response of options—the core technical and comparative insights are preserved. These omissions slightly reduce completeness but do not undermine the factual or logical integrity of the response. The answer remains semantically equivalent in its central claims and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 375,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO‑related positions contain hybrid instruments (CLNs and CDOs) that embed credit‑linked derivatives; a credit event on the reference assets can cause the note’s principal to be partially or fully unrecoverable and forces the firm to absorb changes in the value of the collateral that backs the SPE (the exposure is limited to the VIE’s net assets but can be sizable, as shown by the $6 billion‑plus of derivative‑related exposure in its VIE tables).  \n\nBank of America’s “structured liabilities” are long‑term debt that is recorded under the fair‑value option and includes embedded interest‑rate or credit‑linked swaps; credit‑spread moves are reflected in the fair‑value adjustments and are largely offset by hedges and ALM controls, so a credit event affects earnings through fair‑value gains or losses rather than a direct loss of principal.  \n\nThus, Morgan Stanley’s CDO‑embedded derivatives expose it to direct principal loss and collateral‑value risk on credit events, whereas Bank of America’s structured‑liability derivatives translate credit‑event risk into fair‑value volatility that is managed and hedged within its market‑making and ALM framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley's CDO-related instruments (e.g., CLNs) contain embedded derivatives where credit events on reference entities can lead to principal loss and collateral-value risk, which matches the original answer's emphasis on risk from credit events and non-repayment. (2) For Bank of America, the LLM accurately describes structured liabilities as long-term debt with embedded derivatives under fair-value option, where credit spread changes flow through earnings via fair-value adjustments and are largely offset by hedges—this reflects the original answer’s point about hedging offsetting gains/losses. (3) The $6 billion-plus derivative-related exposure cited is consistent with known VIE disclosures in Morgan Stanley’s filings and is a valid quantitative addition not in the original but factually supportable; no incorrect numbers are present, so quantitative accuracy is perfect. (4) The reasoning correctly synthesizes multi-hop information: it contrasts Morgan Stanley’s direct credit risk (principal loss) with Bank of America’s managed fair-value volatility, capturing the core comparative risk exposure asked in the question. (5) Minor deduction in qualitative accuracy (9/10) because the original answer emphasizes that both are part of market-making, while the LLM implies this for BofA but not explicitly for Morgan Stanley—though contextually clear. Otherwise, semantic equivalence is strong, and contextual relevance is excellent as it directly addresses risk exposure differences in the context of credit events and market-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 451,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce says that, because it has no material operations in jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the new OECD global‑minimum‑tax rules are **not expected to raise its effective tax rate** in any material way (the filing notes the uncertainty around final rules but concludes the impact will be negligible). Microsoft, by contrast, notes that the Pillar‑Two rules will begin to apply to its worldwide earnings in fiscal 2025 and could **add to its projected tax liability**, although it currently expects no material effect on its 2023‑2024 effective tax rate of roughly 18‑19 % and is simply monitoring the rollout.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of impact on both Salesforce and Microsoft under Pillar Two, but introduces significant factual inaccuracies not present in the ground truth. (1) On quantitative accuracy: The LLM claims Salesforce 'has no material operations in jurisdictions below 15%' and thus expects 'no material increase' in its tax rate — a specific conclusion not found in the original answer. The ground truth states only that Salesforce acknowledges potential material impact and highlights uncertainty, without concluding the impact will be negligible. Similarly, the LLM asserts Microsoft 'could add to its projected tax liability', but the original answer explicitly states Microsoft 'does not currently estimate a material impact' — contradicting the implication of increased liability. The 18–19% effective tax rate range is consistent with the ground truth (19% down to 18% in FY2024), so those numbers are acceptable. (2) The fiscal 2025 application for Microsoft is correctly cited. (3) On reasoning: The LLM performs multi-hop synthesis by comparing two companies’ responses to Pillar Two, which is appropriate. However, it overstates certainty in Salesforce’s case and misrepresents Microsoft’s position by suggesting tax liability will increase despite the 'no material impact' expectation. (4) Contextual relevance is high — the answer addresses the core question about comparative impact and implementation uncertainty. However, the incorrect attribution of 'negligible impact' to Salesforce and 'added liability' to Microsoft undermines factual correctness. The original answer emphasizes uncertainty and lack of material impact for Microsoft; the LLM answer shifts this to a more definitive and inaccurate comparative stance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 476,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement (Exhibit 10.2) names **Citibank, N.A.** as the administrative agent and **JPMorgan Chase Bank, N.A.** as the sole syndication agent, with Citibank and JPMorgan jointly serving as lead arrangers and book‑managers. Honeywell’s amended five‑year credit agreement (Exhibit 10.68) uses **Bank of America, N.A.** as the administrative (and swing‑line) agent and appoints **both JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A.** as co‑syndication agents, rather than a single syndication bank.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, with both as joint lead arrangers and book managers. Honeywell's agreement accurately identifies Bank of America, N.A. as administrative and swing-line agent, and both JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as co-syndication agents. (2) There are no numeric values (e.g., dollar amounts, dates) in the question or answer that require verification—only roles and institutions, which are correctly stated. The LLM omits the specific dates (October 30, 2019, for Boeing; March 20, 2023, for Honeywell), but since the question does not explicitly ask for dates and the focus is on syndication structure and key banking partners, this omission does not materially affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, compares syndication structures (sole vs. co-syndication agents), and identifies key partner banks. (4) The answer is semantically equivalent to the original, with clear, concise phrasing that captures the structural differences and commonalities—especially the shared role of JPMorgan while highlighting differing agent structures and partner institutions. The only minor shortcoming is the lack of agreement dates, which slightly reduces completeness but does not impair the core comparison. Hence, a score of 9 is justified—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 448,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the Counter‑cyclical Capital Buffer (CCyB) is set to 0 % for both firms, the only buffers that count toward the Advanced‑Approaches capital‑buffer requirement are the 2.5 % Capital Conservation Buffer and each firm’s 2.5 % G‑SIB surcharge. Therefore, Bank of America and Morgan Stanley each need a total buffer of 5.0 % of risk‑weighted assets under the Advanced Approaches framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: both banks have a 2.5% G-SIB surcharge and a 2.5% Capital Conservation Buffer, summing to a total CET1 buffer requirement of 5.0% under the Advanced Approaches framework. The absence of the CCyB (i.e., 0%) is correctly interpreted. (2) The calculation is accurate: 2.5% + 2.5% = 5.0%, and this is correctly applied to both Bank of America and Morgan Stanley. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies that without the CCyB, only the G-SIB surcharge and Capital Conservation Buffer contribute to the total buffer. (4) The only minor shortcoming is that the LLM assumes Morgan Stanley's G-SIB surcharge is 2.5% without explicitly noting that this value is not provided in the data (as acknowledged in the original answer). The ground truth qualifies this assumption, while the LLM states it definitively. This does not make the answer factually wrong—since 2.5% is correct for Morgan Stanley in reality and consistent with the context—but slightly reduces qualitative accuracy due to lack of hedging. However, the overall meaning, numerical accuracy, and relevance are fully preserved, making the response semantically equivalent for practical purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 373,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s effective tax rate for fiscal 2022 was **about 15 %**. In Apple’s Greater China segment, operating income was $31.2 billion on net sales of $74.2 billion, giving an **operating‑income margin of roughly 42 %**. Thus Apple’s Greater China margin was far higher than NVIDIA’s overall effective tax rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in NVIDIA's effective tax rate: it reports 'about 15%' instead of the correct 1.9% from the ground truth. This is a major factual inaccuracy. However, the Apple operating income margin is correctly calculated and reported as approximately 42%, with accurate input figures ($31.2 billion vs $31,153 million and $74.2 billion vs $74,200 million — acceptable rounding). (2) Quantitative accuracy is compromised primarily due to the incorrect tax rate. The Apple figures are accurate within reasonable rounding (e.g., $31.2B ≈ $31,153M). The 42% margin is correctly derived (31,153 / 74,200 ≈ 0.4199 or 42%). However, NVIDIA’s actual effective tax rate of 1.9% is drastically different from 15%, which undermines the quantitative integrity. (3) The multi-hop reasoning is structurally sound — the model correctly identifies the need to compare NVIDIA’s tax rate with Apple’s regional margin and performs the margin calculation properly. It also draws a relevant comparison between the two metrics. However, the flawed input for NVIDIA breaks the validity of the conclusion. (4) Contextual relevance is high — the answer addresses both parts of the question and attempts the cross-company, multi-metric comparison. Qualitative accuracy is moderate because the reasoning framework is correct, but the key fact is wrong. Correctness score is 5 due to one major factual error despite otherwise correct structure and partial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 410,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing (BA) states that its Level 2 fair‑value models are built on a wide range of market‑observable data – reported trades, broker quotes, benchmark yields and base spreads, plus more detailed inputs such as swap‑curve rates, cash‑flow analyses, rating‑agency spreads and inter‑dealer broker rates. United Parcel Service (UPS), by contrast, notes that its Level 2 valuations rely principally on observable yield‑curve information, foreign‑currency exchange rates and forward‑price data for its interest‑rate and currency derivatives. Thus, Boeing emphasizes a broader set of observable inputs (including credit spreads and cash‑flow modeling), while UPS concentrates mainly on yield‑curve and FX‑rate inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Boeing (BA) emphasizes inputs like benchmark yields, swap curves, inter-dealer broker rates, credit spreads, and cash-flow analyses for its fixed income Level 2 assets, while UPS relies on yield curves, foreign exchange rates, and forward prices for its derivative instruments. These inputs match the original answer precisely. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct representation of financial concepts—this is handled correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in observable inputs emphasized by two companies (BA and UPS) for Level 2 asset valuation, drawing appropriate contrasts between fixed income instruments (BA) and derivatives (UPS). (4) The LLM slightly generalizes BA’s inputs as a 'broader set' and mentions 'reported trades' and 'broker quotes' not explicitly in the ground truth, but these are reasonable inferences consistent with 'pricing models based on observable inputs' and do not contradict the original. The core distinction—BA focusing on credit/yield for fixed income vs. UPS on FX and interest rates for derivatives—is preserved and accurately conveyed. Minor wording differences do not affect semantic equivalence. Thus, the answer earns a 9/10 for correctness due to slight expansion beyond the source, but remains factually and conceptually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 423,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s capital structure gives Class B shares ten votes for every one vote attached to a Class A share (each Class A share has one vote, each Class B share has ten votes) 【page 81】, while Netflix’s common stock is a single‑class security in which every share carries one vote 【page 61】.  Even though Alphabet spent $62.2 billion repurchasing Class A and Class C shares in 2023 【page 81】, the voting‑power imbalance between its two common‑stock classes remains, whereas Netflix’s shareholders all retain equal voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $62.2 billion share repurchase amount in 2023 is accurately cited, and the voting rights (1 vote for Class A, 10 votes for Class B at GOOGL, 1 vote per share at NFLX) match the original answer. Format variations (e.g., $62.2 billion) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: GOOGL (Alphabet) and NFLX (Netflix), their respective stock classes, and the relevant year (2023). (3) The reasoning is sound: it contrasts the dual-class voting structure at GOOGL with the single-class, uniform voting at NFLX, and acknowledges that despite the large repurchase program targeting Class A and C shares, the voting disparity persists. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the *mechanism* by which repurchases preserve Class B control—specifically, that reducing the number of Class A shares limits the dilution effect when Class B shares are transferred and converted, thus indirectly reinforcing Class B's relative voting power. This nuance is present in the original answer but only implied in the LLM version. However, the core facts, comparisons, and implications are correctly conveyed, and the omission does not undermine the overall correctness. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 413,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN reports its U.S. Treasury and agency bonds in the Level 2 tier of the fair‑value hierarchy, meaning they are valued using observable inputs other than quoted market prices (e.g., yield curves) rather than the quoted prices that define Level 1 assets. Because most companies—including the UPS filing, which classifies U.S. government debt securities as Level 1 because they trade in active markets 【page 80】, and AVGO’s disclosures that follow the same practice—use Level 1 pricing, ACN’s Level 2 treatment makes a direct comparison of the composition, valuation methodology and associated risk of the two firms’ investment portfolios less meaningful.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the exact dollar amount ($9,765 million) from ACN is not explicitly mentioned in the LLM response, this is the only minor omission. All other entities—ACN, AVGO, UPS—are correctly identified, and the classification levels (Level 1 vs Level 2) are accurately described. (2) The reasoning correctly synthesizes multi-hop information: it references UPS’s classification of U.S. government debt as Level 1 due to active markets, notes AVGO’s use of Level 1 for such securities based on quoted prices, and contrasts this with ACN’s Level 2 classification. (3) The qualitative analysis is sound: the LLM correctly infers that using Level 2 for these securities reduces comparability in valuation methodology and portfolio risk assessment, which matches the original answer’s conclusion about reduced transparency and comparability. (4) The wording differs slightly but maintains semantic equivalence—e.g., 'valued using observable inputs other than quoted market prices' correctly describes Level 2, and the reference to yield curves as an example is reasonable. The only reason for not scoring a 10 is the missing explicit mention of the $9,765 million figure, which is a factual detail present in the ground truth and expected in a fully complete response. However, since the focus is on classification impact rather than the amount itself, the omission does not undermine the core reasoning. Contextual relevance is perfect—the response directly addresses the comparability issue arising from differing classification practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 442,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive said it began applying the supplier‑finance disclosure requirements of ASU 2022‑04 on **January 1 2023** (and started providing the roll‑forward schedule on **January 1 2024**)【page_57】【page_84】.  \n\nTarget’s 2024 Form 10‑K includes the required table and shows a **confirmed vendor‑obligation balance of $3.398 billion at fiscal year‑end 2024 (and $3.666 billion at fiscal year‑end 2025)**【page_54】.  \n\nThe Colgate excerpt does not disclose a comparable year‑end “confirmed amount outstanding,” so while Colgate adopted the ASU earlier, Target’s filing provides the specific outstanding amount ($3.4 billion) that Colgate’s disclosed material does not show.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, with the roll-forward disclosure effective January 1, 2024, it incorrectly claims that Target disclosed a confirmed vendor-obligation balance of $3.398 billion at fiscal year-end 2024 and $3.666 billion at fiscal year-end 2025. The original answer (ground truth) explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt' for Target, meaning the LLM fabricated specific dollar figures not present in the source material. This is a critical error in quantitative accuracy. (2) The numbers attributed to Target are entirely unsupported by the ground truth and contradict it directly. There is no mention of a $3.398B or $3.666B obligation, nor any indication of a fiscal year-end 2025 figure. These values appear to be either hallucinated or drawn from an external source not in the context. (3) The reasoning is partially sound in structure—comparing adoption timelines and disclosure completeness—but fails on multi-hop synthesis because it misrepresents Target’s disclosures. The conclusion that 'Target’s filing provides the specific outstanding amount... that Colgate’s disclosed material does not show' would be valid *if* the number were accurate, but since it is not, the comparison is invalid. (4) The contextual relevance is high because the answer attempts the right comparison and cites relevant disclosure practices. However, the correctness score is low due to the severe factual inaccuracy in financial figures, which undermines trust in the entire response. Minor note: 'fiscal year-end 2025' is also problematic as it refers to a future date relative to the ASU implementation timeline, further suggesting data confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 496,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s 2024 filing notes that its reliance on a few strategic‑technology partners – most notably Microsoft Azure for the Aladdin platform and other cloud‑based services – creates “operational, execution, technology and regulatory‑oversight risks” that could trigger service outages, data‑security incidents or regulatory scrutiny and therefore damage its reputation (see Item 1A, Key technology partnerships – pages 28‑29).  \n\nMastercard, by contrast, does not depend on a single external cloud provider; instead it manages reputational exposure through a formal operational‑resilience program that integrates privacy, data‑protection, AI‑governance and information‑security controls, continuous monitoring and board‑level oversight of those controls (see Item 1A, Privacy, Data Protection, AI and Information Security and Operational Resilience – pages 24‑27).  \n\nThus, BlackRock’s risk stems from third‑party technology dependence, whereas Mastercard mitigates similar reputational risk by embedding resilience and security controls within its own governance and risk‑management framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as introducing operational, execution, technology, and regulatory risks that could lead to reputational harm. Mastercard’s approach is correctly characterized as internally focused, with a formal operational resilience program integrated into its governance framework to mitigate reputational risk. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and precise referencing of risk categories and controls supports a perfect score here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), identifies the nature of their operational risk exposure (third-party vs. internal resilience), and draws a valid comparative conclusion about reputational risk management strategies. (4) The LLM answer conveys the same core insight as the original: both firms recognize reputational consequences from operational failures, but differ in risk origin and mitigation—BlackRock’s vulnerability stems from external dependencies, while Mastercard proactively embeds resilience into its governance. The only minor shortcoming is that the LLM does not explicitly mention that Mastercard names 'Reputational Impact' as a formal risk factor in its 10-K, which is a small but notable detail present in the ground truth. Otherwise, the answer is semantically equivalent, contextually precise, and well-supported by accurate reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 472,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was a major BMS customer in 2021 – it was the third‑largest U.S. pharmaceutical wholesaler and accounted for about 20 % of Bristol‑Myers Squibb’s gross product‑sales revenue that year. At CVS, Cardinal is a 50 % owner of Red Oak Sourcing, LLC, the joint generic‑drug sourcing venture through which CVS and Cardinal pool their sourcing and supply‑chain expertise to negotiate and secure generic pharmaceutical contracts for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% revenue figure for Cardinal Health's share of BMY's (Bristol-Myers Squibb's) 2021 revenue is correct, and the 50% ownership in Red Oak Sourcing, LLC is accurately stated. (2) The answer correctly identifies Cardinal Health as a major customer and explains its role in the CVS joint venture, Red Oak Sourcing, LLC, including the pooling of sourcing expertise and joint negotiation of generic drug contracts. (3) The multi-hop reasoning is sound: it connects Cardinal’s role as a BMY customer with its strategic partnership in CVS’s supply chain via Red Oak. (4) Minor omission: the original answer notes that Red Oak does not involve inventory ownership, which adds nuance to the operational model—this detail is missing in the LLM response, slightly reducing completeness. Also, the LLM refers to 'BMS' instead of 'BMY' (though BMY is Bristol-Myers Squibb, and BMS is a common shorthand), which is acceptable but slightly less precise. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only minor room for improvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 338,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B shares do not trade on any public market and can vote only on a narrow set of matters (such as certain merger‑type votes). When they are allowed to vote, each Class B share is counted multiple times – the number of votes per share is multiplied by the conversion rate that would apply if the share were converted into Class A stock (Meta’s charter uses a 10‑to‑1 multiplier). In contrast, Netflix’s common stock carries a single vote per share on every shareholder matter, giving each holder the same voting weight on all issues. Thus, Meta’s Class B holders have a potentially higher per‑share vote‑count but only in limited voting scenarios, whereas Netflix shareholders have one vote per share on all matters. [Meta 10‑K, p. 57; Netflix 10‑K, p. 59]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Meta's Class B shares have restricted voting rights applicable only in specific scenarios (e.g., mergers), and that each share carries multiple votes based on the conversion rate—specifically citing a 10-to-1 multiplier, which aligns with known Meta corporate structure and is consistent with the type of conversion mechanism referenced in the ground truth. The comparison to Netflix’s one vote per share is factually correct. (2) There are no numerical inaccuracies; the 10-to-1 multiplier is a well-documented feature of Meta’s Class B shares and matches the concept of a 'conversion rate' in the original answer. While the ground truth does not specify the exact multiplier, the LLM’s inclusion of '10-to-1' is a precise and correct detail drawn from actual filings, enhancing rather than distorting accuracy. (3) The multi-hop reasoning—comparing voting rights across two companies (Meta and Netflix) with different share structures—is sound: the model correctly synthesizes that Meta Class B has conditional but amplified voting power, while Netflix common stock has unconditional, proportional voting rights. (4) Minor difference: the ground truth lists additional specific scenarios (e.g., exiting core payments business, charter amendments), which the LLM omits, instead generalizing to 'narrow set of matters' and 'merger-type votes'. This is a slight incompleteness but does not undermine the correctness of the core comparison. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 450,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter says a Class B share “may be converted at any time … and automatically converts upon sale or transfer to Class A” (GOOGL 10‑K p. 81), so any transfer instantly eliminates the ten‑vote share and adds a one‑vote share to the market. By contrast, Meta’s certificate of incorporation requires a separate majority vote of the Class B holders for any transaction that would change control of the company (Meta 10‑K p. 48‑49), preserving the concentrated voting power of the ten‑vote stock even when shares are transferred. Mastercard’s dual‑class design adds another layer of protection: Class B shares are convertible one‑for‑one into Class A, but the conversion agreement obligates the holder to sell or otherwise transfer the resulting Class A shares (Mastercard 10‑K p. 99‑100), effectively forcing a post‑conversion divestiture that limits the ability of converted shares to accrue voting influence and is a key factor when evaluating the strength of dual‑class governance frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires separate Class B approval for change-of-control transactions; Mastercard mandates post-conversion sale or transfer of Class A shares. The descriptions of each company’s dual-class mechanisms are factually sound and supported by cited 10-K page references. (2) There are no numeric values (e.g., percentages, dollar amounts, vote ratios) in dispute—though the ground truth mentions the 35% threshold for META’s Class B voting power, the LLM omits this specific number. This is a minor omission but does not invalidate the correctness of the statement, as the core governance mechanism (separate Class B approval for change-of-control) is accurately described. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes governance differences across GOOGL, META, and Mastercard, contrasting preservation vs. dilution of voting control. It accurately identifies that Mastercard’s post-conversion divestiture requirement limits long-term voting influence, which is central to evaluating dual-class frameworks. (4) Semantic equivalence is high—the LLM conveys the same analytical conclusion as the ground truth: META entrenches control, while GOOGL and Mastercard implement mechanisms that erode concentrated voting power over time. The only reason for not scoring a 10 is the omission of the 35% threshold in META’s provision, which is a minor but notable detail in the original answer. Otherwise, the response is complete, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 451,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s filings note that its products can qualify for an additional six‑month pediatric exclusivity under the FDAMA, giving the company a modest, predictable extension of market protection for eligible drugs. In contrast, Amgen’s 10‑K highlights that recent regulatory changes – such as the removal of a mandatory 10‑year data‑exclusivity provision and ongoing discussions about the scope of the 12‑year biologics data‑protection period – create uncertainty and heighten the risk that biosimilar competitors could enter the market earlier than previously expected. Thus, Merck enjoys a defined pediatric‑exclusivity upside, while Amgen confronts potential erosion of its biologics exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Merck's six-month pediatric exclusivity under FDAMA is accurately stated, and Amgen's exposure to changes in biologics data exclusivity (12-year protection period and policy uncertainty) is correctly described. There are no numerical or factual inaccuracies. (2) The answer correctly identifies both companies (MRK and AMGN), relevant regulatory frameworks (FDAMA, biologics data protection), and product implications (e.g., market entry of biosimilars). (3) The multi-hop reasoning is sound: it contrasts Merck’s predictable, proactive IP strategy leveraging pediatric exclusivity with Amgen’s vulnerability to regulatory shifts in biologics exclusivity, particularly around data protection duration and 'umbrella exclusivity'—a nuance implied in the original answer through 'scope' discussions. (4) While the LLM does not explicitly mention EPOGEN or the 'umbrella exclusivity' term, it captures the essence of Amgen’s risk due to policy uncertainty, and Merck’s strategic benefit from pediatric exclusivity. The omission is minor and does not detract from the core factual and comparative accuracy. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slightly less specificity on Amgen’s product example and umbrella exclusivity mechanism, but overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 398,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s capital structure creates a strong voting‑power split: every Class B share carries 15 votes and, because only one shareholder (Brian L. Roberts) owns all of the 7 million B shares, the B class accounts for roughly one‑third of the total voting power (33 ⅓ %) while the publicly‑traded Class A shares hold the remaining 66 ⅔ % (each Class A share has one vote).  \n\nVisa’s structure is the opposite – the non‑public Class B‑1 (and the newer Class C) shares have essentially no voting rights except on a narrow set of matters (e.g., a merger, exit from the core payments business or charter amendments), and when they do vote they are counted together with Class A shareholders at the applicable conversion rate; thus voting control is concentrated in the publicly‑traded Class A stock, with the B and C classes providing only limited, conditional influence.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative aspects of MA's dual-class structure: Class B shares have 15 votes per share, are held entirely by Brian L. Roberts, and represent 33⅓% of voting power, with Class A holding 66⅔%. These numbers match the ground truth exactly, earning high marks for quantitative accuracy. However, the description of V's (Visa's) structure contains significant factual inaccuracies. The ground truth states that V's Class B shares are subject to transferability and convertibility conditions tied to U.S. covered litigation, with conversion rates adjustable based on follow-on offerings or litigation outcomes. It also mentions a Class C with no transfer restrictions and an exchange program that partially releases restrictions on Class B shares. In contrast, the LLM incorrectly claims that Visa's Class B and C shares have 'essentially no voting rights' and that voting control is concentrated in Class A. This misrepresents the mechanism: the issue with Visa is not about voting rights per se but about transfer restrictions and conditional conversion, not disenfranchisement. The LLM confuses control concentration via voting rights (MA) with control via transfer and conversion mechanics (V), failing to accurately contrast the two structures. While it captures that MA has concentrated voting power in Class B, it mischaracterizes Visa’s structure entirely, missing the litigation-linked conversion and exchange program. Thus, while the MA portion is accurate and well-articulated, the V analysis is fundamentally flawed in reasoning and entity understanding, leading to a partial correctness score. The answer is contextually relevant and attempts the comparison, but the qualitative inaccuracy in describing Visa’s mechanism undermines the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 490,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX states that its FAR‑regulated U.S. government fixed‑price contracts “generally result in revenue recognized in excess of billings which we present as **Contract assets** on the Consolidated Balance Sheet” (RTX 10‑K p. 79). Because these contracts are governed by the FAR and Cost Accounting Standards, RTX is exposed to audit‑related adjustments that could turn those contract‑asset balances into liabilities.  \n\nLockheed Martin’s filing likewise notes that its U.S. government contracts are subject to the FAR and CAS and therefore to government audits, but it does **not disclose a comparable contract‑asset amount** (the pages provided contain only the risk‑factor discussion and no specific contract‑asset figure), indicating that its exposure to “revenue‑in‑excess‑of‑billings” risk is either smaller or not quantified in the same way as RTX’s.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth, with strong quantitative and contextual precision. (1) It correctly identifies RTX's revenue recognized in excess of billings as Contract assets, citing the correct 10-K page (p. 79), and accurately links this to FAR and CAS regulations. It also correctly notes that LMT faces audit risks under the same regulatory framework. (2) There are no numerical inaccuracies—though no specific dollar amounts are mentioned, the absence is justified because the LLM correctly states that LMT’s filing did not disclose a comparable contract-asset figure in the provided pages, which is consistent with the limitations of the input. (3) The multi-hop reasoning is sound: it compares RTX’s balance sheet exposure (contract assets) with LMT’s lack of disclosed equivalent, inferring a difference in risk disclosure or magnitude. However, it stops short of fully articulating the qualitative distinction emphasized in the ground truth—namely, that RTX’s risk is balance sheet-driven while LMT’s is compliance/enforcement-driven (e.g., debarment, penalties). This nuance is partially captured but not explicitly synthesized. (4) The answer remains highly relevant, directly addressing the comparison of financial exposure and audit-related liabilities. While it could deepen the contrast in risk profiles, it does not misstate facts and correctly bases its claims on disclosed data availability. Hence, a score of 8 is warranted for high accuracy with minor qualitative incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 422,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "- Meta Platforms uses a dual‑class structure in which each Class A share carries **one vote** and each Class B share carries **ten votes** (the Class B shares are not publicly traded) 【page_57】.  \n\n- Alphabet (Google) also has a dual‑class structure: each Class A share gets **one vote**, each Class B share gets **ten votes**, and its Class C capital stock has **no voting rights** 【page_81】.  \n\nThus, both companies give the same 10‑to‑1 voting weight to their Class B shares, but Alphabet adds a non‑voting Class C series, whereas Meta’s voting power is split only between the 1‑vote Class A and the 10‑vote Class B shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the voting rights per share for Meta (incorrectly states 10 votes for Class B instead of 15, and 1 vote for Class A instead of the correct structure where Class A holds 66 2/3% and Class B 33 1/3% of total voting power despite fewer shares). For GOOGL, it correctly identifies 1 vote for Class A and 10 for Class B, but fails to note that the original answer emphasizes the lack of disclosed percentage split, which the LLM omits. (2) Quantitatively, the voting ratios are wrong for Meta: ground truth specifies 15 votes per Class B share, not 10. This error undermines the comparison. The claim that Meta’s Class A has 1 vote is misleading because while technically true per share, the overall voting power distribution (66 2/3% vs 33 1/3%) is critical context that the LLM does not convey. (3) The reasoning is partially sound in recognizing both companies use dual-class structures and comparing per-share voting weights, but it fails the multi-hop synthesis by not contrasting META’s higher per-share voting premium (15:1) versus GOOGL’s (10:1), and incorrectly equates them as 'same 10-to-1'. It also introduces Class C at GOOGL correctly but doesn't acknowledge that META does not have a non-voting class, which affects voting concentration interpretation. (4) Contextual relevance is high as it addresses the core question about voting power distribution and compares both firms’ structures, but due to key numerical errors and incomplete synthesis—especially misrepresenting META’s voting structure—the correctness and quantitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 443,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "Bristol‑Myers’ biologics such as Opdivo are shielded by a 12‑year U.S. regulatory‑data‑protection period, but that barrier disappears once the data exclusivity expires, at which point “a generic manufacturer may file an aNDA and allege that one or more of the patents … is invalid … a Paragraph IV certification” (JNJ 10‑K p. 8). When the data‑protection window closes, the likelihood of Paragraph IV filings rises sharply, as the company itself notes that “the increased likelihood of generic and biosimilar challenges … has increased the risk of loss of innovators’ market exclusivity” (JNJ 10‑K p. 9). Because Stelara faces a similar patent‑expiration horizon, the same post‑protection environment that will trigger more Paragraph IV ANDA challenges to Opdivo creates a clear precedent that J&J can expect a surge of Paragraph IV litigation on Stelara, expanding its exposure to patent‑infringement suits and potential market‑share loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core multi-hop reasoning: BMY's Opdivo exclusivity expiration sets a precedent for Paragraph IV ANDA challenges, which will likely affect JNJ's Stelara as its protections lapse. The answer correctly identifies the link between data exclusivity expiration and increased Paragraph IV filings, and cites JNJ's 10-K to support the heightened litigation risk, aligning with the ground truth's emphasis on patent litigation as a material risk. However, there are key quantitative and factual inaccuracies: (1) The claim that BMY’s biologics have a '12-year U.S. regulatory-data-protection period' is not supported in the original answer or typical for small-molecule drugs like Opdivo—Opdivo is an oncology biologic, but the original answer references a five-year data protection period, consistent with New Chemical Entity (NCE) exclusivity, not the 12-year Biologics Price Competition and Innovation Act (BPCIA) exclusivity. The LLM incorrectly generalizes biologic exclusivity without confirming the drug type or regulatory pathway. (2) The original answer references AbbVie’s experience as a litigation example, not JNJ’s own Paragraph IV filings, but the LLM attributes the Paragraph IV mechanism explanation to JNJ’s 10-K, which may misrepresent sourcing. (3) The original answer notes Stelara generated over $8 billion in 2022—this specific financial figure is omitted in the LLM response, a notable completeness gap. Despite these issues, the reasoning is logically sound: it connects the expiration of exclusivity to increased generic challenges and anticipates similar litigation exposure for JNJ. The answer is contextually relevant and synthesizes across entities (BMY, JNJ) and regulatory concepts correctly, but with moderate factual imprecision on exclusivity duration and missing key financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 495,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s charter ties change‑of‑control authority to its Class B shares: any merger or similar transaction must be approved by a majority of the Class B voting bloc until the Class B stock falls below 35 % of the company’s total voting power (Meta 10‑K p. 50; see also p. 49).  By contrast, Alphabet’s structure gives each Class B share ten votes, but those shares may be converted at the holder’s option and automatically convert to one‑vote Class A shares on any sale or transfer, so the high‑vote control dissipates when the shares change hands rather than being tied to a voting‑power threshold (Alphabet 10‑K p. 81).  Thus Meta preserves founder control through a voting‑power trigger, whereas Google’s system relies on the conversion feature to limit the persistence of super‑voting power.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: META's requirement of Class B majority approval for change-of-control transactions until Class B voting power drops below 35% is accurately stated, with correct citation to the 10-K (p. 50). GOOGL's Class B shares carrying 10 votes and automatic conversion to Class A upon transfer is also correctly described, with accurate reference to Alphabet’s 10-K (p. 81). (2) Quantitative accuracy is perfect: the 35% threshold and 10-vote weight are correctly reported, with no calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes governance mechanisms across two companies (META and GOOGL), compares their structural differences (threshold-based persistence vs. transfer-triggered conversion), and correctly infers that Meta’s system provides more enduring control due to non-automatic dilution. (4) The answer is contextually relevant, directly addressing the comparative structure of dual-class shares as asked. Wording differs slightly from the original answer but conveys the same meaning with equivalent precision and nuance. No omissions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 337,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS handled its 2023 shift to SOFR “by hand” – it moved the affected debt and contracts to the new rate but **did not use any of the practical‑expedient provisions of ASU 2020‑04**. In contrast, 3M’s filing notes that the ASU 2020‑04 reforms **provide optional relief that can be used through Dec. 31 2024** and, given the language describing the optional expedients and the fact that 3M’s hedging program is heavily based on interest‑rate swaps, it is reasonable to infer that 3M **relied on those optional expedients to adjust its hedging relationships** rather than treating the transition entirely on a full‑GAAP basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not apply the practical expedients under ASU 2020-04 during its 2023 SOFR transition, which matches the original answer. It also correctly notes that MMM could use the optional relief through December 31, 2024, due to ASU 2022-06 extending the sunset date—this is factually correct and contextually relevant. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the original answer mentions $152 million reclassified from AOCI, the LLM answer does not include this figure. However, its omission does not detract from correctness because the LLM still supports its inference about MMM’s likely use of expedients through qualitative reasoning (e.g., reference to 3M’s interest-rate swap hedging program). The absence of the specific dollar amount is a minor completeness gap but not a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the availability of ASU 2020-04 relief, its extension via ASU 2022-06, and MMM’s active hedging program to infer that MMM likely used the expedients—this is a reasonable and logical conclusion supported by the evidence. (4) The wording differs slightly (e.g., 'by hand', 'full-GAAP basis'), but these are semantically acceptable paraphrasings. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning with only a minor omission of a supporting quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 421,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Mondelez notes that exchange‑traded commodity futures are cash‑settled each day, so the contracts are not carried as assets or liabilities on the balance sheet and therefore are omitted from its fair‑value tables. Nevertheless, their fair value is measured at Level 1 using the quoted market prices on the commodity exchanges—exactly the same hierarchy classification that PepsiCo applies to its own exchange‑traded commodity futures. Thus, the daily cash‑settlement causes Mondelez to exclude the contracts from the balance‑sheet presentation, but it does not change the Level 1 valuation methodology, which mirrors PepsiCo’s approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that exchange-traded commodity futures are daily cash-settled, which leads to their exclusion from the balance sheet and fair value tables—consistent with both MDLZ and PEP disclosures. The use of Level 1 valuation based on quoted market prices is accurately attributed to both companies. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all financial concepts (e.g., mark-to-market, cash settlement, Level 1 classification) are correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly links PEP’s exposure and disclosure practices to MDLZ’s valuation methodology, recognizing that similar instruments imply consistent fair value hierarchy treatment. It accurately infers that daily cash settlement affects balance sheet presentation but not the Level 1 classification. (4) The only minor limitation is that the LLM slightly reframes the causality—saying the settlement causes exclusion from the balance sheet—whereas the original emphasizes that the settlement mechanism supports reliance on market prices. This nuance does not undermine correctness. Overall, the answer is complete, logically structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 375,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s capital structure gives each Class A share one vote and each Class B share fifteen votes; the single Class B share owned by Brian Roberts accounts for roughly one‑third (33 ⅓ %) of the company’s total voting power, with the remaining two‑thirds held by the much larger base of Class A shareholders. Google’s structure also uses a dual‑class system, but its Class B shares carry ten votes each and are held in sufficient quantity by insiders to provide a clear majority of the voting power (well over 50 %). Thus, while both companies grant extra votes to a small class of shares, Comcast’s high‑vote class controls only about a third of the votes, whereas Google’s high‑vote class controls the controlling majority of the votes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy in the comparison of voting power concentration. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares have 15 votes per share and account for 33⅓% of voting power, with Class A holding 66⅔%, which matches the ground truth. It also correctly notes that GOOGL's Class B shares carry 10 votes per share versus 1 for Class A, and that Class C has no voting rights (though this last point is omitted in the LLM answer, it's implied by the dual-class framing). (2) However, the LLM incorrectly claims that Google’s high-vote Class B shares are held 'in sufficient quantity by insiders to provide a clear majority of the voting power (well over 50%)' — this is not supported by the original answer, which does not specify the actual distribution of voting power between classes at GOOGL, only the per-share vote weight. The ground truth makes no claim about the percentage of total voting power held by GOOGL's Class B shareholders, so asserting 'well over 50%' introduces unsupported information. (3) The reasoning is otherwise sound: it correctly identifies the multi-hop nature of the question, comparing both per-share voting rights and overall control implications. The conclusion that CMCSA concentrates less voting power in its high-vote class than GOOGL does is reasonable, but the basis for the GOOGL claim is weakened by the lack of specific voting power distribution data in the original. (4) Despite this, the answer remains contextually relevant and captures the core contrast: CMCSA’s Class B has higher per-share voting power (15x) but less total control (33⅓%), while GOOGL’s Class B has lower per-share weight (10x) but is structured to maintain control — though the extent of that control is overstated. Hence, correctness is reduced due to the unsupported 'well over 50%' claim, but the answer remains largely accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 521,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America explicitly quantifies the result of its market‑making activity that involves embedded derivatives – the “Gains (Losses) Related to Assets and Liabilities Accounted for Under the Fair Value Option” table shows a **$4.2 billion net gain in 2024** (and $4.8 billion in 2023) from those activities.  \n\nMorgan Stanley’s filing, by contrast, only describes its participation in credit‑linked notes (CLNs) as a **qualitative exposure to credit‑event risk** – the notes explain that the firm “transfers assets … enters into a derivative … and sells the securities … Upon the occurrence of a credit event … the SPE will deliver securities collateral … exposing the Firm to changes in the collateral’s value.” No dollar‑amount gain or loss is disclosed for the CLN‑related embedded‑derivative component.  \n\nThus, while BAC reports a measurable multi‑billion‑dollar gain from embedded‑derivative market‑making, MS’s CLN activities are presented only as a risk exposure without a specific gain/loss figure, even though both involve similar credit‑event risk in structured notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims BAC had a '$4.2 billion net gain in 2024' and '$4.8 billion in 2023' from market-making activities involving embedded derivatives. However, the original answer (ground truth) does not provide any specific dollar amounts or years for BAC's gains — it only states that gains (losses) are typically offset by hedging activities. There is no mention of 2023 or 2024 figures in the ground truth, making these numbers fabricated or hallucinated. (2) The LLM incorrectly implies that BAC explicitly quantifies these gains in a table titled 'Gains (Losses) Related to Assets and Liabilities Accounted for Under the Fair Value Option' — this level of detail is not present in the original answer and cannot be verified from the provided truth. (3) Regarding MS, the LLM accurately captures the qualitative nature of the exposure — that CLNs are structured as hybrid instruments where MS faces credit event risk — and correctly notes the absence of disclosed dollar amounts for gains/losses, aligning with the ground truth. (4) The multi-hop reasoning is partially sound: the model identifies that both firms have exposure to credit-linked derivatives via structured notes and contrasts BAC’s hedging approach with MS’s risk retention. However, the erroneous insertion of specific financial figures for BAC severely compromises factual correctness. While the overall structure and intent of the comparison are relevant and contextually appropriate, the hallucinated numbers result in a low quantitative accuracy and reduced overall correctness. Semantic equivalence fails due to the introduction of unsupported data. The answer would have scored higher if it had stuck to the descriptive, non-quantitative comparison provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 503,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce flags the OECD’s Pillar Two model rules – a new 15 % global minimum tax – as a key global‑tax development. Intel notes that a large share of its earnings is taxed outside the United States and that it is still assessing how the Pillar Two rules will apply in those jurisdictions. If the rules are adopted, the minimum‑tax floor would likely lift the tax rate on Intel’s low‑tax foreign income, pushing its overall effective tax rate higher than it is today.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: the 15% global minimum tax under OECD's Pillar Two is accurately stated, and there are no numerical errors. (2) The LLM correctly identifies Salesforce (CRM) as flagging Pillar Two as a material tax development and Intel (INTC) as having significant non-US income subject to evaluation under the new rules. (3) The multi-hop reasoning is sound: it connects Salesforce's identification of Pillar Two to Intel's exposure via its international income and correctly infers that the 15% floor would likely increase Intel's effective tax rate by limiting benefits from low-tax jurisdictions. (4) Minor omission: the LLM does not explicitly mention that EU Member States and other jurisdictions have begun enacting the rules starting in 2024, which adds context to the timing and implementation urgency. However, this does not undermine the correctness of the conclusion. Wording differs but semantic meaning is equivalent. All entities (Salesforce, Intel, OECD, Pillar Two, effective tax rate) are correctly identified and logically linked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 330,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "Raytheon (RTX) accounts for most of its FAR‑regulated U.S. government fixed‑price work on a percentage‑of‑completion basis, so revenue is recorded as the work is performed while the government typically withholds a portion of the price until final delivery. This creates contract‑asset balances—revenue recognized ahead of billings—and makes cash receipts lag the reported earnings, reducing short‑term cash‑flow predictability. Boeing, by contrast, notes that its U.S. government contracts can be terminated for convenience, but the contracts require the government to pay for all work already completed (and allowable termination costs), so cash inflows are more closely tied to actual performance and, although future cash‑flow exposure exists, the timing of cash receipt is less mismatched than RTX’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and captures the core contrast between RTX's revenue recognition timing and Boeing's (BA) termination risk under FAR-regulated U.S. government contracts. It correctly states that RTX recognizes revenue on a percentage-of-completion basis, leading to revenue recognized in advance of billings and the creation of contract assets, which causes cash receipts to lag earnings—this aligns with the ground truth. The mention of cash flow timing mismatches reducing short-term predictability is accurate and relevant. On the Boeing side, the answer correctly identifies that contracts can be terminated for convenience and that the government pays for work completed and allowable termination costs, which limits but does not eliminate financial risk. However, the LLM answer omits a critical part of the ground truth: the possibility of termination for default, which could result in liabilities for re-procurement costs—a key factor increasing Boeing’s cash flow unpredictability. This omission weakens the qualitative accuracy and completeness of the multi-hop comparison. While the LLM implies Boeing has less cash receipt mismatch than RTX, it understates the severity of termination risk by not acknowledging that termination for default could lead to revenue reversals or outflows, not just halted inflows. Quantitatively, no specific numbers (e.g., 80–90% payment coverage via PBPs) are included, but the absence of incorrect figures earns a high quantitative score. Contextually, the response is highly relevant and well-structured. The reasoning is sound but incomplete in synthesizing the full risk profile for Boeing, which affects the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 467,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 2024 10‑K shows that the current portion of its long‑term debt includes floating‑rate notes with put provisions totaling **$119 million that are due in 2025** (see page 69). GE’s 2024 10‑K notes that **$315 million of fixed‑ and floating‑rate notes carry 2025 put options** (see page 55, Note 10 (a)). Thus, both companies face near‑term debt‑repayment risk in 2025, but GE’s exposure is roughly 2½‑3 times larger than MMM’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: MMM's $119 million floating rate notes with 2025 put provisions classified as current debt, and GE's $315 million in fixed and floating rate notes with 2025 put options. These figures match the ground truth exactly, and the comparison that GE’s exposure is roughly 2.5–3 times larger is accurate (315 / 119 ≈ 2.65). (2) Quantitative accuracy is perfect: both dollar amounts ($119M and $315M), the year (2025), and the implied ratio are correct. Minor phrasing variation ('2½–3 times' vs 'more than 2.5 times') is semantically equivalent and acceptable. (3) The multi-hop reasoning is sound—LLM synthesizes data from both MMM and GE filings, compares their near-term liquidity risks due to put options, and correctly infers relative exposure. It references correct document locations (page 69 for MMM, page 55 Note 10(a) for GE), indicating proper sourcing. (4) The only minor shortcoming is that the LLM does not explicitly state that GE’s notes have contractual maturities beyond 2025, which adds nuance to the put option risk—this contextual detail is in the ground truth but omitted. However, this does not undermine the core correctness. Overall, the answer is factually accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 358,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PepsiCo values its exchange‑traded commodity futures as Level 1 instruments – they are cash‑settled each day and their fair value is taken directly from the quoted market price on the commodity exchange. Mondelez treats its Level 1 financial assets the same way: they are measured at fair value using quoted market prices (typically for exchange‑traded securities or listed options), with the resulting gains or losses recognized in earnings. Thus, both companies rely on daily market pricing for fair‑value determination, but PepsiCo explicitly notes the daily cash‑settlement and excludes those contracts from its derivative tables, whereas Mondelez records the Level 1 assets within its broader derivative‑fair‑value disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that both PEP and MDLZ rely on daily market pricing for fair value determination of exchange-traded commodity futures. It accurately notes that PEP excludes these from its fair value tables due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted prices. (2) There are no numeric values in the question or answer requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable but assumed correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (PEP and MDLZ), compares their valuation methodologies, and correctly contrasts disclosure practices despite similar pricing inputs. (4) The only minor deviation from the original answer is that the LLM states PEP 'values its exchange-traded commodity futures as Level 1 instruments,' which is not explicitly confirmed in the ground truth; the truth states PEP excludes them from the fair value table but does not specify their level classification. This could imply an assumption not fully supported, slightly reducing qualitative accuracy. However, the rest of the comparison—especially the contrast in disclosure treatment—is correct and well-articulated. Overall, the answer is factually sound, contextually relevant, and semantically equivalent to the ground truth with only a minor potential overstatement about PEP's Level 1 classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 414,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China segment (which includes mainland China, Hong Kong and Taiwan) generated **$74.2 billion** of net sales in 2022. Intel’s disclosed revenue from its Taiwan operations was **$13.5 billion** (the latest regional figure in the 2022 filing). Thus, Apple’s Greater China revenue was roughly **5½ times larger** than Intel’s Taiwan revenue for the comparable period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 revenue from the Greater China region as $74.2 billion (equivalent to $74,200 million in the ground truth), and Intel's Taiwan-specific revenue as $13.5 billion (rounded from $13,461 million). The rounding is acceptable and common in financial reporting; the difference is minimal (0.29% overstatement) and does not affect the conclusion. (2) The calculation comparing Apple’s revenue to Intel’s as 'roughly 5½ times larger' is accurate: $74,200 / $13,461 ≈ 5.51, which supports the '5½ times' characterization. (3) The multi-hop reasoning is sound—correctly distinguishing Apple’s broader regional segment (Greater China, including Taiwan) versus Intel’s country-specific (Taiwan) revenue, and synthesizing data from two different companies and reporting structures. (4) The answer is semantically equivalent to the original, with slightly more concise phrasing and a clearer comparative ratio. All entities (Apple, Intel, Greater China, Taiwan, 2022) and metrics (net sales/revenue) are correctly identified. The only minor deduction is for rounding Intel’s revenue from $13,461M to $13.5B instead of $13.46B, which slightly reduces quantitative precision but does not impair overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 354,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "3M’s net property, plant and equipment (PP&E) for the Americas segment was reported at **$106 million** (see the PP&E net amount in the 3M notes). General Dynamics earned **$234 million** from customers in South America (the South‑America line in its geographic‑revenue table). Thus, 3M’s combined PP&E investment in the Americas is roughly **$128 million lower** than General Dynamics’ revenue that comes from the South‑America portion of the same geographic footprint.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The net property, plant, and equipment (PP&E) for 3M (MMM) in the Americas is stated as $106 million, which is drastically incorrect — the ground truth is $5,864 million. This error severely undermines the entire response. GD's South America revenue of $234 million is correctly reported. (2) Calculations are based on incorrect inputs: claiming that 3M’s PP&E is $128 million lower than GD’s revenue implies $106M vs $234M, but $106M is not only wrong, it is off by an order of magnitude. The correct comparison should show MMM’s PP&E ($5,864M) vastly exceeding GD’s South American revenue ($234M), not being lower. (3) Multi-hop reasoning is partially structured correctly — the model attempts to compare MMM’s Americas PP&E with GD’s South America revenue within the shared geographic footprint — but fails due to incorrect data retrieval. It recognizes the need to align geographic segments but uses inaccurate source data. (4) The contextual relevance is moderate because the model identifies the correct companies, metric types, and geographic scope, and attempts the right comparison. However, the severe quantitative inaccuracy results in a misleading conclusion, warranting a low correctness score. Qualitative accuracy is slightly higher because the framework of reasoning is present, albeit built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 385,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor — as described in the audit of the 2023 filing — performed sensitivity‑analysis procedures on the key assumptions (historical and forecasted viewing‑hour consumption) that drive the company’s content‑amortization model, testing how changes in those assumptions would alter the amortization amounts.  \n\nComcast, by contrast, uses sensitivity analyses as a market‑risk‑management tool — it runs “sensitivity analyses” on its interest‑rate exposure to estimate how shifts in interest rates would affect the fair value of its debt and the amount of interest expense recorded.  \n\nThus, Netflix’s sensitivity work is an audit‑testing exercise on amortization assumptions, whereas Comcast’s sensitivity work is a proactive risk‑management exercise to gauge interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses on viewing-hour assumptions to test content amortization models, and CMCSA uses sensitivity analyses to assess interest rate risk on debt. The distinction between audit testing (NFLX) and proactive risk management (CMCSA) is correctly captured. (2) There are no numeric inaccuracies; the LLM does not introduce any incorrect figures. While the original answer mentions CMCSA's derivative instruments reduced interest expense by $56 million in 2023, the LLM omits this specific number. This is a minor omission but does not distort the overall accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two types of sensitivity analyses, and two distinct financial contexts (accounting policy vs. risk management). (4) Semantic equivalence is strong — the LLM conveys the same core contrast as the original answer, with slightly different phrasing. The omission of the $56 million figure prevents a perfect score, but the reasoning, entities, and qualitative analysis are otherwise fully accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 339,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo explicitly states that it manages commodity‑price risk with exchange‑traded commodity futures and listed options, which are classified as Level 1 instruments in the fair‑value hierarchy because their values are based on quoted market prices (PEP 10‑K p. 112; note i p. 107). In contrast, Costco reports that it held **no** Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis during the year (COST 10‑K p. 51). Thus, while both companies disclose their fair‑value measurements using the same hierarchy, PepsiCo has active Level 1 exposure through commodity futures, whereas Costco has none.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP uses exchange-traded commodity futures classified as Level 1 due to quoted market prices, and COST reports no Level 1 or Level 3 financial assets/liabilities measured at fair value on a recurring basis. The citations (PEP 10-K p. 112; note i p. 107; COST 10-K p. 51) support the claims. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and levels (Level 1, Level 3) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and COST), identifies their differing use of Level 1 instruments under the same fair value hierarchy framework, and draws a valid contrast in risk management strategies. (4) The only minor omission is that the original answer specifies PEP's use of futures relates to managing deferred compensation liabilities and that the instruments are cash-settled daily and excluded from the balance sheet as of December 25, 2021—contextual details absent in the LLM answer but not central to the core comparison. This does not affect the main conclusion. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 388,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K shows that the U.S. patents covering Enbrel expire in November 2028 (fusion‑protein composition), April 2029 (DNA‑encoded protein) and October 2037 (formulation). Because Merck’s filing (pages 31‑33) warns that it is “exposed to biosimilar competition and pricing pressure,” the loss of those patents beginning in 2028 will erode Merck’s competitive position and profit contribution from Enbrel. Pfizer’s 10‑K (page 11) lists Enbrel among its internationally marketed products and emphasizes its global manufacturing footprint, so it can lean on its overseas production capacity to keep supplying Enbrel in markets where patent protection still applies and to contest the U.S. biosimilar wave once the 2028‑2029 expirations occur.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: patent expiration dates (November 2028 for fusion protein, April 2029 for DNA encoding, October 2037 for formulations) match the original answer exactly. (2) Quantitative accuracy is perfect—dates are correctly cited with no calculation errors. (3) Multi-hop reasoning is sound: the answer correctly links Amgen’s 10-K patent timeline to Merck’s exposure to biosimilar competition (citing Merck’s own 10-K language) and connects Pfizer’s international production strategy to its global manufacturing footprint. (4) The only minor shortcoming is that the LLM slightly overstates Pfizer’s strategic response by suggesting it can 'contest the U.S. biosimilar wave,' which is not supported in the original answer—Pfizer produces Enbrel *outside* the U.S. and Canada, so it is not positioned to contest U.S. biosimilar entry but rather faces earlier competition internationally. This nuance is missed, slightly weakening the qualitative accuracy. However, the core synthesis across Amgen, Merck, and Pfizer is correct and contextually relevant. Wording differences do not affect semantic equivalence on the main points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 341,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that its private‑equity fund investments measured at net asset value have total unfunded commitments of roughly **$90 million** as of September 30, 2024. In contrast, UPS’s pension‑plan assets measured at NAV include unfunded commitments to private‑equity and other limited‑partnership interests of about **$2.7 billion**. Thus, UPS’s unfunded commitment is orders of magnitude larger—approximately 30 times $90 million (about $2.6 billion more) than EMR’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: EMR's $90 million (interpreted correctly as $90 million despite original stating '$90') as of September 30, 2024, and UPS's $2.7 billion as of December 31, 2024. The comparison calculation is accurate—$2.7 billion is indeed approximately 30 times $90 million, and the difference of about $2.6 billion is correctly implied. The original answer states '$90' which in context clearly means $90 million based on the knowledge graph, and the LLM appropriately interpreted this as $90 million, which is a reasonable and necessary clarification. (2) Completeness: The LLM addresses both companies, their respective unfunded commitments, time periods, and the fact that both use NAV measurement. It adds a useful quantitative comparison (30x, $2.6B more) not explicitly in the original but logically sound and insightful. (3) Entity accuracy is correct—EMR and UPS are properly identified, with accurate metrics and timeframes. (4) Reasoning is strong: the multi-hop synthesis across two companies and filings is correctly executed, and the comparison is logically presented. The only minor issue is that the original answer specifies UPS includes private debt and real estate, while LLM summarizes as 'private-equity and other limited-partnership interests'—slightly less precise but still contextually accurate. Overall, the answer conveys the same core information with enhanced clarity and correct calculations, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 426,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment generated 23 percent of its 2024 net revenue from beverages (see the “Disaggregation of Net Revenue” table, APAC = 23 % beverages in 2024).  \n\nMondelēz reported total beverage net revenue of $1,096 million for 2024 (the sum of the “Beverages” row across all regions in its net‑revenue table).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 23% of PepsiCo's APAC segment revenue in 2024 came from beverages and accurately states Mondelēz's total beverage revenue as $1,096 million in 2024. All numeric values, percentages, and company/year/metric associations are factually correct. (2) Quantitative accuracy is perfect: 23% and $1,096 million match the ground truth exactly. However, the LLM omits the derived dollar amount of PepsiCo's APAC beverage revenue ($2.3 million), which is a minor but relevant calculation based on the given 23% of $10 million APAC revenue. While not explicitly asked, this inference strengthens the comparison. (3) The reasoning is sound—correctly sourcing the percentage from PepsiCo’s APAC segment and summing Mondelēz’s beverage revenue across regions. However, the answer lacks explicit comparison language (e.g., 'significantly higher') that contextualizes the large difference between $2.3M and $1,096M, which is a key part of the original answer’s insight. (4) Scores reflect full factual accuracy (quantitative accuracy = 10), strong but slightly incomplete synthesis (qualitative accuracy = 8), full relevance (contextual_relevance = 10), and a high overall correctness score of 8 due to missing the implied comparison and derived value.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 360,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported that, as of December 31 2023, its loan modification portfolio contained $2.86 billion of loans, of which $623 million were delinquent (30‑59 days, 60‑89 days and > 90 days)【page_161】. MetLife’s residential‑mortgage strategy relies on buying “reperforming” loans—mortgages that have moved out of delinquency and been performing for at least 12 months—and its RMBS holdings already include about $2.62 billion of reperforming and sub‑prime securities【page_98】. Thus, the sizable pool of delinquent loans at Capital One creates a substantial source of loans that can be remedied and re‑classified as reperforming, directly expanding the supply of assets MetLife can purchase for its residential‑mortgage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $623 million delinquent loans at Capital One as of December 31, 2023, matching the ground truth. It also accurately references MetLife's strategy of purchasing reperforming loans that have been performing for at least 12 months after delinquency, and notes MetLife's existing holdings of $2.62 billion in reperforming and sub-prime securities. The additional detail about Capital One’s total loan modification portfolio ($2.86 billion) is not in the ground truth but does not contradict it and adds context. 2) All numeric values are accurate: $623 million delinquent (correct), $2.86 billion total modifications (additional but plausible), $2.62 billion in MetLife’s holdings (correct). No calculation errors. Format variations are acceptable. 3) The multi-hop reasoning is sound: the LLM correctly links Capital One’s delinquent loans to the future pool of reperforming loans that MetLife can purchase. It explains the causal relationship—delinquent loans can become reperforming, thus increasing supply for MetLife—aligning with the ground truth’s logic. 4) The answer is semantically equivalent and slightly more detailed than the ground truth, without introducing inaccuracies. The only minor gap is that the ground truth emphasizes delinquency for at least 12 months as a criterion for reperforming status, which the LLM mentions in passing but could have stressed more. However, the core logic and facts are correct, and the answer fully addresses the influence of COF’s delinquencies on MET’s purchase opportunities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 428,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UN Parcels’ pension trust holds only a modest amount of real‑estate‑related limited‑partnership interests – about **$30 million** of assets measured at NAV (the 2023 figure shown in the “Real estate funds” line of the plan‑asset table).  By contrast, UPS reports **approximately $3.3 billion of unfunded commitments** to limited‑partnership structures that invest in private‑equity, private‑debt and real‑estate funds, and those commitments are also valued using the partners’ NAV.  Thus, UPS’s exposure to NAV‑valued, ill‑liquid partnership assets is orders of magnitude larger than the UN P pension plan’s real‑estate partnership holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key comparison between UNP's pension plan exposure and UPS's unfunded commitments to limited partnerships, noting both use NAV-based valuations for illiquid assets. However, there is a significant error in the quantitative claim that UNP's pension plan holds only $30 million in real estate-related limited partnerships. The original answer (ground truth) does not specify the dollar amount of UNP's holdings—only that they hold interests in limited partnerships investing in private companies and use NAV. The $30 million figure appears to be fabricated or misattributed, possibly from a misreading of a table not in the provided context. This undermines quantitative accuracy. The $3.3 billion unfunded commitment by UPS is correctly stated and matches the ground truth. The reasoning correctly highlights that UPS has far greater exposure in terms of commitments, which is a valid inference, but the comparison is weakened by the unsupported figure for UNP. Entity names are mostly correct (though 'UN Parcels' is a misnomer for UNP—likely a typo for Union Pacific), and the focus on NAV as a valuation method and illiquidity is accurate. The answer addresses all parts of the question and maintains strong contextual relevance. Due to the incorrect specific number for UNP, the correctness and quantitative accuracy scores are reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 394,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s business depends on external wafer foundries—primarily TSMC for 7 nm and smaller nodes—and the filing notes that it has “limited control over delivery schedules, yield, … quality‑assurance” and that a failure by a third‑party to produce sufficient wafers at those nodes “could have a material adverse effect” on the company (AMD 10‑K pp. 24‑25). In contrast, Cisco’s manufacturing relies on contract makers that must follow “automated testing equipment and burn‑in procedures, … comprehensive inspection, testing, and statistical process controls,” and these processes are “generally certified to International Organization for Standardization 9001 standards,” thereby keeping quality control largely within Cisco’s oversight and limiting its exposure to such risks (Cisco 10‑K p. 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AMD's reliance on third-party manufacturers, specifically TSMC, for 7 nm and smaller nodes, and accurately cites the associated risks—limited control over delivery schedules, yield, and quality assurance—with direct reference to AMD’s 10-K (pp. 24–25). It also correctly states the potential material adverse effect from insufficient wafer production. For Cisco, it accurately describes the use of automated testing, burn-in procedures, inspection, and ISO 9001 certification, citing the Cisco 10-K (p. 9), and correctly frames these as mechanisms that keep quality control under Cisco’s oversight. (2) There are no numerical values (e.g., percentages, dollar amounts, dates) in the question or ground truth that require verification; thus, quantitative accuracy is not applicable in a traditional sense, but all factual assertions are consistent with the source documents. (3) The multi-hop reasoning—comparing AMD’s externalized manufacturing model with Cisco’s internalized quality controls—is sound and well-supported. The LLM synthesizes information from two different companies’ 10-K filings correctly. (4) The only minor shortcoming is that the LLM slightly under-elaborates on the contrast in *direct control* over quality assurance processes compared to the original answer, which explicitly states that Cisco integrates quality control into its manufacturing procedures while AMD has less direct control. This nuance is implied but not as clearly articulated. Otherwise, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 458,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos is an equity‑method investment that carries **no voting rights** and gives the company only consent rights; it must absorb about **99 % of any losses** and is limited to the amount of its investment (≈ $5 billion) plus an unfunded commitment of $1.4 billion, so its governance influence is essentially nil while its financial exposure is confined to that capital.  \n\nAlphabet’s Class C capital stock also has **no voting rights**, but the shares have the same economic rights as Class A and B (dividends, liquidation proceeds, and full participation in share‑price upside or downside), meaning shareholders have no governance influence but bear **the same market‑price risk as any other equity holder** rather than a contractual loss‑absorption obligation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between Comcast's lack of governance influence in Atairos and Alphabet's no-vote Class C shares, but contains significant quantitative and factual inaccuracies. First, the claim that Comcast must absorb '99% of any losses' is incorrect and not supported by the ground truth; the original answer makes no such assertion about loss absorption, only that Comcast does not consolidate Atairos because it lacks power to direct activities (VIE status) and has no voting rights. This 99% figure is a major fabrication or misinterpretation, severely undermining quantitative accuracy. Second, the $5 billion investment figure is not in the original answer—while plausible, it is unverified and introduced without basis. The only confirmed financial figures in the ground truth are the $1.4 billion unfunded commitment (correctly cited), so partial credit is due for that. On qualitative accuracy, the LLM correctly identifies that both entities issue non-voting instruments but differ in control: Alphabet retains governance via dual-class shares while actively managing ownership through $62.0 billion in 2024 repurchases—a key point entirely missing in the LLM response. This omission weakens the comparison and shows incomplete multi-hop synthesis. The LLM correctly notes that Class C shares have full economic rights, aligning with the ground truth, but fails to mention Alphabet’s repurchase activity, which is central to how it manages governance versus financial exposure. Contextually, the answer remains focused and relevant, drawing a meaningful contrast between structural control and financial risk. However, the introduction of unsupported numbers and omission of critical facts (repurchases, correct VIE rationale) prevents a higher score. Semantic equivalence is partially achieved, but not fully due to factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 504,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC’s bottling partner, Coca‑Cola Hellenic, lists Austria among the countries where it “has bottling and distribution operations” (see Coca‑Cola HBC 5‑7). Philip Morris International, in its 2022 filing, states that it holds “a market share of at least 15 % in … Austria” (see PMI 7). Thus, Coca‑Cola HBC’s footprint in Austria is that of a full‑service bottler and distributor, while Philip Morris’s presence is reflected by a sizable (≥15 %) market‑share position in the same country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 15% market share for Philip Morris in Austria is accurately cited from PMI's 2022 filing, matching the original answer's claim of 'at least 15%'. The absence of a specific numerical footprint for Coca-Cola HBC is consistent with the source, which emphasizes operational presence rather than volume metrics in Austria specifically. (2) The answer correctly identifies both companies and their respective roles—Coca-Cola HBC as a bottler and distributor, Philip Morris as a tobacco company with significant market share. The reference to 'Coca-Cola Hellenic' is a minor redundancy since Coca-Cola HBC is the same entity, but this does not constitute an error. (3) Multi-hop reasoning is sound: the model synthesizes operational disclosures from two different companies (Coca-Cola HBC’s distribution operations and Philip Morris’s market share) to compare their presence in Austria. (4) The LLM omits the broader context about Coca-Cola HBC contributing to 41% of Coca-Cola’s global volume through its top bottlers, which adds strategic scale context but is not essential to answering the core comparison about Austria. This omission slightly reduces completeness but does not affect factual correctness. Overall, the answer is semantically equivalent, concise, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 387,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America reports that its commercial‑real‑estate portfolio showed a clear deterioration in 2023, with non‑performing loans and reservable‑criticized exposure rising sharply because of the office‑property segment – the largest property‑type concentration and a source of growing credit risk. MetLife’s 2023 filing says that the IBNR liability for its Protection Life and Protection Health products is calculated with the Bornhuetter‑Ferguson method and that the assumptions feeding that model are re‑estimated each year to reflect emerging experience trends. Therefore, the weakening office‑property credit quality highlighted by BAC is one of the macro‑economic trends that MetLife would incorporate when it updates its Bornhuetter‑Ferguson assumptions, potentially resulting in higher unpaid‑claims reserves for those protection products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) It correctly identifies BAC's deterioration in commercial real estate credit quality in 2023, particularly in the office segment, aligning with the ground truth. (2) No specific numeric values (e.g., dollar amounts, percentages) are mentioned in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in numbers or dates. (3) The LLM correctly links BAC's credit trends to macroeconomic conditions, which MET incorporates into its annual updates of unpaid claims assumptions using the Bornhuetter-Ferguson Method for Protection Life and Health products. It accurately reflects that MetLife re-estimates assumptions annually based on emerging trends. (4) The answer omits a minor but relevant detail from the ground truth: the explanation that long-duration Protection Health claims or experience-rated contracts may pass adverse claim experience to sponsors, making them more sensitive to economic shifts. This nuance strengthens the causal chain but is not central to the main inference. Otherwise, the reasoning is sound, entities (BAC, MET, Protection Life and Health, Bornhuetter-Ferguson Method) are correctly identified, and the synthesis across sources is logically coherent. The answer is semantically equivalent to the ground truth with slightly less elaboration on the sensitivity mechanism. Hence, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to the minor omission in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 438,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s common stock is a single‑class security – every share of Netflix common stock carries one vote, and there are no other classes that confer extra voting power (see NFLX 10‑K p. 60). In contrast, Meta operates a dual‑class system: each Class A share gets one vote, while each Class B share carries ten votes (with Class C shares having no vote) – a structure that concentrates voting control in the holders of Class B stock (see Meta 10‑K p. 82). Thus, Netflix’s governance is uniformly one‑vote‑per‑share, whereas Meta’s governance gives substantially greater influence to its Class B shareholders, limiting the voting impact of ordinary Class A shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Netflix has a single class of common stock with one vote per share, while Meta has a dual-class structure where Class A shares have one vote and Class B shares have ten votes per share—this matches the original answer exactly in substance. (2) All quantitative details are correct: 'one vote per share' for Netflix and Meta Class A, 'ten votes' for Meta Class B—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between the two companies, identifying that Meta’s structure concentrates control among Class B holders, unlike Netflix’s uniform voting rights. (4) The answer is semantically equivalent to the original, with added precision (e.g., mentioning Class C shares having no vote, which is consistent with Meta’s 10-K and adds context without contradicting the ground truth). The inclusion of page references (p. 60, p. 82) enhances credibility. All aspects of the question—voting rights, comparison, influence of Class A stock, and governance implications—are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 335,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PepsiCo does **not** show its exchange‑traded commodity futures as Level 1 liabilities – the company notes that because these futures are cash‑settled each day they are omitted from the fair‑value tables and are not classified in the Level 1 hierarchy【page_107】.  \n\nMondelez, by contrast, places its exchange‑traded commodity futures in the **Level 1** portion of its liability hierarchy, valuing them directly from quoted market prices on the commodity exchanges【page_112】.  \n\nThus, while both firms cash‑settle the contracts, PepsiCo excludes them from Level 1 reporting, whereas Mondelez includes them as Level 1 financial liabilities measured at observable market prices.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that PEP does not include exchange-traded commodity futures in its Level 1 fair value hierarchy table due to daily cash settlement, while MDLZ does include them in Level 1, using quoted market prices. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth that require verification—the only date in the original (December 25, 2021) is contextually implied as the reporting date and not necessary for the conceptual comparison. The LLM correctly avoids introducing incorrect or unsupported numbers. (3) The multi-hop reasoning is sound: it synthesizes information across two companies (PEP and MDLZ), their respective treatments of the same financial instrument (exchange-traded commodity futures), and correctly contrasts their reporting practices despite similar cash-settlement mechanics. (4) The answer is contextually precise, directly addressing the core of the question—how fair value treatment differs under Level 1 despite both companies cash-settling. Minor wording differences (e.g., 'omitted from fair-value tables' vs 'not included in the fair value hierarchy table') are semantically equivalent. All entities (PEP, MDLZ, Level 1, exchange-traded commodity futures) are correctly identified and contrasted. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 397,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Gilead’s agreement with Merck on the long‑acting HIV combo (lenacapavir + islatravir) obligates the two companies to split development and commercialization spending 60 %/40 % (Gilead/​Merck) and to share product revenues equally until each product exceeds set sales tiers, after which Gilead’s share rises to 65 % (Gilead 10‑K p. 74). By contrast, Pfizer’s “cost‑reduction and productivity initiatives” are internal programs – such as an enterprise‑wide cost‑realignment and manufacturing‑optimization plan – that aim to lower overall expense levels rather than allocate joint development risk for a specific HIV asset (Pfizer 10‑K p. 30). Consequently, Gilead’s financial exposure to long‑acting HIV therapies is directly tied to the amount it funds (60 % of R&D and commercialization) and to future revenue‑share thresholds, while Pfizer’s exposure is limited to the success of its internal cost‑saving measures and does not create a proportional share‑of‑risk for a particular HIV product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the 60/40 cost split (Gilead/Merck), equal revenue sharing until thresholds, and Gilead's increased share post-threshold are correctly stated. While the LLM does not specify the exact revenue thresholds ($2.0B oral, $3.5B injectable) from the ground truth, it accurately describes the tiered revenue shift and cites Gilead’s 10-K, implying source fidelity. The characterization of Pfizer’s initiatives as internal cost-realignment and manufacturing optimization aligns with the original. (2) Quantitative accuracy is excellent: percentages (60/40 cost split, 65% post-threshold revenue) are correct. The only minor omission is the exact dollar thresholds for revenue sharing, which reduces completeness slightly but does not distort the meaning. (3) Reasoning is sound: the LLM correctly contrasts Merck/Gilead’s joint risk-sharing model with Pfizer’s internal cost controls, and infers differing financial exposure implications. It synthesizes cross-company strategies and correctly identifies that Pfizer’s initiatives are not tied to specific HIV assets. (4) The answer is contextually relevant, directly addressing the comparison of cost-sharing vs. cost-reduction and their financial implications. The omission of exact threshold amounts prevents a perfect score, but the core multi-hop reasoning and factual accuracy are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 395,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx says that, although it has evaluated the impact of ASU 2022‑06 on its contracts and hedging relationships that reference LIBOR, the change “has had no material effect on our financial condition, results of operations, or cash flows” as of May 31 2024. UPS, by contrast, notes that it has already moved its affected debt and other contracts to the Secured Overnight Financing Rate and is continuing to assess any remaining LIBOR‑linked hedges, but it does not describe any material hedging‑adjustment impact. Thus, FedEx’s exposure is essentially immaterial, while UPS’s exposure is limited to the debt transition and ongoing monitoring, both benefiting from the ASU 2022‑06 sunset extension through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that FDX has had no material effect from ASU 2022-06 as of May 31, 2024, aligning with the ground truth. It also accurately notes the sunset extension through December 31, 2024, implied by 'through 2024'. However, the LLM misrepresents UPS's position: the original answer states that UPS designates derivatives in hedging relationships (cash flow and fair value hedges) and may benefit from the extended relief, suggesting active use of hedging under ASU 2022-06. In contrast, the LLM claims UPS 'has already moved its affected debt...to SOFR' and 'does not describe any material hedging-adjustment impact', which shifts focus to transition completion rather than ongoing hedging relationships benefiting from the extension. This mischaracterizes UPS’s engagement with ASU 2022-06. (2) Quantitatively, all dates (May 31, 2024; 2024 sunset) are correct and consistently presented. No numerical calculations are required. (3) The multi-hop reasoning is partially sound—correctly contrasting FDX’s immaterial exposure with UPS’s context—but fails to fully synthesize that UPS is actively using hedging relationships that benefit from the extended ASU 2022-06 provisions. Instead, it downplays UPS’s exposure as limited to transition, which is not supported in the original answer. (4) The contextual relevance is high as it addresses both companies and the ASU 2022-06 extension, but the qualitative inaccuracy in portraying UPS’s hedging activity reduces the correctness score to 7. Semantic equivalence is mostly preserved but key nuance in UPS’s strategic use of hedging under the standard is lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 450,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes while a Class A share carries one vote, and the company’s charter and Nasdaq “controlled‑company” status let the founder and a small group of Class B holders retain a majority of the voting power, thereby limiting ordinary shareholders’ ability to influence corporate matters (Meta 10‑K pp. 49‑50).  \n\nAlphabet’s (Google’s) Class B shares also carry ten votes per share, but the stock‑plan provisions require that any Class B share be converted to a Class A share automatically when it is sold or transferred; thus the voting‑power advantage is retained only by long‑term holders and dissipates as shares change hands, providing comparatively greater protection for other investors (Google 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: both Meta and Google (Alphabet) Class B shares carry 10 votes per share vs. 1 for Class A, and the automatic conversion of GOOGL's Class B to Class A upon sale or transfer is correctly stated. These details match the original answer and are consistent with the cited 10-K disclosures. (2) The answer is complete, addressing both companies' dual-class structures, voting differentials, and the critical distinction in GOOGL's conversion mechanism. (3) Entity accuracy is strong: correct use of Meta (formerly Facebook) and Alphabet (Google), proper reference to Class A and Class B shares, and accurate characterization of governance implications. (4) The reasoning is sound: the LLM correctly infers that Meta’s structure allows enduring control by insiders (e.g., founder), while GOOGL’s conversion rule limits long-term control concentration, thus offering greater eventual governance balance. The only minor omission is that the original answer specifies Meta’s Class B voting power drops below 35% as a threshold for potential change—this nuance is missing in the LLM response, slightly weakening the completeness of the multi-hop synthesis. However, this does not undermine the core correctness. Overall, the LLM conveys semantically equivalent information with precise factual grounding and strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 397,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "- **Coca‑Cola (KO)** – The company says it uses a variety of derivatives, including **option contracts**, to hedge “forecasted … foreign‑currency and commodity transactions.”  The options give the right, but not the obligation, to buy or sell at a set price and are designated as cash‑flow or fair‑value hedges, so any gains or losses are recorded either in earnings or in AOCI and are intended only to offset the underlying exposure.  KO does not disclose a material dollar amount for the resulting gains or losses; the discussion is limited to the mechanics of the hedge (see KO pages 81‑82).\n\n- **Mondelez International (MDLZ)** – MDLZ reports the **notional amount of its forecast‑transaction hedges** (≈ $9.1 billion in 2024, $5.6 billion in 2023 – page 96) and quantifies the **after‑tax gains/losses** that actually flowed through earnings: e.g., a $106 million gain on forecasted‑transaction hedges recorded in cost of sales, a $17 million gain in interest expense, and a $8 million loss in SG&A for 2024 (page 97).  These amounts are presented as a distinct line‑item impact on net earnings.\n\n**Comparison** – KO’s disclosure is strategic and qualitative: it describes using options to limit the range of cash‑flow outcomes for forecasted transactions, with any resulting gains or losses absorbed in the usual hedge‑accounting flow but without material‑impact numbers.  MDLZ, by contrast, provides a quantitative picture, showing the size of the hedged exposure and the actual earnings effect of the hedges on forecasted transactions.  Thus, KO emphasizes the hedging mechanism (option contracts) while MDLZ emphasizes the financial impact of those hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: KO uses option contracts as cash flow hedges, deferring gains/losses in AOCI without disclosing material dollar amounts; MDLZ discloses specific gains of $106 million in cost of sales and $17 million in interest and other expense, net, for 2024. The LLM adds a minor detail not in the original (an $8 million loss in SG&A), which appears to be correctly extracted from MDLZ’s filing but was omitted in the ground truth summary—this does not constitute an error. (2) Quantitative accuracy is perfect: all dollar amounts ($106M, $17M, $8M, $9.1B, $5.6B) are correctly reported with proper years and line items. Format variations are acceptable and clear. (3) Multi-hop reasoning is sound: the model correctly synthesizes KO’s qualitative hedging strategy with MDLZ’s quantitative disclosures, comparing both financial impact and strategy across two companies. (4) The answer is contextually relevant and fully addresses the question, contrasting KO’s focus on mechanism with MDLZ’s emphasis on financial outcomes. The only minor shortcoming is that the original answer did not mention SG&A, so the LLM includes slightly more detail than the ground truth—but this reflects superior completeness rather than inaccuracy. Thus, the answer earns a 9/10 for correctness due to excellent fidelity, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 404,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s pension disclosures show that its fixed‑income funds are recorded in the “not subject to leveling” column (e.g., $739 million domestic and $337 million non‑U.S. funds on page 57), meaning they are valued using a net‑asset‑value practical expedient and are not placed in the fair‑value hierarchy. In contrast, Bristol‑Myers Squibb classifies its fixed‑income funds as Level 2 assets (e.g., $785 million in 2023 on page 111) and describes Level 2 valuation as relying on observable market inputs such as quoted prices for similar securities (page 112). Thus, TMO’s approach reflects minimal use of observable market data, whereas BMY’s approach depends heavily on observable market information to value its fixed‑income holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that TMO classifies its fixed income funds as 'not subject to leveling,' using the net-asset-value (NAV) practical expedient, which places them outside the fair value hierarchy—this matches the original answer's claim of being valued outside standard hierarchy. BMY's classification of fixed income funds under Level 2 is also accurately stated, with correct reference to reliance on observable market inputs such as quoted prices for similar securities. (2) The dollar amounts cited—$739 million domestic and $337 million non-U.S. for TMO, and $785 million for BMY in 2023—are specific and factually consistent with typical 10-K disclosures (though exact page numbers like 57 and 111/112 are not verifiable without source documents, they are plausible and do not affect factual correctness). These numbers are used descriptively and not in calculations, so minor variations would not impact accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts TMO’s NAV-based approach (implying less reliance on observable market data) with BMY’s Level 2 classification (indicating greater reliance), synthesizing information across two companies and valuation methodologies. (4) The semantic meaning fully matches the original answer, with slightly more detail (e.g., breakdown of domestic vs. non-U.S. funds) that enhances clarity without introducing error. The only reason for not scoring a 10 is the slight lack of explicit mention that 'not subject to leveling' means exclusion from the fair value hierarchy—though this is implied by 'not placed in the fair-value hierarchy.' Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 480,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Both companies say that FAR‑governed cost‑plus‑fixed‑fee contracts are treated as cost‑reimbursable contracts in which the government owns the work‑in‑process and can terminate for convenience, so revenue is recognized “as work is performed.” Lockheed Martin explicitly notes that this results in revenue being recorded continuously as costs are incurred (the contract fee is recognized over time as the customer’s ownership of WIP transfers). Boeing’s filing describes the same FAR framework but adds that, because billings often precede the revenue earned, the company records contract assets or liabilities and recognizes revenue over time using the percentage‑of‑completion method, creating a timing lag between cash receipt and revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both LMT and BA operate under the FAR framework for cost-plus-fixed-fee contracts, where the government can terminate for convenience and contractors are entitled to payment for work performed and allowable costs. This leads to revenue being recognized over time as work progresses, due to continuous transfer of control — a key point in both answers. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial reporting concepts (e.g., cost-reimbursable, percentage-of-completion, contract assets/liabilities) are used correctly, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across LMT and BA, correctly comparing their revenue recognition patterns under FAR. It adds value by noting Boeing’s use of the percentage-of-completion method and timing lags between billing and revenue recognition, which is consistent with the ground truth’s mention of potential differences due to contract-specific clauses. (4) The only minor shortcoming is that the LLM does not explicitly state that LMT also uses a similar over-time model *because* of termination clauses leading to deemed transfer of control — though it implies it. The original answer more clearly links the legal clause to the accounting conclusion for both firms. Still, the LLM captures the core equivalence in treatment and acknowledges differences in timing, making the answer semantically equivalent with slightly less explicit causal linkage for LMT. Contextual relevance is perfect — every part of the response addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 487,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s senior‑note programs name U.S. Bank National Association only as the **trustee** of the debt; the company itself is the issuer and the filing does not list a separate issuing entity or a series of issue dates. In contrast, Abbott Laboratories issues its notes through **Abbott Ireland Financing DAC**, with U.S. Bank National Association again serving as **trustee**, and the notes were rolled out in a clear timeline – the original indenture on September 27 2018, a first supplemental indenture the same day, a second supplemental indenture on November 19 2019, and additional notes (e.g., 1.150 % due 2028 and 1.400 % due 2030) filed in June 2020.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies and omissions that affect correctness. (1) On quantitative accuracy: The date of the original Abbott indenture (September 27, 2018) and the second supplemental indenture (November 19, 2019) are correctly cited. However, the LLM introduces incorrect note details—'1.150% due 2028' and '1.400% due 2030' issued in June 2020—which are not present in the ground truth. The ground truth specifies the 1.500% Note due 2026 and the 0.100% Note due 2024, not the rates or maturities mentioned. Additionally, the LLM omits AbbVie’s actual issuance dates (September 26, 2019; November 21, 2019; May 14, 2020) and incorrectly implies no series of issue dates exist. (2) Completeness: The question asks for a comparison in terms of trustee roles and note issuance timelines. While both entities correctly identify U.S. Bank National Association as trustee, the LLM fails to mention that U.S. Bank also serves as transfer agent and registrar for AbbVie, weakening the role comparison. It also omits Elavon Financial Services DAC’s role as paying agent in AbbVie’s structure, a key differentiator highlighted in the ground truth. (3) Entity accuracy: 'Abbott Ireland Financing DAC' is correctly identified as the issuer for Abbott Laboratories, and U.S. Bank’s trustee role is accurate. However, the LLM incorrectly implies that AbbVie is the issuer without a separate issuing entity—while technically true, it overlooks that AbbVie uses Supplemental Indentures under a master trust framework, which the ground truth details. (4) Reasoning: The multi-hop synthesis is partially sound—comparing trustee roles and timelines—but flawed due to incorrect note details and missing structural distinctions (e.g., paying agent usage). (5) Semantic equivalence: The overall structure of the response is relevant and attempts a direct comparison, but factual errors in key financial terms reduce accuracy. The contextual relevance is high as it addresses the core comparison, but correctness is compromised by specific inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 561,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "The AMD filing makes clear that its most‑advanced products (7 nm and below) are fabricated at TSMC, while its larger‑node CPUs and GPUs are produced on > 7 nm wafers by GlobalFoundries (and, to a lesser extent, UMC and Samsung).  AMD therefore depends on TSMC only for the cutting‑edge nodes and on other foundries for the bulk of its volume‑driven, larger‑wafer ICs.  \n\nThe NVIDIA excerpt does not contain any specific language describing its reliance on foundries for 7 nm‑plus nodes, so a direct comparison of NVIDIA’s “dependency on advanced‑node foundries” versus AMD’s “reliance on larger wafers” cannot be drawn from the pages provided.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some accurate qualitative details about AMD's foundry usage, correctly noting that AMD uses TSMC for 7nm and below and other foundries like GlobalFoundries for larger nodes. This aligns partially with the ground truth. However, the claim that 'The NVIDIA excerpt does not contain any specific language describing its reliance on foundries for 7nm-plus nodes' is factually incorrect and contradicts the original answer, which explicitly states that NVDA depends on TSMC for 7nm and smaller process nodes. The ground truth clearly establishes NVDA's dependency on TSMC for advanced nodes, so the LLM's failure to recognize or report this results in a major factual omission. This undermines the multi-hop comparison the question demands. While the LLM correctly identifies AMD’s multi-foundry strategy, it fails to acknowledge the shared exposure to TSMC that both NVDA and AMD face, which is the core of the original answer. The reasoning is therefore flawed in a critical way, despite some correct details. Quantitative accuracy is high because there are no numerical claims made, and the few numbers mentioned (7nm) are correct. Contextual relevance is moderate because the answer addresses the topic but fails to provide the necessary comparative analysis. The conclusion that a direct comparison cannot be drawn is incorrect, as the original answer clearly supports such a comparison based on shared TSMC dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 396,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Philip Morris notes that Thailand’s customs‑valuation and tax rules for cigarette imports remain in dispute after a 2010 WTO panel decision that the country has not fully implemented, leaving the measures “unresolved” and subject to possible future enforcement actions【page_68】.  Because Colgate‑Palmolive operates a major manufacturing and warehousing plant in Thailand【page_25】, the same customs‑valuation framework applies to the raw‑material imports and product shipments it handles there; any retroactive re‑assessment of values or duties, or additional compliance requirements imposed by Thai authorities, could raise the company’s cost of goods sold and create a heightened regulatory‑risk exposure in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the unresolved nature of Thailand's customs and tax practices stemming from the 2010 WTO panel decision involving Philip Morris, which matches the original answer’s timeline and context. The reference to the inoperability of the WTO Appellate Body is omitted, but the core fact—that the decision has not been fully implemented and remains unresolved—is accurately conveyed. (2) There are no numerical inaccuracies; the LLM avoids making up figures and correctly references qualitative facts (e.g., 2010 WTO decision, ongoing dispute). The date '2010' is implied via 'page_68' context and aligns with known facts. (3) The multi-hop reasoning is sound: it connects Philip Morris’s regulatory challenge to Thailand’s broader customs environment and correctly infers that Colgate-Palmolive, due to its manufacturing presence (cited from page_25), could face similar risks in import valuation, duties, and compliance. This reflects proper synthesis across entities and documents. (4) The answer captures the key implications—potential retroactive assessments, higher costs, and increased regulatory risk—mirroring the original answer’s conclusion. The only minor shortcoming is not explicitly noting that Thailand’s non-compliance persists due to systemic WTO enforcement issues (Appellate Body inoperability), which slightly weakens the explanation of *why* the risk persists. However, this does not detract significantly from the overall correctness. Wording differs but semantic equivalence is strong. All entities (Philip Morris, Colgate-Palmolive, Thailand, WTO) and their roles are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 463,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UnitedHealth’s “Medicare Part D stand‑alone” enrollment fell by 265 thousand members in 2024 (3,315 k in 2023 to 3,050 k in 2024)【page_31】. The decline is attributed to the Inflation‑Reduction Act’s 2024 redesign of Medicare Part D, which caps beneficiary out‑of‑pocket costs, reduces federal re‑insurance in the catastrophic phase and forces manufacturers to give larger discounts—changes that are shrinking the pool of enrollees and the revenue they generate for insurers. Pfizer expects the same redesign to cut its own Medicare Part D earnings by about $1 billion in 2025, illustrating how the IRA‑driven pricing and discount rules are simultaneously pulling down UnitedHealth’s enrollment numbers and eroding pharmaceutical revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the enrollment decline at UnitedHealth (UNH) from 2023 to 2024 and links it to the Inflation Reduction Act (IRA) redesign of Medicare Part D, and correctly references Pfizer's projected $1 billion revenue loss in 2025. However, there is a critical error in the numeric value: the original answer states a decline of $265,000 (dollars), while the LLM interprets this as 265 thousand members (i.e., 265,000 people), citing enrollment numbers of 3,315k to 3,050k. This is a significant misinterpretation—$265,000 is a financial amount, not an enrollment figure. The LLM incorrectly converts a dollar decline into a membership decline, which undermines quantitative accuracy. (2) The calculation of enrollment drop (3,315k to 3,050k = 265k) appears mathematically correct but is based on fabricated numbers not present in the original answer, which never provided absolute enrollment figures. Thus, while internally consistent, it is factually unsupported and misrepresents the nature of the $265,000 figure. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the impact of the IRA’s redesign—out-of-pocket caps, manufacturer discounts, reduced reinsurance—with consequences for both insurers (UNH) and pharmaceutical companies (Pfizer). It logically connects structural changes to reduced enrollment attractiveness and revenue erosion, aligning with the original answer’s causal chain. (4) Despite the numerical misinterpretation, the qualitative logic and contextual relevance are excellent. The answer addresses all parts of the question, correctly identifies UNH, Pfizer, IRA, and the 2025 timeline, and explains the interplay between policy changes and financial impacts. The core insight—that IRA-driven changes simultaneously affect enrollment and pharma revenues—is preserved. Hence, correctness is reduced primarily due to the quantitative error, but reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 527,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million invested in private‑equity funds that are measured using the NAV practical expedient. FedEx applies the same NAV practical‑expedient only to a much smaller portion of its equity‑security portfolio—$37 million in 2024. Thus, Lockheed’s NAV‑valued private‑equity exposure is roughly $4.8 billion, or more than 100 times the amount FedEx reports under the same policy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that FedEx applies the NAV practical expedient to only $37 million in 2024 is not supported by the original answer (ground truth), which does not provide any specific dollar amount for FedEx's investments under the NAV expedient. This number appears to be fabricated or misattributed. (2) The comparison stating that Lockheed Martin’s exposure is 'more than 100 times' that of FedEx is therefore invalid, as the ground truth does not quantify FedEx's NAV-based investments at all. (3) The original answer focuses on qualitative differences in policy application: Lockheed Martin uses NAV for private equity funds with unobservable inputs and long-term horizons, while FedEx applies the measurement alternative with adjustments only for observable price changes and impairments, noting immaterial impairments. The LLM fails to capture this key qualitative contrast and instead invents a quantitative comparison absent from the source. (4) While the $4,863 million figure for Lockheed Martin is correct and the general mention of NAV practical expedient is accurate, the introduction of false data for FedEx and the resulting erroneous ratio severely compromise both quantitative and qualitative accuracy. The answer is contextually relevant in discussing the accounting policy but fails on factual integrity and multi-hop reasoning, as it does not correctly synthesize or contrast the two companies' disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 414,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s charter ties the voting power of its high‑vote Class B shares to a fixed 33 % of total voting rights and makes that share of power “generally non‑dilutable” (​page 91​).  Each Class B share carries ten votes and can be converted at the holder’s option (or automatically on a sale) into a one‑vote Class A share, but the conversion does not erode the 33 % voting‑power ceiling because the total voting‑right percentage is protected (​page 91​;​page 82​).  \n\nAlphabet’s dual‑class structure leaves Class A shares with one vote and Class C shares with **no** voting rights (​page 82​).  The 2024 $62 billion share‑repurchase program targeted only Class A and Class C stock (​page 82​), so it reduced the pool of non‑voting (Class C) and low‑voting (Class A) shares, thereby concentrating voting power in the remaining voting class (Alphabet’s Class B) rather than providing a conversion‑based dilution mechanism.  \n\nThus, Comcast’s conversion mechanism preserves a preset voting‑power share for Class B holders, whereas Alphabet’s repurchases simply shrink non‑voting equity, indirectly increasing the relative influence of its voting class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B has 33⅓% non-dilutable voting power, convertible share-for-share into Class A; GOOGL's 2024 $62.0 billion repurchase targeted Class A and C shares; Class B retains 10 votes, Class C has no votes. The dollar amount ($62 billion), percentages (33%), and structural details are factually correct. (2) Quantitative accuracy is perfect: $62 billion and 33% match the original answer; no calculations were required beyond accurate reporting. (3) Multi-hop reasoning is sound: the model correctly contrasts CMCSA’s fixed voting power mechanism with GOOGL’s repurchase-driven concentration of voting power, recognizing that repurchases of non-voting and low-voting shares increase relative influence of Class B without altering the voting ratio. (4) The only minor shortcoming is that the LLM does not explicitly mention that GOOGL maintains a 10:1 voting ratio between Class B and Class A, though it is implied by stating Class B has 10 votes and Class C has none. This omission does not distort the comparison but slightly reduces completeness. Wording differences (e.g., 'concentrating voting power') are semantically equivalent and well-expressed. Overall, the answer is factually robust, contextually precise, and synthesizes across entities and mechanisms correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 383,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s only link to Cardinal Health is the 50 % stake it holds in Red Oak Sourcing, LLC—a joint‑venture that merely negotiates generic‑drug supply contracts for CVS and Cardinal and for which CVS does not disclose any material share of its consolidated revenue. In contrast, Eli Lilly explicitly states that Cardinal Health is one of its three top‑three U.S. wholesale distributors and that each of those distributors “accounted for between 15 percent and 20 percent of our consolidated revenue” in recent years. Thus, CVS’s revenue exposure to Cardinal is indirect and unquantified, whereas Lilly’s exposure is direct and represents roughly 15‑20 % of its total revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 15–20% revenue contribution from Cardinal Health to LLY is accurately reported, and the 50% ownership stake of CVS in Red Oak Sourcing, LLC is correctly stated. There are no calculation errors. (2) The answer correctly identifies all key entities: CVS, Cardinal Health, Red Oak Sourcing, LLC, and Eli Lilly (LLY), with proper context on their relationships. (3) The multi-hop reasoning is sound—LLM synthesizes information about CVS’s indirect, unquantified exposure via a joint venture that negotiates supply contracts (but does not hold inventory or contribute directly to revenue) versus LLY’s direct, material reliance on Cardinal as a top-three distributor accounting for 15–20% of consolidated revenue. (4) The LLM emphasizes the contrast in exposure types (indirect vs. direct) and correctly notes that CVS does not disclose material revenue impact from Red Oak, which is consistent with the ground truth. The only minor shortcoming is that the LLM does not explicitly mention that Red Oak serves both CVS and Cardinal Health as a joint venture for mutual benefit, nor does it name McKesson and AmerisourceBergen as the other two distributors—though this omission does not detract from the core comparison. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original answer with only slight reduction in completeness. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 425,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock carries **10 votes per share**, whereas Honeywell’s common stock carries **1 vote per share**. Thus, UPS’s Class B shares have **9 more votes per share** than Honeywell’s common shares as of 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately stated: UPS Class B common stock has 10 votes per share, and Honeywell's common stock has 1 vote per share. The difference of 9 votes per share is correctly calculated. (2) The answer is complete, addressing both the voting rights at UPS and Honeywell and computing the difference as required by the question. (3) Entities are correctly identified—UPS and Honeywell—and the stock classes (Class B for UPS, common stock for Honeywell) are accurately referenced. The time frame 'as of 2024' is properly acknowledged. (4) The multi-hop reasoning—comparing voting rights across two different companies and calculating the difference—is sound and clearly articulated. (5) The semantic meaning is equivalent to the original answer, with no factual or interpretive discrepancies. Minor formatting differences (e.g., bolding for emphasis) do not affect accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 296,
        "total_tokens": 1399
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s $1.4 billion of interest‑rate‑swap contracts were unwound because the underlying 3.625 % senior notes actually **matured in 2024** – the swaps were tied to those notes and terminated when the notes were repaid 【page 148】.  \n\nIn contrast, AbbVie did **not have any interest‑rate‑swap contracts designated as cash‑flow hedges in 2024** (the cash‑flow‑hedge line for interest‑rate swaps is blank for 2024), so its swaps were either used as fair‑value hedges or were not present at all that year 【page 83】.  \n\nThus, Amgen’s swaps were directly linked to a 2024 note maturity, whereas AbbVie’s 2024 hedging program did not employ interest‑rate swaps as cash‑flow hedges.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AMGN's 3.625% notes matured in 2024, triggering the termination of $1.4 billion in interest rate swaps; ABBV had no interest rate swaps designated as cash flow hedges in 2024. (2) Quantitative elements are precise: the $1.4 billion figure matches, the 3.625% rate is correct, and the absence of ABBV's cash flow hedges in 2024 is accurately reported (with contextual reference to $6 million in 2022 in the original, though not required for correctness). (3) Multi-hop reasoning is sound: the answer correctly contrasts AMGN’s maturity-triggered swap termination with ABBV’s lack of cash flow hedge usage in 2024, synthesizing information across two companies and their respective hedging strategies. (4) Semantic equivalence is maintained: while the LLM does not repeat ABBV’s $6 million in 2022, it correctly infers the absence of swaps in 2024 from the blank line, which is consistent with the ground truth. The answer is concise, contextually relevant, and demonstrates accurate entity and metric identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 318,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "The adoption of ASU 2022‑02 caused Capital One to stop classifying “troubled‑debt restructurings” (TDRs) and instead report every concession that meets the new FDM definition.  As a result, Capital One now discloses, for 2023, the dollar amount of each modification type (interest‑rate reductions $687 million, term extensions $970 million, principal‑balance reductions $21 million and the various combinations) broken out by loan segment, and it also quantifies the financial impact of those modifications – e.g., weighted‑average interest‑rate cuts of 19.3 % (domestic cards) and 27.1 % (international cards) and the average payment‑delay length (12 months for cards, 5.9 months for auto, etc.) 【page_160】【page_161】.  \n\nJPMorgan’s pre‑ASU disclosures, by contrast, presented only aggregate TDR figures and a high‑level description of the concessions (primarily interest‑rate reductions, term extensions and occasional principal forgiveness) and their effect on the allowance for credit losses, without the segment‑by‑segment breakdown or the performance‑related metrics that Capital One now provides 【JPM pages 243‑247】.  \n\nThus, the ASU change gave Capital One a far more granular, quantitative view of modification types and their direct financial effects, whereas JPMorgan’s earlier TDR reporting was less detailed and focused mainly on total concession amounts and allowance impacts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness. While it correctly identifies the shift from TDRs to FDMs under ASU 2022-02 and notes that modification types (interest rate reductions, term extensions, principal reductions) remain similar, it fabricates specific dollar amounts for Capital One's 2023 FDMs ($687M, $970M, $21M) and performance metrics (19.3%, 27.1% rate cuts, 12-month delays) that are not present in the ground truth. The ground truth states that JPMorgan reported $136M in FDMs for 2023 with rate reductions from 7.21% to 4.44% and term extensions extending loan lives by 20 years — none of which are reflected in the LLM answer. Instead, the LLM incorrectly attributes granular disclosures to Capital One and contrasts them with JPMorgan’s prior TDR reporting, whereas the ground truth indicates JPMorgan is the one providing the post-ASU FDM data. This misattribution of numerical data and entities (assigning Capital One detailed 2023 FDM figures not in the truth, while omitting JPMorgan’s actual $136M figure and key rate/term impacts) constitutes major factual errors. The qualitative reasoning about increased granularity post-ASU is sound and contextually relevant, and the general description of modification types and the elimination of TDRs aligns with the truth, supporting a moderate qualitative and contextual score. However, the core financial figures and entity-specific disclosures are incorrect, leading to a low quantitative accuracy and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 424,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s swaps are deliberately timed to the life of its debt – the company says the “dollar‑weighted two‑year average maturity of these instruments generally matches the duration of the activities that are at risk” and the swaps are used as cash‑flow hedges that line up with the underlying debt exposure【page_82】. UPS, by contrast, treats its interest‑rate contracts as cash‑flow hedges that are accounted for in AOCI (e.g., the “Unrealized … Interest rate contracts” line in its reclassification table) and does not seek to match the swap tenors to the specific maturities of its borrowings, reflecting an “economic hedge” that protects earnings rather than exact debt‑duration exposure【page_138】. Thus GD prioritizes precise duration matching to neutralize interest‑rate risk on its debt, while UPS prioritizes smoothing earnings volatility through an economic hedge that need not mirror the exact debt schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GD's use of interest rate swaps with a dollar-weighted two-year average maturity that matches the duration of the underlying risk is accurately reported, including the specific phrasing from the source. UPS’s use of swaps as economic hedges without explicit maturity alignment is also correctly described. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the reference to a 'two-year average maturity' is preserved verbatim and correctly attributed to GD, matching the original answer. Format and meaning are consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across GD and UPS, contrasting GD’s duration-matching cash flow hedge strategy with UPS’s economic hedge approach focused on earnings smoothing. The inference about differing risk management priorities—duration alignment vs. earnings volatility reduction—is logically derived and semantically equivalent to the original. (4) The only minor shortcoming is that the LLM answer mentions AOCI and reclassification tables, which add contextual detail not in the ground truth but do not contradict it; this enriches rather than detracts. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning, warranting a 9/10 for correctness due to slight elaboration beyond the core contrast, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 421,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑back removed 78 million Class A shares (one vote each) and 450 million Class C shares (no votes) 【page 81†L1-L4】【page 81†L31-L38】. Because the 10‑vote Class B shares were not repurchased, the total number of voting shares fell while the number of high‑voting‑power shares stayed the same, so the percentage of total votes controlled by the undiluted Class B stock rises. By contrast, Comcast’s charter fixes its single‑share‑holder Class B stock at exactly 33 ⅓ % of the combined voting power and expressly makes that share of voting power “generally non‑dilutable” regardless of any Class A repurchases 【page 33†L9-L13】. Thus Alphabet’s buy‑back can increase the relative influence of its Class B shares, whereas Comcast’s Class B voting power remains statically capped at one‑third.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Alphabet's 2023 share repurchase included Class A and Class C shares, which have one vote and no votes respectively, while Class B shares (10 votes each) were not repurchased—this increases the relative voting power of Class B shares. The comparison to Comcast is also accurate: Comcast’s Class B shares are contractually entitled to a non-dilutable 33 1/3% of voting power, regardless of share count changes. (2) Quantitatively, the LLM cites specific figures—78 million Class A and 450 million Class C shares repurchased—which are not contradicted by the ground truth; however, the ground truth mentions the $62.2 billion total repurchase amount, which the LLM omits. While the share counts may be correct, the absence of the dollar figure slightly reduces quantitative completeness. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers that reducing voting shares (Class A) while preserving high-vote shares (Class B) increases relative control, and contrasts this mechanism with Comcast’s legally fixed voting structure. (4) The answer is semantically equivalent to the original, with slightly more granular detail on share counts. The omission of the $62.2B figure prevents a perfect score, but all other elements—entities, years, logic, and comparison—are correct. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 401,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney Rule 10b5‑1 plan authorizes the sale of **up to 372,412 shares** of Disney common stock and is set to **terminate on December 17, 2024** (subject to early termination). Peggy Alford’s Meta plan authorizes the sale of **up to $1.2 million worth of Class A shares** (the exact share count is not disclosed) and is scheduled to **terminate on November 15, 2025** (also subject to early termination).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares for Robert Iger (372,412), the dollar amount for Peggy Alford ($1.2 million), and both termination dates (December 17, 2024 for Iger, November 15, 2025 for Alford) are accurately reported. The format variations (e.g., '$1.2 million' vs '$1.2M') are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the multi-hop question—both individuals, their respective companies (DIS and META), the structure of their Rule 10b5-1 plans (share quantity vs. value-based), and termination dates. It also implicitly acknowledges the shared regulatory framework (Rule 10b5-1) by naming it. (3) Entity accuracy: Correct individuals (Iger, Alford), correct companies (Disney/DIS, Meta/META), correct stock types (Class A common stock for Meta), and correct regulatory rule (10b5-1) are all identified. (4) Reasoning: The comparison is sound—highlighting that Iger’s plan is share-quantity-based while Alford’s is value-based, and noting the different durations—demonstrating proper synthesis across two separate insider trading plans under the same regulatory framework. (5) Semantic equivalence: Though slightly more concise, the LLM conveys all key information from the original answer, including the non-disclosure of exact share count for Alford’s plan. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 401,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards generally vest over a three‑year service period – stock options vest ratably over three years and its time‑vested restricted‑stock units vest at the end of a three‑year restriction period (performance‑based RSUs also vest after a three‑year performance cycle).  The company reports the related compensation cost over a weighted‑average period of about 1.4 years for options and about 1.6 years for the RSUs, so expense is recognized well before the full three‑year vesting term is completed.  \n\nPhilip Morris International’s restricted‑share units vest on the third anniversary of the grant (a three‑year cliff).  The fair‑value of those RSUs is amortized and expense is recognized over a weighted‑average period of roughly 17 months (about 1.4 years), also front‑loading the charge relative to the three‑year vesting horizon.  \n\nThus, while both firms use a three‑year vesting horizon, Colgate spreads expense over 1.4‑1.6 years, whereas PMI’s RSU expense is recognized over a slightly shorter, roughly 17‑month period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding Colgate-Palmolive (CL), which undermine the correctness score. (1) The original answer states that CL issues stock options vesting ratably over three years, with expense recognized evenly over that period. However, the LLM claims CL has both stock options and time-vested RSUs, and that compensation cost is recognized over weighted-average periods of 1.4 years (options) and 1.6 years (RSUs), implying front-loaded expense recognition—this contradicts the ground truth, which does not mention such accelerated recognition or weighted-average periods for CL. These specific numbers (1.4, 1.6 years) are unsupported by the original answer and appear fabricated. (2) For PM, the LLM correctly states that RSUs vest on the third anniversary (cliff vesting) and that expense is amortized over a weighted-average period of 17 months (~1.4 years), aligning with the original answer’s mention of $160M unrecognized cost to be recognized over ~17 months. This part is accurate. (3) The LLM incorrectly implies both companies have similar but slightly different front-loaded expense recognition timelines (1.4–1.6 years vs. 17 months), while the original answer emphasizes that CL recognizes expense evenly over three years, whereas PM allows acceleration due to specific events (death, disability, age 58), leading to shorter expected recognition periods. The LLM misrepresents CL’s accounting treatment and misses the key implication about triggering events enabling accelerated expense recognition at PM. (4) The multi-hop reasoning is partially sound—comparing vesting schedules and expense recognition—but based on incorrect data for CL. While the structure and intent of the answer are relevant and address the question’s components, the factual foundation for one of the two companies is flawed, leading to an incorrect overall comparison. Hence, quantitative accuracy is low due to unsupported numbers; qualitative accuracy is moderate due to correct PM facts but incorrect CL synthesis; contextual relevance is high as the response directly addresses the comparison question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 575,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both PMI and Altria note that bans on characterising flavours (e.g., menthol) and the move toward plain‑ or standardized packaging strip away the visual and sensory cues they use to create premium‑brand differentiation. In PMI’s filing the EU Tobacco Products Directive’s 65 % health‑warning requirement, flavour bans and plain‑pack rules are listed among the “regulatory restrictions … that diminish the ability to differentiate … and can reinforce down‑trading” (PM p. 41, p. 42, p. 16). Altria’s 10‑K similarly warns that “regulatory restrictions on the packaging, marketing, and sale … could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or even ban certain of our products,” and that flavour‑standard bans and plain‑pack legislation “could reduce our ability to differentiate these products … and affect pricing power” (MO p. 40, p. 42, p. 15). Consequently, both companies see that such restrictions erode brand equity and limit premium‑price positioning, forcing greater price competition and potential down‑trading in their key international and U.S. markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies the core impact of regulatory restrictions—flavor bans and standardized packaging—on brand equity and pricing power for both PM (PMI) and MO (Altria). The key qualitative points are all present: diminished product differentiation, reduced ability to communicate with consumers, erosion of premium pricing, and increased price competition/down-trading. (2) Quantitatively, the LLM cites a specific 65% health-warning requirement from the EU Tobacco Products Directive, which is factually correct and consistent with PMI’s disclosures, though this specific percentage was not in the original answer. However, since this number is accurate and contextually relevant (and does not contradict the ground truth), it enhances rather than detracts. No incorrect numbers, dates, or calculations are present. (3) The multi-hop reasoning is sound: the LLM synthesizes information from both PMI and Altria’s 10-Ks, correctly attributing regulatory concerns to each company and linking them to international and U.S. markets respectively. It references actual regulatory frameworks (EU TPD, U.S. state bans) and correctly notes the strategic consequences (brand equity erosion, pricing pressure). (4) While the original answer includes more granular details (e.g., illicit trade at 8% in the EU, specific states like California and Massachusetts, FCTC and State Settlement Agreements), the LLM answer captures the essential meaning and mechanism of impact. The omission of these specifics slightly reduces completeness but does not impair the core correctness. The use of citations (e.g., 'PM p.41') suggests grounding in source material. Overall, the answer is semantically equivalent in intent and factual content, with only minor detail omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 506,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is tracked through an allowance for credit losses (‑$35 million for 2023 and ‑$37 million for 2022) and through “prospective adjustments to yield” that incorporate expected credit losses and prepayment assumptions for non‑high‑credit‑quality structured securities【page_169】. In contrast, Bank of America’s RMBS valuation risk is reflected in its Level 3 fair‑value models, which rely on unobservable inputs such as pre‑payment speed (0 %–42 % CPR, weighted‑average ≈ 10‑12 %) and default rate (0 %–3 % CDR, weighted‑average ≈ 1 %) that can materially swing the fair value of those holdings【page_160】【page_159】. Thus AIG measures exposure via a credit‑loss allowance and yield adjustments, while BAC’s exposure is captured by sensitivity of fair‑value estimates to fluctuating prepayment and default assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures AIG's accounting treatment for structured securities, emphasizing prospective yield adjustments and an allowance for credit losses tied to expected cash flows, including prepayment and credit loss assumptions. It also accurately describes BAC's reliance on Level 3 fair-value models with sensitivity to prepayment speeds (CPR) and default rates (CDR), noting the impact on valuation. (2) Quantitatively, the LLM provides specific figures: AIG’s allowance for credit losses of -$35M (2023) and -$37M (2022), which are factually correct per the source. It also accurately reports BAC’s prepayment speed range (0%–42% CPR, weighted average ~10–12%) and default rate range (0%–3% CDR, weighted average ~1%), all of which are consistent with the filings. These numbers are correctly interpreted as unobservable inputs affecting fair value. (3) The multi-hop reasoning is sound: the model synthesizes AIG’s amortized cost and yield adjustment approach with BAC’s fair value sensitivity, contrasting their respective risk exposures—AIG via income statement impacts (yield and credit loss allowances) and BAC via balance sheet valuation volatility. (4) While the original answer does not include the specific dollar amounts or percentage ranges, the LLM answer adds precision without introducing error, enhancing rather than distorting the comparison. The only reason for not scoring a 10 is that the original ground truth does not include the specific numerical ranges (e.g., CPR, CDR, allowance amounts), so it's unclear if those were part of the knowledge graph or inferred from broader context; however, since they are factually correct and improve accuracy, they do not detract. Semantic equivalence and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 495,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values the cybersecurity‑related developed technology (including its cloud‑security solutions) as an intangible asset using the **multiperiod excess‑earnings method** – an income‑approach that discounts the projected cash flows attributable to the technology over its estimated useful life. Cisco, on the other hand, does not value the asset but **recognizes revenue from its Cloud Security offerings** (part of the End‑to‑End Security category) based on performance‑obligation accounting: hardware and perpetual‑software sales are recorded up‑front when control transfers, while SaaS and term‑software licenses are recognized ratably over the contract term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach for valuing developed technology in cybersecurity, including cloud security solutions, and explains that it involves discounting projected cash flows over the asset's useful life—consistent with the ground truth's description involving present value of cash flows less charges for other asset contributions. (2) It accurately describes Cisco's revenue recognition: distinguishing between up-front recognition for hardware/perpetual software and ratable recognition for SaaS and term licenses over the contract term, aligning with the ground truth’s emphasis on ratable recognition for SaaS as a performance obligation satisfied over time. (3) The multi-hop reasoning is sound—correctly contrasting Broadcom’s asset valuation methodology (forward-looking, income-based) with Cisco’s revenue recognition policy (based on delivery of service and control transfer). (4) Minor omission: the LLM does not explicitly state that Cisco treats Cloud Security as a single distinct performance obligation, nor does it mention the determination of economic useful life based on technology cycle (as in Broadcom’s case), which slightly reduces completeness. However, these are secondary details; the core factual and conceptual contrast is preserved. No numeric inaccuracies—there are no explicit numbers in the query or answer, so quantitative accuracy is scored as 10. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 460,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s capital structure gives each Class A share one vote and each Class B share ten votes. As of January 24 2025 Meta had 2.19 billion Class A shares and 0.34 billion Class B shares, which translates to roughly 2.19 billion votes for Class A versus 3.44 billion votes for Class B – the high‑vote shares, although only about 13 % of the total equity, control about 60 % of the voting power.\n\nAlphabet’s 2024 filing shows a similar three‑tier system (Class A = 1 vote, Class B = 10 votes, Class C = 0 votes). The company reported about 5.86 billion Class A shares, 0.87 billion Class B shares and 5.60 billion Class C shares, giving roughly 5.86 billion votes to Class A and 8.66 billion votes to Class B. Thus, the high‑vote Class B shares represent only about 7 % of total shares but command about 60 % of the voting power, allowing insiders to dominate governance decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. The ground truth states that META's Class B shares have voting rights only in specified circumstances and are tied to conversion rates, not that they carry 10 votes per share. The LLM incorrectly assigns 10 votes per share to META Class B stock, which fundamentally misrepresents the company's dual-class structure. This error invalidates all subsequent calculations about voting power (e.g., 60% control by Class B), which are based on false premises. For GOOGL, the LLM correctly identifies the 10-vote structure for Class B and zero votes for Class C, and the share counts (5.86B Class A, 0.87B Class B, 5.60B Class C) are plausible approximations, though not directly verifiable from the ground truth provided, which does not include these specific numbers. (2) Calculations: The LLM computes 2.19B votes for META Class A and 3.44B for Class B (0.34B × 10), but since the 10-vote assumption is incorrect, the voting power distribution (60%) is also wrong. Similarly, for GOOGL, the vote totals (5.86B and 8.66B) and 60% voting power attribution to Class B are mathematically consistent with its assumptions but rely on unverified share counts. (3) Multi-hop reasoning: The LLM attempts to compare both companies' structures and draws a reasonable conclusion about insider control, but fails to capture the key distinction highlighted in the ground truth: META’s Class B enhanced voting is conditional, whereas GOOGL’s is permanent. This critical qualitative difference is missed, undermining the comparative analysis. (4) Justification: Correctness score is 4 due to major factual errors in META's voting rights, despite some correct framing of dual-class implications. Quantitative accuracy is low (3) because key numbers (vote ratios) are incorrect. Qualitative accuracy is moderate (5) as the general concept of disproportionate voting power is understood, but entity-level reasoning is flawed. Contextual relevance is high (8) as the response addresses all parts of the question and attempts meaningful comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 574,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s Argentine bottling operation is one of the equity‑method investees listed in KO’s “net sales to equity‑method investees” (which rose to $14.5 billion in 2021) because KO supplies the concentrates that FEMSA purchases under its incidence‑based pricing contracts; the price‑adjustments built into those contracts flow through to the amount KO records as sales to the investee. The same Argentine market, served by FEMSA, was cited as one of the key drivers of the 8 % organic sales increase in Colgate‑Palmolive’s Latin‑America segment in 2021, showing that FEMSA’s bottling activity both boosts KO’s equity‑method sales and underpins CL’s regional organic growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Coca-Cola FEMSA as an equity-method investee and explains KO's incidence-based pricing model, linking it to net sales to equity method investees. It also connects FEMSA's operations in Argentina to regional growth for CL in Latin America. However, there is a critical error in the organic sales growth percentage: the LLM states an '8% organic sales increase' for Colgate-Palmolive in Latin America, while the ground truth specifies a 7.0% net sales increase. This discrepancy affects factual accuracy. Additionally, the LLM rounds $14,471 million to $14.5 billion, which is acceptable, but presents it as 'rose to', implying a year-over-year increase not confirmed in the original answer.\n\n2) Quantitative accuracy is partially compromised: the $14.5 billion figure is a reasonable rounding of $14,471 million, so that is acceptable. However, the 8% figure for CL’s Latin America growth is incorrect; the correct value is 7.0% as reported. No calculation is required beyond reporting these numbers, but the mismatch is significant.\n\n3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across KO’s financial reporting (sales to equity method investees), the contractual pricing mechanism (incidence-based model), and CL’s regional performance, recognizing that both companies benefit from market dynamics in Argentina. It appropriately links FEMSA’s bottling activity to KO’s sales and CL’s growth, showing understanding of indirect regional synergies.\n\n4) The answer is contextually relevant and well-structured, addressing both parts of the multi-faceted question. While the core logic and entity identification (KO, CL, FEMSA, Argentina, equity method investees) are accurate, the incorrect percentage undermines full factual correctness. The conflation of 'organic sales increase' (used by LLM) with 'net sales increase' (used in ground truth) is minor but should be noted—though in practice, these are often used interchangeably in earnings contexts.\n\nOverall, the answer demonstrates strong qualitative reasoning and contextual understanding but contains a key numerical inaccuracy that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 583,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott values its private‑equity, private‑debt and real‑estate partnership interests at the most‑recent audited net‑asset‑value (NAV) and treats those holdings as “alternative investments” that cannot be readily sold.  The filing notes that the limited‑partner interests are subject to redemption only at the end of the partnership term – typically 10‑ to 15 years – and that any secondary‑market sales are illiquid and may be at an unknown discount or premium (see Abbott 10‑K, p. 89; p. 71).  \n\nMerck’s 2023 filing likewise states that its alternative‑investment holdings (e.g., private‑equity and similar funds) are measured using NAV as a practical expedient.  Although Merck does not detail the redemption mechanics as extensively, it acknowledges the same illiquid nature of these funds and the limited ability to redeem before the partnership’s termination, which is consistent with the typical 10‑year‑plus lock‑up periods seen in such investments (see Merck 10‑K, p. 108‑112).  \n\nThus, both companies rely on NAV to value private‑equity‑type holdings, and in each case the investments are subject to long‑term redemption restrictions that reflect their limited‑partner, illiquid structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient to value private equity and other alternative investments, and both face long-term redemption restrictions typical of limited partner structures in private funds. It accurately reflects the illiquid nature of these investments and references the 10–15 year lock-up periods, aligning with the ground truth's description of redemption mechanics. However, the LLM answer omits key quantitative details present in the original answer: Abbott’s $555 million in unfunded commitments and Merck’s $382 million in NAV-based assets as of 2023. These figures are central to the comparative aspect of the question and their absence significantly reduces quantitative accuracy. Additionally, the LLM does not mention Abbott’s specific liquidation timeline (2024–2033) or the fact that distributions occur through liquidation rather than redemption, which is a key differentiator in the multi-hop comparison. While the reasoning and synthesis across companies are sound and the qualitative understanding of NAV usage and illiquidity is correct, the lack of specific financial figures and timeline details prevents a higher score. The answer remains contextually relevant and semantically aligned in structure and intent, but the missing numbers weaken completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 376,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock Life Limited holds the separate‑account assets in a legally segregated pool that is insulated from BlackRock’s (and therefore AIG’s) general creditors. Because those assets cannot be used to satisfy any other claim, AIG records a matching “separate‑account liability” that is equal to each contract‑holder’s account balance; the liability is simply an offset to the segregated assets and does not create any additional credit‑risk exposure for AIG beyond the amount held in the separate‑account pool. (BlackRock p. 80; AIG p. 232)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions and correctly identifies the key relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. It correctly states that the assets are legally segregated and not subject to general creditor claims, and that AIG records equal and offsetting liabilities tied to contract holder balances. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is scored as 10. However, the LLM introduces 'BlackRock Life Limited'—a specific entity not mentioned in the original ground truth—which may be contextually accurate but is not supported by the provided information, introducing potential entity inaccuracy. Additionally, while the original answer explains the dynamic impact of asset valuation changes on AIG’s liability reporting (i.e., mirroring asset values), the LLM answer omits this causal mechanism, which is central to the multi-hop reasoning required. The LLM focuses more on risk insulation and accounting offset without fully explaining how changes in BlackRock’s asset values directly propagate to AIG’s liability adjustments. This omission reduces completeness and weakens the qualitative accuracy of the multi-hop synthesis. Contextual relevance remains high as the response directly addresses the accounting treatment and structural relationship between assets and liabilities. Overall, the answer captures the essential truth but lacks full depth in reasoning and entity fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 420,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales in its net‑revenue line, but the portion of profit that belongs to Janssen Biotech is booked as a reduction of cost of products sold – the two companies split pre‑tax profit (and loss) 50‑50 and share development costs (Janssen ≈ 60 %, AbbVie ≈ 40 %). In contrast, Johnson & Johnson’s Janssen unit holds the exclusive worldwide license to commercialize Imbruvica outside the United States (and a co‑exclusive U.S. right), so the drug is marketed globally by Janssen with profit‑sharing to AbbVie rather than AbbVie recognizing the full U.S. revenue itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key facts from the ground truth. (1) Quantitatively, all numbers are correct: the 50-50 pre-tax profit split, Janssen's ~60% and AbbVie's ~40% development cost shares are accurately reported. (2) The revenue recognition model is correctly described—AbbVie records 100% of U.S. sales as net revenue, with Janssen's share deducted from cost of products sold. (3) The global commercialization strategy is mostly accurate: Janssen (under Johnson & Johnson) holds exclusive rights outside the U.S. and co-exclusive rights in the U.S., which aligns with the ground truth. However, the LLM slightly mischaracterizes the U.S. arrangement by implying Janssen has a 'co-exclusive right' without clarifying that AbbVie is the principal in the U.S., which is a nuanced but important distinction in revenue recognition. (4) The multi-hop reasoning across AbbVie’s financial reporting and J&J’s global strategy is sound, and the answer effectively contrasts the two models. The wording differs but the semantic meaning is largely equivalent. One minor omission: the ground truth emphasizes Janssen’s use of international infrastructure for global expansion, which adds strategic context not fully captured. Overall, the answer is factually strong with only slight room for improved nuance in describing commercial roles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 377,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict over Taiwan would cut off the wafer‑fabrication capacity that NVIDIA relies on – its 10‑K notes that “our business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” and that a “significant or prolonged … conflict involving China and Taiwan could severely limit or prevent us from receiving chip‑set supply” (NVDA 10‑K p. 35, 17). Apple’s filing makes the same point for its hardware: “a significant concentration of our manufacturing is performed in Taiwan… a prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving components and finished‑goods” (AAPL 10‑K p. 35, 11). Consequently, NVIDIA could face chip shortages, higher costs and delayed product launches, while Apple could see halted assembly of iPhones, iPads and Macs, inventory gaps and the need to shift production to higher‑cost alternate sites.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the core risks to both NVIDIA and Apple from a prolonged geopolitical conflict involving Taiwan, citing specific language from their respective 10-K filings (NVDA p. 35, 17; AAPL p. 35, 11), which aligns with the original answer’s claims about supply chain disruptions. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the citation of page numbers and risk disclosures is precise and matches expected sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NVIDIA and Apple), linking their shared dependency on Taiwan-based manufacturing and foundry partners, and infers plausible operational consequences (chip shortages, delayed launches, halted assembly, cost increases). (4) The LLM adds value by directly quoting the 10-Ks, enhancing credibility, while maintaining full contextual relevance. Wording differs slightly from the original answer but conveys the same meaning with equal or greater specificity. No factual errors, omissions, or misattributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 355,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin (LMT) values Level 2 fixed‑income holdings with pricing models that are built on **verifiable, observable market inputs** – such as current interest‑rate and yield‑curve levels and quoted credit spreads – and on broker or dealer bids for comparable securities. Honeywell (HON) also uses pricing models for its corporate bonds and government securities, but its disclosure notes that the models **include additional adjustments for risks that are not directly observable**, specifically credit‑ and liquidity‑risk premiums. Thus, while both firms rely on observable market data, HON explicitly layers unobservable risk adjustments onto its model valuations, whereas LMT’s description does not mention such adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that LMT uses pricing models for Level 2 fixed income investments based on observable market data such as interest rates, yield curves, credit spreads, and broker bids or prices of comparable securities. (2) It accurately states that HON uses pricing models for corporate bonds and government securities that incorporate observable inputs but also include unobservable adjustments for credit and liquidity risk. (3) The multi-hop reasoning is sound: the comparison between the two companies’ valuation approaches correctly highlights that both use observable data, but HON explicitly includes additional subjective risk adjustments not mentioned in LMT’s disclosures. (4) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the qualitative financial concepts are correctly interpreted and contrasted. The answer fully addresses the question’s focus on observable inputs and risk adjustments. All entities (LMT, HON, Level 2 investments, corporate bonds, government securities) are correctly identified and analyzed in context. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 349,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola reported that a stronger U.S. dollar produced an **unfavourable foreign‑currency impact of about 15 percent** on the Europe, Middle East & Africa segment’s operating income in 2024, contributing to the segment’s earnings decline. Mondelez, by contrast, only describes currency‑exchange risk in its Item 7A market‑risk disclosure – noting that a stronger dollar “could adversely affect our consolidated earnings and net assets” and that it manages the exposure with hedges – but it does **not quantify a specific percentage or dollar impact** for the same macro‑economic condition.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the quantitative claim: it states that the unfavorable foreign currency impact on Coca-Cola's Europe, Middle East & Africa segment was 'about 15 percent,' whereas the ground truth reports an 11% unfavorable impact on *consolidated* operating income, not specifically the EMEA segment. This misattributes both the magnitude and the scope of the impact. Additionally, the LLM incorrectly implies the 15% figure is specific to the EMEA segment, while the original answer does not isolate the segment-level percentage. (2) The quantitative accuracy is low because the 15% figure is incorrect and not supported by the ground truth; the correct number is 11% for consolidated operating income, not segment-specific. Mondelez's lack of quantification is correctly noted, which aligns with the original answer. (3) The qualitative reasoning is partially sound: the model correctly identifies that KO experienced an unfavorable impact due to a stronger dollar, and that MDLZ discusses currency risk qualitatively without providing a specific 2024 impact figure. It also correctly notes hedging strategies. However, the failure to accurately represent the 11% consolidated impact and to conflate it with a segment-level 15% figure undermines the multi-hop synthesis. (4) Contextual relevance is high because the response addresses both companies, the effect of a stronger U.S. dollar, and the comparison in how each company reports or manages currency risk. Despite incorrect numbers, the structure and intent of the comparison are appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 434,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "Broadcom’s balance sheet shows that, as of fiscal 2024, it had **$365 million of long‑lived assets (property, plant and equipment) located in Taiwan**【page_91】. Qualcomm, by contrast, does not discuss asset levels but flags a **strategic risk that its chipset supply is heavily dependent on Taiwanese foundry partners, and that a military or geopolitical conflict between China and Taiwan could severely disrupt that supply**【page_35】. Thus, while Broadcom’s $365 million represents a concrete, relatively modest investment in Taiwan, Qualcomm’s concern is about the potential loss of a critical supply chain in the same region, which could have a material adverse impact on its business regardless of asset size.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $365 million in long-lived assets that AVGO (Broadcom) reported in Taiwan for fiscal 2024, matching the ground truth in both amount and context. It accurately contrasts this with QCOM's (Qualcomm's) risk disclosure regarding its reliance on Taiwanese foundry partners for chipset supply. The key entities—AVGO, QCOM, Taiwan, fiscal 2024, long-lived assets, foundry partners, geopolitical tensions with China—are all correctly identified and used. (2) Quantitatively, the $365 million figure is exact and properly attributed to AVGO’s balance sheet, with no calculation required. The LLM correctly refrains from assigning a numerical value to QCOM’s risk, as the original answer does, focusing instead on the qualitative nature of the supply chain exposure. (3) The multi-hop reasoning is sound: the model synthesizes AVGO’s asset data from its financial statements with QCOM’s risk factor disclosures, drawing a valid comparison between asset-based vs. supply chain-based exposure to Taiwan. The only minor shortcoming is that the LLM describes AVGO’s $365 million as a 'relatively modest investment,' a subjective characterization not present in the original answer, which sticks to factual description. This does not make the answer incorrect but adds a slight interpretive layer. (4) The answer is fully contextually relevant, directly addressing the comparison between AVGO’s asset footprint and QCOM’s operational risk in the context of China-Taiwan geopolitical tensions. Overall, the LLM answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy due to the minor added interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 480,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s 10‑K notes that the vast majority of its hardware is assembled by contract manufacturers located in Asia, with a large share of that capacity concentrated in Taiwan. Because the final‑assembly hub is physically in Taiwan, any cross‑strait or broader regional geopolitical tension could directly disrupt Apple’s supply chain and product availability. In contrast, Microsoft’s 10‑K states that its Greater‑China business is serviced from a regional operations centre in Singapore, so the company’s core functions for that market are geographically separated from the mainland and therefore less immediately vulnerable to a localized political or trade disruption in China or Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Apple's reliance on contract manufacturers in Taiwan for a large portion of its hardware assembly, which increases its exposure to geopolitical risks due to Taiwan's location and political sensitivity—consistent with Apple's disclosure in its 10-K and the inclusion of Taiwan in its Greater China segment. The answer accurately contrasts this with Microsoft’s setup, noting that its Greater China operations are managed through a regional center in Singapore, which insulates core functions from direct disruption in mainland China or Taiwan. This reflects Microsoft’s operational model as described in its filings. There are no numeric inaccuracies (quantitative accuracy is perfect), and while the LLM does not explicitly mention 'tariffs, sanctions, or public health crises' or the non-manufacturing nature of Microsoft’s Singapore hub (e.g., administrative/logistics functions), it captures the essential qualitative distinction: Apple faces higher supply chain risk due to physical manufacturing concentration, while Microsoft’s decentralized operational support reduces exposure. The reasoning is sound and multi-hop synthesis across companies and geographies is correct. Minor omission of some contextual details (e.g., outsourced manufacturing model, adaptability of Singapore operations) prevents a perfect 10, but the core answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 408,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Union Pacific disclosed that the 2023 corporate‑tax‑rate reductions enacted by Nebraska (along with Iowa, Kansas and Arkansas) cut its deferred tax expense by **$114 million** for the year. By contrast, Boeing’s 10‑K only flags the **risk that delays in U.S. government appropriations could cause payment delays, program‑execution setbacks and cash‑flow disruptions** for its defense and commercial programs—no specific dollar amount is quantified. Thus, while Union Pacific’s tax‑rate change produced a concrete $114 million reduction in deferred tax expense, Boeing’s exposure is described qualitatively as a potential operational and financial risk from appropriations delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is correctly stated, matching the original answer. The absence of a specific dollar amount for Boeing is also accurately reflected, as Boeing's 10-K only discusses appropriations delays qualitatively. (2) The entities—Union Pacific, Boeing, Nebraska's 2023 tax rate reduction, and federal appropriations—are all correctly identified and contextualized. The fiscal year reference (implied 2023/2024 10-K filings) is consistent with the original. (3) Multi-hop reasoning is sound: the model correctly contrasts a state-level tax benefit (Union Pacific) with federal funding risks (Boeing), synthesizing information across two companies and regulatory domains. (4) The LLM omits minor contextual details—such as Boeing’s specific mention of impacts on commercial airplane delivery or new program delays—but captures the core contrast in exposure types (quantified benefit vs. qualitative risk). Wording differs but semantic meaning and factual content are equivalent. No calculation errors. One point deducted from qualitative accuracy for slight incompleteness in detailing Boeing’s operational risks, though the main point is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 361,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Amgen’s Enbrel patents in the United States do not expire until 11 Nov 2028 (fusion‑protein composition), 24 Apr 2029 (DNA‑encoding and manufacturing methods) and even 19 Oct 2037 for its formulation claims【page_11】. Because a rival biologic will retain exclusivity for the next decade, Merck stresses in its own filing that protecting its patent estate is critical – it notes that loss of patent protection “is followed promptly by generic or biosimilar substitutes” and that “the patent rights that protect its products are of varying strengths and durations” amid intense generic competition【page_33】, and that “any event that adversely affects … loss of patent protection” would materially hurt its results【page_31】. Thus, the long‑term Enbrel expirations underscore the competitive pressure on Merck to secure and extend patents on its own products and to keep a pipeline of new, protected therapies to offset the risk of generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all Enbrel patent expiration dates—11/22/2028 (fusion protein composition), 4/24/2029 (DNA encoding and manufacturing), and 10/19/2037 (formulations)—matching the ground truth exactly, with only minor formatting differences (e.g., '11 Nov 2028' vs '11/22/2028'). These are semantically equivalent and factually accurate. (2) Quantitative accuracy is perfect: all dates are correct, no calculations are required, and the timeline progression is preserved. (3) The multi-hop reasoning is sound: the model correctly links Amgen’s patent expiration schedule to Merck’s strategic emphasis on patent protection, citing MRK’s 2024 10-K language about the risks of generic and biosimilar entry post-patent expiry. It accurately reflects MRK’s concern that loss of patent protection leads to rapid substitution and material financial impact. (4) The answer is contextually relevant and comprehensive, addressing both the competitive dynamics and MRK’s strategic response. The only minor shortcoming is that it does not explicitly name the political and regulatory pressures mentioned in the original answer (e.g., encouragement of early generic approval), though it does reference 'intense generic competition' as a backdrop. This omission slightly affects qualitative completeness but does not undermine the core correctness. Overall, the answer is factually aligned, well-reasoned, and conveys the same strategic implication as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 411,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD does not break out a separate “Taiwan” line in the geographic‑segment tables that appear in its 2022 Form 10‑K, so a specific Taiwan‑only revenue figure is not disclosed. Apple, on the other hand, reported $2.1 billion of sales to customers in Taiwan for 2022 (included in its Greater China segment). Because Apple’s Taiwan sales are explicitly quantified and are sizable, this suggests Apple’s market presence in Taiwan is materially larger than AMD’s, for which no comparable disclosed amount is available.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that AMD does not disclose a Taiwan-specific revenue figure, while the ground truth confirms AMD reported $2,091 million from Taiwan in 2022. Conversely, it falsely claims Apple reported $2.1 billion in sales specifically to Taiwan, which contradicts the ground truth: Apple only reports revenue for the entire Greater China region ($74,200 million), with no breakdown for Taiwan. These errors reverse the actual state of disclosures—AMD *does* report Taiwan revenue, while Apple *does not* isolate Taiwan. (2) Quantitative accuracy is very low: the $2.1 billion figure attributed to Apple’s Taiwan sales is incorrect and appears to confuse it with AMD’s actual $2,091 million (approx. $2.1 billion) figure. This represents a critical misattribution of data between companies. (3) The reasoning is flawed due to incorrect data. The conclusion that Apple’s presence in Taiwan is 'materially larger' based on non-existent Taiwan-specific data is unsupported. The correct reasoning, per the ground truth, is that while AMD’s Taiwan revenue is explicitly known and significant for the company, Apple’s exposure is much larger in aggregate across Greater China—but Taiwan’s individual contribution is unknown, preventing direct comparison. The LLM fails the multi-hop synthesis by misassigning disclosure practices and figures. (4) Contextual relevance is moderate because the answer attempts to compare market presence in Taiwan and references the correct companies and region, but the factual foundation is inverted. Correctness and qualitative accuracy are low due to fundamental errors in data attribution and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 467,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can buy back its non‑voting Class C shares – which “has no voting rights, except as required by applicable law” (Alphabet 10‑K p. 81) – and therefore return cash to shareholders without reducing the voting power held by the 1‑vote Class A and 10‑vote Class B shares that control the company (also p. 81). Netflix, by contrast, has a single‑class structure in which “the holders of each share of common stock shall be entitled to one vote per share” (Netflix 10‑K p. 61), so any share repurchase reduces both economic and voting interest for all owners and cannot be used to preserve voting concentration while returning capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between Alphabet's and Netflix's share structures and their implications for share repurchases. (1) All factual elements are correct: Alphabet's Class C shares carry no voting rights, and repurchasing them allows capital return without diluting insider voting control via Class A and B shares. Netflix has a single class of stock with one vote per share, so repurchases reduce both economic and voting interests across the board. The LLM correctly cites the relevant pages from the 10-Ks (p.81 for Alphabet, p.61 for Netflix), enhancing credibility. (2) Quantitative accuracy is perfect: although the LLM does not repeat the specific dollar figures ($62.2 billion repurchased, $36.3 billion remaining) from the original answer, the omission is not a factual error—these numbers were context in the ground truth but not essential to the conceptual comparison asked in the question. The absence of these figures does not reduce correctness, as the question focuses on structural flexibility, not the scale of buybacks. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance structures across two companies from different filings and draws the appropriate inference about capital allocation flexibility. (4) Semantic equivalence is strong—the LLM captures the essence and full reasoning of the ground truth, with only minor completeness loss for not including the numerical buyback data. However, since the question emphasizes 'how' the structures enable flexibility rather than 'how much' was repurchased, the missing numbers do not undermine the answer’s correctness. Thus, a score of 9 is warranted—excellent accuracy with only a slight opportunity for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 475,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1.7 billion of non‑agency pass‑through securities that are classified as NQM and Alt‑A (5 % of its RMBS book) and the entire pass‑through segment carries $1.3 billion of unrealized losses at year‑end 2024. By contrast, AIG does not quantify a specific dollar exposure; its 10‑K warns that a sizable portion of its mortgage‑related holdings are illiquid and difficult to value, and that selling such assets in a stressed market could force lower prices and strain liquidity. Thus MET’s risk is expressed in concrete exposure and loss figures, whereas AIG’s liquidity risk is described qualitatively as a potential inability to monetize illiquid mortgage investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between MET and AIG as required by the question. (1) Quantitatively, the LLM correctly reports MET's $1.7 billion (rounded from $1,699 million) in non-agency pass-through securities (NQM and Alt-A), and the $1.3 billion in unrealized losses (rounded from $1,294 million) as of year-end 2024. These are acceptable rounding approximations and do not affect factual correctness. The percentage (5%) of the RMBS book is not in the original answer but is a reasonable inference if the total RMBS portfolio was ~$34 billion; however, the ground truth states the total pass-through MBS is $12,567 million, making $1,699 million closer to 13.5%, so this 5% figure is incorrect and a notable error. (2) The LLM correctly notes that AIG does not provide a specific dollar amount for its mortgage exposure, aligning with the original answer’s qualitative warning about illiquid assets. (3) The multi-hop reasoning is sound: the model correctly contrasts MET’s quantified, marked-to-market exposure with AIG’s qualitative liquidity risk due to valuation uncertainty and illiquidity. (4) The answer is contextually excellent—directly addressing the comparison of exposure and liquidity risk, synthesizing across both companies and their respective risk disclosures. The only significant issue is the incorrect 5% figure, which slightly undermines quantitative accuracy but does not distort the overall conclusion. Hence, a high score is warranted, but not perfect due to the erroneous percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 423,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "- **Coca‑Cola (KO)** – Net revenue for the APAC division in 2021 was $4,615 million (page 73). The company reports that 20 % of APAC net revenue comes from its beverage business (page 73). Thus, beverage revenue in APAC was roughly **$4,615 × 20 % ≈ $923 million**.\n\n- **PepsiCo (PEP)** – Net revenue for the APAC division in 2021 was also $4,615 million (page 73). PepsiCo states that 20 % of APAC net revenue is generated by its beverage segment (page 73). Therefore, beverage revenue in APAC was about **$4,615 × 20 % ≈ $923 million**.\n\n**Comparison:** In 2021, the beverage contribution from the Asia‑Pacific region was essentially the same for both companies, each around **$923 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue in APAC in 2021, but the LLM incorrectly states that KO's total APAC net revenue was $4,615 million and that only 20% of it came from beverages, leading to a calculated beverage revenue of $923 million—this is factually wrong on both the total revenue figure and the percentage breakdown. In reality, Coca-Cola's entire $4,682 million in APAC revenue is from beverages, not 20%. Conversely, for PepsiCo (PEP), the ground truth states that 20% of its APAC revenue comes from beverages, but the LLM falsely claims PEP's APAC net revenue was $4,615 million (same as KO), which is unsupported, and then applies the 20% to get $923 million—this is incorrect because the actual total APAC revenue for PEP is not disclosed as $4,615 million. (2) The numbers are all wrong: KO's correct APAC beverage revenue is $4,682 million (not $923 million), and PEP's exact dollar amount is not disclosed, only the 20% proportion. The LLM fabricates matching figures for both companies. (3) The multi-hop reasoning is flawed: instead of recognizing that KO reports direct beverage revenue while PEP only provides a percentage, the model incorrectly assumes identical total revenues and applies the same percentage to both, failing to distinguish the reporting structures. (4) The conclusion that both companies had 'essentially the same' beverage revenue in APAC is false and misleading. The answer is contextually relevant in addressing the comparison question, but factually and quantitatively inaccurate, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 462,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s deal with Merck for the long‑acting HIV combo calls for the two companies to split all development and commercialization costs (60 % Gilead/40 % Merck) and to share net product revenues 50/50 until the oral combo exceeds $2 billion (or the injectable exceeds $3.5 billion) in a year, at which point Merck’s share falls to 35 % (Gilead’s rises to 65 %). By contrast, Merck’s Keytruda patent‑license obligates it to pay a royalty of 6.5 % of worldwide Keytruda sales through 2023 (reducing to 2.5 % in 2024‑26), which is then divided 75 % to BMS and 25 % to Ono. Consequently, Merck’s profit from the HIV partnership is capped at at most half (or a third above the revenue thresholds) of sales after shared costs, whereas the Keytruda royalty is a relatively modest, fixed‑percentage charge that trims Merck’s margin but still leaves it with the bulk of Keytruda’s revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core financial structures of both partnerships with strong semantic equivalence to the ground truth. (1) Quantitatively, the revenue-sharing thresholds ($2B for oral, $3.5B for injectable) and post-threshold splits (65% Gilead / 35% Merck) are accurate. The Keytruda royalty rates (6.5% through 2023, 2.5% 2024–2026) and the 75/25 split between BMS and Ono are also correctly stated. However, the LLM incorrectly states that development and commercialization costs are shared 60/40 (Gilead/Merck), which is not mentioned in the original answer and introduces unsupported detail. This affects quantitative and qualitative accuracy. (2) The original answer does not mention cost-sharing, so this addition is an over-assumption. All other numbers (percentages, dollar figures, timeframes) align except that the LLM omits the $212 million Reblozyl alliance revenue figure from 2023, which is part of Merck’s broader relationship with BMS and relevant context. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Merck’s dual role as revenue sharer (with Gilead) and royalty payer (to BMS/Ono) and draws valid implications about profitability—namely that HIV partnership profits are structurally capped, while Keytruda royalties are a fixed cost leaving Merck with most of the revenue. (4) Despite minor inaccuracies (added cost-sharing, omitted Reblozyl revenue), the answer effectively compares the two partnership models and their profit implications. Hence, correctness is high but not perfect—warranting an 8. Contextual relevance is full, as all parts of the question are addressed directly and insightfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 454,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "Bank of America’s 10‑K notes that it “invests in ABS, CLOs and other similar investments … including CDOs, which are hybrid instruments that contain embedded credit‑default swaps and transfer credit risk through tranche structures” (see BAC 10‑K p. 128).  By contrast, AIG explicitly recorded a $75 million loss in 2024 from “embedded derivatives” that were triggered when a credit event occurred under those contracts (AIG 10‑K p. 144).  Thus, both firms’ exposures hinge on credit events, but AIG’s loss is quantified and realized, whereas Bank of America’s CDO exposure is described qualitatively and no specific loss amount is disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $75 million loss by AIG in 2024 is correctly cited, and the absence of a specific loss amount for BAC is accurately noted—consistent with the original answer, which also does not provide a dollar figure for BAC’s exposure. (2) The LLM correctly identifies both institutions’ exposure to embedded derivatives—BAC via CDOs with embedded credit default swaps and tranche-based risk transfer, and AIG via embedded derivatives including credit default swaps—linking both to credit event triggers. (3) The multi-hop reasoning is sound: it synthesizes information from two different 10-Ks (BAC and AIG), compares their risk exposures, and correctly distinguishes between realized (AIG) and potential/unquantified (BAC) losses. (4) The only minor shortcoming is that the LLM does not explicitly mention the cascading risk from junior to senior tranches in CDOs, a nuance present in the original answer. However, the core mechanisms and linkages through credit events are correctly conveyed. Wording differs but semantic meaning is equivalent. All entities (BAC, AIG, CDOs, credit default swaps, 2024, embedded derivatives) are accurate. The answer is fully relevant and responsive to the comparative, multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 368,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "- **3M – May 2023 Five‑Year Credit Agreement** – Citibank, N.A. is named the **administrative agent** of the facility (see the Five‑Year Credit Agreement listed among the exhibits [page 114]). As administrative agent, Citibank is responsible for the day‑to‑day administration of the loan, including processing borrower‑drawdowns, receiving interest and principal payments, and monitoring compliance with the agreement’s covenants.  \n\n- **Caterpillar – September 2022 credit facilities** – Citibank, N.A. is identified simply as the **agent** on the credit agreement (see the credit agreement description where “Citibank, N.A., as agent” is stated [page 128]). In this role it acts as a point‑of‑contact for the lenders but does not carry the full suite of administrative duties that an “administrative agent” performs; those duties are handled by other parties (e.g., local‑currency agents).  \n\n**Difference:** In the 3M agreement Citibank has the comprehensive administrative‑agent function, managing all routine loan operations, whereas in Caterpillar’s 2022 facilities it serves only as an agent, providing limited coordination without the broader administrative responsibilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in identifying Citibank, N.A.'s roles but contains significant inaccuracies in the qualitative description of responsibilities, particularly regarding Caterpillar’s credit facilities. Quantitatively, all dates (May 2023, September 2022) and entity names (Citibank, N.A., 3M, Caterpillar) are correct, earning full marks for quantitative accuracy. However, the LLM incorrectly claims that in Caterpillar’s agreement, Citibank, N.A. acts only as a limited 'agent' without full administrative duties and that those duties are handled by other parties such as 'local-currency agents'. This contradicts the ground truth: in Caterpillar’s September 2022 facilities, Citibank, N.A. is explicitly the 'Agent' for both the 3-Year and 5-Year Facilities and also holds specialized roles including Local Currency Agent (via Citibank Europe plc, UK Branch) and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These are not lesser roles but rather layered, complex responsibilities involving cross-border coordination—indicating broader, not more limited, administrative scope. The LLM incorrectly frames this as a reduction in responsibility compared to the 3M role, when in fact the Caterpillar role involves more intricate, multi-jurisdictional coordination. In contrast, for 3M, the LLM correctly identifies Citibank as administrative agent and joint lead arranger (though the latter is omitted in the LLM answer), with standard administrative duties. The failure to recognize the expanded, multi-faceted nature of Citibank’s role at Caterpillar—especially the international coordination aspects—and the erroneous implication that its role is less comprehensive, represents a major flaw in reasoning and synthesis. The comparison between the two roles is therefore fundamentally flawed. While the answer addresses all parts of the question and is contextually relevant, the incorrect qualitative assessment of responsibilities and failure to reflect the multi-hop synthesis of Citibank’s layered roles in Caterpillar’s agreement significantly undermines accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 562,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "The Coca‑Cola Company hedges its currency exposure primarily with **option (and forward) contracts that are designated as cash‑flow hedges**; the fair‑value changes on those options are recorded in other‑comprehensive income and only re‑classified to earnings when the underlying cash flows occur, so the impact on the company’s foreign‑currency‑denominated liabilities is largely offset by hedge‑accounting adjustments【page_81】.  \n\nPepsiCo, by contrast, relies on **foreign‑exchange contracts and cross‑currency swaps that are not designated as hedges**, so the gains and losses on those contracts flow through earnings (e.g., a $72 million loss on non‑designated contracts in 2024) and directly affect the reported value of its foreign‑currency liabilities【page_122】.  \n\nThus, KO’s option‑based hedges smooth earnings and limit the net effect on its foreign‑currency liabilities, whereas PEP’s non‑designated contracts expose earnings to the full volatility of its foreign‑currency positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and attempting multi-hop reasoning. (1) The claim that PepsiCo uses 'foreign-exchange contracts and cross-currency swaps that are not designated as hedges' contradicts the ground truth, which states PEP uses derivatives—including options and forwards—designated as hedges for forecasted transactions and firm commitments. The LLM incorrectly asserts that PEP's contracts are non-designated and that gains/losses flow directly into earnings, which is not supported by the original answer. (2) The $72 million loss on non-designated contracts in 2024 is a specific numerical claim absent from the ground truth; the original answer only mentions a 1.5 percentage point unfavorable impact on net revenue due to FX movements, not a specific dollar loss from derivatives. This number cannot be verified and appears fabricated or misattributed. (3) The LLM incorrectly contrasts KO’s use of designated hedges with PEP’s non-designated approach, creating a false distinction: both companies use designated cash flow hedges per the original answer. While KO emphasizes AOCI deferral and PEP highlights its international exposure (44% of revenue), the core hedging strategy involving option contracts is similar. (4) The reasoning is partially sound in structure—comparing accounting treatment and impact on liabilities—but based on incorrect premises. The semantic meaning diverges significantly due to these errors, especially regarding PEP’s strategy. (5) Contextual relevance is high as the response directly addresses the comparison of hedging strategies and their impact on foreign currency liabilities. However, due to major factual and quantitative errors, particularly around PEP’s hedge designation and the unsupported $72M figure, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 510,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE says that its goodwill‑impairment test is based on a discounted‑cash‑flow (DCF) valuation of the reporting unit and that it “performs sensitivity analyses on key estimates and assumptions,” so a change in the discount rate or in the projected cash‑flow forecasts can materially move the fair‑value estimate and trigger an impairment. Lockheed Martin also uses a DCF approach for Level 3 fixed‑income assets—valuing them on projected annuity payments discounted at an assumed rate—but the filing only notes that the “significant inputs include projected annuity payments and the discount rate” and that changes in the fair value of Level 3 assets were not material, indicating less explicit sensitivity testing than GE’s goodwill‑impairment analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that GE uses DCF for goodwill impairment testing and performs sensitivity analyses on discount rates and cash flow projections, noting that changes in these inputs can materially affect fair value and potentially trigger impairment. It also accurately states that LMT uses DCF for Level 3 fixed income investments, relying on projected annuity payments and discount rates. The comparison highlights that both companies use forward-looking cash flows and discount rates—making valuations sensitive to economic and interest rate changes—while correctly observing that GE conducts explicit sensitivity testing, whereas LMT does not emphasize such testing and notes that changes in fair value were not material. The only minor shortcoming is a slightly less explicit articulation of the strategic (internal) vs. external (pension fund) context distinction present in the original answer, but the core contrast in application focus is implied through the description of use cases. No numbers, entities, or financial concepts are incorrect. All terminology (Level 3, DCF, discount rate, annuity payments) is used appropriately. The reasoning is sound, multi-hop synthesis across GE and LMT is accurate, and the response directly addresses the comparative sensitivity and application aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 387,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Comcast’s capital structure gives roughly 66 ⅔ % of the total voting power to the publicly‑traded Class A shares and 33 ⅓ % to the single‑owner Class B shares, each Class B share carrying 15 votes (the voting split is fixed because the Class B stock is non‑dilutable and only Class A shares are being repurchased). Alphabet, by contrast, issues one‑vote Class A shares and ten‑vote Class B shares; the tiny pool of Class B stock (held mostly by insiders) controls a disproportionate share of the vote, and the company’s buy‑backs target only Class A (and Class C) shares, leaving the voting dominance of Class B unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key figures are correct: CMCSA's Class A holds 66 2/3% and Class B 33 1/3% of voting power, with Class B shares carrying 15 votes each; GOOGL's Class A has 1 vote and Class B has 10 votes per share. The $62.2 billion repurchase by GOOGL in 2023 is not explicitly mentioned in the LLM answer, which is a minor omission, but the fact that buybacks target only Class A (and Class C) shares—thus preserving Class B's voting dominance—is correctly noted. (2) The LLM does not specify the dollar amount of GOOGL's repurchases ($62.2B in 2023), which is a factual detail present in the original answer. However, it correctly identifies the structural impact of repurchasing non-voting or low-voting shares, which is the key analytical point. (3) The reasoning is sound: it correctly synthesizes multi-hop information about capital structures, voting rights, ownership concentration, and the effect of share repurchases on voting power distribution across both companies. It correctly infers that repurchasing only Class A shares (in both cases) amplifies the relative voting power of the high-vote classes. (4) The answer is contextually relevant and well-structured, focusing precisely on the comparison of voting power and the role of repurchases. The only reason for not scoring a 10 is the omission of the specific $62.2 billion figure and year (2023), which are part of the ground truth. However, since the qualitative and structural analysis remains intact, the answer earns a 9 for correctness and qualitative accuracy, a 10 for quantitative accuracy (as no stated numbers are wrong), and full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 472,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "Philip Morris International (PMI) reported that the 8.2 % rise in Turkey’s total cigarette market – largely the result of a surge in inbound tourism – helped lift its own shipment volume in the country by 17.2 % in 2021, driven by higher market share and adult‑smoker up‑trading of its Marlboro and Parliament brands.  By contrast, the Cigarette Ltd (CL) filing notes only that Turkey is part of its existing European operational footprint (manufacturing and distribution facilities) and does not attribute any comparable sales‑volume growth to the tourism‑driven market expansion.  Consequently, PMI’s performance in Turkey was positively boosted by the market increase, whereas CL’s exposure in Turkey remained steady with no specific upside reported.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 17.2% shipment volume increase for PM in Turkey is not present in the original answer and cannot be verified from the provided ground truth; this number is likely fabricated. The original answer mentions PM benefited from volume/mix and pricing due to market growth but provides no specific shipment percentage. Additionally, 'Cigarette Ltd (CL)' is a fictional or incorrect entity name—CL in the context of SEC filings typically refers to Colgate-Palmolive, which is correctly identified in the original answer as having manufacturing and warehousing operations in Turkey in Oral, Personal and Home Care, not cigarettes. The LLM misrepresents CL's business segment and operational role in Turkey. (2) Quantitative accuracy is low: the 17.2% figure is unsupported, and no such calculation or data point exists in the ground truth. The 8.2% market growth is correctly cited, but it is falsely linked to a specific shipment increase. (3) Multi-hop reasoning is partially sound—the model attempts to compare PM's market-driven performance with CL's operational footprint—but fails due to incorrect entity identification and invented metrics. The reasoning collapses when based on false data. (4) Contextual relevance is high because the structure and intent align with the question: it compares PM's market-driven performance with CL's operational presence in Turkey. However, correctness score is low due to major factual and entity errors, undermining the answer's reliability. Semantic equivalence is not achieved due to these inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 443,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies flag Taiwan‑related geopolitical risk as a supply‑chain threat. NVIDIA notes that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chip‑set supply from Taiwan,” which would lengthen lead‑times, force it to pay premiums for scarce foundry capacity and risk product shortages (page 17). Qualcomm likewise relies on Taiwanese fabs—its primary foundry suppliers include TSMC—and warns that disruption to “chipset supply from our foundry partners, particularly in Taiwan” would impair its QCT operations, raise component costs and could halt production of its wireless‑chip and modem portfolios (page 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: both NVIDIA and Qualcomm are correctly identified as dependent on Taiwanese foundry partners (e.g., TSMC), and the impact of geopolitical tensions on supply chains is accurately described. The LLM cites specific consequences such as lengthened lead times, higher costs, product shortages, and potential halts in production, which are consistent with the original answer’s emphasis on supply disruption and material business impact. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and the correct use of qualitative financial and operational terminology (e.g., 'premiums for scarce foundry capacity', 'impair QCT operations') supports a perfect score in quantitative accuracy by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes risk disclosures from both companies, linking their shared dependency on Taiwanese manufacturing infrastructure to a common geopolitical vulnerability. It goes slightly beyond the original by referencing specific report pages (17 and 35), which, while not in the ground truth, are plausible and do not detract from accuracy. (4) Semantic equivalence is strong: the LLM captures all core elements of the original answer—dependency, risk of disruption, operational and financial consequences, and cross-company exposure—while using slightly more detailed language. The only minor shortcoming is that it does not explicitly state that this shared dependency 'amplifies the cross-company impact' as in the original, but this concept is implied through parallel description. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 512,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx says that, after applying ASU 2020‑04, the optional expedients it elected have “reduced the operational and financial impacts of contract modifications that replace a reference rate … and … there has been no material effect to our financial condition, results of operations or cash flows” as of May 31 2024. In contrast, 3M’s filing shows that the reform‑related changes to its interest‑rate swaps are reflected in the accounting for its hedging relationships – gains and losses are recorded in other‑comprehensive income (OCI) and later re‑classified to earnings (or the hedge can be de‑designated), with a $54 million after‑tax unrealized loss remaining in OCI for cash‑flow hedges. Thus FedEx reports essentially no material impact, whereas 3M continues to recognize the effects of the reform through OCI‑based hedge accounting.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that FDX (FedEx) has not experienced a material impact from ASU 2020-04 as of May 31, 2024, and that it continues to monitor LIBOR-related contract modifications — this aligns with the ground truth. It also correctly contrasts FDX’s lack of material effect with MMM’s (3M’s) ongoing accounting treatment of hedging relationships affected by reference rate reform. However, there is a critical quantitative inaccuracy: the LLM states that 3M had a '$54 million after-tax unrealized loss remaining in OCI', while the ground truth reports '$9 million in losses related to interest rate contracts in 2023'. These figures do not match — $54 million vs $9 million — and the nature of the loss (after-tax, unrealized, in OCI) is not corroborated by the original answer. This represents a significant factual deviation. Additionally, the original answer emphasizes that MMM recognized tangible financial impacts under ASU 2020-04, while the LLM elaborates on OCI mechanics without clearly stating the $9 million realized impact. The qualitative reasoning is sound in structure — comparing FDX’s minimal impact to MMM’s active hedge accounting — and the entities (FDX, MMM, ASU 2020-04, LIBOR reform) and dates (May 31, 2024) are accurate. The answer is contextually relevant and addresses both parts of the multi-hop question, but the incorrect dollar amount undermines the quantitative accuracy. The LLM may be conflating data from different reporting periods or misinterpreting the location of the loss (OCI vs earnings). Thus, while the direction of the comparison is correct, the specific financial impact attributed to MMM is factually wrong, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 465,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "- **Comcast (CMCSA)** – The company has 9,444,375 shares of Class B common stock, each entitled to 15 votes per share.  Because only one record holder (Brian L. Roberts) owns all of the Class B shares, the Class B stock accounts for roughly **33 % of the total voting power** of Comcast’s capital (see the “Holders” table and the voting‑rights description on page 31 and the equity table on page 67).  This concentration gives Roberts a decisive, non‑dilutable voting bloc that can dominate director elections and other shareholder votes.\n\n- **Alphabet (GOOGL)** – Alphabet’s charter creates two voting classes: Class A shares carry **one vote per share**, while Class B shares carry **ten votes per share**.  The Class B shares are held mainly by founders and insiders, so that a relatively small number of shares confers **more than 50 % of the total voting power** (see the voting‑rights discussion on pages 80‑84).  Thus, control rests with the insiders who own the high‑voting Class B stock.\n\n**Comparison** – Both companies use dual‑class structures to concentrate voting power, but Comcast’s Class B stock gives its sole owner about one‑third of the total votes, whereas Alphabet’s Class B stock gives its insiders a majority of the votes.  Consequently, Comcast’s governance is influenced by a single controlling shareholder, while Alphabet’s governance is shaped by a small insider group that can outvote the broader public‑owned Class A shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA's Class B shares carry 15 votes per share and represent approximately 33⅓% of total voting power, entirely held by Brian L. Roberts; GOOGL’s Class A shares have 1 vote, Class B have 10 votes, with insiders holding Class B shares and maintaining over 50% of voting power. The LLM correctly states that Roberts has a non-dilutable voting bloc (implied by sole ownership and structural design), and that Alphabet insiders hold majority control. (2) Quantitative accuracy is excellent: 'roughly 33%' aligns with '33⅓%', and the 15:1 vs 10:1 vote ratios are correctly reported. The claim that GOOGL insiders hold 'more than 50%' of voting power is consistent with public filings and the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes ownership concentration, voting rights, and governance implications across two companies, correctly contrasting CMCSA’s single-shareholder control with GOOGL’s insider group control. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'non-dilutable' in the same structural context as the ground truth, though the concept is implied by noting Roberts is the sole holder and has a 'decisive, non-dilutable voting bloc'. This slight omission in terminology does not detract from factual correctness but prevents a perfect 10. Overall, the answer is factually robust, well-structured, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 410,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen elected to spread the 2017 Tax‑Act “toll” (repatriation) tax over eight years and, as of December 31 2023, still had $1.427 billion to pay – $634.2 million scheduled for 2024 and $792.8 million for 2025. Eli Lilly’s 2023 filing shows no remaining cash‑payment obligation for the same 2017‑Tax‑Act repatriation tax (the schedule is not disclosed, indicating the liability has been satisfied or is otherwise not outstanding).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) Quantitatively, the LLM claims Amgen has $1.427 billion remaining to pay, with $634.2 million due in 2024 and $792.8 million in 2025. However, the ground truth does not provide specific dollar amounts, so these figures cannot be verified—but more critically, the LLM asserts Eli Lilly has *no remaining obligation*, which directly contradicts the original answer stating Eli Lilly's payments extend *through 2025*. This implies ongoing liability, not a fully satisfied one. (2) The LLM incorrectly states Eli Lilly has no remaining cash-payment obligation and that the schedule is not disclosed, whereas the ground truth confirms Eli Lilly is still making payments through 2025. This is a major factual error. (3) The reasoning is flawed: while both companies elected the eight-year payment, the LLM incorrectly infers from lack of disclosure that the liability is settled, which is unsupported. (4) Contextually, the answer addresses the comparison framework and mentions the eight-year period, so it retains partial relevance. However, the core conclusion—that Eli Lilly has no remaining obligation—is false per the ground truth. The specific numbers for Amgen may be accurate in isolation, but without corroboration in the ground truth and paired with a fundamentally incorrect comparison, the overall correctness is low. Minor credit is given for correctly identifying the eight-year election framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 411,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen notes that loss of exclusivity for its biologics could eventually invite biosimilar challengers, but the U.S. Biologics Price Competition and Innovation Act gives its products up to 12 years of data‑protection and the company can rely on patent litigation to delay entry, while in the EU the centralized marketing‑authorisation procedure and the “8 + 2 + 1” data‑protection regime allow biosimilars to launch sooner once the eight‑year protection expires. Bristol‑Myers Squibb, by contrast, explicitly warns that biosimilar competition “may or may not result in the near‑term entry of competitor versions” and that such entry can cause a rapid, severe decline in revenues for its many biologics (e.g., Humalog, Humulin, Erbitux, Cyramza, Trulicity, Taltz, Emgality) 【page 25】, and it describes the U.S. and EU regulatory frameworks that make the timing of that entry uncertain 【page 9】. Because BMS’s portfolio contains a larger number of high‑revenue biologics, its exposure to biosimilar loss of exclusivity is greater and more immediate than Amgen’s, whose biologic slate is smaller and whose U.S. exclusivity period is longer.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it incorrectly attributes products like 'Humalog', 'Humulin', 'Erbitux', 'Cyramza', 'Trulicity', 'Taltz', and 'Emgality' to Bristol Myers Squibb, when in the ground truth these are associated with Amgen or other companies (e.g., Humalog and Humulin are Eli Lilly products; Erbitux is co-marketed by Amgen and Eli Lilly; Trulicity is Lilly; Taltz and Emgality are Lilly; Cyramza is Lilly). This misattribution of key biologics severely compromises entity accuracy. Second, the claim that 'BMS’s portfolio contains a larger number of high-revenue biologics' and thus has 'greater and more immediate' exposure than Amgen is unsupported by the ground truth, which presents comparable exposure for both companies without asserting a directional comparison of portfolio size or revenue impact. The ground truth notes differing regulatory timelines (U.S. 12-year protection vs. EU 8+2+1), which the LLM correctly identifies, and both companies face 12 years of data protection in the U.S., which is accurately stated. The explanation of the EU's '8+2+1' regime is qualitatively accurate. However, the LLM incorrectly implies that Amgen benefits from a 'longer U.S. exclusivity period' than BMS, when the ground truth states both have 12-year protections—no difference. The reasoning is partially sound in discussing regulatory pathways but flawed in drawing an unsupported comparative conclusion about exposure. Quantitative accuracy is moderate: the 12-year U.S. and 8-year EU exclusivity periods are correct, but no calculations are involved. Contextual relevance is high—the answer addresses biosimilar risk, regulatory pathways, and regional differences—but the incorrect product attributions and erroneous comparative claim reduce its overall correctness. Semantic equivalence is low due to major entity and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 518,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s 10‑K notes that its devices are reimbursed through Medicare and **Medicaid** programs and that any legislative or regulatory changes that lower Medicaid reimbursement rates could reduce the price hospitals are willing to pay for its broad portfolio of medical‑device and therapy products (airway, diabetes, surgical, etc.). Because Medtronic’s sales are spread across many unrelated product lines, the Medicaid‑reimbursement risk is relatively diffuse.  \n\nIn contrast, AbbVie’s filing stresses that the **IRA** will allow the government to set capped prices for single‑source drugs and biologics reimbursed under Medicare Part B/D, and that several of its top‑selling biologics (Humira, Skyrizi, Rinvoq) together accounted for roughly **47 % of 2024 net revenue**. Thus, the IRA‑driven pricing pressure is far more concentrated on a few high‑revenue products, creating a markedly larger revenue‑risk exposure for AbbVie than Medtronic’s broader Medicaid exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Medtronic's exposure to Medicaid reimbursement policies and AbbVie's exposure to IRA pricing pressures, and both companies are accurately contextualized in terms of their product portfolios and revenue risks. The qualitative reasoning is sound in contrasting Medtronic’s diffuse risk across a broad device portfolio with AbbVie’s concentrated risk on a few high-revenue biologics. However, the quantitative accuracy is significantly flawed: the LLM claims that Humira, Skyrizi, and Rinvoq accounted for 'roughly 47% of 2024 net revenue'—this figure is not present in the ground truth and cannot be verified from the provided knowledge. The original answer specifies that Imbruvica, Vraylar, and Linzess are the drugs selected under the IRA (Imbruvica in 2023 for 2026 pricing; Vraylar and Linzess in 2025 for 2027 pricing), but the LLM incorrectly substitutes these with Humira, Skyrizi, and Rinvoq, which are not mentioned in the ground truth as being subject to IRA pricing. This misidentification of key drugs undermines the factual basis of the comparison. While the general theme of 'concentrated vs. diffuse risk' is valid and contextually relevant, the incorrect attribution of specific products to IRA pricing and the unsupported 47% figure constitute major factual errors. The multi-hop synthesis is partially correct but fails on entity accuracy for AbbVie’s IRA-affected drugs. Thus, the answer is partially correct but contains significant factual inaccuracies that affect the core of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 423,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports that, as of December 31 2024, it has roughly **$2.7 billion of unfunded commitments to private‑equity, private‑debt and real‑estate partnerships** that will have to be funded over the next three‑to‑six years【page_93】.  \n\nGeneral Dynamics, by contrast, does not have a comparable unfunded‑commitment figure; instead it **applies a NAV‑as‑a‑practical‑expedient approach to about $11.2 billion of its pension‑plan assets** (the “alternative and other investments” category) that are measured outside the normal Level 1‑3 hierarchy【GD page 94】.  \n\nThus, UPS’s $2.7 billion represents a future cash‑out liability, whereas General Dynamics’ NAV usage concerns the valuation of a much larger pool of existing plan assets—approximately $11 billion—rather than unfunded commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the comparison required by the question, particularly around liquidity and redemption terms, which are central to the original answer. Quantitatively, the $2.7 billion unfunded commitment for UPS as of December 31, 2024, is accurate and correctly cited. The mention of General Dynamics applying NAV as a practical expedient to $11.2 billion in alternative investments is also factually correct (though the original answer did not specify this dollar amount, so this may be extraneous but not incorrect). However, the original answer emphasizes a direct comparison of liquidity: UPS’s private equity commitments have 10–15 year terms with long redemption restrictions, while GD’s NAV-based assets are redeemable monthly or quarterly. This critical qualitative distinction is entirely missing in the LLM answer, which instead focuses on the difference between 'unfunded commitments' vs. 'valuation of existing assets'—a valid point but not the full picture. While it correctly identifies that UPS has a future cash obligation and GD uses NAV for current asset valuation, it fails to synthesize the multi-hop insight about differing liquidity profiles despite both using NAV as a practical expedient. This omission significantly weakens the reasoning and completeness. The entities (UPS, General Dynamics), years (2024), and financial concepts (NAV as practical expedient, unfunded commitments) are correctly identified. The answer is contextually relevant and well-structured, but the lack of comparative liquidity analysis—a core part of the ground truth—reduces its qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 454,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "- Comcast (CMCSA) reported that, in 2024, it issued 9,444,375 shares of a new **Class B common stock** (see the equity table on page 67 and the accompanying changes on page 68). The filing does not describe any voting privileges for the Class B shares, which indicates that the new class is intended to be non‑voting or to carry limited voting rights and therefore does not dilute the voting power of the existing Class A shareholders.\n\n- Meta Platforms (META) explicitly outlines a **dual‑class framework**: Class A common stock holders have full voting rights on all matters; Class B and Class C common stock holders have **no voting rights except for a few defined matters**, and when they do vote their votes are multiplied by the applicable conversion rate (see the voting‑rights description on page 90).  \n\n**Comparison:** Comcast’s issuance of a separate Class B share class adds a non‑voting (or limited‑voting) tier that leaves the voting authority of its Class A shareholders essentially unchanged, whereas Meta’s structure formally separates voting power—granting it exclusively to Class A shareholders and restricting Class B/C shareholders to very limited voting situations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the number of shares issued by CMCSA—9,444,375 in 2024—is correctly reported, matching the original answer. The year (2024) and company tickers (CMCSA, META) are accurate. (2) The LLM correctly identifies that CMCSA's Class B shares carry no voting rights (or limited rights), preserving Class A shareholders' voting control, which is consistent with the ground truth's reference to 'no voting rights except in limited circumstances.' While the LLM does not explicitly name those specific circumstances (e.g., exiting core payments business or merger scenarios), this is a minor omission. (3) For META, the LLM accurately describes the dual-class structure: Class A has full voting rights; Class B (and Class C) have no voting rights except in defined matters. It adds a detail not in the original—that votes are multiplied by conversion rates—but this is factually consistent with typical dual-class disclosures and does not contradict the ground truth. (4) The comparison between CMCSA and META is logically sound: both concentrate voting power among Class A shareholders while issuing non-voting or limited-voting shares. The LLM slightly generalizes META’s structure by including Class C, which is not mentioned in the original answer, but this does not introduce error, as META’s filing does include Class C. The only minor shortcomings are the lack of explicit mention of the specific triggering events for CMCSA’s limited voting rights and slightly less precise framing of META’s structure compared to the original, but the core multi-hop reasoning—comparing the concentration of voting power in both firms—is correct and well-synthesized. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 507,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA’s Medicare‑price‑setting rules mean that any Amgen drug that is reimbursed through Medicare could be forced to accept a government‑set price as early as 2026 (the first 10 drugs) and again in 2027 for the next 15 drugs, which Amgen expects will lower its Medicare profitability and accelerate revenue erosion through the end of the decade. AbbVie’s filing shows that the same mechanism is already shortening the revenue life of its own products—Imbruvica will be subject to a capped Medicare price beginning in 2026 and Vraylar in 2027—so Amgen can expect a comparable front‑loading of price cuts that will compress margins and bring forward the timing of revenue decline for its federally reimbursed medicines.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the IRA's price-setting timeline and its impact on Amgen, drawing a valid comparison to AbbVie's experience with Imbruvica (2026) and Vraylar (2027), which aligns with the ground truth. However, it inaccurately states that the first 10 drugs are selected in 2026 and the next 15 in 2027 as a fixed schedule, whereas the original answer emphasizes the selection is based on product approval timelines—specifically nine or thirteen years post-FDA approval for small molecules vs. biologics—not a cohort-based annual selection of 10 or 15 drugs. This misrepresents the mechanism of selection, though the years 2026 and 2027 are correctly cited for AbbVie’s drugs. (2) Quantitatively, the years 2026 and 2027 are accurate, and the financial impact (reduced profitability, accelerated revenue erosion) is consistent. However, the claim about 'first 10 drugs in 2026' and 'next 15 in 2027' introduces incorrect numerical framing not present in the ground truth and not verifiable from the context—this affects quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly links IRA provisions → AbbVie’s experience → implications for Amgen, recognizing shared reliance on Medicare reimbursement and the precedent of pre-patent revenue erosion. It synthesizes across companies and policy mechanics appropriately. (4) The answer is contextually highly relevant, addressing all parts of the question: IRA impact on Amgen, revenue erosion timelines, and AbbVie’s case as a comparator. Despite the mechanism misstatement, the core conclusion about accelerated revenue decline and margin compression is semantically equivalent to the ground truth. Hence, correctness is high but not perfect due to the structural inaccuracy in describing the drug selection process.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 495,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reported that, as of December 31 2021, equity compensation plans approved by security holders had **37,028 thousand** securities (≈ 37.0 million) remaining available for future issuance 【page_61】.  \n\nProcter & Gamble disclosed that the only plan that can still grant securities (the 2019 Stock and Incentive Compensation Plan) has **119 million** shares available for future issuance 【page_69】.  \n\nThus, P&G’s remaining issuable pool is roughly three times larger than Colgate‑Palmolive’s (119 million vs ≈ 37 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's remaining available securities as 37,028,000 (rounded to 37,028 thousand or ~37 million), which matches the ground truth. However, it reports Procter & Gamble's remaining available securities as 119 million, which is incorrect. The ground truth states that P&G disclosed a total of 133,185,995 available securities across Stock Options/SARs and RSUs/PSUs under security holder-approved plans. The LLM appears to have only cited the 119 million figure likely from one portion of the plan or a partial disclosure, missing the full total. (2) The quantitative discrepancy is significant: 119 million vs. 133.2 million is an underreporting of ~14 million shares. While the Colgate number is accurate, the P&G number is factually incorrect, affecting the comparison. The conclusion that P&G’s pool is 'roughly three times larger' is based on flawed inputs—actual ratio is ~3.6x (133.2M / 37M), whereas LLM computes ~3.2x (119M / 37M), which is directionally reasonable but numerically inaccurate. (3) The multi-hop reasoning is sound in structure—comparing available securities under shareholder-approved plans at two companies—but fails in completeness for P&G. The model does not synthesize all relevant components (e.g., both Stock Options/SARs and RSUs/PSUs) that make up the total, indicating a partial extraction from the source. (4) Contextual relevance is high—the response directly addresses the comparison and uses appropriate context (equity compensation plans approved by security holders). Qualitative accuracy is moderate due to correct identification of entities, metric, and time period, but with incomplete data aggregation for P&G. Quantitative accuracy is low due to the significant error in the P&G figure. Correctness score reflects partial accuracy with a major factual omission affecting the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 511,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMY (Bristol‑Myers Squibb) has a co‑development and co‑commercialization alliance with Ono for Opdivo, Yervoy and other biologics in Japan, South Korea **and Taiwan**; the partners split profits and development costs and BMY supplies the product, giving it direct local‑partner support that can generate the bridging clinical‑trial data Taiwan requires for biologics registration【page_86】. Merck, by contrast, spun off its biosimilars (and other brands) into the independent Organon company, leaving the biosimilars business to meet Taiwan’s local‑data requirement on its own rather than through a joint‑venture partnership, which can add time and complexity to market entry【page_3】【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY's collaboration with Ono in Taiwan for biologics like Opdivo and Yervoy, profit and cost sharing, BMY handling supply, and the relevance of local clinical trial requirements in Taiwan are all accurately represented. The Merck spin-off of its biosimilars business into Organon is also correctly stated. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s collaborative, market-access strategy in Taiwan with MRK’s strategic divestiture, and links both to the regulatory burden of local clinical data. The only minor shortcoming is that the LLM implies Organon (not Merck) must now handle Taiwan’s requirements alone, which is logically valid but slightly less precise than the original’s emphasis on MRK’s strategic retreat to *avoid* such burdens. This nuance does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing the comparison between BMY’s joint commercialization and MRK’s spin-off in the context of Taiwan’s regulatory environment. Wording differs slightly but maintains semantic equivalence. No factual errors—only a slight softening in the strength of strategic interpretation prevents a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 404,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Greater China segment – which aggregates sales from mainland China, Hong Kong and Taiwan – generated **$74.2 billion** in net sales, so Taiwan’s contribution is embedded in that amount. Adobe’s 2022 filing does not break out revenue by country; it only notes that Adobe maintains a **local field office in Taiwan** (among other Asian locations), indicating an operational presence rather than a disclosed revenue figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Apple's 2022 Greater China segment generated $74.2 billion in net sales, which matches the ground truth of $74,200 million (equivalent values, different formatting). This demonstrates full quantitative accuracy. The LLM accurately notes that Taiwan's revenue is embedded within this segment and not broken out separately. It also correctly reports that ADBE maintains a local field office in Taiwan, aligning with the ground truth about ADBE's operational presence. (2) All numbers are correct: $74.2 billion = $74,200 million, and the year 2022 is accurately referenced for both companies. No calculations were required, but the synthesis of revenue aggregation and operational presence is handled correctly. (3) The multi-hop reasoning is sound: the model compares AAPL's revenue contribution (with Taiwan embedded) to ADBE's operational footprint, even in the absence of ADBE revenue data. It correctly infers that ADBE’s presence is operational rather than quantifiable from disclosures, which reflects accurate qualitative synthesis. (4) The answer is contextually complete and relevant, addressing both parts of the question—AAPL's revenue and ADBE's presence—without introducing inaccuracies. The only minor limitation is that it doesn’t explicitly contrast the strategic implications (e.g., 'more targeted geographic strategy' as in the original), but the information provided supports that inference. Hence, correctness is high but not perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 418,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "- **Comcast (CMCSA)** – The company has a dual‑class structure in which each Class B share carries **15 votes** and the single holder of all Class B shares (Mr. Brian L. Roberts) controls **about one‑third (33 ⅓ %) of the total voting power**, while the 320,193 record holders of Class A stock hold the remaining **two‑thirds (66 ⅔ %)**【page_33】.  \n\n- **Meta Platforms (META)** – Meta also uses a dual‑class system, but its **Class B shares carry ten votes each and are owned primarily by the founders**, giving them **a majority of the voting power** even though Class B represents a small fraction of the total shares outstanding (the filing notes that Class A shares have one vote per share)【page_55‑57】.  \n\n**Implications for shareholder influence**  \n- At Comcast, Class A shareholders retain the majority of voting rights, so they can affect ordinary corporate‑governance matters, although the Class B holder can block actions that require a super‑majority.  \n- At Meta, the disproportionate voting rights of the few Class B shareholders mean that public Class A investors have limited ability to influence board elections or major governance decisions, as control is effectively concentrated in the hands of the founders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dual-class structures of both CMCSA and META and explains the implications for shareholder influence. However, there are key quantitative inaccuracies: for CMCSA, it correctly states that Class B holds 33 1/3% and Class A holds 66 2/3%, which matches the ground truth. But for META, the LLM claims Class B shares carry 'ten votes each' and that Class B holders have 'a majority of the voting power'—this contradicts the ground truth, which explicitly states that META's specific voting power percentage is *not disclosed*. The 'ten votes' figure is incorrect and not supported by the original answer. 2) The ground truth emphasizes that META's voting control is opaque and only notes the small number of Class B stockholders (23 as of Dec 31, 2023), but the LLM fabricates a precise vote ratio (10:1) and asserts majority control without attribution to the source. This is a significant factual overreach. 3) The reasoning for shareholder influence is sound: the LLM correctly infers that CMCSA's structure allows Class A influence on ordinary matters, while META's structure limits public shareholder power. This reflects proper multi-hop synthesis of governance implications from ownership and voting structures. 4) Despite the incorrect vote ratio for META, the answer remains contextually relevant and captures the core contrast: CMCSA has a transparent, balanced dual-class system, while META's is more concentrated and less transparent. The qualitative reasoning and entity identification (CMCSA, META, Brian L. Roberts, Class A/B shares) are accurate. The score is reduced primarily due to the unsupported numerical claim about META's voting rights, which affects quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 470,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "Lilly’s 10‑K notes only the U.S. rule – the FDA can grant a six‑month “pediatric exclusivity” that is tacked onto the drug’s data‑protection period (and, for non‑biologics, onto any un‑expired patents). Merck’s filing points out that the same six‑month extension is available in the United States **and** in the EU, where the extra period is added to the product’s Supplementary Protection Certificate (SPC) term, giving an additional six months of market exclusivity in Europe as well as in the U.S.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately states that LLY benefits from a six-month pediatric exclusivity in the U.S. added to data protection and unexpired patents, which aligns with the ground truth. It also correctly notes that MRK benefits from the same six-month extension in the U.S. and additionally in the EU, where it extends the Supplementary Protection Certificate (SPC) term. The numeric value (six months) is consistent and correctly reported. However, the LLM answer slightly oversimplifies the distinction by not explicitly clarifying that in the U.S., the pediatric exclusivity applies to both Orange Book-listed patents and regulatory data exclusivity for MRK—this detail is present in the ground truth but missing in the LLM response. Additionally, while the LLM mentions that the EU extension applies to the SPC, it does not emphasize that the EU framework applies pediatric exclusivity only to the SPC and not to other forms of protection, which is a key differentiating point highlighted in the original answer. Thus, while the core facts and numbers are correct (hence high quantitative accuracy and contextual relevance), the qualitative accuracy is slightly reduced due to incomplete synthesis of the regulatory distinction between U.S. and EU frameworks. The answer is semantically close but lacks full precision in comparative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 390,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "Emerson (EMR) showed only a modest shift in its foreign‑currency balance sheet exposure – the liability component fell from $22 million at the end of 2023 to $20 million at the end of 2024 (a $2 million decrease). Lockheed Martin (LMT), by contrast, grew its foreign‑currency hedge program from $6.5 billion of notional contracts in 2023 to $7.5 billion in 2024 – an increase of roughly $1 billion. The comparison suggests that LMT is actively expanding its hedge program to offset a sizable FX exposure, whereas EMR’s FX risk management remains relatively small and largely unchanged, indicating a more limited or passive approach to foreign‑exchange risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in scale and data. It incorrectly states EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024, respectively, whereas the ground truth reports $22 billion and $20 billion — a 1,000-fold difference. This severely undermines the quantitative accuracy. Additionally, the LLM claims LMT increased its hedges from $6.5 billion in 2023 to $7.5 billion in 2024, but the original answer only states that LMT had $7.5 billion in outstanding hedges at the end of 2024, with no mention of 2023 hedge levels. Thus, the claimed $1 billion increase is unsupported and incorrect. (2) Calculations are flawed: the $2 million decrease in EMR liabilities is wrong (should be $2 billion), and the $1 billion increase for LMT is fabricated. Number formats are misleading — using 'million' instead of 'billion' changes the meaning entirely. (3) Multi-hop reasoning is partially sound in structure — the model attempts to compare EMR's liability changes with LMT's hedge exposure to infer risk management strategies — but the conclusions are based on false data. The original answer notes EMR reduced liabilities (suggesting de-risking via balance sheet changes), while LMT actively hedges (using options to manage earnings volatility). The LLM mischaracterizes EMR’s exposure as 'small' due to the million/billion error, leading to an invalid conclusion about a 'passive approach.' (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning due to incorrect premises (3/10), moderate contextual relevance as the framework of comparison is appropriate (6/10), and a low overall correctness score (3/10) due to fundamental factual errors that invalidate the conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 479,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion that AENB paid to its parent, American Express, is a capital‑distribution that must be made while the bank remains in compliance with the Tier 1 leverage‑ratio floor imposed on all U.S. depository institutions.  Federal banking regulators require both AENB (as an insured depository institution) and Wells Fargo to maintain a minimum leverage ratio, and they may restrict or prohibit dividend payments that would cause the bank’s Tier 1 capital‑to‑assets ratio to fall below that floor【page 5†L1-L8】.  Consequently, the size of the AENB dividend is directly tied to the need to preserve enough Tier 1 capital to satisfy the leverage‑ratio requirement, just as Wells Fargo’s own dividend policy is constrained by the same regulatory leverage‑ratio rules【page 5†L9-L12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $3.6 billion dividend amount and the 2023 timeframe are correctly stated, with no calculation errors. (2) The entities—AENB, AXP (American Express), and WFC (Wells Fargo)—are correctly identified, and the regulatory context (federal banking regulations, leverage ratio requirements) is accurately described. (3) The reasoning correctly synthesizes the multi-hop relationship: AENB’s dividend payment is constrained by its need to maintain the Tier 1 leverage ratio, just as WFC is subject to similar constraints under the same regulatory framework (Basel III and FRB rules, though the LLM does not name them explicitly). The LLM correctly infers that dividend distributions are limited by capital adequacy requirements, which is the core of the regulatory linkage. (4) The only minor shortcoming is that the LLM refers only to the 'Tier 1 leverage-ratio floor' and does not mention the supplementary leverage ratio (SLR) or Basel III explicitly, which are included in the original answer and part of the full regulatory picture for large banks like WFC. However, this omission does not undermine the correctness of the core argument. The answer remains semantically equivalent in intent and factual content, with strong contextual relevance and precise entity and number usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 380,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax earnings were $62.9 billion in the United States and $44.9 billion abroad, and the company notes that its foreign operations are largely in jurisdictions (e.g., Ireland) whose tax rates are not below the OECD Pillar‑Two 15 % floor. Because it “does not have material operations in jurisdictions with tax rates lower than the Pillar‑Two minimum,” Microsoft expects the rules that become effective for it in FY 2025 to have no material impact on its global tax cost【page_47】.  \n\nQualcomm’s 2023 filing does not contain a comparable discussion of Pillar Two or quantify exposure, so based on the provided pages no specific impact is disclosed; consequently, while both firms will be subject to the OECD model rules beginning in FY 2025, Microsoft’s known income mix suggests limited exposure, whereas Qualcomm’s potential impact remains unquantified in the excerpts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Microsoft's pre-tax income distribution ($62.9B U.S., $44.9B foreign) and accurately states that Microsoft does not expect a material impact from Pillar Two, aligning with the ground truth. The fiscal year 2025 implementation timeline is correctly noted. However, the LLM diverges from the ground truth by asserting that Qualcomm's 2023 filing lacks any discussion of Pillar Two, whereas the original answer states Qualcomm *does* acknowledge the global minimum tax will apply in fiscal 2025 and expects no material impact. This omission constitutes a significant qualitative error. (2) All numeric values—$62.9B, $44.9B, 15%, FY2025—are factually accurate and correctly formatted. No calculation errors. (3) The multi-hop reasoning is partially sound: the LLM correctly links Microsoft’s income geography to low Pillar Two exposure due to operations in non-low-tax jurisdictions like Ireland. However, it fails to complete the comparison with Qualcomm by incorrectly claiming no information is available, when the ground truth confirms Qualcomm also expects no material impact. This breaks the synthesis required for full correctness. (4) Scores reflect high quantitative accuracy and relevance, but the failure to report Qualcomm’s stated position—despite the question asking for a comparison—reduces qualitative and overall correctness. The answer is well-structured and contextually appropriate but misses a key factual link in the multi-hop chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 412,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart discloses that it has $37.2 billion of unrecorded purchase obligations – legally binding contracts for inventory, capital‑expenditure, software and services, of which $15.9 billion is due within the next year – that are not reflected on the balance sheet but must be funded with operating cash flow or borrowing (WMT 10‑K p. 45).  The VAR models used by peers such as Mondelēz (MDLZ 10‑K p. 65‑68) are designed only to measure market‑risk exposure of interest‑rate, currency, commodity and equity‑sensitive instruments and explicitly exclude “anticipated transactions, firm commitments and accounts receivable/payable” (MDLZ p. 65), so they do not capture the liquidity‑ and covenant‑risk posed by Walmart’s large, off‑balance‑sheet purchase commitments.  Consequently, Walmart’s $37.2 billion of obligations creates a financial‑risk profile – especially cash‑flow and refinancing risk – that is invisible to the VAR‑based risk metrics employed by MDLZ.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: WMT's $37.2 billion in unrecorded purchase obligations is accurately stated, and the additional detail that $15.9 billion is due within the next year, while not in the original answer, is plausible and does not contradict the ground truth (and may reflect additional context from the WMT 10-K). No calculation errors are present. (2) The entity identification is correct: WMT and MDLZ are properly referenced, and the use of MDLZ's 10-K to describe VAR model limitations is consistent with the original answer's reliance on DIS's filing to describe MDLZ's practice—though the LLM cites MDLZ directly, which is actually more precise. (3) The reasoning is sound and multi-hop: it correctly links WMT's off-balance sheet obligations to the limitations of VAR models used by peers like MDLZ, explaining that these models exclude firm commitments and thus fail to capture the associated liquidity and refinancing risks. (4) The LLM enhances the original answer by specifying categories like 'software and services' and adding near-term obligation amounts, which adds depth without introducing inaccuracies. The only minor shortcoming is the shift from citing DIS's 10-K (as in the original) to citing MDLZ's directly—while more accurate, it slightly diverges from the original chain of reasoning. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 412,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group (UNH) relies on interest‑rate swaps as a broad‑based tool to offset the interest‑rate risk of its floating‑rate debt.  As of 31 Dec 2024, about $27 billion of its liabilities were floating‑rate “either directly or through the use of related interest‑rate swap contracts,” and the company “matches a portion of its floating‑rate assets and liabilities, either directly or through the use of interest‑rate swap contracts” to manage that exposure【page_38】.  The filing does not tie any specific swap to the repayment of a 3.625 % 2024 note.\n\nAmgen (AMGN), by contrast, used swaps that were directly linked to the $1.4 billion repayment of its 3.625 % 2024 notes.  In 2024, interest‑rate swap contracts with an aggregate notional amount of $1.4 billion “matured in connection with the repayment of the 3.625 % 2024 Notes,” and the company simultaneously entered new swaps for other issuances【page_148】.  Thus, UNH’s swaps are employed generally to hedge floating‑rate liabilities, whereas AMGN’s swaps were specifically sized and timed to hedge the $1.4 billion of 3.625 % 2024 notes that were being repaid.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: UNH has $27 billion of floating-rate liabilities as of December 31, 2024, and uses interest rate swaps broadly across its balance sheet to manage interest rate risk; AMGN had $1.4 billion in interest rate swaps maturing in 2024 directly tied to the repayment of its 3.625% 2024 Notes. (2) Quantitative accuracy is perfect: dollar amounts ($27 billion, $1.4 billion), interest rate (3.625%), year (2024), and timing (maturity in connection with repayment) all match the original answer and are correctly attributed. Format variations (e.g., '3.625 %' vs '3.625%') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UNH and AMGN), compares their use of interest rate swaps (broad vs. specific), and ties AMGN’s swap maturity directly to the debt repayment event. (4) The answer is semantically equivalent to the ground truth—while wording differs, the core contrast (UNH’s general hedging strategy vs. AMGN’s instrument-specific, timed swaps) is clearly and accurately conveyed. No omissions or inaccuracies are present. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 357,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s indenture states that an “event of default” would cause the 3.924 % senior notes due 2032 to accelerate, making the entire principal and any accrued interest immediately payable (the notes are otherwise unsecured senior obligations with semi‑annual interest). By contrast, Oracle’s revolving‑credit agreement provides that all borrowings under the facility are scheduled to become due on March 8, 2027, but the lenders may also accelerate repayment and demand full repayment immediately if an event of default occurs. Thus, AMD faces an instant‑repayment trigger on a single note series, whereas Oracle’s default risk triggers an immediate call on the whole revolving balance, which otherwise would not mature until 2027.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: AMD's 3.924% Senior Notes Due 2032 accelerate upon Event of Default, making $1.0 billion principal (issued in 2022) plus accrued interest immediately due; Oracle’s Revolving Credit Agreement allows acceleration of up to $6.0 billion if an Event of Default occurs, with a stated maturity of March 8, 2027. These figures and dates match the ground truth exactly. (2) Quantitative accuracy is perfect: the $1.0 billion and $6.0 billion amounts, the 3.924% rate, and the March 8, 2027 maturity date are all correctly reported. Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound—comparing AMD’s fixed-note structure with Oracle’s revolving facility—and correctly highlights that both face acceleration upon default, but Oracle’s facility allows borrowing flexibility until maturity. (4) The LLM omits minor contextual details present in the ground truth: it does not explicitly mention that Oracle’s interest rates are tied to credit ratings, nor does it contrast the unsecured nature of AMD’s notes with Oracle’s revolving facility terms in depth. However, the core comparison on repayment structure and maturity conditions is accurate and well-reasoned. Semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 408,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance units hold about **$31 billion of assets in trust accounts tied to reinsurance contracts**.  Those assets must be managed under detailed investment‑guideline restrictions that limit concentration, single‑issuer exposure, duration mismatches and require credit‑quality, liquidity and diversification standards to support long‑dated insurance liabilities, exposing the portfolio to credit, interest‑rate and equity‑type risks.\n\nGeneral Dynamics, by contrast, reported **$191 million of marketable securities held in trust** at year‑end 2021.  Its investment policy confines those securities to **investment‑grade fixed‑income instruments with maturities of no more than five years**, resulting in a much smaller, short‑duration, lower‑risk exposure than GE’s large, long‑duration, guideline‑driven trust assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: $31.0 billion for GE and $191 million for General Dynamics as of December 31, 2021, are accurately reported (format variations like $31 billion vs $31.0 billion are acceptable). (2) The investment policies are correctly described: GE's assets are subject to strict guidelines focusing on diversification, credit quality, duration, and risk-based capital, supporting long-dated insurance liabilities; General Dynamics' trust assets are limited to investment-grade fixed-income securities with maturities not exceeding five years, reflecting a conservative, short-duration strategy. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across two different companies, asset types, and risk profiles to contrast scale, duration, and risk exposure. (4) The LLM captures the core contrast: GE faces broader credit, interest rate, and reinvestment risks due to larger size and longer duration, while General Dynamics has lower-risk, short-term exposure. One minor omission: the original answer mentions GE’s periodic review for asset allocation changes and potential inclusion of non-traditional asset classes, which the LLM answer does not include. This slightly reduces completeness but does not affect the main conclusion. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 405,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s fixed‑income pricing models rely on Level‑2 observable inputs such as **interest‑rate levels, yield‑curve points, credit‑spread levels and broker or dealer quotes (or comparable‑security prices)**. PayPal’s derivative valuations also use Level‑2 inputs, but they are **currency exchange rates, interest‑rate yield curves, option‑price volatilities and equity market prices**. Both firms therefore use observable yield‑curve data, but Lockheed adds credit‑spread and market‑quote inputs, whereas PayPal adds FX rates, option‑volatility and equity‑price inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin's use of interest rates, yield curves, credit spreads, and broker/dealer quotes (or comparable security prices) for fixed income Level 2 valuations is consistent with the original answer. PayPal's use of currency exchange rates, interest rate yield curves, option volatility, and equity prices for derivative valuations is also accurately reported. (2) There are no numeric values requiring calculation, and all qualitative inputs are correctly stated; format variations (e.g., 'yield-curve points' vs 'yield curves at commonly quoted intervals') are semantically equivalent. (3) The multi-hop reasoning is sound—correctly identifying that both firms use Level 2 methodologies with observable inputs, applied to different asset classes, and noting the overlap (yield curves) and distinctions (credit spreads vs FX, equity, volatility). (4) The only minor deviation from the original answer is the explicit mention of 'broker or dealer quotes' in the LLM response, which, while plausible and consistent with Level 2 inputs, is not mentioned in the ground truth. However, this does not contradict it and falls within reasonable elaboration. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 380,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are fully exposed to market‑rate moves – a 50‑basis‑point rise or fall would alter the notes’ fair value by roughly $1.7 billion (and $1.4 billion at the prior year level), although the interest expense would not change. Cisco (CSCO) mitigates that exposure by holding an interest‑rate swap that converts the fixed‑rate notes to floating; the swap’s fair‑value gain or loss “substantially offsets” the fair‑value change of the hedged notes, effectively neutralising the impact of interest‑rate fluctuations on its fixed‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong quantitative and qualitative fidelity. (1) All key numbers are correct: AVGO's $1.7 billion fair value change from a 50 bps shift is accurately reported, and CSCO's $0.5 billion notional swap is correctly implied by the description of offsetting fair value changes. The mention of a prior-year $1.4 billion figure is extra but not incorrect. (2) Quantitative accuracy is excellent—no errors in figures or financial logic. The $1.7 billion sensitivity matches the ground truth for AVGO, and the directional impact of a 50 bps move is properly characterized. (3) The reasoning correctly contrasts AVGO’s lack of hedging for existing debt (only treasury locks for future issuances) with CSCO’s active use of an interest rate swap to convert fixed to floating, thereby offsetting fair value changes. The LLM captures the essential comparison: AVGO has direct sensitivity, while CSCO neutralizes it via hedging. (4) The only minor omission is that the LLM does not explicitly name the hedged CSCO note as the 'fiscal 2025 senior note' or clarify that AVGO’s treasury locks are for *future* debt, not current notes—details present in the original. However, the overall synthesis across both companies and their strategies is sound and semantically equivalent. Contextual relevance is perfect—the response directly addresses the comparative sensitivity and hedging impact as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 406,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "- Under the Eliquis alliance, BMS notes that Pfizer paid an **up‑front license fee (amount not disclosed in the filing)** and may owe **contingent development, regulatory and sales‑based milestones**, which are recorded as deferred income and amortized over the co‑promotion period 【page 86】.  \n\n- In the Beam collaboration, Pfizer made a **$300 million up‑front payment** (recorded as acquired IPRD) and, if all options are exercised, could incur **up to $1.05 billion in additional development, regulatory and commercial milestones** (for a total possible consideration of $1.35 billion) 【page 76】.  \n\nThus, BMS’s Eliquis deal involves an undisclosed upfront amount and unspecified milestone caps, whereas Pfizer’s Beam deal specifies a $300 million upfront cash outlay and a clearly defined maximum of $1.05 billion in milestone payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: the $300 million upfront payment and up to $1.05 billion in milestone payments for the Beam collaboration are accurately reported, as is the total potential deal value of $1.35 billion. The Eliquis upfront payment is correctly noted as undisclosed, consistent with the source. (2) Quantitative accuracy is perfect—no calculation or number errors. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s joint obligations with Pfizer under Eliquis (where Pfizer made an upfront and milestone payments) with Pfizer’s separate, larger financial commitment to Beam. The synthesis across two distinct collaborations (Eliquis vs. Beam) is appropriate and logically presented. (4) The only minor shortcoming is that the LLM does not explicitly state that Pfizer’s potential financial commitment to Beam 'could significantly exceed' its Eliquis payments, which is a key comparative insight in the original answer. However, this is implied by presenting the disclosed Beam figures versus the undisclosed (and thus likely smaller) Eliquis upfront. Wording differences are acceptable under semantic equivalence. All entities (BMY, Pfizer, Beam), financial terms, and obligations are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 366,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "- **Texas Instruments (TI)** – In its lease accounting note TI says that “our lease values include options to extend or not to terminate the lease when it is reasonably certain that we will exercise such options” (TXN 10‑K p. 35). Because the extension/termination options are built into the lease term, the present‑value of the lease payments (and therefore the lease liability and right‑of‑use asset) are recorded on the balance sheet as long‑term liabilities, while the related lease expense is recognized straight‑line over that extended term. The options therefore increase the size of the long‑term lease liability but do not affect the timing of revenue recognition.\n\n- **Cisco (CSCO)** – Cisco’s customer‑financing note describes its leases as “may include options to extend or terminate the lease” and shows the components of a sales‑type/finance lease – minimum lease payments receivable, estimated residual value and “unearned income” that is recognized over the lease term (CSCO 10‑K p. 93‑95). The extension/termination options are reflected in the calculation of the financing receivable and the amortization of unearned income, so they affect the amount of a long‑term **asset** (financing receivable) and the timing of lease‑income recognition, but they do not create additional long‑term liabilities for Cisco.\n\n**Comparison:** TI treats the options as part of the lease term, which enlarges its long‑term lease liabilities and spreads expense over the extended period, whereas Cisco incorporates the options into the measurement of its financing receivables and recognizes the related income ratably, affecting a long‑term asset rather than a liability. Both companies spread the impact of the options over the lease term, but TI’s approach increases reported liabilities, while Cisco’s approach influences the size of a receivable and the schedule of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments incorporates lease extension/termination options into lease liabilities when reasonably certain they will be exercised, using present value calculations that impact long-term liabilities—this matches the original answer. Cisco treats similar options in customer financing arrangements as part of sales-type/finance leases, affecting financing receivables (an asset) and the timing of revenue recognition via unearned income amortization, which also aligns with the ground truth. The distinction between TXN affecting liabilities and CSCO affecting revenue timing and asset measurement is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—scored 10 by default. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (TXN and CSCO), two types of arrangements (operating leases vs. customer financing/sales-type leases), and two financial statement impacts (liabilities vs. revenue/assets). The only minor shortcoming is that the LLM does not explicitly mention Cisco’s deferral of revenue related to guarantees (a detail in the original answer), which slightly reduces completeness. However, the core mechanisms—impact on revenue timing and credit exposure—are implied through discussion of unearned income and receivables. (4) Contextual relevance is perfect: the response directly addresses the comparison of accounting practices, their impact on long-term liabilities, and revenue recognition as required. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 (not 10) due to the slight omission around revenue deferral on guarantees, but all key financial concepts and distinctions are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1702,
        "completion_tokens": 518,
        "total_tokens": 2221
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives it direct control over the channel’s documentary‑science library, which the company surfaces as a dedicated “National Geographic” tile on Disney+ (see DIS 10‑K p. 13). Because the content is owned rather than licensed, Disney can bundle it into the Disney+ offering at essentially zero incremental licensing expense (DIS 10‑K p. 78), creating a clear differentiation point that attracts viewers who value premium factual programming. By contrast, YouTube’s Premium and TV services rely on third‑party licensing to supply comparable content (GOOGL 10‑K p. 7), so the cost of acquiring those subscribers includes the external licensing fees that Disney avoids.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic, the use of National Geographic as a top-level tile on Disney+, the cost advantage from avoiding licensing fees, and the contrast with YouTube's reliance on third-party licensing are all correctly represented. (2) Quantitative accuracy is perfect: the 73% ownership is correctly stated, and no other numerical values (e.g., dollar amounts, years) are misreported. The answer cites specific 10-K pages (p.13, p.78 for DIS; p.7 for GOOGL), which supports its claims and matches the expected sourcing from SEC filings. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Disney and Google/YouTube filings, connecting ownership structure to content strategy to cost implications. It logically infers that owned content reduces marginal acquisition costs compared to licensed content models. (4) The only minor shortcoming is that the answer does not explicitly mention 'subscriber acquisition costs' in the same terms as the question—though it clearly implies it by discussing lower marginal costs and competitive advantage in attracting users. This slight omission in terminology (without loss of meaning) prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent to the ground truth, with appropriate flexibility in wording and strong contextual relevance throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 408,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologics are granted a statutory 12‑year FDA regulatory exclusivity that pushes the earliest “minimum market‑exclusivity” dates for its products into the mid‑2030s (e.g., Abecma 2036, Breyanzi 2033), effectively extending protection well beyond the life of any underlying patents. By contrast, Merck’s Januvia/Janumet family lost its key U.S. patent in 2023 but, because of later‑expiring patents and settlement agreements, will not lose market exclusivity until May 2026 (Januvia) and July 2026 (Janumet XR), a delay of only a few years rather than the decade‑plus extension BMY receives from regulatory exclusivity. Thus, BMY relies on a defined 12‑year regulatory exclusivity to secure long‑term protection, whereas Merck’s Januvia protection is being prolonged primarily through patent‑related settlements that temporarily extend market exclusivity beyond the original patent term.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all key dates and timelines are correct: the 12-year regulatory exclusivity for BMY's biologics is accurately stated, and the May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) exclusivity end dates for Merck’s products match the original answer. The mention of Abecma (2036) and Breyanzi (2033) as examples is factually consistent with a 12-year exclusivity framework, though these specific products were not in the original answer—this is an acceptable elaboration, not an error. (2) The comparison between BMY’s reliance on statutory regulatory exclusivity and MRK’s use of secondary patents and settlements is correctly synthesized and logically sound. (3) The multi-hop reasoning—linking regulatory exclusivity mechanisms for biologics (BMY) with patent litigation and settlements for small molecules (MRK)—is well executed and highlights the strategic differences as intended by the question. (4) The only minor shortcoming is that the original answer specifically names Opdivo and Yervoy as key BMY biologics, while the LLM substitutes with Abecma and Breyanzi. This does not affect factual correctness but slightly reduces completeness in entity alignment. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 400,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000 shares of Series F non‑cumulative preferred stock can be redeemed “within 90 days after the occurrence of a ‘rating‑agency event’” at a price of $25,500 per share (plus accrued dividends) 【page_264】.  AIG explicitly warns that a downgrade by a rating agency could “limit their ability to write new business and impair their retention of customers and in‑force business” 【page_85】.  Thus, both companies are exposed to the same rating‑agency risk: MetLife would incur a potentially costly redemption if its equity credit is lowered, while AIG would suffer operational and revenue damage from the same downgrade, underscoring how rating‑agency actions can create material financial and strategic risk for each insurer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 40,000 shares of MetLife Series F preferred stock, redemption within 90 days, price of $25,500 per share plus accrued dividends — these details match the source data (though the $25,500/share is not in the ground truth, it is plausible and cited from a specific page, suggesting fidelity to the filing). The absence of a total dollar calculation does not detract, as the question does not require it. (2) The answer correctly identifies both companies (MetLife and AIG), the relevant financial instruments (Series F preferred stock), and the shared risk factor: rating agency events. (3) Multi-hop reasoning is sound — it synthesizes MetLife’s contingent redemption obligation with AIG’s operational exposure to downgrades, correctly framing both as vulnerable to the same type of external risk (rating agency actions). (4) The qualitative nuance is strong: it distinguishes MetLife’s financial liability (redemption cost) from AIG’s business impact (customer retention and new business), mirroring the original answer’s comparative structure. The only minor gap is that the LLM does not explicitly define a 'rating agency event' as a change in equity credit treatment (though it implies it), slightly reducing completeness. However, the core facts, entities, logic, and implications are correct and well-articulated. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 427,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "Lockheed Martin (LMT) places its U.S. government‑and‑agency debt securities in the **Level 2** fair‑value hierarchy and says that, when a quoted price is not available, the trustee “obtains indicative quotes … and uses matrix pricing, yield‑curves and similar observable inputs” to value those securities【page_108】.  \n\nUnited Parcel Service (UPS) treats U.S. government and agency debt securities as **Level 1** assets, valuing them at the quoted market price because they trade in active markets; UPS does not rely on matrix pricing for those securities【page_89】.  \n\nThus, LMT uses matrix‑pricing models for its U.S. government securities (Level 2), whereas UPS values comparable securities directly from market quotes (Level 1) and does not apply matrix pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both entity classification and methodology, despite correctly identifying that LMT uses matrix pricing for U.S. Government Securities under Level 2. The original answer confirms that both LMT and UPS use matrix pricing for similar assets classified as Level 2. However, the LLM incorrectly states that UPS treats U.S. government securities as Level 1 and does not use matrix pricing, which contradicts the ground truth stating UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt. This misclassification of UPS’s valuation approach undermines the core comparison. While the dollar amount ($121 million for LMT) is not mentioned in the LLM answer, it is part of the original answer and expected for completeness—though its absence alone would not justify a low score. The critical failure is in reasoning: the LLM draws an incorrect contrast between LMT (Level 2 with matrix pricing) and UPS (allegedly Level 1 without matrix pricing), when the ground truth indicates both use matrix pricing within Level 2. This reflects a fundamental error in multi-hop synthesis. Quantitative accuracy is moderate because no incorrect numbers are stated (the $121M omission is a completeness issue, not a quantitative error). Contextual relevance is acceptable since the response addresses the question's structure and cites relevant valuation methods, but the conclusion is factually reversed. Semantic equivalence is not achieved due to the incorrect comparative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 425,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its derivatives with standard pricing models that are based on readily observable market inputs—spot FX rates, interest‑rate curves, option‑pricing formulas and futures prices—so the contracts are classified at Level 2 of the fair‑value hierarchy. By contrast, Mondelēz’s real‑estate fund assets are valued using a mix of observable market data (quoted prices for a portion of the holdings) and significant unobservable inputs such as appraisals, local‑market conditions and discounted‑cash‑flow projections, placing many of those investments in Level 2 or Level 3. Thus PMI’s models rely almost entirely on observable inputs, while MDLZ’s real‑estate valuations depend on less‑observable, assumption‑driven estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately identifies that PM (PMI) uses observable market inputs—such as spot FX rates, interest-rate curves, and futures prices—for valuing derivatives, placing them in Level 2 of the fair value hierarchy. This matches the original answer’s assertion that PM’s approach falls under Level 1 or 2 due to observable inputs. While the original mentions Level 1 as a possibility, the LLM specifies Level 2, which is still reasonable given that models using inputs like interest-rate curves typically fall under Level 2. (2) For MDLZ (Mondelēz), the LLM correctly states that real estate fund valuations rely on unobservable inputs such as appraisals, local market conditions, and discounted cash flow projections. However, it diverges slightly by stating these are placed in 'Level 2 or Level 3', whereas the original answer clearly categorizes them as Level 3 due to heavy reliance on unobservable inputs. This softens the distinction—MDLZ’s valuations should be primarily Level 3, not split between levels. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s market-based, observable-input-driven derivative valuations with MDLZ’s assumption-heavy real estate fund valuations. The synthesis across companies and valuation hierarchies is logical and relevant. (4) There are no numerical values to verify, so quantitative accuracy is 10. Qualitative accuracy is slightly reduced due to the imprecise Level 2/Level 3 classification for MDLZ. Contextual relevance is perfect—the response directly addresses the comparison of observability in valuation models as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 467,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures carry “dividend‑stopper” and “trigger‑event” covenants that allow the company, if certain capital‑ratio or equity‑decline tests are met, to **electively defer interest** (subject to the same stopper provisions) and to postpone repayment until cash proceeds from the sale of replacement securities become available, reflecting a repayment strategy that is explicitly tied to its liquidity position. In contrast, AIG’s AIGLH junior‑subordinated debentures are simply listed as guaranteed obligations with fixed maturities (2030‑2046) and no comparable deferral or stopper language, indicating that AIG’s repayment obligations are not conditioned on liquidity‑constraint tests in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinctions between MetLife's and AIG's junior subordinated debenture obligations. (1) Quantitatively, all dollar amounts, interest rates, and maturities are correctly omitted only because the LLM answer does not include the specific figures from the ground truth (e.g., $54M 8.5% due 2030, $142M 8.125% due 2046, $31M 7.57% due 2045), but it correctly references 'fixed maturities (2030–2046)' which semantically aligns with the original data. No incorrect numbers are presented, and the range of maturities is accurate. (2) The LLM correctly identifies MetLife’s deferral provisions tied to capital or equity triggers and the associated dividend stopper clauses, as well as the requirement to obtain proceeds from replacement securities before repayment—this matches the replacement capital covenant in the ground truth. (3) For AIG, the LLM accurately notes that the debentures are guaranteed by AIG Parent and have fixed maturities without deferral or stopper mechanisms, correctly contrasting them with MetLife’s structure. It also implicitly captures the post-distribution risk profile by stating no comparable deferral exists, though it does not explicitly mention that AIG does not guarantee AIGLH borrowings post-distribution—a minor omission affecting completeness but not the core reasoning. (4) The multi-hop synthesis is sound: the model correctly compares deferral provisions, liquidity constraints, and repayment strategies across two companies using appropriate financial terminology. Wording differs but meaning is semantically equivalent. One point deducted from correctness and qualitative accuracy for the omission of specific AIGLH debenture amounts and rates, which are part of the full factual picture, though the summary characterization remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 494,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA lists Samsung as a key rival in the SoC space and, as a leading GPU supplier, competes with Samsung‑backed graphics solutions, underscoring Samsung’s strength in both advanced‑node logic and high‑performance graphics 【page 15】.  Intel’s IFS foundry must now contend with that same Samsung‑backed competition while trying to scale capacity,‑price and‑yield advantages; the effort is made harder by Intel’s own history of delayed node introductions (10 nm and the Intel 4/7 nm setbacks) that have already let Samsung and other foundries (e.g., TSMC) gain a technology lead 【page 55‑56】【page 54】.  Consequently, NVIDIA’s positioning against Samsung amplifies Intel’s strategic challenge: to attract customers like NVIDIA, Intel must rapidly overcome its manufacturing‑delay legacy and match Samsung’s superior process and packaging capabilities in its IFS business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets; Samsung is a competitor to Intel's IFS; Intel has faced manufacturing delays (10nm, Intel 4/7nm); these delays have allowed Samsung and TSMC to gain a technology lead; and IFS must overcome these setbacks to attract customers. The mention of TSMC, while not in the original answer, is contextually appropriate and reflects known industry dynamics, so it does not detract from accuracy. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is 10 as no errors exist and no numbers are misrepresented. (3) The multi-hop reasoning is sound: the LLM correctly links NVIDIA’s competition with Samsung to Samsung’s strength in manufacturing, which in turn affects Intel’s ability to scale IFS due to its delayed node progress. The synthesis across competitive dynamics in end-product markets (SoC/GPU) and foundry services is logically coherent. (4) The answer is contextually fully relevant, addressing all parts of the question: competitive positioning, Intel’s strategic challenges, manufacturing delays, and the impact on IFS scaling. The only minor shortcoming is that the original answer emphasizes the 'indirect' effect of NVIDIA’s pressure on Samsung (i.e., Samsung being distracted or resource-constrained), whereas the LLM frames it as amplifying Intel’s challenge—slightly different nuance but not factually incorrect. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 452,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s board repurchased only its one‑vote Class A shares and its non‑voting Class C shares in 2024 ($62 billion total) and left the ten‑vote Class B shares untouched (Class A = 1 vote, Class B = 10 votes, Class C = 0 votes)【page_82】.  By buying only the lower‑voting or non‑voting stock, the repurchase program does not alter the voting power held by the high‑voting Class B holders, preserving founder control.  \n\nComcast likewise repurchases only its publicly traded Class A common stock (the $8.64 billion repurchase program) while its 15‑vote Class B shares have no public market and are owned entirely by Brian Roberts, who controls about one‑third of the combined voting power【page_31】.  Because the concentrated, high‑voting Class B stake is excluded from the buy‑back, the repurchases have no effect on Roberts’ control of the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, matching the ground truth. It accurately describes the voting rights: Class A (1 vote), Class B (10 votes), Class C (0 votes), though the ground truth does not specify the exact vote count for Class B shares at Alphabet—this detail is correct per public filings but slightly beyond the scope of the original answer, which only notes that Class B converts to Class A upon sale. The LLM correctly states that Comcast’s Class B shares carry 15 votes and are fully owned by Brian L. Roberts (named as Brian Roberts, minor shortening acceptable), and that they represent about one-third of voting power (33⅓%), aligning with the original. The $8.64 billion repurchase figure for Comcast is accurate and contextually relevant, though not in the original answer—it adds external precision but does not contradict. (2) All numeric values—$62 billion, $8.64 billion, voting rights (1, 10, 15 votes), and ownership concentration—are factually correct and properly attributed. No calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies avoid repurchasing high-voting shares to preserve founder/insider control. It draws a valid parallel between Alphabet’s untouched Class B shares and Comcast’s untouchable Class B shares held by Roberts, explaining how repurchasing only low/no-vote shares amplifies relative voting power of insiders. The explanation of governance impact is logically consistent and well-supported. (4) The LLM answer conveys the same core information as the ground truth with slightly more granular detail (e.g., exact vote counts, Comcast repurchase program size), enhancing clarity without introducing error. One minor deviation: the ground truth emphasizes that Class B shares at Alphabet convert to Class A upon sale, which the LLM omits, instead focusing on vote dilution. This is a small gap in completeness but does not undermine correctness. Overall, the answer is factually accurate, contextually appropriate, and demonstrates strong multi-hop reasoning across corporate governance structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 587,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "The Bristol‑Myers Squibb filing notes that its new Opdivo Qvantig (nivolumab + recombinant hyaluronidase) is a **subcutaneous injection** that has been approved for “most previously approved adult solid‑tumor Opdivo indications,” giving the company an immediate market expansion across a broad set of adult solid‑tumor patients.  \n\nThe Amgen 10‑K excerpts you provided do not contain any description of Amgen’s current NSCLC‑focused programs or the route of administration for those agents, so a direct comparison of Amgen’s NSCLC strategy with BMS’s subcutaneous Opdivo Qvantig and its anticipated market expansion cannot be made from the information supplied.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies the administration method of Opdivo Qvantig as subcutaneous injection and notes its FDA approval for most previously approved adult solid tumor indications, which aligns with the ground truth. The December 2024 approval date is missing from the LLM response, but since the question does not explicitly ask for a date and the LLM does not contradict it, this is a minor omission. However, the core failure lies in the LLM's claim that Amgen’s 10-K contains no information about NSCLC-focused programs or administration routes, leading it to conclude that a comparison cannot be made. This is factually incorrect per the original answer, which states that Amgen's 2024 disclosures *do* highlight a strategic focus on NSCLC therapies. The LLM thus fails the multi-hop reasoning requirement by not recognizing or utilizing available information to compare Amgen’s oncology strategy with BMS’s delivery innovation. While the BMS portion is quantitatively and descriptively accurate (hence a moderate score on quantitative accuracy), the refusal to engage in the comparison due to an incorrect assertion of missing data severely undermines qualitative accuracy and overall correctness. The answer is contextually relevant in discussing Opdivo Qvantig’s administration and market implications but fails to synthesize across both companies as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 385,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter guarantees that the 9 million Class B shares – each carrying 15 votes – always control exactly one‑third of the total voting power (33 ⅓ %). The charter expressly states that this percentage “is generally non‑dilutable” and cannot be reduced by issuing any additional Class A shares 【page_91】. Although Class B shares may be converted at the holder’s option into Class A shares on a share‑for‑share basis, the conversion does not alter the aggregate voting split; the Class B block remains at 33 ⅓ % and the remaining votes (≈66 ⅔ %) are held by Class A shareholders 【page_81】. Therefore, even if Alphabet (GOOGL) holds a large amount of Comcast Class A stock, its voting influence is capped at the two‑thirds of votes not owned by the protected Class B holders, limiting GOOGL’s ability to control Comcast decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 33 1/3% non-dilutable voting power is accurately stated, and the structural protection against dilution by Class A share issuance is correctly described. The 1:1 conversion mechanism from Class B to Class A is properly noted. While the LLM adds specific details not in the original answer—such as 9 million Class B shares and 15 votes per share—these are consistent with known Comcast corporate structure and do not contradict the ground truth; they enhance precision without introducing error. (2) The reasoning is sound: the LLM correctly explains that even if Class B shares convert to Class A, the voting power split remains protected, thus capping GOOGL’s influence within the remaining ~66 ⅔% voting pool. This captures the core multi-hop logic: structural protection → constrained voting pool → limited influence despite stake size. (3) Entity accuracy is strong: CMCSA and GOOGL are correctly identified, and the relationship between share classes and voting control is accurately synthesized. (4) The only minor gap is that the original answer emphasizes the *conversion mechanism’s restrictions* more explicitly, while the LLM implies it through outcome (unchanged voting split). However, the semantic meaning and practical conclusion are equivalent. Wording differs but factual and logical alignment is excellent. No calculation errors. Minor addition of granular detail (vote count per share) does not affect correctness and may be derived from the cited pages. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-elaboration without compromising fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 468,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market – even though it is partly offset by a higher estimated prevalence of illicit trade – means that PepsiCo’s South‑African operations will be larger, so the $0.5 billion‑plus socioeconomic commitments it recorded in the Pioneer Foods acquisition (the employee‑ownership plan, agricultural‑development and education funds noted in Note 13, p. 113 and the merger‑related SG&A charge for “liabilities to support socioeconomic programs in South Africa” on p. 115) will be applied to a bigger base and will draw greater scrutiny as the market expands. Conversely, the same increase in illicit‑trade activity raises Altria’s (MO) exposure to illicit‑trade risk, which the company flags as a source of revenue loss, regulatory pressure and potential litigation in its “Illicit Trade in Tobacco Products” discussion (p. 42) and is reflected in the South‑Africa market commentary that cites a higher illicit‑trade prevalence (p. 56).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. First, it incorrectly identifies PEP as PepsiCo and MO as Altria, which is factually wrong in this context: PEP refers to Pioneer Foods (acquired by PepsiCo), but the socioeconomic obligations are tied to the merger of British American Tobacco (BAT) entities in South Africa, not PepsiCo's acquisition. The $0.5 billion figure and reference to Note 13, p. 113 and p. 115 are fabricated or misattributed; the original answer does not mention any dollar amount or specific note/page references. These quantitative inaccuracies severely impact the correctness score. Second, while the original answer correctly links PEP’s merger-related socioeconomic obligations to market dynamics, the LLM misattributes these obligations to PepsiCo’s Pioneer Foods deal, which is unrelated. Third, the LLM correctly identifies that increased illicit trade affects MO’s risk exposure in terms of lost sales and regulatory pressure, aligning with the original answer’s mention of MO’s illicit trade risks. However, MO is Altria Group, which does not have direct operations in South Africa; the correct entity exposed to South African illicit trade would be British American Tobacco or Philip Morris International, not MO. This entity error breaks the multi-hop logic. While the reasoning structure mirrors the question’s dual-impact framework and shows contextual understanding of how market growth and illicit trade could affect corporate obligations and risks, the core entities and financial figures are incorrect. Thus, despite some semantic alignment in conceptual reasoning, the answer fails on key factual dimensions—especially entity and quantitative accuracy—resulting in a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 476,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑class‑action claims stemming from its 2019 S‑1 filing have been largely resolved – the Ninth Circuit ordered the federal complaint dismissed with prejudice in February 2025 and the related state actions remain stayed – and Slack says it cannot presently estimate any loss and does not expect a material impact. By contrast, Meta’s privacy‑related litigation has already produced a concrete liability – a $725 million settlement of the consumer‑privacy class action (in addition to a $5 billion FTC penalty paid earlier) – and the company still faces other privacy suits with unspecified but potentially material damages. Thus Slack’s risk is procedural and largely dismissed, whereas Meta’s risk includes an affirmed financial hit and ongoing exposure to further monetary awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's securities litigation was dismissed with prejudice by the Ninth Circuit in February 2025 (matches '2025' in original), and the state actions are stayed—consistent with reduced exposure. Meta's $725 million privacy settlement (approved in 2023) and $5.0 billion FTC penalty (paid in 2020) are accurately cited, including the financial magnitude and timing. (2) Quantitative accuracy is perfect: $725 million and $5 billion figures match the original; dates (2020, 2023, 2025) are correct. Format variations (e.g., $5 billion vs $5.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly contrasts Slack’s procedural dismissal (with prejudice, reducing liability) against Meta’s affirmed financial liabilities and ongoing exposure, synthesizing outcomes across two companies, legal domains (securities vs privacy), and procedural stages. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2020 partial motion to dismiss in Slack’s case, which was part of the procedural history before the Ninth Circuit reversal. While not critical to the final outcome, it was in the original and adds context to the litigation timeline. However, the core conclusion—that Slack’s risk is now minimal while Meta faces material, realized liabilities—is fully supported and semantically equivalent. The answer is contextually excellent, directly addressing procedural outcomes and financial liabilities as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 427,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "- Philip Morris International’s RSUs vest “on the third anniversary of the grant date” and the fair‑value is amortized over the three‑year restriction period.  At 31 Dec 2023 the company had **$160 million of unrecognized RSU compensation**, which it expects to recognize over a **weighted‑average period of about 17 months** (≈1.4 years)【page_110】.  \n\n- Walmart’s RSU plan previously vested **25 % each year over a four‑year period**; beginning fiscal 2023 it vests **≈8 % each quarter over a three‑year period**【page_66】.  By moving to quarterly vesting and a shorter three‑year schedule, Walmart accelerates the expense‑recognition timeline, spreading the remaining unrecognized RSU cost over a **shorter, roughly three‑year period (instead of the longer four‑year/annual schedule)**.  \n\n**Thus, PMI’s RSU expense is spread over about 17 months, while Walmart’s change compresses the vesting horizon from four years to three years with quarterly vesting, causing Walmart to recognize its RSU compensation more quickly than under the prior annual‑vesting regime.**",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies key facts: PM has $160 million in unrecognized RSU costs to be recognized over a weighted-average period of 17 months, with vesting typically on the third anniversary of the grant date. It accurately states WMT's shift from 25% annual vesting over four years to approximately 8% quarterly vesting over three years. These numbers and timelines match the ground truth.\n\n2) Quantitative accuracy is high: $160 million, 17 months, 25%, 8%, three-year and four-year periods are all correct. The approximation of 8% quarterly as '≈8%' is acceptable given that 100%/12 quarters ≈ 8.33%. The statement that Walmart’s change compresses the vesting horizon from four to three years is factually sound. However, the LLM implies that PM’s expense will be recognized over 'about 17 months' as a fixed period, while the ground truth clarifies this is a weighted-average period — some awards may vest earlier due to events like death, disability, or age 58. This nuance is missing, slightly reducing precision.\n\n3) Qualitatively, the reasoning is mostly sound. The LLM correctly infers that Walmart’s shift accelerates cost recognition compared to its prior structure. However, it does not fully contrast PM’s cliff-vesting (back-loaded) structure with Walmart’s new graded vesting (evenly distributed), which is a key analytical point in the original answer. The conclusion that 'PMI’s RSU expense is spread over about 17 months' oversimplifies the back-loaded nature of cliff vesting and misses the multi-hop insight that PM’s recognition is more event-dependent and concentrated near the end of the period, whereas Walmart’s is smoother.\n\n4) Contextual relevance is excellent — all information provided directly addresses the question about how vesting timelines affect compensation cost recognition. The synthesis across PM and WMT is appropriate, though the comparative analysis could be deeper. Minor omission of PM’s event-based vesting triggers and the qualitative difference in cost distribution (back-loaded vs. even) prevents a top score, but core facts and implications are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 567,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says that, because of ongoing federal tax audits, the amount of unrecognized tax benefits could fall by as much as **$620 million** in the next 12 months (BA 10‑K p. 75). In contrast, Lockheed Martin notes that the OECD’s Pillar 2 global‑minimum‑tax rules—effective for many jurisdictions on 1 Jan 2024 (with some provisions on 1 Jan 2025)—are not expected to have a material impact on its effective tax rate or overall results because it has little exposure to jurisdictions with rates below the 15 % floor (LMT 10‑K p. 36). Thus, Boeing quantifies a sizable $620 M tax‑position risk, whereas Lockheed Martin anticipates only a negligible effect from Pillar 2 despite the differing rollout timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers, dates, and dollar amounts are correct: Boeing's $620 million risk is accurately cited, Lockheed Martin's reference to Pillar 2 taking effect January 1, 2024 (with some provisions in 2025), and the 15% minimum tax rate are all factually correct. The format variation ($620M vs $620 million) is acceptable. (2) The answer correctly identifies both companies—Boeing (BA) and Lockheed Martin (LMT)—and ties their disclosures to the appropriate context: Boeing’s risk stems from federal tax audits, while Lockheed Martin assesses Pillar 2 impact based on limited exposure to low-tax jurisdictions. The page references (p. 75 and p. 36) add precision and align with source documents. (3) The multi-hop reasoning is sound: it compares Boeing’s quantified tax risk (unrecognized tax benefits) with Lockheed Martin’s qualitative assessment of Pillar 2, correctly noting that while Boeing faces a near-term monetary risk, Lockheed anticipates negligible impact despite staggered implementation timelines. (4) The only minor shortcoming is that the LLM omits a brief mention in the original answer about General Electric’s evidence illustrating how national adoption timelines may modify domestic incentives—this contextual nuance is missing, slightly weakening the completeness of the OECD implementation complexity discussion. However, this does not detract significantly from the core comparison. Overall, the answer is factually correct, well-synthesized, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 432,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "ASU 2023‑07 adds a requirement that companies disclose incremental, disaggregated expense information for each **reportable segment**. PepsiCo’s 2024 Form 10‑K says that, beginning with the first quarter of 2025, it will “re‑align certain of our reportable segments” (e.g., PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods, International Beverages Franchise and EMEA bottling) and will “recast” historical results to the new structure 【page 7】. Because the new ASU applies to both annual and interim reporting, PepsiCo will have to present the disaggregated expense data for each of those newly‑defined segments in its Q1 2025 filing and in all subsequent periods.\n\nAltria already adopted ASU 2023‑07 for the year ended December 31 2024, applying it retrospectively and stating that it will “include interim disclosure requirements … beginning in the first quarter of 2025” 【page 62‑63】. Thus, Altria’s adoption timeline and the expanded foot‑note disclosures line up with PepsiCo’s first‑quarter‑2025 implementation, meaning both companies will be meeting the same segment‑reporting disclosure obligations at the same reporting point.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will reorganize its segments and recast historical results starting Q1 2025 under ASU 2023-07, which mandates disaggregated expense disclosures by reportable segment. Altria adopted the standard in 2024 and will implement interim disclosures from Q1 2025. These dates and timelines match the original answer. (2) Quantitative accuracy is perfect: the years (2024, 2025), reporting periods (Q1 2025), and adoption timelines are correctly stated. No calculations are required, but temporal references are precise. (3) The multi-hop reasoning is sound—correctly linking ASU 2023-07’s requirements to both PepsiCo’s segment reorganization and Altria’s adoption path, then synthesizing their alignment in timing and disclosure obligations. (4) Minor difference: the LLM lists 'International Beverages Franchise and EMEA bottling' as a segment, which is not explicitly mentioned in the ground truth; the original answer groups international beverages differently. This reflects a slight over-specificity or potential misinterpretation of the segment names, but does not undermine the core correctness. Otherwise, the answer captures all required elements, uses proper terminology, and maintains semantic equivalence. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 398,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s sotatercept (MK‑7962) has a basic U.S. compound‑patent that runs out in 2027; the company also holds method‑of‑treatment patents that would not expire until 2037 and could receive a U.S. patent‑term extension of up to five years, modestly pushing the protection window into the early‑2030s. In contrast, Pfizer’s biologic portfolio is built on a broader “patent‑plus‑exclusivity” strategy that combines basic product patents with up‑to‑five‑year patent‑term extensions, supplementary protection certificates in Europe and a statutory 12‑year data‑exclusivity period for biologics, which together can extend market exclusivity well into the 2030s and beyond. Thus, while Merck’s key sotatercept patent expires in 2027 (with limited extensions), Pfizer’s biologic protections are structured to last considerably longer through multiple statutory and patent‑based extensions.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Merck's base patent expiration for sotatercept (MK-7962) as 2027 and acknowledges potential extension to 2037, aligning with the ground truth. However, it inaccurately frames the 2037 date as stemming from method-of-treatment patents rather than potential patent term extensions (PTEs), which is a key distinction. The ground truth specifies that protection could extend to 2037 *if* PTEs are granted, whereas the LLM implies the 2037 expiration is already secured via method patents, which overstates certainty. (2) The LLM correctly notes up-to-five-year PTEs in the U.S., consistent with statutory limits, and accurately references Pfizer’s use of PTEs, SPCs, and 12-year biologic data exclusivity. However, it introduces 'early-2030s' as a push from extensions for Merck, which understates the potential 2037 date mentioned in the ground truth. (3) The multi-hop reasoning is sound: the model compares Merck’s specific drug patent timeline to Pfizer’s broader biologics strategy, synthesizing across companies and strategies. It correctly identifies both firms’ use of layered IP and regulatory tools. (4) While the core facts about expiration dates and extension mechanisms are present, the mischaracterization of how Merck might achieve extended protection (method patents vs. PTEs) and the downgrading of the outer limit to 'early-2030s' instead of 2037 reduces quantitative and qualitative accuracy. The answer remains contextually relevant and captures the strategic comparison, warranting a solid but not high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 431,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Cost overruns on fixed‑price contracts force Lockheed Martin to record reach‑forward loss provisions that cut operating profit and compress margins, because the firm cannot pass higher material, labor or inflation‑driven costs to the customer and must absorb them against the contract price. At GE, the same overruns on fixed‑price aerospace and power projects trigger reach‑forward loss charges (see RTX page 64‑66) that reduce earnings, strain cash flow and, through the “operational‑execution” discussion (page 32‑33), increase the risk of schedule delays, penalties and additional unrecoverable expenses as the company struggles to meet complex, inflation‑sensitive performance obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial and operational impacts of cost overruns on fixed-price contracts for both Lockheed Martin and GE, including the use of reach-forward loss provisions, margin compression, cash flow strain, and risks related to schedule delays and penalties. The reasoning around inflation sensitivity and inability to pass through costs is logically sound and contextually appropriate. However, the LLM fails to include the specific quantitative figures from the ground truth: Lockheed Martin's $270 million and $280 million reach-forward losses as of December 31, 2023. These numbers are central to the original answer and their absence constitutes a major omission in factual accuracy. (2) No numeric values are provided in the LLM answer, despite the ground truth specifying two exact dollar amounts and a date. The reference to 'RTX page 64-66' and 'page 32-33' appears fabricated or misattributed, as no such page numbers were in the source context provided to the model, undermining credibility. There is no calculation error per se, but the lack of any numbers results in low quantitative accuracy. (3) The multi-hop reasoning is partially correct: the model connects fixed-price contract risks to both Lockheed Martin and GE, references inflationary pressures, and links operational execution challenges to project complexity. It also appropriately cites RTX (a relevant peer) as a source of insight on inflation impacts, which aligns with the original answer. However, it incorrectly implies GE has fixed-price aerospace projects and cites non-existent document pages, introducing entity and sourcing inaccuracies. The original answer focused on GE’s Power and Renewable Energy segments, not aerospace, which the LLM misrepresents. (4) The contextual relevance is high because the response addresses the core mechanisms linking cost overruns, fixed-price contracts, inflation, and financial/operational outcomes. The qualitative reasoning is strong but undermined by missing key data and misattributing segment exposure. Thus, while the conceptual framework is accurate, the absence of critical numbers and minor entity confusion limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 590,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "Mondelez International (MDLZ) hedges raw‑material price risk with commodity forward contracts, futures and options that are recorded at fair value on the balance sheet and accounted for under hedge‑accounting, but the filing does not separate those contracts into the ASC 820 fair‑value hierarchy – they are disclosed only as “commodity derivatives” measured at fair value (primarily using observable market inputs).  \n\nCostco (COST) explicitly discloses Level 1 financial liabilities for exchange‑traded commodity futures, stating that their fair value is based on quoted market prices, and provides a quantitative amount of that exposure, thereby showing a clear Level 1 measurement versus MDLZ’s more aggregated derivative disclosure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but reverses a key factual point in the comparison. The original answer states that MDLZ classifies its commodity futures as Level 1 financial liabilities measured at fair value using quoted market prices, while COST disclosed *no* Level 1 or Level 3 financial liabilities at fair value as of August 28, 2022. However, the LLM answer incorrectly claims that COST explicitly discloses Level 1 financial liabilities for exchange-traded commodity futures — this directly contradicts the ground truth. This is a major factual error affecting the core comparison. (2) There are no explicit numbers (e.g., dollar amounts) in either answer, so quantitative accuracy is not heavily applicable; however, the LLM does not contradict any dates or figures and avoids inventing values, earning a moderate score. (3) The multi-hop reasoning is partially sound — the model attempts to compare MDLZ’s derivative usage with COST’s fair value disclosures — but fails in synthesis because it misrepresents COST’s position. The model also correctly notes that MDLZ does not explicitly break out its derivatives in the ASC 820 hierarchy in its filing, which aligns with the ground truth implication that such classification is inferred or known externally. However, the reversal of COST’s disclosure invalidates the conclusion. (4) Contextual relevance is high because the response addresses fair value measurement, derivative exposure, and the contrast between the two companies’ disclosures. Despite correct framing and terminology, the critical error in entity disclosure (COST having Level 1 liabilities when it does not) reduces correctness and qualitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 472,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS has 121 million Class A shares outstanding, and all of those shares are fully convertible into Class B shares. Lockheed Martin’s non‑qualified pension trust held $658 million of assets as of December 31 2024.  Thus, the convertible UPS shares total 121 million, while the Lockheed trust assets total about $658 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the number of UPS Class A convertible shares. The ground truth states 4.6 billion shares, but the LLM incorrectly reports 121 million, which is off by over 3,600%. However, the Lockheed Martin nonqualified pension trust asset value of $658 million is correct and matches the ground truth. (2) Quantitative accuracy is severely compromised due to the UPS share count error. The $658 million figure is accurate, but the 121 million shares figure is not. No calculations were required beyond reporting, but the core numeric data is partially wrong. (3) The multi-hop reasoning is structurally sound—the model attempts to address both parts of the question and compare the two figures—but fails due to incorrect data retrieval for UPS. Entity identification is otherwise correct: UPS Class A to Class B convertibility and Lockheed Martin’s nonqualified pension trust are accurately referenced. (4) Contextual relevance is high because the answer addresses both components of the question and attempts a direct comparison. However, the severe inaccuracy in the UPS share number undermines the overall correctness, warranting a low correctness score despite correct structure and one accurate data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 354,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are highly sensitive to interest‑rate moves – a 50‑basis‑point shift would alter the aggregate fair value of the $56.3 billion of notes by roughly $1.7 billion (about $3.4 billion per 100 bps), even though the interest expense itself would not change. Cisco (CSCO) manages comparable exposure with a $0.5 billion interest‑rate swap that is accounted for as a fair‑value hedge; the swap’s gain‑loss essentially offsets the fair‑value change on the hedged portion of its fixed‑rate notes, producing only modest net effects (e.g., a $30 million loss in 2024 versus a $31 million gain in 2023). Thus, while AVGO’s notes show a large fair‑value swing from rate changes, Cisco’s swap hedge neutralizes most of that swing, limiting the impact to a few tens of millions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) All key numbers are correct: AVGO's $56.3 billion fixed-rate debt, $1.7 billion fair value impact from a 50 bps rate increase, and CSCO's $0.5 billion notional interest rate swap are all accurately reported. The implied sensitivity of ~$3.4 billion per 100 bps is a valid extrapolation. (2) The qualitative reasoning is sound: the LLM correctly contrasts AVGO's unhedged exposure with CSCO's use of fair-value hedging via swaps tied to SOFR (implied in 'floating rates' and hedging mechanics). The mention of net effects ($30M loss in 2024 vs $31M gain in 2023) adds detail not in the original but is consistent with hedging effectiveness and does not contradict the ground truth. (3) Multi-hop synthesis is strong—linking AVGO's sensitivity to its large unhedged debt and contrasting it with CSCO's active risk management via swaps demonstrates correct cross-company, cross-strategy reasoning. (4) The only minor shortcoming is that the LLM does not explicitly name SOFR as the floating rate benchmark (though 'floating rates' is sufficient contextually), and the original answer emphasizes CSCO's strategy offsets fair value changes directly, which the LLM captures implicitly but could have stated more precisely. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 399,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "- **Philip Morris International (PM)** – its VAR model uses a “parametric delta‑gamma” approximation **only to capture the observed inter‑relationships between interest‑rate and foreign‑currency movements** and to assess the risk of the underlying interest‑rate‑ and currency‑sensitive derivative positions. The technique is applied to the portfolio of debt, forwards, swaps and options that are primarily interest‑rate‑ and FX‑sensitive.\n\n- **Mondelēz International (MDLZ)** – its VAR model also relies on a parametric delta‑gamma approximation, but **extends it to three separate return distributions – interest rates, currency exchange rates and commodity prices**. The method is used to calculate VAR for each asset class (fixed‑income, currency‑exchange and commodity) and to value currency‑ and commodity‑linked options whose values do not move one‑to‑one with the underlying.\n\nThus, while both firms use the same approximation technique, PM limits it to interest‑rate and FX risk, whereas MDLZ applies it more broadly to interest‑rate, FX **and** commodity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation within VAR models. (1) It correctly identifies that PM applies the technique only to interest-rate and foreign currency movements, while MDLZ extends it to include commodity prices—this aligns with the ground truth. (2) There are no numeric values (e.g., percentages, dollar amounts, specific dates) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the temporal scope (e.g., 'prior quarter', 'four preceding quarters') is correctly implied in the context of VAR calculations, and the LLM does not introduce any incorrect timeframes. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use the same base methodology but differ in scope—MDLZ includes commodity prices and explicitly accounts for non-linear behavior in options, which the LLM captures by noting that MDLZ values 'currency- and commodity-linked options whose values do not move one-to-one with the underlying,' a correct interpretation of non-linear (gamma) effects. (4) The only minor omission is that the original answer explicitly states MDLZ accounts for the non-linear behavior of currency and commodity options, while the LLM implies this through the 'do not move one-to-one' phrasing—semantically equivalent but slightly less precise. Otherwise, entities (PM, MDLZ), financial concepts (VAR, delta-gamma, interest rates, currencies, commodities), and model applications are all correctly identified and contrasted. The answer is fully relevant and directly addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 468,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 2024 filing stresses that “patients around the world deserve access to our life‑saving products, and we are driven to use our local presence and scale to increase the adoption of our products and services in markets around the globe” (MDT 10‑K p. 6). In contrast, Amgen reports that large PBMs such as Express Scripts are demanding deeper discounts and rebates, which have forced the company to cut Repatha’s net and list prices yet still leave many payers imposing utilization restrictions that limit patient affordability and access (Amgen 10‑K p. 38; also p. 37 on Repatha restrictions). Thus, while Medtronic is actively expanding global patient access, Amgen is contending with payer‑driven pricing pressure that hampers affordable access to its therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: Medtronic's 2024 10-K emphasizes global patient access through local presence and scale, and Amgen faces payer pressure from PBMs like Express Scripts, leading to deeper discounts and access restrictions for Repatha. The LLM correctly cites Amgen’s 10-K page 38 (and references page 37) regarding payer restrictions and price reductions. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts Medtronic’s proactive access strategy with Amgen’s reactive challenges due to PBM-driven pricing dynamics. It identifies the role of Express Scripts and similar PBMs in limiting access via formulary restrictions, even though it doesn’t explicitly mention the 'top six PBMs controlling 94%' or 'Medicare patient abandonment' details from the ground truth. These omissions are minor and do not affect the core accuracy. (4) The answer is contextually fully relevant, directly addressing the comparison between Medtronic’s and Amgen’s patient access dynamics. Wording differs but semantic meaning matches. One point deducted from qualitative and overall scores for not fully elaborating on the mechanism by which Express Scripts’ rebate model leads to higher out-of-pocket costs and patient abandonment, which is a key nuance in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 419,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is limited to **Class A and Class C shares** – it does not purchase any Class B stock, even though Class B shares carry **ten votes per share** and can be **converted at any time into Class A shares** (which have one vote each) 【page_81†L1-L5】【page_81†L7-L12】. By targeting only the lower‑voting Class A and non‑voting Class C securities, the repurchase strategy leaves the high‑voting Class B pool untouched, preserving the existing voting power structure. Because Class A shares are also listed and held by other large public investors (e.g., Comcast’s publicly traded Class A stock), reducing the float of Class A could shift voting influence toward those external holders, but the company’s focus on non‑Class B shares suggests it is not seeking to alter its own voting control.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Alphabet's share repurchase strategy focusing on Class A and Class C shares while excluding Class B shares, and accurately explains the conversion rights and voting power structure (10 votes for Class B, 1 vote for Class A). It also correctly notes that Class A shares are publicly traded by another major corporation, referencing Comcast as in the ground truth. However, the LLM answer omits all quantitative details from the original answer: the $62.2 billion repurchased in 2023 and the $36.3 billion remaining authorization as of December 31, 2023. These are key factual elements that were present in the ground truth and directly related to the repurchase strategy. (2) The absence of these numbers results in a significant deficit in quantitative accuracy, even though no incorrect numbers are stated. The model does not fabricate figures but fails to include them entirely, which is a critical omission for a financial question requiring precise data. (3) The multi-hop reasoning is sound: the model correctly synthesizes the implications of not repurchasing Class B shares (preserving voting control), understands conversion mechanics, and connects the public trading of Class A shares by Comcast to broader governance considerations. The logic that avoiding Class B repurchases maintains the existing control structure aligns with the ground truth. (4) Despite strong qualitative reasoning and contextual relevance, the lack of specific dollar amounts and dates prevents a higher correctness score. The answer is semantically close but incomplete on key measurable facts, warranting a 7 for overall correctness, 4 for quantitative accuracy due to missing figures, 8 for strong reasoning, and 9 for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 480,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s use of tight formulary criteria and step‑therapy requirements to curb use of high‑cost biologics such as Amgen’s Repatha shows how payer‑driven restrictions can shrink the eligible patient pool, force deeper discounts and lower net prices. Eli Lilly’s 10‑K repeatedly warns that its biologic revenues are highly dependent on third‑party coverage and patient access; therefore, if UnitedHealth applies similar restrictions to Lilly’s biologics, the company could see reduced utilization, tighter reimbursement terms and weaker revenue growth for those products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UnitedHealth Group's formulary restrictions on high-cost biologics are accurately exemplified by Repatha, and Eli Lilly's dependence on patient access for biologic revenue is correctly cited from its 10-K. There are no numeric values in the question or answers that require verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised. (2) The answer is complete: it addresses how UnitedHealth’s restrictions (like step therapy and prior authorization) limit patient access, references the Repatha case as evidence, and links this to Eli Lilly’s revenue risk through reduced utilization and reimbursement pressure. (3) Entity accuracy is strong: UnitedHealth Group, Repatha (Amgen’s drug), and Eli Lilly are correctly identified; the reference to Lilly’s 10-K aligns with the original answer’s implication that Lilly acknowledges access risks. (4) Multi-hop reasoning is sound—connecting payer power (UnitedHealth) to precedent (Repatha) to potential impact on Lilly’s biologics revenue. The only minor shortcoming is that the original answer emphasizes UnitedHealth’s systemic market power (controlling 94% of prescriptions via top six PBMs), which the LLM omits. While the LLM implies payer influence, it doesn’t quantify or contextualize the concentration of payer power as strongly, slightly weakening the depth of synthesis. However, this does not detract from core correctness. Wording differs but meaning is preserved. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 447,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s 10‑K notes that it maintains a $3 billion commercial‑paper program that can be used to issue unsecured short‑term promissory notes for general corporate purposes; the program is “up to $10 billion” and, although no commercial‑paper notes were outstanding at May 31 2022, the company can draw on it quickly to meet liquidity needs【page_91】.  \n\nCisco’s 10‑K, by contrast, shows that it carries about $9 billion of senior fixed‑rate notes that are recorded as long‑term debt (with a current portion) and are used for general corporate financing; the notes rank pari‑passu with any short‑term borrowings and are subject to interest‑rate risk, reflecting Cisco’s reliance on a larger, existing debt issuance rather than a revolving commercial‑paper facility【CSCO pages 55‑59, 88‑92】.  \n\nThus, while both companies depend on short‑term‑market financing, Oracle keeps a standby commercial‑paper line for rapid, low‑cost funding, whereas Cisco’s exposure comes from a sizable fixed‑rate senior‑note portfolio that functions as the primary source of debt financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Oracle's $3.0 billion commercial paper program and notes that no commercial paper was outstanding as of May 31, 2022, matching the ground truth. It also accurately states Cisco's $9.0 billion in senior fixed-rate notes outstanding as of July 30, 2022 (though the LLM does not specify the exact date, it correctly references the amount and characterizes it as long-term debt). However, the LLM incorrectly states Oracle's program is 'up to $10 billion,' which contradicts the ground truth of a $3.0 billion program—this is a factual error. 2) Quantitatively, the $3.0 billion and $9.0 billion figures are correct, and the absence of outstanding commercial paper for Oracle is accurate. The date for Oracle (May 31, 2022) is correctly cited; Cisco’s date (July 30, 2022) is not mentioned in the LLM answer, a minor omission. The $1.5 billion interest rate swap detail from the ground truth—where Cisco converts fixed to floating rates—is missing in the LLM answer, reducing completeness. 3) The reasoning correctly contrasts Oracle’s flexible, unused short-term commercial paper facility with Cisco’s reliance on larger, structured long-term debt that ranks pari-passu with short-term borrowings. The synthesis across both companies’ debt structures is sound and addresses the shared exposure to short-term financing mechanisms. However, the absence of Cisco’s use of interest rate swaps—a key risk management aspect—weakens the qualitative depth. 4) The answer is contextually relevant, directly addressing the comparison of debt mechanisms. Despite the $10 billion error and missing hedging detail, the core comparison is factually grounded and logically presented, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 472,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The SEC’s decision to keep the ASU 2022‑06 reference‑rate‑reform relief in place through December 31 2024 lets each company continue to treat its existing LIBOR‑linked swaps as qualified hedges. FedEx notes that the optional expedients for LIBOR‑referencing contracts remain available and have not materially affected its results, so it can keep using its fixed‑to‑floating and other interest‑rate derivatives under the same hedge‑accounting methodology. Caterpillar’s match‑funding policy likewise relies on fixed‑to‑floating, floating‑to‑fixed and floating‑to‑floating contracts; the extension of the relief means those LIBOR‑based swaps can remain designated as fair‑value or cash‑flow hedges through 2024, avoiding the accounting and operational disruption that would arise from a forced rate transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 relief is extended until December 31, 2024 — matching the original answer’s date. This is correctly cited in the LLM response, satisfying quantitative accuracy. (2) Entity accuracy is strong: FedEx and Caterpillar are correctly identified with appropriate context — FedEx has not experienced material impact, and Caterpillar uses interest rate contracts as part of its risk management (referred to via 'match-funding policy'). (3) The reasoning is sound and reflects multi-hop synthesis: the extension allows continued use of hedge accounting for LIBOR-linked derivatives, avoiding disruption. The LLM correctly infers that both companies benefit from consistent accounting treatment, even if FedEx hasn't seen material effects. (4) Semantic equivalence is maintained: while the LLM uses more technical terms like 'fair-value or cash-flow hedges' and 'fixed-to-floating swaps', these are consistent with the original answer’s meaning. The only minor gap is that the LLM does not explicitly state that both companies are using the extension to support their transition away from LIBOR — a point emphasized in the original. However, this is implied in the discussion of avoiding forced transition disruption. No calculation errors; all dates and concepts are accurate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 417,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank, N.A. solely as the **administrative agent**, while JPMorgan Chase Bank, N.A. serves as the **syndication agent** and both banks act as joint lead arrangers and book‑managers; the only amendment disclosed was Amendment No. 1 in 2022. In contrast, Caterpillar’s multi‑facility 364‑day credit facilities list Citibank, N.A. as the **agent** (and local‑currency agent) with no separate syndication agent, and the company executed a new 2023 facility and a Japan‑local‑currency addendum to the 2022 facility, indicating amendment activity in both 2022 and 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all dates and roles are accurate: Boeing's amendment occurred on August 25, 2022 (referred to correctly as Amendment No. 1), and Caterpillar's facilities were dated September 1, 2022, with activity in 2023 (new facility and Japan addendum). The roles of Citibank, N.A. as administrative agent for Boeing and agent for Caterpillar are correctly stated, as are the roles of JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger. (2) The LLM correctly identifies that Boeing had only one amendment in 2022, while Caterpillar had amendment activity in both 2022 and 2023, which matches the ground truth. However, the LLM omits mention of MUFG Bank, Ltd. and Citibank Europe plc in Caterpillar’s agreements, which is a notable detail regarding international syndication structure. (3) The reasoning is sound: the model correctly synthesizes information across two companies and multiple years, comparing syndication structures (presence vs. absence of syndication agent) and amendment timelines. It accurately infers that Caterpillar’s structure is more complex due to local currency addenda and multiple facilities. (4) The answer is contextually relevant and directly addresses the comparison in syndication structure and amendment activity. The only shortcoming is the omission of co-agents in Caterpillar’s case, which slightly reduces completeness and qualitative accuracy. Overall, the answer is factually strong and semantically equivalent to the original in key aspects, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 453,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s 10‑K makes clear that its Class B shares carry ten votes each and, together with the founder‑CEO, hold a controlling majority of the voting power, so ordinary Class A investors have little ability to influence corporate decisions (Meta 2023 p. 49).  Comcast also has a dual‑class structure, but its Class B shares (15 votes per share) represent only about one‑third of total voting power and are “share‑for‑share” convertible into Class A stock, which over time can dilute that voting block (Comcast 2023 p. 91).  Because Comcast’s conversion mechanism can eventually reduce the disproportionate influence of Class B holders, it is generally viewed as less likely to erode investor confidence than Meta’s entrenched, non‑dilutable voting control.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between META and CMCSA's dual-class structures with sound reasoning. However, there are minor quantitative inaccuracies that affect precision. The LLM states that Meta's Class B shares have 'ten votes each' and Comcast's Class B shares have '15 votes per share,' but the original answer (ground truth) does not specify vote counts per share for either company—these numbers are not present in the provided ground truth and may not be verifiable from the cited knowledge graph. Thus, introducing specific vote multipliers (10x, 15x) constitutes a factual overreach, even if they align with external knowledge. The ground truth emphasizes that CMCSA’s Class B holds 33⅓% of voting power (which the LLM correctly paraphrases as 'about one-third') and notes the share-for-share convertibility and smaller quantity of Class B shares (9,444,375), which the LLM omits. While the LLM captures the qualitative implications—reduced investor confidence due to concentrated control at Meta versus a potentially self-correcting mechanism at CMCSA through conversion—the omission of the exact number of Class B shares is a minor completeness gap. The reasoning is strong: it correctly synthesizes that CMCSA’s conversion mechanism can dilute voting control over time, contrasting with Meta’s 'entrenched' structure, which aligns with the original answer’s implication about investor confidence. The answer is contextually relevant, directly addressing the comparative impact on investor confidence. Semantic equivalence is mostly preserved, though the added vote ratios introduce unsupported specifics. Hence, high scores for qualitative accuracy and relevance, a moderate deduction for quantitative accuracy due to unverified vote counts, and a slight reduction in overall correctness for partial incompleteness and unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 509,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "In 2021 The Coca‑Cola Company recorded net sales to its equity‑method investees of **$14.471 billion**.  \n\nCoca‑Cola FEMSA’s bottling and distribution footprint includes **Mexico (central, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia (most of the country), Venezuela, Brazil (São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires metropolitan area) and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million is accurately reported as $14.471 billion—this is a correct format conversion (1 billion = 1,000 million), so $14,471 million = $14.471 billion. (2) The regions covered by Coca-Cola FEMSA are completely and accurately listed, with all countries and sub-national regions matching the original answer: Mexico (central, southeast, northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (specified states including parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas, referred to as 'metropolitan area'—semantically equivalent), and Uruguay. (3) The multi-hop reasoning is sound: the model correctly identifies both the financial figure from The Coca-Cola Company's 2021 reporting and synthesizes geographic operational data about Coca-Cola FEMSA, an equity-method investee. (4) All entities—The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA, and the listed countries/regions—are correctly identified and contextually relevant. There are no factual errors, omissions, or misstatements. The answer is concise, precise, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 359,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology revenue fell from $1.168 billion in 2020 to $1.124 billion in 2021 – a drop of roughly 4 percent – as Remicade sales slipped 9 percent (to $299 million) amid biosimilar competition (Simponi was essentially flat at $825 million)【page_61】. By contrast, AbbVie’s flagship biologic Humira, which accounts for a far larger share of its overall sales, is already losing market share to biosimilars in Europe and elsewhere; the company notes that its composition‑of‑matter patent expired in 2016 (EU in 2018) and that it has entered settlement and licensing agreements with biosimilar makers to manage the expected erosion【page_15】【page_13】. Thus Merck’s immunology segment sees a modest, single‑digit revenue dip, whereas AbbVie’s exposure to biosimilar pressure on Humira is much greater because the product represents a core revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports that Merck's immunology revenue declined from $1.168 billion in 2020 to $1.124 billion in 2021 (a ~4% drop), consistent with the impact of Remicade's 9% sales decline in 2021 to $299 million due to biosimilar competition. The mention of Simponi being flat at $825 million adds contextual detail not in the original answer but does not contradict it. For AbbVie, the LLM correctly identifies Humira's patent expiration (2016 in the U.S., 2018 in the EU) and the company's strategy of using settlements and licensing agreements to manage biosimilar erosion—information semantically aligned with the original answer’s emphasis on patent protection and delayed U.S. biosimilar entry. (2) All numbers are accurate: Remicade’s $299 million in 2021 sales, the 9% decline, and the immunology segment revenue figures are correctly cited. The calculation of a ~4% decline in segment revenue is accurate ((1.168 - 1.124)/1.168 ≈ 3.77%). AbbVie’s Humira patent timeline matches the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes Merck’s declining immunology revenue due to Remicade biosimilars and contrasts it with AbbVie’s broader exposure via Humira, correctly inferring relative risk based on product importance and strategic response. (4) The only minor shortcoming is that the original answer notes Remicade’s 20% decline in 2020, which the LLM omits—this is a small completeness gap but does not undermine the correctness of the 2021 focus. Otherwise, the answer is comprehensive, precise, and contextually appropriate, earning high marks across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 462,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s receipt of Garrett’s Series B Preferred Stock was moved into the “investments and long‑term receivables” line of the balance sheet, amounting to **about $423 million** after the December 2021 partial redemption(s) (see page 103). The amendment to the Series B design‑ation that accelerated the first redemption and added a second redemption left the **present value of the remaining unredeemed shares at roughly $207 million** as of December 31, 2021 (see page 102).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key quantitative figures. According to the ground truth, Honeywell received $375 million and 834.8 million shares of Series B Preferred Stock, with a First Partial Redemption of $211 million completed on December 28, 2021. As of December 31, 2021, the present value of the remaining mandatory redemptions was $423 million, which was included in long-term receivables. However, the LLM incorrectly states that the present value of the remaining unredeemed shares was 'roughly $207 million,' which is less than half the correct amount. Additionally, it incorrectly implies that the $423 million on the balance sheet is after the partial redemption, but misattributes this figure to the wrong context. (2) The numbers are significantly off: $207M vs $423M is a critical error. The $211M redemption is acknowledged in the ground truth, but the LLM fails to correctly compute or report the remaining present value. There is no indication in the ground truth that $207 million was a reported or calculated value. (3) The reasoning is partially sound in that the LLM recognizes the movement of the investment into long-term receivables and references redemption events, showing some multi-hop understanding of the indemnification resolution, stock receipt, and redemption schedule. However, it fails to correctly synthesize the financial impact post-redemption, likely confusing the second redemption amount ($200M) with the present value of future payments. (4) Contextual relevance is high—the answer addresses the right companies (Honeywell, Garrett), instrument (Series B Preferred Stock), time frame (December 31, 2021), and financial statement impact. But due to severe quantitative inaccuracies and a flawed final figure, the overall correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 500,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s proxy‑statement shows that the single holder of all 9.44 million Class B shares – Brian L. Roberts – controls roughly one‑third of the company’s voting power (the other two‑thirds belong to the roughly 4 billion outstanding Class A shares) and the Class B shares can be converted into Class A at any time【page_33】.  The 2023 share‑repurchase program, however, bought only Class A stock (262 million shares) and left the high‑voting Class B stock untouched, thereby preserving Roberts’ voting influence【page_33】【page_70】.  Alphabet’s structure is analogous: its ten‑vote‑per‑share Class B stock (which concentrates voting control) is never repurchased, while the company’s $62 billion repurchase program targets only Class A (one‑vote) and non‑voting Class C shares【page_81】, keeping the dominant voting power of the Class B holders unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that Brian L. Roberts owns all of CMCSA's Class B shares, which carry 15 votes per share and represent one-third of voting power, matching the original answer’s '33 1/3%' and '15 votes per share' details. The LLM notes that only Class A shares were repurchased (262 million shares), preserving Roberts’ control—consistent with the ground truth. For GOOGL, it accurately states that Class B shares have 10 votes, are not repurchased, and that the $62 billion repurchase targeted Class A and Class C shares, which matches the original’s '$62.2 billion' (minor rounding to $62 billion is acceptable). The remaining authorization of $36.3 billion is omitted, but this is a minor detail. (2) Quantitatively, all key numbers are correct or acceptably rounded; the 262 million Class A shares repurchased by CMCSA and $62 billion (vs $62.2B) for GOOGL are within reasonable approximation. The 15 votes (CMCSA) and 10 votes (GOOGL) per Class B share are exact. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies use dual-class structures where high-vote shares are held by insiders and excluded from repurchases, thus preserving control while returning capital via repurchases of low-vote shares. (4) The answer is contextually fully relevant, directly addressing the interplay between voting structure and repurchase activity in both firms. The only minor shortcoming is the omission of the exact $62.2B figure and the remaining $36.3B authorization, which prevents a perfect 10. Overall, the answer demonstrates strong factual accuracy, correct synthesis, and appropriate reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 465,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both companies use essentially the same VAR approach. Mondelēz states that the parameters for its normal‑market VAR model are derived from “interest‑rate, currency‑exchange and commodity‑price movements **over the prior quarter**” (and the four prior quarters for average‑year calculations) and that the model uses a **95 % confidence interval** (page 64). Philip Morris describes an identical methodology – it “observes interest‑rate and forward‑currency movements **primarily over the preceding quarter**” (and the four preceding quarters for average/high/low figures) and also applies a **95 % confidence interval** (page 81). Thus, the time‑horizon for the observed rate movements and the confidence level are the same for MDLZ and PM.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies that both MDLZ and PM use a 95% confidence interval and a one-day holding period under normal market conditions, which aligns with the original answer. (2) The time horizons for observing interest rate and currency movements are correctly reported: MDLZ uses the prior quarter for point-in-time VAR and the four prior quarters for average VAR; PM uses the preceding quarter (primarily) for point-in-time and the four preceding quarters for average, high, and low VAR amounts—this is semantically equivalent to the ground truth. (3) The multi-hop reasoning is sound, correctly synthesizing information from both companies' methodologies and comparing them directly. (4) All entities (MDLZ, PM, VAR, confidence interval, time horizons) are accurately referenced, and the conclusion that the methodologies are essentially the same is justified. Minor wording differences (e.g., 'over the prior quarter' vs 'primarily over the preceding quarter') do not affect factual accuracy and reflect appropriate interpretation of source language. No calculation errors or omissions present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 332,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater‑China segment is anchored in physical production – the company notes that “substantially all of the Company’s manufacturing is performed … by outsourcing partners located primarily in Asia, including China mainland” and that Greater China is defined as “China mainland, Hong Kong and Taiwan”【page_9】【page_40】. In contrast, Microsoft’s presence in Greater China is service‑ and software‑focused: a regional operations centre in Singapore “supports … Greater China” and the firm “localizes many of our products to reflect local languages and conventions”【page_16】. Thus Apple relies on China‑Mainland factories for hardware supply, while Microsoft relies on a regional support hub and localized product offerings rather than on‑site manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing as part of its Greater China segment (including China mainland, Hong Kong, and Taiwan), and contrasts this with Microsoft's service- and software-focused presence. The use of direct quotes from the documents (e.g., 'substantially all of the Company’s manufacturing...') supports factual claims and matches the original answer’s emphasis on supply-chain intensity for Apple. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their operational models in Greater China, distinguishing between manufacturing dependency (Apple) and regional support/localization (Microsoft). The mention of Microsoft’s regional operations center in Singapore supporting Greater China is accurate and reflects the correct interpretation of infrastructure versus production. (4) The only minor shortcoming is that the LLM answer does not explicitly name the risks (e.g., trade tensions, tariffs, supply chain disruptions) associated with Apple’s reliance, which the original answer includes for completeness. However, the core contrast—Apple’s supply-chain exposure vs. Microsoft’s customer-facing localization and support infrastructure—is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, addressing all aspects of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 450,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency forwards, swaps and other OTC derivatives with pricing models that draw primarily on market‑observable data—such as current yield curves, spot and forward FX rates and commodity prices—so the contracts are placed in Level 2 of the fair‑value hierarchy. In contrast, GE’s insurance‑contract reserves and pension‑plan obligations are measured with Level 3 techniques because their valuations depend on significant unobservable assumptions (e.g., mortality‑ and morbidity‑rates, long‑term discount rates, cash‑flow projections), which require substantial management judgment. Thus, UPS’s models rely on observable inputs, whereas GE’s valuations are driven by inputs that cannot be directly observed in the market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that UPS uses pricing models with observable inputs (e.g., yield curves, FX rates) for foreign currency derivatives, justifying their Level 2 classification, while GE uses Level 3 techniques for insurance and pension liabilities due to reliance on unobservable inputs. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—but all financial concepts and classifications are correctly represented. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two valuation levels (Level 2 vs Level 3), and two types of financial instruments (derivatives vs insurance/pension liabilities), synthesizing information across domains. (4) The LLM adds slightly more detail (e.g., mentioning OTC derivatives, mortality/morbidity rates, cash-flow projections) that enriches the answer without introducing error. Wording differs slightly but meaning is preserved: 'observable inputs' vs 'market-observable data', 'unobservable assumptions' vs 'inputs not corroborated by market data'. All entities (UPS, GE, Level 2, Level 3, foreign currency derivatives, insurance reserves, pension obligations) are correctly identified and contextualized. No factual errors, omissions, or misrepresentations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 401,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola does not operate its own bottling plants in Hong Kong; the company’s finished‑product sales there are handled by its independent bottling partner Swire Beverages, which is listed among Coca‑Cola’s five largest bottlers and is described as the partner that “has bottling and distribution operations … in Hong Kong” (KO 10‑K, page 7).  \n\nColgate‑Palmolive, by contrast, reports its own results for the Greater China market as part of its Asia‑Pacific segment, showing net sales of $2.867 billion and operating profit of $844 million in 2021 (a 6 % sales increase and a 9 % profit increase, with operating profit equal to 29.4 % of sales) (CL 10‑K, page 42).  \n\nThus, Coca‑Cola’s presence in Hong Kong is dependent on the Swire Beverages bottler, whereas Colgate‑Palmolive records direct, growing sales and profitability in the same market without referencing a bottling partner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Coca-Cola relies on Swire Beverages as its bottling partner in Hong Kong, and Swire is one of its top five bottlers (per KO 10-K, p.7). Colgate-Palmolive reports $2.867 billion (i.e., $2,867 million) in Asia Pacific net sales in 2021 (CL 10-K, p.42), with strong performance in Greater China, particularly in Oral Care. The LLM correctly notes Colgate’s 6% sales growth and 9% profit growth, along with $844 million operating profit (29.4% margin), which are not in the original answer but are factually correct and add valuable context. (2) Quantitative accuracy is perfect: $2.867 billion = $2,867 million, and the percentages and financial figures match the source. (3) Multi-hop reasoning is sound—correctly contrasting Coca-Cola’s indirect distribution model via Swire with Colgate-Palmolive’s direct operational presence and financial reporting in the region. (4) The only minor shortcoming is that the original answer includes Coca-Cola’s 2021 non-U.S. unit case volume (83% of global volume) and Colgate’s 3.0% organic sales growth in Asia Pacific, which the LLM omits. While not critical, including these would have made the comparison more complete. However, the core comparison of strategic models (partner-dependent vs. direct operations) is clearly and correctly conveyed. Thus, the answer is factually excellent, slightly less comprehensive than the original, but semantically equivalent in intent and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 420,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "Bank of America reports its CDO‑type holdings (ABS, CLOs and other VIE‑backed securities) in terms of a **maximum‑loss‑exposure** figure that reflects the worst‑case loss if the underlying assets become worthless and incorporates any downgrade‑related collateral calls (see the “Maximum loss exposure” tables on page 130). JPMorgan, by contrast, values its structured notes with embedded derivatives by **discounted‑cash‑flow models that explicitly price the embedded option (using Black‑Scholes, Monte‑Carlo or similar simulations) and then adjust the result for the firm’s own credit risk (DVA)**, placing the fair‑value measurement in Level 2 or Level 3 of the hierarchy (see page 187). Thus, BAC’s approach is a static loss‑capacity metric, while JPM’s method is a market‑based valuation that models option risk and credit‑risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies BAC's approach to CDOs with embedded derivatives through maximum loss exposure, tied to its investments in VIEs, and notes that these instruments involve credit risk via sold credit protection—consistent with the ground truth. It accurately contrasts this with JPM's valuation methodology, correctly stating that JPM uses discounted cash flow models incorporating Black-Scholes, Monte Carlo, or similar simulation techniques, and adjusts for its own credit risk (DVA). These modeling details and the Level 2/Level 3 fair value hierarchy placement are factually correct and enhance precision. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all references to modeling techniques and valuation frameworks are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms (BAC and JPM), two types of structured products (CDOs vs. structured notes with embedded derivatives), and compares both risk exposure frameworks and valuation methodologies. The conclusion that BAC uses a static risk metric while JPM employs a dynamic, model-driven valuation is a valid and insightful synthesis. (4) The only reason for not scoring a 10 is minor: the original answer mentions the hybrid instrument context and credit protection sold to the issuer more explicitly, which the LLM implies but does not directly state. However, this does not detract from the overall correctness. Wording differs but semantic equivalence is preserved. All entities (BAC, JPM, CDOs, VIEs, DVA, Black-Scholes, Monte Carlo, Level 2/3) are accurate and appropriately used.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 482,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock does **not** carry the normal voting power of a share – holders can vote only on a narrow set of matters (e.g., a merger, a core‑business exit or certain charter amendments) and, when they do vote, their votes are multiplied by the applicable conversion rate 【page 90】. In contrast, every share of Netflix’s common stock gives its holder **one vote on all shareholder matters**, with no such restrictions 【page 61】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, specifying the narrow set of matters (merger, core-business exit, charter amendments), which matches the original answer. It also accurately contrasts this with NFLX's one-vote-per-share structure on all matters. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or share counts), so quantitative accuracy pertains to correct representation of structural metrics—such as 'one vote per share' and the use of the conversion rate in voting calculations—which are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes governance structures from two different companies (CMCSA and NFLX) and correctly contrasts their voting frameworks based on disclosed limitations. (4) The answer is contextually precise, directly addressing the comparison of voting rights as structured in the disclosures, citing relevant page numbers as supporting evidence. Minor wording differences (e.g., 'core payments business' vs. 'core-business exit') do not affect factual accuracy and are within acceptable semantic variation. All key elements—limited vs. full voting rights, conversion rate application, and structural governance—are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 379,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley does not separately price the embedded derivative component of its CDO and CLN holdings; the securities are recorded as trading assets and measured at fair value in aggregate, with the derivative risk treated the same as any other derivative exposure and reflected in the overall fair‑value measurement of the CDO (see MS pages 127‑129). In contrast, JPMorgan Chase values structured notes that contain embedded derivatives by running a discounted‑cash‑flow analysis that explicitly models the embedded option features (using Black‑Scholes, simulation or similar models) and then adjusts the result for its own credit risk (see JPM pages 185‑187).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley does not separately price the embedded derivatives in CDOs and instead measures them at fair value as a whole, which matches the original answer's description of treating CDOs as hybrid instruments with embedded derivatives. (2) It accurately contrasts this with JPMorgan Chase’s methodology, noting the use of discounted cash flow analyses that explicitly model embedded derivative features using models like Black-Scholes and simulation models—this is consistent with the ground truth. (3) The LLM correctly adds that JPMorgan adjusts for its own credit risk (DVA), a detail present in the original answer. (4) The only minor omission is that the LLM does not explicitly mention the credit protection aspect or the risk of non-repayment upon a credit event for Morgan Stanley’s CDOs, which adds contextual nuance to the hybrid instrument treatment. However, this does not undermine the core factual accuracy. (5) All entities (Morgan Stanley, JPMorgan Chase, CDOs, structured notes, embedded derivatives) are correctly identified and compared. (6) There are no numerical inaccuracies—both answers rely on qualitative descriptions rather than specific numbers, so formatting and calculation checks are not applicable. (7) The multi-hop reasoning is sound: the model synthesizes information across two firms and their respective valuation methodologies for similar but differently structured instruments. (8) Semantic equivalence is strong; the LLM conveys the same essential comparison as the ground truth, with slightly more procedural detail on valuation techniques. The answer is fully contextually relevant and directly addresses the comparative methodology question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 485,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that “the expiration or loss of intellectual‑property protection … could … reduce … future revenues and operating income” and that “competitors’ intellectual‑property may prevent Abbott from selling its products” (see pages 12 and 14 of Abbott’s 2022 Form 10‑K).  By contrast, AbbVie – through its subsidiary Forest Laboratories Holdings Ltd. – is actively pursuing patent‑infringement litigation to preserve the exclusivity of Vraylar, a strategy that is intended to protect and sustain the drug’s contribution to AbbVie’s pharmaceutical sales (see page 113 of AbbVie’s 2022 Form 10‑K).  The two disclosures illustrate how IP outcomes are a direct revenue driver: a loss of protection could depress Abbott’s earnings, while successful enforcement helps AbbVie maintain the cash flow from Vraylar.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Abbott's exposure to IP risks is accurately described, including the citation of its 2022 10-K pages 12 and 14, and the financial risk from IP expiration or third-party IP barriers. AbbVie’s enforcement actions through Forest Laboratories Holdings Ltd. to protect Vraylar are correctly noted, with reference to page 113 of AbbVie’s 2022 10-K. (2) Quantitative accuracy is perfect: while no specific dollar figures or dates beyond December 2019 appear in the ground truth, the LLM does not introduce any incorrect numbers. The mention of the 2022 10-Ks is consistent with the timeframe implied in the original answer (litigation initiated in 2019, ongoing into subsequent years). The December 2019 filing date is omitted in the LLM answer, which is a minor omission but does not detract significantly from correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across Abbott and AbbVie, linking Abbott’s general IP vulnerability with AbbVie’s active IP enforcement strategy, and draws a logical contrast in how IP outcomes affect each company’s revenue—negatively for Abbott if protection is lost, positively for AbbVie if enforcement succeeds. (4) Semantic equivalence is strong: the core implication—that IP outcomes directly impact pharmaceutical revenue streams—is clearly conveyed. The only minor shortcoming is the lack of specific detail about the defendants (Sun Pharmaceutical, Aurobindo Pharma) and the court (U.S. District Court for the District of Delaware), which are present in the ground truth but not essential to the central argument. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 488,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedging program is built around specific FX derivatives – it enters into foreign‑currency forwards, cross‑currency swaps (and, where needed, options or foreign‑currency‑denominated debt) to offset the translation risk of its non‑U.S. equity subsidiaries, with the resulting fair‑value changes recorded in the foreign‑currency translation adjustment (CTA) component of AOCI. Morgan Stanley, on the other hand, does not rely on such instrument‑by‑instrument hedges for its trading books; it manages market‑risk exposure chiefly through a Value‑at‑Risk (VaR) model that quantifies potential losses across interest‑rate, equity, FX and commodity positions and is used for limit‑setting, stress‑testing and daily risk monitoring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, and options (or foreign-currency-denominated debt) to hedge net investments in non-U.S. subsidiaries, with fair value changes recorded in CTA within AOCI under ASC 815—this matches the original answer. It also accurately describes Morgan Stanley’s reliance on VaR models to quantify market risk across trading portfolios, including the use of diversification and hedging effects, and notes its application in limit-setting and stress testing. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly contrasts Citigroup’s instrument-specific hedging strategy with Morgan Stanley’s aggregate, model-based risk management approach. However, the LLM omits the mention of Southern Company Gas and its use of weather derivatives, which is part of the original answer and serves as a connecting entity demonstrating broader risk management applications. While this detail is not central to the direct comparison between Citigroup and Morgan Stanley, its absence slightly reduces completeness. (4) Despite this minor omission, the core of the question—comparing Citigroup’s hedging instruments to Morgan Stanley’s VaR-based approach—is thoroughly and correctly addressed, with precise terminology and correct entity attribution. The answer is semantically equivalent to the ground truth on the key comparison, hence a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 451,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive actively hedges its foreign‑exchange exposure by entering into forward, swap **and option contracts** that cover purchases, assets, liabilities and net‑investment positions; the contracts are short‑term (generally ≤ 12 months) and are recorded as cash‑flow or fair‑value hedges (e.g., $1.0 bn of cash‑flow hedges and $1.7 bn of fair‑value hedges as of 12/31/2024) 【page_90】【page_92】. By contrast, Walmart does not use derivative hedges for its currency risk but instead carries large **firm‑commitment purchase obligations** (e.g., $37.2 bn of unrecorded purchase obligations, of which $15.9 bn is due within one year) that are legally binding and must be funded from operating cash 【page_45】. Consequently, Colgate’s option‑based hedging smooths earnings and cash‑flow volatility from FX movements, whereas Walmart’s exposure through firm commitments creates cash‑flow demands that are not offset by hedges, making its cash‑flow profile more susceptible to changes in inventory and utility costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: Walmart's $37.2 billion in unrecorded purchase obligations and $15.9 billion due within one year match the original answer exactly. While the LLM adds specific hedge values for Colgate-Palmolive ($1.0 billion cash-flow hedges, $1.7 billion fair-value hedges as of 12/31/2024), these are not contradicted by the ground truth and may reflect additional detail from the source documents (e.g., page_90, page_92). These additions do not introduce error but enhance specificity. (2) The LLM correctly identifies that Colgate uses option contracts (among other derivatives) to hedge foreign exchange risk, consistent with the original answer’s focus on options. The duration (≤12 months) and purpose (to reduce earnings and cash flow volatility) are accurately described. (3) For Walmart, the answer correctly states the absence of derivative hedges and highlights the risk from legally binding firm commitments, matching the original answer’s emphasis. (4) The reasoning is sound: the multi-hop comparison between Colgate’s proactive hedging (using options) and Walmart’s unhedged exposure through purchase obligations is logically synthesized and directly addresses the question about cash flow stability. (5) Minor deduction in qualitative accuracy due to broadening Colgate’s strategy to include forwards and swaps beyond just options—while factually likely correct, the original answer specifically emphasizes option contracts, so the LLM slightly overgeneralizes. However, since options are included and the core contrast on cash flow impact remains valid, this does not undermine the overall correctness. Semantic equivalence is maintained, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 487,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "Thermo Fisher said it **adopted ASU 2023‑07 in its 2024 annual filing** and applied the rule retrospectively to all prior periods; the adoption added “increased disclosures in Note 11” – a new segment‑reporting note that must show the significant expenses regularly provided to the chief operating decision‑maker, the total of any other items in segment operating results and a qualitative description of those items, plus the CODM’s title, position and how the CODM uses the segment measure.  \n\nCVS disclosed that it **adopted the same ASU on January 1 2024 for its fiscal‑year reporting** (with the interim‑reporting requirement becoming effective for periods beginning after December 15 2024) and, in Note 19, it now must present the same significant‑segment‑expense and “other items” breakdown, a description of those other items, and the CODM’s title, role and use of the segment operating results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and adoption timelines are correct: TMO adopted in its 2024 annual filing (consistent with '2024 annual report' in ground truth), and CVS adopted on January 1, 2024, with interim reporting effective after December 15, 2024—both matching the original answer. (2) The required disclosures are correctly detailed: both companies must disclose the CODM’s title, how segment results are used, and provide breakdowns of significant expenses and 'other items' in segment operating results, as noted in Notes 11 (TMO) and 19 (CVS). (3) The multi-hop reasoning is sound—differences in adoption timing (annual vs. fiscal year start) and scope (retrospective application, inclusion of interim reporting alignment for CVS) are accurately synthesized. (4) The only minor shortcoming is that the LLM slightly over-specifies the disclosures by implying that 'position' and 'role' of the CODM are required for both companies, while the ground truth emphasizes these elements more clearly for CVS. However, this does not constitute a factual error, as such details are generally part of ASU 2023-07 compliance. Wording differs but semantic meaning and factual content are equivalent. All parts of the question—adoption timeline differences and specific disclosures—are fully addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 380,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "- **Accenture (ACN)** – The 2022 Form 10‑K does not attribute any change in its 2021 effective tax rate to the Philippines’ corporate‑income‑tax‑rate reduction; the filing makes no material‑impact disclosure for that jurisdiction.  \n\n- **Advanced Micro Devices (AMD)** – AMD’s 2022 Form 10‑K states that the Philippines’ corporate‑income‑tax‑rate reduction, enacted in the first quarter of 2021, **partially offset** other upward pressures on its tax expense, leaving AMD’s 2021 effective tax rate at **21.8 %** (a 0.1‑percentage‑point increase versus 2020).  \n\nThus, while Accenture reports no discernible effect from the Philippines tax change, AMD explicitly notes a modest, offsetting impact that helped keep its 2021 effective tax rate only slightly higher than the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and reverses the roles of ACN and AMD, leading to a mostly incorrect response. (1) Quantitatively, the LLM incorrectly attributes the 21.8% effective tax rate and the beneficial impact of the Philippines' tax rate reduction to AMD, when the ground truth states this applies to ACN. The 21.8% rate and the offsetting effect of the Philippines tax cut are explicitly tied to Accenture (ACN), not AMD. (2) The LLM claims AMD reported a 21.8% effective tax rate and a beneficial impact from the Philippines reform, but the ground truth states AMD reported *no impact* from tax reform, with a $0 value for that line item. Conversely, the LLM says ACN reported *no impact*, which contradicts the original answer stating ACN *did* benefit from the reduction. (3) The multi-hop reasoning is flawed: the model fails to correctly associate each company with its respective tax treatment and misattributes disclosures. (4) While the question structure is followed (discussing both companies and comparing tax reform effects), the reversal of facts renders the comparison invalid. The contextual relevance is moderate because the answer addresses the right companies and topic, but the substance is factually inverted. Minor formatting like '21.8%' is acceptable, but the core entities and impacts are swapped, resulting in a severe accuracy failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 383,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values the fixed‑income holdings in its pension trusts with pricing models that are anchored to observable market data (interest‑rate curves, yields, broker bids) but that also incorporate adjustments for credit and liquidity risks that are not directly observable. 3M’s approach makes the same distinction explicitly: Level‑2 fixed‑income assets are valued using pricing models that rely on verifiable observable inputs, whereas Level‑3 assets are priced only when observable inputs are unavailable and therefore depend on unobservable assumptions (e.g., projected cash flows and discount rates). Thus, Honeywell’s models blend observable inputs with some unobservable risk adjustments, while 3M separates the two, using observable inputs for Level 2 and relying on unobservable inputs for Level 3 valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell uses pricing models with observable inputs (e.g., interest-rate curves, broker bids) and adds unobservable adjustments for credit and liquidity risks. 3M explicitly categorizes its fixed income investments into Level 2 (observable inputs like yield curves) and Level 3 (unobservable inputs such as projected cash flows and discount rates), which matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the conceptual use of terms like 'observable' and 'unobservable' inputs is precise and consistent with SEC valuation hierarchies. (3) The multi-hop reasoning is sound—correctly comparing two companies' pension investment valuation methodologies across different levels of input observability. The synthesis of how each company treats observable vs. unobservable inputs is logically structured and factually correct. (4) The only minor shortcoming is that the LLM omits mention of both companies using discounted cash flow techniques and the NAV practical expedient disclosure, which appears in the original answer. However, this is a secondary detail and does not undermine the core comparison about input observability. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (by conceptual alignment).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 434,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "At Comcast, each Class B share carries ten (later fifteen) votes and can be converted at the holder’s option into a single‑vote Class A share; the conversion ‑ while it changes the number of shares outstanding ‑ does not dilute the 33 % voting power that Class B holders permanently retain (see CMCSA Note 11‑12, pages 81 & 91). Alphabet’s program, by contrast, simply retires existing Class A (voting) and Class C (non‑voting) shares – 78 million Class A and 450 million Class C in 2023 – shrinking the equity base and modestly raising the proportion of votes held by the remaining Class A shareholders, but it involves no conversion of high‑vote shares and therefore does not alter the fundamental voting‑rights structure (see GOOGL Note 11, page 81).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) It incorrectly states that each Class B share at CMCSA carries ten (later fifteen) votes — the ground truth does not specify vote counts per share, only that Class B holders collectively control 33 1/3% of voting power, which is non-dilutable. This is a major quantitative and conceptual error. (2) The claim that Class B holders 'permanently retain' 33% voting power due to conversion mechanics is misleading; while the structure protects their proportion, it's not accurate to say conversion doesn't affect dilution without clarifying the share-for-share conversion mechanism and its implications. (3) For GOOGL, the LLM cites specific numbers — 78 million Class A and 450 million Class C shares repurchased — but the ground truth provides dollar amounts ($62.2 billion in repurchases, $36.3 billion remaining authorization), not share counts. These figures cannot be verified and appear fabricated or misattributed. (4) The LLM correctly identifies that GOOGL’s repurchases shrink the equity base and increase proportional ownership, and that no conversion of high-vote shares occurs, which aligns with the ground truth. (5) It omits key information: GOOGL’s Class B shares carry 10 votes each and automatically convert to Class A upon sale — a critical point in understanding control dynamics. (6) The reasoning about differing mechanisms — structural voting protection vs. repurchase-driven influence — is partially sound and contextually relevant, but weakened by incorrect specifics. Overall, while the conceptual framework is somewhat aligned, the answer fails on key quantitative and entity-specific facts, warranting a mid-range score due to partial correctness in logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 483,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that, because the WHO Framework Convention on Tobacco Control (FCTC) recommends “partial or total bans on tobacco advertising, marketing, promotions and sponsorships,” the company could face future, possibly‑global advertising restrictions, but most of those rules are still prospective and are already reflected only in U.S. settlement‑agreement limits on brand advertising. In contrast, Philip Morris International reports that several jurisdictions – notably Australia and Russia – have already enacted point‑of‑sale display bans and other advertising prohibitions, forcing PMI to rely on reduced‑risk product platforms and non‑branding communication to reach adult smokers. Consequently, Altria must prepare its international marketing for potentially tighter FCTC‑driven limits, while PMI’s strategy is already oriented toward product‑innovation and alternative channels in markets where advertising bans are in force.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Altria, while acknowledging FCTC recommendations in its 2022 10-K, faces limited direct regulatory impact because the U.S. is not a party to the FCTC, and that current U.S. advertising limits stem from settlement agreements rather than FCTC implementation—this matches the original answer. It also accurately contrasts this with Philip Morris International (PMI), noting that Australia and Russia have already implemented point-of-sale display bans and advertising restrictions, which is factually correct and consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond the 2022 10-K reference, which is correctly cited—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes Altria’s U.S.-centric exposure and future risk with PMI’s current operational reality in FCTC-compliant markets. The conclusion that PMI has already adapted its strategy (e.g., shifting to reduced-risk products and non-branding communication) while Altria faces prospective risk is logically derived and matches the original’s implication about differing marketing strategy constraints. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the U.S. is a signatory but not a party to the FCTC—a nuance present in the original—but this does not undermine the overall correctness. The LLM still correctly conveys the limited current impact on Altria and the more immediate constraints on PMI. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent as all parts of the multi-part question are addressed: FCTC exposure comparison, specific country examples, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 505,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that because the Dodd‑Frank Act (and related Basel rules) imposes higher fees, compliance costs and activity limits on U.S.‑based banks, it may be unable to offer cryptocurrencies and related digital‑asset products that competitors such as JPMorgan can provide 【page_13】.  \n\nMorgan Stanley, by contrast, flags that in many emerging‑market jurisdictions the legal and regulatory framework for securities and financial services is uncertain, evolving and sometimes inconsistent with U.S. law, creating a risk that cross‑border cryptocurrency‑related transactions could be restricted or delayed 【page_24】.  \n\nThus, Goldman Sachs’ disadvantage is a domestic‑regulatory cost and product‑restriction issue versus JPMorgan, whereas Morgan Stanley’s risk stems from broader, foreign‑jurisdiction regulatory uncertainty that could impede its international crypto‑related activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank and Basel rules limiting its cryptocurrency offerings compared to JPMorgan is accurately described, with correct attribution to regulatory burdens. Morgan Stanley's exposure to regulatory uncertainty in emerging markets affecting cross-border crypto activities is also correctly represented. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—both responses reference the 2024 10-K filings implicitly by discussing current risk factors, which matches the context. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (Goldman Sachs and Morgan Stanley), identifies distinct regulatory challenges (domestic compliance burdens vs. foreign regulatory uncertainty), and contrasts their implications for cryptocurrency-related activities. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'higher fees, compliance costs and activity limits' instead of 'compliance burdens'), the meaning is consistent with the original. The only minor shortcoming is that the LLM does not explicitly state that Goldman’s limitations are 'self-imposed' due to U.S. frameworks—a nuance present in the original—but it clearly implies this by attributing the restriction to Dodd-Frank and Basel rules. This small omission prevents a perfect 10 on qualitative accuracy, but overall the response is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 449,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "Both companies had to add the new supplier‑finance disclosure mandated by ASU 2022‑04. 3M adopted the standard on 1 Jan 2023 and, beginning 2024, it now presents a roll‑forward table in Note 16 that shows the confirmed‑invoice balance (≈ $0.3 billion at year‑end) together with the 2024 activity – roughly $1.5 billion of invoices confirmed and $1.5 billion paid (and related adjustments). GE also adopted the same ASU and is required to give the same key‑term, balance‑sheet and roll‑forward information, but because its supplier‑finance program is immaterial, GE’s note (in the supplied pages) only describes the program and does not include a quantitative roll‑forward, indicating that the requirement is satisfied with a narrative disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant factual inaccuracies that impact the overall correctness. (1) Quantitative Accuracy: The LLM incorrectly states that 3M adopted ASU 2022-04 on January 1, 2023. The ground truth does not specify 3M's adoption date, only that the roll-forward began in 2024. More critically, the LLM claims $1.5 billion confirmed and $1.5 billion paid — while the original answer states $1.5 billion of invoices were confirmed and paid during the year, implying a single figure for total activity, not two separate flows. The LLM introduces an unsupported breakdown and implies a net zero change, which is not confirmed. (2) Completeness: The answer addresses both companies and the roll-forward requirement, but misrepresents GE’s disclosure. The original answer states GE *did* begin providing roll-forward information in 2024 as required, while the LLM claims GE omitted quantitative roll-forwards due to immateriality — a detail not present in the ground truth and potentially incorrect. The knowledge graph does not support the claim of immateriality or narrative-only disclosure. (3) Entity Accuracy: Companies (3M, GE) and years (2023, 2024) are correctly identified. The reference to Note 16 in 3M’s filing is plausible but not verifiable from the ground truth provided. (4) Reasoning: The multi-hop synthesis is partially sound — the LLM correctly links ASU 2022-04 to enhanced disclosures and roll-forwards in 2024. However, it incorrectly infers GE’s qualitative treatment based on immateriality, which is not in the original answer, showing flawed reasoning. (5) Semantic Equivalence: The core idea — that both companies are subject to new roll-forward disclosures starting in 2024 under ASU 2022-04 — is aligned. However, the specific details about adoption dates, payment/confirmation amounts, and GE’s disclosure approach diverge factually. These errors reduce confidence in the answer’s reliability despite some correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 537,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 net‑sales table shows that virtually all of its revenue comes from “other countries” ( $32.3 billion of $32.4 billion ) and its risk‑factors section warns that sales outside the United States are vulnerable to “changes in laws or regulatory requirements, changes in local healthcare delivery, payment and reimbursement policies…mandatory price controls, price‑referencing and other government‑driven cost‑containment measures” (MDT – pages 105 & 21).  Amgen’s filing makes the same point for its drug portfolio, noting that in many foreign markets governments impose price caps, health‑technology‑assessment‑based pricing and reimbursement limits that can curb drug‑price increases (AMGN – pages 16‑20).  Because Medtronic’s earnings are concentrated in those same non‑U.S. jurisdictions, it is exposed to regulatory and reimbursement pressures that mirror the international pricing challenges Amgen describes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM reports $32.3 billion in revenue from 'other countries' compared to the ground truth $32.251 billion from 'Total other countries, excluding Ireland'—a negligible rounding difference that does not affect accuracy. The total revenue of $32.4 billion is consistent with MDT's overall fiscal 2024 net sales. (2) The LLM correctly identifies that MDT’s international revenue concentration exposes it to regulatory and reimbursement risks such as price controls, price referencing, and cost-containment measures, citing specific examples from the MDT filing (pages 105 & 21). (3) It draws a valid parallel to AMGN’s exposure in international markets, where governments impose price caps, health-technology assessments, and reimbursement limits (citing AMGN pages 16–20), accurately reflecting the multi-hop synthesis required between MDT and AMGN’s regulatory risks. (4) The reasoning is sound: both companies face similar pressures from non-U.S. payers seeking cost control, despite differing product types. The only minor shortcoming is that the LLM slightly overstates the concentration by implying 'virtually all' revenue comes from other countries, when in fact U.S. revenue is a meaningful portion (the $32.3B is international, but not 'virtually all' of total revenue). However, this does not undermine the core factual and logical correctness. All entities (MDT, AMGN), fiscal year (2024), and regulatory concepts are accurately represented. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 440,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s capital‑buffer requirement is the sum of a 2.5 % stress‑capital buffer (applied to the holding company) and a 2.5 % capital‑conservation buffer for its bank subsidiary, with the counter‑cyclical buffer set at 0 % – a total of **5 % above the minimum risk‑based ratios**. JPMorgan’s buffer is larger: under the Basel III Standardized approach it equals the 5.4 % systemic‑capital buffer plus the 3.0 % G‑SIB surcharge (CCyB 0 %), i.e., **8.4 %**, and under the Advanced approach it is 2.5 % capital‑conservation plus the 3.0 % G‑SIB surcharge, i.e., **5.5 %**. Thus, JPMorgan’s combined buffer exceeds Schwab’s, especially when the Standardized approach is used.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details for JPM. According to the ground truth, JPM has a stress capital buffer (SCB) of 2.9% and a capital conservation buffer (CCoB) of 2.5%, with countercyclical buffer (CCyB) at 0%, totaling 5.4%. However, the LLM incorrectly states JPM's buffer under the Advanced approach as 2.5% + 3.0% G-SIB surcharge = 5.5%, conflating the G-SIB surcharge with the SCB and misrepresenting the components. It further introduces an 8.4% figure under the 'Standardized approach' combining a '5.4% systemic-capital buffer' and 3.0% G-SIB, which is not supported by the ground truth. The ground truth does not mention G-SIB surcharge or different approaches (Standardized vs Advanced), nor does it report a 5.5% or 8.4% total. (2) For SCHW, the LLM correctly identifies the 2.5% stress capital buffer and 2.5% capital conservation buffer, totaling 5.0%, which matches the ground truth. However, it incorrectly frames the stress buffer as applying to the holding company and conservation buffer to the bank subsidiary, adding operational detail not in the source and potentially misleading. (3) The multi-hop reasoning is partially sound in comparing SCHW and JPM’s total buffers, but the synthesis is flawed due to incorrect component values for JPM. The conclusion that JPM has a higher buffer than SCHW is directionally correct (5.5% or 8.4% vs 5.0%), but the magnitude and basis are wrong. (4) The contextual relevance is fair as it addresses the comparison of buffer requirements and mentions relevant buffer types, but introduces extraneous and incorrect regulatory frameworks (Basel III Standardized vs Advanced, G-SIB surcharge) not present in the original data. Thus, while the high-level conclusion is directionally correct, the factual and quantitative inaccuracies severely limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 509,
        "total_tokens": 1869
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.76,
    "average_quantitative_accuracy": 8.33,
    "average_qualitative_accuracy": 7.98,
    "average_contextual_relevance": 9.41,
    "score_distribution": {
      "excellent": 380,
      "good": 85,
      "fair": 94,
      "poor": 41
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 9648.58,
    "timestamp": "2026-02-03T23:06:50.505090"
  }
}